data_2mt9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mt9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.47 143.89 31.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -132.29 145.77 51.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.381 1.872 . . . . 0.0 108.104 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.63 117.52 4.85 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.26 112.35 21.95 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 118.983 1.391 . . . . 0.0 108.054 169.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -106.42 142.9 35.32 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.525 1.13 . . . . 0.0 111.83 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.27 169.14 25.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 110.163 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.14 137.89 7.91 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 168.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -138.75 135.57 34.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.791 1.636 . . . . 0.0 108.076 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -87.19 -28.9 22.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.8 p -108.74 -90.8 0.45 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.8 m -162.03 -11.79 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.546 2.738 . . . . 0.0 113.21 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -62.78 -46.75 86.56 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.979 -1.701 . . . . 0.0 112.272 -167.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -34.51 77.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.3 -48.25 80.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.07 0.948 . . . . 0.0 110.437 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 70.2 mtm -65.99 -40.35 91.1 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.908 -0.495 . . . . 0.0 110.943 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.59 98.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.873 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.68 -48.12 75.63 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.075 0.95 . . . . 0.0 110.634 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -59.11 -44.92 92.02 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.18 -54.51 39.93 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 124.658 1.224 . . . . 0.0 109.024 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -53.03 -56.23 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.888 0.767 . . . . 0.0 109.775 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -38.53 78.14 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.59 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.6 -46.73 74.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 122.878 0.471 . . . . 0.0 111.377 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.5 mt -68.05 -47.18 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.572 1.149 . . . . 0.0 108.504 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.0 mt -70.61 -50.17 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.722 0.809 . . . . 0.0 110.159 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.29 115.13 0.85 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.19 3.7 3.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.396 2.731 . . . . 0.0 112.945 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.4 -34.67 70.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.132 1.373 . . . . 0.0 108.996 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -21.02 3.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -169.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.51 142.47 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 120.909 1.686 . . . . 0.0 108.727 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -132.86 129.73 38.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.399 1.08 . . . . 0.0 109.528 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.37 146.41 48.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.64 0.776 . . . . 0.0 111.666 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -139.39 121.69 15.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.632 1.973 . . . . 0.0 107.301 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -103.72 90.43 3.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.33 -15.13 22.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.089 1.356 . . . . 0.0 114.392 -167.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -12.83 61.71 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -131.73 -35.28 1.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.016 1.326 . . . . 0.0 112.22 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -81.75 145.34 30.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.044 1.338 . . . . 0.0 109.651 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -83.95 143.54 43.23 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.36 -8.04 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.501 2.134 . . . . 0.0 111.072 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -57.21 -35.54 69.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.763 1.62 . . . . 0.0 111.823 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -21.37 66.76 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.261 -0.9 . . . . 0.0 113.194 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -13.32 23.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.673 1.189 . . . . 0.0 112.034 170.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.33 -27.46 61.53 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.626 -1.296 . . . . 0.0 111.043 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.68 -49.46 16.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.853 0.751 . . . . 0.0 110.167 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -65.4 140.83 58.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.944 1.298 . . . . 0.0 108.86 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.84 -31.07 68.72 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.356 0.662 . . . . 0.0 110.755 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.77 144.54 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -133.7 152.32 51.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.53 0.605 . . . . 0.0 110.246 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.66 121.67 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -120.67 137.44 54.46 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 108.991 -172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.33 122.3 3.79 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-O 118.02 -1.434 . . . . 0.0 113.236 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.47 126.07 26.62 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 119.15 1.475 . . . . 0.0 111.829 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -78.51 142.95 18.84 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.433 2.755 . . . . 0.0 109.187 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -92.23 110.09 21.47 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -95.63 171.56 8.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.493 1.117 . . . . 0.0 110.37 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 26.89 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.722 2.809 . . . . 0.0 115.647 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 55.11 76.27 0.27 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.928 1.291 . . . . 0.0 112.481 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.18 16.36 79.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.44 154.5 21.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.458 1.123 . . . . 0.0 108.565 168.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -82.75 153.57 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.04 138.37 44.16 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.89 -24.44 67.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -165.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -87.83 -25.92 23.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.986 0.514 . . . . 0.0 110.606 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -68.46 -39.52 81.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.013 -0.429 . . . . 0.0 110.393 170.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -55.56 -32.87 63.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.023 0.529 . . . . 0.0 111.346 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.91 71.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.424 0.69 . . . . 0.0 111.971 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.7 -12.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.745 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.3 t-105 -54.25 -28.03 38.83 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.529 1.531 . . . . 0.0 112.059 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.44 -46.13 64.47 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.055 1.342 . . . . 0.0 111.227 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -67.56 -32.02 72.5 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.319 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.63 -30.16 62.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.871 1.214 . . . . 0.0 111.445 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.3 -32.41 70.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.634 0.774 . . . . 0.0 111.354 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.85 -22.7 33.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.963 0.905 . . . . 0.0 110.728 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -73.63 159.8 32.53 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.689 1.233 . . . . 0.0 111.341 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -91.52 101.66 14.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.645 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -122.9 3.93 9.41 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.665 1.186 . . . . 0.0 113.215 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -67.03 115.38 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.72 5.12 78.59 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.61 1.576 . . . . 0.0 115.288 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.2 149.98 33.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 118.125 0.963 . . . . 0.0 110.047 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -86.23 139.08 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.09 129.63 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 124.756 1.222 . . . . 0.0 108.925 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.05 118.0 35.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 mt -90.12 143.01 27.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.975 0.807 . . . . 0.0 111.776 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -135.29 156.33 49.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.898 0.879 . . . . 0.0 108.657 168.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.24 162.46 30.59 Favored Glycine 0 CA--C 1.505 -0.546 0 O-C-N 120.874 -1.141 . . . . 0.0 111.939 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.6 153.28 40.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.01 -145.75 5.84 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -151.73 145.13 24.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.157 2.183 . . . . 0.0 108.149 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.58 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -85.95 -31.59 22.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.752 2.021 . . . . 0.0 114.019 172.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.82 -32.93 62.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.356 0.98 . . . . 0.0 112.782 -167.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.71 -19.94 23.3 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 124.843 1.211 . . . . 0.0 111.521 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.502 ' C ' ' H ' ' A' ' 95' ' ' GLU . 25.5 m-85 -126.44 -88.64 0.57 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.189 0.996 . . . . 0.0 108.872 -169.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.46 -50.26 2.43 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 128.295 2.855 . . . . 0.0 107.812 -167.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.7 mm-40 -69.02 -32.66 72.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.483 1.913 . . . . 0.0 110.533 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -111.89 0.83 16.25 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.793 1.237 . . . . 0.0 111.656 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.11 126.33 22.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.71 -1.243 . . . . 0.0 109.897 169.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.61 24.7 9.09 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.719 1.608 . . . . 0.0 113.46 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.76 -41.65 97.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.791 -1.193 . . . . 0.0 110.426 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.441 0.697 . . . . 0.0 111.368 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.33 -46.82 88.68 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.544 0.738 . . . . 0.0 110.927 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.1 95.14 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.6 mtm -68.44 -43.39 77.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 117.74 0.77 . . . . 0.0 112.559 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.519 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -63.82 -33.04 74.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.6 1.091 . . . . 0.0 111.28 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -66.0 -41.03 91.57 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.031 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.93 -31.49 66.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.698 1.999 . . . . 0.0 112.155 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -61.86 -61.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.49 -18.83 56.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.761 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -61.87 -31.11 71.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.145 1.339 . . . . 0.0 111.55 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -22.35 56.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.627 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -82.12 4.73 22.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.518 1.927 . . . . 0.0 112.876 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.05 31.49 78.0 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -82.69 169.82 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -116.8 142.27 47.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -110.04 147.45 33.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.57 1.077 . . . . 0.0 111.723 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.82 178.54 4.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.187 0.995 . . . . 0.0 109.24 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.15 34.22 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.326 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -75.65 151.69 37.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.837 1.818 . . . . 0.0 108.446 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.71 148.27 67.81 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 117.095 -1.431 . . . . 0.0 108.946 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.922 1.365 . . . . 0.0 109.696 168.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.484 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 79.7 p . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.496 1.518 . . . . 0.0 113.692 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -163.53 -59.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.695 0.68 . . . . 0.0 109.283 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.325 3.7 t 54.97 7.73 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.628 2.771 . . . . 0.0 114.173 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.5 p -72.84 146.09 87.48 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.66 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.98 -11.28 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.935 2.423 . . . . 0.0 113.867 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -79.87 -48.07 1.4 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -169.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.61 39.98 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.295 1.997 . . . . 0.0 112.8 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 148.82 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 120.949 -1.094 . . . . 0.0 110.408 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.02 -172.16 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.123 1.769 . . . . 0.0 109.666 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.42 -117.38 0.94 Allowed 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.24 8.36 33.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.016 1.326 . . . . 0.0 112.011 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.36 20.21 20.84 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.352 0.977 . . . . 0.0 112.865 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.31 -17.21 17.39 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.971 1.308 . . . . 0.0 110.779 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.34 144.33 49.56 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.683 0.793 . . . . 0.0 111.026 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.4 m-85 -79.13 154.65 29.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.48 1.512 . . . . 0.0 109.776 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.18 -15.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.492 1.117 . . . . 0.0 112.479 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.35 -178.47 41.19 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.592 1.087 . . . . 0.0 111.698 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.7 135.39 54.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.08 124.56 47.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.66 159.57 34.3 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.515 1.126 . . . . 0.0 109.9 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.63 139.63 29.71 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.525 1.53 . . . . 0.0 107.254 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.21 4.22 16.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.043 1.337 . . . . 0.0 111.048 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -24.06 15.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.21 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -147.42 -30.35 0.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -81.29 9.93 6.33 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.342 0.974 . . . . 0.0 111.871 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -55.07 -20.67 10.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.977 0.911 . . . . 0.0 112.792 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.78 -27.01 57.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.522 0.729 . . . . 0.0 110.934 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.77 -11.72 6.62 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 p -52.56 -35.82 54.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 110.476 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.04 -39.93 87.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.529 1.532 . . . . 0.0 111.466 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -31.66 59.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 109.667 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.16 -29.81 57.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.856 -0.528 . . . . 0.0 109.812 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.37 -57.23 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.04 -43.83 82.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 122.661 0.384 . . . . 0.0 111.746 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -65.72 -34.15 77.54 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.055 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -66.51 -45.2 80.33 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.812 0.815 . . . . 0.0 109.802 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.37 -37.17 72.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.813 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -68.5 -26.69 65.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.199 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.13 -43.52 12.98 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.909 -1.044 . . . . 0.0 112.091 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.8 pt -64.07 -36.4 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.874 1.67 . . . . 0.0 109.85 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.2 -47.7 6.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.3 -35.44 77.36 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.41 0.55 . . . . 0.0 110.225 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.4 mtm -77.9 -43.45 30.04 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.322 1.049 . . . . 0.0 110.601 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.68 73.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.922 0.889 . . . . 0.0 111.252 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.75 -30.76 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.94 1.296 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.542 0.737 . . . . 0.0 110.599 169.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.91 -1.65 56.87 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.719 1.608 . . . . 0.0 113.818 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.089 0.556 . . . . 0.0 110.494 -179.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttm . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.162 0.506 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 147.31 51.6 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 127.946 2.498 . . . . 0.0 106.978 168.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.41 147.07 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.645 1.578 . . . . 0.0 109.0 -166.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.87 119.09 4.78 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.08 108.1 19.08 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -103.73 143.84 32.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.68 1.192 . . . . 0.0 109.998 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -161.09 174.63 13.43 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.956 0.503 . . . . 0.0 109.826 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.17 142.9 9.93 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -140.81 147.19 38.64 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.607 1.163 . . . . 0.0 108.012 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 -29.54 33.08 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 169.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.8 p -104.29 -77.43 0.58 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p 175.66 -7.78 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.997 2.919 . . . . 0.0 110.891 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.46 -44.06 88.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.01 1.732 . . . . 0.0 110.542 -168.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -31.53 70.07 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -64.53 -47.43 78.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.453 1.101 . . . . 0.0 110.207 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.7 mtm -64.11 -40.27 95.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.193 0.451 . . . . 0.0 110.875 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.23 96.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.056 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -47.9 73.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.015 0.926 . . . . 0.0 110.713 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -60.3 -43.78 95.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -63.9 -54.22 38.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.502 1.121 . . . . 0.0 108.974 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -51.52 -56.18 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.039 0.836 . . . . 0.0 109.769 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -39.52 82.6 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.732 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.17 -46.92 69.4 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.424 0.453 . . . . 0.0 111.226 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.45 -48.24 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.25 1.42 . . . . 0.0 108.488 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.0 mt -72.59 -50.16 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.529 0.731 . . . . 0.0 110.513 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.77 114.11 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.392 0.996 . . . . 0.0 110.855 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 4.09 3.36 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.399 2.732 . . . . 0.0 113.056 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.84 -36.12 64.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.553 1.541 . . . . 0.0 109.262 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.74 -26.1 6.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.434 1.893 . . . . 0.0 110.766 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.33 140.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.114 1.779 . . . . 0.0 109.683 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -130.59 129.56 42.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.676 1.19 . . . . 0.0 109.718 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.47 149.87 45.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.072 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -144.88 112.79 6.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.083 1.753 . . . . 0.0 107.393 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -87.21 108.47 18.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.2 mt -66.38 -7.53 19.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -61.92 -27.54 68.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.9 1.227 . . . . 0.0 111.47 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.36 -33.3 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.677 1.191 . . . . 0.0 112.278 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -83.13 140.51 32.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -82.95 142.21 44.55 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -74.07 -8.79 21.5 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.787 1.658 . . . . 0.0 111.037 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -56.3 -36.68 68.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.879 1.672 . . . . 0.0 111.599 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.34 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -11.52 13.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 112.169 170.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.66 -30.83 63.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.589 -1.32 . . . . 0.0 111.24 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -75.19 -47.92 26.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.88 0.764 . . . . 0.0 110.904 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -63.37 146.55 53.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.77 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -71.43 -24.99 62.13 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.852 0.861 . . . . 0.0 110.402 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.5 t -150.47 151.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.687 1.995 . . . . 0.0 106.166 -168.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.19 155.28 50.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.195 0.907 . . . . 0.0 110.219 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.28 122.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 168.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.48 139.76 51.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.62 0.768 . . . . 0.0 109.046 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.07 121.69 2.8 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.802 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.39 136.67 27.38 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 118.49 1.145 . . . . 0.0 110.972 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.13 153.87 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.244 1.963 . . . . 0.0 108.921 166.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -108.94 94.77 5.23 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -83.13 168.67 16.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.324 1.05 . . . . 0.0 111.509 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t0 18.36 69.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 129.395 3.078 . . . . 0.0 115.251 166.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 56.48 67.6 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.581 1.153 . . . . 0.0 111.861 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.6 23.04 77.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -83.21 154.7 24.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.598 1.159 . . . . 0.0 110.12 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.5 mt -96.18 149.14 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -66.78 143.85 56.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.52 -26.77 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.532 0.733 . . . . 0.0 112.119 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -30.45 71.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.418 0.687 . . . . 0.0 110.898 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -82.05 -42.14 19.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.48 1.112 . . . . 0.0 110.404 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.3 -34.91 64.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.388 0.54 . . . . 0.0 110.956 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.49 72.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.05 -13.27 8.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.697 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.518 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.1 t-105 -53.81 -28.68 36.86 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.624 1.57 . . . . 0.0 111.933 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.57 -45.28 59.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.887 1.275 . . . . 0.0 111.055 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.55 -29.86 68.51 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.336 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -56.18 -31.93 63.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.187 1.358 . . . . 0.0 111.111 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.33 -32.58 74.07 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.604 0.762 . . . . 0.0 111.811 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.93 -27.29 43.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.32 0.648 . . . . 0.0 110.518 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.47 157.24 37.99 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.659 1.219 . . . . 0.0 111.376 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -89.9 97.1 10.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.009 -1.905 . . . . 0.0 108.265 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -117.74 3.02 12.31 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 122.194 0.997 . . . . 0.0 113.197 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -68.6 113.01 5.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.23 49.7 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.768 -1.018 . . . . 0.0 115.053 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.57 156.17 29.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.969 1.385 . . . . 0.0 109.282 169.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.49 145.78 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -173.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.1 129.36 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.346 1.458 . . . . 0.0 109.658 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.99 119.53 39.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 166.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.24 141.44 28.7 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.338 0.972 . . . . 0.0 111.49 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -134.7 160.72 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.093 0.957 . . . . 0.0 108.456 168.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.79 40.08 Favored Glycine 0 N--CA 1.442 -0.919 0 O-C-N 120.939 -1.1 . . . . 0.0 111.074 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.54 148.65 48.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.168 -1.016 . . . . 0.0 108.401 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.44 -155.31 8.81 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.15 138.5 13.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.204 1.802 . . . . 0.0 106.437 168.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.467 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -94.03 -24.54 17.58 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 124.02 0.928 . . . . 0.0 112.164 -175.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.72 -51.87 67.54 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.905 0.775 . . . . 0.0 110.946 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.68 -27.13 7.69 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.694 1.14 . . . . 0.0 113.202 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.3 29.37 5.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -168.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.3 -43.1 42.89 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.17 1.35 . . . . 0.0 110.866 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -64.81 -16.46 63.11 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.381 -1.07 . . . . 0.0 112.348 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -130.02 14.03 5.74 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.09 1.756 . . . . 0.0 111.899 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -47.24 127.3 10.51 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.795 2.038 . . . . 0.0 110.56 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 47.36 28.98 1.17 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.902 1.281 . . . . 0.0 112.606 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -63.83 -37.94 89.26 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.804 -1.185 . . . . 0.0 109.815 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.94 74.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.594 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 tp -59.88 -46.03 90.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.888 0.875 . . . . 0.0 110.342 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.54 -41.88 99.65 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.0 mtm -64.86 -43.83 91.71 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.113 0.957 . . . . 0.0 111.463 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.518 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.5 mt -64.43 -35.72 81.83 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 119.623 1.101 . . . . 0.0 111.143 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -64.47 -41.6 96.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.145 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.88 -42.71 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.93 -59.33 4.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.695 1.198 . . . . 0.0 108.406 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.83 -19.83 57.07 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.627 -0.671 . . . . 0.0 110.855 -170.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.3 t -62.39 -29.79 70.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.31 0.959 . . . . 0.0 110.386 169.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.94 -23.58 52.43 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.305 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 111' ' ' LYS . 20.0 mmmt -81.94 4.38 22.79 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.104 1.762 . . . . 0.0 113.172 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.24 33.84 86.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.519 0.6 . . . . 0.0 111.749 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.45 170.45 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 123.522 0.729 . . . . 0.0 109.224 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -115.83 140.07 49.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.82 149.0 30.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.797 1.181 . . . . 0.0 112.213 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.9 m -129.51 -179.63 3.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.218 1.007 . . . . 0.0 109.995 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.35 39.35 26.65 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.085 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -82.67 149.86 27.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.426 1.613 . . . . 0.0 109.339 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.47 146.36 49.58 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.376 -1.297 . . . . 0.0 108.696 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.6 135.06 25.41 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.395 1.397 . . . . 0.0 110.248 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 48.4 p . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 126.219 1.808 . . . . 0.0 112.993 176.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -164.52 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 109.482 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.302 3.0 t 58.5 8.48 0.88 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.757 2.823 . . . . 0.0 114.956 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 148.3 47.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.398 1.479 . . . . 0.0 111.468 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.31 -14.57 3.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.836 2.357 . . . . 0.0 114.644 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -80.46 -50.02 1.13 Allowed Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.31 37.35 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 CA-C-N 122.008 1.753 . . . . 0.0 112.674 -168.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 148.3 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.414 1.086 . . . . 0.0 110.207 -167.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -172.23 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 126.217 1.807 . . . . 0.0 109.514 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.52 -117.31 0.92 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.041 1.336 . . . . 0.0 107.549 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.26 8.33 33.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.775 1.23 . . . . 0.0 111.918 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.59 20.08 20.68 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.483 1.04 . . . . 0.0 112.713 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.62 -16.84 17.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.889 1.276 . . . . 0.0 110.594 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.94 145.09 50.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.457 0.703 . . . . 0.0 110.98 174.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -80.13 154.24 28.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.429 1.492 . . . . 0.0 109.608 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.15 -12.39 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.681 1.193 . . . . 0.0 112.621 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.12 -177.37 44.15 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.682 1.128 . . . . 0.0 111.889 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.3 tp -67.05 133.0 49.03 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.11 56.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.8 mt -117.13 154.52 30.9 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 108.597 170.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.52 101.1 4.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -0.64 54.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.835 0.854 . . . . 0.0 112.548 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.03 -26.01 14.37 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.451 0.569 . . . . 0.0 111.134 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.453 HD22 ' NE2' ' A' ' 90' ' ' GLN . 8.5 p30 -139.84 -27.78 0.76 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -87.94 11.63 15.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.942 0.792 . . . . 0.0 111.449 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -53.66 -25.97 20.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.888 1.222 . . . . 0.0 112.525 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.07 -26.15 56.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 110.954 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 pp -130.61 -6.43 4.13 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 112.957 -169.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.4 m -55.59 -29.65 59.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.084 1.311 . . . . 0.0 109.772 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.28 -41.04 78.99 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.445 1.098 . . . . 0.0 111.743 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -75.88 -31.77 59.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.461 1.104 . . . . 0.0 109.738 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -74.73 -30.84 61.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.32 -59.52 4.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.69 -39.42 80.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.7 m -62.53 -38.95 91.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.943 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -66.74 -44.45 81.51 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.9 m -57.05 -34.82 68.61 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.937 0.895 . . . . 0.0 109.548 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -31.7 72.65 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.618 0.573 . . . . 0.0 110.582 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.38 -45.95 12.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.504 173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 pt -64.18 -38.43 82.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 120.994 1.725 . . . . 0.0 109.833 -170.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.43 -12.26 29.66 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -49.15 5.9 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 125.797 1.639 . . . . 0.0 108.266 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.4 -23.49 67.3 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.252 -170.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 66.9 mtm -94.09 -45.25 7.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.434 1.094 . . . . 0.0 110.979 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.64 49.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.477 0.711 . . . . 0.0 110.823 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -69.4 -28.06 65.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.98 1.312 . . . . 0.0 109.679 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -70.78 -45.71 64.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.814 1.245 . . . . 0.0 110.443 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -22.34 62.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.017 -175.556 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.56 142.78 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -131.67 148.16 52.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.776 2.03 . . . . 0.0 108.488 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.49 118.81 4.93 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.013 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 108.98 19.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.212 1.506 . . . . 0.0 109.838 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -105.57 145.81 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.537 1.535 . . . . 0.0 110.979 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -163.47 175.7 10.5 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.736 0.814 . . . . 0.0 110.231 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.49 141.97 9.2 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 106.502 -2.639 . . . . 0.0 106.502 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -150.03 140.29 22.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.528 1.164 . . . . 0.0 110.891 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -36.37 13.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.692 1.197 . . . . 0.0 110.015 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 p -93.99 -6.64 44.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.217 1.407 . . . . 0.0 112.009 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m 68.05 9.98 7.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.588 1.955 . . . . 0.0 113.091 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -63.83 -45.43 89.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.33 1.423 . . . . 0.0 110.386 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -33.28 74.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.665 0.786 . . . . 0.0 108.918 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.54 -49.55 70.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 109.397 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.45 -38.89 92.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.895 0.316 . . . . 0.0 110.809 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.01 98.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.866 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.09 76.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.956 0.902 . . . . 0.0 110.491 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -59.1 -45.97 89.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.21 -55.79 25.0 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 125.106 1.363 . . . . 0.0 108.831 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.6 mt -52.59 -56.48 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 118.458 0.572 . . . . 0.0 109.967 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -38.5 72.78 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.258 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.47 -46.87 74.92 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.902 0.481 . . . . 0.0 111.339 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.24 -47.85 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.567 1.147 . . . . 0.0 108.854 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -72.13 -49.69 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.702 0.801 . . . . 0.0 110.048 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 115.69 0.86 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.64 3.74 4.06 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.256 2.637 . . . . 0.0 112.689 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.76 -34.53 67.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.11 1.364 . . . . 0.0 109.027 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 -22.7 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.552 1.541 . . . . 0.0 111.641 -169.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.3 140.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 120.479 1.491 . . . . 0.0 108.924 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -131.26 128.96 40.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.206 1.003 . . . . 0.0 109.824 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.19 149.1 47.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.636 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.6 111.67 5.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.193 1.797 . . . . 0.0 107.144 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.43 111.26 20.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.96 -8.19 35.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -60.24 -27.99 67.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.248 0.931 . . . . 0.0 111.584 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -132.42 -33.82 1.25 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.495 1.118 . . . . 0.0 112.122 -171.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -83.05 140.45 32.68 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.177 0.991 . . . . 0.0 108.585 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -83.44 142.23 43.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.23 -4.75 15.79 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.774 1.649 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -55.21 -35.42 64.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.723 1.601 . . . . 0.0 111.977 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -19.34 65.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -12.15 19.6 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.324 1.049 . . . . 0.0 112.326 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.09 -23.35 48.0 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.828 -1.17 . . . . 0.0 111.543 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -75.4 -48.96 20.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -68.98 150.28 47.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.21 1.404 . . . . 0.0 108.381 -170.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -81.96 -23.78 35.92 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 110.502 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.27 144.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.71 156.11 48.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.398 0.679 . . . . 0.0 110.205 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.61 123.59 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.7 138.6 54.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.3 124.79 3.82 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.442 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.49 135.32 27.27 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 118.84 1.32 . . . . 0.0 110.842 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.11 145.44 12.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.793 1.662 . . . . 0.0 108.511 166.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.9 m -90.46 123.49 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -108.11 170.73 7.82 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.455 1.902 . . . . 0.0 110.249 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t0 15.37 69.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 129.542 3.137 . . . . 0.0 115.217 168.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 58.59 67.79 0.9 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.427 1.491 . . . . 0.0 110.401 172.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.66 32.61 70.91 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.354 0.5 OUTLIER -99.15 153.83 18.61 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.625 1.17 . . . . 0.0 109.827 168.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.96 148.87 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -62.38 142.67 57.71 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.85 -28.14 69.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.14 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.69 -29.48 70.03 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.646 0.778 . . . . 0.0 110.509 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -81.94 -42.51 19.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.745 0.818 . . . . 0.0 110.785 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.62 -33.99 64.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.408 0.549 . . . . 0.0 110.872 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.91 73.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.464 1.105 . . . . 0.0 111.838 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.09 -11.31 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.9 t-105 -53.04 -28.8 26.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.846 1.658 . . . . 0.0 111.817 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.71 -45.87 67.28 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.189 1.396 . . . . 0.0 111.414 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.67 -31.97 73.27 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.005 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.5 mt -56.66 -32.47 65.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.709 1.14 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.42 -31.77 71.34 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.47 0.708 . . . . 0.0 111.166 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.95 -16.72 35.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.675 0.79 . . . . 0.0 111.448 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.98 156.3 39.32 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 122.227 1.013 . . . . 0.0 113.47 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -89.12 75.19 7.92 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.766 2.427 . . . . 0.0 106.335 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.301 56.1 tp -118.11 7.32 12.15 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 125.514 1.526 . . . . 0.0 113.606 -165.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -74.15 138.04 43.57 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.406 1.882 . . . . 0.0 109.656 -172.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.69 8.49 86.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 125.599 1.571 . . . . 0.0 114.489 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -90.69 148.81 22.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.953 1.301 . . . . 0.0 109.37 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -84.2 139.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.96 127.95 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 C-N-CA 125.052 1.341 . . . . 0.0 108.828 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.95 115.33 30.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 167.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 mt -86.73 143.19 27.66 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.127 0.876 . . . . 0.0 111.184 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -136.86 158.76 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.77 0.828 . . . . 0.0 109.034 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.63 176.96 41.05 Favored Glycine 0 CA--C 1.508 -0.385 0 O-C-N 120.944 -1.098 . . . . 0.0 112.441 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.36 145.16 50.9 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.29 32.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.93 139.12 23.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.151 1.476 . . . . 0.0 108.625 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.458 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -89.62 -20.24 23.94 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.969 1.308 . . . . 0.0 114.403 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.55 -47.43 69.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.045 1.293 . . . . 0.0 111.25 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.67 -21.03 10.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.086 0.851 . . . . 0.0 112.195 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 41.77 2.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.116 0.967 . . . . 0.0 111.307 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.95 -43.54 72.79 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 125.007 1.289 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.508 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.8 mm-40 -67.33 -26.12 66.35 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -94.0 -10.5 33.38 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.957 2.503 . . . . 0.0 112.628 -171.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -49.57 130.09 20.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.505 2.722 . . . . 0.0 110.913 -169.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 48.91 27.92 1.79 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.228 1.011 . . . . 0.0 112.599 172.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.46 -36.48 84.32 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.03 -1.044 . . . . 0.0 110.023 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.08 77.14 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.641 0.376 . . . . 0.0 111.515 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.95 -48.15 83.15 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 110.009 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.09 97.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.62 -44.65 89.86 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.043 0.922 . . . . 0.0 111.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.4 mt -63.9 -34.54 78.19 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.508 1.049 . . . . 0.0 111.158 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -64.06 -41.91 97.19 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.222 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.59 -31.22 66.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.966 2.106 . . . . 0.0 112.249 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -62.73 -61.87 2.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.2 mt -76.32 -19.75 57.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.39 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -61.15 -31.08 70.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.022 1.283 . . . . 0.0 111.427 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -21.16 54.19 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -83.9 6.02 23.2 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.407 1.883 . . . . 0.0 112.46 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.15 32.2 76.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.41 170.13 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.713 0.805 . . . . 0.0 108.908 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -119.96 142.63 48.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.95 148.73 31.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.916 1.235 . . . . 0.0 111.911 -169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.06 179.56 3.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.275 1.03 . . . . 0.0 108.992 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 36.37 40.0 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-O 118.398 -1.223 . . . . 0.0 113.894 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -79.83 151.55 30.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 119.556 1.678 . . . . 0.0 108.83 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.405 ' HE1' HD13 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -126.28 152.52 73.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.264 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 135.12 33.16 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.292 1.328 . . . . 0.0 109.98 169.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.488 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 55.1 p . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 125.935 1.694 . . . . 0.0 112.902 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.457 -0.106 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -168.54 -48.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 0.0 109.466 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.32 3.3 t 59.74 7.53 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.075 2.95 . . . . 0.0 114.639 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 149.03 56.9 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.954 1.302 . . . . 0.0 112.624 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -90.04 -13.67 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.889 2.393 . . . . 0.0 114.025 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.54 -52.29 2.93 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 117.965 -1.017 . . . . 0.0 113.297 -169.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -85.96 40.07 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 121.695 1.641 . . . . 0.0 112.053 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.19 145.91 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.607 1.163 . . . . 0.0 109.227 -168.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.4 -176.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.78 1.232 . . . . 0.0 112.074 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.94 -110.58 0.53 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 127.026 2.131 . . . . 0.0 109.155 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -99.41 -0.71 40.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.552 1.541 . . . . 0.0 111.958 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.0 26.06 9.95 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.146 -0.971 . . . . 0.0 111.798 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -20.48 13.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.142 1.377 . . . . 0.0 108.444 -175.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.98 138.9 51.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.993 1.317 . . . . 0.0 110.863 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 43.2 m-85 -78.47 151.8 32.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.4 m -63.12 -13.71 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.827 1.251 . . . . 0.0 112.201 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.8 -174.08 42.04 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 119.458 1.026 . . . . 0.0 111.737 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.405 HD13 ' HE1' ' A' ' 119' ' ' TRP . 28.2 tp -64.29 128.63 36.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.07 123.36 47.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.18 156.59 33.39 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.039 1.335 . . . . 0.0 108.363 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.435 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -141.08 123.98 16.24 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -100.78 14.32 32.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.429 1.092 . . . . 0.0 110.824 -169.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.42 -24.3 5.44 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.458 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.49 -48.72 3.06 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.605 1.093 . . . . 0.0 108.39 172.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -104.4 21.88 15.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.434 1.494 . . . . 0.0 112.659 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -53.47 -24.69 13.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.58 -26.01 41.4 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.83 -12.95 8.35 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.043 0.937 . . . . 0.0 112.244 -170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -58.85 -27.48 65.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.84 1.2 . . . . 0.0 110.781 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.87 -47.07 81.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.326 1.05 . . . . 0.0 110.967 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.99 -32.38 72.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.753 0.787 . . . . 0.0 109.485 -171.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -75.18 -27.52 59.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.875 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.34 -55.2 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -51.67 -47.98 63.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.922 0.889 . . . . 0.0 109.853 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -68.08 -35.91 78.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.561 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -64.92 -44.37 89.75 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.452 0.644 . . . . 0.0 109.778 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.3 m -58.88 -36.59 74.88 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.664 0.786 . . . . 0.0 109.474 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -69.72 -29.26 66.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.31 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.73 -46.64 16.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.355 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -64.75 -38.5 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 120.872 1.669 . . . . 0.0 110.21 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.19 -15.34 59.69 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.227 0.611 . . . . 0.0 111.94 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -96.4 -46.16 6.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.15 -41.95 89.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.909 0.777 . . . . 0.0 109.503 -173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.2 mtm -75.67 -37.24 59.74 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.561 0.744 . . . . 0.0 110.938 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.01 -47.15 60.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.926 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.41 -30.72 71.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 110.021 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -63.17 -47.27 83.35 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.463 0.574 . . . . 0.0 110.391 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -3.01 49.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.592 1.157 . . . . 0.0 113.765 -175.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.249 0.477 . . . . 0.0 110.647 178.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.05 144.67 47.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.156 1.382 . . . . 0.0 108.427 169.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.4 mtm -124.01 150.65 44.63 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.935 2.494 . . . . 0.0 108.741 -167.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.43 120.32 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.11 102.98 15.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.621 1.211 . . . . 0.0 110.101 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -102.7 145.57 29.5 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.044 1.338 . . . . 0.0 111.467 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -164.14 172.61 13.48 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.981 0.912 . . . . 0.0 109.897 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.69 137.4 8.23 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 169.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -135.61 130.69 34.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.149 1.38 . . . . 0.0 109.978 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -91.26 -38.33 12.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.93 0.492 . . . . 0.0 110.016 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 p -93.99 -85.69 0.28 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.18 -3.9 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.491 2.717 . . . . 0.0 111.867 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -68.85 -42.83 76.57 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 119.729 -1.857 . . . . 0.0 112.171 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -35.97 82.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -64.68 -49.35 71.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 109.921 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.5 mtm -64.87 -38.71 91.89 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.093 -0.379 . . . . 0.0 111.465 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.15 98.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.0 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.21 79.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.031 0.932 . . . . 0.0 110.61 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -57.64 -47.1 83.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -61.68 -54.41 43.02 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 124.733 1.271 . . . . 0.0 108.995 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.97 -57.02 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.83 0.741 . . . . 0.0 109.691 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -39.11 70.29 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 123.431 0.693 . . . . 0.0 110.339 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.68 -47.7 68.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.801 0.44 . . . . 0.0 111.486 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.7 mt -65.79 -45.5 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 108.51 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.77 -52.1 27.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.913 0.885 . . . . 0.0 110.546 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.72 115.45 0.85 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.83 3.15 4.64 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.451 2.767 . . . . 0.0 112.686 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.09 -34.39 68.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.451 1.5 . . . . 0.0 109.556 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -4.34 4.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.157 1.783 . . . . 0.0 111.95 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.77 144.46 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 120.955 1.707 . . . . 0.0 109.3 167.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -134.91 130.67 36.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.856 1.263 . . . . 0.0 110.31 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.78 149.62 45.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -146.9 108.76 4.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.182 1.793 . . . . 0.0 108.345 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -82.64 112.92 19.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.73 -9.82 22.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -58.95 -29.02 66.84 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.261 0.937 . . . . 0.0 111.624 168.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -129.95 -33.8 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.544 1.138 . . . . 0.0 111.728 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -87.57 142.04 28.15 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.314 1.046 . . . . 0.0 109.192 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -83.78 143.15 43.08 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -74.65 -2.19 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.706 1.604 . . . . 0.0 111.412 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -56.82 -33.83 67.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.094 2.225 . . . . 0.0 112.459 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -18.59 65.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 44.2 ttm -59.17 -14.31 10.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.973 2.109 . . . . 0.0 111.654 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -74.36 -30.4 61.98 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.83 -1.169 . . . . 0.0 110.699 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.48 -48.84 16.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.775 0.716 . . . . 0.0 109.721 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -67.74 134.28 50.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.95 -6.57 48.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.1 t -135.27 140.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 156.47 48.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 118.206 0.457 . . . . 0.0 109.865 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.26 122.56 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 168.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.73 132.66 55.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.12 115.98 2.82 Favored Glycine 0 CA--C 1.511 -0.158 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.484 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 125.15 28.0 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 118.775 1.288 . . . . 0.0 109.347 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.27 143.34 7.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.912 2.408 . . . . 0.0 107.925 168.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -88.56 128.36 35.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -117.65 170.11 9.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.875 1.67 . . . . 0.0 109.688 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 28.21 58.68 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.117 2.567 . . . . 0.0 115.325 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 56.58 73.64 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.666 1.187 . . . . 0.0 112.427 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.98 15.54 76.32 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -82.3 152.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.451 1.12 . . . . 0.0 109.095 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -83.97 153.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.752 -1.574 . . . . 0.0 106.752 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -60.5 141.73 56.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.912 0.863 . . . . 0.0 108.835 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.93 -28.09 68.66 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -79.66 -22.77 43.11 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.822 -0.549 . . . . 0.0 110.289 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -76.63 -43.79 36.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.211 0.604 . . . . 0.0 111.234 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -53.5 -34.9 59.76 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.126 0.57 . . . . 0.0 110.943 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.21 71.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.099 0.96 . . . . 0.0 112.149 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -109.11 -9.32 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.8 t-105 -53.08 -28.93 27.44 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.457 1.503 . . . . 0.0 111.69 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.51 -45.35 72.49 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.825 1.25 . . . . 0.0 111.623 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.9 -27.74 66.91 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.105 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.26 -32.02 67.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.726 1.148 . . . . 0.0 111.062 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.2 -30.36 69.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.536 0.734 . . . . 0.0 111.148 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.53 -11.35 37.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.18 0.992 . . . . 0.0 111.631 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.97 174.02 9.17 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.142 0.973 . . . . 0.0 110.783 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -114.92 103.77 11.26 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.115 1.766 . . . . 0.0 107.582 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.8 8.47 7.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.778 1.231 . . . . 0.0 113.068 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -67.32 116.52 8.18 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.22 9.99 85.33 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.305 1.431 . . . . 0.0 114.847 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -80.59 152.58 28.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.006 0.903 . . . . 0.0 109.693 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HD13 ' CD2' ' A' ' 171' ' ' HIS . 4.2 mt -87.16 141.49 14.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 168.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.11 131.61 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.851 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.14 116.37 30.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.08 142.75 27.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.99 0.814 . . . . 0.0 111.792 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -136.83 159.09 42.9 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.28 175.88 37.87 Favored Glycine 0 N--CA 1.447 -0.573 0 O-C-N 120.884 -1.135 . . . . 0.0 111.934 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -125.44 153.66 43.15 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.82 -155.39 8.96 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -155.69 137.64 14.5 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.081 1.352 . . . . 0.0 108.433 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.511 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -87.43 -22.58 24.89 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 113.845 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.9 mt -67.15 -48.01 69.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.823 1.192 . . . . 0.0 110.638 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.66 -26.28 9.27 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.759 1.171 . . . . 0.0 112.328 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.13 33.55 3.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.57 -42.89 58.61 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.659 1.572 . . . . 0.0 111.131 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -61.63 -18.54 59.89 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 117.694 0.747 . . . . 0.0 112.538 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.67 11.83 7.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.081 1.752 . . . . 0.0 112.563 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.12 122.96 4.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.34 1.456 . . . . 0.0 108.682 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 52.33 28.72 5.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.133 0.973 . . . . 0.0 112.959 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.62 -39.66 94.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.519 -1.363 . . . . 0.0 110.72 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.32 73.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.113 0.565 . . . . 0.0 111.485 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.91 -47.0 87.54 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.067 0.947 . . . . 0.0 110.458 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.85 97.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.9 mtm -66.47 -43.89 84.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.946 0.873 . . . . 0.0 111.717 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.515 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.6 mt -64.93 -34.58 78.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.455 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.7 -41.97 98.03 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.927 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.16 -42.28 89.22 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.536 1.134 . . . . 0.0 111.578 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.67 -58.44 7.5 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.798 1.239 . . . . 0.0 108.292 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.4 mt -78.17 -19.62 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.453 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 t -61.58 -28.8 69.6 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 110.298 168.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -22.94 52.58 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.628 -1.295 . . . . 0.0 109.608 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -83.64 4.66 27.54 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.236 1.814 . . . . 0.0 112.371 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.0 33.42 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.624 0.647 . . . . 0.0 112.032 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.87 170.91 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -115.5 143.18 45.69 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.43 147.01 33.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.936 0.789 . . . . 0.0 111.358 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.0 178.02 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.255 1.022 . . . . 0.0 109.081 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.49 37.26 31.57 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-O 118.615 -1.103 . . . . 0.0 114.126 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -79.32 144.2 34.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.647 1.724 . . . . 0.0 108.628 171.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -121.81 147.32 48.13 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 117.326 -1.321 . . . . 0.0 108.922 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.39 138.59 39.37 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 120.804 1.323 . . . . 0.0 109.596 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.451 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 59.0 p . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.806 1.643 . . . . 0.0 113.383 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.94 -58.88 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 O-C-N 121.767 -0.583 . . . . 0.0 109.709 -170.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.327 2.7 t 58.83 10.15 1.41 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.505 2.722 . . . . 0.0 114.648 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -67.11 139.84 95.46 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.733 -1.229 . . . . 0.0 108.885 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.45 -13.28 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.504 2.136 . . . . 0.0 113.735 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -80.35 -48.84 1.23 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.7 37.65 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.017 1.756 . . . . 0.0 112.737 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 146.52 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 124.243 1.017 . . . . 0.0 109.74 -166.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.41 -172.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 126.024 1.73 . . . . 0.0 109.636 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.73 -116.53 0.86 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.173 1.389 . . . . 0.0 107.528 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.36 8.33 33.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.822 1.249 . . . . 0.0 112.068 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.53 20.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.73 1.157 . . . . 0.0 112.823 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -100.55 -17.33 17.14 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.744 1.218 . . . . 0.0 110.775 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.49 145.26 51.03 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.308 0.643 . . . . 0.0 111.088 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 61.1 m-85 -80.84 155.07 26.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.205 1.402 . . . . 0.0 110.005 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.1 m -66.86 -12.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.802 1.241 . . . . 0.0 112.869 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.11 -179.03 43.53 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 119.659 1.118 . . . . 0.0 112.454 -170.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 25.1 tp -66.06 128.52 36.39 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.68 119.86 40.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -120.4 159.36 25.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.652 1.181 . . . . 0.0 108.728 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.406 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -143.69 122.6 12.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.36 18.42 16.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.673 -169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 -20.49 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.878 0.871 . . . . 0.0 112.873 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.511 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -115.97 -53.51 2.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.198 1.363 . . . . 0.0 108.652 170.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.53 16.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -168.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.72 -26.28 9.07 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.933 0.893 . . . . 0.0 112.504 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.91 -26.81 54.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.175 0.99 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.13 -7.66 9.83 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.414 1.086 . . . . 0.0 112.257 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 m -50.47 -33.82 22.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.761 1.164 . . . . 0.0 110.31 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.49 -41.39 85.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.303 1.041 . . . . 0.0 111.742 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -33.43 65.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.866 1.266 . . . . 0.0 109.796 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -22.9 41.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.769 0.828 . . . . 0.0 110.363 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.16 -60.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.78 -41.81 74.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.366 0.53 . . . . 0.0 112.331 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 60.0 p -66.56 -35.69 80.82 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.053 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.402 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 45.5 t90 -65.46 -43.26 90.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 109.528 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.1 m -58.74 -36.66 74.68 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 123.717 0.807 . . . . 0.0 109.575 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.29 -32.8 73.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.359 0.412 . . . . 0.0 111.175 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -77.14 -45.84 25.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.476 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -65.28 -38.28 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 120.878 1.672 . . . . 0.0 110.415 -173.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.26 -12.32 50.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.54 0.609 . . . . 0.0 112.267 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -95.02 -47.86 6.22 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.45 -35.69 78.32 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.846 0.748 . . . . 0.0 110.69 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.9 mtm -81.48 -39.83 24.18 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.249 1.019 . . . . 0.0 110.518 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.83 63.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.933 0.893 . . . . 0.0 110.916 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.64 -32.08 69.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.872 1.269 . . . . 0.0 109.436 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.416 ' CD2' HD13 ' A' ' 81' ' ' ILE . 61.6 t60 -62.78 -49.86 73.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -3.26 29.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.521 1.129 . . . . 0.0 113.555 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.511 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.92 146.15 51.54 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 126.504 1.922 . . . . 0.0 108.196 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -136.57 146.99 46.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.548 1.539 . . . . 0.0 109.271 -166.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.0 119.45 4.88 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.22 111.46 21.68 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.627 1.213 . . . . 0.0 108.315 169.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -107.3 144.68 33.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 111.167 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -161.79 175.91 11.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.548 0.739 . . . . 0.0 110.716 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.9 11.91 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -140.99 143.78 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.131 1.372 . . . . 0.0 110.58 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -93.29 -39.19 11.11 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.675 1.19 . . . . 0.0 109.857 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -96.56 -85.86 0.33 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 p -173.91 -4.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.97 2.508 . . . . 0.0 112.336 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -66.39 -43.38 86.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.956 -1.715 . . . . 0.0 111.402 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -34.74 76.77 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.61 -49.33 77.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.166 0.986 . . . . 0.0 109.985 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.2 mtm -66.33 -41.21 89.93 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.917 -0.489 . . . . 0.0 110.837 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.33 93.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.687 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.8 77.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.01 0.924 . . . . 0.0 110.553 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -59.13 -44.32 92.02 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.71 -55.04 30.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 124.762 1.288 . . . . 0.0 108.7 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.05 -56.08 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.07 0.85 . . . . 0.0 109.79 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -39.14 82.66 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.814 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.48 -47.76 69.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.042 0.537 . . . . 0.0 111.227 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.31 -47.53 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.014 1.326 . . . . 0.0 108.424 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -48.99 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.669 0.788 . . . . 0.0 110.324 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.49 114.97 0.88 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.25 3.66 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.432 2.755 . . . . 0.0 112.875 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -73.8 -35.62 64.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.334 1.454 . . . . 0.0 109.18 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.96 -27.19 5.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.282 1.833 . . . . 0.0 110.872 -172.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 141.68 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 120.705 1.593 . . . . 0.0 109.569 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 m -133.38 129.83 37.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.572 1.149 . . . . 0.0 109.648 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.38 150.44 45.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.559 0.744 . . . . 0.0 111.921 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -145.64 112.23 5.88 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.423 1.889 . . . . 0.0 107.087 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -87.12 110.86 20.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.17 -8.76 26.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -58.35 -29.24 65.81 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.162 0.892 . . . . 0.0 111.538 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.93 -33.84 1.15 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -82.86 141.43 32.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.121 0.969 . . . . 0.0 108.756 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 m -84.74 141.69 38.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.79 -6.59 18.86 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.651 1.567 . . . . 0.0 111.734 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -55.42 -37.19 67.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.894 1.679 . . . . 0.0 111.706 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -19.3 65.8 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -11.8 16.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 112.534 170.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.61 -31.08 66.52 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 111.376 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.3 -46.29 42.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.722 0.772 . . . . 0.0 110.431 -169.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.99 149.36 50.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.912 1.285 . . . . 0.0 108.719 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -73.61 -25.05 60.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.872 0.869 . . . . 0.0 110.337 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.0 t -151.93 147.55 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.684 1.993 . . . . 0.0 105.929 -168.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.36 158.69 35.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.288 0.949 . . . . 0.0 111.034 168.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.58 121.53 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.38 136.13 54.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.45 120.16 3.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.3 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.5 131.47 24.44 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 119.091 1.445 . . . . 0.0 111.129 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.98 149.25 15.64 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.134 1.89 . . . . 0.0 108.331 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -96.09 128.38 42.94 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -121.11 171.28 8.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 109.84 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 30.65 54.89 0.19 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.983 2.513 . . . . 0.0 115.616 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 56.74 75.78 0.34 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 112.267 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 31.19 68.94 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.458 0.543 . . . . 0.0 114.458 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.19 156.13 17.38 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.727 1.611 . . . . 0.0 109.571 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.93 151.19 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -65.78 142.99 57.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.03 -27.16 68.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.226 -169.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -66.89 -26.15 66.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.883 0.873 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -84.45 -42.85 15.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.165 0.986 . . . . 0.0 110.782 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.42 -34.69 64.65 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.45 0.568 . . . . 0.0 110.978 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.57 71.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.576 1.15 . . . . 0.0 112.237 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.05 -10.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.514 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.1 t-105 -53.75 -28.85 36.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.476 1.51 . . . . 0.0 111.668 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.42 -44.51 67.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.81 1.244 . . . . 0.0 111.338 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.53 -27.94 66.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.438 1.095 . . . . 0.0 112.355 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.7 mt -57.24 -30.06 64.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.755 1.161 . . . . 0.0 111.409 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.95 -32.04 71.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.59 0.756 . . . . 0.0 111.366 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.96 -27.94 39.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 110.805 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.24 160.21 32.6 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.571 1.177 . . . . 0.0 111.431 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.3 96.27 10.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.163 -1.835 . . . . 0.0 108.572 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.0 4.73 13.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.131 0.967 . . . . 0.0 113.132 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -69.37 113.97 7.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.6 55.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.623 -1.098 . . . . 0.0 115.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.89 160.78 25.4 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.25 1.525 . . . . 0.0 109.697 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 mt -94.03 150.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 118.365 0.53 . . . . 0.0 109.993 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.8 t -135.45 127.9 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.59 116.94 32.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.65 141.51 28.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.231 0.923 . . . . 0.0 111.327 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -137.39 162.21 34.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 177.76 38.62 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 121.037 -1.039 . . . . 0.0 111.931 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 mt -122.84 150.04 43.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.89 -157.9 11.49 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -157.33 137.31 12.51 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.031 1.332 . . . . 0.0 107.879 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.633 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -86.86 -21.43 26.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.54 -45.47 65.44 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.622 1.101 . . . . 0.0 110.776 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.94 -29.13 9.33 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.302 0.953 . . . . 0.0 112.423 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.09 33.83 3.87 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.07 -42.61 61.66 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 120.155 1.343 . . . . 0.0 111.29 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.46 -17.42 62.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.825 0.812 . . . . 0.0 112.728 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -127.06 10.45 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.915 1.686 . . . . 0.0 112.342 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -41.96 124.36 2.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.476 1.91 . . . . 0.0 110.393 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 49.47 29.01 2.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.322 1.049 . . . . 0.0 112.72 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.751 -1.218 . . . . 0.0 110.255 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.35 73.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.407 0.283 . . . . 0.0 111.094 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.0 tp -61.69 -46.57 89.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.186 0.994 . . . . 0.0 110.633 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.25 -41.92 98.51 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.2 mtm -65.6 -44.72 85.7 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.616 0.708 . . . . 0.0 111.783 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.514 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.4 mt -64.74 -35.09 79.94 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.161 175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.77 -42.01 97.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.946 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.77 -43.45 88.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.615 1.166 . . . . 0.0 111.69 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -54.19 -58.97 5.37 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.516 1.126 . . . . 0.0 108.486 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.25 -19.05 57.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.741 -170.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 t -62.22 -29.37 70.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.365 0.984 . . . . 0.0 110.51 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -22.16 56.44 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.604 -1.31 . . . . 0.0 109.735 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -84.67 5.5 27.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.089 1.755 . . . . 0.0 112.935 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.05 35.15 90.2 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.25 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 124.326 1.051 . . . . 0.0 109.375 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.54 140.31 52.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -112.49 147.14 37.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 111.206 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.22 -178.96 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 109.335 169.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.6 34.01 41.0 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.006 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.97 146.17 39.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 119.694 1.747 . . . . 0.0 108.354 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 144.82 40.57 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-O 117.319 -1.324 . . . . 0.0 108.467 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.26 138.78 40.27 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 120.691 1.282 . . . . 0.0 109.22 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.455 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 68.0 p . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 125.985 1.714 . . . . 0.0 113.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.22 -46.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.438 1.017 . . . . 0.0 110.453 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.3 3.4 t 59.77 8.6 1.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.764 2.826 . . . . 0.0 115.179 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -90.15 147.86 37.99 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.975 1.31 . . . . 0.0 111.458 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.63 -9.33 5.77 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.955 2.436 . . . . 0.0 114.162 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -72.93 -55.01 4.25 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.26 40.52 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 121.553 1.59 . . . . 0.0 112.413 -168.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.68 149.24 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.588 1.085 . . . . 0.0 110.748 -166.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.27 -172.39 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 126.209 1.803 . . . . 0.0 109.86 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.95 -116.54 0.85 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.099 1.359 . . . . 0.0 107.81 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.28 8.24 33.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.974 1.309 . . . . 0.0 111.89 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.92 20.56 20.95 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.724 1.154 . . . . 0.0 112.618 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -99.43 -18.06 17.65 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.752 1.221 . . . . 0.0 110.782 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 143.35 50.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.231 0.612 . . . . 0.0 110.927 174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 59.0 m-85 -77.68 155.28 31.43 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.232 1.413 . . . . 0.0 109.64 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.18 -14.94 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 112.422 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.91 -178.15 42.72 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 119.763 1.165 . . . . 0.0 111.968 -173.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 13.9 tp -64.76 129.68 40.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.66 110.14 18.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.31 151.32 24.99 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.374 0.669 . . . . 0.0 109.716 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.87 138.02 25.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -107.87 30.84 5.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.132 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 t -133.09 -39.04 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.633 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.6 OUTLIER -88.04 -53.21 4.84 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.937 1.695 . . . . 0.0 106.76 171.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.7 16.89 23.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.015 1.326 . . . . 0.0 112.763 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -52.42 -27.92 17.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.214 0.915 . . . . 0.0 112.562 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.86 -19.57 30.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.996 0.518 . . . . 0.0 111.896 -173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.21 -2.96 7.54 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.968 1.307 . . . . 0.0 112.542 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 p -55.62 -32.39 63.09 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.869 1.213 . . . . 0.0 110.297 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.31 -42.03 90.43 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.401 1.08 . . . . 0.0 111.502 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -33.54 57.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.626 1.17 . . . . 0.0 109.941 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -70.01 -32.88 71.27 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.306 1.042 . . . . 0.0 108.413 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 52.8 mt -67.27 -59.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -58.37 -38.47 77.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.6 m -64.08 -37.8 88.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.667 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.407 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 36.2 t90 -66.5 -44.95 81.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.87 0.843 . . . . 0.0 110.168 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.1 m -56.93 -35.37 68.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.946 0.898 . . . . 0.0 109.72 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -70.76 -30.53 67.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.546 0.529 . . . . 0.0 109.852 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.77 -47.22 15.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.518 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -64.08 -39.71 86.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 CA-C-N 121.132 1.787 . . . . 0.0 110.36 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.62 -14.11 56.54 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.369 0.667 . . . . 0.0 112.136 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.64 -45.98 6.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.37 -42.97 88.17 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.758 0.708 . . . . 0.0 109.525 -173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.5 mtm -76.9 -36.31 56.75 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.45 63.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.133 0.973 . . . . 0.0 109.959 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.52 -32.02 73.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.23 1.412 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.55 -47.78 80.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.161 0.584 . . . . 0.0 110.382 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -6.13 48.03 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.208 1.003 . . . . 0.0 113.707 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 118.785 0.72 . . . . 0.0 110.645 -178.572 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.85 140.29 29.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.99 148.25 47.13 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.632 2.373 . . . . 0.0 108.815 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.55 118.66 4.7 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.01 112.49 23.43 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.945 1.373 . . . . 0.0 108.928 170.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.0 144.86 34.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.159 1.384 . . . . 0.0 111.219 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.51 175.6 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.949 0.899 . . . . 0.0 110.74 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.22 140.51 7.91 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.592 -2.603 . . . . 0.0 106.592 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 141.24 43.3 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.727 1.264 . . . . 0.0 109.444 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -83.25 -40.34 19.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.442 1.097 . . . . 0.0 109.723 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.6 p -96.7 -82.26 0.4 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.622 1.569 . . . . 0.0 107.271 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 p -177.71 -6.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 128.781 2.832 . . . . 0.0 111.619 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.22 -41.26 86.05 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 119.769 -1.832 . . . . 0.0 111.806 -168.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -35.05 74.95 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -63.32 -46.46 86.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.991 0.917 . . . . 0.0 110.326 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.9 -38.85 87.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.011 -0.431 . . . . 0.0 111.044 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.69 93.89 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.683 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.65 -47.22 77.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.041 0.936 . . . . 0.0 110.621 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.64 -44.52 93.49 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.81 -55.43 26.48 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 124.546 1.154 . . . . 0.0 109.112 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.11 -56.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 118.974 0.806 . . . . 0.0 109.719 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.17 77.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.636 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.28 -46.58 73.19 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.013 0.525 . . . . 0.0 111.347 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -67.39 -45.76 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.826 1.25 . . . . 0.0 108.417 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.95 -50.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.765 0.826 . . . . 0.0 110.241 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.51 114.27 0.79 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.489 1.042 . . . . 0.0 110.607 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.56 3.79 3.98 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.532 2.821 . . . . 0.0 112.681 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.8 -34.61 69.52 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.178 1.391 . . . . 0.0 109.194 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 -20.27 4.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.553 1.541 . . . . 0.0 111.602 -169.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.98 143.12 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.958 1.708 . . . . 0.0 109.083 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.6 m -133.68 129.24 36.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.562 1.145 . . . . 0.0 109.76 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.06 149.1 46.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.85 0.86 . . . . 0.0 111.687 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -144.09 112.32 6.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.445 1.898 . . . . 0.0 106.929 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -87.71 110.71 20.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.19 -8.39 31.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -59.77 -28.88 67.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.225 0.92 . . . . 0.0 111.476 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.36 -33.44 1.28 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.418 1.087 . . . . 0.0 112.285 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -83.34 140.6 32.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.218 1.007 . . . . 0.0 108.672 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m -84.88 141.63 38.27 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.05 -5.33 16.89 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.674 1.583 . . . . 0.0 111.764 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -54.06 -38.21 65.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.489 1.495 . . . . 0.0 111.338 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -20.55 66.27 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.116 -0.99 . . . . 0.0 113.16 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -12.23 27.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.331 1.053 . . . . 0.0 112.514 169.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -74.01 -26.26 60.34 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.941 -1.099 . . . . 0.0 110.581 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.31 -50.28 13.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.942 0.792 . . . . 0.0 110.106 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.89 146.16 55.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.575 1.15 . . . . 0.0 108.666 -169.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.72 -25.84 54.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.486 0.66 . . . . 0.0 110.648 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -145.54 140.36 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.09 155.77 41.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.648 0.658 . . . . 0.0 110.769 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.28 121.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 168.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 138.25 54.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.03 122.93 3.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-O 118.076 -1.402 . . . . 0.0 112.687 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 130.14 24.56 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.66 1.184 . . . . 0.0 110.307 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.04 146.69 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.352 2.035 . . . . 0.0 108.368 167.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -93.53 129.35 39.78 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -122.74 172.23 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.228 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 26.25 57.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 128.796 2.838 . . . . 0.0 115.702 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 57.84 76.11 0.34 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.412 1.485 . . . . 0.0 111.722 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.29 73.57 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.75 158.33 21.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.809 1.244 . . . . 0.0 109.68 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.56 151.6 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.02 143.59 57.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.47 -26.74 68.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.141 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -66.67 -26.7 67.17 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.525 0.73 . . . . 0.0 110.74 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -84.64 -42.36 15.43 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.16 0.984 . . . . 0.0 110.702 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.34 -34.34 64.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.206 0.457 . . . . 0.0 111.039 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.257 1.023 . . . . 0.0 112.16 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.04 -10.86 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.506 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.1 t-105 -53.62 -29.02 36.01 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.639 1.576 . . . . 0.0 111.849 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.57 -43.32 69.7 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.989 1.316 . . . . 0.0 111.302 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.62 -29.34 66.82 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.549 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.74 -33.31 68.32 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.17 1.35 . . . . 0.0 110.747 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.84 -29.15 68.99 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.927 0.891 . . . . 0.0 111.795 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -80.96 -24.52 38.03 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.976 0.511 . . . . 0.0 111.256 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -74.21 162.61 28.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.919 1.342 . . . . 0.0 112.23 -168.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -98.41 99.02 10.16 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.568 1.947 . . . . 0.0 108.842 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.8 10.48 15.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.9 121.22 12.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -169.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.75 -0.88 89.38 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.572 1.558 . . . . 0.0 115.17 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -73.75 154.21 39.69 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 118.239 1.019 . . . . 0.0 109.681 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.28 140.67 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.46 130.15 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 124.706 1.202 . . . . 0.0 109.012 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.57 115.5 30.03 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 167.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 mt -86.95 143.02 27.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.869 0.759 . . . . 0.0 111.455 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -137.7 161.27 36.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.24 176.5 39.44 Favored Glycine 0 CA--C 1.506 -0.488 0 O-C-N 120.844 -1.16 . . . . 0.0 112.558 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.6 mt -121.0 153.33 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.91 -153.9 9.22 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -154.02 142.48 20.69 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.973 1.709 . . . . 0.0 108.099 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.541 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -90.58 -23.38 20.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 175.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.14 -36.97 80.53 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.805 1.184 . . . . 0.0 112.027 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.7 -27.51 58.79 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -69.07 0.25 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.674 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.31 -39.54 3.09 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.576 1.56 . . . . 0.0 110.385 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.9 mm-40 -76.71 -35.35 57.91 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.59 -13.43 56.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.879 1.672 . . . . 0.0 111.528 -173.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -50.92 123.87 10.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 126.614 1.966 . . . . 0.0 109.322 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.0 26.71 4.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.259 1.023 . . . . 0.0 112.597 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.88 -37.33 86.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.688 -1.257 . . . . 0.0 110.622 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -32.74 73.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.825 0.45 . . . . 0.0 111.761 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.93 -47.72 85.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.86 -40.83 97.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.7 mtm -65.61 -43.83 88.41 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.829 0.814 . . . . 0.0 112.376 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.506 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.7 mt -63.84 -33.82 76.55 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.567 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.55 -38.27 86.74 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.265 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.46 -30.54 64.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.091 2.156 . . . . 0.0 112.019 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -63.46 -62.01 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.07 -19.1 58.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.028 -0.986 . . . . 0.0 112.577 -166.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.1 p -60.23 -31.35 70.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.75 1.159 . . . . 0.0 111.125 169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -23.11 47.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -77.96 2.16 18.43 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.671 1.188 . . . . 0.0 112.414 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.79 32.88 66.54 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.999 0.818 . . . . 0.0 112.113 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.49 176.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.843 0.857 . . . . 0.0 109.743 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 146.92 47.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 166.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.6 149.01 31.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.991 0.814 . . . . 0.0 111.8 -169.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.39 -179.76 3.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.326 1.05 . . . . 0.0 108.977 169.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.83 33.5 46.18 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.986 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.6 m-30 -78.09 144.04 36.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.765 1.783 . . . . 0.0 108.47 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -119.32 145.43 38.56 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-O 117.344 -1.312 . . . . 0.0 108.662 171.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.16 138.33 43.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.708 1.289 . . . . 0.0 109.215 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.462 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 69.0 p . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 125.661 1.585 . . . . 0.0 113.582 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -164.68 -54.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.867 0.758 . . . . 0.0 109.696 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 3.8 t 57.96 8.18 0.7 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.19 2.596 . . . . 0.0 114.624 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -63.97 140.49 97.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 121.113 -0.992 . . . . 0.0 109.531 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.84 -11.5 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.834 2.356 . . . . 0.0 112.863 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -75.64 -52.35 2.84 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.922 1.237 . . . . 0.0 114.112 -168.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.04 42.02 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.944 1.73 . . . . 0.0 111.609 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.58 150.5 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.815 -1.178 . . . . 0.0 110.147 -167.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.84 -172.38 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 126.11 1.764 . . . . 0.0 109.913 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.4 -116.58 0.81 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.566 1.547 . . . . 0.0 107.487 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.1 8.93 34.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.844 1.257 . . . . 0.0 111.764 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.72 21.13 22.34 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.808 1.194 . . . . 0.0 112.486 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.24 -18.4 17.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.865 1.266 . . . . 0.0 110.586 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.71 142.49 49.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 111.311 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.38 155.5 31.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.182 1.393 . . . . 0.0 109.923 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.97 -12.87 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.601 1.16 . . . . 0.0 112.428 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.22 -178.85 43.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 119.907 1.23 . . . . 0.0 112.322 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 18.9 tp -65.46 130.26 42.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.09 117.71 33.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.9 mt -113.9 152.08 31.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.92 0.888 . . . . 0.0 108.723 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.59 128.22 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -102.47 17.89 22.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.59 1.156 . . . . 0.0 110.408 -171.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.62 -21.55 5.65 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.541 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.4 OUTLIER -112.71 -49.02 2.96 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.03 1.332 . . . . 0.0 108.25 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.55 19.31 20.59 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.107 1.363 . . . . 0.0 113.664 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -52.96 -22.99 6.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.58 -25.35 30.99 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.857 0.863 . . . . 0.0 111.864 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -120.56 -10.13 9.29 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -55.36 -32.41 62.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.096 1.316 . . . . 0.0 110.854 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.59 -40.42 83.13 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.603 1.161 . . . . 0.0 111.731 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -31.75 62.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.291 1.037 . . . . 0.0 109.786 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -78.88 -28.97 44.16 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.7 mt -63.12 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -58.0 -41.58 83.37 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.2 m -63.23 -37.05 85.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.772 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.401 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 42.4 t90 -67.12 -44.37 80.07 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.716 0.77 . . . . 0.0 110.22 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.3 m -57.11 -36.13 70.26 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.087 0.955 . . . . 0.0 109.506 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.78 -29.02 66.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.338 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.03 -46.55 16.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.318 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.7 pt -64.43 -38.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.961 1.709 . . . . 0.0 110.271 -171.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.2 -15.59 60.24 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.228 0.611 . . . . 0.0 112.036 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -95.92 -46.39 6.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.66 -40.43 83.47 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.711 0.687 . . . . 0.0 109.755 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.19 -37.99 36.92 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.737 0.815 . . . . 0.0 110.983 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.01 -46.77 70.32 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.008 0.923 . . . . 0.0 109.901 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.62 -29.88 69.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.106 1.362 . . . . 0.0 109.777 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -63.6 -48.47 77.21 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.553 0.615 . . . . 0.0 110.506 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.52 50.1 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.414 1.086 . . . . 0.0 113.741 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.485 178.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 119.704 -0.188 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.56 140.62 30.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -129.27 146.78 51.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.648 1.979 . . . . 0.0 108.947 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.27 117.63 4.77 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.597 -1.113 . . . . 0.0 110.445 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.82 113.32 23.37 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 119.254 1.527 . . . . 0.0 108.354 169.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -108.87 145.04 35.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.913 1.285 . . . . 0.0 111.442 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -159.96 173.35 16.02 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.652 0.781 . . . . 0.0 109.927 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.49 139.95 8.66 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -141.48 131.85 25.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.395 1.478 . . . . 0.0 108.837 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.7 m -84.29 -28.93 26.79 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.741 0.246 . . . . 0.0 110.739 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.1 p -112.47 -79.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.448 1.099 . . . . 0.0 108.165 -172.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.8 p -173.04 -13.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.18 -42.64 79.65 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 119.711 -1.868 . . . . 0.0 113.333 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -34.38 77.77 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.48 -49.25 76.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.454 1.102 . . . . 0.0 109.866 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.3 mtm -66.34 -41.83 89.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.346 0.521 . . . . 0.0 111.182 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.19 94.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.005 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.48 77.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 123.863 0.865 . . . . 0.0 110.436 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.88 -44.26 91.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -63.39 -54.93 29.1 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 124.79 1.306 . . . . 0.0 108.996 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.07 -56.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.956 0.798 . . . . 0.0 109.716 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -39.11 83.02 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.3 -46.92 72.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.939 0.496 . . . . 0.0 111.227 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -66.17 -46.62 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.962 1.305 . . . . 0.0 108.596 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 83.3 mt -72.66 -50.23 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.93 114.34 0.78 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.399 1.0 . . . . 0.0 110.67 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.12 4.03 3.57 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.494 2.796 . . . . 0.0 112.814 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.56 -34.05 64.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.505 1.522 . . . . 0.0 109.149 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.26 -22.77 3.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.772 1.629 . . . . 0.0 111.409 -169.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.16 140.73 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.657 1.571 . . . . 0.0 109.091 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.5 m -130.17 129.09 43.0 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.485 1.114 . . . . 0.0 109.679 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.42 148.96 46.39 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.481 0.712 . . . . 0.0 111.942 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -142.88 110.46 5.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.429 1.892 . . . . 0.0 106.621 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -86.74 110.65 20.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.0 -8.07 20.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -60.62 -28.04 68.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.25 0.932 . . . . 0.0 111.729 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -132.33 -33.97 1.25 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.77 1.228 . . . . 0.0 111.886 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -82.73 140.77 32.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.091 0.957 . . . . 0.0 108.565 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 m -83.96 140.82 40.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -74.13 -1.9 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.163 1.451 . . . . 0.0 110.983 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -56.36 -33.97 66.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.246 2.293 . . . . 0.0 111.921 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -19.36 64.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.0 ttm -58.17 -16.34 13.13 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.266 2.226 . . . . 0.0 111.702 169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -73.65 -31.14 63.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.056 -1.027 . . . . 0.0 110.795 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -78.16 -47.07 18.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.341 0.591 . . . . 0.0 110.019 -169.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -65.84 140.33 58.38 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.58 -169.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.5 -17.16 56.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.41 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.55 149.9 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 126.434 1.893 . . . . 0.0 106.069 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.1 mt -138.34 151.31 47.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.667 0.787 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.36 121.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.0 135.75 54.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.19 122.79 4.37 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-O 117.773 -1.57 . . . . 0.0 113.12 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 126.61 25.78 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 119.286 1.543 . . . . 0.0 110.63 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.44 144.66 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.689 2.259 . . . . 0.0 107.799 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -87.81 131.27 34.59 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.98 169.47 10.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.22 1.808 . . . . 0.0 109.62 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 28.85 54.67 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.275 2.63 . . . . 0.0 115.319 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 55.98 78.73 0.19 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.312 1.445 . . . . 0.0 112.23 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 13.49 76.11 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.07 160.8 19.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.555 1.142 . . . . 0.0 109.125 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 mt -92.18 154.64 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -59.13 140.82 55.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.99 0.916 . . . . 0.0 108.787 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.83 -28.92 69.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -80.33 -20.95 43.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.642 -0.661 . . . . 0.0 110.58 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -77.0 -44.31 31.44 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.83 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -53.33 -35.85 60.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.473 0.709 . . . . 0.0 110.751 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.4 71.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.008 0.923 . . . . 0.0 112.209 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.44 -9.78 11.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.529 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.6 t-105 -53.32 -29.46 33.84 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 111.71 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.32 -44.76 74.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.959 1.304 . . . . 0.0 111.459 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -68.48 -29.67 68.34 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.113 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.5 mt -57.65 -31.06 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.995 1.27 . . . . 0.0 111.122 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.56 -28.95 65.3 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.499 0.72 . . . . 0.0 111.205 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.02 -23.34 38.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.139 0.576 . . . . 0.0 111.173 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 mt -72.94 157.84 36.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 123.038 1.399 . . . . 0.0 112.878 -167.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -90.94 91.53 8.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.738 -2.028 . . . . 0.0 107.978 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -111.38 11.63 21.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.84 128.33 35.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.06 30.86 69.57 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.294 0.95 . . . . 0.0 114.469 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.91 156.68 34.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.59 1.195 . . . . 0.0 109.633 169.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.4 mt -88.63 146.81 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.37 130.17 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.084 1.354 . . . . 0.0 109.263 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.06 117.93 35.07 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.05 143.13 27.05 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.389 0.995 . . . . 0.0 112.085 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -136.38 156.04 49.19 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.229 1.011 . . . . 0.0 109.13 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.55 164.54 35.16 Favored Glycine 0 CA--C 1.506 -0.475 0 O-C-N 120.801 -1.187 . . . . 0.0 112.154 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.4 158.63 36.79 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.57 -137.75 3.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.5 150.81 21.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.535 1.934 . . . . 0.0 108.046 168.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -89.08 -31.29 18.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.919 1.688 . . . . 0.0 114.149 173.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.6 -33.25 62.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.487 1.04 . . . . 0.0 113.082 -167.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.52 -19.33 35.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 124.788 1.185 . . . . 0.0 111.206 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.499 ' C ' ' H ' ' A' ' 95' ' ' GLU . 26.8 m-85 -126.85 -90.07 0.54 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.547 1.139 . . . . 0.0 108.721 -170.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.59 -50.8 2.55 Favored Glycine 0 N--CA 1.464 0.555 0 C-N-CA 128.517 2.96 . . . . 0.0 107.755 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 93' ' ' TYR . 12.3 mm-40 -69.65 -30.63 68.38 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.67 1.988 . . . . 0.0 110.536 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -115.14 0.73 13.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.75 1.22 . . . . 0.0 112.021 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.91 127.04 24.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.883 1.273 . . . . 0.0 109.545 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 56.28 23.8 7.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.57 1.548 . . . . 0.0 113.666 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.74 -36.78 78.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.551 -1.343 . . . . 0.0 110.698 -171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.64 72.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.104 0.561 . . . . 0.0 111.467 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.38 -46.76 88.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.799 0.84 . . . . 0.0 110.756 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.52 96.44 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.8 mtm -66.07 -44.94 83.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 117.712 0.756 . . . . 0.0 112.152 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.529 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.2 mt -64.33 -32.82 74.58 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.606 1.094 . . . . 0.0 111.807 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -63.53 -40.11 96.17 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.109 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.0 -36.13 69.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.758 1.623 . . . . 0.0 112.204 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.4 tptt -57.42 -47.03 82.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.688 0.795 . . . . 0.0 109.894 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -93.76 -20.65 19.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.037 -0.983 . . . . 0.0 112.33 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.2 p -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.748 1.613 . . . . 0.0 111.665 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -79.15 -17.43 55.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.071 0.548 . . . . 0.0 110.059 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -79.54 1.42 25.96 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.114 1.366 . . . . 0.0 111.943 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.01 34.79 58.34 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.941 0.792 . . . . 0.0 111.908 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.43 171.9 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.961 0.904 . . . . 0.0 109.787 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -121.09 142.91 49.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.44 150.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.903 1.229 . . . . 0.0 111.999 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.88 -178.66 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.649 1.179 . . . . 0.0 109.157 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 33.9 43.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-O 118.417 -1.213 . . . . 0.0 113.977 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -71.8 147.32 47.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.437 1.619 . . . . 0.0 107.784 170.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.66 144.98 51.69 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.236 169.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -69.58 140.12 42.57 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-N 121.012 1.397 . . . . 0.0 109.472 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.474 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 59.4 p . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 125.568 1.547 . . . . 0.0 113.555 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -167.15 -57.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -170.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 2.9 t 56.2 7.52 0.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.844 2.858 . . . . 0.0 114.364 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -69.61 144.17 93.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 120.991 -1.068 . . . . 0.0 110.515 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.84 -14.5 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.722 2.281 . . . . 0.0 113.76 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -80.53 -48.98 1.18 Allowed Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.26 39.33 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.383 2.056 . . . . 0.0 112.579 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 148.43 21.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 109.589 -167.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -172.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.998 1.719 . . . . 0.0 109.666 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.85 -116.37 0.84 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.135 1.374 . . . . 0.0 107.306 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.38 7.8 33.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 112.202 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.28 20.13 18.85 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.996 1.284 . . . . 0.0 112.475 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.02 -17.11 17.66 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.686 1.194 . . . . 0.0 110.668 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 144.04 50.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 110.879 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 50.4 m-85 -78.26 154.87 30.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.953 1.301 . . . . 0.0 109.246 174.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.44 -14.91 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.15 -176.31 40.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.561 1.073 . . . . 0.0 111.901 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 16.3 tp -65.66 129.55 40.17 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.22 129.66 55.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.9 mt -130.47 158.68 39.24 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.724 1.61 . . . . 0.0 109.215 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.42 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -137.0 125.6 23.71 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.025 176.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -98.91 6.35 46.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.534 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -20.7 11.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.244 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.23 -42.33 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 112.675 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.13 7.2 19.6 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.091 0.86 . . . . 0.0 112.808 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -55.58 -21.55 17.89 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.522 1.056 . . . . 0.0 113.088 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.57 -25.61 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 111.536 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -129.26 3.8 5.19 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.08 0.952 . . . . 0.0 112.446 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -50.96 -29.4 12.11 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.81 -1.181 . . . . 0.0 110.842 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.36 -39.29 94.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.747 1.619 . . . . 0.0 110.604 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 16.2 mm-40 -72.28 -46.35 56.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 129.374 3.07 . . . . 0.0 108.194 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -25.39 62.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.841 -1.981 . . . . 0.0 108.273 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.28 -62.33 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -57.17 -37.34 71.96 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.2 m -63.53 -38.39 90.93 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.428 0.455 . . . . 0.0 110.751 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -66.52 -44.56 82.13 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.438 -0.788 . . . . 0.0 110.179 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 72.8 m -55.89 -35.53 66.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.553 0.741 . . . . 0.0 109.809 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -33.58 76.28 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.485 0.491 . . . . 0.0 110.259 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -81.93 -46.14 14.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.498 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.3 pt -64.55 -39.47 85.69 Favored 'Isoleucine or valine' 0 C--N 1.337 0.061 0 CA-C-N 121.417 1.917 . . . . 0.0 109.977 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.6 -14.25 57.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -96.44 -45.65 6.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.885 1.274 . . . . 0.0 107.888 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.29 -41.08 88.13 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.886 0.767 . . . . 0.0 109.724 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.37 -35.65 54.32 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.169 0.988 . . . . 0.0 110.951 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.48 -47.32 42.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.335 1.054 . . . . 0.0 110.004 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.53 -29.56 68.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.405 1.482 . . . . 0.0 110.129 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -60.66 -45.78 92.82 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.266 0.485 . . . . 0.0 110.302 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.78 -1.63 58.09 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 114.055 -174.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.422 177.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 145.26 30.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.876 1.27 . . . . 0.0 108.636 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.8 mtm -130.45 147.25 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.127 1.771 . . . . 0.0 108.984 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.4 118.63 5.07 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 118.81 -0.995 . . . . 0.0 110.947 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.09 105.9 18.12 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.86 1.33 . . . . 0.0 109.952 171.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -105.0 145.74 30.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.47 1.508 . . . . 0.0 111.301 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -164.93 175.47 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.007 0.923 . . . . 0.0 110.431 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.91 142.33 10.02 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 168.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -146.52 147.69 31.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.25 1.025 . . . . 0.0 111.401 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -95.79 -45.89 6.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.543 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.5 p -90.19 -10.93 42.6 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.006 1.722 . . . . 0.0 111.41 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.276 44.5 m 73.64 13.67 4.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.2 2.2 . . . . 0.0 113.697 -168.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.6 -44.2 94.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.593 1.542 . . . . 0.0 110.764 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -34.29 77.28 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -64.45 -49.07 72.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.409 1.084 . . . . 0.0 109.99 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.8 -38.89 92.51 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.94 -0.475 . . . . 0.0 111.151 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.76 97.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.848 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.13 79.03 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.776 0.83 . . . . 0.0 110.611 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.37 -46.74 83.06 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.903 0.481 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.32 -54.86 34.44 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 124.732 1.27 . . . . 0.0 108.923 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mt -53.41 -56.87 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 118.447 0.567 . . . . 0.0 109.584 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -38.99 72.81 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.343 0.657 . . . . 0.0 110.539 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.62 -48.1 67.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.992 0.517 . . . . 0.0 111.201 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.8 mt -64.64 -47.11 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.996 1.318 . . . . 0.0 108.8 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.5 mt -72.58 -51.55 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.783 0.833 . . . . 0.0 110.52 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.67 115.59 0.76 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.44 3.54 4.11 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.29 2.66 . . . . 0.0 112.98 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.73 -35.12 65.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.25 1.42 . . . . 0.0 108.966 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -26.96 5.57 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.067 1.747 . . . . 0.0 111.369 -173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.47 140.43 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 120.781 1.628 . . . . 0.0 109.088 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.7 m -129.91 129.62 44.1 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.54 1.136 . . . . 0.0 110.073 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.79 148.99 47.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.875 0.87 . . . . 0.0 112.154 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -145.21 108.84 4.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.697 1.599 . . . . 0.0 107.762 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -82.31 112.03 18.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.77 -9.44 36.92 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -59.12 -28.49 66.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.422 1.01 . . . . 0.0 111.509 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.64 -34.22 1.56 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.473 1.109 . . . . 0.0 112.112 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.26 140.2 33.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 m -82.95 139.72 42.97 Favored Pre-proline 0 N--CA 1.452 -0.358 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.81 -1.62 11.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 121.172 1.454 . . . . 0.0 111.425 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 122.153 2.251 . . . . 0.0 111.713 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -18.78 64.68 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.91 -15.62 13.66 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.993 2.117 . . . . 0.0 111.971 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.1 -32.99 63.45 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.191 -0.943 . . . . 0.0 110.601 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.62 -48.11 28.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.58 0.705 . . . . 0.0 110.04 -170.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -70.86 131.86 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.94 -3.34 58.9 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.8 t -140.57 146.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -140.63 153.86 46.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.999 0.52 . . . . 0.0 109.789 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -129.32 122.84 56.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 mp -119.73 136.71 54.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 119.71 2.87 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 117.957 -1.468 . . . . 0.0 112.785 -171.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.03 133.64 25.0 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.046 1.423 . . . . 0.0 110.309 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.74 157.07 15.97 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.222 1.948 . . . . 0.0 108.717 166.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -101.22 125.26 47.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -113.71 172.18 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.802 1.641 . . . . 0.0 109.829 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.96 62.5 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.793 2.837 . . . . 0.0 115.225 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 55.93 71.52 0.55 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 112.363 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.27 79.34 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.27 155.39 24.87 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.548 1.139 . . . . 0.0 109.948 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.25 151.61 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -65.8 143.5 57.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.91 -26.67 68.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.035 -169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.03 -26.7 66.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.674 0.789 . . . . 0.0 110.761 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -83.99 -42.74 15.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.108 0.963 . . . . 0.0 110.71 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.41 -34.92 64.82 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.581 0.628 . . . . 0.0 110.819 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.7 71.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.359 1.064 . . . . 0.0 112.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.31 -11.46 10.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.514 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t-105 -53.52 -28.98 34.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.653 1.581 . . . . 0.0 111.724 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.29 -44.68 64.73 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.006 1.322 . . . . 0.0 111.384 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.73 -30.37 70.58 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.568 -1.206 . . . . 0.0 111.95 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.703 1.138 . . . . 0.0 111.096 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.14 -31.33 70.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 111.421 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.41 -26.44 38.46 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.355 0.662 . . . . 0.0 110.887 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.24 159.79 33.37 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.565 1.174 . . . . 0.0 112.062 -169.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.68 96.85 10.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 112.832 -1.986 . . . . 0.0 108.215 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -118.92 6.6 11.4 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.122 0.969 . . . . 0.0 113.141 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.0 118.35 11.8 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -168.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.79 70.5 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.943 1.259 . . . . 0.0 115.687 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.68 154.74 23.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.083 1.441 . . . . 0.0 109.106 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.5 mt -85.21 143.78 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 118.87 0.759 . . . . 0.0 109.283 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.5 t -132.44 134.13 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.526 1.53 . . . . 0.0 109.854 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.77 120.6 41.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.1 143.68 26.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 119.145 0.884 . . . . 0.0 111.644 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -137.13 159.39 42.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.37 178.13 39.08 Favored Glycine 0 N--CA 1.448 -0.555 0 O-C-N 121.044 -1.035 . . . . 0.0 112.524 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -127.67 151.12 49.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.73 -157.76 9.85 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -155.12 137.68 15.11 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.606 1.562 . . . . 0.0 108.333 168.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.508 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -90.57 -20.76 22.24 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.74 -49.33 68.81 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.781 1.173 . . . . 0.0 110.836 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.53 -27.36 8.6 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.189 0.9 . . . . 0.0 112.149 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -131.4 33.07 4.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -166.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.45 -42.66 57.55 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-N 120.354 1.434 . . . . 0.0 111.012 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.82 -19.75 60.35 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 117.986 0.893 . . . . 0.0 112.318 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -125.84 12.56 7.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.871 1.668 . . . . 0.0 112.432 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -45.61 122.05 3.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.487 1.515 . . . . 0.0 108.679 170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 52.86 28.2 6.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.033 0.933 . . . . 0.0 112.971 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.91 -40.29 94.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 120.648 -1.282 . . . . 0.0 110.113 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.94 -33.75 76.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 111.709 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.96 -47.72 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 110.456 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.11 97.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.3 mtm -65.02 -44.56 88.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.01 0.905 . . . . 0.0 111.78 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.514 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.9 mt -64.43 -35.44 80.93 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.295 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -64.24 -41.46 96.98 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.387 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.34 -42.6 92.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -55.06 -59.49 4.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.267 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.26 -20.84 57.01 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.628 -0.67 . . . . 0.0 110.794 -170.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.8 t -62.2 -30.29 70.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.165 0.893 . . . . 0.0 110.304 168.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -24.12 48.66 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.7 -1.25 . . . . 0.0 109.279 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 23.6 mmmt -81.19 2.38 27.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.025 1.73 . . . . 0.0 112.59 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.69 33.15 79.83 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 118.643 0.656 . . . . 0.0 112.102 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.18 169.51 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 117.619 0.709 . . . . 0.0 109.468 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -113.61 140.25 48.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.45 148.08 32.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.072 1.305 . . . . 0.0 112.43 -168.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.6 -179.98 3.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.817 1.247 . . . . 0.0 109.577 168.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.77 33.41 33.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 118.342 -1.254 . . . . 0.0 114.741 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -78.86 139.6 38.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.933 1.866 . . . . 0.0 108.784 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 148.96 42.1 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.59 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.33 138.99 37.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 120.949 1.375 . . . . 0.0 109.108 168.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.459 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 60.2 p . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 113.441 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -162.49 -61.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.167 0.894 . . . . 0.0 110.07 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.333 2.1 t 58.74 11.13 1.69 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.575 2.75 . . . . 0.0 114.801 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 p -66.47 142.87 97.94 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.851 -1.156 . . . . 0.0 109.095 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.75 -15.36 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.283 1.989 . . . . 0.0 113.852 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -80.81 -48.21 1.15 Allowed Pre-proline 0 C--N 1.344 0.344 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.34 36.63 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.705 1.603 . . . . 0.0 112.484 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.093 0.957 . . . . 0.0 109.843 -166.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.77 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 109.456 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.94 -116.83 0.86 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.959 1.304 . . . . 0.0 107.62 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.14 7.82 33.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.761 1.224 . . . . 0.0 111.831 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.68 20.1 20.4 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.724 1.154 . . . . 0.0 112.575 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -100.36 -17.25 17.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.852 1.261 . . . . 0.0 110.859 -172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 145.29 51.25 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.286 0.634 . . . . 0.0 110.876 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 61.2 m-85 -81.27 155.45 26.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 110.221 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.02 -12.44 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.725 1.21 . . . . 0.0 112.755 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.67 -178.28 42.64 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.612 1.097 . . . . 0.0 111.879 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.2 tp -65.54 127.92 33.81 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.55 116.02 29.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.15 157.57 24.6 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.98 15.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -98.97 17.26 20.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.883 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.94 -23.57 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.508 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -114.17 -52.6 2.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.702 1.137 . . . . 0.0 109.18 172.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -98.16 14.46 27.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.52 1.128 . . . . 0.0 113.896 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -52.07 -26.13 10.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.906 0.882 . . . . 0.0 112.485 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.37 -27.9 46.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 111.38 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -7.03 13.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.045 0.938 . . . . 0.0 111.218 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.2 m -53.07 -26.91 17.7 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.719 -1.238 . . . . 0.0 110.862 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.16 -40.18 90.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 122.035 0.921 . . . . 0.0 110.269 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -70.92 -46.2 62.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 129.827 3.251 . . . . 0.0 107.825 -177.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -69.49 -28.12 65.79 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.199 -1.819 . . . . 0.0 108.322 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.34 -61.05 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.88 -41.19 77.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 118.908 0.776 . . . . 0.0 112.259 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 m -65.59 -35.68 81.52 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.635 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -66.65 -43.95 83.26 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.464 -0.772 . . . . 0.0 109.79 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.7 m -57.55 -35.49 70.4 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.903 0.881 . . . . 0.0 109.644 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.12 -27.99 63.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.014 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -80.2 -46.41 16.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.148 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.2 -39.54 85.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 121.308 1.867 . . . . 0.0 110.614 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.11 -15.37 59.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -96.53 -45.11 6.87 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 124.683 1.193 . . . . 0.0 107.799 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.31 -42.02 90.41 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.122 0.874 . . . . 0.0 109.574 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.9 mtm -74.36 -41.92 60.23 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.142 0.977 . . . . 0.0 110.081 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.94 -44.41 80.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.286 1.035 . . . . 0.0 110.647 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -69.81 -32.2 70.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.082 1.353 . . . . 0.0 109.785 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -61.53 -42.44 98.82 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.474 0.654 . . . . 0.0 109.913 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -2.16 35.6 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.02 1.728 . . . . 0.0 113.758 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-N 118.406 0.548 . . . . 0.0 110.567 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.14 142.54 33.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 mtm -131.14 146.43 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.648 1.979 . . . . 0.0 108.276 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.55 117.94 5.0 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 118.637 -1.091 . . . . 0.0 110.397 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.72 113.12 24.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.268 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -109.92 147.36 33.57 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.77 1.628 . . . . 0.0 111.451 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -164.13 175.25 10.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.748 1.219 . . . . 0.0 109.704 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.54 142.95 11.16 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 168.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -148.87 144.61 27.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.303 1.051 . . . . 0.0 111.452 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 m -96.07 -37.87 10.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 111.389 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -95.09 -8.9 35.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 111.594 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.264 56.9 m 71.5 15.01 6.22 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.745 2.018 . . . . 0.0 114.121 -170.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -65.28 -42.94 92.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.434 1.47 . . . . 0.0 110.353 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.18 -33.66 75.88 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -64.3 -46.93 81.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.0 110.096 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 -40.85 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.592 -0.692 . . . . 0.0 111.548 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.4 94.02 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.638 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.37 79.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.902 0.881 . . . . 0.0 110.788 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.34 -45.3 88.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -61.73 -54.33 43.92 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 124.701 1.251 . . . . 0.0 108.725 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.414 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.1 mt -53.58 -56.73 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.852 0.751 . . . . 0.0 109.958 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.22 76.75 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.0 0.52 . . . . 0.0 110.484 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.92 -48.01 69.96 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.995 0.518 . . . . 0.0 111.21 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mt -65.27 -47.28 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.133 0.973 . . . . 0.0 108.533 -176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.83 -50.49 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.383 0.673 . . . . 0.0 110.402 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.29 113.69 0.73 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 171.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.15 4.08 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.357 2.705 . . . . 0.0 112.69 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.89 -34.4 66.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.022 1.329 . . . . 0.0 109.228 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.86 -21.33 4.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.558 1.543 . . . . 0.0 111.814 -169.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -94.04 141.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 120.659 1.572 . . . . 0.0 109.028 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 m -130.44 128.23 40.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 110.006 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.41 148.66 48.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.932 0.893 . . . . 0.0 112.163 174.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.25 109.7 4.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.094 1.758 . . . . 0.0 107.41 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -83.82 112.11 19.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.16 -10.53 42.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -58.06 -29.11 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.19 0.905 . . . . 0.0 111.542 169.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.34 -34.37 1.62 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.573 1.149 . . . . 0.0 112.08 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.26 140.27 33.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -84.01 139.98 39.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.97 -4.46 15.18 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.087 1.424 . . . . 0.0 111.643 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -54.16 -36.96 63.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.08 1.764 . . . . 0.0 111.524 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -20.59 66.24 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.224 -0.923 . . . . 0.0 113.449 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -11.9 26.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.329 1.052 . . . . 0.0 112.185 169.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -74.57 -25.7 59.46 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.866 -1.146 . . . . 0.0 110.961 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.79 -51.57 11.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.183 0.901 . . . . 0.0 110.195 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -66.72 142.13 57.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.288 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.44 -27.56 61.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 110.694 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.26 144.27 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -135.33 152.77 51.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.546 0.612 . . . . 0.0 110.293 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.88 121.32 54.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -120.72 137.8 54.3 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.145 0.978 . . . . 0.0 108.473 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.71 2.57 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-O 117.543 -1.698 . . . . 0.0 111.85 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.14 127.69 26.45 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 119.476 1.638 . . . . 0.0 111.405 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.47 145.45 13.27 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.818 1.679 . . . . 0.0 108.16 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 m -89.6 137.43 32.33 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -133.02 173.37 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.884 2.074 . . . . 0.0 109.406 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.7 t0 36.13 51.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.331 2.252 . . . . 0.0 114.47 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 56.05 80.71 0.14 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.271 1.429 . . . . 0.0 112.483 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.25 10.27 84.31 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.33 163.88 14.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.708 1.603 . . . . 0.0 110.509 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mt -89.84 152.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -68.47 144.44 54.66 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.39 -29.62 70.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.185 0.594 . . . . 0.0 112.193 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.59 -23.6 65.4 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.943 -0.473 . . . . 0.0 111.169 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -86.12 -41.98 14.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.301 1.04 . . . . 0.0 110.937 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.72 -34.66 65.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.586 0.63 . . . . 0.0 111.016 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.27 -30.36 70.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.752 1.221 . . . . 0.0 111.874 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.19 -12.97 10.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.544 ' CD1' ' HE2' ' A' ' 107' ' ' LYS . 2.9 t-105 -53.31 -29.42 33.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.007 1.323 . . . . 0.0 111.801 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.27 -43.33 70.69 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.147 1.379 . . . . 0.0 111.387 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.23 -31.23 70.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.936 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.1 mt -56.59 -31.03 63.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.936 1.244 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.73 -28.49 65.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.665 0.786 . . . . 0.0 111.545 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.9 -24.97 32.91 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.417 0.687 . . . . 0.0 111.038 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 mt -72.95 158.62 35.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 123.046 1.403 . . . . 0.0 112.679 -167.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.53 95.98 10.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.549 174.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mt -118.23 8.09 12.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.61 121.21 13.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.4 8.05 88.04 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.284 1.421 . . . . 0.0 114.495 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -76.2 147.89 38.08 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 117.743 0.771 . . . . 0.0 109.203 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -86.64 138.41 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 167.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.98 129.63 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.765 1.226 . . . . 0.0 108.589 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.69 117.61 34.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -90.92 141.38 28.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.941 0.791 . . . . 0.0 111.93 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -137.85 161.91 35.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.894 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.25 174.72 36.2 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 121.295 -0.878 . . . . 0.0 112.389 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 mt -124.21 148.5 47.24 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.396 1.079 . . . . 0.0 108.755 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.45 27.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.332 0.492 . . . . 0.0 112.241 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -133.45 112.69 11.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -29.44 28.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.459 0.171 . . . . 0.0 111.271 -172.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.96 -46.25 58.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.148 0.579 . . . . 0.0 110.395 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.08 -34.65 12.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.04 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.39 28.95 4.91 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.54 -34.34 60.03 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 120.33 1.423 . . . . 0.0 112.411 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.2 -24.32 63.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.063 0.932 . . . . 0.0 112.369 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -113.15 -47.5 3.02 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.521 1.528 . . . . 0.0 110.089 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.265 1.6 t80 43.97 -131.36 0.77 Allowed 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 128.478 2.711 . . . . 0.0 109.514 -172.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.58 39.38 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 130.697 3.599 . . . . 0.0 113.787 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.14 -43.05 87.09 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 119.437 -2.039 . . . . 0.0 111.123 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.98 -32.1 71.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.946 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.13 -47.39 82.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.478 0.711 . . . . 0.0 110.189 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.27 99.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.1 mtm -62.97 -48.15 80.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 117.556 0.678 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.06 -30.86 71.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.651 -0.656 . . . . 0.0 111.201 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -60.83 -46.29 91.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.3 0.5 . . . . 0.0 109.826 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.72 -41.2 92.54 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.448 1.099 . . . . 0.0 111.657 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 7.0 tptt -55.6 -62.27 1.79 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.553 1.141 . . . . 0.0 107.936 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.16 -21.04 62.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.536 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -61.65 -29.4 70.04 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.649 1.113 . . . . 0.0 110.729 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.48 -22.1 54.96 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.819 -1.176 . . . . 0.0 109.799 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.73 1.61 37.87 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.636 1.574 . . . . 0.0 112.541 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.32 33.66 68.62 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.477 0.58 . . . . 0.0 111.842 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.25 170.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.622 0.769 . . . . 0.0 109.319 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -117.26 143.14 46.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -110.33 148.05 32.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.56 1.073 . . . . 0.0 111.899 -170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.42 178.17 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.664 1.185 . . . . 0.0 108.439 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.78 34.21 39.62 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 118.52 -1.155 . . . . 0.0 114.368 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -71.95 155.72 40.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.613 1.707 . . . . 0.0 107.948 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.403 ' HE1' HD13 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -138.45 142.05 33.48 Favored Pre-proline 0 CA--C 1.514 -0.437 0 CA-C-O 116.939 -1.505 . . . . 0.0 109.227 176.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.45 143.08 56.31 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.038 1.406 . . . . 0.0 109.618 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.518 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 73.9 p . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.899 1.68 . . . . 0.0 113.776 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -163.01 -53.88 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 118.752 0.705 . . . . 0.0 109.454 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.361 3.1 t 61.66 8.12 2.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.066 2.547 . . . . 0.0 114.939 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.2 t -67.85 138.13 92.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -84.7 -10.56 8.42 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.251 2.634 . . . . 0.0 112.77 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -78.42 -49.93 1.72 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -88.46 39.84 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.381 2.054 . . . . 0.0 112.593 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 148.43 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.509 1.124 . . . . 0.0 109.612 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.02 -171.98 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 C-N-CA 126.369 1.867 . . . . 0.0 109.861 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.39 -116.11 0.86 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.203 1.401 . . . . 0.0 107.443 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.55 8.34 33.28 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.059 1.344 . . . . 0.0 112.222 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.99 21.12 19.13 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.76 1.171 . . . . 0.0 112.506 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -100.69 -18.32 16.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.793 1.237 . . . . 0.0 110.8 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.14 144.23 51.24 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.887 0.475 . . . . 0.0 110.876 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.78 156.58 30.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.7 m -65.2 -18.11 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.478 0.711 . . . . 0.0 112.108 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.07 -178.76 39.66 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.403 1.001 . . . . 0.0 111.114 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.403 HD13 ' HE1' ' A' ' 119' ' ' TRP . 20.1 tp -61.23 128.26 35.5 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.15 125.5 53.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.1 mt -121.99 150.23 42.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.65 132.4 38.91 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -111.57 10.67 21.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.705 -170.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.258 0.5 OUTLIER -108.21 -31.17 8.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 176.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -136.14 -27.33 1.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.096 0.862 . . . . 0.0 113.267 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -89.5 12.08 17.57 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.914 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -57.69 -21.77 42.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.874 1.215 . . . . 0.0 113.475 -170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.54 -19.29 28.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.647 0.779 . . . . 0.0 112.141 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.0 mt -113.49 -24.48 9.25 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 126.702 2.001 . . . . 0.0 111.4 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.5 p -51.43 -35.77 40.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.366 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.395 0.678 . . . . 0.0 110.26 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.88 -29.63 66.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.547 0.339 . . . . 0.0 111.744 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -78.97 -28.11 43.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.704 0.802 . . . . 0.0 110.039 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 mt -66.05 -54.26 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.97 -44.77 82.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.588 0.755 . . . . 0.0 112.257 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.4 p -67.19 -35.64 80.06 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.933 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -64.63 -45.12 88.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.844 0.83 . . . . 0.0 109.553 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.7 m -57.53 -35.42 70.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.134 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -34.7 77.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.83 0.452 . . . . 0.0 110.273 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.24 -46.27 18.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.373 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -65.18 -38.61 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 120.858 1.663 . . . . 0.0 110.002 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.28 -14.3 60.41 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.286 0.494 . . . . 0.0 112.016 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -95.03 -46.14 6.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 107.871 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.46 -36.02 77.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.841 0.746 . . . . 0.0 110.209 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.1 mtm -77.67 -44.19 28.84 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.329 1.052 . . . . 0.0 110.508 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -42.45 78.18 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.819 0.848 . . . . 0.0 111.052 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.18 -31.11 68.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.91 1.284 . . . . 0.0 109.791 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -41.91 97.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.297 0.639 . . . . 0.0 110.487 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -1.25 56.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.901 1.681 . . . . 0.0 113.919 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.318 179.239 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.2 143.86 30.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.0 mtm -132.12 146.51 52.09 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.773 2.029 . . . . 0.0 108.187 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.75 118.42 4.94 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-O 118.622 -1.099 . . . . 0.0 110.51 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 111.54 22.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.986 1.393 . . . . 0.0 108.885 169.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.88 146.44 36.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.988 1.315 . . . . 0.0 111.047 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -161.91 174.88 12.49 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.234 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.2 10.2 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.578 -2.609 . . . . 0.0 106.578 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.4 p -146.38 122.47 10.78 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.326 1.063 . . . . 0.0 111.614 -169.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 m -80.83 -37.87 29.28 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.205 0.457 . . . . 0.0 111.638 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.9 p -107.93 8.55 28.55 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.866 1.266 . . . . 0.0 112.092 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.7 m 65.35 11.71 7.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.85 2.06 . . . . 0.0 114.192 -171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -66.63 -46.94 74.2 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.318 -1.489 . . . . 0.0 111.224 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -33.44 75.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.88 -46.56 87.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 110.312 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.4 mtm -65.49 -43.37 90.38 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.774 -0.578 . . . . 0.0 111.384 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.55 -39.81 89.29 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 122.005 -0.434 . . . . 0.0 110.886 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.74 81.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.206 1.002 . . . . 0.0 110.53 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.5 -44.77 85.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.93 -53.88 47.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.721 1.263 . . . . 0.0 108.997 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.55 -56.82 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.724 0.693 . . . . 0.0 109.768 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -38.49 78.63 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.574 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.57 -47.78 71.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.004 0.522 . . . . 0.0 111.121 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 mt -65.27 -48.0 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.682 1.193 . . . . 0.0 108.697 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.96 -50.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.502 0.721 . . . . 0.0 110.54 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.59 114.34 0.75 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.5 1.048 . . . . 0.0 110.707 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.39 3.76 3.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.625 2.883 . . . . 0.0 112.677 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -73.49 -34.12 65.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.206 1.403 . . . . 0.0 109.226 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -22.53 3.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.4 1.48 . . . . 0.0 111.824 -169.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 120.333 1.424 . . . . 0.0 108.752 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 m -129.17 129.58 45.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.539 1.136 . . . . 0.0 110.022 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.05 146.28 45.97 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.299 1.039 . . . . 0.0 112.068 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -144.09 107.97 4.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.616 1.567 . . . . 0.0 107.313 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -83.29 112.42 19.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.31 -8.95 20.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.94 0.896 . . . . 0.0 113.155 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.91 -29.14 66.83 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.209 0.913 . . . . 0.0 111.753 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -130.82 -34.25 1.52 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.714 1.206 . . . . 0.0 111.842 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -82.16 141.78 32.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.982 0.913 . . . . 0.0 108.756 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -81.35 147.97 61.7 Favored Pre-proline 0 N--CA 1.45 -0.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -78.19 -2.95 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.177 1.251 . . . . 0.0 111.36 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -55.75 -35.3 66.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 122.101 2.228 . . . . 0.0 112.011 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -20.09 66.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.7 ttm -59.28 -15.51 16.21 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.674 1.99 . . . . 0.0 111.477 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -73.2 -30.83 63.8 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.194 -0.941 . . . . 0.0 110.913 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -76.01 -46.28 30.24 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.976 0.807 . . . . 0.0 110.834 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.98 141.87 56.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.1 -168.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -74.54 -19.96 60.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.318 0.647 . . . . 0.0 110.509 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.7 t -145.41 148.7 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -138.27 150.3 46.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.99 0.916 . . . . 0.0 109.183 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.5 120.65 51.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.7 132.59 55.7 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.89 118.33 3.67 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-O 117.541 -1.699 . . . . 0.0 112.757 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 126.01 27.24 Favored Pre-proline 0 N--CA 1.472 0.625 0 CA-C-N 119.608 1.704 . . . . 0.0 111.45 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -80.27 144.82 16.63 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.351 2.701 . . . . 0.0 108.987 167.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 m -94.96 131.54 40.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -121.91 171.33 9.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.524 1.93 . . . . 0.0 109.442 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 20.12 67.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.921 2.888 . . . . 0.0 115.459 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 54.0 70.05 0.65 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.689 1.196 . . . . 0.0 112.112 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 21.11 79.65 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.165 0.826 . . . . 0.0 115.165 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.305 0.4 OUTLIER -88.34 156.4 19.19 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 166.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.21 150.36 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -55.34 139.59 42.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.181 0.991 . . . . 0.0 108.545 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.63 -28.22 69.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -78.47 -19.51 52.95 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.726 -0.609 . . . . 0.0 110.434 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -81.08 -43.06 20.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.377 0.671 . . . . 0.0 111.192 169.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.26 -33.44 58.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.531 0.605 . . . . 0.0 111.008 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.24 71.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.252 1.021 . . . . 0.0 112.33 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.86 -8.92 12.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.9 t-105 -53.2 -28.96 29.35 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.31 1.444 . . . . 0.0 111.902 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.72 -44.71 76.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.992 1.317 . . . . 0.0 111.635 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -68.58 -29.01 67.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.05 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.75 -29.84 65.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 111.114 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.33 -29.47 66.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.515 0.726 . . . . 0.0 111.452 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.87 -24.62 38.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.391 0.676 . . . . 0.0 111.366 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.4 159.91 33.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.808 1.289 . . . . 0.0 112.998 -168.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.4 92.31 7.59 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 126.663 1.985 . . . . 0.0 108.539 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -113.5 10.15 18.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.66 126.43 28.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.98 21.66 79.01 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.818 1.199 . . . . 0.0 115.678 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.21 155.8 21.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.802 1.301 . . . . 0.0 108.828 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.7 mt -87.25 145.79 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.01 130.2 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.046 1.338 . . . . 0.0 109.29 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 118.07 35.84 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -90.45 141.73 28.45 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.227 0.921 . . . . 0.0 111.554 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -136.78 160.58 38.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.205 1.002 . . . . 0.0 108.43 168.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.13 170.81 36.29 Favored Glycine 0 N--CA 1.446 -0.641 0 O-C-N 121.005 -1.06 . . . . 0.0 111.82 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.8 mt -129.32 153.14 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.42 -154.87 11.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -149.77 137.52 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.101 1.36 . . . . 0.0 108.074 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.571 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -90.62 -22.83 21.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.306 1.443 . . . . 0.0 113.44 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.28 -39.55 53.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.054 1.297 . . . . 0.0 111.627 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.42 -26.28 16.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.418 1.008 . . . . 0.0 112.232 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.36 35.46 2.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -167.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.66 52.54 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.186 1.357 . . . . 0.0 110.973 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -62.71 -15.02 50.86 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.067 0.947 . . . . 0.0 112.133 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -126.22 8.89 7.28 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.351 1.86 . . . . 0.0 112.128 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -48.93 124.86 9.33 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.496 1.518 . . . . 0.0 109.389 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.17 28.63 9.29 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.182 0.993 . . . . 0.0 112.855 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.1 -36.89 82.91 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 120.444 -1.41 . . . . 0.0 110.684 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 111.325 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 tp -60.41 -48.11 83.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.016 0.926 . . . . 0.0 110.535 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.45 98.13 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mtm -65.16 -44.54 88.22 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.849 0.825 . . . . 0.0 112.101 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.527 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.3 mt -65.29 -35.31 80.61 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.365 0.984 . . . . 0.0 111.169 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -62.94 -42.14 99.72 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.656 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.12 -43.1 88.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.29 -59.11 5.11 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.848 1.259 . . . . 0.0 108.4 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.69 -22.19 54.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.241 -169.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 t -62.02 -28.77 69.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.975 0.807 . . . . 0.0 110.534 169.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.92 -24.36 44.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.588 -1.32 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -80.57 -0.95 39.98 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.409 1.484 . . . . 0.0 112.489 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.1 59.95 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.814 0.734 . . . . 0.0 111.895 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.57 172.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.764 0.782 . . . . 0.0 109.696 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -118.09 145.41 44.86 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.89 151.71 33.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 120.289 1.404 . . . . 0.0 112.994 -168.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.67 -178.97 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.821 1.248 . . . . 0.0 109.46 169.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.76 29.92 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.202 -1.332 . . . . 0.0 115.091 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -75.49 152.32 37.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.909 1.854 . . . . 0.0 109.008 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.31 148.15 69.02 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 117.16 -1.4 . . . . 0.0 109.088 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.87 140.02 41.24 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 121.11 1.432 . . . . 0.0 110.429 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.444 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 66.6 p . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.364 1.866 . . . . 0.0 113.296 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -161.75 -58.76 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.328 1.9 t 58.64 11.71 1.88 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.103 2.561 . . . . 0.0 114.609 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 p -66.56 133.28 94.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.864 -1.148 . . . . 0.0 107.908 167.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.13 -14.26 5.07 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.16 1.907 . . . . 0.0 113.326 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -80.6 -47.41 1.24 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 117.756 -1.116 . . . . 0.0 114.007 -169.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.15 39.37 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.078 1.852 . . . . 0.0 112.428 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.37 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.333 -167.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -172.55 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 126.069 1.748 . . . . 0.0 109.968 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.08 -116.52 0.84 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.054 1.342 . . . . 0.0 107.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.21 8.0 33.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.828 1.251 . . . . 0.0 111.885 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.42 20.3 20.43 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.129 1.347 . . . . 0.0 112.803 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.25 -16.83 17.59 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.877 1.271 . . . . 0.0 110.944 -172.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 144.53 50.44 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.279 0.631 . . . . 0.0 111.186 173.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 58.2 m-85 -78.78 154.37 30.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.698 1.599 . . . . 0.0 109.676 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -14.32 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.157 . . . . 0.0 112.707 173.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.45 -179.62 40.89 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 119.69 1.132 . . . . 0.0 111.968 -170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 14.5 tp -65.7 129.78 40.97 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.09 124.15 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.71 160.16 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.981 0.912 . . . . 0.0 108.879 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.533 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.13 124.93 31.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -105.29 10.24 33.65 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.779 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -25.65 11.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.207 1.003 . . . . 0.0 110.862 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.06 -46.93 1.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.703 1.138 . . . . 0.0 111.169 174.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -89.74 15.35 9.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -53.67 -22.05 8.16 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.71 -26.55 31.91 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.258 1.023 . . . . 0.0 111.291 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -116.14 -13.73 11.16 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.293 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.7 p -57.3 -27.41 62.13 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.129 1.331 . . . . 0.0 112.381 -171.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -52.76 -39.1 61.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.781 1.632 . . . . 0.0 111.788 173.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.36 -30.47 68.49 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.701 1.6 . . . . 0.0 111.003 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -92.46 -18.16 23.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.037 1.335 . . . . 0.0 110.484 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.84 -60.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -51.82 -44.8 63.67 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.128 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 p -67.59 -35.22 78.57 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.077 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.423 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.7 t90 -65.35 -44.87 86.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.026 0.917 . . . . 0.0 109.656 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.82 -35.9 71.49 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.808 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.74 -29.78 66.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.404 0.547 . . . . 0.0 111.173 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -79.07 -45.76 19.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.931 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.89 -39.27 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 120.865 1.666 . . . . 0.0 109.862 -171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.49 -14.64 58.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.2 0.6 . . . . 0.0 111.984 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -96.2 -45.94 6.65 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.64 -42.47 88.37 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.968 0.804 . . . . 0.0 109.387 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 73.3 mtm -77.29 -35.51 55.02 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.706 0.802 . . . . 0.0 110.716 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -48.4 56.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.351 1.06 . . . . 0.0 109.678 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.49 -31.15 72.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.216 1.406 . . . . 0.0 109.951 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -63.96 -49.04 74.13 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.487 0.585 . . . . 0.0 110.447 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.23 -3.84 44.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.586 179.325 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 140.23 30.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 168.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 mtm -123.13 148.67 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.574 2.349 . . . . 0.0 108.386 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.29 118.47 4.69 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.48 114.44 25.1 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.944 1.372 . . . . 0.0 108.754 170.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.15 146.32 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.635 1.574 . . . . 0.0 110.535 172.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.01 172.74 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.189 0.996 . . . . 0.0 109.814 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.72 140.56 9.3 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -153.3 164.66 37.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.11 0.955 . . . . 0.0 112.007 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -132.08 -41.32 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.192 1.397 . . . . 0.0 110.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.2 p -76.5 -15.52 59.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.502 0.721 . . . . 0.0 110.551 169.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.261 57.5 m 73.57 16.15 3.99 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.479 2.311 . . . . 0.0 113.831 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -63.24 -43.6 97.57 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.371 -1.456 . . . . 0.0 110.584 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -33.72 73.24 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.45 -47.38 84.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.454 0.702 . . . . 0.0 109.644 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -65.51 -39.54 91.97 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.186 0.448 . . . . 0.0 111.145 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.64 93.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.846 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.43 79.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.038 0.935 . . . . 0.0 110.674 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -57.2 -44.95 84.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.34 -56.46 16.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.804 1.315 . . . . 0.0 108.94 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -51.88 -56.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 118.274 0.488 . . . . 0.0 110.099 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.24 -36.4 73.14 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.877 0.871 . . . . 0.0 111.122 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.32 -45.74 62.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.682 0.393 . . . . 0.0 111.084 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.67 -47.11 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.292 1.037 . . . . 0.0 108.802 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.34 -50.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.539 0.736 . . . . 0.0 110.279 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.36 112.25 0.41 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.79 -4.29 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.443 2.762 . . . . 0.0 112.29 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.1 -33.68 59.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.057 1.743 . . . . 0.0 109.387 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.44 -21.42 4.18 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.708 1.603 . . . . 0.0 111.417 -169.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.82 139.17 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 120.397 1.453 . . . . 0.0 109.108 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -128.25 129.09 45.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.606 1.163 . . . . 0.0 110.056 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.66 147.9 43.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.726 1.21 . . . . 0.0 112.049 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.09 111.94 5.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.987 1.715 . . . . 0.0 107.121 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.14 109.98 19.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.5 -7.57 26.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -62.43 -26.49 68.53 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.597 1.09 . . . . 0.0 111.669 169.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -132.83 -33.59 1.18 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 112.184 -171.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -84.04 141.16 31.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.49 1.116 . . . . 0.0 108.286 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -86.73 141.64 33.97 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -71.86 -4.24 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.079 1.853 . . . . 0.0 111.186 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -54.97 -35.76 64.63 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 120.347 1.43 . . . . 0.0 112.179 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -20.58 66.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 175.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -65.34 -10.96 37.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 112.539 169.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.02 -30.19 68.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.514 1.052 . . . . 0.0 110.159 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.62 -51.46 9.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.422 0.63 . . . . 0.0 110.295 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.99 143.55 57.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.616 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -76.15 -24.49 54.83 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.543 0.687 . . . . 0.0 110.766 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.8 t -145.18 139.18 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -169.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 153.49 43.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.612 0.642 . . . . 0.0 110.875 174.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 125.41 67.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.32 136.55 54.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.947 0.899 . . . . 0.0 109.886 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.05 116.52 2.99 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.006 -1.996 . . . . 0.0 111.689 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 130.1 24.9 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-N 120.229 2.014 . . . . 0.0 112.409 170.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.83 141.69 10.88 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.453 2.102 . . . . 0.0 107.792 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 m -89.45 124.35 34.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -115.24 174.7 5.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.526 1.93 . . . . 0.0 109.351 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 31.06 55.64 0.22 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.085 2.554 . . . . 0.0 115.253 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 55.69 78.84 0.18 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.71 1.204 . . . . 0.0 112.71 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.09 9.85 85.37 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.86 159.67 17.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.15 1.38 . . . . 0.0 110.803 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -91.05 152.9 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.04 144.5 55.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.68 -28.88 69.71 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.113 0.965 . . . . 0.0 112.4 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.262 0.625 . . . . 0.0 111.012 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -79.98 -43.49 21.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 110.195 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.46 -34.39 61.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.28 0.632 . . . . 0.0 111.024 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.379 1.072 . . . . 0.0 112.174 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.27 -10.41 9.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.9 t-105 -53.37 -27.73 25.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.505 1.522 . . . . 0.0 112.166 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.23 -45.56 66.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.209 1.404 . . . . 0.0 111.524 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -64.91 -33.05 75.1 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.929 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.63 -31.68 66.5 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.725 1.148 . . . . 0.0 111.393 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.29 -27.49 61.58 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.345 0.658 . . . . 0.0 111.178 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.64 -19.29 31.18 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.832 0.853 . . . . 0.0 111.482 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.99 171.65 12.45 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.053 0.93 . . . . 0.0 110.721 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.47 112.22 24.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.22 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.02 10.3 6.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.838 0.855 . . . . 0.0 112.945 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.62 119.41 10.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -170.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.83 85.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 124.822 1.201 . . . . 0.0 114.148 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -79.17 149.37 32.0 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.002 0.901 . . . . 0.0 108.86 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -86.38 140.35 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.52 131.38 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 109.447 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.53 112.91 24.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 166.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.39 143.99 26.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.799 0.727 . . . . 0.0 111.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -141.87 164.22 30.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.948 1.299 . . . . 0.0 109.03 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.48 38.88 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 121.195 -0.94 . . . . 0.0 113.218 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -128.56 153.76 46.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.437 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.71 -153.9 9.17 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.07 138.83 10.56 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 126.75 2.02 . . . . 0.0 107.775 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.522 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -89.39 -21.74 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.864 1.265 . . . . 0.0 114.267 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.51 -48.11 65.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.756 1.162 . . . . 0.0 110.664 -173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.93 -26.27 19.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.034 0.826 . . . . 0.0 112.33 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -130.92 27.75 4.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.44 58.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-N 121.116 1.78 . . . . 0.0 112.524 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.12 -15.92 58.3 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.033 -1.275 . . . . 0.0 113.222 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -125.16 -49.65 1.7 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.745 1.618 . . . . 0.0 111.433 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.261 2.0 t80 43.82 -133.59 0.61 Allowed 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.204 2.602 . . . . 0.0 109.844 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.98 40.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.816 3.646 . . . . 0.0 113.188 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -58.75 -43.08 90.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.554 -1.966 . . . . 0.0 111.42 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.72 71.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.276 0.63 . . . . 0.0 110.584 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -62.75 -47.98 81.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.649 0.78 . . . . 0.0 110.384 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.44 99.19 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.6 mtm -62.0 -46.3 89.81 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 117.765 0.782 . . . . 0.0 111.218 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.519 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -67.99 -31.43 71.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.735 -0.603 . . . . 0.0 111.7 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.36 -49.97 75.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.011 0.434 . . . . 0.0 109.927 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.45 -40.17 92.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.419 1.088 . . . . 0.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -54.2 -58.8 6.0 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.397 1.479 . . . . 0.0 108.444 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.9 -18.59 55.97 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.544 -0.723 . . . . 0.0 110.672 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -60.91 -26.93 67.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.985 0.811 . . . . 0.0 110.557 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -24.19 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.771 -1.206 . . . . 0.0 109.849 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -82.94 1.66 38.49 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.576 1.55 . . . . 0.0 112.627 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.06 34.27 70.33 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 118.633 0.651 . . . . 0.0 111.982 172.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.53 171.24 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 117.823 0.812 . . . . 0.0 109.89 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -116.23 140.6 49.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -108.53 147.6 31.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.55 1.068 . . . . 0.0 111.756 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.75 179.07 4.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 108.982 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.25 33.52 44.23 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-O 118.65 -1.084 . . . . 0.0 114.344 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.17 149.69 46.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.589 1.694 . . . . 0.0 108.044 169.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.37 135.65 27.75 Favored Pre-proline 0 CA--C 1.516 -0.334 0 CA-C-O 116.917 -1.516 . . . . 0.0 108.578 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.63 138.76 50.67 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 121.36 1.521 . . . . 0.0 109.776 169.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.447 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 67.3 p . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 126.522 1.929 . . . . 0.0 113.191 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -166.43 -52.98 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.477 1.035 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.326 3.1 t 57.45 10.64 1.0 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.237 2.615 . . . . 0.0 114.536 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 141.81 88.0 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.509 1.523 . . . . 0.0 109.783 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.24 -13.37 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.214 1.943 . . . . 0.0 114.114 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -80.0 -50.33 1.2 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.87 38.65 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.0 1.8 . . . . 0.0 112.827 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 149.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -166.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -172.28 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 125.906 1.683 . . . . 0.0 110.005 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.6 -116.89 0.89 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.65 8.0 32.92 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.016 1.326 . . . . 0.0 112.161 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.61 20.35 19.79 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.613 1.102 . . . . 0.0 112.591 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -100.15 -16.97 17.63 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.735 1.214 . . . . 0.0 110.713 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.02 142.45 49.58 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.445 0.698 . . . . 0.0 110.404 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.0 m-85 -77.47 157.7 30.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.863 1.265 . . . . 0.0 108.725 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.19 -18.69 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.915 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.04 -179.83 40.31 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 119.604 1.093 . . . . 0.0 112.066 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.8 tp -61.01 129.26 40.53 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.03 119.13 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -117.15 156.61 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.134 0.974 . . . . 0.0 109.223 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.97 122.15 12.21 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -97.56 18.15 16.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.843 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 -20.92 4.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.879 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.522 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -114.72 -53.95 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.239 1.381 . . . . 0.0 108.547 169.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.78 17.71 17.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -52.0 -25.2 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.036 0.934 . . . . 0.0 112.496 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.99 -26.65 54.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 0.0 111.426 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.46 -8.47 9.11 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.111 0.965 . . . . 0.0 112.331 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.6 m -51.59 -34.17 35.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.982 1.264 . . . . 0.0 110.554 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.54 -49.14 75.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.65 0.78 . . . . 0.0 110.238 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.11 -32.12 73.04 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.27 1.028 . . . . 0.0 109.892 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -74.98 -29.31 60.86 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 118.256 -0.878 . . . . 0.0 108.982 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.15 -58.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.44 -45.05 65.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.495 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.1 m -69.69 -35.23 74.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.587 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.401 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 34.6 t90 -67.08 -45.32 77.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.628 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 86.5 m -58.73 -33.88 70.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.823 0.849 . . . . 0.0 109.765 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -70.88 -32.33 69.27 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -78.63 -47.41 17.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.271 -1.347 . . . . 0.0 112.257 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -64.24 -37.19 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 121.23 1.832 . . . . 0.0 109.838 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.3 -13.0 33.7 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -51.07 5.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.649 1.58 . . . . 0.0 107.875 169.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.93 -22.8 67.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.355 0.662 . . . . 0.0 111.46 -169.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.43 -44.08 8.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 111.472 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.39 57.44 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.506 0.722 . . . . 0.0 110.709 -172.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.49 -27.69 66.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.897 1.279 . . . . 0.0 109.51 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -70.33 -48.27 57.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 110.378 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.42 -17.23 60.23 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.791 -179.205 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 142.68 29.83 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 mtm -130.94 147.96 52.65 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.447 1.899 . . . . 0.0 108.516 -169.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.25 117.63 4.77 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-O 118.824 -0.987 . . . . 0.0 110.807 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 98.02 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.879 1.339 . . . . 0.0 109.548 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -95.88 146.41 24.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.506 1.122 . . . . 0.0 110.447 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 36.3 p90 -165.36 174.6 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.686 0.794 . . . . 0.0 109.024 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.28 133.8 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 106.188 -2.765 . . . . 0.0 106.188 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 147.77 28.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.8 t -126.23 -27.56 3.21 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.944 1.298 . . . . 0.0 109.834 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.9 p -81.45 -74.28 0.34 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 169.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.0 p 175.7 -14.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.163 1.785 . . . . 0.0 113.839 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -63.44 -48.2 78.74 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.646 -1.284 . . . . 0.0 114.359 -164.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -33.71 74.93 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 6.5 tt0 -62.98 -47.79 81.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.2 mtm -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 118.004 0.365 . . . . 0.0 111.444 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.45 -41.65 90.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.69 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.76 82.25 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.995 0.918 . . . . 0.0 110.754 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.82 -44.96 90.97 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.2 -56.64 16.62 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 124.616 1.198 . . . . 0.0 108.43 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.58 -56.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 118.821 0.737 . . . . 0.0 109.966 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -38.96 71.71 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.428 0.691 . . . . 0.0 110.514 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.88 -46.9 73.53 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.792 0.437 . . . . 0.0 111.442 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.66 -47.85 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.517 1.127 . . . . 0.0 108.727 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.32 -50.97 32.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 123.876 0.87 . . . . 0.0 110.309 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.28 114.92 0.7 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 170.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.86 2.83 4.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.374 2.716 . . . . 0.0 112.812 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.91 -34.01 66.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 -23.89 3.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.672 1.589 . . . . 0.0 111.549 -169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.81 140.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.45 1.477 . . . . 0.0 109.278 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.7 m -129.36 128.66 43.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.689 1.195 . . . . 0.0 110.477 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.12 148.07 49.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 112.094 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -148.87 110.26 4.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.61 1.564 . . . . 0.0 107.618 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -86.92 113.14 22.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.23 -10.45 42.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -58.68 -26.91 64.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.981 0.809 . . . . 0.0 111.88 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.74 -28.72 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.889 0.875 . . . . 0.0 112.005 -167.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -87.63 145.36 26.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.377 1.471 . . . . 0.0 108.614 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -83.63 148.42 54.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.633 0.773 . . . . 0.0 108.976 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -79.27 -11.21 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.793 2.329 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -56.68 -36.6 69.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.446 1.476 . . . . 0.0 111.488 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -20.23 66.17 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.332 -0.855 . . . . 0.0 113.023 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -13.82 25.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.403 1.081 . . . . 0.0 112.156 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.94 -26.7 60.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.079 -1.013 . . . . 0.0 110.897 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.35 -50.65 13.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.786 0.803 . . . . 0.0 110.107 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -65.29 144.03 57.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.093 1.357 . . . . 0.0 108.248 -169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -75.52 -25.13 56.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.753 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.15 140.24 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 158.65 36.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.659 0.663 . . . . 0.0 110.757 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.23 123.31 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.9 135.65 55.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.832 0.853 . . . . 0.0 108.872 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.24 3.67 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 130.09 24.89 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 118.824 1.312 . . . . 0.0 110.558 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.24 138.31 7.6 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.289 2.659 . . . . 0.0 107.887 168.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 m -87.19 126.32 34.72 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -113.19 172.77 6.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.253 1.821 . . . . 0.0 109.89 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 21.94 63.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.241 3.017 . . . . 0.0 115.469 169.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.17 71.39 0.54 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.713 1.205 . . . . 0.0 112.151 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.89 13.35 80.8 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.97 151.14 35.8 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.662 1.22 . . . . 0.0 109.302 168.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.63 148.84 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -64.35 144.75 56.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.44 -27.65 68.71 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.162 -172.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -64.82 -27.75 69.09 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.806 0.842 . . . . 0.0 112.401 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -88.53 -40.5 13.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.832 1.253 . . . . 0.0 110.59 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.12 -35.83 65.07 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.726 0.694 . . . . 0.0 111.009 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.11 71.33 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.165 0.986 . . . . 0.0 112.139 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.99 -12.4 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.727 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.0 t-105 -54.85 -28.76 52.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.114 1.366 . . . . 0.0 111.804 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.51 -44.86 61.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.681 1.192 . . . . 0.0 110.876 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.24 -29.6 67.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.22 -1.371 . . . . 0.0 112.559 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 mt -55.66 -32.86 63.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.228 1.376 . . . . 0.0 110.895 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.07 -33.68 76.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.69 0.796 . . . . 0.0 111.819 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.99 -26.62 48.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.277 0.631 . . . . 0.0 110.767 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.95 152.82 40.01 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.88 1.324 . . . . 0.0 110.511 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -85.11 103.59 14.25 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.558 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.5 mt -124.75 4.41 8.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.767 1.227 . . . . 0.0 113.032 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -68.48 113.14 5.76 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.74 79.86 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.34 1.447 . . . . 0.0 115.094 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -82.76 153.0 25.48 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.324 1.062 . . . . 0.0 109.914 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.99 141.59 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.53 129.1 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.163 1.385 . . . . 0.0 108.632 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.71 117.81 35.02 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.92 142.26 27.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.082 0.856 . . . . 0.0 111.524 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -140.37 161.33 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.006 0.922 . . . . 0.0 108.95 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.04 179.53 39.58 Favored Glycine 0 N--CA 1.45 -0.415 0 O-C-N 120.841 -1.162 . . . . 0.0 112.338 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.46 153.96 42.72 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 109.233 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.44 -157.86 13.33 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -148.88 141.94 24.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.486 1.514 . . . . 0.0 109.254 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.554 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -88.96 -21.03 23.75 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.79 -40.94 68.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.874 1.216 . . . . 0.0 111.804 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.91 -22.93 19.22 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 124.592 1.091 . . . . 0.0 111.512 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.453 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.6 m-85 -121.38 -84.8 0.66 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.764 1.225 . . . . 0.0 108.071 -170.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.0 -50.27 2.64 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 128.237 2.827 . . . . 0.0 108.6 -168.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 93' ' ' TYR . 1.3 mp0 -71.74 -36.21 70.39 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 126.613 1.965 . . . . 0.0 110.169 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -106.66 1.27 24.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.334 1.054 . . . . 0.0 112.085 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.29 120.83 2.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.587 1.555 . . . . 0.0 109.009 168.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 55.46 25.7 8.06 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.13 0.972 . . . . 0.0 113.465 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.88 -38.57 91.4 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 120.855 -1.153 . . . . 0.0 110.743 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.61 -32.99 73.14 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.074 -0.391 . . . . 0.0 111.795 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.75 -46.29 91.04 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.116 0.966 . . . . 0.0 110.797 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.66 -40.35 96.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.5 mtm -68.52 -43.1 77.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.875 0.837 . . . . 0.0 112.461 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.7 mt -63.5 -33.27 75.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.3 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -65.35 -42.46 92.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.969 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.33 -42.46 92.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.675 1.19 . . . . 0.0 111.743 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -55.19 -59.33 4.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.619 1.168 . . . . 0.0 108.403 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 mt -76.95 -20.17 56.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.445 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -62.31 -28.81 70.0 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.234 0.924 . . . . 0.0 110.425 168.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.09 -24.07 47.7 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.646 -1.284 . . . . 0.0 109.572 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -80.83 3.64 21.84 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.295 1.838 . . . . 0.0 113.08 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.17 80.4 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 118.593 0.633 . . . . 0.0 111.635 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.74 171.67 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.674 0.79 . . . . 0.0 109.046 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -117.98 141.9 47.95 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.51 147.69 32.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.487 1.039 . . . . 0.0 111.514 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.27 178.4 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.315 1.046 . . . . 0.0 108.802 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 35.94 37.57 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 118.608 -1.107 . . . . 0.0 114.286 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -77.87 152.82 33.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.667 1.733 . . . . 0.0 109.201 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -128.18 147.44 63.51 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 117.411 -1.281 . . . . 0.0 108.45 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.52 140.53 40.05 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.132 1.221 . . . . 0.0 109.651 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.493 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 78.8 p . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 125.878 1.671 . . . . 0.0 113.822 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -163.52 -53.01 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.218 0.607 . . . . 0.0 109.711 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 2.9 t 58.64 8.81 0.97 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.969 2.508 . . . . 0.0 114.616 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -68.46 139.74 92.03 Favored Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 120.835 -1.166 . . . . 0.0 108.817 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -85.03 -11.3 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.9 2.4 . . . . 0.0 113.085 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -77.85 -50.61 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -168.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -88.39 42.54 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.179 1.919 . . . . 0.0 112.163 -169.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 147.66 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.771 -1.206 . . . . 0.0 109.806 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 -172.47 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 125.968 1.707 . . . . 0.0 110.182 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.07 -116.49 0.84 Allowed 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.1 1.36 . . . . 0.0 107.579 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.25 8.56 33.96 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.839 1.256 . . . . 0.0 111.871 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.25 21.56 19.73 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.986 1.279 . . . . 0.0 112.504 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -99.77 -18.32 17.27 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.693 1.197 . . . . 0.0 110.764 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.5 144.35 51.07 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.257 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.5 m-85 -78.13 154.98 30.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.114 1.366 . . . . 0.0 109.826 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.61 -12.49 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.587 1.155 . . . . 0.0 112.618 175.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.84 -177.21 44.69 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 119.763 1.165 . . . . 0.0 112.475 -172.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.7 tp -65.77 131.26 45.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.08 112.88 20.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.9 mt -110.96 154.2 24.45 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.268 1.027 . . . . 0.0 109.59 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.47 128.27 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -102.5 13.79 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.399 1.079 . . . . 0.0 110.793 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -22.44 5.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.554 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.1 -49.24 2.98 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.765 1.226 . . . . 0.0 108.153 172.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.48 22.38 15.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.36 1.464 . . . . 0.0 112.809 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -52.52 -26.86 14.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.138 0.575 . . . . 0.0 112.411 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.75 -25.19 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.43 0.692 . . . . 0.0 111.677 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -125.13 -11.31 7.03 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.121 0.969 . . . . 0.0 112.153 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.0 m -56.94 -29.77 63.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.017 1.28 . . . . 0.0 109.351 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.83 -37.78 77.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.219 1.408 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.8 -37.49 27.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.577 1.151 . . . . 0.0 110.039 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -67.89 -31.06 70.6 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.33 -54.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -52.67 -47.73 66.98 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.061 1.344 . . . . 0.0 110.411 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.3 m -66.41 -36.31 82.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.256 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -66.27 -44.67 82.94 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.547 0.689 . . . . 0.0 109.963 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.5 m -58.18 -36.1 72.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.794 0.838 . . . . 0.0 109.691 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -69.62 -31.33 69.39 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.597 0.561 . . . . 0.0 109.854 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -79.59 -47.58 15.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.674 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.8 pt -64.32 -38.85 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 121.018 1.735 . . . . 0.0 110.349 -169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.94 -14.28 59.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.104 0.561 . . . . 0.0 111.976 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.23 -46.54 6.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.57 -39.5 80.46 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.292 0.637 . . . . 0.0 110.062 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.49 -38.3 41.17 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.3 62.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.145 0.978 . . . . 0.0 109.96 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.15 -29.68 70.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.036 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -64.36 -47.63 78.58 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 110.58 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -2.12 51.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.601 1.161 . . . . 0.0 113.649 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.49 178.738 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.443 ' CE ' ' CE1' ' A' ' 172' ' ' TYR . 27.2 ttm . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.58 144.24 51.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.943 2.097 . . . . 0.0 106.344 169.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.95 146.4 50.33 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 -166.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.29 114.27 3.93 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.09 101.32 13.98 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.816 1.308 . . . . 0.0 110.665 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.84 146.65 26.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.773 1.229 . . . . 0.0 111.57 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.84 173.86 12.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.364 1.066 . . . . 0.0 109.61 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.23 139.85 8.66 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 169.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -136.83 133.18 35.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.763 1.225 . . . . 0.0 110.551 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.48 -42.24 13.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.806 0.843 . . . . 0.0 109.307 174.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.3 p -97.27 -84.24 0.38 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 p -174.83 -5.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.189 2.596 . . . . 0.0 112.104 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -67.73 -40.91 84.18 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 119.796 -1.815 . . . . 0.0 111.449 -168.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -34.86 78.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -64.74 -48.48 74.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.016 0.926 . . . . 0.0 109.918 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.3 mtm -66.76 -36.86 83.42 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.644 -0.66 . . . . 0.0 111.452 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.99 97.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.646 -0.659 . . . . 0.0 110.69 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.07 85.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.544 1.137 . . . . 0.0 111.278 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.82 -48.52 81.04 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.182 0.993 . . . . 0.0 109.238 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -59.71 -56.44 21.88 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.35 -56.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.066 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -53.78 -43.19 69.04 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.129 0.971 . . . . 0.0 110.349 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.91 -42.5 69.86 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.024 0.53 . . . . 0.0 111.144 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.8 mt -65.25 -49.83 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 108.822 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.87 -52.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.143 0.977 . . . . 0.0 110.254 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.07 112.56 0.4 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.65 -3.99 11.3 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.243 2.628 . . . . 0.0 112.639 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.98 -34.46 59.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.693 1.597 . . . . 0.0 109.546 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -27.71 6.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.152 1.781 . . . . 0.0 109.99 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.5 140.08 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.953 1.706 . . . . 0.0 109.428 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 m -132.69 129.73 39.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.28 1.7 pt? -101.39 156.78 17.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.549 1.068 . . . . 0.0 113.044 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -147.93 113.93 5.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.164 1.386 . . . . 0.0 109.142 -166.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.9 112.38 19.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.74 -10.53 20.13 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.973 0.909 . . . . 0.0 113.309 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -57.88 -29.19 64.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.115 0.871 . . . . 0.0 111.798 168.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -130.05 -33.93 1.72 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.785 1.234 . . . . 0.0 111.708 -172.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -84.04 141.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.12 0.968 . . . . 0.0 108.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.0 m -85.09 143.15 39.25 Favored Pre-proline 0 C--O 1.225 -0.218 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.79 -6.51 18.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.781 1.654 . . . . 0.0 111.736 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -54.92 -37.4 66.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.781 1.628 . . . . 0.0 111.313 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -21.22 66.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -13.65 22.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 169.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.72 -26.0 61.42 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.89 -1.131 . . . . 0.0 110.669 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -77.6 -50.3 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.062 0.847 . . . . 0.0 110.273 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.09 139.44 58.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.89 -21.93 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.23 0.538 . . . . 0.0 111.399 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.38 141.96 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.74 158.14 40.21 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.892 0.377 . . . . 0.0 110.755 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.63 122.49 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.87 134.28 55.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.77 119.11 3.08 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 117.826 -1.541 . . . . 0.0 112.725 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.89 132.54 24.22 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 119.114 1.457 . . . . 0.0 110.864 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.46 149.1 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.427 2.085 . . . . 0.0 108.297 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 m -94.52 130.15 41.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -124.54 170.93 10.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.881 1.673 . . . . 0.0 109.472 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 31.92 54.89 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.736 2.414 . . . . 0.0 115.313 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 57.23 76.65 0.31 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.111 1.364 . . . . 0.0 112.755 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.42 25.42 75.5 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.791 -0.568 . . . . 0.0 114.482 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -97.37 164.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.72 1.608 . . . . 0.0 110.318 169.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.8 mt -101.73 151.85 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 126.153 1.781 . . . . 0.0 106.461 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.1 144.08 56.91 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.65 -27.2 68.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.114 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -66.77 -26.49 66.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.806 0.843 . . . . 0.0 110.642 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -84.55 -43.05 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.27 1.028 . . . . 0.0 110.819 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.26 -36.09 63.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.443 0.565 . . . . 0.0 110.746 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -31.07 71.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.49 1.116 . . . . 0.0 112.174 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.12 -10.8 10.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.518 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.4 t-105 -53.57 -29.29 36.52 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.604 . . . . 0.0 111.621 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.8 -43.64 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.004 1.322 . . . . 0.0 111.154 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -69.24 -29.71 67.7 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.114 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.99 -31.1 64.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.086 1.312 . . . . 0.0 111.055 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.48 -28.17 64.78 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.625 0.77 . . . . 0.0 111.22 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.96 -23.59 36.01 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.511 0.724 . . . . 0.0 111.114 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.68 158.22 32.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.937 1.351 . . . . 0.0 111.961 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -91.72 99.87 12.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.866 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.77 9.08 11.96 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.17 122.16 15.94 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.98 84.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.93 1.252 . . . . 0.0 114.564 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -83.05 147.35 28.19 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.206 1.003 . . . . 0.0 110.274 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.412 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -80.99 139.11 18.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.73 123.98 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 125.016 1.326 . . . . 0.0 109.127 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.43 30.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 mt -88.78 141.58 28.38 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 118.828 0.74 . . . . 0.0 111.572 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -140.2 163.36 32.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.431 1.093 . . . . 0.0 108.5 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 179.24 38.59 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.115 -0.99 . . . . 0.0 112.519 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.8 mt -123.67 152.76 41.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.148 0.979 . . . . 0.0 108.809 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 -163.04 13.27 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.834 0.73 . . . . 0.0 111.306 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.77 117.21 7.46 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.753 2.021 . . . . 0.0 105.99 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -28.75 24.9 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.992 0.36 . . . . 0.0 111.397 -171.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.93 -45.86 55.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.164 0.585 . . . . 0.0 110.284 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.36 -36.29 17.76 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.727 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -135.24 37.8 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.75 -39.75 68.72 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 119.687 1.13 . . . . 0.0 111.322 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.41 -17.15 58.5 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 117.962 0.881 . . . . 0.0 112.626 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -129.54 13.19 5.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.031 1.732 . . . . 0.0 112.342 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -44.6 126.38 5.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.796 1.638 . . . . 0.0 110.013 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.87 25.83 2.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.186 1.395 . . . . 0.0 113.34 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.03 -37.2 84.04 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 120.402 -1.436 . . . . 0.0 110.707 -170.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.72 73.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.24 0.616 . . . . 0.0 111.961 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -60.92 -46.26 91.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.199 0.999 . . . . 0.0 110.771 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.64 99.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.9 mtm -62.08 -45.67 92.48 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 117.578 0.689 . . . . 0.0 111.607 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.518 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -65.54 -33.44 75.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.84 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -62.01 -39.53 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.246 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.11 -36.23 66.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.796 1.638 . . . . 0.0 112.192 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.9 tptt -57.51 -46.05 84.24 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.726 0.81 . . . . 0.0 109.98 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.39 -19.07 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.623 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p -61.4 -31.94 71.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.663 1.574 . . . . 0.0 111.88 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -78.36 -18.35 55.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.794 -0.566 . . . . 0.0 110.368 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -78.96 1.39 23.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.134 1.373 . . . . 0.0 112.031 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.96 65.01 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.79 0.723 . . . . 0.0 111.908 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.38 170.32 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.738 0.815 . . . . 0.0 109.603 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -118.33 135.09 54.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -102.81 147.1 27.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.5 m -127.3 175.61 8.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.58 39.09 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.822 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -72.98 150.78 42.19 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.124 1.962 . . . . 0.0 108.008 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.41 ' HE1' HD13 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -130.53 145.12 56.15 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.009 176.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.04 141.89 45.29 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 121.177 1.456 . . . . 0.0 109.238 168.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.498 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 81.9 p . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 125.81 1.644 . . . . 0.0 113.894 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -160.09 -57.0 0.06 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.799 0.727 . . . . 0.0 110.265 -169.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.353 4.3 t 58.59 10.81 1.52 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.935 2.494 . . . . 0.0 114.572 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.6 t -62.96 131.52 94.69 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.28 -13.41 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.397 2.065 . . . . 0.0 112.836 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -80.64 -48.03 1.2 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -169.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -88.04 39.06 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.089 1.859 . . . . 0.0 112.212 -168.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.32 147.04 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 119.212 0.914 . . . . 0.0 109.4 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.852 1.661 . . . . 0.0 109.794 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.81 -116.29 0.84 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.318 1.447 . . . . 0.0 107.491 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -105.21 7.89 33.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.791 1.237 . . . . 0.0 112.111 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.16 20.23 18.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.639 1.114 . . . . 0.0 112.463 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.05 -17.86 17.28 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 110.863 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.96 143.96 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.897 0.479 . . . . 0.0 110.706 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 63.1 m-85 -77.9 156.09 30.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.818 1.247 . . . . 0.0 109.111 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.2 m -66.01 -15.65 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.087 0.955 . . . . 0.0 112.315 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.02 -176.63 40.35 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 119.985 1.266 . . . . 0.0 111.763 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.41 HD13 ' HE1' ' A' ' 119' ' ' TRP . 17.8 tp -63.81 126.86 28.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.0 119.79 40.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.5 mt -113.5 146.09 40.17 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.39 131.11 55.62 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 170.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.57 30.23 7.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.243 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.47 -34.52 0.84 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -116.91 -30.77 5.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 120.131 1.332 . . . . 0.0 111.788 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -89.95 3.5 52.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.872 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -58.28 -21.88 50.51 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.298 0.954 . . . . 0.0 112.137 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.29 -24.43 42.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.277 1.031 . . . . 0.0 111.508 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -126.29 -5.8 6.58 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.735 0.814 . . . . 0.0 112.864 -170.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -56.72 -29.89 62.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.078 0.854 . . . . 0.0 110.482 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.73 -38.18 64.08 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.849 1.66 . . . . 0.0 111.731 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -36.6 23.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.745 1.218 . . . . 0.0 109.945 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -67.44 -26.37 66.37 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.986 0.915 . . . . 0.0 109.52 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.38 -57.58 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' A' ' 158' ' ' GLN . 61.7 mt-30 -49.78 -48.26 50.6 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 110.563 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -65.35 -37.46 87.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.385 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 33.8 t90 -66.36 -43.43 86.04 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -58.18 -35.44 71.6 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.568 0.747 . . . . 0.0 109.426 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -33.78 76.42 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.433 0.458 . . . . 0.0 110.047 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.79 -46.13 15.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.56 -1.21 . . . . 0.0 111.85 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 pt -65.02 -39.78 86.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.375 1.898 . . . . 0.0 109.959 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.87 -21.93 66.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.819 -0.551 . . . . 0.0 110.749 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -89.63 -42.66 11.25 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.75 -31.26 68.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.807 0.73 . . . . 0.0 109.979 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.412 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.9 mtm -86.01 -44.03 12.66 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.889 1.275 . . . . 0.0 109.029 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.5 83.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.317 1.047 . . . . 0.0 111.961 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.52 -27.54 63.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.959 1.304 . . . . 0.0 109.766 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -67.63 -31.77 72.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.558 0.617 . . . . 0.0 111.52 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.443 ' CE1' ' CE ' ' A' ' 1' ' ' MET . 2.8 m-30 -58.43 -29.91 66.48 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 O-C-N 123.745 0.653 . . . . 0.0 111.084 -167.617 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.56 140.83 30.31 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.78 146.65 48.18 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.995 2.118 . . . . 0.0 108.769 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.29 116.49 4.41 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-O 118.49 -1.172 . . . . 0.0 111.215 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 100.2 12.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.339 1.569 . . . . 0.0 110.051 172.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -98.96 145.31 27.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.454 1.502 . . . . 0.0 111.551 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -165.87 173.13 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.742 1.217 . . . . 0.0 109.014 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.22 127.88 2.89 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 172.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -128.85 131.73 47.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.714 1.606 . . . . 0.0 109.148 -170.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -84.59 -36.47 22.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.9 p -103.7 -81.65 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -177.6 -4.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.621 2.768 . . . . 0.0 112.111 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.46 -43.44 73.22 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 122.088 2.222 . . . . 0.0 111.054 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -67.89 -30.94 70.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.757 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.86 -46.41 75.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.962 0.905 . . . . 0.0 110.594 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.12 -35.67 81.53 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.42 98.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.029 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.52 74.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.808 0.843 . . . . 0.0 110.666 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.54 -47.14 85.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 122.89 0.476 . . . . 0.0 110.031 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -61.3 -55.04 36.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.788 1.235 . . . . 0.0 108.905 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.55 -56.49 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.99 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.66 70.84 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.117 0.567 . . . . 0.0 110.372 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.42 -47.01 74.61 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.827 0.451 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.21 -47.98 82.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.299 1.04 . . . . 0.0 108.898 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.03 -50.5 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.765 0.826 . . . . 0.0 110.415 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.55 114.55 0.76 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.63 2.97 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.454 2.769 . . . . 0.0 112.889 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.4 -34.36 67.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.056 1.342 . . . . 0.0 109.09 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.46 -21.43 3.83 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.44 1.496 . . . . 0.0 111.509 -169.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -93.93 142.05 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 120.828 1.649 . . . . 0.0 108.992 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.4 m -132.58 129.47 39.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.437 1.095 . . . . 0.0 110.054 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 147.77 49.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 111.539 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.91 107.16 4.35 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 107.604 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.96 112.79 20.06 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.23 -10.24 22.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.795 1.238 . . . . 0.0 112.999 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -59.93 -28.33 67.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.08 0.855 . . . . 0.0 111.847 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -129.15 -33.96 1.91 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.9 1.28 . . . . 0.0 111.882 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.21 141.71 29.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.29 1.036 . . . . 0.0 109.05 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -84.78 142.53 39.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.0 -6.28 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.481 1.454 . . . . 0.0 111.419 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -54.15 -37.84 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.986 1.721 . . . . 0.0 111.422 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -21.86 66.53 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -14.7 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.061 1.344 . . . . 0.0 112.235 169.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -72.7 -26.14 61.49 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.942 -1.099 . . . . 0.0 110.775 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -78.15 -49.21 14.3 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.869 0.759 . . . . 0.0 110.092 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -65.27 140.0 58.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.74 1.216 . . . . 0.0 108.436 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -73.04 -29.32 62.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.656 0.741 . . . . 0.0 110.827 -174.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.0 t -142.52 143.81 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.66 155.5 49.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.597 0.635 . . . . 0.0 109.512 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.76 122.21 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.37 145.58 47.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 147.3 15.79 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.754 -1.212 . . . . 0.0 115.759 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 134.35 22.03 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.67 1.988 . . . . 0.0 109.582 -169.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -84.92 140.69 8.04 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 107.274 165.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -88.58 103.99 16.42 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -88.07 169.13 12.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.832 0.853 . . . . 0.0 110.709 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 22.97 66.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.886 2.875 . . . . 0.0 115.602 167.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.63 71.29 0.56 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.367 1.067 . . . . 0.0 112.096 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.42 15.7 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.01 148.41 32.53 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.632 1.206 . . . . 0.0 109.737 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.97 153.08 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -60.98 142.84 56.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.773 0.829 . . . . 0.0 108.941 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.37 -27.85 68.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -166.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.07 -24.31 35.32 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.732 -0.605 . . . . 0.0 110.468 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -72.91 -43.76 62.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.914 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.34 -35.51 60.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.661 0.664 . . . . 0.0 110.973 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.76 71.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.538 0.735 . . . . 0.0 111.9 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.1 -11.46 10.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.98 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.8 t-105 -53.46 -28.9 32.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.73 1.612 . . . . 0.0 111.6 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.59 -43.88 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.093 1.357 . . . . 0.0 111.346 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.45 -30.01 67.82 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.092 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.6 mt -57.28 -30.46 64.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.945 1.248 . . . . 0.0 111.236 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.32 -28.47 65.19 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.689 0.796 . . . . 0.0 111.467 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.88 -24.33 35.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.184 0.594 . . . . 0.0 111.275 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.61 158.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 123.169 1.462 . . . . 0.0 112.205 -168.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -92.2 98.51 11.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.931 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -119.64 8.81 11.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.83 120.75 13.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.22 12.32 84.25 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.12 1.343 . . . . 0.0 114.12 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -79.52 148.53 31.77 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 117.659 0.729 . . . . 0.0 109.143 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 171' ' ' HIS . 4.5 mt -85.15 141.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 166.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.02 119.6 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 125.758 1.623 . . . . 0.0 107.167 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.85 116.63 31.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.127 -0.983 . . . . 0.0 108.617 168.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.08 141.89 29.1 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.19 0.904 . . . . 0.0 112.242 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -137.36 155.43 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.995 0.918 . . . . 0.0 109.162 168.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.81 172.17 36.3 Favored Glycine 0 N--CA 1.451 -0.345 0 O-C-N 120.698 -1.251 . . . . 0.0 112.296 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.78 155.83 40.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.389 1.076 . . . . 0.0 108.443 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.19 -155.64 12.96 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -149.23 140.28 22.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.589 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -90.91 -24.6 20.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.002 1.321 . . . . 0.0 113.811 178.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -33.24 43.22 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.164 1.347 . . . . 0.0 112.862 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.5 -20.73 36.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.454 1.026 . . . . 0.0 111.266 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.7 m-85 -122.37 -86.36 0.65 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.689 1.196 . . . . 0.0 108.051 -169.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.42 -53.3 3.15 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 128.719 3.056 . . . . 0.0 107.703 -168.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.5 mm-40 -64.6 -28.0 69.33 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.605 1.962 . . . . 0.0 110.776 -172.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -118.34 6.63 11.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.971 1.308 . . . . 0.0 112.228 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.56 122.22 5.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.976 1.31 . . . . 0.0 109.905 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.41 26.8 7.42 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.195 1.398 . . . . 0.0 113.056 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.47 -38.81 92.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 120.928 -1.108 . . . . 0.0 110.443 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.22 75.28 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.209 0.604 . . . . 0.0 111.907 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.4 tp -60.34 -45.93 91.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.996 0.918 . . . . 0.0 110.403 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.34 97.5 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.6 mtm -66.46 -42.6 87.34 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 118.0 0.9 . . . . 0.0 111.971 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.1 mt -63.16 -35.11 79.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.546 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -65.31 -42.44 93.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.18 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.7 -42.57 95.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.347 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -55.35 -60.67 3.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.719 1.208 . . . . 0.0 108.224 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.75 -20.36 56.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.906 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -60.96 -29.26 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.579 1.081 . . . . 0.0 110.499 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -22.21 55.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.875 -1.14 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -85.09 2.54 42.95 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 112.458 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.67 36.44 82.87 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.37 0.532 . . . . 0.0 112.12 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.8 169.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.838 0.855 . . . . 0.0 110.076 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -104.3 136.36 44.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -106.76 146.8 30.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.881 1.219 . . . . 0.0 110.658 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.85 178.09 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 123.786 0.834 . . . . 0.0 108.799 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.95 38.96 34.35 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-O 118.767 -1.019 . . . . 0.0 113.855 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -79.59 153.99 29.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.462 1.631 . . . . 0.0 109.085 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.21 149.95 75.14 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.635 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.47 140.39 39.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.44 1.426 . . . . 0.0 110.158 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.444 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 59.4 p . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 126.472 1.909 . . . . 0.0 113.503 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.03 -60.43 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.315 1.9 t 56.95 9.4 0.62 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.276 2.63 . . . . 0.0 114.19 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 p -66.82 135.97 94.41 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.832 -1.168 . . . . 0.0 108.974 169.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.98 -13.9 5.38 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.431 2.087 . . . . 0.0 113.671 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.99 -48.41 1.09 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.2 36.96 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.983 1.789 . . . . 0.0 112.965 -168.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.66 147.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.131 0.972 . . . . 0.0 109.529 -167.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.76 -172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.7 . . . . 0.0 109.372 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.01 -117.12 0.87 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.062 1.345 . . . . 0.0 107.518 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -104.88 7.45 34.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.667 1.187 . . . . 0.0 112.003 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.57 20.15 18.12 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.56 1.076 . . . . 0.0 112.787 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.36 -17.26 17.33 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.831 1.252 . . . . 0.0 111.007 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.06 145.25 50.61 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.512 0.725 . . . . 0.0 110.809 174.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 59.4 m-85 -79.84 154.61 28.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.209 1.404 . . . . 0.0 109.845 177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.98 -12.41 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.813 1.245 . . . . 0.0 112.829 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.29 -176.23 41.65 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.617 1.099 . . . . 0.0 111.863 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.0 126.8 28.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.28 121.21 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.8 mt -123.05 155.69 36.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.085 0.954 . . . . 0.0 109.512 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.511 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -137.49 120.82 16.96 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.07 3.66 44.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.553 -172.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -30.84 10.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.537 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.9 -46.61 2.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.257 0.935 . . . . 0.0 110.637 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -99.57 24.01 8.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.334 1.054 . . . . 0.0 111.31 -171.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -53.48 -29.27 35.18 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.712 0.687 . . . . 0.0 111.841 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.97 -22.85 48.82 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.922 0.889 . . . . 0.0 111.213 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.69 -31.04 11.41 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 126.497 1.919 . . . . 0.0 110.245 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.6 m -55.92 -26.11 46.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.993 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.56 -54.71 11.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.071 0.85 . . . . 0.0 109.959 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -62.55 -32.68 73.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.092 0.949 . . . . 0.0 111.793 -170.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -83.94 -24.07 30.85 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.435 1.494 . . . . 0.0 109.692 -170.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.9 mt -60.73 -52.83 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -54.84 -44.99 74.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.861 0.864 . . . . 0.0 110.582 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -71.3 -33.64 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.686 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.45 -44.39 87.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.747 176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.0 m -59.52 -36.24 75.73 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.995 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -68.79 -32.5 72.27 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 122.789 0.435 . . . . 0.0 110.564 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -79.11 -46.42 18.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.741 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.0 pt -65.0 -38.0 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 120.597 1.544 . . . . 0.0 109.838 -171.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.46 -12.26 50.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.477 0.581 . . . . 0.0 112.187 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -95.29 -46.6 6.67 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.28 -36.23 79.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.947 0.794 . . . . 0.0 110.637 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.417 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -82.04 -37.38 26.57 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.209 1.003 . . . . 0.0 110.834 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.24 -45.28 56.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 110.228 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.79 -30.07 68.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 110.084 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.421 ' CD2' HD11 ' A' ' 81' ' ' ILE . 68.0 t60 -63.98 -53.11 55.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.068 0.547 . . . . 0.0 109.822 169.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -9.3 58.83 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.681 178.224 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.53 143.49 31.98 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mtm -132.18 149.56 52.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 107.55 -170.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.16 121.23 5.24 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.759 -1.023 . . . . 0.0 110.671 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.61 113.59 25.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.826 1.313 . . . . 0.0 109.07 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 43' ' ' MET . 73.8 m-85 -109.69 145.93 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.395 1.478 . . . . 0.0 111.748 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -162.67 172.23 15.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.237 1.015 . . . . 0.0 109.602 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.36 136.58 7.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 168.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -134.52 128.82 34.09 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.813 1.245 . . . . 0.0 110.871 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.1 m -89.79 -42.26 11.38 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.933 0.493 . . . . 0.0 110.014 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -92.62 -82.33 0.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.7 p -177.13 -6.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.464 2.306 . . . . 0.0 112.559 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.42 -44.47 91.1 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 119.817 -1.802 . . . . 0.0 112.062 -168.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -37.99 88.16 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.3 -46.58 89.72 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.632 0.773 . . . . 0.0 110.316 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.6 mtm -67.34 -43.23 82.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.158 0.436 . . . . 0.0 110.979 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.5 87.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.709 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.72 80.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.776 0.83 . . . . 0.0 110.823 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.65 -44.13 93.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -63.2 -53.86 46.63 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.004 1.321 . . . . 0.0 108.992 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -53.24 -56.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.843 0.747 . . . . 0.0 110.091 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -38.29 79.75 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.385 -178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.36 -47.9 71.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.056 0.542 . . . . 0.0 111.033 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.75 -48.24 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.437 1.095 . . . . 0.0 108.674 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.1 -49.9 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 123.461 0.704 . . . . 0.0 110.25 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.97 114.31 0.77 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.19 4.15 3.52 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.48 2.787 . . . . 0.0 112.577 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.59 -34.38 67.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.225 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 -21.24 3.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.424 1.49 . . . . 0.0 111.694 -169.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.13 141.63 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.583 1.538 . . . . 0.0 108.995 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.3 m -131.56 128.91 40.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.328 1.051 . . . . 0.0 109.817 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.55 149.12 47.44 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.521 0.729 . . . . 0.0 112.048 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -146.97 111.85 5.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.995 1.718 . . . . 0.0 106.926 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.82 112.48 21.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.23 -8.79 19.15 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -59.27 -28.64 66.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.255 0.934 . . . . 0.0 111.762 168.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -132.26 -33.64 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.545 1.138 . . . . 0.0 111.973 -171.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.66 140.5 30.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 109.019 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -86.03 141.66 35.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.57 1.41 6.3 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.666 2.244 . . . . 0.0 111.695 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -59.6 -34.79 73.2 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 119.057 -2.277 . . . . 0.0 111.576 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -17.97 63.29 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 6' ' ' PHE . 15.7 mtm -59.09 -15.84 16.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 0.0 111.791 168.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 54.6 mt-10 -72.3 -26.53 62.0 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.976 -1.078 . . . . 0.0 111.529 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.96 -50.33 11.32 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.984 0.811 . . . . 0.0 110.347 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -67.68 147.19 53.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.124 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -79.13 -23.41 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.968 -0.457 . . . . 0.0 110.938 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.4 t -143.21 138.49 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.91 152.4 47.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.15 125.4 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.29 134.47 52.25 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.686 0.794 . . . . 0.0 109.321 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.54 117.54 3.64 Favored Glycine 0 N--CA 1.463 0.436 0 CA-C-O 116.989 -2.006 . . . . 0.0 111.705 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.32 126.74 27.46 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 120.168 1.984 . . . . 0.0 110.932 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.98 141.79 10.74 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.548 2.832 . . . . 0.0 108.354 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -91.23 112.03 23.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -98.53 170.46 8.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.476 1.111 . . . . 0.0 110.592 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.74 62.92 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.783 2.833 . . . . 0.0 115.449 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 57.09 74.87 0.39 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.762 1.225 . . . . 0.0 112.626 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.11 71.08 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.12 164.28 23.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.564 1.173 . . . . 0.0 108.762 168.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.12 153.27 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -59.85 141.61 55.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.57 -29.36 69.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -166.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.64 -21.17 52.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.614 -0.679 . . . . 0.0 110.283 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -77.84 -45.27 24.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.497 168.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -53.76 -36.0 61.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.182 0.593 . . . . 0.0 110.886 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.73 70.99 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.299 1.04 . . . . 0.0 112.061 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.9 -8.69 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.541 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.0 t-105 -54.31 -28.95 45.74 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 111.677 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -45.11 71.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.771 1.228 . . . . 0.0 111.646 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.43 -26.11 66.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 117.727 -1.13 . . . . 0.0 112.388 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.16 -30.95 68.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.055 1.298 . . . . 0.0 111.042 -176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -70.12 -26.92 64.18 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.238 0.615 . . . . 0.0 111.583 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.09 -23.16 33.22 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.289 0.635 . . . . 0.0 111.484 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -72.14 171.83 11.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.504 1.145 . . . . 0.0 111.073 -170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 13.7 t30 -111.78 103.26 11.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.029 1.732 . . . . 0.0 108.442 173.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -121.83 10.79 10.3 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.67 121.95 15.18 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.9 8.91 86.8 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.169 1.366 . . . . 0.0 114.605 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.79 151.19 32.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 117.976 0.888 . . . . 0.0 109.032 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.99 141.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.34 126.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.002 1.321 . . . . 0.0 108.328 176.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 110.29 22.58 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.5 142.76 27.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.925 0.784 . . . . 0.0 110.637 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -137.62 162.37 33.98 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.168 1.387 . . . . 0.0 108.163 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.1 173.64 36.77 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 121.369 -0.832 . . . . 0.0 112.119 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.8 mt -128.99 154.6 46.45 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.97 1.308 . . . . 0.0 108.087 -172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.67 -152.4 9.43 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -157.22 142.76 17.41 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.739 2.016 . . . . 0.0 107.142 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.558 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -91.98 -26.78 18.23 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.81 -32.93 63.98 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.894 1.224 . . . . 0.0 112.835 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.7 -16.52 48.45 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 124.251 0.929 . . . . 0.0 111.795 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.452 ' C ' ' H ' ' A' ' 95' ' ' GLU . 43.5 m-85 -127.54 -88.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.49 1.516 . . . . 0.0 108.761 -168.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.26 -50.74 2.8 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 129.247 3.308 . . . . 0.0 108.364 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 93' ' ' TYR . 17.7 mm-40 -68.22 -25.78 65.38 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 125.636 1.574 . . . . 0.0 110.885 -172.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -119.12 8.09 11.48 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.949 1.3 . . . . 0.0 112.449 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -46.7 123.08 4.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.191 1.397 . . . . 0.0 110.399 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 52.36 27.52 4.93 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.011 1.324 . . . . 0.0 113.122 173.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.22 -34.75 78.14 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.529 -170.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.27 71.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.453 0.701 . . . . 0.0 111.606 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.42 -47.17 85.27 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.133 0.973 . . . . 0.0 109.972 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.87 -40.87 97.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.2 mtm -66.58 -45.31 79.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.156 0.978 . . . . 0.0 112.214 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -66.48 -32.0 73.09 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.552 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -59.12 -47.93 83.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.064 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.02 -41.26 95.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.286 1.035 . . . . 0.0 111.427 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -55.4 -57.99 9.57 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 108.883 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.8 -19.63 48.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.446 -169.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -61.27 -29.13 69.66 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.109 0.868 . . . . 0.0 110.246 169.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -22.48 56.28 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.68 -1.263 . . . . 0.0 109.769 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -84.48 1.19 46.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.555 1.542 . . . . 0.0 112.36 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.95 34.87 71.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 112.155 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.74 173.02 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.956 0.902 . . . . 0.0 109.85 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -118.28 143.74 46.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.37 147.71 34.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.823 1.192 . . . . 0.0 111.62 -170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.82 -179.79 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.661 0.784 . . . . 0.0 109.945 171.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 38.41 30.64 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.807 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -77.98 151.94 33.38 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.521 1.66 . . . . 0.0 108.368 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.62 146.56 60.97 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-O 116.968 -1.491 . . . . 0.0 109.461 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.49 139.48 45.1 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 CA-C-N 120.953 1.376 . . . . 0.0 110.186 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.481 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.0 p . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 126.228 1.811 . . . . 0.0 113.931 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -164.57 -49.45 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.679 0.672 . . . . 0.0 110.09 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.305 2.5 t 58.7 9.05 1.03 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.149 2.58 . . . . 0.0 114.391 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.98 134.91 52.1 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 109.449 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -86.42 -11.37 6.09 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.53 2.154 . . . . 0.0 113.948 -172.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.46 -48.86 3.04 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -89.77 38.32 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.708 1.646 . . . . 0.0 112.113 -169.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.44 150.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.632 1.173 . . . . 0.0 110.166 -166.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.96 -172.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 126.322 1.849 . . . . 0.0 109.805 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.02 -116.64 0.85 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.123 1.369 . . . . 0.0 107.606 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.22 8.38 33.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.964 1.306 . . . . 0.0 111.957 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.17 21.0 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.875 1.226 . . . . 0.0 112.593 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -99.58 -17.36 17.88 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.781 1.232 . . . . 0.0 110.573 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.93 142.71 49.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.043 0.537 . . . . 0.0 111.305 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.3 m-85 -77.4 155.8 31.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.375 1.47 . . . . 0.0 108.926 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.24 -14.56 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.356 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -162.46 179.83 37.52 Favored Glycine 0 N--CA 1.47 0.948 0 O-C-N 119.974 -1.704 . . . . 0.0 111.987 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.9 tp -63.31 128.1 34.29 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.91 126.44 55.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.28 156.37 37.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.475 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.77 115.36 15.87 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -93.0 26.17 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.934 -168.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.7 -25.87 3.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.778 168.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.39 -36.05 3.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.343 1.429 . . . . 0.0 111.654 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -84.26 -2.82 57.63 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.863 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -55.29 -24.63 29.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.056 1.753 . . . . 0.0 112.376 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.97 -20.84 28.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.038 1.335 . . . . 0.0 112.83 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 -6.78 8.91 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.957 1.303 . . . . 0.0 113.025 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -54.23 -28.63 42.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.46 1.482 . . . . 0.0 111.329 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -52.35 -40.49 62.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.843 1.257 . . . . 0.0 111.611 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -31.49 69.25 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.33 1.852 . . . . 0.0 111.318 -177.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -92.46 -19.4 22.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.765 1.226 . . . . 0.0 110.606 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.46 -58.53 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.04 -42.57 69.33 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.861 0.864 . . . . 0.0 112.617 -174.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 p -68.16 -35.22 77.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 35.9 t90 -65.64 -45.02 84.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.041 0.924 . . . . 0.0 109.604 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.0 -34.59 70.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.336 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.42 -28.19 63.82 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.947 0.499 . . . . 0.0 110.386 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -83.55 -45.92 13.01 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.67 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -63.64 -36.96 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.945 1.702 . . . . 0.0 109.75 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.9 -12.31 35.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.51 -51.23 5.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.679 1.592 . . . . 0.0 107.795 169.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.77 -22.61 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.161 0.584 . . . . 0.0 111.752 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 68.7 mtm -93.78 -42.11 9.3 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 124.926 1.29 . . . . 0.0 111.514 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.45 -43.8 38.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.584 0.753 . . . . 0.0 110.854 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.03 -28.86 65.82 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.217 1.407 . . . . 0.0 109.603 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -61.57 -43.54 98.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.97 -1.59 57.98 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 113.454 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.384 178.217 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.19 142.98 30.79 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 mtm -131.62 147.35 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.383 1.873 . . . . 0.0 107.858 -170.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.74 119.24 5.02 Favored Glycine 0 N--CA 1.46 0.28 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 99.49 12.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.799 1.3 . . . . 0.0 109.326 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -97.86 146.79 25.09 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.704 1.202 . . . . 0.0 109.979 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -165.27 173.11 11.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.49 132.45 6.21 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 105.889 -2.885 . . . . 0.0 105.889 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -152.52 147.86 26.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -125.23 -31.98 3.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.294 1.438 . . . . 0.0 108.876 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 p -88.36 -6.51 57.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.348 1.859 . . . . 0.0 111.618 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.25 43.8 m 71.69 10.13 6.34 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 127.754 2.422 . . . . 0.0 115.144 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -65.87 -44.79 84.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.807 1.64 . . . . 0.0 111.016 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -34.96 79.57 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -65.45 -46.97 77.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.014 0.926 . . . . 0.0 110.422 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.0 mtm -63.89 -39.4 94.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.388 0.54 . . . . 0.0 110.9 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.02 99.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.739 172.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.39 76.83 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.928 0.891 . . . . 0.0 110.539 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -57.21 -47.32 81.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.013 0.525 . . . . 0.0 109.69 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.61 -54.02 45.82 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 124.598 1.186 . . . . 0.0 108.525 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.4 mt -52.94 -56.78 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 118.733 0.697 . . . . 0.0 109.562 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -38.98 72.68 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.262 0.625 . . . . 0.0 110.529 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -46.69 73.05 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.745 0.418 . . . . 0.0 111.275 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -66.17 -48.15 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.785 1.234 . . . . 0.0 108.704 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.97 -50.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.768 0.827 . . . . 0.0 110.415 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.98 115.22 0.73 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 170.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.06 3.47 3.95 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.479 2.786 . . . . 0.0 112.788 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.12 -34.35 66.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.036 1.334 . . . . 0.0 109.236 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 -23.49 3.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.838 1.655 . . . . 0.0 111.422 -169.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.55 141.04 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.696 1.589 . . . . 0.0 109.352 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -130.23 128.61 42.01 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.216 1.007 . . . . 0.0 110.043 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.38 145.26 51.24 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.98 0.912 . . . . 0.0 111.216 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -148.66 112.71 5.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -93.3 116.59 29.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -67.15 -11.12 56.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.768 -174.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -58.72 -25.82 63.32 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.6 . . . . 0.0 111.618 168.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -134.8 -31.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.804 0.842 . . . . 0.0 111.85 -167.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.12 154.12 18.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.658 1.183 . . . . 0.0 112.05 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -96.28 134.39 23.64 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 125.153 1.381 . . . . 0.0 109.715 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.45 -6.62 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 112.366 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -49.22 -40.03 32.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.441 1.473 . . . . 0.0 111.526 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -23.09 67.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -14.6 31.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.374 1.07 . . . . 0.0 112.378 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.97 -25.51 61.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.053 -1.029 . . . . 0.0 110.615 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -75.89 -49.89 16.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.23 0.923 . . . . 0.0 110.24 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -66.73 147.68 52.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.436 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.0 -28.06 60.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.829 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.7 t -144.95 142.56 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -168.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.84 160.28 32.27 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.681 0.673 . . . . 0.0 111.133 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.26 123.66 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 166.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -121.53 145.69 47.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.04 150.66 22.23 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.668 -1.253 . . . . 0.0 114.855 173.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 135.11 24.93 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.382 1.873 . . . . 0.0 109.453 -169.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.11 141.45 9.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 N-CA-C 107.64 -1.716 . . . . 0.0 107.64 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.0 m -86.33 104.92 16.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -86.89 168.77 13.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.926 1.29 . . . . 0.0 109.613 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 19.72 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.483 3.113 . . . . 0.0 115.878 166.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 56.24 72.39 0.5 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.338 1.055 . . . . 0.0 112.279 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.79 11.58 78.01 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.46 149.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.61 1.195 . . . . 0.0 110.635 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mt -84.72 153.51 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 172.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -62.19 143.47 56.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.72 -27.23 68.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.39 -28.94 31.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.635 -0.666 . . . . 0.0 110.653 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -65.55 -44.02 88.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -55.92 -37.78 69.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.37 0.532 . . . . 0.0 110.92 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.8 73.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.947 0.499 . . . . 0.0 111.761 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 m -99.64 -11.85 8.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.727 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.523 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -53.87 -28.81 38.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.184 1.793 . . . . 0.0 111.606 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.34 -43.22 64.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.267 1.427 . . . . 0.0 111.125 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.33 -31.03 70.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 117.772 -1.108 . . . . 0.0 111.843 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.1 mt -56.5 -32.76 65.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.863 1.21 . . . . 0.0 110.923 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.94 -28.53 66.73 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.375 0.67 . . . . 0.0 111.43 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.02 -25.58 34.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.327 0.651 . . . . 0.0 111.193 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 159.6 34.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.972 1.367 . . . . 0.0 112.511 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.5 98.3 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.678 -2.056 . . . . 0.0 108.694 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.09 8.8 11.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.4 120.52 12.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.4 12.85 83.93 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.984 1.278 . . . . 0.0 113.88 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -81.45 150.76 28.17 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 117.796 0.798 . . . . 0.0 109.309 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.405 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.8 mt -87.13 141.03 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.52 121.29 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 124.87 1.268 . . . . 0.0 108.052 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.95 115.73 28.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.93 -1.106 . . . . 0.0 108.328 168.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 105' ' ' HIS . 51.1 mt -91.2 140.4 29.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.195 0.907 . . . . 0.0 112.448 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -139.73 157.83 45.1 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.455 1.502 . . . . 0.0 109.405 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.02 179.53 35.5 Favored Glycine 0 CA--C 1.512 -0.129 0 O-C-N 120.668 -1.27 . . . . 0.0 112.619 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.83 153.58 40.83 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.949 0.9 . . . . 0.0 109.35 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.41 -167.98 28.89 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.85 136.19 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.585 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -86.18 -24.25 26.19 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.052 0.941 . . . . 0.0 113.356 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.8 mt -81.14 -33.25 33.29 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.779 1.172 . . . . 0.0 112.71 -169.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.1 -22.5 32.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.102 0.858 . . . . 0.0 111.039 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 95' ' ' GLU . 42.0 m-85 -125.23 -87.88 0.6 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.0 -47.95 1.98 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 128.41 2.91 . . . . 0.0 108.866 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 93' ' ' TYR . 18.3 mm-40 -65.72 -28.84 69.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.837 1.655 . . . . 0.0 110.725 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -117.46 9.14 13.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.205 1.402 . . . . 0.0 112.133 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -47.65 122.61 5.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.034 1.334 . . . . 0.0 109.582 169.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.22 25.62 5.95 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.403 1.481 . . . . 0.0 113.379 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.95 -36.97 86.09 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.98 -30.95 71.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.886 -0.509 . . . . 0.0 112.043 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.0 -45.69 91.22 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.146 0.978 . . . . 0.0 111.009 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.13 96.11 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.9 mtm -67.01 -44.39 80.44 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.132 0.966 . . . . 0.0 112.115 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -64.64 -33.04 75.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.924 0.784 . . . . 0.0 111.55 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CD2' ' HB ' ' A' ' 140' ' ' VAL . 0.2 OUTLIER -60.23 -47.49 85.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.22 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.21 -40.8 94.65 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.581 1.153 . . . . 0.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 14.1 tptt -55.21 -60.07 3.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.784 1.234 . . . . 0.0 108.795 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.29 -19.21 54.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.063 -169.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 t -61.2 -28.73 69.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.088 0.858 . . . . 0.0 110.274 169.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -21.84 55.59 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.733 -1.229 . . . . 0.0 109.992 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -85.24 1.59 47.56 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.642 1.577 . . . . 0.0 112.659 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.14 34.36 75.64 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.419 0.554 . . . . 0.0 111.897 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -86.26 170.33 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.979 0.912 . . . . 0.0 109.449 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.48 140.8 48.97 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 168.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -105.16 148.25 27.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.598 0.635 . . . . 0.0 110.531 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.97 177.43 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.22 39.18 27.59 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-O 118.441 -1.199 . . . . 0.0 113.983 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -76.35 151.7 36.57 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.704 1.752 . . . . 0.0 108.182 169.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.48 146.25 61.1 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.653 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.56 139.41 37.41 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.128 1.439 . . . . 0.0 109.52 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.442 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 64.4 p . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.019 1.728 . . . . 0.0 113.334 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -164.02 -60.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.002 0.819 . . . . 0.0 109.611 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.337 2.0 t 58.06 9.94 1.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.671 2.788 . . . . 0.0 114.768 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.9 p -66.02 139.16 96.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.785 -1.197 . . . . 0.0 108.953 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.9 -15.54 3.82 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.444 2.096 . . . . 0.0 113.383 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -80.55 -47.33 1.26 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -86.88 35.94 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.072 1.848 . . . . 0.0 112.165 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.65 148.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.92 1.288 . . . . 0.0 109.556 -167.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -172.95 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 125.978 1.711 . . . . 0.0 110.128 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.88 -116.22 0.83 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.302 1.441 . . . . 0.0 107.531 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.99 7.55 34.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.995 1.318 . . . . 0.0 111.879 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.45 18.85 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.998 1.285 . . . . 0.0 112.455 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.65 -17.59 17.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.645 1.178 . . . . 0.0 110.934 -172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.93 143.07 50.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.925 0.49 . . . . 0.0 111.212 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 58.3 m-85 -77.56 155.8 31.32 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.169 1.388 . . . . 0.0 108.658 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 105' ' ' HIS . 35.0 m -69.12 -16.35 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.763 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.88 -176.64 38.61 Favored Glycine 0 C--N 1.338 0.669 0 O-C-N 120.572 -1.33 . . . . 0.0 111.65 -172.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 21.2 tp -65.96 130.13 42.2 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.38 117.63 32.97 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.289 1.035 . . . . 0.0 108.27 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.03 153.66 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.317 1.047 . . . . 0.0 109.71 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.477 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -139.79 122.83 16.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -105.23 7.97 33.78 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.263 1.025 . . . . 0.0 110.716 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 -27.41 12.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.494 1.118 . . . . 0.0 110.39 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -124.9 -47.08 1.81 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.302 0.955 . . . . 0.0 111.025 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.18 17.14 7.37 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.7 0.8 . . . . 0.0 112.493 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -51.76 -22.88 3.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.043 0.937 . . . . 0.0 112.952 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -79.72 -25.85 41.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.846 0.858 . . . . 0.0 111.472 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -122.74 -13.12 7.98 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.241 1.017 . . . . 0.0 112.623 -171.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.1 p -55.71 -31.37 62.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.655 1.116 . . . . 0.0 110.681 -175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.58 -38.69 75.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.096 1.358 . . . . 0.0 111.476 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.46 -34.01 60.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.442 1.097 . . . . 0.0 109.414 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.72 60.26 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.676 0.79 . . . . 0.0 109.651 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.23 -60.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -56.09 -40.21 73.32 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.4 m -68.65 -33.3 73.76 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.017 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -66.28 -43.37 86.57 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.98 -34.75 72.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.794 0.837 . . . . 0.0 110.062 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.75 -31.35 68.13 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.93 0.492 . . . . 0.0 109.989 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -79.47 -45.82 18.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.515 171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 pt -64.69 -38.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 120.944 1.702 . . . . 0.0 110.032 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.4 -12.17 49.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.216 0.462 . . . . 0.0 112.18 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.92 -46.27 6.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.742 1.217 . . . . 0.0 107.893 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.3 -36.36 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.114 0.87 . . . . 0.0 110.719 -172.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' MET . . . . . 0.405 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.4 mtm -80.94 -35.15 32.66 Favored 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.941 0.896 . . . . 0.0 110.972 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -46.42 33.89 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.382 1.073 . . . . 0.0 110.335 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.1 -30.21 70.17 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.259 1.424 . . . . 0.0 110.253 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -63.25 -54.31 39.24 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.95 0.5 . . . . 0.0 110.293 169.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.31 -7.21 55.63 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -169.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 C-N-CA 123.159 0.583 . . . . 0.0 110.632 179.189 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 142.99 31.23 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -130.92 147.06 52.52 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.49 1.916 . . . . 0.0 108.18 -170.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 118.37 5.07 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-O 118.563 -1.132 . . . . 0.0 110.409 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.39 109.96 19.93 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.026 1.413 . . . . 0.0 108.573 169.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -103.25 143.91 32.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.933 1.293 . . . . 0.0 111.398 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.8 172.86 17.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.162 0.585 . . . . 0.0 110.79 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.18 139.34 8.06 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -160.52 135.29 7.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.942 1.297 . . . . 0.0 108.207 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -99.86 -27.7 13.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.226 1.011 . . . . 0.0 110.909 169.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 p -99.37 -3.15 34.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.887 1.675 . . . . 0.0 111.753 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.7 m 70.87 8.55 6.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.657 2.383 . . . . 0.0 115.126 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -63.66 -45.3 90.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.365 1.438 . . . . 0.0 110.76 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 -35.67 79.57 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.0 -46.0 91.13 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 123.463 0.705 . . . . 0.0 110.085 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.7 mtm -64.71 -39.37 93.52 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.96 -0.462 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.26 95.45 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.013 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.69 -47.69 73.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.951 0.9 . . . . 0.0 110.641 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.89 -44.23 94.33 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -63.41 -54.2 40.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 124.596 1.185 . . . . 0.0 109.321 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -52.53 -55.83 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.973 0.806 . . . . 0.0 109.614 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -39.04 79.26 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.966 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.62 -46.72 74.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.102 0.477 . . . . 0.0 111.21 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.23 -46.89 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.152 1.381 . . . . 0.0 108.484 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.37 -49.56 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.604 0.762 . . . . 0.0 110.286 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.99 115.99 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.46 1.029 . . . . 0.0 110.548 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.22 3.18 4.25 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.427 2.751 . . . . 0.0 112.48 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.82 -34.74 69.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.28 1.432 . . . . 0.0 109.253 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.84 -23.06 3.74 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.641 1.576 . . . . 0.0 111.484 -169.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.48 139.95 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 120.509 1.504 . . . . 0.0 108.652 173.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -129.14 129.54 45.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.223 1.009 . . . . 0.0 109.349 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.65 146.26 51.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.29 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -145.4 99.67 3.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -81.49 124.47 29.5 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.61 -8.62 58.15 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -37.38 62.25 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.411 1.085 . . . . 0.0 108.986 169.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -98.55 -31.48 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.884 1.673 . . . . 0.0 112.822 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.13 172.17 13.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.305 1.442 . . . . 0.0 111.299 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.0 m -92.59 155.47 42.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -79.71 -9.73 14.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.779 2.319 . . . . 0.0 111.368 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -57.1 -36.87 71.13 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.962 1.71 . . . . 0.0 111.203 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -13.15 21.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.404 1.081 . . . . 0.0 112.355 170.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -73.37 -26.4 60.99 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.798 -1.188 . . . . 0.0 111.176 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.09 -51.33 12.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.097 0.862 . . . . 0.0 110.206 -171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -66.16 142.99 57.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.301 1.44 . . . . 0.0 109.246 -169.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.05 -27.6 61.84 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.41 144.19 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.79 152.54 51.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.2 119.65 53.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.79 144.56 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.82 148.56 19.55 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.461 -1.352 . . . . 0.0 115.839 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 136.67 26.52 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.94 2.096 . . . . 0.0 109.502 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.04 141.21 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 N-CA-C 107.839 -1.639 . . . . 0.0 107.839 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.7 m -87.82 116.35 25.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -99.43 167.79 10.4 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.104 1.762 . . . . 0.0 110.164 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 13.16 75.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 130.093 3.357 . . . . 0.0 115.272 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 56.54 65.03 1.51 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.842 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.16 70.15 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.358 0.5 OUTLIER -94.28 152.92 18.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.381 1.073 . . . . 0.0 109.956 168.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mt -95.86 151.21 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.582 1.553 . . . . 0.0 106.812 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -59.78 140.41 56.56 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.39 -27.46 69.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.134 0.574 . . . . 0.0 111.947 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -28.92 64.69 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.979 0.511 . . . . 0.0 111.207 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -77.76 -42.85 32.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.676 0.79 . . . . 0.0 110.268 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -55.78 -35.9 66.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.597 0.635 . . . . 0.0 110.909 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.98 -31.56 72.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.89 0.876 . . . . 0.0 111.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.9 -12.37 8.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.689 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.508 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -54.25 -28.86 44.32 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.551 1.541 . . . . 0.0 111.656 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.49 -44.08 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.97 1.308 . . . . 0.0 111.025 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -69.21 -30.13 68.25 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.457 -1.259 . . . . 0.0 112.675 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.85 -31.55 64.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.186 1.357 . . . . 0.0 110.685 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.3 -28.56 67.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.878 0.871 . . . . 0.0 111.566 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.45 -24.42 36.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.642 0.777 . . . . 0.0 111.254 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.89 157.33 33.38 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 123.122 1.439 . . . . 0.0 112.503 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -90.64 95.88 10.37 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.53 7.78 12.77 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.06 120.94 13.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.83 -0.39 89.14 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 125.393 1.473 . . . . 0.0 114.824 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -72.35 150.48 43.44 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.035 0.918 . . . . 0.0 109.46 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.98 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.3 t -132.67 128.03 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.427 1.091 . . . . 0.0 108.655 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 118.45 36.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -90.06 142.85 27.31 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.966 0.803 . . . . 0.0 111.692 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -140.59 158.76 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.079 0.952 . . . . 0.0 108.875 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.45 -179.93 39.5 Favored Glycine 0 CA--C 1.508 -0.367 0 O-C-N 120.678 -1.264 . . . . 0.0 112.125 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.39 145.2 45.36 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.71 11.79 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 169.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -159.63 135.0 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.463 1.505 . . . . 0.0 107.224 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.486 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -88.85 -20.81 24.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.57 -47.84 68.62 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.655 1.116 . . . . 0.0 110.608 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.88 -29.13 7.43 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.491 1.043 . . . . 0.0 112.391 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -132.27 33.95 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -166.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.43 -38.77 63.47 Favored Glycine 0 N--CA 1.47 0.939 0 CA-C-N 120.024 1.284 . . . . 0.0 111.725 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.91 -17.01 62.79 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.362 1.081 . . . . 0.0 112.737 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -128.52 14.37 6.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 112.079 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.65 123.17 2.16 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.717 1.607 . . . . 0.0 109.762 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.52 27.85 2.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.939 1.296 . . . . 0.0 112.978 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.16 -37.82 86.69 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.68 -1.263 . . . . 0.0 110.628 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.92 76.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.527 0.331 . . . . 0.0 111.454 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.2 tp -60.1 -47.41 86.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.366 1.066 . . . . 0.0 110.505 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.78 98.58 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.1 mtm -64.15 -45.03 90.29 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.927 0.864 . . . . 0.0 111.829 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.508 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.9 mt -63.3 -35.14 79.37 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.345 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.23 -43.38 95.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.202 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.82 -42.1 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.776 1.23 . . . . 0.0 111.571 175.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.89 -59.85 4.17 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.679 1.191 . . . . 0.0 108.311 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.39 -20.45 54.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.871 -169.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 t -60.98 -29.09 69.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.256 0.934 . . . . 0.0 110.499 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -22.15 53.55 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.012 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -83.66 1.6 41.62 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 125.582 1.553 . . . . 0.0 112.583 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.47 31.88 68.16 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.641 0.655 . . . . 0.0 112.207 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.22 173.12 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.004 0.922 . . . . 0.0 109.193 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.51 148.6 44.25 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.32 150.49 30.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.098 0.863 . . . . 0.0 112.275 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.01 -179.7 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.718 1.207 . . . . 0.0 109.059 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.03 35.75 37.78 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-O 118.463 -1.187 . . . . 0.0 114.165 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -79.05 145.92 33.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.711 1.755 . . . . 0.0 108.713 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -120.53 148.29 47.5 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.363 170.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.41 139.16 37.35 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 CA-C-N 120.703 1.287 . . . . 0.0 109.187 168.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.438 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 72.8 p . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 125.774 1.63 . . . . 0.0 113.161 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.49 -57.74 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.364 0.984 . . . . 0.0 110.487 -171.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 4.0 t 58.17 11.07 1.41 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.282 2.633 . . . . 0.0 114.567 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -63.94 132.71 95.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -83.92 -12.23 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.718 2.278 . . . . 0.0 112.694 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -80.51 -48.83 1.19 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -88.3 38.81 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.314 2.009 . . . . 0.0 112.643 -168.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 146.72 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.205 -0.934 . . . . 0.0 110.056 -167.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.2 -172.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.107 1.763 . . . . 0.0 109.594 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.47 -117.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.988 1.315 . . . . 0.0 107.588 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -104.97 7.74 34.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.753 1.221 . . . . 0.0 112.011 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.02 20.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.572 1.082 . . . . 0.0 112.749 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -100.04 -17.47 17.48 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.746 1.218 . . . . 0.0 110.767 -172.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.55 144.67 50.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.306 0.642 . . . . 0.0 110.88 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 59.1 m-85 -79.93 154.64 28.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.147 1.379 . . . . 0.0 110.048 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.79 -12.61 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.7 1.2 . . . . 0.0 112.654 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.75 -177.69 44.06 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 119.479 1.036 . . . . 0.0 111.83 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.3 tp -64.67 127.84 33.24 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.71 107.55 16.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.48 155.21 17.03 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.56 115.89 8.51 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.55 27.13 2.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.489 -168.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 t -133.31 -19.89 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.486 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -116.76 -45.02 2.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.428 1.467 . . . . 0.0 109.309 171.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -79.62 -0.44 33.75 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.416 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.18 -25.27 21.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.018 1.735 . . . . 0.0 112.787 -171.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.7 -20.68 25.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.76 1.224 . . . . 0.0 112.738 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pp -124.48 -6.98 7.52 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.215 1.406 . . . . 0.0 113.088 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.7 m -53.49 -32.12 48.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.037 1.289 . . . . 0.0 110.24 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.94 -40.79 81.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.125 0.57 . . . . 0.0 111.455 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.68 -34.53 67.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.134 1.374 . . . . 0.0 109.564 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -78.83 -28.58 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.143 0.977 . . . . 0.0 109.224 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.71 -60.62 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -57.1 -41.08 78.27 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 118.727 0.694 . . . . 0.0 112.479 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -64.77 -36.22 83.61 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.536 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 39.9 t90 -66.35 -45.02 81.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 110.037 176.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.1 m -56.53 -37.06 69.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.168 0.987 . . . . 0.0 109.506 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.71 -29.06 66.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.474 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -80.74 -45.76 16.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.044 -0.979 . . . . 0.0 111.22 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.9 pt -64.6 -38.7 83.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 CA-C-N 120.84 1.654 . . . . 0.0 110.238 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.17 -15.2 59.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.304 0.642 . . . . 0.0 112.034 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.16 -45.88 6.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.06 -41.59 88.31 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 118.704 0.684 . . . . 0.0 109.574 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.4 mtm -76.27 -38.01 56.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.706 0.803 . . . . 0.0 110.837 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.76 66.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.813 0.845 . . . . 0.0 109.927 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.58 -30.38 70.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.452 1.501 . . . . 0.0 109.921 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -63.28 -47.46 82.23 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 118.558 0.617 . . . . 0.0 110.502 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -2.74 47.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.775 1.23 . . . . 0.0 113.688 -175.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.418 179.519 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.95 141.46 44.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.138 1.375 . . . . 0.0 108.652 169.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm -120.68 147.59 45.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.291 2.237 . . . . 0.0 108.657 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.84 120.1 5.61 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.666 -1.075 . . . . 0.0 110.711 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 116.03 27.28 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 118.828 1.314 . . . . 0.0 108.601 169.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.37 147.25 35.59 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.807 1.643 . . . . 0.0 111.403 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -161.99 173.88 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.023 0.929 . . . . 0.0 110.81 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.35 138.51 7.98 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -140.68 131.61 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.34 1.456 . . . . 0.0 108.715 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.4 m -90.33 -36.85 14.42 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -94.58 -84.99 0.31 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.2 p -174.68 -6.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.739 2.016 . . . . 0.0 113.106 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -68.85 -42.39 77.18 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 119.839 -1.788 . . . . 0.0 112.249 -168.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -35.78 82.28 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.25 -47.55 83.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.4 mtm -66.69 -41.06 88.63 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.906 -0.496 . . . . 0.0 111.295 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.19 92.33 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 118.835 -0.603 . . . . 0.0 110.655 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.41 79.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.979 0.912 . . . . 0.0 110.872 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -58.68 -43.97 90.09 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.09 -55.32 26.42 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.813 1.245 . . . . 0.0 108.81 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -52.51 -56.66 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 119.018 0.826 . . . . 0.0 109.832 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -38.98 77.12 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.759 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.51 -47.22 70.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 122.737 0.415 . . . . 0.0 111.553 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mt -66.12 -45.56 90.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.743 1.217 . . . . 0.0 108.456 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.35 -51.81 27.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.636 0.774 . . . . 0.0 110.484 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.3 114.06 0.75 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.432 1.015 . . . . 0.0 110.592 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.28 3.61 3.97 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.351 2.701 . . . . 0.0 112.693 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.97 -35.05 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.222 1.409 . . . . 0.0 109.118 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -24.7 5.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.876 1.67 . . . . 0.0 111.438 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.77 140.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 121.103 1.774 . . . . 0.0 109.242 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 m -130.69 130.13 43.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.541 1.137 . . . . 0.0 109.788 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.79 148.53 46.18 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.734 0.814 . . . . 0.0 112.06 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.56 115.14 10.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.872 1.669 . . . . 0.0 108.666 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.16 100.57 9.15 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.96 -21.65 66.43 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.844 1.656 . . . . 0.0 112.847 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -60.41 -28.84 68.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 112.468 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -109.89 -32.51 7.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.339 1.056 . . . . 0.0 112.993 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.63 167.62 16.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.636 1.175 . . . . 0.0 111.476 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -93.46 147.41 33.62 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.812 1.645 . . . . 0.0 109.07 -170.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -76.0 -1.52 11.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.588 1.525 . . . . 0.0 111.107 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -55.97 -33.74 65.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 122.346 2.339 . . . . 0.0 111.908 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.39 -19.87 65.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 ttm -58.91 -16.04 15.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.913 2.085 . . . . 0.0 111.627 169.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.37 -27.69 56.51 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.241 -0.912 . . . . 0.0 110.753 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.88 -51.55 12.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.751 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.36 133.18 47.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.01 -10.2 53.71 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.22 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.4 t -134.09 143.84 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.9 mt -140.34 149.05 42.24 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.8 121.63 56.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.63 147.08 44.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.93 147.49 17.36 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 119.589 -1.291 . . . . 0.0 115.66 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.5 135.93 23.13 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 126.894 2.078 . . . . 0.0 109.602 -171.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.97 144.02 7.07 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 165.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.9 m -88.73 117.21 27.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -98.77 169.95 9.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.592 1.157 . . . . 0.0 110.561 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 22.72 64.99 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.915 2.886 . . . . 0.0 115.517 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.75 70.8 0.6 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.586 1.154 . . . . 0.0 112.097 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.42 17.3 79.77 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.81 151.26 27.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.314 1.054 . . . . 0.0 109.555 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.31 153.03 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -61.14 141.02 57.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.862 0.839 . . . . 0.0 108.774 170.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.62 -27.4 68.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -166.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.11 -23.63 35.58 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.063 0.545 . . . . 0.0 110.391 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -73.44 -43.95 59.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -53.51 -34.24 57.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.336 0.655 . . . . 0.0 111.084 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.18 71.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 111.862 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 m -104.98 -9.36 9.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.566 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.6 t-105 -53.09 -29.49 30.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.708 1.603 . . . . 0.0 111.932 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.42 -43.81 76.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.33 -29.76 66.55 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.247 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -58.02 -31.03 66.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.828 1.194 . . . . 0.0 111.157 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.77 -26.92 62.63 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.549 0.74 . . . . 0.0 111.558 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.22 -22.34 35.96 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.316 0.646 . . . . 0.0 110.934 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.1 mt -73.93 156.89 37.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.982 1.372 . . . . 0.0 112.313 -167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.08 97.45 11.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.666 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -119.26 8.92 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.08 123.9 20.25 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.36 9.0 87.08 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.494 1.521 . . . . 0.0 114.329 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.48 146.94 34.12 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.646 0.723 . . . . 0.0 109.617 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 171' ' ' HIS . 4.9 mt -85.62 139.02 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 167.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.41 132.43 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 124.867 1.267 . . . . 0.0 109.143 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.03 119.46 37.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.69 143.82 26.49 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.122 0.874 . . . . 0.0 112.032 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.94 157.81 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.095 0.958 . . . . 0.0 109.253 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.68 177.04 38.1 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 120.452 -1.405 . . . . 0.0 112.849 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.69 157.24 36.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.195 0.998 . . . . 0.0 108.478 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.12 -152.75 9.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -154.73 135.13 13.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.548 1.539 . . . . 0.0 107.493 166.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -87.47 -22.83 24.7 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.733 1.213 . . . . 0.0 113.277 -178.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.5 mt -77.59 -40.19 43.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 120.016 1.28 . . . . 0.0 111.556 -171.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.43 -28.4 11.57 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.814 1.197 . . . . 0.0 112.166 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.78 34.61 3.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -168.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.06 61.11 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 119.99 1.268 . . . . 0.0 111.381 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.53 -16.4 55.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.757 0.778 . . . . 0.0 112.169 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.7 10.01 7.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.506 1.922 . . . . 0.0 112.112 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -47.5 124.01 6.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.38 1.472 . . . . 0.0 109.411 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.55 27.48 5.13 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 124.42 1.075 . . . . 0.0 112.781 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.09 -37.39 87.34 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.505 -1.372 . . . . 0.0 110.605 -172.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.36 75.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.917 0.487 . . . . 0.0 111.696 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.72 -47.62 84.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.167 0.987 . . . . 0.0 110.29 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.78 97.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.4 mtm -64.97 -42.76 94.3 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 117.853 0.827 . . . . 0.0 111.864 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.566 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.8 mt -66.0 -33.78 76.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.814 1.188 . . . . 0.0 111.856 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -62.3 -40.64 96.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.741 -0.599 . . . . 0.0 110.334 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.81 -35.07 69.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.432 1.493 . . . . 0.0 111.813 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -58.11 -43.98 87.48 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.614 0.765 . . . . 0.0 109.916 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.4 mt -98.58 -18.16 18.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.917 -1.039 . . . . 0.0 112.446 -170.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p -60.64 -32.23 71.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 111.611 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -79.8 -18.74 50.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.1 0.56 . . . . 0.0 110.23 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -79.33 1.42 25.18 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.408 1.483 . . . . 0.0 111.969 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.83 63.86 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 118.601 0.637 . . . . 0.0 111.883 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.2 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.827 0.851 . . . . 0.0 109.376 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -118.27 141.33 48.63 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -106.15 147.14 29.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.336 0.971 . . . . 0.0 111.526 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.35 177.76 5.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.715 1.206 . . . . 0.0 108.921 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.35 35.73 32.63 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.389 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -79.86 146.87 31.97 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.888 1.844 . . . . 0.0 109.138 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -122.82 148.57 54.09 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 124.986 1.314 . . . . 0.0 108.488 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.71 138.07 31.18 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.585 1.524 . . . . 0.0 110.465 169.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 48.0 p . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 126.381 1.872 . . . . 0.0 112.939 176.75 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -165.2 -57.57 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.907 0.883 . . . . 0.0 108.929 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.339 2.1 t 59.71 10.52 2.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.873 2.869 . . . . 0.0 114.895 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.7 p -67.33 139.12 94.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.867 -1.146 . . . . 0.0 108.683 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -86.91 -14.79 4.08 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.245 1.963 . . . . 0.0 113.532 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -81.7 -46.68 1.05 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -86.31 38.35 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.979 1.786 . . . . 0.0 112.395 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 146.52 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.183 0.993 . . . . 0.0 108.988 -167.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -172.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.737 1.615 . . . . 0.0 109.708 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.98 -116.01 0.82 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.479 1.512 . . . . 0.0 107.371 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.03 7.63 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.886 1.274 . . . . 0.0 111.881 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.72 20.84 17.97 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.94 1.257 . . . . 0.0 112.601 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.56 -16.8 17.36 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.945 1.298 . . . . 0.0 110.844 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.99 145.3 50.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.427 0.691 . . . . 0.0 110.882 174.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -80.18 153.91 28.31 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.715 1.606 . . . . 0.0 109.295 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.4 m -66.7 -12.55 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 112.599 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.99 -177.42 43.16 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.523 1.056 . . . . 0.0 112.019 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 20.0 tp -66.15 129.64 40.52 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.99 123.53 48.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 157.63 27.76 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.478 1.111 . . . . 0.0 108.136 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.424 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -142.93 120.04 11.43 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -98.19 12.8 33.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -21.5 11.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.196 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.4 -40.7 1.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.366 1.439 . . . . 0.0 113.249 172.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -80.63 4.92 17.02 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.386 0.994 . . . . 0.0 112.57 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.12 -25.02 28.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.439 1.472 . . . . 0.0 112.663 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.77 -26.05 49.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.749 1.22 . . . . 0.0 111.5 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.21 -6.49 6.56 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.321 1.049 . . . . 0.0 112.753 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.1 m -51.76 -33.8 36.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.208 1.367 . . . . 0.0 110.172 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.48 -42.65 78.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.836 1.255 . . . . 0.0 111.516 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -75.08 -33.43 61.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.797 1.239 . . . . 0.0 109.817 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -76.26 -30.98 58.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.704 -0.623 . . . . 0.0 109.651 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.9 -55.96 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.18 -43.1 87.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -65.21 -35.19 80.28 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.971 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.3 t90 -66.05 -45.3 81.9 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.841 0.829 . . . . 0.0 110.247 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 84.5 m -57.09 -36.48 70.64 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.161 0.985 . . . . 0.0 109.416 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.44 -28.65 66.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.323 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -81.27 -45.36 16.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.407 171.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.5 pt -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 120.923 1.692 . . . . 0.0 110.008 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.58 -14.14 56.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.835 -0.541 . . . . 0.0 112.108 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -94.47 -46.9 6.8 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.7 -34.79 76.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.681 0.673 . . . . 0.0 110.477 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 73.0 mtm -81.39 -43.12 19.44 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.32 1.048 . . . . 0.0 110.182 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.12 72.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.054 0.942 . . . . 0.0 111.222 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.06 -30.51 66.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.802 1.241 . . . . 0.0 109.607 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.406 ' CD2' HD11 ' A' ' 81' ' ' ILE . 67.5 t60 -66.45 -47.61 72.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -12.0 61.23 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.506 1.122 . . . . 0.0 113.388 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 C-N-CA 122.962 0.505 . . . . 0.0 110.793 -178.49 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.48 144.08 29.8 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 mtm -131.21 146.11 52.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.621 1.969 . . . . 0.0 107.854 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.42 117.22 4.98 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-O 118.478 -1.179 . . . . 0.0 110.628 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.63 115.41 26.14 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.245 1.522 . . . . 0.0 108.461 169.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.39 146.36 37.27 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.198 1.399 . . . . 0.0 111.382 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -161.93 176.44 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.166 0.986 . . . . 0.0 110.755 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.7 144.51 12.53 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 p -152.67 139.82 19.32 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.64 1.22 . . . . 0.0 112.647 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.7 m -99.87 -34.72 10.02 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.7 p -93.59 0.59 56.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.133 0.973 . . . . 0.0 111.86 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m 65.4 13.36 8.78 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.869 2.068 . . . . 0.0 113.538 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.37 -48.43 77.96 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.217 -1.552 . . . . 0.0 111.149 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -32.82 74.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.27 -48.75 80.46 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 109.679 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -65.35 -40.41 93.59 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.05 -0.406 . . . . 0.0 111.133 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.52 98.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.872 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.03 -47.42 77.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.279 1.032 . . . . 0.0 110.764 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.89 -45.23 90.74 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -61.77 -56.5 18.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 124.825 1.328 . . . . 0.0 108.994 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -51.96 -56.08 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 118.649 0.659 . . . . 0.0 110.108 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.93 78.31 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.27 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.06 -47.47 74.22 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.802 0.441 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.8 mt -65.74 -47.42 85.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.502 1.121 . . . . 0.0 108.966 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.8 mt -72.35 -49.26 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.605 0.762 . . . . 0.0 110.173 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.09 115.57 0.89 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.599 1.095 . . . . 0.0 110.47 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.38 3.85 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.412 2.742 . . . . 0.0 112.814 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.68 -34.55 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.943 1.297 . . . . 0.0 109.054 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.99 -21.35 4.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 111.639 -169.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.21 141.33 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.592 1.542 . . . . 0.0 108.944 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -131.56 128.83 40.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.436 1.094 . . . . 0.0 109.974 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.49 148.78 46.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.932 0.893 . . . . 0.0 112.034 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.73 110.89 6.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.582 1.953 . . . . 0.0 107.081 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.55 109.97 19.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.0 mt -66.17 -8.54 24.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -58.93 -29.14 66.88 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.113 0.87 . . . . 0.0 111.425 169.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -132.45 -33.79 1.24 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 111.995 -172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -80.95 139.96 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 m -84.27 139.94 39.18 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -74.31 -0.39 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.256 1.484 . . . . 0.0 111.107 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -56.84 -33.16 66.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.939 2.154 . . . . 0.0 112.208 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -19.45 65.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.9 ttm -58.59 -16.22 14.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.752 2.021 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 69.0 mt-10 -74.1 -29.29 61.78 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.028 -1.045 . . . . 0.0 111.095 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -76.75 -47.15 22.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.852 0.751 . . . . 0.0 109.974 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.26 139.23 57.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.601 -1.181 . . . . 0.0 107.968 -169.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.54 -26.96 61.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.228 0.537 . . . . 0.0 110.272 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -141.35 147.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -139.29 150.59 45.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.964 0.505 . . . . 0.0 109.985 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.4 120.48 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 170.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.29 138.61 53.59 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 108.629 -172.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.23 122.56 3.5 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-O 118.239 -1.312 . . . . 0.0 112.442 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.99 130.93 24.04 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 118.613 1.206 . . . . 0.0 109.963 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -84.84 146.63 10.47 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 108.387 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 m -88.33 129.57 35.35 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -119.7 170.65 9.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.091 1.757 . . . . 0.0 109.618 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 27.36 57.65 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.255 2.622 . . . . 0.0 115.265 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 56.85 76.99 0.28 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.983 1.313 . . . . 0.0 112.247 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.42 14.23 71.68 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.41 160.07 21.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.603 1.161 . . . . 0.0 109.666 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -97.4 152.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.55 144.0 55.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 171.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.54 -28.59 69.96 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.164 0.586 . . . . 0.0 112.354 -168.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.73 -24.33 63.54 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.925 -0.484 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -83.37 -42.8 16.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.933 0.893 . . . . 0.0 110.866 170.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.55 -35.49 65.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.624 0.647 . . . . 0.0 110.818 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.02 71.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.596 1.158 . . . . 0.0 111.88 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 m -106.07 -11.64 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.68 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.514 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -52.89 -29.06 26.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.693 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.79 -46.56 65.47 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.15 1.38 . . . . 0.0 111.248 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.79 -29.53 69.5 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 117.435 -1.269 . . . . 0.0 112.14 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 mt -56.36 -35.91 68.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.798 1.181 . . . . 0.0 110.867 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.48 -33.14 75.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.384 0.674 . . . . 0.0 111.701 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.78 -12.92 43.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 111.184 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.28 171.38 12.24 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.381 1.086 . . . . 0.0 110.65 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.43 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 6.2 t30 -111.02 98.82 7.82 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.812 1.645 . . . . 0.0 107.641 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -118.77 6.29 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -65.12 112.86 3.58 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.48 -3.21 68.5 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.849 1.69 . . . . 0.0 116.076 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -75.36 155.12 36.8 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.537 1.168 . . . . 0.0 110.115 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 mt -89.41 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.44 133.33 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.676 1.19 . . . . 0.0 109.416 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.8 117.41 33.34 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.11 142.75 27.41 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 119.023 0.829 . . . . 0.0 111.752 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.75 159.89 41.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.222 1.009 . . . . 0.0 108.878 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.02 177.51 39.05 Favored Glycine 0 N--CA 1.447 -0.578 0 O-C-N 121.14 -0.975 . . . . 0.0 112.207 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.77 153.67 42.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.17 -158.15 10.75 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -152.2 141.08 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.094 1.358 . . . . 0.0 109.141 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.578 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -87.35 -22.36 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.37 -39.92 70.95 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.931 1.241 . . . . 0.0 112.265 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.97 -18.44 31.86 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.171 0.891 . . . . 0.0 111.512 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.473 ' C ' ' H ' ' A' ' 95' ' ' GLU . 41.3 m-85 -126.93 -89.91 0.54 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.939 1.296 . . . . 0.0 108.13 -169.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.58 -50.21 2.47 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 128.497 2.951 . . . . 0.0 107.936 -168.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 93' ' ' TYR . 15.9 mm-40 -67.77 -28.42 67.6 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.365 1.866 . . . . 0.0 110.767 -175.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -117.53 6.61 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.651 1.181 . . . . 0.0 112.349 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -43.96 121.87 2.61 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.496 1.518 . . . . 0.0 109.592 168.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 52.85 25.88 4.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.588 1.155 . . . . 0.0 113.512 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.47 -36.0 82.59 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.516 -1.365 . . . . 0.0 110.603 -172.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.69 74.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.255 0.622 . . . . 0.0 112.06 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.48 -46.49 89.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.141 0.976 . . . . 0.0 110.413 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.21 97.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 mtm -67.14 -42.73 83.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.841 0.821 . . . . 0.0 112.239 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.514 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.5 mt -63.49 -36.15 82.82 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.201 172.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -63.6 -41.25 98.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.973 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.18 -43.19 92.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -55.6 -58.44 7.8 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.97 -20.27 58.03 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.728 -0.608 . . . . 0.0 110.385 -169.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t -62.95 -29.66 70.97 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.846 0.748 . . . . 0.0 110.022 167.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.0 -27.38 39.58 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.047 1.294 . . . . 0.0 108.427 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -73.58 2.47 7.91 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.503 1.121 . . . . 0.0 113.176 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.35 85.96 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.427 1.012 . . . . 0.0 112.378 169.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.66 173.75 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.795 0.838 . . . . 0.0 109.304 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 145.75 45.2 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 165.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.96 150.1 28.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.854 0.752 . . . . 0.0 111.878 -169.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.7 m -127.47 179.59 3.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 109.304 169.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 36.24 43.4 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.532 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -71.73 153.52 41.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.091 1.445 . . . . 0.0 108.139 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.411 ' HE1' HD12 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -133.23 145.87 58.56 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-O 116.944 -1.503 . . . . 0.0 108.835 169.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.68 140.46 39.29 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 CA-C-N 120.895 1.355 . . . . 0.0 109.618 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 80.6 p . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 113.583 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -163.9 -50.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.952 0.796 . . . . 0.0 110.275 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.303 2.8 t 57.79 8.93 0.77 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.479 2.712 . . . . 0.0 114.512 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -83.55 144.51 46.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.977 1.311 . . . . 0.0 110.861 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -88.94 -12.52 3.4 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.895 2.397 . . . . 0.0 113.775 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -50.91 3.77 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 117.916 -1.04 . . . . 0.0 113.402 -168.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -88.29 38.98 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.751 1.634 . . . . 0.0 112.091 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 148.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.083 -1.011 . . . . 0.0 110.241 -166.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.37 -172.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 126.361 1.864 . . . . 0.0 109.981 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.03 -116.03 0.81 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.486 1.515 . . . . 0.0 107.327 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.09 8.14 34.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.579 1.152 . . . . 0.0 111.889 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.87 21.03 19.69 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.993 1.282 . . . . 0.0 112.506 -173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -100.06 -18.16 17.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 110.837 -172.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.86 143.31 50.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.303 0.641 . . . . 0.0 111.328 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.8 m-85 -78.14 155.39 30.5 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.076 1.35 . . . . 0.0 109.457 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.5 -14.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.546 1.138 . . . . 0.0 112.804 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.32 -178.3 42.4 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 119.65 1.114 . . . . 0.0 112.184 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 HD12 ' HE1' ' A' ' 119' ' ' TRP . 28.2 tp -64.97 130.29 42.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.33 117.96 31.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.13 152.52 34.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.433 1.093 . . . . 0.0 109.164 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.72 124.06 13.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -99.26 15.05 27.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.235 1.014 . . . . 0.0 110.576 -169.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 t -123.04 -22.27 5.25 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.578 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.2 -48.54 2.96 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.759 1.223 . . . . 0.0 108.041 171.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -105.21 22.64 15.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.641 1.577 . . . . 0.0 112.474 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -52.6 -25.78 11.62 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.826 0.739 . . . . 0.0 112.279 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.09 -25.32 52.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.781 . . . . 0.0 111.478 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -125.02 -14.44 6.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.5 m -57.67 -28.95 64.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.098 1.317 . . . . 0.0 109.769 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.23 -49.21 78.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.595 0.758 . . . . 0.0 111.06 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -66.7 -33.17 75.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.081 0.943 . . . . 0.0 109.329 -171.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -79.13 -23.46 44.01 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.219 -174.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.59 -53.71 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -53.64 -47.07 70.67 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 123.636 0.775 . . . . 0.0 110.136 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.9 m -66.83 -36.79 83.17 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.146 0.278 . . . . 0.0 110.521 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -65.79 -46.06 80.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.716 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.3 m -58.04 -34.55 70.2 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -31.81 71.9 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.028 0.531 . . . . 0.0 110.601 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -83.03 -45.52 13.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.942 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.24 -37.82 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 120.849 1.658 . . . . 0.0 110.048 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.83 -11.8 30.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -49.82 5.72 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 125.704 1.601 . . . . 0.0 108.088 169.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.33 -28.44 70.01 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.951 -0.468 . . . . 0.0 110.913 -169.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.2 mtm -89.34 -40.71 12.59 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 124.132 0.973 . . . . 0.0 111.429 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.28 33.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.575 0.75 . . . . 0.0 110.784 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.0 -29.72 63.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.233 1.413 . . . . 0.0 109.452 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -63.06 -49.79 73.16 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.227 0.467 . . . . 0.0 109.914 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -2.4 34.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.332 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.648 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.5 141.5 31.6 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtm -129.17 145.05 51.4 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.582 1.953 . . . . 0.0 108.489 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.48 115.52 4.09 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.99 121.63 28.05 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -115.63 144.7 43.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.335 1.054 . . . . 0.0 111.679 171.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -156.62 169.88 23.67 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.762 1.225 . . . . 0.0 110.29 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.33 138.57 8.02 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 p -142.05 136.47 30.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.707 1.203 . . . . 0.0 109.814 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -92.75 -39.23 11.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.14 0.976 . . . . 0.0 110.09 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -85.99 -86.34 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 p -177.76 4.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.04 3.336 . . . . 0.0 110.763 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -67.27 -45.43 76.66 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.091 -1.631 . . . . 0.0 111.59 -166.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -34.28 77.11 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -60.98 -47.67 85.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.302 0.641 . . . . 0.0 110.151 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -64.89 -40.43 95.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 122.217 -0.302 . . . . 0.0 111.035 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.07 97.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.824 -0.607 . . . . 0.0 110.623 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.97 -45.7 78.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.085 0.954 . . . . 0.0 110.971 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.86 -45.21 93.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -63.43 -57.55 9.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.699 1.249 . . . . 0.0 108.84 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -51.92 -55.53 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 118.248 0.476 . . . . 0.0 110.015 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -38.23 74.52 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.868 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.77 -48.79 65.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.826 0.451 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.76 -46.32 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 108.788 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -71.14 -50.14 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 110.038 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.08 114.9 0.8 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.57 1.33 5.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.326 2.684 . . . . 0.0 112.458 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.22 -33.83 65.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 109.404 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.04 -19.63 3.94 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.43 -169.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.63 141.61 15.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.702 1.592 . . . . 0.0 108.755 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.6 m -131.66 129.03 40.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.75 145.53 25.56 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.17 127.55 30.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.007 2.123 . . . . 0.0 107.935 -168.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.26 88.2 3.07 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.724 1.609 . . . . 0.0 107.373 -168.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.45 -16.11 21.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.925 1.29 . . . . 0.0 114.352 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -13.55 62.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.721 -0.612 . . . . 0.0 112.45 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -129.75 -35.43 1.68 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.313 1.445 . . . . 0.0 112.145 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -81.56 145.08 30.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.054 1.342 . . . . 0.0 109.553 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.82 147.69 59.26 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -76.1 -8.95 19.12 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.431 2.087 . . . . 0.0 111.029 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -55.05 -36.54 65.67 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.699 1.59 . . . . 0.0 111.325 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -22.94 67.13 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.119 -0.988 . . . . 0.0 113.397 176.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -14.15 31.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -73.06 -26.65 61.36 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.767 -1.208 . . . . 0.0 110.716 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -76.75 -51.11 12.02 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.524 1.056 . . . . 0.0 109.97 -171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -66.01 142.02 57.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.615 -169.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.73 -24.0 56.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.806 0.812 . . . . 0.0 111.611 -172.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.31 144.18 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -172.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.56 153.21 51.83 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.672 0.669 . . . . 0.0 110.47 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.54 120.03 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -118.84 132.4 56.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -172.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.18 116.32 3.02 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-O 117.793 -1.56 . . . . 0.0 112.571 -173.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.49 121.45 32.04 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 119.314 1.557 . . . . 0.0 110.758 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -76.8 146.41 26.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.941 2.427 . . . . 0.0 108.941 168.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -94.06 139.81 30.5 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -133.05 167.73 19.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.624 2.37 . . . . 0.0 109.905 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 27.5 56.7 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 129.244 3.018 . . . . 0.0 116.663 167.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . 0.253 3.0 m-85 51.97 81.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.14 2.576 . . . . 0.0 112.093 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.81 16.9 79.18 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.8 152.89 22.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.254 1.022 . . . . 0.0 108.324 168.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -87.03 156.97 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.36 138.47 50.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.53 -24.86 67.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -165.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -86.01 -26.9 25.15 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.738 -0.602 . . . . 0.0 110.552 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -67.26 -40.74 86.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.34 -32.32 64.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.85 0.46 . . . . 0.0 111.148 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.41 72.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.274 0.63 . . . . 0.0 111.869 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -98.95 -11.52 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.517 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -54.48 -28.79 47.15 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.509 1.524 . . . . 0.0 111.886 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.16 -44.09 66.2 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.042 1.337 . . . . 0.0 111.309 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -69.41 -29.77 67.59 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.057 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.64 -31.38 64.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.188 1.358 . . . . 0.0 111.225 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.82 -29.17 68.27 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.838 0.855 . . . . 0.0 111.479 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.93 -24.17 35.76 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 111.441 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.1 157.65 34.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 123.013 1.387 . . . . 0.0 112.326 -167.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -92.12 97.01 10.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.766 -2.016 . . . . 0.0 108.778 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -119.34 8.08 11.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.57 120.89 13.21 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -170.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.56 87.0 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.363 1.459 . . . . 0.0 114.287 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -76.99 145.55 37.98 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 117.775 0.787 . . . . 0.0 109.239 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.1 mt -84.27 138.07 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.66 127.39 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 124.722 1.209 . . . . 0.0 108.835 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.48 117.78 34.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.5 mt -89.86 141.76 28.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.182 0.901 . . . . 0.0 111.557 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -137.04 159.58 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.19 0.996 . . . . 0.0 109.289 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.56 173.43 37.11 Favored Glycine 0 N--CA 1.45 -0.392 0 O-C-N 121.268 -0.895 . . . . 0.0 111.857 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.0 154.37 48.24 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.296 1.438 . . . . 0.0 107.632 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.26 -155.6 11.86 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -131.84 121.23 23.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.089 3.356 . . . . 0.0 105.997 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -25.25 15.27 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 119.986 1.266 . . . . 0.0 112.836 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -79.09 -41.22 29.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.196 0.198 . . . . 0.0 110.729 -169.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.53 -34.21 36.37 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 118.539 -1.145 . . . . 0.0 111.501 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 96' ' ' TRP 0.277 0.0 OUTLIER -153.87 41.89 0.53 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.84 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.16 -24.73 5.03 Favored Glycine 0 N--CA 1.475 1.29 0 O-C-N 119.646 -1.909 . . . . 0.0 114.069 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 -27.06 6.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.806 1.242 . . . . 0.0 111.497 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TRP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 19.9 m-90 -119.22 -55.31 2.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 116.173 -1.87 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.8 t80 7.27 122.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 130.066 3.346 . . . . 0.0 115.8 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.85 30.07 16.6 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.536 1.534 . . . . 0.0 111.655 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.57 -39.09 91.25 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.938 -1.101 . . . . 0.0 110.685 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.53 72.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 111.34 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.28 -47.79 84.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.54 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.47 -39.93 96.99 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 mtm -65.92 -44.66 84.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 117.918 0.859 . . . . 0.0 112.23 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.517 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -64.29 -34.77 78.9 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.494 173.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.4 -42.34 98.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.048 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.59 -42.86 91.2 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.538 1.135 . . . . 0.0 111.695 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.33 -58.6 6.77 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.631 1.172 . . . . 0.0 108.41 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 mt -78.14 -20.7 51.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.434 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 t -61.32 -28.64 69.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.365 0.984 . . . . 0.0 110.502 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -22.73 50.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.873 1.215 . . . . 0.0 109.787 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -83.35 1.26 42.14 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.854 1.662 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.67 34.04 66.93 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.458 0.572 . . . . 0.0 111.731 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.13 169.07 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.705 0.752 . . . . 0.0 109.38 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -116.13 143.85 44.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -112.34 148.01 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.73 1.15 . . . . 0.0 112.138 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.52 -179.39 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.194 0.998 . . . . 0.0 109.589 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.95 35.72 38.27 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-O 118.473 -1.182 . . . . 0.0 113.987 172.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -78.55 148.59 33.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.48 1.64 . . . . 0.0 108.587 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -124.91 148.1 58.71 Favored Pre-proline 0 CA--C 1.516 -0.35 0 CA-C-O 117.26 -1.352 . . . . 0.0 108.786 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.82 139.3 43.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 N-CA-C 108.877 -1.24 . . . . 0.0 108.877 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.4 p . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.443 1.497 . . . . 0.0 113.289 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 127' ' ' THR . 2.7 p90 -165.11 -69.67 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.426 ' N ' ' CG ' ' A' ' 126' ' ' PHE 0.353 2.8 t 58.62 12.17 2.05 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.11 2.964 . . . . 0.0 114.384 -170.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.3 p -64.59 141.2 98.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.742 -1.224 . . . . 0.0 110.172 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -88.46 -15.28 2.89 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.854 2.37 . . . . 0.0 113.558 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 -49.54 1.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.034 -0.984 . . . . 0.0 113.466 -168.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -91.58 44.37 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.866 1.711 . . . . 0.0 112.266 -168.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 146.56 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 120.944 -1.097 . . . . 0.0 109.467 -168.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -172.7 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.843 1.657 . . . . 0.0 109.819 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.18 -116.3 0.82 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.162 1.385 . . . . 0.0 107.546 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -105.37 7.46 33.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.965 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.84 20.73 18.01 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.779 1.181 . . . . 0.0 112.838 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.55 -17.29 17.17 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.734 1.214 . . . . 0.0 110.857 -173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.15 144.54 50.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.303 0.641 . . . . 0.0 111.155 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 57.7 m-85 -79.33 154.22 29.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.351 1.46 . . . . 0.0 109.866 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.2 m -66.07 -13.74 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.591 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -169.68 -177.56 40.23 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 120.035 1.289 . . . . 0.0 112.206 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 23.1 tp -63.68 125.96 26.0 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.2 121.28 44.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.9 mt -121.29 160.53 23.75 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.9 135.77 41.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 172.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.65 15.4 14.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.129 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -117.63 -22.82 7.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -140.23 -28.66 0.72 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.202 1.001 . . . . 0.0 113.139 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -86.91 8.38 23.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.411 1.005 . . . . 0.0 111.809 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.95 -24.16 22.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.274 0.943 . . . . 0.0 112.589 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.76 -26.27 44.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.286 1.034 . . . . 0.0 111.667 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -124.97 -13.74 6.79 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.3 m -55.55 -28.86 57.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.277 0.944 . . . . 0.0 111.533 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.5 -43.07 71.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.271 1.029 . . . . 0.0 111.318 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.87 -31.68 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.856 0.836 . . . . 0.0 109.677 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -77.42 -25.23 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.275 0.63 . . . . 0.0 109.667 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -55.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -52.65 -47.22 67.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.633 1.173 . . . . 0.0 110.187 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -68.51 -35.49 77.56 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.315 0.384 . . . . 0.0 110.58 -177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 25.3 t90 -65.72 -45.54 82.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.627 0.727 . . . . 0.0 109.816 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -59.1 -34.53 72.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.667 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.49 70.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.051 0.54 . . . . 0.0 110.889 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -85.4 -45.58 11.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.16 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.34 -37.9 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 120.603 1.547 . . . . 0.0 109.897 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.58 -13.2 28.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -49.67 5.85 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 108.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.91 -28.13 69.85 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.376 0.535 . . . . 0.0 111.051 -169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.5 mtm -89.4 -41.22 12.22 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.46 1.104 . . . . 0.0 111.416 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.93 -44.09 27.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.393 0.677 . . . . 0.0 110.727 -174.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -73.25 -28.44 62.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.331 1.452 . . . . 0.0 109.862 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -60.16 -49.9 75.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -1.0 48.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.853 0.461 . . . . 0.0 110.581 178.188 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.47 143.89 31.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -132.29 145.77 51.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.381 1.872 . . . . 0.0 108.104 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.63 117.52 4.85 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.26 112.35 21.95 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 118.983 1.391 . . . . 0.0 108.054 169.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -106.42 142.9 35.32 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.525 1.13 . . . . 0.0 111.83 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.27 169.14 25.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 110.163 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.14 137.89 7.91 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 168.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -138.75 135.57 34.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.791 1.636 . . . . 0.0 108.076 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -87.19 -28.9 22.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.8 p -108.74 -90.8 0.45 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.8 m -162.03 -11.79 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.546 2.738 . . . . 0.0 113.21 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -62.78 -46.75 86.56 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.979 -1.701 . . . . 0.0 112.272 -167.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -34.51 77.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.3 -48.25 80.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.07 0.948 . . . . 0.0 110.437 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 70.2 mtm -65.99 -40.35 91.1 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.908 -0.495 . . . . 0.0 110.943 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.59 98.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.873 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.68 -48.12 75.63 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.075 0.95 . . . . 0.0 110.634 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -59.11 -44.92 92.02 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.18 -54.51 39.93 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 124.658 1.224 . . . . 0.0 109.024 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -53.03 -56.23 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.888 0.767 . . . . 0.0 109.775 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -38.53 78.14 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.59 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.6 -46.73 74.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 122.878 0.471 . . . . 0.0 111.377 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.5 mt -68.05 -47.18 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.572 1.149 . . . . 0.0 108.504 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.0 mt -70.61 -50.17 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.722 0.809 . . . . 0.0 110.159 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.29 115.13 0.85 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.19 3.7 3.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.396 2.731 . . . . 0.0 112.945 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.4 -34.67 70.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.132 1.373 . . . . 0.0 108.996 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -21.02 3.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -169.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.51 142.47 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 120.909 1.686 . . . . 0.0 108.727 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -132.86 129.73 38.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.399 1.08 . . . . 0.0 109.528 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.37 146.41 48.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.64 0.776 . . . . 0.0 111.666 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -139.39 121.69 15.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.632 1.973 . . . . 0.0 107.301 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -103.72 90.43 3.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.33 -15.13 22.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.089 1.356 . . . . 0.0 114.392 -167.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -12.83 61.71 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -131.73 -35.28 1.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.016 1.326 . . . . 0.0 112.22 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -81.75 145.34 30.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.044 1.338 . . . . 0.0 109.651 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -83.95 143.54 43.23 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.36 -8.04 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.501 2.134 . . . . 0.0 111.072 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -57.21 -35.54 69.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.763 1.62 . . . . 0.0 111.823 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -21.37 66.76 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.261 -0.9 . . . . 0.0 113.194 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -13.32 23.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.673 1.189 . . . . 0.0 112.034 170.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.33 -27.46 61.53 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.626 -1.296 . . . . 0.0 111.043 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.68 -49.46 16.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.853 0.751 . . . . 0.0 110.167 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -65.4 140.83 58.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.944 1.298 . . . . 0.0 108.86 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.84 -31.07 68.72 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.356 0.662 . . . . 0.0 110.755 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.77 144.54 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -133.7 152.32 51.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.53 0.605 . . . . 0.0 110.246 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.66 121.67 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -120.67 137.44 54.46 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 108.991 -172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.33 122.3 3.79 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-O 118.02 -1.434 . . . . 0.0 113.236 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.47 126.07 26.62 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 119.15 1.475 . . . . 0.0 111.829 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -78.51 142.95 18.84 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.433 2.755 . . . . 0.0 109.187 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -92.23 110.09 21.47 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -95.63 171.56 8.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.493 1.117 . . . . 0.0 110.37 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 26.89 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.722 2.809 . . . . 0.0 115.647 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 55.11 76.27 0.27 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.928 1.291 . . . . 0.0 112.481 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.18 16.36 79.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.44 154.5 21.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.458 1.123 . . . . 0.0 108.565 168.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -82.75 153.57 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.04 138.37 44.16 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.89 -24.44 67.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -165.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -87.83 -25.92 23.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.986 0.514 . . . . 0.0 110.606 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -68.46 -39.52 81.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.013 -0.429 . . . . 0.0 110.393 170.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -55.56 -32.87 63.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.023 0.529 . . . . 0.0 111.346 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.91 71.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.424 0.69 . . . . 0.0 111.971 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.7 -12.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.745 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.3 t-105 -54.25 -28.03 38.83 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.529 1.531 . . . . 0.0 112.059 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.44 -46.13 64.47 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.055 1.342 . . . . 0.0 111.227 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -67.56 -32.02 72.5 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.319 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.63 -30.16 62.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.871 1.214 . . . . 0.0 111.445 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.3 -32.41 70.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.634 0.774 . . . . 0.0 111.354 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.85 -22.7 33.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.963 0.905 . . . . 0.0 110.728 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -73.63 159.8 32.53 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.689 1.233 . . . . 0.0 111.341 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -91.52 101.66 14.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.645 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -122.9 3.93 9.41 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.665 1.186 . . . . 0.0 113.215 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -67.03 115.38 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.72 5.12 78.59 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.61 1.576 . . . . 0.0 115.288 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.2 149.98 33.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 118.125 0.963 . . . . 0.0 110.047 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -86.23 139.08 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 167.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.09 129.63 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 124.756 1.222 . . . . 0.0 108.925 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.05 118.0 35.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 mt -90.12 143.01 27.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.975 0.807 . . . . 0.0 111.776 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -135.29 156.33 49.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.898 0.879 . . . . 0.0 108.657 168.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.24 162.46 30.59 Favored Glycine 0 CA--C 1.505 -0.546 0 O-C-N 120.874 -1.141 . . . . 0.0 111.939 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.6 153.28 40.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.01 -145.75 5.84 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -151.73 145.13 24.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.157 2.183 . . . . 0.0 108.149 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.58 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -85.95 -31.59 22.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.752 2.021 . . . . 0.0 114.019 172.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.82 -32.93 62.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.356 0.98 . . . . 0.0 112.782 -167.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.71 -19.94 23.3 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 124.843 1.211 . . . . 0.0 111.521 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.502 ' C ' ' H ' ' A' ' 95' ' ' GLU . 25.5 m-85 -126.44 -88.64 0.57 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.189 0.996 . . . . 0.0 108.872 -169.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.46 -50.26 2.43 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 128.295 2.855 . . . . 0.0 107.812 -167.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.7 mm-40 -69.02 -32.66 72.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.483 1.913 . . . . 0.0 110.533 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -111.89 0.83 16.25 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.793 1.237 . . . . 0.0 111.656 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.11 126.33 22.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.71 -1.243 . . . . 0.0 109.897 169.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.61 24.7 9.09 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.719 1.608 . . . . 0.0 113.46 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.76 -41.65 97.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.791 -1.193 . . . . 0.0 110.426 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.441 0.697 . . . . 0.0 111.368 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.33 -46.82 88.68 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.544 0.738 . . . . 0.0 110.927 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.1 95.14 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.6 mtm -68.44 -43.39 77.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 117.74 0.77 . . . . 0.0 112.559 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -63.82 -33.04 74.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.6 1.091 . . . . 0.0 111.28 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -66.0 -41.03 91.57 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.031 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.93 -31.49 66.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.698 1.999 . . . . 0.0 112.155 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -61.86 -61.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.49 -18.83 56.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.761 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -61.87 -31.11 71.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.145 1.339 . . . . 0.0 111.55 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -22.35 56.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.627 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -82.12 4.73 22.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.518 1.927 . . . . 0.0 112.876 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.05 31.49 78.0 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -82.69 169.82 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -116.8 142.27 47.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -110.04 147.45 33.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.57 1.077 . . . . 0.0 111.723 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.82 178.54 4.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.187 0.995 . . . . 0.0 109.24 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.15 34.22 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.326 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -75.65 151.69 37.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.837 1.818 . . . . 0.0 108.446 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.71 148.27 67.81 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 117.095 -1.431 . . . . 0.0 108.946 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.922 1.365 . . . . 0.0 109.696 168.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.484 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 79.7 p -74.33 -12.9 60.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.496 1.518 . . . . 0.0 113.692 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.08 144.95 56.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.8 0.809 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.54 76.04 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.95 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.73 169.21 18.07 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.976 1.71 . . . . 0.0 108.962 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.15 126.81 40.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.577 1.551 . . . . 0.0 107.916 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -163.53 -59.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.695 0.68 . . . . 0.0 109.283 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.325 3.7 t 54.97 7.73 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.628 2.771 . . . . 0.0 114.173 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.5 p -72.84 146.09 87.48 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.66 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.98 -11.28 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.935 2.423 . . . . 0.0 113.867 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -79.87 -48.07 1.4 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -169.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.61 39.98 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.295 1.997 . . . . 0.0 112.8 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 148.82 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 120.949 -1.094 . . . . 0.0 110.408 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.02 -172.16 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.123 1.769 . . . . 0.0 109.666 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.42 -117.38 0.94 Allowed 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.24 8.36 33.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.016 1.326 . . . . 0.0 112.011 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.36 20.21 20.84 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.352 0.977 . . . . 0.0 112.865 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.31 -17.21 17.39 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.971 1.308 . . . . 0.0 110.779 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.34 144.33 49.56 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.683 0.793 . . . . 0.0 111.026 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.4 m-85 -79.13 154.65 29.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.48 1.512 . . . . 0.0 109.776 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.18 -15.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.492 1.117 . . . . 0.0 112.479 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.35 -178.47 41.19 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.592 1.087 . . . . 0.0 111.698 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.7 135.39 54.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.08 124.56 47.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.66 159.57 34.3 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.515 1.126 . . . . 0.0 109.9 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.63 139.63 29.71 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.525 1.53 . . . . 0.0 107.254 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.21 4.22 16.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.043 1.337 . . . . 0.0 111.048 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -24.06 15.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.21 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -147.42 -30.35 0.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -81.29 9.93 6.33 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.342 0.974 . . . . 0.0 111.871 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -55.07 -20.67 10.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.977 0.911 . . . . 0.0 112.792 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.78 -27.01 57.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.522 0.729 . . . . 0.0 110.934 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.77 -11.72 6.62 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 p -52.56 -35.82 54.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 110.476 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.04 -39.93 87.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.529 1.532 . . . . 0.0 111.466 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -31.66 59.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 109.667 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.16 -29.81 57.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.856 -0.528 . . . . 0.0 109.812 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.37 -57.23 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -57.04 -43.83 82.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 122.661 0.384 . . . . 0.0 111.746 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -65.72 -34.15 77.54 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.055 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -66.51 -45.2 80.33 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.812 0.815 . . . . 0.0 109.802 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 89.9 m -57.37 -37.17 72.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.813 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -68.5 -26.69 65.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.199 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.13 -43.52 12.98 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.909 -1.044 . . . . 0.0 112.091 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.8 pt -64.07 -36.4 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.874 1.67 . . . . 0.0 109.85 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.2 -47.7 6.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.3 -35.44 77.36 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.41 0.55 . . . . 0.0 110.225 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.4 mtm -77.9 -43.45 30.04 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.322 1.049 . . . . 0.0 110.601 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.68 73.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.922 0.889 . . . . 0.0 111.252 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.75 -30.76 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.94 1.296 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.542 0.737 . . . . 0.0 110.599 169.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.91 -1.65 56.87 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.719 1.608 . . . . 0.0 113.818 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.089 0.556 . . . . 0.0 110.494 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttm . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.162 0.506 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 147.31 51.6 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 127.946 2.498 . . . . 0.0 106.978 168.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.41 147.07 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.645 1.578 . . . . 0.0 109.0 -166.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.87 119.09 4.78 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.08 108.1 19.08 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -103.73 143.84 32.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.68 1.192 . . . . 0.0 109.998 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -161.09 174.63 13.43 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.956 0.503 . . . . 0.0 109.826 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.17 142.9 9.93 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -140.81 147.19 38.64 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.607 1.163 . . . . 0.0 108.012 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 -29.54 33.08 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 169.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.8 p -104.29 -77.43 0.58 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p 175.66 -7.78 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.997 2.919 . . . . 0.0 110.891 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.46 -44.06 88.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.01 1.732 . . . . 0.0 110.542 -168.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -31.53 70.07 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -64.53 -47.43 78.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.453 1.101 . . . . 0.0 110.207 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.7 mtm -64.11 -40.27 95.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.193 0.451 . . . . 0.0 110.875 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.23 96.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.056 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -47.9 73.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.015 0.926 . . . . 0.0 110.713 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -60.3 -43.78 95.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -63.9 -54.22 38.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.502 1.121 . . . . 0.0 108.974 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -51.52 -56.18 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.039 0.836 . . . . 0.0 109.769 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -39.52 82.6 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.732 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.17 -46.92 69.4 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.424 0.453 . . . . 0.0 111.226 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.45 -48.24 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.25 1.42 . . . . 0.0 108.488 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.0 mt -72.59 -50.16 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.529 0.731 . . . . 0.0 110.513 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.77 114.11 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.392 0.996 . . . . 0.0 110.855 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 4.09 3.36 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.399 2.732 . . . . 0.0 113.056 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.84 -36.12 64.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.553 1.541 . . . . 0.0 109.262 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.74 -26.1 6.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.434 1.893 . . . . 0.0 110.766 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.33 140.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.114 1.779 . . . . 0.0 109.683 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -130.59 129.56 42.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.676 1.19 . . . . 0.0 109.718 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.47 149.87 45.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.072 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -144.88 112.79 6.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.083 1.753 . . . . 0.0 107.393 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -87.21 108.47 18.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.2 mt -66.38 -7.53 19.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -61.92 -27.54 68.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.9 1.227 . . . . 0.0 111.47 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.36 -33.3 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.677 1.191 . . . . 0.0 112.278 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -83.13 140.51 32.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -82.95 142.21 44.55 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -74.07 -8.79 21.5 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.787 1.658 . . . . 0.0 111.037 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -56.3 -36.68 68.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.879 1.672 . . . . 0.0 111.599 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.34 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -11.52 13.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 112.169 170.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.66 -30.83 63.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.589 -1.32 . . . . 0.0 111.24 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -75.19 -47.92 26.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.88 0.764 . . . . 0.0 110.904 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -63.37 146.55 53.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.77 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -71.43 -24.99 62.13 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.852 0.861 . . . . 0.0 110.402 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.5 t -150.47 151.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.687 1.995 . . . . 0.0 106.166 -168.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.19 155.28 50.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.195 0.907 . . . . 0.0 110.219 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.28 122.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 168.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.48 139.76 51.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.62 0.768 . . . . 0.0 109.046 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.07 121.69 2.8 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.802 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.39 136.67 27.38 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 118.49 1.145 . . . . 0.0 110.972 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.13 153.87 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.244 1.963 . . . . 0.0 108.921 166.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.1 m -108.94 94.77 5.23 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -83.13 168.67 16.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.324 1.05 . . . . 0.0 111.509 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t0 18.36 69.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 129.395 3.078 . . . . 0.0 115.251 166.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 56.48 67.6 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.581 1.153 . . . . 0.0 111.861 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.6 23.04 77.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -83.21 154.7 24.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.598 1.159 . . . . 0.0 110.12 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.5 mt -96.18 149.14 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -66.78 143.85 56.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.52 -26.77 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.532 0.733 . . . . 0.0 112.119 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -30.45 71.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.418 0.687 . . . . 0.0 110.898 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -82.05 -42.14 19.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.48 1.112 . . . . 0.0 110.404 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.3 -34.91 64.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.388 0.54 . . . . 0.0 110.956 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.49 72.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.05 -13.27 8.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.697 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.518 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.1 t-105 -53.81 -28.68 36.86 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.624 1.57 . . . . 0.0 111.933 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.57 -45.28 59.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.887 1.275 . . . . 0.0 111.055 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.55 -29.86 68.51 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.336 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -56.18 -31.93 63.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.187 1.358 . . . . 0.0 111.111 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.33 -32.58 74.07 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.604 0.762 . . . . 0.0 111.811 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.93 -27.29 43.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.32 0.648 . . . . 0.0 110.518 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.47 157.24 37.99 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.659 1.219 . . . . 0.0 111.376 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -89.9 97.1 10.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.009 -1.905 . . . . 0.0 108.265 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -117.74 3.02 12.31 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 122.194 0.997 . . . . 0.0 113.197 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -68.6 113.01 5.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -169.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.23 49.7 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.768 -1.018 . . . . 0.0 115.053 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.57 156.17 29.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.969 1.385 . . . . 0.0 109.282 169.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 7.0 mt -85.49 145.78 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -173.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.1 129.36 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.346 1.458 . . . . 0.0 109.658 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.99 119.53 39.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 166.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.24 141.44 28.7 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.338 0.972 . . . . 0.0 111.49 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -134.7 160.72 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.093 0.957 . . . . 0.0 108.456 168.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.79 40.08 Favored Glycine 0 N--CA 1.442 -0.919 0 O-C-N 120.939 -1.1 . . . . 0.0 111.074 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.54 148.65 48.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.168 -1.016 . . . . 0.0 108.401 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.44 -155.31 8.81 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.15 138.5 13.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.204 1.802 . . . . 0.0 106.437 168.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.467 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -94.03 -24.54 17.58 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 124.02 0.928 . . . . 0.0 112.164 -175.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.72 -51.87 67.54 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.905 0.775 . . . . 0.0 110.946 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.68 -27.13 7.69 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.694 1.14 . . . . 0.0 113.202 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.3 29.37 5.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -168.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.3 -43.1 42.89 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.17 1.35 . . . . 0.0 110.866 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -64.81 -16.46 63.11 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.381 -1.07 . . . . 0.0 112.348 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -130.02 14.03 5.74 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.09 1.756 . . . . 0.0 111.899 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -47.24 127.3 10.51 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.795 2.038 . . . . 0.0 110.56 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 47.36 28.98 1.17 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.902 1.281 . . . . 0.0 112.606 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -63.83 -37.94 89.26 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.804 -1.185 . . . . 0.0 109.815 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.94 74.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.594 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 tp -59.88 -46.03 90.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.888 0.875 . . . . 0.0 110.342 172.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.54 -41.88 99.65 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.0 mtm -64.86 -43.83 91.71 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.113 0.957 . . . . 0.0 111.463 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.518 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.5 mt -64.43 -35.72 81.83 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 119.623 1.101 . . . . 0.0 111.143 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -64.47 -41.6 96.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.145 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.88 -42.71 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.93 -59.33 4.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.695 1.198 . . . . 0.0 108.406 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.83 -19.83 57.07 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.627 -0.671 . . . . 0.0 110.855 -170.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.3 t -62.39 -29.79 70.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.31 0.959 . . . . 0.0 110.386 169.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.94 -23.58 52.43 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.305 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 111' ' ' LYS . 20.0 mmmt -81.94 4.38 22.79 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.104 1.762 . . . . 0.0 113.172 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.24 33.84 86.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.519 0.6 . . . . 0.0 111.749 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.45 170.45 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 123.522 0.729 . . . . 0.0 109.224 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -115.83 140.07 49.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.82 149.0 30.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.797 1.181 . . . . 0.0 112.213 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.9 m -129.51 -179.63 3.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.218 1.007 . . . . 0.0 109.995 169.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.35 39.35 26.65 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.085 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -82.67 149.86 27.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.426 1.613 . . . . 0.0 109.339 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.47 146.36 49.58 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.376 -1.297 . . . . 0.0 108.696 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.6 135.06 25.41 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.395 1.397 . . . . 0.0 110.248 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 48.4 p -74.26 -14.58 60.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.219 1.808 . . . . 0.0 112.993 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.95 140.49 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.92 0.867 . . . . 0.0 110.87 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.14 -5.85 52.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.736 1.636 . . . . 0.0 113.533 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.03 170.61 9.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.065 1.346 . . . . 0.0 111.154 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.05 130.44 52.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.641 1.576 . . . . 0.0 108.0 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -164.52 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 109.482 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.302 3.0 t 58.5 8.48 0.88 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.757 2.823 . . . . 0.0 114.956 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 148.3 47.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.398 1.479 . . . . 0.0 111.468 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.31 -14.57 3.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.836 2.357 . . . . 0.0 114.644 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -80.46 -50.02 1.13 Allowed Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.31 37.35 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 CA-C-N 122.008 1.753 . . . . 0.0 112.674 -168.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 148.3 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.414 1.086 . . . . 0.0 110.207 -167.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -172.23 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 126.217 1.807 . . . . 0.0 109.514 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.52 -117.31 0.92 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.041 1.336 . . . . 0.0 107.549 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.26 8.33 33.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.775 1.23 . . . . 0.0 111.918 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.59 20.08 20.68 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.483 1.04 . . . . 0.0 112.713 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.62 -16.84 17.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.889 1.276 . . . . 0.0 110.594 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.94 145.09 50.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.457 0.703 . . . . 0.0 110.98 174.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -80.13 154.24 28.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.429 1.492 . . . . 0.0 109.608 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.15 -12.39 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.681 1.193 . . . . 0.0 112.621 177.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.12 -177.37 44.15 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.682 1.128 . . . . 0.0 111.889 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.3 tp -67.05 133.0 49.03 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.11 56.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.8 mt -117.13 154.52 30.9 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 108.597 170.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.52 101.1 4.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -0.64 54.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.835 0.854 . . . . 0.0 112.548 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.03 -26.01 14.37 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.451 0.569 . . . . 0.0 111.134 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.453 HD22 ' NE2' ' A' ' 90' ' ' GLN . 8.5 p30 -139.84 -27.78 0.76 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -87.94 11.63 15.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.942 0.792 . . . . 0.0 111.449 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -53.66 -25.97 20.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.888 1.222 . . . . 0.0 112.525 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.07 -26.15 56.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 110.954 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 pp -130.61 -6.43 4.13 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 112.957 -169.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.4 m -55.59 -29.65 59.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.084 1.311 . . . . 0.0 109.772 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.28 -41.04 78.99 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.445 1.098 . . . . 0.0 111.743 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -75.88 -31.77 59.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.461 1.104 . . . . 0.0 109.738 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -74.73 -30.84 61.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.32 -59.52 4.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.69 -39.42 80.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.7 m -62.53 -38.95 91.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.943 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -66.74 -44.45 81.51 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.9 m -57.05 -34.82 68.61 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.937 0.895 . . . . 0.0 109.548 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -31.7 72.65 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.618 0.573 . . . . 0.0 110.582 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.38 -45.95 12.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.504 173.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.9 pt -64.18 -38.43 82.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 120.994 1.725 . . . . 0.0 109.833 -170.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.43 -12.26 29.66 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -49.15 5.9 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 125.797 1.639 . . . . 0.0 108.266 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.4 -23.49 67.3 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.252 -170.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 66.9 mtm -94.09 -45.25 7.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.434 1.094 . . . . 0.0 110.979 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.64 49.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.477 0.711 . . . . 0.0 110.823 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -69.4 -28.06 65.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.98 1.312 . . . . 0.0 109.679 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -70.78 -45.71 64.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.814 1.245 . . . . 0.0 110.443 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -22.34 62.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.017 -175.556 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.56 142.78 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -131.67 148.16 52.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.776 2.03 . . . . 0.0 108.488 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.49 118.81 4.93 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.013 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 108.98 19.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.212 1.506 . . . . 0.0 109.838 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -105.57 145.81 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.537 1.535 . . . . 0.0 110.979 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -163.47 175.7 10.5 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.736 0.814 . . . . 0.0 110.231 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.49 141.97 9.2 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 106.502 -2.639 . . . . 0.0 106.502 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -150.03 140.29 22.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.528 1.164 . . . . 0.0 110.891 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -36.37 13.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.692 1.197 . . . . 0.0 110.015 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 p -93.99 -6.64 44.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.217 1.407 . . . . 0.0 112.009 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m 68.05 9.98 7.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.588 1.955 . . . . 0.0 113.091 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -63.83 -45.43 89.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.33 1.423 . . . . 0.0 110.386 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -33.28 74.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.665 0.786 . . . . 0.0 108.918 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.54 -49.55 70.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 109.397 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.45 -38.89 92.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.895 0.316 . . . . 0.0 110.809 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.01 98.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.866 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.09 76.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.956 0.902 . . . . 0.0 110.491 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -59.1 -45.97 89.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -62.21 -55.79 25.0 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 125.106 1.363 . . . . 0.0 108.831 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.6 mt -52.59 -56.48 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 118.458 0.572 . . . . 0.0 109.967 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -38.5 72.78 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.258 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.47 -46.87 74.92 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.902 0.481 . . . . 0.0 111.339 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.8 mt -66.24 -47.85 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.567 1.147 . . . . 0.0 108.854 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -72.13 -49.69 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.702 0.801 . . . . 0.0 110.048 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 115.69 0.86 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.64 3.74 4.06 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.256 2.637 . . . . 0.0 112.689 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.76 -34.53 67.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.11 1.364 . . . . 0.0 109.027 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 -22.7 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.552 1.541 . . . . 0.0 111.641 -169.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.3 140.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 120.479 1.491 . . . . 0.0 108.924 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -131.26 128.96 40.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.206 1.003 . . . . 0.0 109.824 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.19 149.1 47.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.636 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.6 111.67 5.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.193 1.797 . . . . 0.0 107.144 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.43 111.26 20.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.96 -8.19 35.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -60.24 -27.99 67.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.248 0.931 . . . . 0.0 111.584 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -132.42 -33.82 1.25 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.495 1.118 . . . . 0.0 112.122 -171.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -83.05 140.45 32.68 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.177 0.991 . . . . 0.0 108.585 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -83.44 142.23 43.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.23 -4.75 15.79 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.774 1.649 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -55.21 -35.42 64.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.723 1.601 . . . . 0.0 111.977 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -19.34 65.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -12.15 19.6 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.324 1.049 . . . . 0.0 112.326 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.09 -23.35 48.0 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.828 -1.17 . . . . 0.0 111.543 175.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -75.4 -48.96 20.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -68.98 150.28 47.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.21 1.404 . . . . 0.0 108.381 -170.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -81.96 -23.78 35.92 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 110.502 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.27 144.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.71 156.11 48.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.398 0.679 . . . . 0.0 110.205 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.61 123.59 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.7 138.6 54.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -133.3 124.79 3.82 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.442 -172.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.49 135.32 27.27 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 118.84 1.32 . . . . 0.0 110.842 178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.11 145.44 12.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.793 1.662 . . . . 0.0 108.511 166.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.9 m -90.46 123.49 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -108.11 170.73 7.82 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.455 1.902 . . . . 0.0 110.249 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t0 15.37 69.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 129.542 3.137 . . . . 0.0 115.217 168.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 58.59 67.79 0.9 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.427 1.491 . . . . 0.0 110.401 172.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.66 32.61 70.91 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.354 0.5 OUTLIER -99.15 153.83 18.61 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.625 1.17 . . . . 0.0 109.827 168.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.96 148.87 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -62.38 142.67 57.71 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.85 -28.14 69.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.14 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.69 -29.48 70.03 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.646 0.778 . . . . 0.0 110.509 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -81.94 -42.51 19.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.745 0.818 . . . . 0.0 110.785 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.62 -33.99 64.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.408 0.549 . . . . 0.0 110.872 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.91 73.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.464 1.105 . . . . 0.0 111.838 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.09 -11.31 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.9 t-105 -53.04 -28.8 26.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.846 1.658 . . . . 0.0 111.817 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.71 -45.87 67.28 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.189 1.396 . . . . 0.0 111.414 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.67 -31.97 73.27 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.005 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.5 mt -56.66 -32.47 65.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.709 1.14 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.42 -31.77 71.34 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.47 0.708 . . . . 0.0 111.166 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.95 -16.72 35.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.675 0.79 . . . . 0.0 111.448 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.98 156.3 39.32 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 122.227 1.013 . . . . 0.0 113.47 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -89.12 75.19 7.92 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.766 2.427 . . . . 0.0 106.335 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.301 56.1 tp -118.11 7.32 12.15 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 125.514 1.526 . . . . 0.0 113.606 -165.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -74.15 138.04 43.57 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.406 1.882 . . . . 0.0 109.656 -172.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.69 8.49 86.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 125.599 1.571 . . . . 0.0 114.489 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -90.69 148.81 22.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.953 1.301 . . . . 0.0 109.37 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -84.2 139.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.96 127.95 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 C-N-CA 125.052 1.341 . . . . 0.0 108.828 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.95 115.33 30.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 167.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 mt -86.73 143.19 27.66 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.127 0.876 . . . . 0.0 111.184 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -136.86 158.76 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.77 0.828 . . . . 0.0 109.034 168.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.63 176.96 41.05 Favored Glycine 0 CA--C 1.508 -0.385 0 O-C-N 120.944 -1.098 . . . . 0.0 112.441 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.36 145.16 50.9 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.29 32.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.93 139.12 23.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.151 1.476 . . . . 0.0 108.625 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.458 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -89.62 -20.24 23.94 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.969 1.308 . . . . 0.0 114.403 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.55 -47.43 69.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.045 1.293 . . . . 0.0 111.25 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.67 -21.03 10.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.086 0.851 . . . . 0.0 112.195 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 41.77 2.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.116 0.967 . . . . 0.0 111.307 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.95 -43.54 72.79 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 125.007 1.289 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.508 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.8 mm-40 -67.33 -26.12 66.35 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -94.0 -10.5 33.38 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.957 2.503 . . . . 0.0 112.628 -171.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -49.57 130.09 20.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.505 2.722 . . . . 0.0 110.913 -169.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 48.91 27.92 1.79 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.228 1.011 . . . . 0.0 112.599 172.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.46 -36.48 84.32 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.03 -1.044 . . . . 0.0 110.023 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.08 77.14 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.641 0.376 . . . . 0.0 111.515 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.95 -48.15 83.15 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 110.009 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.09 97.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.62 -44.65 89.86 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.043 0.922 . . . . 0.0 111.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.4 mt -63.9 -34.54 78.19 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.508 1.049 . . . . 0.0 111.158 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -64.06 -41.91 97.19 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.222 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.59 -31.22 66.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.966 2.106 . . . . 0.0 112.249 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -62.73 -61.87 2.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.2 mt -76.32 -19.75 57.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.39 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -61.15 -31.08 70.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.022 1.283 . . . . 0.0 111.427 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -21.16 54.19 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -83.9 6.02 23.2 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.407 1.883 . . . . 0.0 112.46 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.15 32.2 76.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.41 170.13 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.713 0.805 . . . . 0.0 108.908 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -119.96 142.63 48.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.95 148.73 31.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.916 1.235 . . . . 0.0 111.911 -169.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.06 179.56 3.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.275 1.03 . . . . 0.0 108.992 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 36.37 40.0 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-O 118.398 -1.223 . . . . 0.0 113.894 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -79.83 151.55 30.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 119.556 1.678 . . . . 0.0 108.83 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.405 ' HE1' HD13 ' A' ' 142' ' ' LEU . 0.5 OUTLIER -126.28 152.52 73.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.264 172.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 135.12 33.16 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.292 1.328 . . . . 0.0 109.98 169.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.488 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 55.1 p -73.59 -15.03 61.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.935 1.694 . . . . 0.0 112.902 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.22 145.21 56.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.903 0.881 . . . . 0.0 109.152 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.37 18.75 79.46 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.946 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.09 163.7 25.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.694 1.998 . . . . 0.0 109.012 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.33 126.19 40.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 125.627 1.571 . . . . 0.0 107.648 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -168.54 -48.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 0.0 109.466 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.32 3.3 t 59.74 7.53 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.075 2.95 . . . . 0.0 114.639 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 149.03 56.9 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.954 1.302 . . . . 0.0 112.624 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -90.04 -13.67 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.889 2.393 . . . . 0.0 114.025 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.54 -52.29 2.93 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 117.965 -1.017 . . . . 0.0 113.297 -169.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -85.96 40.07 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 121.695 1.641 . . . . 0.0 112.053 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.19 145.91 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.607 1.163 . . . . 0.0 109.227 -168.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.4 -176.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.78 1.232 . . . . 0.0 112.074 178.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.94 -110.58 0.53 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 127.026 2.131 . . . . 0.0 109.155 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -99.41 -0.71 40.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.552 1.541 . . . . 0.0 111.958 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.0 26.06 9.95 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.146 -0.971 . . . . 0.0 111.798 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -20.48 13.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.142 1.377 . . . . 0.0 108.444 -175.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.98 138.9 51.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.993 1.317 . . . . 0.0 110.863 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 43.2 m-85 -78.47 151.8 32.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.4 m -63.12 -13.71 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.827 1.251 . . . . 0.0 112.201 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.8 -174.08 42.04 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 119.458 1.026 . . . . 0.0 111.737 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.405 HD13 ' HE1' ' A' ' 119' ' ' TRP . 28.2 tp -64.29 128.63 36.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.07 123.36 47.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.18 156.59 33.39 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.039 1.335 . . . . 0.0 108.363 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.435 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -141.08 123.98 16.24 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -100.78 14.32 32.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.429 1.092 . . . . 0.0 110.824 -169.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.42 -24.3 5.44 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.458 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.2 OUTLIER -111.49 -48.72 3.06 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.605 1.093 . . . . 0.0 108.39 172.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -104.4 21.88 15.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.434 1.494 . . . . 0.0 112.659 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -53.47 -24.69 13.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.58 -26.01 41.4 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.83 -12.95 8.35 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.043 0.937 . . . . 0.0 112.244 -170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -58.85 -27.48 65.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.84 1.2 . . . . 0.0 110.781 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.87 -47.07 81.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.326 1.05 . . . . 0.0 110.967 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.99 -32.38 72.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.753 0.787 . . . . 0.0 109.485 -171.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -75.18 -27.52 59.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.875 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.34 -55.2 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -51.67 -47.98 63.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.922 0.889 . . . . 0.0 109.853 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -68.08 -35.91 78.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.561 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -64.92 -44.37 89.75 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.452 0.644 . . . . 0.0 109.778 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.415 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.3 m -58.88 -36.59 74.88 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.664 0.786 . . . . 0.0 109.474 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -69.72 -29.26 66.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.31 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.73 -46.64 16.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.355 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -64.75 -38.5 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 120.872 1.669 . . . . 0.0 110.21 -170.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.19 -15.34 59.69 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.227 0.611 . . . . 0.0 111.94 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -96.4 -46.16 6.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.15 -41.95 89.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.909 0.777 . . . . 0.0 109.503 -173.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.2 mtm -75.67 -37.24 59.74 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.561 0.744 . . . . 0.0 110.938 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.01 -47.15 60.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.926 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.41 -30.72 71.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 110.021 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -63.17 -47.27 83.35 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.463 0.574 . . . . 0.0 110.391 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -3.01 49.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.592 1.157 . . . . 0.0 113.765 -175.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.249 0.477 . . . . 0.0 110.647 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.05 144.67 47.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.156 1.382 . . . . 0.0 108.427 169.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.4 mtm -124.01 150.65 44.63 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.935 2.494 . . . . 0.0 108.741 -167.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.43 120.32 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.11 102.98 15.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.621 1.211 . . . . 0.0 110.101 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -102.7 145.57 29.5 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.044 1.338 . . . . 0.0 111.467 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -164.14 172.61 13.48 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.981 0.912 . . . . 0.0 109.897 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.69 137.4 8.23 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 169.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -135.61 130.69 34.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.149 1.38 . . . . 0.0 109.978 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -91.26 -38.33 12.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.93 0.492 . . . . 0.0 110.016 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 p -93.99 -85.69 0.28 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.18 -3.9 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.491 2.717 . . . . 0.0 111.867 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -68.85 -42.83 76.57 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 119.729 -1.857 . . . . 0.0 112.171 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -35.97 82.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -64.68 -49.35 71.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 109.921 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.5 mtm -64.87 -38.71 91.89 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.093 -0.379 . . . . 0.0 111.465 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.15 98.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.0 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.21 79.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.031 0.932 . . . . 0.0 110.61 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -57.64 -47.1 83.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -61.68 -54.41 43.02 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 124.733 1.271 . . . . 0.0 108.995 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.97 -57.02 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.83 0.741 . . . . 0.0 109.691 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -39.11 70.29 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 123.431 0.693 . . . . 0.0 110.339 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.68 -47.7 68.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.801 0.44 . . . . 0.0 111.486 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.7 mt -65.79 -45.5 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 108.51 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.77 -52.1 27.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.913 0.885 . . . . 0.0 110.546 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.72 115.45 0.85 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.83 3.15 4.64 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.451 2.767 . . . . 0.0 112.686 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.09 -34.39 68.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.451 1.5 . . . . 0.0 109.556 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -4.34 4.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.157 1.783 . . . . 0.0 111.95 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.77 144.46 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 120.955 1.707 . . . . 0.0 109.3 167.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -134.91 130.67 36.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.856 1.263 . . . . 0.0 110.31 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.78 149.62 45.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -146.9 108.76 4.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.182 1.793 . . . . 0.0 108.345 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -82.64 112.92 19.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.73 -9.82 22.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -58.95 -29.02 66.84 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.261 0.937 . . . . 0.0 111.624 168.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -129.95 -33.8 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.544 1.138 . . . . 0.0 111.728 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -87.57 142.04 28.15 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.314 1.046 . . . . 0.0 109.192 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -83.78 143.15 43.08 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -74.65 -2.19 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.706 1.604 . . . . 0.0 111.412 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -56.82 -33.83 67.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.094 2.225 . . . . 0.0 112.459 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -18.59 65.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 44.2 ttm -59.17 -14.31 10.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.973 2.109 . . . . 0.0 111.654 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -74.36 -30.4 61.98 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.83 -1.169 . . . . 0.0 110.699 173.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.48 -48.84 16.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.775 0.716 . . . . 0.0 109.721 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -67.74 134.28 50.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.95 -6.57 48.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.1 t -135.27 140.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 156.47 48.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 118.206 0.457 . . . . 0.0 109.865 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.26 122.56 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 168.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.73 132.66 55.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.12 115.98 2.82 Favored Glycine 0 CA--C 1.511 -0.158 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.484 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.48 125.15 28.0 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 118.775 1.288 . . . . 0.0 109.347 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.27 143.34 7.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.912 2.408 . . . . 0.0 107.925 168.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -88.56 128.36 35.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -117.65 170.11 9.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.875 1.67 . . . . 0.0 109.688 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 28.21 58.68 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.117 2.567 . . . . 0.0 115.325 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 56.58 73.64 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.666 1.187 . . . . 0.0 112.427 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.98 15.54 76.32 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -82.3 152.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.451 1.12 . . . . 0.0 109.095 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -83.97 153.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.752 -1.574 . . . . 0.0 106.752 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -60.5 141.73 56.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.912 0.863 . . . . 0.0 108.835 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.93 -28.09 68.66 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -79.66 -22.77 43.11 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.822 -0.549 . . . . 0.0 110.289 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 11.5 m95 -76.63 -43.79 36.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.211 0.604 . . . . 0.0 111.234 170.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -53.5 -34.9 59.76 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.126 0.57 . . . . 0.0 110.943 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.21 71.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.099 0.96 . . . . 0.0 112.149 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -109.11 -9.32 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.515 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.8 t-105 -53.08 -28.93 27.44 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.457 1.503 . . . . 0.0 111.69 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.51 -45.35 72.49 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.825 1.25 . . . . 0.0 111.623 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.9 -27.74 66.91 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.105 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.26 -32.02 67.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.726 1.148 . . . . 0.0 111.062 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.2 -30.36 69.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.536 0.734 . . . . 0.0 111.148 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.53 -11.35 37.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.18 0.992 . . . . 0.0 111.631 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.97 174.02 9.17 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.142 0.973 . . . . 0.0 110.783 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -114.92 103.77 11.26 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.115 1.766 . . . . 0.0 107.582 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.8 8.47 7.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.778 1.231 . . . . 0.0 113.068 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -67.32 116.52 8.18 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.22 9.99 85.33 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.305 1.431 . . . . 0.0 114.847 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -80.59 152.58 28.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.006 0.903 . . . . 0.0 109.693 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HD13 ' CD2' ' A' ' 171' ' ' HIS . 4.2 mt -87.16 141.49 14.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 168.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.11 131.61 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.851 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.14 116.37 30.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.08 142.75 27.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.99 0.814 . . . . 0.0 111.792 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -136.83 159.09 42.9 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.28 175.88 37.87 Favored Glycine 0 N--CA 1.447 -0.573 0 O-C-N 120.884 -1.135 . . . . 0.0 111.934 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -125.44 153.66 43.15 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.82 -155.39 8.96 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -155.69 137.64 14.5 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.081 1.352 . . . . 0.0 108.433 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.511 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -87.43 -22.58 24.89 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 113.845 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.9 mt -67.15 -48.01 69.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.823 1.192 . . . . 0.0 110.638 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.66 -26.28 9.27 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.759 1.171 . . . . 0.0 112.328 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.13 33.55 3.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.57 -42.89 58.61 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.659 1.572 . . . . 0.0 111.131 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -61.63 -18.54 59.89 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 117.694 0.747 . . . . 0.0 112.538 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.67 11.83 7.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.081 1.752 . . . . 0.0 112.563 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.12 122.96 4.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.34 1.456 . . . . 0.0 108.682 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 52.33 28.72 5.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.133 0.973 . . . . 0.0 112.959 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.62 -39.66 94.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.519 -1.363 . . . . 0.0 110.72 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.32 73.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.113 0.565 . . . . 0.0 111.485 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.1 tp -59.91 -47.0 87.54 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.067 0.947 . . . . 0.0 110.458 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.85 97.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.9 mtm -66.47 -43.89 84.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.946 0.873 . . . . 0.0 111.717 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.515 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.6 mt -64.93 -34.58 78.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.455 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.7 -41.97 98.03 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.927 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.16 -42.28 89.22 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.536 1.134 . . . . 0.0 111.578 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.67 -58.44 7.5 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.798 1.239 . . . . 0.0 108.292 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.4 mt -78.17 -19.62 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.453 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 t -61.58 -28.8 69.6 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 110.298 168.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -22.94 52.58 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.628 -1.295 . . . . 0.0 109.608 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -83.64 4.66 27.54 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.236 1.814 . . . . 0.0 112.371 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.0 33.42 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.624 0.647 . . . . 0.0 112.032 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.87 170.91 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -115.5 143.18 45.69 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.43 147.01 33.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.936 0.789 . . . . 0.0 111.358 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -128.0 178.02 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.255 1.022 . . . . 0.0 109.081 170.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.49 37.26 31.57 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-O 118.615 -1.103 . . . . 0.0 114.126 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -79.32 144.2 34.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.647 1.724 . . . . 0.0 108.628 171.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -121.81 147.32 48.13 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 117.326 -1.321 . . . . 0.0 108.922 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.39 138.59 39.37 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 120.804 1.323 . . . . 0.0 109.596 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.451 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 59.0 p -74.14 -6.8 49.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.806 1.643 . . . . 0.0 113.383 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.73 140.83 57.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.257 1.027 . . . . 0.0 109.543 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.87 -11.42 59.88 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.556 1.551 . . . . 0.0 113.67 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -92.8 158.97 15.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.815 1.308 . . . . 0.0 111.017 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -128.76 125.82 38.67 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.559 2.344 . . . . 0.0 106.086 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -163.94 -58.88 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 O-C-N 121.767 -0.583 . . . . 0.0 109.709 -170.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.327 2.7 t 58.83 10.15 1.41 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.505 2.722 . . . . 0.0 114.648 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -67.11 139.84 95.46 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.733 -1.229 . . . . 0.0 108.885 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.45 -13.28 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.504 2.136 . . . . 0.0 113.735 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -80.35 -48.84 1.23 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.7 37.65 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.017 1.756 . . . . 0.0 112.737 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 146.52 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 124.243 1.017 . . . . 0.0 109.74 -166.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.41 -172.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 126.024 1.73 . . . . 0.0 109.636 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.73 -116.53 0.86 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.173 1.389 . . . . 0.0 107.528 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.36 8.33 33.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.822 1.249 . . . . 0.0 112.068 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.53 20.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.73 1.157 . . . . 0.0 112.823 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -100.55 -17.33 17.14 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.744 1.218 . . . . 0.0 110.775 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.49 145.26 51.03 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.308 0.643 . . . . 0.0 111.088 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 61.1 m-85 -80.84 155.07 26.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.205 1.402 . . . . 0.0 110.005 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.1 m -66.86 -12.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.802 1.241 . . . . 0.0 112.869 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.11 -179.03 43.53 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 119.659 1.118 . . . . 0.0 112.454 -170.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.402 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 25.1 tp -66.06 128.52 36.39 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.68 119.86 40.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -120.4 159.36 25.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.652 1.181 . . . . 0.0 108.728 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.406 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -143.69 122.6 12.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.36 18.42 16.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.673 -169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 -20.49 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.878 0.871 . . . . 0.0 112.873 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.511 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -115.97 -53.51 2.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.198 1.363 . . . . 0.0 108.652 170.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.53 16.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -168.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.72 -26.28 9.07 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.933 0.893 . . . . 0.0 112.504 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.91 -26.81 54.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.175 0.99 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.13 -7.66 9.83 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.414 1.086 . . . . 0.0 112.257 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 m -50.47 -33.82 22.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.761 1.164 . . . . 0.0 110.31 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.49 -41.39 85.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.303 1.041 . . . . 0.0 111.742 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -33.43 65.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.866 1.266 . . . . 0.0 109.796 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -22.9 41.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.769 0.828 . . . . 0.0 110.363 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.16 -60.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -55.78 -41.81 74.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.366 0.53 . . . . 0.0 112.331 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 60.0 p -66.56 -35.69 80.82 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.053 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.402 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 45.5 t90 -65.46 -43.26 90.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 109.528 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.1 m -58.74 -36.66 74.68 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 123.717 0.807 . . . . 0.0 109.575 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.29 -32.8 73.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.359 0.412 . . . . 0.0 111.175 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -77.14 -45.84 25.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.476 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -65.28 -38.28 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 120.878 1.672 . . . . 0.0 110.415 -173.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.26 -12.32 50.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.54 0.609 . . . . 0.0 112.267 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -95.02 -47.86 6.22 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.45 -35.69 78.32 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.846 0.748 . . . . 0.0 110.69 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.9 mtm -81.48 -39.83 24.18 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.249 1.019 . . . . 0.0 110.518 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.83 63.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.933 0.893 . . . . 0.0 110.916 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.64 -32.08 69.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.872 1.269 . . . . 0.0 109.436 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.416 ' CD2' HD13 ' A' ' 81' ' ' ILE . 61.6 t60 -62.78 -49.86 73.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -3.26 29.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.521 1.129 . . . . 0.0 113.555 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.511 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.92 146.15 51.54 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 126.504 1.922 . . . . 0.0 108.196 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -136.57 146.99 46.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.548 1.539 . . . . 0.0 109.271 -166.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.0 119.45 4.88 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.22 111.46 21.68 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.627 1.213 . . . . 0.0 108.315 169.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -107.3 144.68 33.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 111.167 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -161.79 175.91 11.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.548 0.739 . . . . 0.0 110.716 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.9 11.91 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -140.99 143.78 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.131 1.372 . . . . 0.0 110.58 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -93.29 -39.19 11.11 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.675 1.19 . . . . 0.0 109.857 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -96.56 -85.86 0.33 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 p -173.91 -4.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.97 2.508 . . . . 0.0 112.336 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -66.39 -43.38 86.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.956 -1.715 . . . . 0.0 111.402 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -34.74 76.77 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.61 -49.33 77.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.166 0.986 . . . . 0.0 109.985 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.2 mtm -66.33 -41.21 89.93 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.917 -0.489 . . . . 0.0 110.837 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.33 93.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.687 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.8 77.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.01 0.924 . . . . 0.0 110.553 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -59.13 -44.32 92.02 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.71 -55.04 30.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 124.762 1.288 . . . . 0.0 108.7 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.05 -56.08 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.07 0.85 . . . . 0.0 109.79 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -39.14 82.66 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.814 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.48 -47.76 69.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.042 0.537 . . . . 0.0 111.227 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.31 -47.53 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.014 1.326 . . . . 0.0 108.424 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -48.99 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.669 0.788 . . . . 0.0 110.324 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.49 114.97 0.88 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.25 3.66 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.432 2.755 . . . . 0.0 112.875 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -73.8 -35.62 64.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.334 1.454 . . . . 0.0 109.18 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.96 -27.19 5.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.282 1.833 . . . . 0.0 110.872 -172.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 141.68 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 120.705 1.593 . . . . 0.0 109.569 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 m -133.38 129.83 37.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.572 1.149 . . . . 0.0 109.648 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.38 150.44 45.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.559 0.744 . . . . 0.0 111.921 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -145.64 112.23 5.88 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.423 1.889 . . . . 0.0 107.087 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -87.12 110.86 20.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.17 -8.76 26.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -58.35 -29.24 65.81 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.162 0.892 . . . . 0.0 111.538 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.93 -33.84 1.15 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -82.86 141.43 32.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.121 0.969 . . . . 0.0 108.756 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 m -84.74 141.69 38.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.79 -6.59 18.86 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.651 1.567 . . . . 0.0 111.734 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -55.42 -37.19 67.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.894 1.679 . . . . 0.0 111.706 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -19.3 65.8 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -11.8 16.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 112.534 170.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.61 -31.08 66.52 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 111.376 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.3 -46.29 42.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.722 0.772 . . . . 0.0 110.431 -169.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.99 149.36 50.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.912 1.285 . . . . 0.0 108.719 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -73.61 -25.05 60.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.872 0.869 . . . . 0.0 110.337 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.0 t -151.93 147.55 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.684 1.993 . . . . 0.0 105.929 -168.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.36 158.69 35.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.288 0.949 . . . . 0.0 111.034 168.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.58 121.53 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.38 136.13 54.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.45 120.16 3.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.3 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.5 131.47 24.44 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 119.091 1.445 . . . . 0.0 111.129 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.98 149.25 15.64 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.134 1.89 . . . . 0.0 108.331 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -96.09 128.38 42.94 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -121.11 171.28 8.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 109.84 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 30.65 54.89 0.19 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.983 2.513 . . . . 0.0 115.616 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 56.74 75.78 0.34 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 112.267 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 31.19 68.94 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.458 0.543 . . . . 0.0 114.458 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.19 156.13 17.38 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.727 1.611 . . . . 0.0 109.571 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.93 151.19 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -65.78 142.99 57.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.03 -27.16 68.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.226 -169.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -66.89 -26.15 66.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.883 0.873 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -84.45 -42.85 15.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.165 0.986 . . . . 0.0 110.782 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.42 -34.69 64.65 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.45 0.568 . . . . 0.0 110.978 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.57 71.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.576 1.15 . . . . 0.0 112.237 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.05 -10.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.514 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.1 t-105 -53.75 -28.85 36.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.476 1.51 . . . . 0.0 111.668 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.42 -44.51 67.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.81 1.244 . . . . 0.0 111.338 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.53 -27.94 66.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.438 1.095 . . . . 0.0 112.355 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.7 mt -57.24 -30.06 64.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.755 1.161 . . . . 0.0 111.409 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.95 -32.04 71.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.59 0.756 . . . . 0.0 111.366 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.96 -27.94 39.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 110.805 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.24 160.21 32.6 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.571 1.177 . . . . 0.0 111.431 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.3 96.27 10.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.163 -1.835 . . . . 0.0 108.572 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.0 4.73 13.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.131 0.967 . . . . 0.0 113.132 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -69.37 113.97 7.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -169.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.6 55.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.623 -1.098 . . . . 0.0 115.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.89 160.78 25.4 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.25 1.525 . . . . 0.0 109.697 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.5 mt -94.03 150.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 118.365 0.53 . . . . 0.0 109.993 -169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.8 t -135.45 127.9 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.59 116.94 32.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.65 141.51 28.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.231 0.923 . . . . 0.0 111.327 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -137.39 162.21 34.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 177.76 38.62 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 121.037 -1.039 . . . . 0.0 111.931 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 mt -122.84 150.04 43.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.89 -157.9 11.49 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -157.33 137.31 12.51 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.031 1.332 . . . . 0.0 107.879 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.633 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -86.86 -21.43 26.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.54 -45.47 65.44 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.622 1.101 . . . . 0.0 110.776 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.94 -29.13 9.33 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.302 0.953 . . . . 0.0 112.423 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.09 33.83 3.87 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.07 -42.61 61.66 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 120.155 1.343 . . . . 0.0 111.29 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.46 -17.42 62.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.825 0.812 . . . . 0.0 112.728 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -127.06 10.45 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.915 1.686 . . . . 0.0 112.342 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -41.96 124.36 2.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.476 1.91 . . . . 0.0 110.393 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 49.47 29.01 2.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.322 1.049 . . . . 0.0 112.72 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.751 -1.218 . . . . 0.0 110.255 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.35 73.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.407 0.283 . . . . 0.0 111.094 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.0 tp -61.69 -46.57 89.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.186 0.994 . . . . 0.0 110.633 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.25 -41.92 98.51 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.2 mtm -65.6 -44.72 85.7 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.616 0.708 . . . . 0.0 111.783 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.514 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.4 mt -64.74 -35.09 79.94 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.161 175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.77 -42.01 97.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.946 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.77 -43.45 88.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.615 1.166 . . . . 0.0 111.69 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -54.19 -58.97 5.37 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.516 1.126 . . . . 0.0 108.486 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.25 -19.05 57.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.741 -170.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 t -62.22 -29.37 70.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.365 0.984 . . . . 0.0 110.51 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -22.16 56.44 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.604 -1.31 . . . . 0.0 109.735 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -84.67 5.5 27.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.089 1.755 . . . . 0.0 112.935 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.05 35.15 90.2 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.25 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 124.326 1.051 . . . . 0.0 109.375 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.54 140.31 52.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -112.49 147.14 37.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 111.206 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.5 m -129.22 -178.96 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 109.335 169.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.6 34.01 41.0 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.006 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.97 146.17 39.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 119.694 1.747 . . . . 0.0 108.354 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 144.82 40.57 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-O 117.319 -1.324 . . . . 0.0 108.467 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.26 138.78 40.27 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 120.691 1.282 . . . . 0.0 109.22 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.455 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 68.0 p -73.98 -4.32 34.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.985 1.714 . . . . 0.0 113.337 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.59 141.58 57.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.997 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.51 -7.33 58.13 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.625 1.583 . . . . 0.0 113.619 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -94.34 161.29 14.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 0.0 110.097 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.55 131.05 46.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.22 -46.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.438 1.017 . . . . 0.0 110.453 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.3 3.4 t 59.77 8.6 1.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.764 2.826 . . . . 0.0 115.179 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -90.15 147.86 37.99 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.975 1.31 . . . . 0.0 111.458 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.63 -9.33 5.77 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.955 2.436 . . . . 0.0 114.162 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -72.93 -55.01 4.25 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.26 40.52 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 121.553 1.59 . . . . 0.0 112.413 -168.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.68 149.24 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.588 1.085 . . . . 0.0 110.748 -166.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.27 -172.39 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 126.209 1.803 . . . . 0.0 109.86 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.95 -116.54 0.85 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.099 1.359 . . . . 0.0 107.81 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.28 8.24 33.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.974 1.309 . . . . 0.0 111.89 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.92 20.56 20.95 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.724 1.154 . . . . 0.0 112.618 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -99.43 -18.06 17.65 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.752 1.221 . . . . 0.0 110.782 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 143.35 50.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.231 0.612 . . . . 0.0 110.927 174.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 59.0 m-85 -77.68 155.28 31.43 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.232 1.413 . . . . 0.0 109.64 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.18 -14.94 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 112.422 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.91 -178.15 42.72 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 119.763 1.165 . . . . 0.0 111.968 -173.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 13.9 tp -64.76 129.68 40.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.66 110.14 18.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.31 151.32 24.99 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.374 0.669 . . . . 0.0 109.716 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.87 138.02 25.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -107.87 30.84 5.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.132 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 t -133.09 -39.04 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.633 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.6 OUTLIER -88.04 -53.21 4.84 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.937 1.695 . . . . 0.0 106.76 171.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.7 16.89 23.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.015 1.326 . . . . 0.0 112.763 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -52.42 -27.92 17.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.214 0.915 . . . . 0.0 112.562 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.86 -19.57 30.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.996 0.518 . . . . 0.0 111.896 -173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.21 -2.96 7.54 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.968 1.307 . . . . 0.0 112.542 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 p -55.62 -32.39 63.09 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.869 1.213 . . . . 0.0 110.297 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.31 -42.03 90.43 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.401 1.08 . . . . 0.0 111.502 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -33.54 57.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.626 1.17 . . . . 0.0 109.941 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -70.01 -32.88 71.27 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.306 1.042 . . . . 0.0 108.413 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 52.8 mt -67.27 -59.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -58.37 -38.47 77.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.6 m -64.08 -37.8 88.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.667 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.407 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 36.2 t90 -66.5 -44.95 81.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.87 0.843 . . . . 0.0 110.168 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.1 m -56.93 -35.37 68.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.946 0.898 . . . . 0.0 109.72 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -70.76 -30.53 67.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.546 0.529 . . . . 0.0 109.852 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.77 -47.22 15.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.518 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -64.08 -39.71 86.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 CA-C-N 121.132 1.787 . . . . 0.0 110.36 -169.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.62 -14.11 56.54 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.369 0.667 . . . . 0.0 112.136 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.64 -45.98 6.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.37 -42.97 88.17 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.758 0.708 . . . . 0.0 109.525 -173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.5 mtm -76.9 -36.31 56.75 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.45 63.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.133 0.973 . . . . 0.0 109.959 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.52 -32.02 73.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.23 1.412 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.55 -47.78 80.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.161 0.584 . . . . 0.0 110.382 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -6.13 48.03 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.208 1.003 . . . . 0.0 113.707 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 118.785 0.72 . . . . 0.0 110.645 -178.572 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.85 140.29 29.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.99 148.25 47.13 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.632 2.373 . . . . 0.0 108.815 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.55 118.66 4.7 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.01 112.49 23.43 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.945 1.373 . . . . 0.0 108.928 170.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.0 144.86 34.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.159 1.384 . . . . 0.0 111.219 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.51 175.6 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.949 0.899 . . . . 0.0 110.74 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.22 140.51 7.91 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.592 -2.603 . . . . 0.0 106.592 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 141.24 43.3 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.727 1.264 . . . . 0.0 109.444 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -83.25 -40.34 19.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.442 1.097 . . . . 0.0 109.723 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.6 p -96.7 -82.26 0.4 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.622 1.569 . . . . 0.0 107.271 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 p -177.71 -6.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 128.781 2.832 . . . . 0.0 111.619 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.22 -41.26 86.05 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 119.769 -1.832 . . . . 0.0 111.806 -168.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -35.05 74.95 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -63.32 -46.46 86.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.991 0.917 . . . . 0.0 110.326 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.9 -38.85 87.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.011 -0.431 . . . . 0.0 111.044 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.69 93.89 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.683 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.65 -47.22 77.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.041 0.936 . . . . 0.0 110.621 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.64 -44.52 93.49 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.81 -55.43 26.48 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 124.546 1.154 . . . . 0.0 109.112 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.11 -56.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 118.974 0.806 . . . . 0.0 109.719 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.17 77.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.636 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.28 -46.58 73.19 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.013 0.525 . . . . 0.0 111.347 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.4 mt -67.39 -45.76 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.826 1.25 . . . . 0.0 108.417 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -71.95 -50.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.765 0.826 . . . . 0.0 110.241 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.51 114.27 0.79 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.489 1.042 . . . . 0.0 110.607 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.56 3.79 3.98 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.532 2.821 . . . . 0.0 112.681 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.8 -34.61 69.52 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.178 1.391 . . . . 0.0 109.194 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 -20.27 4.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.553 1.541 . . . . 0.0 111.602 -169.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.98 143.12 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.958 1.708 . . . . 0.0 109.083 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.6 m -133.68 129.24 36.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.562 1.145 . . . . 0.0 109.76 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.06 149.1 46.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.85 0.86 . . . . 0.0 111.687 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -144.09 112.32 6.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.445 1.898 . . . . 0.0 106.929 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -87.71 110.71 20.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.19 -8.39 31.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -59.77 -28.88 67.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.225 0.92 . . . . 0.0 111.476 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.36 -33.44 1.28 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.418 1.087 . . . . 0.0 112.285 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -83.34 140.6 32.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.218 1.007 . . . . 0.0 108.672 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m -84.88 141.63 38.27 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.05 -5.33 16.89 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.674 1.583 . . . . 0.0 111.764 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -54.06 -38.21 65.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.489 1.495 . . . . 0.0 111.338 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -20.55 66.27 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.116 -0.99 . . . . 0.0 113.16 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -12.23 27.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.331 1.053 . . . . 0.0 112.514 169.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -74.01 -26.26 60.34 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.941 -1.099 . . . . 0.0 110.581 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.31 -50.28 13.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.942 0.792 . . . . 0.0 110.106 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.89 146.16 55.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.575 1.15 . . . . 0.0 108.666 -169.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.72 -25.84 54.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.486 0.66 . . . . 0.0 110.648 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -145.54 140.36 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.09 155.77 41.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.648 0.658 . . . . 0.0 110.769 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.28 121.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 168.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 138.25 54.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.03 122.93 3.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-O 118.076 -1.402 . . . . 0.0 112.687 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.75 130.14 24.56 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.66 1.184 . . . . 0.0 110.307 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.04 146.69 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.352 2.035 . . . . 0.0 108.368 167.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -93.53 129.35 39.78 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -122.74 172.23 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.228 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 26.25 57.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 128.796 2.838 . . . . 0.0 115.702 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 57.84 76.11 0.34 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.412 1.485 . . . . 0.0 111.722 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.29 73.57 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.75 158.33 21.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.809 1.244 . . . . 0.0 109.68 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.56 151.6 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.02 143.59 57.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.47 -26.74 68.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.141 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -66.67 -26.7 67.17 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.525 0.73 . . . . 0.0 110.74 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -84.64 -42.36 15.43 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.16 0.984 . . . . 0.0 110.702 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.34 -34.34 64.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.206 0.457 . . . . 0.0 111.039 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.257 1.023 . . . . 0.0 112.16 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.04 -10.86 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.506 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.1 t-105 -53.62 -29.02 36.01 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.639 1.576 . . . . 0.0 111.849 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.57 -43.32 69.7 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.989 1.316 . . . . 0.0 111.302 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.62 -29.34 66.82 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.549 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.74 -33.31 68.32 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.17 1.35 . . . . 0.0 110.747 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.84 -29.15 68.99 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.927 0.891 . . . . 0.0 111.795 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -80.96 -24.52 38.03 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.976 0.511 . . . . 0.0 111.256 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -74.21 162.61 28.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.919 1.342 . . . . 0.0 112.23 -168.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -98.41 99.02 10.16 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.568 1.947 . . . . 0.0 108.842 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.8 10.48 15.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.9 121.22 12.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -169.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.75 -0.88 89.38 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.572 1.558 . . . . 0.0 115.17 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -73.75 154.21 39.69 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 118.239 1.019 . . . . 0.0 109.681 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -91.28 140.67 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.46 130.15 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 124.706 1.202 . . . . 0.0 109.012 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.57 115.5 30.03 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 167.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 mt -86.95 143.02 27.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.869 0.759 . . . . 0.0 111.455 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -137.7 161.27 36.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.24 176.5 39.44 Favored Glycine 0 CA--C 1.506 -0.488 0 O-C-N 120.844 -1.16 . . . . 0.0 112.558 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.6 mt -121.0 153.33 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.91 -153.9 9.22 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -154.02 142.48 20.69 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.973 1.709 . . . . 0.0 108.099 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.541 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -90.58 -23.38 20.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 175.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.14 -36.97 80.53 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.805 1.184 . . . . 0.0 112.027 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.7 -27.51 58.79 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -69.07 0.25 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.674 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.31 -39.54 3.09 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.576 1.56 . . . . 0.0 110.385 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.9 mm-40 -76.71 -35.35 57.91 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.453 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.59 -13.43 56.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.879 1.672 . . . . 0.0 111.528 -173.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -50.92 123.87 10.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 126.614 1.966 . . . . 0.0 109.322 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.0 26.71 4.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.259 1.023 . . . . 0.0 112.597 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.88 -37.33 86.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.688 -1.257 . . . . 0.0 110.622 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -32.74 73.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.825 0.45 . . . . 0.0 111.761 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 tp -60.93 -47.72 85.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.86 -40.83 97.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.7 mtm -65.61 -43.83 88.41 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.829 0.814 . . . . 0.0 112.376 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.506 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.7 mt -63.84 -33.82 76.55 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.567 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.55 -38.27 86.74 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.265 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.46 -30.54 64.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.091 2.156 . . . . 0.0 112.019 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -63.46 -62.01 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.07 -19.1 58.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.028 -0.986 . . . . 0.0 112.577 -166.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.1 p -60.23 -31.35 70.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.75 1.159 . . . . 0.0 111.125 169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -23.11 47.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -77.96 2.16 18.43 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.671 1.188 . . . . 0.0 112.414 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.79 32.88 66.54 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.999 0.818 . . . . 0.0 112.113 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.49 176.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.843 0.857 . . . . 0.0 109.743 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 146.92 47.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 166.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.6 149.01 31.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.991 0.814 . . . . 0.0 111.8 -169.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.5 m -127.39 -179.76 3.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.326 1.05 . . . . 0.0 108.977 169.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.83 33.5 46.18 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.986 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.6 m-30 -78.09 144.04 36.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.765 1.783 . . . . 0.0 108.47 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -119.32 145.43 38.56 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-O 117.344 -1.312 . . . . 0.0 108.662 171.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.16 138.33 43.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.708 1.289 . . . . 0.0 109.215 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.462 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 69.0 p -73.94 -6.88 49.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.661 1.585 . . . . 0.0 113.582 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.51 141.93 55.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.04 0.924 . . . . 0.0 109.868 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.64 59.93 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.499 1.523 . . . . 0.0 113.75 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -88.99 163.44 15.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.591 1.195 . . . . 0.0 110.639 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -127.56 124.81 39.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -164.68 -54.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.867 0.758 . . . . 0.0 109.696 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 3.8 t 57.96 8.18 0.7 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.19 2.596 . . . . 0.0 114.624 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -63.97 140.49 97.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 121.113 -0.992 . . . . 0.0 109.531 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.84 -11.5 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.834 2.356 . . . . 0.0 112.863 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -75.64 -52.35 2.84 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.922 1.237 . . . . 0.0 114.112 -168.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.04 42.02 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.944 1.73 . . . . 0.0 111.609 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.58 150.5 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.815 -1.178 . . . . 0.0 110.147 -167.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.84 -172.38 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 126.11 1.764 . . . . 0.0 109.913 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.4 -116.58 0.81 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.566 1.547 . . . . 0.0 107.487 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.1 8.93 34.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.844 1.257 . . . . 0.0 111.764 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.72 21.13 22.34 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.808 1.194 . . . . 0.0 112.486 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.24 -18.4 17.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.865 1.266 . . . . 0.0 110.586 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.71 142.49 49.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 111.311 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.38 155.5 31.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.182 1.393 . . . . 0.0 109.923 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.97 -12.87 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.601 1.16 . . . . 0.0 112.428 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.22 -178.85 43.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 119.907 1.23 . . . . 0.0 112.322 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 18.9 tp -65.46 130.26 42.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.09 117.71 33.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.9 mt -113.9 152.08 31.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.92 0.888 . . . . 0.0 108.723 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.59 128.22 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -102.47 17.89 22.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.59 1.156 . . . . 0.0 110.408 -171.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.62 -21.55 5.65 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.541 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.4 OUTLIER -112.71 -49.02 2.96 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.03 1.332 . . . . 0.0 108.25 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.55 19.31 20.59 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.107 1.363 . . . . 0.0 113.664 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -52.96 -22.99 6.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.58 -25.35 30.99 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.857 0.863 . . . . 0.0 111.864 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -120.56 -10.13 9.29 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -55.36 -32.41 62.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.096 1.316 . . . . 0.0 110.854 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.59 -40.42 83.13 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.603 1.161 . . . . 0.0 111.731 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -31.75 62.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.291 1.037 . . . . 0.0 109.786 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -78.88 -28.97 44.16 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.7 mt -63.12 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -58.0 -41.58 83.37 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.2 m -63.23 -37.05 85.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.772 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.401 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 42.4 t90 -67.12 -44.37 80.07 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.716 0.77 . . . . 0.0 110.22 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.3 m -57.11 -36.13 70.26 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.087 0.955 . . . . 0.0 109.506 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.78 -29.02 66.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.338 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.03 -46.55 16.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.318 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.7 pt -64.43 -38.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.961 1.709 . . . . 0.0 110.271 -171.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.2 -15.59 60.24 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.228 0.611 . . . . 0.0 112.036 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -95.92 -46.39 6.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.66 -40.43 83.47 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.711 0.687 . . . . 0.0 109.755 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 71.5 mtm -79.19 -37.99 36.92 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.737 0.815 . . . . 0.0 110.983 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.01 -46.77 70.32 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.008 0.923 . . . . 0.0 109.901 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.62 -29.88 69.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.106 1.362 . . . . 0.0 109.777 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -63.6 -48.47 77.21 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.553 0.615 . . . . 0.0 110.506 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.52 50.1 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.414 1.086 . . . . 0.0 113.741 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.485 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 119.704 -0.188 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.56 140.62 30.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -129.27 146.78 51.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.648 1.979 . . . . 0.0 108.947 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.27 117.63 4.77 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.597 -1.113 . . . . 0.0 110.445 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.82 113.32 23.37 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 119.254 1.527 . . . . 0.0 108.354 169.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -108.87 145.04 35.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.913 1.285 . . . . 0.0 111.442 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -159.96 173.35 16.02 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.652 0.781 . . . . 0.0 109.927 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.49 139.95 8.66 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -141.48 131.85 25.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.395 1.478 . . . . 0.0 108.837 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.7 m -84.29 -28.93 26.79 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.741 0.246 . . . . 0.0 110.739 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.1 p -112.47 -79.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.448 1.099 . . . . 0.0 108.165 -172.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.8 p -173.04 -13.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.18 -42.64 79.65 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 119.711 -1.868 . . . . 0.0 113.333 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -34.38 77.77 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.48 -49.25 76.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.454 1.102 . . . . 0.0 109.866 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.3 mtm -66.34 -41.83 89.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.346 0.521 . . . . 0.0 111.182 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.19 94.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.005 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.48 77.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 123.863 0.865 . . . . 0.0 110.436 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.88 -44.26 91.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -63.39 -54.93 29.1 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 124.79 1.306 . . . . 0.0 108.996 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.07 -56.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.956 0.798 . . . . 0.0 109.716 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -39.11 83.02 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.3 -46.92 72.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.939 0.496 . . . . 0.0 111.227 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -66.17 -46.62 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.962 1.305 . . . . 0.0 108.596 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 83.3 mt -72.66 -50.23 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.93 114.34 0.78 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.399 1.0 . . . . 0.0 110.67 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.12 4.03 3.57 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.494 2.796 . . . . 0.0 112.814 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.56 -34.05 64.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.505 1.522 . . . . 0.0 109.149 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.26 -22.77 3.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.772 1.629 . . . . 0.0 111.409 -169.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.16 140.73 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.657 1.571 . . . . 0.0 109.091 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.5 m -130.17 129.09 43.0 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.485 1.114 . . . . 0.0 109.679 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.42 148.96 46.39 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.481 0.712 . . . . 0.0 111.942 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -142.88 110.46 5.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.429 1.892 . . . . 0.0 106.621 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -86.74 110.65 20.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.0 -8.07 20.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -60.62 -28.04 68.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.25 0.932 . . . . 0.0 111.729 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -132.33 -33.97 1.25 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.77 1.228 . . . . 0.0 111.886 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -82.73 140.77 32.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.091 0.957 . . . . 0.0 108.565 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 m -83.96 140.82 40.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -74.13 -1.9 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.163 1.451 . . . . 0.0 110.983 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -56.36 -33.97 66.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.246 2.293 . . . . 0.0 111.921 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -19.36 64.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.0 ttm -58.17 -16.34 13.13 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.266 2.226 . . . . 0.0 111.702 169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -73.65 -31.14 63.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.056 -1.027 . . . . 0.0 110.795 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -78.16 -47.07 18.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.341 0.591 . . . . 0.0 110.019 -169.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -65.84 140.33 58.38 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.58 -169.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.5 -17.16 56.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.41 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.55 149.9 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 126.434 1.893 . . . . 0.0 106.069 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.1 mt -138.34 151.31 47.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.667 0.787 . . . . 0.0 109.218 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.36 121.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.0 135.75 54.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.19 122.79 4.37 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-O 117.773 -1.57 . . . . 0.0 113.12 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 126.61 25.78 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 119.286 1.543 . . . . 0.0 110.63 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.44 144.66 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.689 2.259 . . . . 0.0 107.799 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -87.81 131.27 34.59 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.98 169.47 10.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.22 1.808 . . . . 0.0 109.62 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 28.85 54.67 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.275 2.63 . . . . 0.0 115.319 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 55.98 78.73 0.19 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.312 1.445 . . . . 0.0 112.23 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 13.49 76.11 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.07 160.8 19.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.555 1.142 . . . . 0.0 109.125 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 mt -92.18 154.64 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -59.13 140.82 55.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.99 0.916 . . . . 0.0 108.787 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.83 -28.92 69.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -80.33 -20.95 43.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.642 -0.661 . . . . 0.0 110.58 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -77.0 -44.31 31.44 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.83 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -53.33 -35.85 60.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.473 0.709 . . . . 0.0 110.751 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.4 71.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.008 0.923 . . . . 0.0 112.209 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.44 -9.78 11.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.529 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.6 t-105 -53.32 -29.46 33.84 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 111.71 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.32 -44.76 74.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.959 1.304 . . . . 0.0 111.459 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -68.48 -29.67 68.34 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.113 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.5 mt -57.65 -31.06 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.995 1.27 . . . . 0.0 111.122 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.56 -28.95 65.3 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.499 0.72 . . . . 0.0 111.205 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.02 -23.34 38.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.139 0.576 . . . . 0.0 111.173 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 mt -72.94 157.84 36.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 123.038 1.399 . . . . 0.0 112.878 -167.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -90.94 91.53 8.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.738 -2.028 . . . . 0.0 107.978 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -111.38 11.63 21.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.84 128.33 35.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.06 30.86 69.57 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.294 0.95 . . . . 0.0 114.469 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.91 156.68 34.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.59 1.195 . . . . 0.0 109.633 169.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.4 mt -88.63 146.81 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.37 130.17 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.084 1.354 . . . . 0.0 109.263 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.06 117.93 35.07 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.05 143.13 27.05 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.389 0.995 . . . . 0.0 112.085 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -136.38 156.04 49.19 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.229 1.011 . . . . 0.0 109.13 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.55 164.54 35.16 Favored Glycine 0 CA--C 1.506 -0.475 0 O-C-N 120.801 -1.187 . . . . 0.0 112.154 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.4 158.63 36.79 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.57 -137.75 3.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.5 150.81 21.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.535 1.934 . . . . 0.0 108.046 168.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -89.08 -31.29 18.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.919 1.688 . . . . 0.0 114.149 173.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.6 -33.25 62.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.487 1.04 . . . . 0.0 113.082 -167.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.52 -19.33 35.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 124.788 1.185 . . . . 0.0 111.206 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.499 ' C ' ' H ' ' A' ' 95' ' ' GLU . 26.8 m-85 -126.85 -90.07 0.54 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.547 1.139 . . . . 0.0 108.721 -170.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.59 -50.8 2.55 Favored Glycine 0 N--CA 1.464 0.555 0 C-N-CA 128.517 2.96 . . . . 0.0 107.755 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 93' ' ' TYR . 12.3 mm-40 -69.65 -30.63 68.38 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.67 1.988 . . . . 0.0 110.536 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -115.14 0.73 13.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.75 1.22 . . . . 0.0 112.021 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.91 127.04 24.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.883 1.273 . . . . 0.0 109.545 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 56.28 23.8 7.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.57 1.548 . . . . 0.0 113.666 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.74 -36.78 78.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.551 -1.343 . . . . 0.0 110.698 -171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.64 72.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.104 0.561 . . . . 0.0 111.467 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.38 -46.76 88.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.799 0.84 . . . . 0.0 110.756 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.52 96.44 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.8 mtm -66.07 -44.94 83.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 117.712 0.756 . . . . 0.0 112.152 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.529 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.2 mt -64.33 -32.82 74.58 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.606 1.094 . . . . 0.0 111.807 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -63.53 -40.11 96.17 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.109 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.0 -36.13 69.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.758 1.623 . . . . 0.0 112.204 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.4 tptt -57.42 -47.03 82.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.688 0.795 . . . . 0.0 109.894 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -93.76 -20.65 19.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.037 -0.983 . . . . 0.0 112.33 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.2 p -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.748 1.613 . . . . 0.0 111.665 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -79.15 -17.43 55.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.071 0.548 . . . . 0.0 110.059 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -79.54 1.42 25.96 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.114 1.366 . . . . 0.0 111.943 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.01 34.79 58.34 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.941 0.792 . . . . 0.0 111.908 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.43 171.9 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.961 0.904 . . . . 0.0 109.787 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -121.09 142.91 49.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.44 150.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.903 1.229 . . . . 0.0 111.999 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.88 -178.66 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.649 1.179 . . . . 0.0 109.157 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 33.9 43.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-O 118.417 -1.213 . . . . 0.0 113.977 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -71.8 147.32 47.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.437 1.619 . . . . 0.0 107.784 170.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.66 144.98 51.69 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.236 169.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -69.58 140.12 42.57 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-N 121.012 1.397 . . . . 0.0 109.472 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.474 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 59.4 p -73.77 -11.01 60.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.568 1.547 . . . . 0.0 113.555 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.48 144.8 55.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.902 0.858 . . . . 0.0 109.338 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.83 19.2 79.29 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.123 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.4 165.49 27.36 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.868 2.067 . . . . 0.0 108.317 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -140.28 133.53 29.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.339 1.856 . . . . 0.0 108.485 -173.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -167.15 -57.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -170.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 2.9 t 56.2 7.52 0.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.844 2.858 . . . . 0.0 114.364 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -69.61 144.17 93.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 120.991 -1.068 . . . . 0.0 110.515 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.84 -14.5 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.722 2.281 . . . . 0.0 113.76 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -80.53 -48.98 1.18 Allowed Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.26 39.33 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.383 2.056 . . . . 0.0 112.579 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 148.43 21.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 109.589 -167.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -172.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.998 1.719 . . . . 0.0 109.666 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.85 -116.37 0.84 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.135 1.374 . . . . 0.0 107.306 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.38 7.8 33.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 112.202 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.28 20.13 18.85 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.996 1.284 . . . . 0.0 112.475 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.02 -17.11 17.66 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.686 1.194 . . . . 0.0 110.668 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 144.04 50.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 110.879 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 50.4 m-85 -78.26 154.87 30.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.953 1.301 . . . . 0.0 109.246 174.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.44 -14.91 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.15 -176.31 40.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.561 1.073 . . . . 0.0 111.901 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 16.3 tp -65.66 129.55 40.17 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.22 129.66 55.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.9 mt -130.47 158.68 39.24 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.724 1.61 . . . . 0.0 109.215 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.42 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -137.0 125.6 23.71 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.025 176.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -98.91 6.35 46.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.534 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -20.7 11.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.244 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.23 -42.33 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 112.675 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.13 7.2 19.6 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.091 0.86 . . . . 0.0 112.808 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -55.58 -21.55 17.89 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.522 1.056 . . . . 0.0 113.088 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.57 -25.61 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 111.536 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -129.26 3.8 5.19 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.08 0.952 . . . . 0.0 112.446 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -50.96 -29.4 12.11 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.81 -1.181 . . . . 0.0 110.842 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.36 -39.29 94.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.747 1.619 . . . . 0.0 110.604 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 16.2 mm-40 -72.28 -46.35 56.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 129.374 3.07 . . . . 0.0 108.194 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -25.39 62.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.841 -1.981 . . . . 0.0 108.273 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.28 -62.33 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -57.17 -37.34 71.96 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.2 m -63.53 -38.39 90.93 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.428 0.455 . . . . 0.0 110.751 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -66.52 -44.56 82.13 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.438 -0.788 . . . . 0.0 110.179 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 72.8 m -55.89 -35.53 66.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.553 0.741 . . . . 0.0 109.809 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -33.58 76.28 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.485 0.491 . . . . 0.0 110.259 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -81.93 -46.14 14.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.498 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.3 pt -64.55 -39.47 85.69 Favored 'Isoleucine or valine' 0 C--N 1.337 0.061 0 CA-C-N 121.417 1.917 . . . . 0.0 109.977 -169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.6 -14.25 57.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -96.44 -45.65 6.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.885 1.274 . . . . 0.0 107.888 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.29 -41.08 88.13 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.886 0.767 . . . . 0.0 109.724 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 73.0 mtm -77.37 -35.65 54.32 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.169 0.988 . . . . 0.0 110.951 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.48 -47.32 42.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.335 1.054 . . . . 0.0 110.004 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.53 -29.56 68.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.405 1.482 . . . . 0.0 110.129 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -60.66 -45.78 92.82 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.266 0.485 . . . . 0.0 110.302 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.78 -1.63 58.09 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 114.055 -174.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.422 177.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 145.26 30.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.876 1.27 . . . . 0.0 108.636 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.8 mtm -130.45 147.25 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.127 1.771 . . . . 0.0 108.984 -168.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.4 118.63 5.07 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 118.81 -0.995 . . . . 0.0 110.947 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.09 105.9 18.12 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.86 1.33 . . . . 0.0 109.952 171.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -105.0 145.74 30.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.47 1.508 . . . . 0.0 111.301 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -164.93 175.47 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.007 0.923 . . . . 0.0 110.431 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.91 142.33 10.02 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 168.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -146.52 147.69 31.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.25 1.025 . . . . 0.0 111.401 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -95.79 -45.89 6.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.543 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.5 p -90.19 -10.93 42.6 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.006 1.722 . . . . 0.0 111.41 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.276 44.5 m 73.64 13.67 4.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.2 2.2 . . . . 0.0 113.697 -168.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.6 -44.2 94.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.593 1.542 . . . . 0.0 110.764 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -34.29 77.28 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -64.45 -49.07 72.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.409 1.084 . . . . 0.0 109.99 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.8 -38.89 92.51 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.94 -0.475 . . . . 0.0 111.151 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.76 97.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.848 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.13 79.03 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.776 0.83 . . . . 0.0 110.611 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.37 -46.74 83.06 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.903 0.481 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.32 -54.86 34.44 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 124.732 1.27 . . . . 0.0 108.923 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.8 mt -53.41 -56.87 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 118.447 0.567 . . . . 0.0 109.584 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -38.99 72.81 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.343 0.657 . . . . 0.0 110.539 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.62 -48.1 67.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.992 0.517 . . . . 0.0 111.201 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.8 mt -64.64 -47.11 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.996 1.318 . . . . 0.0 108.8 -176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.5 mt -72.58 -51.55 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.783 0.833 . . . . 0.0 110.52 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.67 115.59 0.76 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.44 3.54 4.11 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.29 2.66 . . . . 0.0 112.98 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.73 -35.12 65.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.25 1.42 . . . . 0.0 108.966 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -26.96 5.57 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.067 1.747 . . . . 0.0 111.369 -173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.47 140.43 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 120.781 1.628 . . . . 0.0 109.088 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.7 m -129.91 129.62 44.1 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.54 1.136 . . . . 0.0 110.073 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.79 148.99 47.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.875 0.87 . . . . 0.0 112.154 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -145.21 108.84 4.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.697 1.599 . . . . 0.0 107.762 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -82.31 112.03 18.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.77 -9.44 36.92 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -59.12 -28.49 66.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.422 1.01 . . . . 0.0 111.509 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.64 -34.22 1.56 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.473 1.109 . . . . 0.0 112.112 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.26 140.2 33.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 m -82.95 139.72 42.97 Favored Pre-proline 0 N--CA 1.452 -0.358 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.81 -1.62 11.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 121.172 1.454 . . . . 0.0 111.425 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 122.153 2.251 . . . . 0.0 111.713 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -18.78 64.68 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.91 -15.62 13.66 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.993 2.117 . . . . 0.0 111.971 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.1 -32.99 63.45 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.191 -0.943 . . . . 0.0 110.601 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.62 -48.11 28.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.58 0.705 . . . . 0.0 110.04 -170.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -70.86 131.86 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.94 -3.34 58.9 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.8 t -140.57 146.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -140.63 153.86 46.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.999 0.52 . . . . 0.0 109.789 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -129.32 122.84 56.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 mp -119.73 136.71 54.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.2 119.71 2.87 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 117.957 -1.468 . . . . 0.0 112.785 -171.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.03 133.64 25.0 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.046 1.423 . . . . 0.0 110.309 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.74 157.07 15.97 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.222 1.948 . . . . 0.0 108.717 166.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -101.22 125.26 47.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -113.71 172.18 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.802 1.641 . . . . 0.0 109.829 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.96 62.5 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.793 2.837 . . . . 0.0 115.225 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 55.93 71.52 0.55 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 112.363 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.27 79.34 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.27 155.39 24.87 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.548 1.139 . . . . 0.0 109.948 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.25 151.61 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -65.8 143.5 57.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.91 -26.67 68.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.035 -169.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.03 -26.7 66.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.674 0.789 . . . . 0.0 110.761 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -83.99 -42.74 15.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.108 0.963 . . . . 0.0 110.71 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.41 -34.92 64.82 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.581 0.628 . . . . 0.0 110.819 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.7 71.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.359 1.064 . . . . 0.0 112.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.31 -11.46 10.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.514 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t-105 -53.52 -28.98 34.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.653 1.581 . . . . 0.0 111.724 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.29 -44.68 64.73 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.006 1.322 . . . . 0.0 111.384 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.73 -30.37 70.58 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.568 -1.206 . . . . 0.0 111.95 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.703 1.138 . . . . 0.0 111.096 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.14 -31.33 70.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 111.421 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.41 -26.44 38.46 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.355 0.662 . . . . 0.0 110.887 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.24 159.79 33.37 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.565 1.174 . . . . 0.0 112.062 -169.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.68 96.85 10.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 112.832 -1.986 . . . . 0.0 108.215 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -118.92 6.6 11.4 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.122 0.969 . . . . 0.0 113.141 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.0 118.35 11.8 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -168.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.79 70.5 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.943 1.259 . . . . 0.0 115.687 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.68 154.74 23.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.083 1.441 . . . . 0.0 109.106 171.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.5 mt -85.21 143.78 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 118.87 0.759 . . . . 0.0 109.283 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.5 t -132.44 134.13 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.526 1.53 . . . . 0.0 109.854 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.77 120.6 41.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.1 143.68 26.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 119.145 0.884 . . . . 0.0 111.644 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -137.13 159.39 42.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.37 178.13 39.08 Favored Glycine 0 N--CA 1.448 -0.555 0 O-C-N 121.044 -1.035 . . . . 0.0 112.524 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -127.67 151.12 49.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.73 -157.76 9.85 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -155.12 137.68 15.11 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.606 1.562 . . . . 0.0 108.333 168.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.508 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -90.57 -20.76 22.24 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.74 -49.33 68.81 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.781 1.173 . . . . 0.0 110.836 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.53 -27.36 8.6 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.189 0.9 . . . . 0.0 112.149 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -131.4 33.07 4.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -166.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.45 -42.66 57.55 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-N 120.354 1.434 . . . . 0.0 111.012 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.82 -19.75 60.35 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 117.986 0.893 . . . . 0.0 112.318 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -125.84 12.56 7.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.871 1.668 . . . . 0.0 112.432 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -45.61 122.05 3.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.487 1.515 . . . . 0.0 108.679 170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 52.86 28.2 6.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.033 0.933 . . . . 0.0 112.971 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.91 -40.29 94.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 120.648 -1.282 . . . . 0.0 110.113 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.94 -33.75 76.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 111.709 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.6 tp -59.96 -47.72 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 110.456 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.11 97.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.3 mtm -65.02 -44.56 88.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.01 0.905 . . . . 0.0 111.78 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.514 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.9 mt -64.43 -35.44 80.93 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.295 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -64.24 -41.46 96.98 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.387 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.34 -42.6 92.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -55.06 -59.49 4.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.267 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.26 -20.84 57.01 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.628 -0.67 . . . . 0.0 110.794 -170.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.8 t -62.2 -30.29 70.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.165 0.893 . . . . 0.0 110.304 168.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -24.12 48.66 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.7 -1.25 . . . . 0.0 109.279 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 23.6 mmmt -81.19 2.38 27.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.025 1.73 . . . . 0.0 112.59 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.69 33.15 79.83 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 118.643 0.656 . . . . 0.0 112.102 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.18 169.51 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 117.619 0.709 . . . . 0.0 109.468 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -113.61 140.25 48.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.45 148.08 32.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.072 1.305 . . . . 0.0 112.43 -168.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.6 -179.98 3.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.817 1.247 . . . . 0.0 109.577 168.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.77 33.41 33.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 118.342 -1.254 . . . . 0.0 114.741 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -78.86 139.6 38.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.933 1.866 . . . . 0.0 108.784 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 148.96 42.1 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.59 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.33 138.99 37.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 120.949 1.375 . . . . 0.0 109.108 168.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.459 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 60.2 p -74.08 -6.78 49.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 113.441 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.15 140.58 57.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.207 1.004 . . . . 0.0 109.724 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.15 -10.02 62.04 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.541 1.543 . . . . 0.0 113.881 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -88.94 162.4 16.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.79 1.295 . . . . 0.0 110.752 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -127.64 125.33 39.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -162.49 -61.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.167 0.894 . . . . 0.0 110.07 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.333 2.1 t 58.74 11.13 1.69 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.575 2.75 . . . . 0.0 114.801 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 p -66.47 142.87 97.94 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.851 -1.156 . . . . 0.0 109.095 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.75 -15.36 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.283 1.989 . . . . 0.0 113.852 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -80.81 -48.21 1.15 Allowed Pre-proline 0 C--N 1.344 0.344 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.34 36.63 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.705 1.603 . . . . 0.0 112.484 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.093 0.957 . . . . 0.0 109.843 -166.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.77 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 109.456 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.94 -116.83 0.86 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.959 1.304 . . . . 0.0 107.62 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.14 7.82 33.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.761 1.224 . . . . 0.0 111.831 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.68 20.1 20.4 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.724 1.154 . . . . 0.0 112.575 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -100.36 -17.25 17.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.852 1.261 . . . . 0.0 110.859 -172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 145.29 51.25 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.286 0.634 . . . . 0.0 110.876 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 61.2 m-85 -81.27 155.45 26.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 110.221 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.02 -12.44 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.725 1.21 . . . . 0.0 112.755 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.67 -178.28 42.64 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.612 1.097 . . . . 0.0 111.879 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.2 tp -65.54 127.92 33.81 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.55 116.02 29.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.15 157.57 24.6 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.98 15.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -98.97 17.26 20.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.883 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.94 -23.57 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.508 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -114.17 -52.6 2.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.702 1.137 . . . . 0.0 109.18 172.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -98.16 14.46 27.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.52 1.128 . . . . 0.0 113.896 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -52.07 -26.13 10.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.906 0.882 . . . . 0.0 112.485 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.37 -27.9 46.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 111.38 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -7.03 13.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.045 0.938 . . . . 0.0 111.218 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.2 m -53.07 -26.91 17.7 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.719 -1.238 . . . . 0.0 110.862 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.16 -40.18 90.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 122.035 0.921 . . . . 0.0 110.269 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.455 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -70.92 -46.2 62.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 129.827 3.251 . . . . 0.0 107.825 -177.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -69.49 -28.12 65.79 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.199 -1.819 . . . . 0.0 108.322 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.34 -61.05 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -56.88 -41.19 77.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 118.908 0.776 . . . . 0.0 112.259 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 m -65.59 -35.68 81.52 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.635 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -66.65 -43.95 83.26 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.464 -0.772 . . . . 0.0 109.79 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 92.7 m -57.55 -35.49 70.4 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.903 0.881 . . . . 0.0 109.644 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.12 -27.99 63.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.014 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -80.2 -46.41 16.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.148 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.2 -39.54 85.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 121.308 1.867 . . . . 0.0 110.614 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.11 -15.37 59.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -96.53 -45.11 6.87 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 124.683 1.193 . . . . 0.0 107.799 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.31 -42.02 90.41 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.122 0.874 . . . . 0.0 109.574 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.9 mtm -74.36 -41.92 60.23 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.142 0.977 . . . . 0.0 110.081 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.94 -44.41 80.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.286 1.035 . . . . 0.0 110.647 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -69.81 -32.2 70.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.082 1.353 . . . . 0.0 109.785 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -61.53 -42.44 98.82 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.474 0.654 . . . . 0.0 109.913 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -2.16 35.6 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.02 1.728 . . . . 0.0 113.758 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-N 118.406 0.548 . . . . 0.0 110.567 -179.204 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.14 142.54 33.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 mtm -131.14 146.43 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.648 1.979 . . . . 0.0 108.276 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.55 117.94 5.0 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 118.637 -1.091 . . . . 0.0 110.397 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.72 113.12 24.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.268 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -109.92 147.36 33.57 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.77 1.628 . . . . 0.0 111.451 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -164.13 175.25 10.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.748 1.219 . . . . 0.0 109.704 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.54 142.95 11.16 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 168.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -148.87 144.61 27.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.303 1.051 . . . . 0.0 111.452 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 m -96.07 -37.87 10.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 111.389 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -95.09 -8.9 35.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 111.594 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.264 56.9 m 71.5 15.01 6.22 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.745 2.018 . . . . 0.0 114.121 -170.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -65.28 -42.94 92.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.434 1.47 . . . . 0.0 110.353 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.18 -33.66 75.88 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -64.3 -46.93 81.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.0 110.096 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 -40.85 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.592 -0.692 . . . . 0.0 111.548 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.4 94.02 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.638 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.37 79.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.902 0.881 . . . . 0.0 110.788 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.34 -45.3 88.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -61.73 -54.33 43.92 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 124.701 1.251 . . . . 0.0 108.725 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.414 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.1 mt -53.58 -56.73 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.852 0.751 . . . . 0.0 109.958 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.22 76.75 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.0 0.52 . . . . 0.0 110.484 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.92 -48.01 69.96 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.995 0.518 . . . . 0.0 111.21 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mt -65.27 -47.28 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.133 0.973 . . . . 0.0 108.533 -176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.83 -50.49 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.383 0.673 . . . . 0.0 110.402 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.29 113.69 0.73 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 171.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.15 4.08 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.357 2.705 . . . . 0.0 112.69 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.89 -34.4 66.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.022 1.329 . . . . 0.0 109.228 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.86 -21.33 4.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.558 1.543 . . . . 0.0 111.814 -169.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -94.04 141.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 120.659 1.572 . . . . 0.0 109.028 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 m -130.44 128.23 40.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 110.006 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.41 148.66 48.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.932 0.893 . . . . 0.0 112.163 174.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.25 109.7 4.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.094 1.758 . . . . 0.0 107.41 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -83.82 112.11 19.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.16 -10.53 42.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -58.06 -29.11 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.19 0.905 . . . . 0.0 111.542 169.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.34 -34.37 1.62 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.573 1.149 . . . . 0.0 112.08 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.26 140.27 33.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -84.01 139.98 39.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.97 -4.46 15.18 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.087 1.424 . . . . 0.0 111.643 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -54.16 -36.96 63.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.08 1.764 . . . . 0.0 111.524 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -20.59 66.24 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.224 -0.923 . . . . 0.0 113.449 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -11.9 26.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.329 1.052 . . . . 0.0 112.185 169.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -74.57 -25.7 59.46 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.866 -1.146 . . . . 0.0 110.961 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.79 -51.57 11.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.183 0.901 . . . . 0.0 110.195 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -66.72 142.13 57.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.288 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.44 -27.56 61.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 110.694 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.26 144.27 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -135.33 152.77 51.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.546 0.612 . . . . 0.0 110.293 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.88 121.32 54.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -120.72 137.8 54.3 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.145 0.978 . . . . 0.0 108.473 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.71 2.57 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-O 117.543 -1.698 . . . . 0.0 111.85 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.14 127.69 26.45 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 119.476 1.638 . . . . 0.0 111.405 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.47 145.45 13.27 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.818 1.679 . . . . 0.0 108.16 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 m -89.6 137.43 32.33 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -133.02 173.37 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.884 2.074 . . . . 0.0 109.406 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.7 t0 36.13 51.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.331 2.252 . . . . 0.0 114.47 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 56.05 80.71 0.14 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.271 1.429 . . . . 0.0 112.483 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.25 10.27 84.31 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 172.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.33 163.88 14.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.708 1.603 . . . . 0.0 110.509 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mt -89.84 152.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -68.47 144.44 54.66 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.39 -29.62 70.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.185 0.594 . . . . 0.0 112.193 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.59 -23.6 65.4 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.943 -0.473 . . . . 0.0 111.169 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -86.12 -41.98 14.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.301 1.04 . . . . 0.0 110.937 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.72 -34.66 65.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.586 0.63 . . . . 0.0 111.016 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.27 -30.36 70.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.752 1.221 . . . . 0.0 111.874 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.19 -12.97 10.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.544 ' CD1' ' HE2' ' A' ' 107' ' ' LYS . 2.9 t-105 -53.31 -29.42 33.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.007 1.323 . . . . 0.0 111.801 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.27 -43.33 70.69 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.147 1.379 . . . . 0.0 111.387 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.23 -31.23 70.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.936 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.1 mt -56.59 -31.03 63.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.936 1.244 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.73 -28.49 65.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.665 0.786 . . . . 0.0 111.545 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.9 -24.97 32.91 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.417 0.687 . . . . 0.0 111.038 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 mt -72.95 158.62 35.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 123.046 1.403 . . . . 0.0 112.679 -167.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.53 95.98 10.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.549 174.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mt -118.23 8.09 12.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.61 121.21 13.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.4 8.05 88.04 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.284 1.421 . . . . 0.0 114.495 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -76.2 147.89 38.08 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 117.743 0.771 . . . . 0.0 109.203 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.3 mt -86.64 138.41 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 167.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.98 129.63 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.765 1.226 . . . . 0.0 108.589 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.69 117.61 34.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -90.92 141.38 28.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.941 0.791 . . . . 0.0 111.93 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -137.85 161.91 35.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.894 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.25 174.72 36.2 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 121.295 -0.878 . . . . 0.0 112.389 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 mt -124.21 148.5 47.24 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.396 1.079 . . . . 0.0 108.755 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.45 27.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.332 0.492 . . . . 0.0 112.241 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -133.45 112.69 11.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.18 -29.44 28.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.459 0.171 . . . . 0.0 111.271 -172.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.96 -46.25 58.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.148 0.579 . . . . 0.0 110.395 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.08 -34.65 12.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.04 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.39 28.95 4.91 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.54 -34.34 60.03 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 120.33 1.423 . . . . 0.0 112.411 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.2 -24.32 63.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.063 0.932 . . . . 0.0 112.369 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -113.15 -47.5 3.02 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.521 1.528 . . . . 0.0 110.089 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.265 1.6 t80 43.97 -131.36 0.77 Allowed 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 128.478 2.711 . . . . 0.0 109.514 -172.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.58 39.38 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 130.697 3.599 . . . . 0.0 113.787 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -58.14 -43.05 87.09 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 119.437 -2.039 . . . . 0.0 111.123 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.98 -32.1 71.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.946 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.13 -47.39 82.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.478 0.711 . . . . 0.0 110.189 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.27 99.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.1 mtm -62.97 -48.15 80.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 117.556 0.678 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.06 -30.86 71.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.651 -0.656 . . . . 0.0 111.201 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -60.83 -46.29 91.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.3 0.5 . . . . 0.0 109.826 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.72 -41.2 92.54 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.448 1.099 . . . . 0.0 111.657 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.544 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 7.0 tptt -55.6 -62.27 1.79 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.553 1.141 . . . . 0.0 107.936 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.16 -21.04 62.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.536 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -61.65 -29.4 70.04 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.649 1.113 . . . . 0.0 110.729 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.48 -22.1 54.96 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.819 -1.176 . . . . 0.0 109.799 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.73 1.61 37.87 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.636 1.574 . . . . 0.0 112.541 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.32 33.66 68.62 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.477 0.58 . . . . 0.0 111.842 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.25 170.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.622 0.769 . . . . 0.0 109.319 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -117.26 143.14 46.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -110.33 148.05 32.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.56 1.073 . . . . 0.0 111.899 -170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.42 178.17 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.664 1.185 . . . . 0.0 108.439 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.78 34.21 39.62 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 118.52 -1.155 . . . . 0.0 114.368 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -71.95 155.72 40.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.613 1.707 . . . . 0.0 107.948 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.403 ' HE1' HD13 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -138.45 142.05 33.48 Favored Pre-proline 0 CA--C 1.514 -0.437 0 CA-C-O 116.939 -1.505 . . . . 0.0 109.227 176.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.45 143.08 56.31 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.038 1.406 . . . . 0.0 109.618 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.518 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 73.9 p -74.69 -0.01 16.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.899 1.68 . . . . 0.0 113.776 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.27 146.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.04 0.936 . . . . 0.0 109.948 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.29 22.83 75.28 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.216 0.913 . . . . 0.0 112.967 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.15 152.45 40.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.838 . . . . 0.0 109.459 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -122.75 133.13 54.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 128.732 2.813 . . . . 0.0 104.682 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -163.01 -53.88 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 118.752 0.705 . . . . 0.0 109.454 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.361 3.1 t 61.66 8.12 2.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.066 2.547 . . . . 0.0 114.939 176.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.2 t -67.85 138.13 92.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -84.7 -10.56 8.42 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.251 2.634 . . . . 0.0 112.77 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -78.42 -49.93 1.72 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -88.46 39.84 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.381 2.054 . . . . 0.0 112.593 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 148.43 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.509 1.124 . . . . 0.0 109.612 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.02 -171.98 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 C-N-CA 126.369 1.867 . . . . 0.0 109.861 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.39 -116.11 0.86 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.203 1.401 . . . . 0.0 107.443 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.55 8.34 33.28 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.059 1.344 . . . . 0.0 112.222 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.99 21.12 19.13 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.76 1.171 . . . . 0.0 112.506 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -100.69 -18.32 16.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.793 1.237 . . . . 0.0 110.8 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.14 144.23 51.24 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.887 0.475 . . . . 0.0 110.876 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.78 156.58 30.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.7 m -65.2 -18.11 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.478 0.711 . . . . 0.0 112.108 174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.07 -178.76 39.66 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.403 1.001 . . . . 0.0 111.114 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.403 HD13 ' HE1' ' A' ' 119' ' ' TRP . 20.1 tp -61.23 128.26 35.5 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.15 125.5 53.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.1 mt -121.99 150.23 42.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.65 132.4 38.91 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -111.57 10.67 21.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.705 -170.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.258 0.5 OUTLIER -108.21 -31.17 8.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 176.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -136.14 -27.33 1.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.096 0.862 . . . . 0.0 113.267 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -89.5 12.08 17.57 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.914 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -57.69 -21.77 42.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.874 1.215 . . . . 0.0 113.475 -170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.54 -19.29 28.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.647 0.779 . . . . 0.0 112.141 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.0 mt -113.49 -24.48 9.25 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 126.702 2.001 . . . . 0.0 111.4 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.5 p -51.43 -35.77 40.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.366 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.395 0.678 . . . . 0.0 110.26 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.88 -29.63 66.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.547 0.339 . . . . 0.0 111.744 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -78.97 -28.11 43.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.704 0.802 . . . . 0.0 110.039 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 mt -66.05 -54.26 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -56.97 -44.77 82.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.588 0.755 . . . . 0.0 112.257 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.4 p -67.19 -35.64 80.06 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.933 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -64.63 -45.12 88.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.844 0.83 . . . . 0.0 109.553 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.7 m -57.53 -35.42 70.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.134 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -34.7 77.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.83 0.452 . . . . 0.0 110.273 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.24 -46.27 18.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.373 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -65.18 -38.61 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 120.858 1.663 . . . . 0.0 110.002 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.28 -14.3 60.41 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.286 0.494 . . . . 0.0 112.016 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -95.03 -46.14 6.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 107.871 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.46 -36.02 77.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.841 0.746 . . . . 0.0 110.209 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.1 mtm -77.67 -44.19 28.84 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.329 1.052 . . . . 0.0 110.508 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -42.45 78.18 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.819 0.848 . . . . 0.0 111.052 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.18 -31.11 68.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.91 1.284 . . . . 0.0 109.791 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -41.91 97.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.297 0.639 . . . . 0.0 110.487 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -1.25 56.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.901 1.681 . . . . 0.0 113.919 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.318 179.239 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.2 143.86 30.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.0 mtm -132.12 146.51 52.09 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.773 2.029 . . . . 0.0 108.187 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.75 118.42 4.94 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-O 118.622 -1.099 . . . . 0.0 110.51 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 111.54 22.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.986 1.393 . . . . 0.0 108.885 169.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.88 146.44 36.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.988 1.315 . . . . 0.0 111.047 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -161.91 174.88 12.49 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.234 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.2 10.2 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.578 -2.609 . . . . 0.0 106.578 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.4 p -146.38 122.47 10.78 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.326 1.063 . . . . 0.0 111.614 -169.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 m -80.83 -37.87 29.28 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.205 0.457 . . . . 0.0 111.638 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.9 p -107.93 8.55 28.55 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.866 1.266 . . . . 0.0 112.092 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.7 m 65.35 11.71 7.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.85 2.06 . . . . 0.0 114.192 -171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -66.63 -46.94 74.2 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.318 -1.489 . . . . 0.0 111.224 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -33.44 75.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.88 -46.56 87.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 110.312 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.4 mtm -65.49 -43.37 90.38 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.774 -0.578 . . . . 0.0 111.384 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.55 -39.81 89.29 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 122.005 -0.434 . . . . 0.0 110.886 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.74 81.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.206 1.002 . . . . 0.0 110.53 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.5 -44.77 85.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.93 -53.88 47.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.721 1.263 . . . . 0.0 108.997 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.55 -56.82 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.724 0.693 . . . . 0.0 109.768 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -38.49 78.63 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.574 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.57 -47.78 71.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.004 0.522 . . . . 0.0 111.121 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.2 mt -65.27 -48.0 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.682 1.193 . . . . 0.0 108.697 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.0 mt -71.96 -50.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.502 0.721 . . . . 0.0 110.54 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.59 114.34 0.75 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.5 1.048 . . . . 0.0 110.707 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.39 3.76 3.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.625 2.883 . . . . 0.0 112.677 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -73.49 -34.12 65.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.206 1.403 . . . . 0.0 109.226 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -22.53 3.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.4 1.48 . . . . 0.0 111.824 -169.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 120.333 1.424 . . . . 0.0 108.752 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 m -129.17 129.58 45.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.539 1.136 . . . . 0.0 110.022 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.05 146.28 45.97 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.299 1.039 . . . . 0.0 112.068 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -144.09 107.97 4.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.616 1.567 . . . . 0.0 107.313 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -83.29 112.42 19.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.31 -8.95 20.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.94 0.896 . . . . 0.0 113.155 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.91 -29.14 66.83 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.209 0.913 . . . . 0.0 111.753 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -130.82 -34.25 1.52 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.714 1.206 . . . . 0.0 111.842 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -82.16 141.78 32.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.982 0.913 . . . . 0.0 108.756 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -81.35 147.97 61.7 Favored Pre-proline 0 N--CA 1.45 -0.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -78.19 -2.95 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.177 1.251 . . . . 0.0 111.36 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -55.75 -35.3 66.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 122.101 2.228 . . . . 0.0 112.011 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -20.09 66.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 49.7 ttm -59.28 -15.51 16.21 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.674 1.99 . . . . 0.0 111.477 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -73.2 -30.83 63.8 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.194 -0.941 . . . . 0.0 110.913 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -76.01 -46.28 30.24 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.976 0.807 . . . . 0.0 110.834 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.98 141.87 56.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.1 -168.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -74.54 -19.96 60.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.318 0.647 . . . . 0.0 110.509 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.7 t -145.41 148.7 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mt -138.27 150.3 46.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.99 0.916 . . . . 0.0 109.183 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.5 120.65 51.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.7 132.59 55.7 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.89 118.33 3.67 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-O 117.541 -1.699 . . . . 0.0 112.757 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 126.01 27.24 Favored Pre-proline 0 N--CA 1.472 0.625 0 CA-C-N 119.608 1.704 . . . . 0.0 111.45 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -80.27 144.82 16.63 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.351 2.701 . . . . 0.0 108.987 167.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 m -94.96 131.54 40.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -121.91 171.33 9.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.524 1.93 . . . . 0.0 109.442 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 20.12 67.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.921 2.888 . . . . 0.0 115.459 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 54.0 70.05 0.65 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.689 1.196 . . . . 0.0 112.112 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 21.11 79.65 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.165 0.826 . . . . 0.0 115.165 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.305 0.4 OUTLIER -88.34 156.4 19.19 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 166.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.21 150.36 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -55.34 139.59 42.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.181 0.991 . . . . 0.0 108.545 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.63 -28.22 69.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -78.47 -19.51 52.95 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.726 -0.609 . . . . 0.0 110.434 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -81.08 -43.06 20.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.377 0.671 . . . . 0.0 111.192 169.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.26 -33.44 58.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.531 0.605 . . . . 0.0 111.008 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.24 71.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.252 1.021 . . . . 0.0 112.33 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.86 -8.92 12.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.527 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.9 t-105 -53.2 -28.96 29.35 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.31 1.444 . . . . 0.0 111.902 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.72 -44.71 76.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.992 1.317 . . . . 0.0 111.635 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -68.58 -29.01 67.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.05 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.75 -29.84 65.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 111.114 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.33 -29.47 66.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.515 0.726 . . . . 0.0 111.452 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.87 -24.62 38.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.391 0.676 . . . . 0.0 111.366 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.4 159.91 33.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.808 1.289 . . . . 0.0 112.998 -168.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.4 92.31 7.59 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 126.663 1.985 . . . . 0.0 108.539 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -113.5 10.15 18.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.66 126.43 28.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.98 21.66 79.01 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.818 1.199 . . . . 0.0 115.678 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.21 155.8 21.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.802 1.301 . . . . 0.0 108.828 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.7 mt -87.25 145.79 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -172.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.01 130.2 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.046 1.338 . . . . 0.0 109.29 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 118.07 35.84 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -90.45 141.73 28.45 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.227 0.921 . . . . 0.0 111.554 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -136.78 160.58 38.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.205 1.002 . . . . 0.0 108.43 168.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.13 170.81 36.29 Favored Glycine 0 N--CA 1.446 -0.641 0 O-C-N 121.005 -1.06 . . . . 0.0 111.82 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.8 mt -129.32 153.14 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.42 -154.87 11.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -149.77 137.52 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.101 1.36 . . . . 0.0 108.074 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.571 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -90.62 -22.83 21.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.306 1.443 . . . . 0.0 113.44 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.28 -39.55 53.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.054 1.297 . . . . 0.0 111.627 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.42 -26.28 16.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.418 1.008 . . . . 0.0 112.232 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.36 35.46 2.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -167.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.66 52.54 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.186 1.357 . . . . 0.0 110.973 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -62.71 -15.02 50.86 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.067 0.947 . . . . 0.0 112.133 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -126.22 8.89 7.28 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.351 1.86 . . . . 0.0 112.128 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -48.93 124.86 9.33 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.496 1.518 . . . . 0.0 109.389 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.17 28.63 9.29 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.182 0.993 . . . . 0.0 112.855 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.1 -36.89 82.91 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 120.444 -1.41 . . . . 0.0 110.684 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 111.325 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 tp -60.41 -48.11 83.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.016 0.926 . . . . 0.0 110.535 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.45 98.13 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mtm -65.16 -44.54 88.22 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.849 0.825 . . . . 0.0 112.101 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.527 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.3 mt -65.29 -35.31 80.61 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.365 0.984 . . . . 0.0 111.169 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -62.94 -42.14 99.72 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.656 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.12 -43.1 88.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.29 -59.11 5.11 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.848 1.259 . . . . 0.0 108.4 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.69 -22.19 54.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.241 -169.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 t -62.02 -28.77 69.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.975 0.807 . . . . 0.0 110.534 169.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.92 -24.36 44.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.588 -1.32 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -80.57 -0.95 39.98 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.409 1.484 . . . . 0.0 112.489 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.1 59.95 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.814 0.734 . . . . 0.0 111.895 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.57 172.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.764 0.782 . . . . 0.0 109.696 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -118.09 145.41 44.86 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.89 151.71 33.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 120.289 1.404 . . . . 0.0 112.994 -168.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.67 -178.97 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.821 1.248 . . . . 0.0 109.46 169.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.76 29.92 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.202 -1.332 . . . . 0.0 115.091 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -75.49 152.32 37.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.909 1.854 . . . . 0.0 109.008 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.31 148.15 69.02 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 117.16 -1.4 . . . . 0.0 109.088 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.87 140.02 41.24 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 121.11 1.432 . . . . 0.0 110.429 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.444 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 66.6 p -76.2 -4.05 39.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.364 1.866 . . . . 0.0 113.296 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.17 141.42 57.49 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.49 -9.54 61.52 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.445 1.497 . . . . 0.0 113.677 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.28 156.16 16.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.896 1.348 . . . . 0.0 110.986 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.52 126.29 44.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -161.75 -58.76 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.328 1.9 t 58.64 11.71 1.88 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.103 2.561 . . . . 0.0 114.609 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 p -66.56 133.28 94.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.864 -1.148 . . . . 0.0 107.908 167.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.13 -14.26 5.07 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.16 1.907 . . . . 0.0 113.326 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -80.6 -47.41 1.24 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 117.756 -1.116 . . . . 0.0 114.007 -169.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.15 39.37 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.078 1.852 . . . . 0.0 112.428 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.37 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.333 -167.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -172.55 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 126.069 1.748 . . . . 0.0 109.968 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.08 -116.52 0.84 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.054 1.342 . . . . 0.0 107.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.21 8.0 33.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.828 1.251 . . . . 0.0 111.885 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.42 20.3 20.43 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.129 1.347 . . . . 0.0 112.803 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.25 -16.83 17.59 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.877 1.271 . . . . 0.0 110.944 -172.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 144.53 50.44 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.279 0.631 . . . . 0.0 111.186 173.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 58.2 m-85 -78.78 154.37 30.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.698 1.599 . . . . 0.0 109.676 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -14.32 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.157 . . . . 0.0 112.707 173.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.45 -179.62 40.89 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 119.69 1.132 . . . . 0.0 111.968 -170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 14.5 tp -65.7 129.78 40.97 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.09 124.15 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.71 160.16 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.981 0.912 . . . . 0.0 108.879 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.533 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.13 124.93 31.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -105.29 10.24 33.65 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.779 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -25.65 11.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.207 1.003 . . . . 0.0 110.862 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.06 -46.93 1.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.703 1.138 . . . . 0.0 111.169 174.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -89.74 15.35 9.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -53.67 -22.05 8.16 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.71 -26.55 31.91 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.258 1.023 . . . . 0.0 111.291 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -116.14 -13.73 11.16 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.293 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.7 p -57.3 -27.41 62.13 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.129 1.331 . . . . 0.0 112.381 -171.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -52.76 -39.1 61.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.781 1.632 . . . . 0.0 111.788 173.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.36 -30.47 68.49 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.701 1.6 . . . . 0.0 111.003 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -92.46 -18.16 23.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.037 1.335 . . . . 0.0 110.484 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.84 -60.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -51.82 -44.8 63.67 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.128 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 p -67.59 -35.22 78.57 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.077 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.423 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.7 t90 -65.35 -44.87 86.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.026 0.917 . . . . 0.0 109.656 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 96.6 m -57.82 -35.9 71.49 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.808 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.74 -29.78 66.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.404 0.547 . . . . 0.0 111.173 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -79.07 -45.76 19.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.931 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.2 pt -64.89 -39.27 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 120.865 1.666 . . . . 0.0 109.862 -171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.49 -14.64 58.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.2 0.6 . . . . 0.0 111.984 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -96.2 -45.94 6.65 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.64 -42.47 88.37 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.968 0.804 . . . . 0.0 109.387 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 73.3 mtm -77.29 -35.51 55.02 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.706 0.802 . . . . 0.0 110.716 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -48.4 56.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.351 1.06 . . . . 0.0 109.678 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.49 -31.15 72.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.216 1.406 . . . . 0.0 109.951 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -63.96 -49.04 74.13 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.487 0.585 . . . . 0.0 110.447 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.23 -3.84 44.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.586 179.325 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 140.23 30.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 168.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 mtm -123.13 148.67 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.574 2.349 . . . . 0.0 108.386 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.29 118.47 4.69 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.48 114.44 25.1 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.944 1.372 . . . . 0.0 108.754 170.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.15 146.32 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.635 1.574 . . . . 0.0 110.535 172.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.01 172.74 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.189 0.996 . . . . 0.0 109.814 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.72 140.56 9.3 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -153.3 164.66 37.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.11 0.955 . . . . 0.0 112.007 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -132.08 -41.32 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.192 1.397 . . . . 0.0 110.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.2 p -76.5 -15.52 59.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.502 0.721 . . . . 0.0 110.551 169.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.261 57.5 m 73.57 16.15 3.99 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.479 2.311 . . . . 0.0 113.831 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -63.24 -43.6 97.57 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.371 -1.456 . . . . 0.0 110.584 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -33.72 73.24 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.45 -47.38 84.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.454 0.702 . . . . 0.0 109.644 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -65.51 -39.54 91.97 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.186 0.448 . . . . 0.0 111.145 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.64 93.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.846 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.43 79.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.038 0.935 . . . . 0.0 110.674 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -57.2 -44.95 84.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.34 -56.46 16.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.804 1.315 . . . . 0.0 108.94 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -51.88 -56.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 118.274 0.488 . . . . 0.0 110.099 -176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.24 -36.4 73.14 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.877 0.871 . . . . 0.0 111.122 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.32 -45.74 62.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.682 0.393 . . . . 0.0 111.084 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.67 -47.11 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.292 1.037 . . . . 0.0 108.802 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.34 -50.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.539 0.736 . . . . 0.0 110.279 -174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.36 112.25 0.41 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.79 -4.29 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.443 2.762 . . . . 0.0 112.29 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.1 -33.68 59.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.057 1.743 . . . . 0.0 109.387 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.44 -21.42 4.18 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.708 1.603 . . . . 0.0 111.417 -169.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.82 139.17 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 120.397 1.453 . . . . 0.0 109.108 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -128.25 129.09 45.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.606 1.163 . . . . 0.0 110.056 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.66 147.9 43.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.726 1.21 . . . . 0.0 112.049 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.09 111.94 5.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.987 1.715 . . . . 0.0 107.121 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.14 109.98 19.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.5 -7.57 26.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -62.43 -26.49 68.53 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.597 1.09 . . . . 0.0 111.669 169.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -132.83 -33.59 1.18 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 112.184 -171.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -84.04 141.16 31.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.49 1.116 . . . . 0.0 108.286 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -86.73 141.64 33.97 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -71.86 -4.24 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.079 1.853 . . . . 0.0 111.186 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -54.97 -35.76 64.63 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 120.347 1.43 . . . . 0.0 112.179 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -20.58 66.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 175.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -65.34 -10.96 37.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 112.539 169.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.02 -30.19 68.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.514 1.052 . . . . 0.0 110.159 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.62 -51.46 9.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.422 0.63 . . . . 0.0 110.295 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.99 143.55 57.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.616 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -76.15 -24.49 54.83 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.543 0.687 . . . . 0.0 110.766 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.8 t -145.18 139.18 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -169.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 153.49 43.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.612 0.642 . . . . 0.0 110.875 174.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 125.41 67.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.32 136.55 54.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.947 0.899 . . . . 0.0 109.886 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.05 116.52 2.99 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.006 -1.996 . . . . 0.0 111.689 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 130.1 24.9 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-N 120.229 2.014 . . . . 0.0 112.409 170.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.83 141.69 10.88 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.453 2.102 . . . . 0.0 107.792 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 m -89.45 124.35 34.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -115.24 174.7 5.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.526 1.93 . . . . 0.0 109.351 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 31.06 55.64 0.22 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.085 2.554 . . . . 0.0 115.253 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 55.69 78.84 0.18 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.71 1.204 . . . . 0.0 112.71 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.09 9.85 85.37 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.86 159.67 17.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.15 1.38 . . . . 0.0 110.803 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -91.05 152.9 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.04 144.5 55.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.68 -28.88 69.71 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.113 0.965 . . . . 0.0 112.4 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.262 0.625 . . . . 0.0 111.012 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -79.98 -43.49 21.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 110.195 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.46 -34.39 61.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.28 0.632 . . . . 0.0 111.024 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.379 1.072 . . . . 0.0 112.174 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.27 -10.41 9.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.519 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.9 t-105 -53.37 -27.73 25.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.505 1.522 . . . . 0.0 112.166 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.23 -45.56 66.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.209 1.404 . . . . 0.0 111.524 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -64.91 -33.05 75.1 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.929 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.63 -31.68 66.5 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.725 1.148 . . . . 0.0 111.393 -175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.29 -27.49 61.58 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.345 0.658 . . . . 0.0 111.178 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.64 -19.29 31.18 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.832 0.853 . . . . 0.0 111.482 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.99 171.65 12.45 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.053 0.93 . . . . 0.0 110.721 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.47 112.22 24.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.22 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.02 10.3 6.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.838 0.855 . . . . 0.0 112.945 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.62 119.41 10.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -170.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.83 85.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 124.822 1.201 . . . . 0.0 114.148 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -79.17 149.37 32.0 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.002 0.901 . . . . 0.0 108.86 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -86.38 140.35 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.52 131.38 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 109.447 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.53 112.91 24.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 166.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.39 143.99 26.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.799 0.727 . . . . 0.0 111.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -141.87 164.22 30.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.948 1.299 . . . . 0.0 109.03 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.48 38.88 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 121.195 -0.94 . . . . 0.0 113.218 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -128.56 153.76 46.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.437 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.71 -153.9 9.17 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.07 138.83 10.56 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 126.75 2.02 . . . . 0.0 107.775 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.522 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -89.39 -21.74 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.864 1.265 . . . . 0.0 114.267 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.51 -48.11 65.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.756 1.162 . . . . 0.0 110.664 -173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.93 -26.27 19.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.034 0.826 . . . . 0.0 112.33 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -130.92 27.75 4.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.44 58.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-N 121.116 1.78 . . . . 0.0 112.524 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.12 -15.92 58.3 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.033 -1.275 . . . . 0.0 113.222 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -125.16 -49.65 1.7 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.745 1.618 . . . . 0.0 111.433 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.261 2.0 t80 43.82 -133.59 0.61 Allowed 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.204 2.602 . . . . 0.0 109.844 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.98 40.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.816 3.646 . . . . 0.0 113.188 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -58.75 -43.08 90.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.554 -1.966 . . . . 0.0 111.42 -169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.72 71.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.276 0.63 . . . . 0.0 110.584 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -62.75 -47.98 81.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.649 0.78 . . . . 0.0 110.384 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.44 99.19 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.6 mtm -62.0 -46.3 89.81 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 117.765 0.782 . . . . 0.0 111.218 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -67.99 -31.43 71.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.735 -0.603 . . . . 0.0 111.7 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.36 -49.97 75.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.011 0.434 . . . . 0.0 109.927 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.45 -40.17 92.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.419 1.088 . . . . 0.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -54.2 -58.8 6.0 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.397 1.479 . . . . 0.0 108.444 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.9 -18.59 55.97 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.544 -0.723 . . . . 0.0 110.672 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -60.91 -26.93 67.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.985 0.811 . . . . 0.0 110.557 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -24.19 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.771 -1.206 . . . . 0.0 109.849 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -82.94 1.66 38.49 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.576 1.55 . . . . 0.0 112.627 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.06 34.27 70.33 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 118.633 0.651 . . . . 0.0 111.982 172.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.53 171.24 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 117.823 0.812 . . . . 0.0 109.89 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -116.23 140.6 49.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -108.53 147.6 31.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.55 1.068 . . . . 0.0 111.756 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.75 179.07 4.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 108.982 169.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.25 33.52 44.23 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-O 118.65 -1.084 . . . . 0.0 114.344 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.17 149.69 46.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.589 1.694 . . . . 0.0 108.044 169.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.37 135.65 27.75 Favored Pre-proline 0 CA--C 1.516 -0.334 0 CA-C-O 116.917 -1.516 . . . . 0.0 108.578 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.63 138.76 50.67 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 121.36 1.521 . . . . 0.0 109.776 169.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.447 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 67.3 p -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.522 1.929 . . . . 0.0 113.191 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.09 139.87 57.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.056 -1.028 . . . . 0.0 109.885 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.78 66.2 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.768 1.651 . . . . 0.0 114.023 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.5 163.19 13.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.179 1.49 . . . . 0.0 110.717 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -129.17 130.39 46.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -166.43 -52.98 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.477 1.035 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.326 3.1 t 57.45 10.64 1.0 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.237 2.615 . . . . 0.0 114.536 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 141.81 88.0 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.509 1.523 . . . . 0.0 109.783 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.24 -13.37 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.214 1.943 . . . . 0.0 114.114 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -80.0 -50.33 1.2 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.87 38.65 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.0 1.8 . . . . 0.0 112.827 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 149.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -166.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -172.28 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 125.906 1.683 . . . . 0.0 110.005 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.6 -116.89 0.89 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.65 8.0 32.92 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.016 1.326 . . . . 0.0 112.161 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.61 20.35 19.79 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.613 1.102 . . . . 0.0 112.591 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -100.15 -16.97 17.63 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.735 1.214 . . . . 0.0 110.713 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.02 142.45 49.58 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.445 0.698 . . . . 0.0 110.404 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.0 m-85 -77.47 157.7 30.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.863 1.265 . . . . 0.0 108.725 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 15.9 m -65.19 -18.69 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.915 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.04 -179.83 40.31 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 119.604 1.093 . . . . 0.0 112.066 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.8 tp -61.01 129.26 40.53 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.03 119.13 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -117.15 156.61 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.134 0.974 . . . . 0.0 109.223 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.97 122.15 12.21 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -97.56 18.15 16.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.843 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 -20.92 4.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.879 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.522 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -114.72 -53.95 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.239 1.381 . . . . 0.0 108.547 169.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.78 17.71 17.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -52.0 -25.2 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.036 0.934 . . . . 0.0 112.496 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.99 -26.65 54.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 0.0 111.426 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.46 -8.47 9.11 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.111 0.965 . . . . 0.0 112.331 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.6 m -51.59 -34.17 35.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.982 1.264 . . . . 0.0 110.554 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.54 -49.14 75.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.65 0.78 . . . . 0.0 110.238 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.11 -32.12 73.04 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.27 1.028 . . . . 0.0 109.892 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -74.98 -29.31 60.86 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 118.256 -0.878 . . . . 0.0 108.982 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.15 -58.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.44 -45.05 65.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.495 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.1 m -69.69 -35.23 74.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.587 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.401 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 34.6 t90 -67.08 -45.32 77.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.628 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 86.5 m -58.73 -33.88 70.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.823 0.849 . . . . 0.0 109.765 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -70.88 -32.33 69.27 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -78.63 -47.41 17.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.271 -1.347 . . . . 0.0 112.257 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.5 pt -64.24 -37.19 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 121.23 1.832 . . . . 0.0 109.838 -170.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.3 -13.0 33.7 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -51.07 5.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.649 1.58 . . . . 0.0 107.875 169.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.93 -22.8 67.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.355 0.662 . . . . 0.0 111.46 -169.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 69.5 mtm -94.43 -44.08 8.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 111.472 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.39 57.44 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.506 0.722 . . . . 0.0 110.709 -172.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.49 -27.69 66.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.897 1.279 . . . . 0.0 109.51 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -70.33 -48.27 57.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 110.378 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.42 -17.23 60.23 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.791 -179.205 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 142.68 29.83 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 mtm -130.94 147.96 52.65 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.447 1.899 . . . . 0.0 108.516 -169.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.25 117.63 4.77 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-O 118.824 -0.987 . . . . 0.0 110.807 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 98.02 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.879 1.339 . . . . 0.0 109.548 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -95.88 146.41 24.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.506 1.122 . . . . 0.0 110.447 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 36.3 p90 -165.36 174.6 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.686 0.794 . . . . 0.0 109.024 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.28 133.8 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 106.188 -2.765 . . . . 0.0 106.188 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 147.77 28.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.8 t -126.23 -27.56 3.21 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.944 1.298 . . . . 0.0 109.834 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.9 p -81.45 -74.28 0.34 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 169.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.0 p 175.7 -14.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.163 1.785 . . . . 0.0 113.839 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -63.44 -48.2 78.74 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.646 -1.284 . . . . 0.0 114.359 -164.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -33.71 74.93 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 6.5 tt0 -62.98 -47.79 81.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.2 mtm -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 118.004 0.365 . . . . 0.0 111.444 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.45 -41.65 90.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.69 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.76 82.25 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.995 0.918 . . . . 0.0 110.754 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.82 -44.96 90.97 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.2 -56.64 16.62 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 124.616 1.198 . . . . 0.0 108.43 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -51.58 -56.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 118.821 0.737 . . . . 0.0 109.966 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -38.96 71.71 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.428 0.691 . . . . 0.0 110.514 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.88 -46.9 73.53 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.792 0.437 . . . . 0.0 111.442 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.66 -47.85 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.517 1.127 . . . . 0.0 108.727 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.32 -50.97 32.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 123.876 0.87 . . . . 0.0 110.309 -176.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.28 114.92 0.7 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 170.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.86 2.83 4.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.374 2.716 . . . . 0.0 112.812 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.91 -34.01 66.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 -23.89 3.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.672 1.589 . . . . 0.0 111.549 -169.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.81 140.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.45 1.477 . . . . 0.0 109.278 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.7 m -129.36 128.66 43.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.689 1.195 . . . . 0.0 110.477 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.12 148.07 49.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 112.094 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -148.87 110.26 4.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.61 1.564 . . . . 0.0 107.618 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -86.92 113.14 22.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.23 -10.45 42.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -58.68 -26.91 64.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.981 0.809 . . . . 0.0 111.88 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.74 -28.72 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.889 0.875 . . . . 0.0 112.005 -167.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -87.63 145.36 26.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.377 1.471 . . . . 0.0 108.614 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -83.63 148.42 54.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.633 0.773 . . . . 0.0 108.976 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -79.27 -11.21 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.793 2.329 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -56.68 -36.6 69.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.446 1.476 . . . . 0.0 111.488 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -20.23 66.17 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.332 -0.855 . . . . 0.0 113.023 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -13.82 25.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.403 1.081 . . . . 0.0 112.156 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.94 -26.7 60.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.079 -1.013 . . . . 0.0 110.897 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.35 -50.65 13.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.786 0.803 . . . . 0.0 110.107 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -65.29 144.03 57.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.093 1.357 . . . . 0.0 108.248 -169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -75.52 -25.13 56.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.753 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.2 t -144.15 140.24 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 158.65 36.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.659 0.663 . . . . 0.0 110.757 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.23 123.31 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.9 135.65 55.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.832 0.853 . . . . 0.0 108.872 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.24 3.67 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 130.09 24.89 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 118.824 1.312 . . . . 0.0 110.558 177.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.24 138.31 7.6 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.289 2.659 . . . . 0.0 107.887 168.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 m -87.19 126.32 34.72 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -113.19 172.77 6.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.253 1.821 . . . . 0.0 109.89 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 21.94 63.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.241 3.017 . . . . 0.0 115.469 169.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.17 71.39 0.54 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.713 1.205 . . . . 0.0 112.151 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.89 13.35 80.8 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.97 151.14 35.8 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.662 1.22 . . . . 0.0 109.302 168.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.63 148.84 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -64.35 144.75 56.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.44 -27.65 68.71 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.162 -172.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -64.82 -27.75 69.09 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.806 0.842 . . . . 0.0 112.401 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -88.53 -40.5 13.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.832 1.253 . . . . 0.0 110.59 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.12 -35.83 65.07 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.726 0.694 . . . . 0.0 111.009 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.11 71.33 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.165 0.986 . . . . 0.0 112.139 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.99 -12.4 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.727 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.0 t-105 -54.85 -28.76 52.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.114 1.366 . . . . 0.0 111.804 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.51 -44.86 61.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.681 1.192 . . . . 0.0 110.876 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.24 -29.6 67.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.22 -1.371 . . . . 0.0 112.559 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 mt -55.66 -32.86 63.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.228 1.376 . . . . 0.0 110.895 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.07 -33.68 76.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.69 0.796 . . . . 0.0 111.819 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.99 -26.62 48.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.277 0.631 . . . . 0.0 110.767 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.95 152.82 40.01 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.88 1.324 . . . . 0.0 110.511 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -85.11 103.59 14.25 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.558 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.5 mt -124.75 4.41 8.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.767 1.227 . . . . 0.0 113.032 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -68.48 113.14 5.76 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.74 79.86 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.34 1.447 . . . . 0.0 115.094 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -82.76 153.0 25.48 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.324 1.062 . . . . 0.0 109.914 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.5 mt -87.99 141.59 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.53 129.1 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.163 1.385 . . . . 0.0 108.632 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.71 117.81 35.02 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.92 142.26 27.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.082 0.856 . . . . 0.0 111.524 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -140.37 161.33 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.006 0.922 . . . . 0.0 108.95 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.04 179.53 39.58 Favored Glycine 0 N--CA 1.45 -0.415 0 O-C-N 120.841 -1.162 . . . . 0.0 112.338 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.46 153.96 42.72 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 109.233 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.44 -157.86 13.33 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -148.88 141.94 24.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.486 1.514 . . . . 0.0 109.254 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.554 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -88.96 -21.03 23.75 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.79 -40.94 68.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.874 1.216 . . . . 0.0 111.804 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.91 -22.93 19.22 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 124.592 1.091 . . . . 0.0 111.512 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.453 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.6 m-85 -121.38 -84.8 0.66 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.764 1.225 . . . . 0.0 108.071 -170.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.0 -50.27 2.64 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 128.237 2.827 . . . . 0.0 108.6 -168.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 93' ' ' TYR . 1.3 mp0 -71.74 -36.21 70.39 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 126.613 1.965 . . . . 0.0 110.169 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -106.66 1.27 24.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.334 1.054 . . . . 0.0 112.085 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.29 120.83 2.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.587 1.555 . . . . 0.0 109.009 168.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 55.46 25.7 8.06 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.13 0.972 . . . . 0.0 113.465 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.88 -38.57 91.4 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 120.855 -1.153 . . . . 0.0 110.743 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.61 -32.99 73.14 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.074 -0.391 . . . . 0.0 111.795 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 tp -60.75 -46.29 91.04 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.116 0.966 . . . . 0.0 110.797 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.66 -40.35 96.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.5 mtm -68.52 -43.1 77.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.875 0.837 . . . . 0.0 112.461 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.7 mt -63.5 -33.27 75.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.3 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -65.35 -42.46 92.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.969 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.33 -42.46 92.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.675 1.19 . . . . 0.0 111.743 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -55.19 -59.33 4.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.619 1.168 . . . . 0.0 108.403 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 mt -76.95 -20.17 56.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.445 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -62.31 -28.81 70.0 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.234 0.924 . . . . 0.0 110.425 168.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.09 -24.07 47.7 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.646 -1.284 . . . . 0.0 109.572 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -80.83 3.64 21.84 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.295 1.838 . . . . 0.0 113.08 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.17 80.4 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 118.593 0.633 . . . . 0.0 111.635 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.74 171.67 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.674 0.79 . . . . 0.0 109.046 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -117.98 141.9 47.95 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.51 147.69 32.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.487 1.039 . . . . 0.0 111.514 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.27 178.4 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.315 1.046 . . . . 0.0 108.802 169.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 35.94 37.57 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 118.608 -1.107 . . . . 0.0 114.286 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -77.87 152.82 33.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.667 1.733 . . . . 0.0 109.201 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -128.18 147.44 63.51 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 117.411 -1.281 . . . . 0.0 108.45 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.52 140.53 40.05 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.132 1.221 . . . . 0.0 109.651 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.493 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 78.8 p -74.37 -7.73 53.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.878 1.671 . . . . 0.0 113.822 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.95 142.7 57.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.065 0.936 . . . . 0.0 110.273 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.93 -5.4 62.28 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.675 1.607 . . . . 0.0 114.038 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -100.69 155.15 18.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.635 1.574 . . . . 0.0 109.904 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -124.11 126.93 47.05 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.998 1.719 . . . . 0.0 106.592 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -163.52 -53.01 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.218 0.607 . . . . 0.0 109.711 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 2.9 t 58.64 8.81 0.97 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.969 2.508 . . . . 0.0 114.616 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -68.46 139.74 92.03 Favored Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 120.835 -1.166 . . . . 0.0 108.817 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -85.03 -11.3 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.9 2.4 . . . . 0.0 113.085 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -77.85 -50.61 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -168.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -88.39 42.54 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.179 1.919 . . . . 0.0 112.163 -169.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 147.66 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.771 -1.206 . . . . 0.0 109.806 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 -172.47 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 125.968 1.707 . . . . 0.0 110.182 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.07 -116.49 0.84 Allowed 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.1 1.36 . . . . 0.0 107.579 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.25 8.56 33.96 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.839 1.256 . . . . 0.0 111.871 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.25 21.56 19.73 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.986 1.279 . . . . 0.0 112.504 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -99.77 -18.32 17.27 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.693 1.197 . . . . 0.0 110.764 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.5 144.35 51.07 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.257 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.5 m-85 -78.13 154.98 30.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.114 1.366 . . . . 0.0 109.826 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.61 -12.49 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.587 1.155 . . . . 0.0 112.618 175.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.84 -177.21 44.69 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 119.763 1.165 . . . . 0.0 112.475 -172.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.7 tp -65.77 131.26 45.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.08 112.88 20.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.9 mt -110.96 154.2 24.45 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.268 1.027 . . . . 0.0 109.59 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.47 128.27 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -102.5 13.79 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.399 1.079 . . . . 0.0 110.793 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -22.44 5.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.554 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.1 -49.24 2.98 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.765 1.226 . . . . 0.0 108.153 172.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.48 22.38 15.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.36 1.464 . . . . 0.0 112.809 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -52.52 -26.86 14.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.138 0.575 . . . . 0.0 112.411 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.75 -25.19 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.43 0.692 . . . . 0.0 111.677 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -125.13 -11.31 7.03 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.121 0.969 . . . . 0.0 112.153 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.0 m -56.94 -29.77 63.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.017 1.28 . . . . 0.0 109.351 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.83 -37.78 77.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.219 1.408 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.8 -37.49 27.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.577 1.151 . . . . 0.0 110.039 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -67.89 -31.06 70.6 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.33 -54.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -52.67 -47.73 66.98 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.061 1.344 . . . . 0.0 110.411 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.3 m -66.41 -36.31 82.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.256 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -66.27 -44.67 82.94 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.547 0.689 . . . . 0.0 109.963 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 87.5 m -58.18 -36.1 72.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.794 0.838 . . . . 0.0 109.691 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -69.62 -31.33 69.39 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.597 0.561 . . . . 0.0 109.854 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -79.59 -47.58 15.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.674 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.8 pt -64.32 -38.85 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 121.018 1.735 . . . . 0.0 110.349 -169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.94 -14.28 59.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.104 0.561 . . . . 0.0 111.976 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.23 -46.54 6.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.57 -39.5 80.46 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.292 0.637 . . . . 0.0 110.062 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.5 mtm -78.49 -38.3 41.17 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 -176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.3 62.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.145 0.978 . . . . 0.0 109.96 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.15 -29.68 70.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.036 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -64.36 -47.63 78.58 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 110.58 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -2.12 51.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.601 1.161 . . . . 0.0 113.649 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.49 178.738 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' CE ' ' CE1' ' A' ' 172' ' ' TYR . 27.2 ttm . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.58 144.24 51.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.943 2.097 . . . . 0.0 106.344 169.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.95 146.4 50.33 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 -166.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.29 114.27 3.93 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.09 101.32 13.98 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.816 1.308 . . . . 0.0 110.665 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.84 146.65 26.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.773 1.229 . . . . 0.0 111.57 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -163.84 173.86 12.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.364 1.066 . . . . 0.0 109.61 178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.23 139.85 8.66 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 169.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -136.83 133.18 35.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.763 1.225 . . . . 0.0 110.551 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.48 -42.24 13.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.806 0.843 . . . . 0.0 109.307 174.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.3 p -97.27 -84.24 0.38 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 p -174.83 -5.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.189 2.596 . . . . 0.0 112.104 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -67.73 -40.91 84.18 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 119.796 -1.815 . . . . 0.0 111.449 -168.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -34.86 78.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -64.74 -48.48 74.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.016 0.926 . . . . 0.0 109.918 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.3 mtm -66.76 -36.86 83.42 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.644 -0.66 . . . . 0.0 111.452 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.99 97.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.646 -0.659 . . . . 0.0 110.69 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.07 85.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.544 1.137 . . . . 0.0 111.278 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.82 -48.52 81.04 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.182 0.993 . . . . 0.0 109.238 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -59.71 -56.44 21.88 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.35 -56.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.066 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -53.78 -43.19 69.04 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.129 0.971 . . . . 0.0 110.349 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.91 -42.5 69.86 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.024 0.53 . . . . 0.0 111.144 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.8 mt -65.25 -49.83 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 108.822 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.87 -52.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.143 0.977 . . . . 0.0 110.254 -173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.07 112.56 0.4 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.65 -3.99 11.3 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.243 2.628 . . . . 0.0 112.639 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.98 -34.46 59.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.693 1.597 . . . . 0.0 109.546 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -27.71 6.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.152 1.781 . . . . 0.0 109.99 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.5 140.08 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.953 1.706 . . . . 0.0 109.428 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 m -132.69 129.73 39.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.28 1.7 pt? -101.39 156.78 17.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.549 1.068 . . . . 0.0 113.044 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -147.93 113.93 5.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.164 1.386 . . . . 0.0 109.142 -166.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.9 112.38 19.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.74 -10.53 20.13 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.973 0.909 . . . . 0.0 113.309 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -57.88 -29.19 64.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.115 0.871 . . . . 0.0 111.798 168.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -130.05 -33.93 1.72 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.785 1.234 . . . . 0.0 111.708 -172.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -84.04 141.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.12 0.968 . . . . 0.0 108.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.0 m -85.09 143.15 39.25 Favored Pre-proline 0 C--O 1.225 -0.218 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.79 -6.51 18.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.781 1.654 . . . . 0.0 111.736 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -54.92 -37.4 66.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.781 1.628 . . . . 0.0 111.313 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -21.22 66.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -13.65 22.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 169.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.72 -26.0 61.42 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.89 -1.131 . . . . 0.0 110.669 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -77.6 -50.3 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.062 0.847 . . . . 0.0 110.273 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.09 139.44 58.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.89 -21.93 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.23 0.538 . . . . 0.0 111.399 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.6 t -140.38 141.96 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.74 158.14 40.21 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.892 0.377 . . . . 0.0 110.755 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.63 122.49 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.87 134.28 55.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.77 119.11 3.08 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 117.826 -1.541 . . . . 0.0 112.725 -172.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.89 132.54 24.22 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 119.114 1.457 . . . . 0.0 110.864 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.46 149.1 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.427 2.085 . . . . 0.0 108.297 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 m -94.52 130.15 41.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -124.54 170.93 10.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.881 1.673 . . . . 0.0 109.472 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 31.92 54.89 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.736 2.414 . . . . 0.0 115.313 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 57.23 76.65 0.31 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.111 1.364 . . . . 0.0 112.755 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.42 25.42 75.5 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.791 -0.568 . . . . 0.0 114.482 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -97.37 164.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.72 1.608 . . . . 0.0 110.318 169.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.8 mt -101.73 151.85 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 126.153 1.781 . . . . 0.0 106.461 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.1 144.08 56.91 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.65 -27.2 68.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.114 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -66.77 -26.49 66.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.806 0.843 . . . . 0.0 110.642 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -84.55 -43.05 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.27 1.028 . . . . 0.0 110.819 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.26 -36.09 63.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.443 0.565 . . . . 0.0 110.746 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -31.07 71.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.49 1.116 . . . . 0.0 112.174 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.12 -10.8 10.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.518 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.4 t-105 -53.57 -29.29 36.52 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.604 . . . . 0.0 111.621 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.8 -43.64 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.004 1.322 . . . . 0.0 111.154 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -69.24 -29.71 67.7 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.114 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.99 -31.1 64.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.086 1.312 . . . . 0.0 111.055 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.48 -28.17 64.78 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.625 0.77 . . . . 0.0 111.22 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.96 -23.59 36.01 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.511 0.724 . . . . 0.0 111.114 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.68 158.22 32.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.937 1.351 . . . . 0.0 111.961 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -91.72 99.87 12.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.866 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.77 9.08 11.96 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.17 122.16 15.94 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.98 84.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.93 1.252 . . . . 0.0 114.564 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -83.05 147.35 28.19 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.206 1.003 . . . . 0.0 110.274 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.412 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -80.99 139.11 18.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.73 123.98 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 125.016 1.326 . . . . 0.0 109.127 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.43 30.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 mt -88.78 141.58 28.38 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 118.828 0.74 . . . . 0.0 111.572 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -140.2 163.36 32.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.431 1.093 . . . . 0.0 108.5 169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 179.24 38.59 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.115 -0.99 . . . . 0.0 112.519 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.8 mt -123.67 152.76 41.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.148 0.979 . . . . 0.0 108.809 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 -163.04 13.27 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.834 0.73 . . . . 0.0 111.306 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.77 117.21 7.46 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.753 2.021 . . . . 0.0 105.99 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -28.75 24.9 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.992 0.36 . . . . 0.0 111.397 -171.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.93 -45.86 55.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.164 0.585 . . . . 0.0 110.284 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.36 -36.29 17.76 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.727 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -135.24 37.8 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.75 -39.75 68.72 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 119.687 1.13 . . . . 0.0 111.322 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.41 -17.15 58.5 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 117.962 0.881 . . . . 0.0 112.626 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -129.54 13.19 5.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.031 1.732 . . . . 0.0 112.342 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -44.6 126.38 5.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.796 1.638 . . . . 0.0 110.013 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.87 25.83 2.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.186 1.395 . . . . 0.0 113.34 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.03 -37.2 84.04 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 120.402 -1.436 . . . . 0.0 110.707 -170.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.72 73.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.24 0.616 . . . . 0.0 111.961 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -60.92 -46.26 91.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.199 0.999 . . . . 0.0 110.771 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.64 99.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.9 mtm -62.08 -45.67 92.48 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 117.578 0.689 . . . . 0.0 111.607 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.518 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -65.54 -33.44 75.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.84 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -62.01 -39.53 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.246 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.11 -36.23 66.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.796 1.638 . . . . 0.0 112.192 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.9 tptt -57.51 -46.05 84.24 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.726 0.81 . . . . 0.0 109.98 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.39 -19.07 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.623 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p -61.4 -31.94 71.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.663 1.574 . . . . 0.0 111.88 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -78.36 -18.35 55.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.794 -0.566 . . . . 0.0 110.368 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -78.96 1.39 23.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.134 1.373 . . . . 0.0 112.031 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.96 65.01 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.79 0.723 . . . . 0.0 111.908 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.38 170.32 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.738 0.815 . . . . 0.0 109.603 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -118.33 135.09 54.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -102.81 147.1 27.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.5 m -127.3 175.61 8.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.58 39.09 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.822 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -72.98 150.78 42.19 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.124 1.962 . . . . 0.0 108.008 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.41 ' HE1' HD13 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -130.53 145.12 56.15 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.009 176.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.04 141.89 45.29 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 121.177 1.456 . . . . 0.0 109.238 168.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.498 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 81.9 p -75.49 -3.82 36.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.81 1.644 . . . . 0.0 113.894 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.37 146.12 45.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.747 0.819 . . . . 0.0 109.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.88 17.17 78.99 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.478 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.53 156.18 49.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.238 1.815 . . . . 0.0 109.491 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.89 129.08 48.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -160.09 -57.0 0.06 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.799 0.727 . . . . 0.0 110.265 -169.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.353 4.3 t 58.59 10.81 1.52 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.935 2.494 . . . . 0.0 114.572 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.6 t -62.96 131.52 94.69 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.28 -13.41 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.397 2.065 . . . . 0.0 112.836 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -80.64 -48.03 1.2 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -169.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -88.04 39.06 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.089 1.859 . . . . 0.0 112.212 -168.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.32 147.04 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 119.212 0.914 . . . . 0.0 109.4 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.852 1.661 . . . . 0.0 109.794 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.81 -116.29 0.84 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.318 1.447 . . . . 0.0 107.491 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -105.21 7.89 33.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.791 1.237 . . . . 0.0 112.111 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.16 20.23 18.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.639 1.114 . . . . 0.0 112.463 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.05 -17.86 17.28 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 110.863 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.96 143.96 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.897 0.479 . . . . 0.0 110.706 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 63.1 m-85 -77.9 156.09 30.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.818 1.247 . . . . 0.0 109.111 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.2 m -66.01 -15.65 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.087 0.955 . . . . 0.0 112.315 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.02 -176.63 40.35 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 119.985 1.266 . . . . 0.0 111.763 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.41 HD13 ' HE1' ' A' ' 119' ' ' TRP . 17.8 tp -63.81 126.86 28.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.0 119.79 40.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.5 mt -113.5 146.09 40.17 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.39 131.11 55.62 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 170.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.57 30.23 7.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.243 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.47 -34.52 0.84 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -116.91 -30.77 5.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 120.131 1.332 . . . . 0.0 111.788 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -89.95 3.5 52.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.872 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -58.28 -21.88 50.51 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.298 0.954 . . . . 0.0 112.137 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.29 -24.43 42.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.277 1.031 . . . . 0.0 111.508 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -126.29 -5.8 6.58 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.735 0.814 . . . . 0.0 112.864 -170.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -56.72 -29.89 62.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.078 0.854 . . . . 0.0 110.482 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.73 -38.18 64.08 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.849 1.66 . . . . 0.0 111.731 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -36.6 23.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.745 1.218 . . . . 0.0 109.945 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -67.44 -26.37 66.37 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.986 0.915 . . . . 0.0 109.52 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.38 -57.58 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.409 ' H ' ' HG3' ' A' ' 158' ' ' GLN . 61.7 mt-30 -49.78 -48.26 50.6 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 110.563 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -65.35 -37.46 87.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.385 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 33.8 t90 -66.36 -43.43 86.04 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -58.18 -35.44 71.6 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.568 0.747 . . . . 0.0 109.426 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -33.78 76.42 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.433 0.458 . . . . 0.0 110.047 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.79 -46.13 15.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.56 -1.21 . . . . 0.0 111.85 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.5 pt -65.02 -39.78 86.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.375 1.898 . . . . 0.0 109.959 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.87 -21.93 66.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.819 -0.551 . . . . 0.0 110.749 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -89.63 -42.66 11.25 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.75 -31.26 68.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.807 0.73 . . . . 0.0 109.979 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.412 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.9 mtm -86.01 -44.03 12.66 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.889 1.275 . . . . 0.0 109.029 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.5 83.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.317 1.047 . . . . 0.0 111.961 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.52 -27.54 63.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.959 1.304 . . . . 0.0 109.766 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -67.63 -31.77 72.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.558 0.617 . . . . 0.0 111.52 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.443 ' CE1' ' CE ' ' A' ' 1' ' ' MET . 2.8 m-30 -58.43 -29.91 66.48 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 O-C-N 123.745 0.653 . . . . 0.0 111.084 -167.617 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.56 140.83 30.31 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.78 146.65 48.18 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.995 2.118 . . . . 0.0 108.769 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.29 116.49 4.41 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-O 118.49 -1.172 . . . . 0.0 111.215 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 100.2 12.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.339 1.569 . . . . 0.0 110.051 172.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -98.96 145.31 27.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.454 1.502 . . . . 0.0 111.551 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -165.87 173.13 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.742 1.217 . . . . 0.0 109.014 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.22 127.88 2.89 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 172.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -128.85 131.73 47.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.714 1.606 . . . . 0.0 109.148 -170.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -84.59 -36.47 22.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.9 p -103.7 -81.65 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -177.6 -4.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.621 2.768 . . . . 0.0 112.111 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.46 -43.44 73.22 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 122.088 2.222 . . . . 0.0 111.054 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -67.89 -30.94 70.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.757 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.86 -46.41 75.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.962 0.905 . . . . 0.0 110.594 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.12 -35.67 81.53 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.42 98.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.029 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.52 74.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.808 0.843 . . . . 0.0 110.666 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.54 -47.14 85.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 122.89 0.476 . . . . 0.0 110.031 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -61.3 -55.04 36.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.788 1.235 . . . . 0.0 108.905 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.55 -56.49 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.99 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.66 70.84 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.117 0.567 . . . . 0.0 110.372 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.42 -47.01 74.61 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.827 0.451 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.21 -47.98 82.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.299 1.04 . . . . 0.0 108.898 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.03 -50.5 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.765 0.826 . . . . 0.0 110.415 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.55 114.55 0.76 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.63 2.97 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.454 2.769 . . . . 0.0 112.889 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.4 -34.36 67.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.056 1.342 . . . . 0.0 109.09 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.46 -21.43 3.83 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.44 1.496 . . . . 0.0 111.509 -169.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -93.93 142.05 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 120.828 1.649 . . . . 0.0 108.992 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.4 m -132.58 129.47 39.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.437 1.095 . . . . 0.0 110.054 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 147.77 49.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 111.539 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.91 107.16 4.35 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 107.604 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.96 112.79 20.06 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.23 -10.24 22.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.795 1.238 . . . . 0.0 112.999 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -59.93 -28.33 67.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.08 0.855 . . . . 0.0 111.847 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -129.15 -33.96 1.91 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.9 1.28 . . . . 0.0 111.882 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.21 141.71 29.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.29 1.036 . . . . 0.0 109.05 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -84.78 142.53 39.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.0 -6.28 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.481 1.454 . . . . 0.0 111.419 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -54.15 -37.84 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.986 1.721 . . . . 0.0 111.422 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -21.86 66.53 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -14.7 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.061 1.344 . . . . 0.0 112.235 169.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -72.7 -26.14 61.49 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.942 -1.099 . . . . 0.0 110.775 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -78.15 -49.21 14.3 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.869 0.759 . . . . 0.0 110.092 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -65.27 140.0 58.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.74 1.216 . . . . 0.0 108.436 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -73.04 -29.32 62.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.656 0.741 . . . . 0.0 110.827 -174.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.0 t -142.52 143.81 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.66 155.5 49.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.597 0.635 . . . . 0.0 109.512 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.76 122.21 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.37 145.58 47.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 147.3 15.79 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.754 -1.212 . . . . 0.0 115.759 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.72 134.35 22.03 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.67 1.988 . . . . 0.0 109.582 -169.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -84.92 140.69 8.04 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 107.274 165.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -88.58 103.99 16.42 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -88.07 169.13 12.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.832 0.853 . . . . 0.0 110.709 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 22.97 66.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.886 2.875 . . . . 0.0 115.602 167.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.63 71.29 0.56 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.367 1.067 . . . . 0.0 112.096 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.42 15.7 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.01 148.41 32.53 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.632 1.206 . . . . 0.0 109.737 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.97 153.08 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -60.98 142.84 56.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.773 0.829 . . . . 0.0 108.941 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.37 -27.85 68.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -166.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.07 -24.31 35.32 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.732 -0.605 . . . . 0.0 110.468 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -72.91 -43.76 62.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.914 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.34 -35.51 60.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.661 0.664 . . . . 0.0 110.973 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.76 71.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.538 0.735 . . . . 0.0 111.9 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.1 -11.46 10.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.98 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.511 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.8 t-105 -53.46 -28.9 32.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.73 1.612 . . . . 0.0 111.6 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.59 -43.88 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.093 1.357 . . . . 0.0 111.346 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.45 -30.01 67.82 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.092 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.6 mt -57.28 -30.46 64.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.945 1.248 . . . . 0.0 111.236 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.32 -28.47 65.19 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.689 0.796 . . . . 0.0 111.467 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.88 -24.33 35.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.184 0.594 . . . . 0.0 111.275 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.61 158.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 123.169 1.462 . . . . 0.0 112.205 -168.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -92.2 98.51 11.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.931 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -119.64 8.81 11.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.83 120.75 13.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.22 12.32 84.25 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.12 1.343 . . . . 0.0 114.12 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -79.52 148.53 31.77 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 117.659 0.729 . . . . 0.0 109.143 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 171' ' ' HIS . 4.5 mt -85.15 141.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 166.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.02 119.6 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 125.758 1.623 . . . . 0.0 107.167 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.85 116.63 31.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.127 -0.983 . . . . 0.0 108.617 168.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.08 141.89 29.1 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.19 0.904 . . . . 0.0 112.242 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -137.36 155.43 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.995 0.918 . . . . 0.0 109.162 168.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.81 172.17 36.3 Favored Glycine 0 N--CA 1.451 -0.345 0 O-C-N 120.698 -1.251 . . . . 0.0 112.296 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.78 155.83 40.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.389 1.076 . . . . 0.0 108.443 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.19 -155.64 12.96 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -149.23 140.28 22.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -90.91 -24.6 20.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.002 1.321 . . . . 0.0 113.811 178.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -33.24 43.22 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.164 1.347 . . . . 0.0 112.862 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.5 -20.73 36.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.454 1.026 . . . . 0.0 111.266 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.7 m-85 -122.37 -86.36 0.65 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.689 1.196 . . . . 0.0 108.051 -169.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.42 -53.3 3.15 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 128.719 3.056 . . . . 0.0 107.703 -168.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.5 mm-40 -64.6 -28.0 69.33 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.605 1.962 . . . . 0.0 110.776 -172.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -118.34 6.63 11.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.971 1.308 . . . . 0.0 112.228 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.56 122.22 5.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.976 1.31 . . . . 0.0 109.905 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.41 26.8 7.42 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.195 1.398 . . . . 0.0 113.056 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.47 -38.81 92.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 120.928 -1.108 . . . . 0.0 110.443 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.22 75.28 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.209 0.604 . . . . 0.0 111.907 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.4 tp -60.34 -45.93 91.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.996 0.918 . . . . 0.0 110.403 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.34 97.5 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.6 mtm -66.46 -42.6 87.34 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 118.0 0.9 . . . . 0.0 111.971 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.1 mt -63.16 -35.11 79.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.546 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -65.31 -42.44 93.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.18 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.7 -42.57 95.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.347 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -55.35 -60.67 3.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.719 1.208 . . . . 0.0 108.224 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.75 -20.36 56.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.906 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -60.96 -29.26 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.579 1.081 . . . . 0.0 110.499 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -22.21 55.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.875 -1.14 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -85.09 2.54 42.95 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 112.458 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.67 36.44 82.87 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.37 0.532 . . . . 0.0 112.12 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.8 169.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.838 0.855 . . . . 0.0 110.076 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -104.3 136.36 44.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -106.76 146.8 30.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.881 1.219 . . . . 0.0 110.658 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.85 178.09 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 123.786 0.834 . . . . 0.0 108.799 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.95 38.96 34.35 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-O 118.767 -1.019 . . . . 0.0 113.855 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -79.59 153.99 29.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.462 1.631 . . . . 0.0 109.085 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.21 149.95 75.14 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.635 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.47 140.39 39.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.44 1.426 . . . . 0.0 110.158 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.444 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 59.4 p -75.51 -4.69 41.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.472 1.909 . . . . 0.0 113.503 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.16 140.81 57.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.99 -1.069 . . . . 0.0 109.961 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.42 -9.43 61.58 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.508 1.528 . . . . 0.0 113.515 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -93.81 150.17 20.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.096 1.448 . . . . 0.0 111.389 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -111.36 126.15 54.61 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 127.529 2.332 . . . . 0.0 105.308 167.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -162.03 -60.43 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -174.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.315 1.9 t 56.95 9.4 0.62 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.276 2.63 . . . . 0.0 114.19 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 p -66.82 135.97 94.41 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.832 -1.168 . . . . 0.0 108.974 169.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.98 -13.9 5.38 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.431 2.087 . . . . 0.0 113.671 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.99 -48.41 1.09 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.2 36.96 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.983 1.789 . . . . 0.0 112.965 -168.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.66 147.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.131 0.972 . . . . 0.0 109.529 -167.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.76 -172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.7 . . . . 0.0 109.372 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.01 -117.12 0.87 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.062 1.345 . . . . 0.0 107.518 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -104.88 7.45 34.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.667 1.187 . . . . 0.0 112.003 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.57 20.15 18.12 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.56 1.076 . . . . 0.0 112.787 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.36 -17.26 17.33 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.831 1.252 . . . . 0.0 111.007 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.06 145.25 50.61 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.512 0.725 . . . . 0.0 110.809 174.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 59.4 m-85 -79.84 154.61 28.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.209 1.404 . . . . 0.0 109.845 177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.98 -12.41 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.813 1.245 . . . . 0.0 112.829 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.29 -176.23 41.65 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.617 1.099 . . . . 0.0 111.863 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.0 126.8 28.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.28 121.21 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.8 mt -123.05 155.69 36.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.085 0.954 . . . . 0.0 109.512 -177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.511 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -137.49 120.82 16.96 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.07 3.66 44.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.553 -172.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -30.84 10.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.537 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.9 -46.61 2.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.257 0.935 . . . . 0.0 110.637 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -99.57 24.01 8.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.334 1.054 . . . . 0.0 111.31 -171.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -53.48 -29.27 35.18 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.712 0.687 . . . . 0.0 111.841 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.97 -22.85 48.82 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.922 0.889 . . . . 0.0 111.213 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.69 -31.04 11.41 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 126.497 1.919 . . . . 0.0 110.245 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.6 m -55.92 -26.11 46.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.993 169.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.56 -54.71 11.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.071 0.85 . . . . 0.0 109.959 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -62.55 -32.68 73.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.092 0.949 . . . . 0.0 111.793 -170.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -83.94 -24.07 30.85 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.435 1.494 . . . . 0.0 109.692 -170.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.9 mt -60.73 -52.83 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -54.84 -44.99 74.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.861 0.864 . . . . 0.0 110.582 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -71.3 -33.64 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.686 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 35.4 t90 -65.45 -44.39 87.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.747 176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.0 m -59.52 -36.24 75.73 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.995 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -68.79 -32.5 72.27 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 122.789 0.435 . . . . 0.0 110.564 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -79.11 -46.42 18.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.741 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.0 pt -65.0 -38.0 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 120.597 1.544 . . . . 0.0 109.838 -171.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.46 -12.26 50.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.477 0.581 . . . . 0.0 112.187 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -95.29 -46.6 6.67 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.28 -36.23 79.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.947 0.794 . . . . 0.0 110.637 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.417 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -82.04 -37.38 26.57 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.209 1.003 . . . . 0.0 110.834 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.24 -45.28 56.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 110.228 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.79 -30.07 68.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 110.084 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.421 ' CD2' HD11 ' A' ' 81' ' ' ILE . 68.0 t60 -63.98 -53.11 55.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.068 0.547 . . . . 0.0 109.822 169.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -9.3 58.83 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.681 178.224 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.53 143.49 31.98 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mtm -132.18 149.56 52.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 107.55 -170.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.16 121.23 5.24 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.759 -1.023 . . . . 0.0 110.671 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.61 113.59 25.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.826 1.313 . . . . 0.0 109.07 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.425 ' CZ ' ' HG3' ' A' ' 43' ' ' MET . 73.8 m-85 -109.69 145.93 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.395 1.478 . . . . 0.0 111.748 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -162.67 172.23 15.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.237 1.015 . . . . 0.0 109.602 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.36 136.58 7.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 168.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -134.52 128.82 34.09 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.813 1.245 . . . . 0.0 110.871 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.1 m -89.79 -42.26 11.38 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.933 0.493 . . . . 0.0 110.014 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -92.62 -82.33 0.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.7 p -177.13 -6.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.464 2.306 . . . . 0.0 112.559 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.42 -44.47 91.1 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 119.817 -1.802 . . . . 0.0 112.062 -168.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -37.99 88.16 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.3 -46.58 89.72 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.632 0.773 . . . . 0.0 110.316 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.6 mtm -67.34 -43.23 82.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.158 0.436 . . . . 0.0 110.979 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.5 87.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.709 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.72 80.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.776 0.83 . . . . 0.0 110.823 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.65 -44.13 93.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -63.2 -53.86 46.63 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.004 1.321 . . . . 0.0 108.992 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -53.24 -56.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.843 0.747 . . . . 0.0 110.091 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -38.29 79.75 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.385 -178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.36 -47.9 71.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.056 0.542 . . . . 0.0 111.033 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.75 -48.24 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.437 1.095 . . . . 0.0 108.674 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.1 -49.9 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 123.461 0.704 . . . . 0.0 110.25 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.97 114.31 0.77 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.19 4.15 3.52 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.48 2.787 . . . . 0.0 112.577 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.59 -34.38 67.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.225 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 -21.24 3.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.424 1.49 . . . . 0.0 111.694 -169.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.13 141.63 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.583 1.538 . . . . 0.0 108.995 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.3 m -131.56 128.91 40.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.328 1.051 . . . . 0.0 109.817 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.55 149.12 47.44 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.521 0.729 . . . . 0.0 112.048 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -146.97 111.85 5.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.995 1.718 . . . . 0.0 106.926 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.82 112.48 21.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.23 -8.79 19.15 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -59.27 -28.64 66.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.255 0.934 . . . . 0.0 111.762 168.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -132.26 -33.64 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.545 1.138 . . . . 0.0 111.973 -171.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.66 140.5 30.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 109.019 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -86.03 141.66 35.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.57 1.41 6.3 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.666 2.244 . . . . 0.0 111.695 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -59.6 -34.79 73.2 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 119.057 -2.277 . . . . 0.0 111.576 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -17.97 63.29 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 6' ' ' PHE . 15.7 mtm -59.09 -15.84 16.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 0.0 111.791 168.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 54.6 mt-10 -72.3 -26.53 62.0 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.976 -1.078 . . . . 0.0 111.529 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.96 -50.33 11.32 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.984 0.811 . . . . 0.0 110.347 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -67.68 147.19 53.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.124 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -79.13 -23.41 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.968 -0.457 . . . . 0.0 110.938 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.4 t -143.21 138.49 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.91 152.4 47.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.15 125.4 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.29 134.47 52.25 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.686 0.794 . . . . 0.0 109.321 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.54 117.54 3.64 Favored Glycine 0 N--CA 1.463 0.436 0 CA-C-O 116.989 -2.006 . . . . 0.0 111.705 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.32 126.74 27.46 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 120.168 1.984 . . . . 0.0 110.932 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.98 141.79 10.74 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.548 2.832 . . . . 0.0 108.354 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -91.23 112.03 23.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -98.53 170.46 8.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.476 1.111 . . . . 0.0 110.592 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.74 62.92 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.783 2.833 . . . . 0.0 115.449 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 57.09 74.87 0.39 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.762 1.225 . . . . 0.0 112.626 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.11 71.08 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.12 164.28 23.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.564 1.173 . . . . 0.0 108.762 168.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.12 153.27 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -59.85 141.61 55.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.57 -29.36 69.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -166.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.64 -21.17 52.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.614 -0.679 . . . . 0.0 110.283 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -77.84 -45.27 24.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.497 168.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -53.76 -36.0 61.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.182 0.593 . . . . 0.0 110.886 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.73 70.99 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.299 1.04 . . . . 0.0 112.061 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.9 -8.69 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.541 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.0 t-105 -54.31 -28.95 45.74 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 111.677 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -45.11 71.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.771 1.228 . . . . 0.0 111.646 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.43 -26.11 66.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 117.727 -1.13 . . . . 0.0 112.388 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.16 -30.95 68.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.055 1.298 . . . . 0.0 111.042 -176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -70.12 -26.92 64.18 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.238 0.615 . . . . 0.0 111.583 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.09 -23.16 33.22 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.289 0.635 . . . . 0.0 111.484 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -72.14 171.83 11.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.504 1.145 . . . . 0.0 111.073 -170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 13.7 t30 -111.78 103.26 11.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.029 1.732 . . . . 0.0 108.442 173.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -121.83 10.79 10.3 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.67 121.95 15.18 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.9 8.91 86.8 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.169 1.366 . . . . 0.0 114.605 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.79 151.19 32.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 117.976 0.888 . . . . 0.0 109.032 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.99 141.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.34 126.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.002 1.321 . . . . 0.0 108.328 176.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.39 110.29 22.58 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -88.5 142.76 27.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.925 0.784 . . . . 0.0 110.637 174.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -137.62 162.37 33.98 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.168 1.387 . . . . 0.0 108.163 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.1 173.64 36.77 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 121.369 -0.832 . . . . 0.0 112.119 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.8 mt -128.99 154.6 46.45 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.97 1.308 . . . . 0.0 108.087 -172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.67 -152.4 9.43 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -157.22 142.76 17.41 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.739 2.016 . . . . 0.0 107.142 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.558 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -91.98 -26.78 18.23 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.81 -32.93 63.98 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.894 1.224 . . . . 0.0 112.835 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.7 -16.52 48.45 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 124.251 0.929 . . . . 0.0 111.795 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.452 ' C ' ' H ' ' A' ' 95' ' ' GLU . 43.5 m-85 -127.54 -88.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.49 1.516 . . . . 0.0 108.761 -168.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.26 -50.74 2.8 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 129.247 3.308 . . . . 0.0 108.364 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 93' ' ' TYR . 17.7 mm-40 -68.22 -25.78 65.38 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 125.636 1.574 . . . . 0.0 110.885 -172.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -119.12 8.09 11.48 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.949 1.3 . . . . 0.0 112.449 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -46.7 123.08 4.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.191 1.397 . . . . 0.0 110.399 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 52.36 27.52 4.93 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.011 1.324 . . . . 0.0 113.122 173.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.22 -34.75 78.14 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.529 -170.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.27 71.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.453 0.701 . . . . 0.0 111.606 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 tp -62.42 -47.17 85.27 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.133 0.973 . . . . 0.0 109.972 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.87 -40.87 97.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.2 mtm -66.58 -45.31 79.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.156 0.978 . . . . 0.0 112.214 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -66.48 -32.0 73.09 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.552 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -59.12 -47.93 83.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.064 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.02 -41.26 95.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.286 1.035 . . . . 0.0 111.427 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -55.4 -57.99 9.57 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 108.883 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.8 -19.63 48.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.446 -169.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -61.27 -29.13 69.66 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.109 0.868 . . . . 0.0 110.246 169.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -22.48 56.28 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.68 -1.263 . . . . 0.0 109.769 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -84.48 1.19 46.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.555 1.542 . . . . 0.0 112.36 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.95 34.87 71.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 112.155 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.74 173.02 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.956 0.902 . . . . 0.0 109.85 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -118.28 143.74 46.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.37 147.71 34.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.823 1.192 . . . . 0.0 111.62 -170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 m -128.82 -179.79 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.661 0.784 . . . . 0.0 109.945 171.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 38.41 30.64 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.807 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -77.98 151.94 33.38 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.521 1.66 . . . . 0.0 108.368 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.62 146.56 60.97 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-O 116.968 -1.491 . . . . 0.0 109.461 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.49 139.48 45.1 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 CA-C-N 120.953 1.376 . . . . 0.0 110.186 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.481 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.0 p -74.8 -6.27 48.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.228 1.811 . . . . 0.0 113.931 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.87 141.3 53.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.03 0.919 . . . . 0.0 110.033 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.04 -10.33 68.9 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.191 1.377 . . . . 0.0 113.628 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -100.82 150.04 23.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.149 1.475 . . . . 0.0 111.107 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.86 128.55 55.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.874 2.469 . . . . 0.0 105.143 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -164.57 -49.45 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.679 0.672 . . . . 0.0 110.09 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.305 2.5 t 58.7 9.05 1.03 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.149 2.58 . . . . 0.0 114.391 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.98 134.91 52.1 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 109.449 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -86.42 -11.37 6.09 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.53 2.154 . . . . 0.0 113.948 -172.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.46 -48.86 3.04 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -89.77 38.32 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.708 1.646 . . . . 0.0 112.113 -169.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.44 150.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.632 1.173 . . . . 0.0 110.166 -166.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.96 -172.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 126.322 1.849 . . . . 0.0 109.805 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.02 -116.64 0.85 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.123 1.369 . . . . 0.0 107.606 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.22 8.38 33.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.964 1.306 . . . . 0.0 111.957 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.17 21.0 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.875 1.226 . . . . 0.0 112.593 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -99.58 -17.36 17.88 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.781 1.232 . . . . 0.0 110.573 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.93 142.71 49.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.043 0.537 . . . . 0.0 111.305 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.3 m-85 -77.4 155.8 31.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.375 1.47 . . . . 0.0 108.926 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.24 -14.56 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.356 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -162.46 179.83 37.52 Favored Glycine 0 N--CA 1.47 0.948 0 O-C-N 119.974 -1.704 . . . . 0.0 111.987 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.9 tp -63.31 128.1 34.29 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.91 126.44 55.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.28 156.37 37.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.475 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.77 115.36 15.87 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -93.0 26.17 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.934 -168.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.7 -25.87 3.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.778 168.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.39 -36.05 3.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.343 1.429 . . . . 0.0 111.654 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -84.26 -2.82 57.63 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.863 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -55.29 -24.63 29.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.056 1.753 . . . . 0.0 112.376 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.97 -20.84 28.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.038 1.335 . . . . 0.0 112.83 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 -6.78 8.91 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.957 1.303 . . . . 0.0 113.025 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -54.23 -28.63 42.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.46 1.482 . . . . 0.0 111.329 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -52.35 -40.49 62.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.843 1.257 . . . . 0.0 111.611 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -31.49 69.25 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.33 1.852 . . . . 0.0 111.318 -177.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -92.46 -19.4 22.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.765 1.226 . . . . 0.0 110.606 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.46 -58.53 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -54.04 -42.57 69.33 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.861 0.864 . . . . 0.0 112.617 -174.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 p -68.16 -35.22 77.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.429 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 35.9 t90 -65.64 -45.02 84.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.041 0.924 . . . . 0.0 109.604 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.0 -34.59 70.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.336 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.42 -28.19 63.82 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.947 0.499 . . . . 0.0 110.386 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -83.55 -45.92 13.01 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.67 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.3 pt -63.64 -36.96 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.945 1.702 . . . . 0.0 109.75 -171.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.9 -12.31 35.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.51 -51.23 5.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.679 1.592 . . . . 0.0 107.795 169.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.77 -22.61 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.161 0.584 . . . . 0.0 111.752 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 68.7 mtm -93.78 -42.11 9.3 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 124.926 1.29 . . . . 0.0 111.514 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.45 -43.8 38.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.584 0.753 . . . . 0.0 110.854 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.03 -28.86 65.82 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.217 1.407 . . . . 0.0 109.603 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -61.57 -43.54 98.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.97 -1.59 57.98 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 113.454 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.384 178.217 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.19 142.98 30.79 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 mtm -131.62 147.35 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.383 1.873 . . . . 0.0 107.858 -170.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.74 119.24 5.02 Favored Glycine 0 N--CA 1.46 0.28 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 99.49 12.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.799 1.3 . . . . 0.0 109.326 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -97.86 146.79 25.09 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.704 1.202 . . . . 0.0 109.979 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -165.27 173.11 11.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.49 132.45 6.21 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 105.889 -2.885 . . . . 0.0 105.889 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -152.52 147.86 26.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -125.23 -31.98 3.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.294 1.438 . . . . 0.0 108.876 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 p -88.36 -6.51 57.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.348 1.859 . . . . 0.0 111.618 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.25 43.8 m 71.69 10.13 6.34 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 127.754 2.422 . . . . 0.0 115.144 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -65.87 -44.79 84.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.807 1.64 . . . . 0.0 111.016 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -34.96 79.57 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -65.45 -46.97 77.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.014 0.926 . . . . 0.0 110.422 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.0 mtm -63.89 -39.4 94.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.388 0.54 . . . . 0.0 110.9 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.02 99.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.739 172.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.39 76.83 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.928 0.891 . . . . 0.0 110.539 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -57.21 -47.32 81.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.013 0.525 . . . . 0.0 109.69 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.61 -54.02 45.82 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 124.598 1.186 . . . . 0.0 108.525 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.4 mt -52.94 -56.78 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 118.733 0.697 . . . . 0.0 109.562 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -38.98 72.68 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.262 0.625 . . . . 0.0 110.529 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -46.69 73.05 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.745 0.418 . . . . 0.0 111.275 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.0 mt -66.17 -48.15 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.785 1.234 . . . . 0.0 108.704 -176.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.97 -50.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.768 0.827 . . . . 0.0 110.415 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.98 115.22 0.73 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 170.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.06 3.47 3.95 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.479 2.786 . . . . 0.0 112.788 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.12 -34.35 66.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.036 1.334 . . . . 0.0 109.236 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 -23.49 3.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.838 1.655 . . . . 0.0 111.422 -169.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.55 141.04 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.696 1.589 . . . . 0.0 109.352 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -130.23 128.61 42.01 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.216 1.007 . . . . 0.0 110.043 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.38 145.26 51.24 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.98 0.912 . . . . 0.0 111.216 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -148.66 112.71 5.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -93.3 116.59 29.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -67.15 -11.12 56.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.768 -174.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -58.72 -25.82 63.32 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.6 . . . . 0.0 111.618 168.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -134.8 -31.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.804 0.842 . . . . 0.0 111.85 -167.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.12 154.12 18.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.658 1.183 . . . . 0.0 112.05 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -96.28 134.39 23.64 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 125.153 1.381 . . . . 0.0 109.715 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.45 -6.62 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 112.366 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -49.22 -40.03 32.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.441 1.473 . . . . 0.0 111.526 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -23.09 67.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -14.6 31.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.374 1.07 . . . . 0.0 112.378 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.97 -25.51 61.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.053 -1.029 . . . . 0.0 110.615 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -75.89 -49.89 16.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.23 0.923 . . . . 0.0 110.24 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -66.73 147.68 52.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.436 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.0 -28.06 60.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.829 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.7 t -144.95 142.56 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -168.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.84 160.28 32.27 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.681 0.673 . . . . 0.0 111.133 173.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.26 123.66 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 166.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -121.53 145.69 47.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.04 150.66 22.23 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.668 -1.253 . . . . 0.0 114.855 173.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.26 135.11 24.93 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.382 1.873 . . . . 0.0 109.453 -169.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.11 141.45 9.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 N-CA-C 107.64 -1.716 . . . . 0.0 107.64 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.0 m -86.33 104.92 16.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -86.89 168.77 13.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.926 1.29 . . . . 0.0 109.613 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 19.72 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.483 3.113 . . . . 0.0 115.878 166.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 56.24 72.39 0.5 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.338 1.055 . . . . 0.0 112.279 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.79 11.58 78.01 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.46 149.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.61 1.195 . . . . 0.0 110.635 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mt -84.72 153.51 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 172.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -62.19 143.47 56.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.72 -27.23 68.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.39 -28.94 31.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.635 -0.666 . . . . 0.0 110.653 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -65.55 -44.02 88.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -55.92 -37.78 69.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.37 0.532 . . . . 0.0 110.92 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.8 73.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.947 0.499 . . . . 0.0 111.761 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 m -99.64 -11.85 8.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.727 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.523 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -53.87 -28.81 38.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.184 1.793 . . . . 0.0 111.606 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.34 -43.22 64.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.267 1.427 . . . . 0.0 111.125 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.33 -31.03 70.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 117.772 -1.108 . . . . 0.0 111.843 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.1 mt -56.5 -32.76 65.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.863 1.21 . . . . 0.0 110.923 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.94 -28.53 66.73 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.375 0.67 . . . . 0.0 111.43 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.02 -25.58 34.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.327 0.651 . . . . 0.0 111.193 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 159.6 34.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.972 1.367 . . . . 0.0 112.511 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.5 98.3 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.678 -2.056 . . . . 0.0 108.694 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.09 8.8 11.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.4 120.52 12.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.4 12.85 83.93 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.984 1.278 . . . . 0.0 113.88 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -81.45 150.76 28.17 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 117.796 0.798 . . . . 0.0 109.309 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.405 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.8 mt -87.13 141.03 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.52 121.29 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 124.87 1.268 . . . . 0.0 108.052 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.95 115.73 28.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.93 -1.106 . . . . 0.0 108.328 168.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 105' ' ' HIS . 51.1 mt -91.2 140.4 29.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.195 0.907 . . . . 0.0 112.448 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -139.73 157.83 45.1 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.455 1.502 . . . . 0.0 109.405 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.02 179.53 35.5 Favored Glycine 0 CA--C 1.512 -0.129 0 O-C-N 120.668 -1.27 . . . . 0.0 112.619 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.83 153.58 40.83 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.949 0.9 . . . . 0.0 109.35 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.41 -167.98 28.89 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.85 136.19 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.585 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -86.18 -24.25 26.19 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.052 0.941 . . . . 0.0 113.356 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.8 mt -81.14 -33.25 33.29 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.779 1.172 . . . . 0.0 112.71 -169.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.1 -22.5 32.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.102 0.858 . . . . 0.0 111.039 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 95' ' ' GLU . 42.0 m-85 -125.23 -87.88 0.6 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.0 -47.95 1.98 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 128.41 2.91 . . . . 0.0 108.866 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 93' ' ' TYR . 18.3 mm-40 -65.72 -28.84 69.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.837 1.655 . . . . 0.0 110.725 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -117.46 9.14 13.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.205 1.402 . . . . 0.0 112.133 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -47.65 122.61 5.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.034 1.334 . . . . 0.0 109.582 169.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.22 25.62 5.95 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.403 1.481 . . . . 0.0 113.379 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.95 -36.97 86.09 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.98 -30.95 71.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.886 -0.509 . . . . 0.0 112.043 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.0 -45.69 91.22 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.146 0.978 . . . . 0.0 111.009 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.13 96.11 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.9 mtm -67.01 -44.39 80.44 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.132 0.966 . . . . 0.0 112.115 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -64.64 -33.04 75.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.924 0.784 . . . . 0.0 111.55 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.462 ' CD2' ' HB ' ' A' ' 140' ' ' VAL . 0.2 OUTLIER -60.23 -47.49 85.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.22 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.21 -40.8 94.65 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.581 1.153 . . . . 0.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.437 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 14.1 tptt -55.21 -60.07 3.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.784 1.234 . . . . 0.0 108.795 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.29 -19.21 54.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.063 -169.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 t -61.2 -28.73 69.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.088 0.858 . . . . 0.0 110.274 169.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -21.84 55.59 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.733 -1.229 . . . . 0.0 109.992 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -85.24 1.59 47.56 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.642 1.577 . . . . 0.0 112.659 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.14 34.36 75.64 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.419 0.554 . . . . 0.0 111.897 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -86.26 170.33 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.979 0.912 . . . . 0.0 109.449 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.48 140.8 48.97 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 168.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -105.16 148.25 27.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.598 0.635 . . . . 0.0 110.531 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.97 177.43 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.22 39.18 27.59 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-O 118.441 -1.199 . . . . 0.0 113.983 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -76.35 151.7 36.57 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.704 1.752 . . . . 0.0 108.182 169.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.48 146.25 61.1 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.653 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.56 139.41 37.41 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.128 1.439 . . . . 0.0 109.52 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.442 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 64.4 p -76.28 -5.06 45.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.019 1.728 . . . . 0.0 113.334 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.43 140.04 58.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.178 0.99 . . . . 0.0 109.703 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.14 -8.95 61.97 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.378 1.466 . . . . 0.0 113.891 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.44 161.94 16.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.915 1.357 . . . . 0.0 110.661 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -164.02 -60.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.002 0.819 . . . . 0.0 109.611 -174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.337 2.0 t 58.06 9.94 1.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.671 2.788 . . . . 0.0 114.768 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.9 p -66.02 139.16 96.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.785 -1.197 . . . . 0.0 108.953 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.9 -15.54 3.82 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.444 2.096 . . . . 0.0 113.383 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -80.55 -47.33 1.26 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -86.88 35.94 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.072 1.848 . . . . 0.0 112.165 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.65 148.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.92 1.288 . . . . 0.0 109.556 -167.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.49 -172.95 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 125.978 1.711 . . . . 0.0 110.128 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.88 -116.22 0.83 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.302 1.441 . . . . 0.0 107.531 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.99 7.55 34.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.995 1.318 . . . . 0.0 111.879 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.45 18.85 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.998 1.285 . . . . 0.0 112.455 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.65 -17.59 17.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.645 1.178 . . . . 0.0 110.934 -172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.93 143.07 50.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.925 0.49 . . . . 0.0 111.212 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 58.3 m-85 -77.56 155.8 31.32 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.169 1.388 . . . . 0.0 108.658 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 105' ' ' HIS . 35.0 m -69.12 -16.35 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.763 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.88 -176.64 38.61 Favored Glycine 0 C--N 1.338 0.669 0 O-C-N 120.572 -1.33 . . . . 0.0 111.65 -172.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 21.2 tp -65.96 130.13 42.2 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.38 117.63 32.97 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.289 1.035 . . . . 0.0 108.27 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.03 153.66 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.317 1.047 . . . . 0.0 109.71 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.477 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -139.79 122.83 16.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -105.23 7.97 33.78 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.263 1.025 . . . . 0.0 110.716 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 -27.41 12.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.494 1.118 . . . . 0.0 110.39 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -124.9 -47.08 1.81 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.302 0.955 . . . . 0.0 111.025 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.18 17.14 7.37 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.7 0.8 . . . . 0.0 112.493 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -51.76 -22.88 3.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.043 0.937 . . . . 0.0 112.952 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -79.72 -25.85 41.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.846 0.858 . . . . 0.0 111.472 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -122.74 -13.12 7.98 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.241 1.017 . . . . 0.0 112.623 -171.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.1 p -55.71 -31.37 62.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.655 1.116 . . . . 0.0 110.681 -175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.58 -38.69 75.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.096 1.358 . . . . 0.0 111.476 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.46 -34.01 60.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.442 1.097 . . . . 0.0 109.414 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.72 60.26 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.676 0.79 . . . . 0.0 109.651 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.23 -60.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -56.09 -40.21 73.32 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.4 m -68.65 -33.3 73.76 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.017 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -66.28 -43.37 86.57 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 174.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 90.6 m -58.98 -34.75 72.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.794 0.837 . . . . 0.0 110.062 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.75 -31.35 68.13 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.93 0.492 . . . . 0.0 109.989 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -79.47 -45.82 18.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.515 171.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 pt -64.69 -38.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 120.944 1.702 . . . . 0.0 110.032 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.4 -12.17 49.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.216 0.462 . . . . 0.0 112.18 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.92 -46.27 6.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.742 1.217 . . . . 0.0 107.893 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.3 -36.36 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.114 0.87 . . . . 0.0 110.719 -172.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.405 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.4 mtm -80.94 -35.15 32.66 Favored 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.941 0.896 . . . . 0.0 110.972 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -46.42 33.89 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.382 1.073 . . . . 0.0 110.335 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.1 -30.21 70.17 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.259 1.424 . . . . 0.0 110.253 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -63.25 -54.31 39.24 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.95 0.5 . . . . 0.0 110.293 169.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.31 -7.21 55.63 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -169.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 C-N-CA 123.159 0.583 . . . . 0.0 110.632 179.189 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 142.99 31.23 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -130.92 147.06 52.52 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.49 1.916 . . . . 0.0 108.18 -170.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 118.37 5.07 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-O 118.563 -1.132 . . . . 0.0 110.409 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.39 109.96 19.93 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.026 1.413 . . . . 0.0 108.573 169.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -103.25 143.91 32.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.933 1.293 . . . . 0.0 111.398 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.8 172.86 17.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.162 0.585 . . . . 0.0 110.79 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.18 139.34 8.06 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -160.52 135.29 7.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.942 1.297 . . . . 0.0 108.207 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -99.86 -27.7 13.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.226 1.011 . . . . 0.0 110.909 169.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 p -99.37 -3.15 34.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.887 1.675 . . . . 0.0 111.753 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.7 m 70.87 8.55 6.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.657 2.383 . . . . 0.0 115.126 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -63.66 -45.3 90.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.365 1.438 . . . . 0.0 110.76 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 -35.67 79.57 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.0 -46.0 91.13 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 123.463 0.705 . . . . 0.0 110.085 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.7 mtm -64.71 -39.37 93.52 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.96 -0.462 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.26 95.45 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.013 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.69 -47.69 73.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.951 0.9 . . . . 0.0 110.641 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.89 -44.23 94.33 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -63.41 -54.2 40.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 124.596 1.185 . . . . 0.0 109.321 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -52.53 -55.83 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.973 0.806 . . . . 0.0 109.614 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -39.04 79.26 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.966 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.62 -46.72 74.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.102 0.477 . . . . 0.0 111.21 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.23 -46.89 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.152 1.381 . . . . 0.0 108.484 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.37 -49.56 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.604 0.762 . . . . 0.0 110.286 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.99 115.99 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.46 1.029 . . . . 0.0 110.548 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.22 3.18 4.25 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.427 2.751 . . . . 0.0 112.48 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.82 -34.74 69.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.28 1.432 . . . . 0.0 109.253 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.84 -23.06 3.74 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.641 1.576 . . . . 0.0 111.484 -169.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.48 139.95 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 120.509 1.504 . . . . 0.0 108.652 173.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -129.14 129.54 45.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.223 1.009 . . . . 0.0 109.349 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.65 146.26 51.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.29 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -145.4 99.67 3.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -81.49 124.47 29.5 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.61 -8.62 58.15 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -37.38 62.25 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.411 1.085 . . . . 0.0 108.986 169.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -98.55 -31.48 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.884 1.673 . . . . 0.0 112.822 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.13 172.17 13.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.305 1.442 . . . . 0.0 111.299 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.0 m -92.59 155.47 42.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -79.71 -9.73 14.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.779 2.319 . . . . 0.0 111.368 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -57.1 -36.87 71.13 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.962 1.71 . . . . 0.0 111.203 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -13.15 21.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.404 1.081 . . . . 0.0 112.355 170.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -73.37 -26.4 60.99 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.798 -1.188 . . . . 0.0 111.176 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.09 -51.33 12.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.097 0.862 . . . . 0.0 110.206 -171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -66.16 142.99 57.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.301 1.44 . . . . 0.0 109.246 -169.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.05 -27.6 61.84 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.41 144.19 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.79 152.54 51.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.2 119.65 53.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.79 144.56 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.82 148.56 19.55 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.461 -1.352 . . . . 0.0 115.839 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 136.67 26.52 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.94 2.096 . . . . 0.0 109.502 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.04 141.21 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 N-CA-C 107.839 -1.639 . . . . 0.0 107.839 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.7 m -87.82 116.35 25.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -99.43 167.79 10.4 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.104 1.762 . . . . 0.0 110.164 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 13.16 75.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 130.093 3.357 . . . . 0.0 115.272 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 56.54 65.03 1.51 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.842 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.16 70.15 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.358 0.5 OUTLIER -94.28 152.92 18.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.381 1.073 . . . . 0.0 109.956 168.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mt -95.86 151.21 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.582 1.553 . . . . 0.0 106.812 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -59.78 140.41 56.56 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.39 -27.46 69.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.134 0.574 . . . . 0.0 111.947 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -28.92 64.69 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.979 0.511 . . . . 0.0 111.207 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -77.76 -42.85 32.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.676 0.79 . . . . 0.0 110.268 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -55.78 -35.9 66.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.597 0.635 . . . . 0.0 110.909 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.98 -31.56 72.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.89 0.876 . . . . 0.0 111.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.9 -12.37 8.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.689 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.508 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -54.25 -28.86 44.32 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.551 1.541 . . . . 0.0 111.656 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.49 -44.08 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.97 1.308 . . . . 0.0 111.025 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -69.21 -30.13 68.25 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.457 -1.259 . . . . 0.0 112.675 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.85 -31.55 64.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.186 1.357 . . . . 0.0 110.685 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.3 -28.56 67.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.878 0.871 . . . . 0.0 111.566 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.45 -24.42 36.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.642 0.777 . . . . 0.0 111.254 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.89 157.33 33.38 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 123.122 1.439 . . . . 0.0 112.503 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -90.64 95.88 10.37 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.53 7.78 12.77 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.06 120.94 13.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.83 -0.39 89.14 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 125.393 1.473 . . . . 0.0 114.824 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -72.35 150.48 43.44 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.035 0.918 . . . . 0.0 109.46 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.98 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.3 t -132.67 128.03 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.427 1.091 . . . . 0.0 108.655 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 118.45 36.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -90.06 142.85 27.31 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.966 0.803 . . . . 0.0 111.692 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -140.59 158.76 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.079 0.952 . . . . 0.0 108.875 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.45 -179.93 39.5 Favored Glycine 0 CA--C 1.508 -0.367 0 O-C-N 120.678 -1.264 . . . . 0.0 112.125 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.39 145.2 45.36 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.71 11.79 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 169.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -159.63 135.0 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.463 1.505 . . . . 0.0 107.224 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.486 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.3 OUTLIER -88.85 -20.81 24.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.57 -47.84 68.62 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.655 1.116 . . . . 0.0 110.608 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.88 -29.13 7.43 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.491 1.043 . . . . 0.0 112.391 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -132.27 33.95 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -166.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.43 -38.77 63.47 Favored Glycine 0 N--CA 1.47 0.939 0 CA-C-N 120.024 1.284 . . . . 0.0 111.725 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.91 -17.01 62.79 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.362 1.081 . . . . 0.0 112.737 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -128.52 14.37 6.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 112.079 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.65 123.17 2.16 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.717 1.607 . . . . 0.0 109.762 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.52 27.85 2.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.939 1.296 . . . . 0.0 112.978 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.16 -37.82 86.69 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.68 -1.263 . . . . 0.0 110.628 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.92 76.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.527 0.331 . . . . 0.0 111.454 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.2 tp -60.1 -47.41 86.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.366 1.066 . . . . 0.0 110.505 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.78 98.58 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.1 mtm -64.15 -45.03 90.29 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.927 0.864 . . . . 0.0 111.829 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.508 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.9 mt -63.3 -35.14 79.37 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.345 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.23 -43.38 95.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.202 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.82 -42.1 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.776 1.23 . . . . 0.0 111.571 175.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.89 -59.85 4.17 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.679 1.191 . . . . 0.0 108.311 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.39 -20.45 54.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.871 -169.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 t -60.98 -29.09 69.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.256 0.934 . . . . 0.0 110.499 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -22.15 53.55 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.012 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -83.66 1.6 41.62 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 125.582 1.553 . . . . 0.0 112.583 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.47 31.88 68.16 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.641 0.655 . . . . 0.0 112.207 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.22 173.12 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.004 0.922 . . . . 0.0 109.193 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.51 148.6 44.25 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.32 150.49 30.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.098 0.863 . . . . 0.0 112.275 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.01 -179.7 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.718 1.207 . . . . 0.0 109.059 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.03 35.75 37.78 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-O 118.463 -1.187 . . . . 0.0 114.165 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -79.05 145.92 33.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.711 1.755 . . . . 0.0 108.713 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -120.53 148.29 47.5 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.363 170.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.41 139.16 37.35 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 CA-C-N 120.703 1.287 . . . . 0.0 109.187 168.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.438 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 72.8 p -73.5 -5.7 41.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.774 1.63 . . . . 0.0 113.161 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.91 140.79 57.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.173 -0.955 . . . . 0.0 109.463 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.79 -10.34 57.15 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.307 1.432 . . . . 0.0 113.735 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.06 160.31 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.969 1.384 . . . . 0.0 110.377 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -129.15 127.62 41.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.49 -57.74 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.364 0.984 . . . . 0.0 110.487 -171.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 4.0 t 58.17 11.07 1.41 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.282 2.633 . . . . 0.0 114.567 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -63.94 132.71 95.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -83.92 -12.23 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.718 2.278 . . . . 0.0 112.694 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -80.51 -48.83 1.19 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -88.3 38.81 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.314 2.009 . . . . 0.0 112.643 -168.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 146.72 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.205 -0.934 . . . . 0.0 110.056 -167.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.2 -172.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.107 1.763 . . . . 0.0 109.594 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.47 -117.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.988 1.315 . . . . 0.0 107.588 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -104.97 7.74 34.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.753 1.221 . . . . 0.0 112.011 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.02 20.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.572 1.082 . . . . 0.0 112.749 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -100.04 -17.47 17.48 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.746 1.218 . . . . 0.0 110.767 -172.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.55 144.67 50.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.306 0.642 . . . . 0.0 110.88 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.438 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 59.1 m-85 -79.93 154.64 28.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.147 1.379 . . . . 0.0 110.048 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.79 -12.61 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.7 1.2 . . . . 0.0 112.654 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.75 -177.69 44.06 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 119.479 1.036 . . . . 0.0 111.83 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.3 tp -64.67 127.84 33.24 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.71 107.55 16.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.48 155.21 17.03 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.56 115.89 8.51 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.55 27.13 2.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.489 -168.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 t -133.31 -19.89 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.486 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -116.76 -45.02 2.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.428 1.467 . . . . 0.0 109.309 171.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -79.62 -0.44 33.75 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.416 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.18 -25.27 21.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.018 1.735 . . . . 0.0 112.787 -171.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.7 -20.68 25.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.76 1.224 . . . . 0.0 112.738 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pp -124.48 -6.98 7.52 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.215 1.406 . . . . 0.0 113.088 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.7 m -53.49 -32.12 48.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.037 1.289 . . . . 0.0 110.24 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.94 -40.79 81.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.125 0.57 . . . . 0.0 111.455 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.68 -34.53 67.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.134 1.374 . . . . 0.0 109.564 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -78.83 -28.58 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.143 0.977 . . . . 0.0 109.224 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.71 -60.62 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -57.1 -41.08 78.27 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 118.727 0.694 . . . . 0.0 112.479 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -64.77 -36.22 83.61 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.536 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.41 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 39.9 t90 -66.35 -45.02 81.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 110.037 176.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.1 m -56.53 -37.06 69.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.168 0.987 . . . . 0.0 109.506 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.71 -29.06 66.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.474 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -80.74 -45.76 16.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.044 -0.979 . . . . 0.0 111.22 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.9 pt -64.6 -38.7 83.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 CA-C-N 120.84 1.654 . . . . 0.0 110.238 -171.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.17 -15.2 59.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.304 0.642 . . . . 0.0 112.034 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.16 -45.88 6.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.06 -41.59 88.31 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 118.704 0.684 . . . . 0.0 109.574 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 72.4 mtm -76.27 -38.01 56.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.706 0.803 . . . . 0.0 110.837 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.76 66.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.813 0.845 . . . . 0.0 109.927 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.58 -30.38 70.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.452 1.501 . . . . 0.0 109.921 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -63.28 -47.46 82.23 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 118.558 0.617 . . . . 0.0 110.502 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -2.74 47.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.775 1.23 . . . . 0.0 113.688 -175.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.418 179.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.95 141.46 44.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.138 1.375 . . . . 0.0 108.652 169.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm -120.68 147.59 45.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.291 2.237 . . . . 0.0 108.657 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.84 120.1 5.61 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.666 -1.075 . . . . 0.0 110.711 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 116.03 27.28 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 118.828 1.314 . . . . 0.0 108.601 169.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.37 147.25 35.59 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.807 1.643 . . . . 0.0 111.403 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -161.99 173.88 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.023 0.929 . . . . 0.0 110.81 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.35 138.51 7.98 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -140.68 131.61 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.34 1.456 . . . . 0.0 108.715 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.4 m -90.33 -36.85 14.42 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -94.58 -84.99 0.31 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.2 p -174.68 -6.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.739 2.016 . . . . 0.0 113.106 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -68.85 -42.39 77.18 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 119.839 -1.788 . . . . 0.0 112.249 -168.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -35.78 82.28 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.25 -47.55 83.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.4 mtm -66.69 -41.06 88.63 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.906 -0.496 . . . . 0.0 111.295 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.19 92.33 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 118.835 -0.603 . . . . 0.0 110.655 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.41 79.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.979 0.912 . . . . 0.0 110.872 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -58.68 -43.97 90.09 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.09 -55.32 26.42 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.813 1.245 . . . . 0.0 108.81 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -52.51 -56.66 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 119.018 0.826 . . . . 0.0 109.832 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -38.98 77.12 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.759 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.51 -47.22 70.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 122.737 0.415 . . . . 0.0 111.553 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.0 mt -66.12 -45.56 90.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.743 1.217 . . . . 0.0 108.456 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.35 -51.81 27.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.636 0.774 . . . . 0.0 110.484 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.3 114.06 0.75 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.432 1.015 . . . . 0.0 110.592 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.28 3.61 3.97 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.351 2.701 . . . . 0.0 112.693 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.97 -35.05 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.222 1.409 . . . . 0.0 109.118 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -24.7 5.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.876 1.67 . . . . 0.0 111.438 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.77 140.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 121.103 1.774 . . . . 0.0 109.242 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 m -130.69 130.13 43.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.541 1.137 . . . . 0.0 109.788 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.79 148.53 46.18 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.734 0.814 . . . . 0.0 112.06 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.56 115.14 10.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.872 1.669 . . . . 0.0 108.666 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.16 100.57 9.15 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.96 -21.65 66.43 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.844 1.656 . . . . 0.0 112.847 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -60.41 -28.84 68.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 112.468 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -109.89 -32.51 7.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.339 1.056 . . . . 0.0 112.993 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.63 167.62 16.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.636 1.175 . . . . 0.0 111.476 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -93.46 147.41 33.62 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.812 1.645 . . . . 0.0 109.07 -170.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -76.0 -1.52 11.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.588 1.525 . . . . 0.0 111.107 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -55.97 -33.74 65.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 122.346 2.339 . . . . 0.0 111.908 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.39 -19.87 65.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.5 ttm -58.91 -16.04 15.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.913 2.085 . . . . 0.0 111.627 169.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.37 -27.69 56.51 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.241 -0.912 . . . . 0.0 110.753 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.88 -51.55 12.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.751 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.36 133.18 47.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.01 -10.2 53.71 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.22 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.4 t -134.09 143.84 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.9 mt -140.34 149.05 42.24 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.8 121.63 56.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.63 147.08 44.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -151.93 147.49 17.36 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 119.589 -1.291 . . . . 0.0 115.66 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.5 135.93 23.13 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 126.894 2.078 . . . . 0.0 109.602 -171.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.97 144.02 7.07 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 165.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.9 m -88.73 117.21 27.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -98.77 169.95 9.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.592 1.157 . . . . 0.0 110.561 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 22.72 64.99 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.915 2.886 . . . . 0.0 115.517 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.75 70.8 0.6 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.586 1.154 . . . . 0.0 112.097 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.42 17.3 79.77 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.81 151.26 27.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.314 1.054 . . . . 0.0 109.555 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.31 153.03 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -61.14 141.02 57.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.862 0.839 . . . . 0.0 108.774 170.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.62 -27.4 68.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -166.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.11 -23.63 35.58 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.063 0.545 . . . . 0.0 110.391 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -73.44 -43.95 59.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -53.51 -34.24 57.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.336 0.655 . . . . 0.0 111.084 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.18 71.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 111.862 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 m -104.98 -9.36 9.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.566 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.6 t-105 -53.09 -29.49 30.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.708 1.603 . . . . 0.0 111.932 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.42 -43.81 76.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.33 -29.76 66.55 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.247 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -58.02 -31.03 66.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.828 1.194 . . . . 0.0 111.157 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.77 -26.92 62.63 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.549 0.74 . . . . 0.0 111.558 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.22 -22.34 35.96 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.316 0.646 . . . . 0.0 110.934 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.1 mt -73.93 156.89 37.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.982 1.372 . . . . 0.0 112.313 -167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.08 97.45 11.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.666 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -119.26 8.92 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.08 123.9 20.25 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -172.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.36 9.0 87.08 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.494 1.521 . . . . 0.0 114.329 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.48 146.94 34.12 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.646 0.723 . . . . 0.0 109.617 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 171' ' ' HIS . 4.9 mt -85.62 139.02 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 167.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.41 132.43 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 124.867 1.267 . . . . 0.0 109.143 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.03 119.46 37.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.69 143.82 26.49 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.122 0.874 . . . . 0.0 112.032 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.94 157.81 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.095 0.958 . . . . 0.0 109.253 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.68 177.04 38.1 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 120.452 -1.405 . . . . 0.0 112.849 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.69 157.24 36.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.195 0.998 . . . . 0.0 108.478 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.12 -152.75 9.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -154.73 135.13 13.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.548 1.539 . . . . 0.0 107.493 166.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -87.47 -22.83 24.7 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.733 1.213 . . . . 0.0 113.277 -178.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.5 mt -77.59 -40.19 43.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 120.016 1.28 . . . . 0.0 111.556 -171.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.43 -28.4 11.57 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.814 1.197 . . . . 0.0 112.166 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.78 34.61 3.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -168.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.06 61.11 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 119.99 1.268 . . . . 0.0 111.381 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.53 -16.4 55.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.757 0.778 . . . . 0.0 112.169 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.7 10.01 7.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.506 1.922 . . . . 0.0 112.112 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -47.5 124.01 6.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.38 1.472 . . . . 0.0 109.411 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.55 27.48 5.13 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 124.42 1.075 . . . . 0.0 112.781 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.09 -37.39 87.34 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.505 -1.372 . . . . 0.0 110.605 -172.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.36 75.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.917 0.487 . . . . 0.0 111.696 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.5 tp -59.72 -47.62 84.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.167 0.987 . . . . 0.0 110.29 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.78 97.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.4 mtm -64.97 -42.76 94.3 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 117.853 0.827 . . . . 0.0 111.864 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.566 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.8 mt -66.0 -33.78 76.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.814 1.188 . . . . 0.0 111.856 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -62.3 -40.64 96.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.741 -0.599 . . . . 0.0 110.334 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.81 -35.07 69.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.432 1.493 . . . . 0.0 111.813 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -58.11 -43.98 87.48 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.614 0.765 . . . . 0.0 109.916 173.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.4 mt -98.58 -18.16 18.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.917 -1.039 . . . . 0.0 112.446 -170.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p -60.64 -32.23 71.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 111.611 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -79.8 -18.74 50.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.1 0.56 . . . . 0.0 110.23 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -79.33 1.42 25.18 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.408 1.483 . . . . 0.0 111.969 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.83 63.86 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 118.601 0.637 . . . . 0.0 111.883 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.2 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.827 0.851 . . . . 0.0 109.376 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -118.27 141.33 48.63 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -106.15 147.14 29.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.336 0.971 . . . . 0.0 111.526 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.35 177.76 5.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.715 1.206 . . . . 0.0 108.921 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.35 35.73 32.63 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.389 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -79.86 146.87 31.97 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.888 1.844 . . . . 0.0 109.138 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -122.82 148.57 54.09 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 124.986 1.314 . . . . 0.0 108.488 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.71 138.07 31.18 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.585 1.524 . . . . 0.0 110.465 169.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 48.0 p -77.99 -6.6 54.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.381 1.872 . . . . 0.0 112.939 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.33 139.19 58.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.21 1.005 . . . . 0.0 110.201 -173.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.9 -3.46 50.73 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.454 1.502 . . . . 0.0 113.519 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.94 164.14 13.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.092 1.357 . . . . 0.0 110.799 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -128.89 124.7 35.9 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.105 1.762 . . . . 0.0 107.568 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -165.2 -57.57 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.907 0.883 . . . . 0.0 108.929 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.339 2.1 t 59.71 10.52 2.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.873 2.869 . . . . 0.0 114.895 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.7 p -67.33 139.12 94.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.867 -1.146 . . . . 0.0 108.683 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -86.91 -14.79 4.08 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.245 1.963 . . . . 0.0 113.532 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -81.7 -46.68 1.05 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -86.31 38.35 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.979 1.786 . . . . 0.0 112.395 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 146.52 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.183 0.993 . . . . 0.0 108.988 -167.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -172.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.737 1.615 . . . . 0.0 109.708 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.98 -116.01 0.82 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.479 1.512 . . . . 0.0 107.371 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.03 7.63 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.886 1.274 . . . . 0.0 111.881 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.72 20.84 17.97 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.94 1.257 . . . . 0.0 112.601 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.56 -16.8 17.36 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.945 1.298 . . . . 0.0 110.844 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.99 145.3 50.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.427 0.691 . . . . 0.0 110.882 174.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -80.18 153.91 28.31 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.715 1.606 . . . . 0.0 109.295 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.4 m -66.7 -12.55 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 112.599 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.99 -177.42 43.16 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.523 1.056 . . . . 0.0 112.019 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.42 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 20.0 tp -66.15 129.64 40.52 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.99 123.53 48.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 157.63 27.76 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.478 1.111 . . . . 0.0 108.136 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.424 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -142.93 120.04 11.43 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -98.19 12.8 33.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -21.5 11.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.196 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.4 -40.7 1.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.366 1.439 . . . . 0.0 113.249 172.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -80.63 4.92 17.02 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.386 0.994 . . . . 0.0 112.57 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.12 -25.02 28.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.439 1.472 . . . . 0.0 112.663 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.77 -26.05 49.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.749 1.22 . . . . 0.0 111.5 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.21 -6.49 6.56 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.321 1.049 . . . . 0.0 112.753 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.1 m -51.76 -33.8 36.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.208 1.367 . . . . 0.0 110.172 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.48 -42.65 78.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.836 1.255 . . . . 0.0 111.516 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -75.08 -33.43 61.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.797 1.239 . . . . 0.0 109.817 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -76.26 -30.98 58.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.704 -0.623 . . . . 0.0 109.651 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.9 -55.96 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -58.18 -43.1 87.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -65.21 -35.19 80.28 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.971 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.3 t90 -66.05 -45.3 81.9 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.841 0.829 . . . . 0.0 110.247 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 84.5 m -57.09 -36.48 70.64 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.161 0.985 . . . . 0.0 109.416 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.44 -28.65 66.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.323 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -81.27 -45.36 16.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.407 171.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.5 pt -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 120.923 1.692 . . . . 0.0 110.008 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.58 -14.14 56.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.835 -0.541 . . . . 0.0 112.108 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -94.47 -46.9 6.8 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.7 -34.79 76.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.681 0.673 . . . . 0.0 110.477 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 73.0 mtm -81.39 -43.12 19.44 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.32 1.048 . . . . 0.0 110.182 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.12 72.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.054 0.942 . . . . 0.0 111.222 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.06 -30.51 66.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.802 1.241 . . . . 0.0 109.607 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.406 ' CD2' HD11 ' A' ' 81' ' ' ILE . 67.5 t60 -66.45 -47.61 72.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -12.0 61.23 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.506 1.122 . . . . 0.0 113.388 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 C-N-CA 122.962 0.505 . . . . 0.0 110.793 -178.49 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.48 144.08 29.8 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 mtm -131.21 146.11 52.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.621 1.969 . . . . 0.0 107.854 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.42 117.22 4.98 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-O 118.478 -1.179 . . . . 0.0 110.628 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.63 115.41 26.14 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.245 1.522 . . . . 0.0 108.461 169.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.39 146.36 37.27 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.198 1.399 . . . . 0.0 111.382 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -161.93 176.44 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.166 0.986 . . . . 0.0 110.755 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.7 144.51 12.53 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 p -152.67 139.82 19.32 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.64 1.22 . . . . 0.0 112.647 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.7 m -99.87 -34.72 10.02 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.7 p -93.59 0.59 56.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.133 0.973 . . . . 0.0 111.86 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m 65.4 13.36 8.78 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.869 2.068 . . . . 0.0 113.538 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.37 -48.43 77.96 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.217 -1.552 . . . . 0.0 111.149 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -32.82 74.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.27 -48.75 80.46 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 109.679 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -65.35 -40.41 93.59 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.05 -0.406 . . . . 0.0 111.133 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.52 98.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.872 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.03 -47.42 77.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.279 1.032 . . . . 0.0 110.764 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.89 -45.23 90.74 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -61.77 -56.5 18.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 124.825 1.328 . . . . 0.0 108.994 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -51.96 -56.08 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 118.649 0.659 . . . . 0.0 110.108 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.93 78.31 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.27 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.06 -47.47 74.22 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.802 0.441 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.8 mt -65.74 -47.42 85.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.502 1.121 . . . . 0.0 108.966 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 78.8 mt -72.35 -49.26 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.605 0.762 . . . . 0.0 110.173 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.09 115.57 0.89 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.599 1.095 . . . . 0.0 110.47 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.38 3.85 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.412 2.742 . . . . 0.0 112.814 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.68 -34.55 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.943 1.297 . . . . 0.0 109.054 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.99 -21.35 4.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 111.639 -169.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.21 141.33 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.592 1.542 . . . . 0.0 108.944 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -131.56 128.83 40.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.436 1.094 . . . . 0.0 109.974 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.49 148.78 46.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.932 0.893 . . . . 0.0 112.034 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.73 110.89 6.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.582 1.953 . . . . 0.0 107.081 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.55 109.97 19.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.0 mt -66.17 -8.54 24.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -58.93 -29.14 66.88 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.113 0.87 . . . . 0.0 111.425 169.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -132.45 -33.79 1.24 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 111.995 -172.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -80.95 139.96 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 m -84.27 139.94 39.18 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -74.31 -0.39 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.256 1.484 . . . . 0.0 111.107 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -56.84 -33.16 66.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.939 2.154 . . . . 0.0 112.208 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -19.45 65.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 42.9 ttm -58.59 -16.22 14.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.752 2.021 . . . . 0.0 111.435 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 69.0 mt-10 -74.1 -29.29 61.78 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.028 -1.045 . . . . 0.0 111.095 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -76.75 -47.15 22.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.852 0.751 . . . . 0.0 109.974 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.26 139.23 57.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.601 -1.181 . . . . 0.0 107.968 -169.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.54 -26.96 61.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.228 0.537 . . . . 0.0 110.272 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -141.35 147.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.3 mt -139.29 150.59 45.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.964 0.505 . . . . 0.0 109.985 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.4 120.48 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 170.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.29 138.61 53.59 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 108.629 -172.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.23 122.56 3.5 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-O 118.239 -1.312 . . . . 0.0 112.442 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.99 130.93 24.04 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 118.613 1.206 . . . . 0.0 109.963 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -84.84 146.63 10.47 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 108.387 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 m -88.33 129.57 35.35 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -119.7 170.65 9.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.091 1.757 . . . . 0.0 109.618 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 27.36 57.65 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.255 2.622 . . . . 0.0 115.265 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 56.85 76.99 0.28 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.983 1.313 . . . . 0.0 112.247 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.42 14.23 71.68 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.41 160.07 21.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.603 1.161 . . . . 0.0 109.666 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -97.4 152.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.55 144.0 55.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 171.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.54 -28.59 69.96 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.164 0.586 . . . . 0.0 112.354 -168.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.73 -24.33 63.54 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.925 -0.484 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -83.37 -42.8 16.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.933 0.893 . . . . 0.0 110.866 170.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.55 -35.49 65.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.624 0.647 . . . . 0.0 110.818 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.02 71.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.596 1.158 . . . . 0.0 111.88 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 m -106.07 -11.64 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.68 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.514 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -52.89 -29.06 26.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.693 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.79 -46.56 65.47 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.15 1.38 . . . . 0.0 111.248 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.79 -29.53 69.5 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 117.435 -1.269 . . . . 0.0 112.14 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 mt -56.36 -35.91 68.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.798 1.181 . . . . 0.0 110.867 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.48 -33.14 75.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.384 0.674 . . . . 0.0 111.701 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.78 -12.92 43.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 111.184 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.28 171.38 12.24 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.381 1.086 . . . . 0.0 110.65 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.43 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 6.2 t30 -111.02 98.82 7.82 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.812 1.645 . . . . 0.0 107.641 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -118.77 6.29 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -65.12 112.86 3.58 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.48 -3.21 68.5 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.849 1.69 . . . . 0.0 116.076 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -75.36 155.12 36.8 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.537 1.168 . . . . 0.0 110.115 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.0 mt -89.41 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.44 133.33 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.676 1.19 . . . . 0.0 109.416 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.8 117.41 33.34 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.11 142.75 27.41 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 119.023 0.829 . . . . 0.0 111.752 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.75 159.89 41.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.222 1.009 . . . . 0.0 108.878 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.02 177.51 39.05 Favored Glycine 0 N--CA 1.447 -0.578 0 O-C-N 121.14 -0.975 . . . . 0.0 112.207 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.77 153.67 42.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.17 -158.15 10.75 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -152.2 141.08 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.094 1.358 . . . . 0.0 109.141 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.578 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -87.35 -22.36 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.37 -39.92 70.95 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.931 1.241 . . . . 0.0 112.265 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.97 -18.44 31.86 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.171 0.891 . . . . 0.0 111.512 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.473 ' C ' ' H ' ' A' ' 95' ' ' GLU . 41.3 m-85 -126.93 -89.91 0.54 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.939 1.296 . . . . 0.0 108.13 -169.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.58 -50.21 2.47 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 128.497 2.951 . . . . 0.0 107.936 -168.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 93' ' ' TYR . 15.9 mm-40 -67.77 -28.42 67.6 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.365 1.866 . . . . 0.0 110.767 -175.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -117.53 6.61 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.651 1.181 . . . . 0.0 112.349 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -43.96 121.87 2.61 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.496 1.518 . . . . 0.0 109.592 168.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 52.85 25.88 4.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.588 1.155 . . . . 0.0 113.512 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.47 -36.0 82.59 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.516 -1.365 . . . . 0.0 110.603 -172.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.69 74.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.255 0.622 . . . . 0.0 112.06 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.9 tp -60.48 -46.49 89.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.141 0.976 . . . . 0.0 110.413 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.21 97.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 mtm -67.14 -42.73 83.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.841 0.821 . . . . 0.0 112.239 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.514 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.5 mt -63.49 -36.15 82.82 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.201 172.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -63.6 -41.25 98.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.973 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.18 -43.19 92.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -55.6 -58.44 7.8 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.97 -20.27 58.03 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.728 -0.608 . . . . 0.0 110.385 -169.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t -62.95 -29.66 70.97 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.846 0.748 . . . . 0.0 110.022 167.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.0 -27.38 39.58 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.047 1.294 . . . . 0.0 108.427 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -73.58 2.47 7.91 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.503 1.121 . . . . 0.0 113.176 170.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.35 85.96 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.427 1.012 . . . . 0.0 112.378 169.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.66 173.75 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.795 0.838 . . . . 0.0 109.304 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 145.75 45.2 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 165.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.96 150.1 28.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.854 0.752 . . . . 0.0 111.878 -169.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.7 m -127.47 179.59 3.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 109.304 169.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 36.24 43.4 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.532 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -71.73 153.52 41.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.091 1.445 . . . . 0.0 108.139 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.411 ' HE1' HD12 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -133.23 145.87 58.56 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-O 116.944 -1.503 . . . . 0.0 108.835 169.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.68 140.46 39.29 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 CA-C-N 120.895 1.355 . . . . 0.0 109.618 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 80.6 p -74.98 -6.48 49.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 113.583 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.1 141.06 57.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.053 0.93 . . . . 0.0 110.246 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.55 -8.83 66.93 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.005 1.764 . . . . 0.0 113.816 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -89.76 163.17 15.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.746 1.273 . . . . 0.0 110.622 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -126.48 123.96 39.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 169.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -163.9 -50.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.952 0.796 . . . . 0.0 110.275 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.303 2.8 t 57.79 8.93 0.77 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.479 2.712 . . . . 0.0 114.512 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -83.55 144.51 46.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.977 1.311 . . . . 0.0 110.861 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -88.94 -12.52 3.4 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.895 2.397 . . . . 0.0 113.775 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -50.91 3.77 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 117.916 -1.04 . . . . 0.0 113.402 -168.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -88.29 38.98 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.751 1.634 . . . . 0.0 112.091 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 148.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.083 -1.011 . . . . 0.0 110.241 -166.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.37 -172.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 126.361 1.864 . . . . 0.0 109.981 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.03 -116.03 0.81 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.486 1.515 . . . . 0.0 107.327 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.09 8.14 34.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.579 1.152 . . . . 0.0 111.889 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.87 21.03 19.69 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.993 1.282 . . . . 0.0 112.506 -173.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -100.06 -18.16 17.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 110.837 -172.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.86 143.31 50.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.303 0.641 . . . . 0.0 111.328 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 56.8 m-85 -78.14 155.39 30.5 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.076 1.35 . . . . 0.0 109.457 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.5 -14.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.546 1.138 . . . . 0.0 112.804 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.32 -178.3 42.4 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 119.65 1.114 . . . . 0.0 112.184 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 HD12 ' HE1' ' A' ' 119' ' ' TRP . 28.2 tp -64.97 130.29 42.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.33 117.96 31.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.13 152.52 34.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.433 1.093 . . . . 0.0 109.164 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.72 124.06 13.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -99.26 15.05 27.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.235 1.014 . . . . 0.0 110.576 -169.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 t -123.04 -22.27 5.25 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.578 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.2 -48.54 2.96 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.759 1.223 . . . . 0.0 108.041 171.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -105.21 22.64 15.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.641 1.577 . . . . 0.0 112.474 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -52.6 -25.78 11.62 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.826 0.739 . . . . 0.0 112.279 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.09 -25.32 52.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.781 . . . . 0.0 111.478 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -125.02 -14.44 6.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.5 m -57.67 -28.95 64.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.098 1.317 . . . . 0.0 109.769 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.23 -49.21 78.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.595 0.758 . . . . 0.0 111.06 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -66.7 -33.17 75.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.081 0.943 . . . . 0.0 109.329 -171.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -79.13 -23.46 44.01 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.219 -174.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.59 -53.71 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -53.64 -47.07 70.67 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 123.636 0.775 . . . . 0.0 110.136 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.9 m -66.83 -36.79 83.17 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.146 0.278 . . . . 0.0 110.521 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -65.79 -46.06 80.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.716 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 85.3 m -58.04 -34.55 70.2 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -31.81 71.9 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.028 0.531 . . . . 0.0 110.601 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -83.03 -45.52 13.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.942 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -64.24 -37.82 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 120.849 1.658 . . . . 0.0 110.048 -170.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.83 -11.8 30.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -49.82 5.72 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 125.704 1.601 . . . . 0.0 108.088 169.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.33 -28.44 70.01 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.951 -0.468 . . . . 0.0 110.913 -169.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.2 mtm -89.34 -40.71 12.59 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 124.132 0.973 . . . . 0.0 111.429 -178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.28 33.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.575 0.75 . . . . 0.0 110.784 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.0 -29.72 63.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.233 1.413 . . . . 0.0 109.452 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -63.06 -49.79 73.16 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.227 0.467 . . . . 0.0 109.914 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -2.4 34.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.332 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.648 179.824 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.5 141.5 31.6 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtm -129.17 145.05 51.4 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.582 1.953 . . . . 0.0 108.489 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.48 115.52 4.09 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.99 121.63 28.05 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -115.63 144.7 43.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.335 1.054 . . . . 0.0 111.679 171.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -156.62 169.88 23.67 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.762 1.225 . . . . 0.0 110.29 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.33 138.57 8.02 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 p -142.05 136.47 30.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.707 1.203 . . . . 0.0 109.814 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -92.75 -39.23 11.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.14 0.976 . . . . 0.0 110.09 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -85.99 -86.34 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 p -177.76 4.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.04 3.336 . . . . 0.0 110.763 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -67.27 -45.43 76.66 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.091 -1.631 . . . . 0.0 111.59 -166.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -34.28 77.11 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -60.98 -47.67 85.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.302 0.641 . . . . 0.0 110.151 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -64.89 -40.43 95.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 122.217 -0.302 . . . . 0.0 111.035 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.07 97.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.824 -0.607 . . . . 0.0 110.623 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.97 -45.7 78.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.085 0.954 . . . . 0.0 110.971 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.86 -45.21 93.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -63.43 -57.55 9.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.699 1.249 . . . . 0.0 108.84 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -51.92 -55.53 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 118.248 0.476 . . . . 0.0 110.015 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -38.23 74.52 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.868 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.77 -48.79 65.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.826 0.451 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.6 mt -65.76 -46.32 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 108.788 -173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 72.3 mt -71.14 -50.14 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 110.038 -177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.08 114.9 0.8 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.57 1.33 5.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.326 2.684 . . . . 0.0 112.458 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.22 -33.83 65.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 109.404 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.04 -19.63 3.94 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.43 -169.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.63 141.61 15.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.702 1.592 . . . . 0.0 108.755 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.6 m -131.66 129.03 40.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.75 145.53 25.56 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.17 127.55 30.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.007 2.123 . . . . 0.0 107.935 -168.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.26 88.2 3.07 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.724 1.609 . . . . 0.0 107.373 -168.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.45 -16.11 21.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.925 1.29 . . . . 0.0 114.352 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -13.55 62.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.721 -0.612 . . . . 0.0 112.45 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -129.75 -35.43 1.68 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.313 1.445 . . . . 0.0 112.145 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -81.56 145.08 30.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.054 1.342 . . . . 0.0 109.553 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.82 147.69 59.26 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -76.1 -8.95 19.12 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.431 2.087 . . . . 0.0 111.029 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -55.05 -36.54 65.67 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.699 1.59 . . . . 0.0 111.325 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -22.94 67.13 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.119 -0.988 . . . . 0.0 113.397 176.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -14.15 31.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -73.06 -26.65 61.36 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.767 -1.208 . . . . 0.0 110.716 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -76.75 -51.11 12.02 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.524 1.056 . . . . 0.0 109.97 -171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -66.01 142.02 57.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.615 -169.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.73 -24.0 56.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.806 0.812 . . . . 0.0 111.611 -172.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.31 144.18 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -172.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.56 153.21 51.83 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.672 0.669 . . . . 0.0 110.47 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.54 120.03 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -118.84 132.4 56.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -172.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.18 116.32 3.02 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-O 117.793 -1.56 . . . . 0.0 112.571 -173.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.49 121.45 32.04 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 119.314 1.557 . . . . 0.0 110.758 178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -76.8 146.41 26.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.941 2.427 . . . . 0.0 108.941 168.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -94.06 139.81 30.5 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -133.05 167.73 19.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.624 2.37 . . . . 0.0 109.905 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 27.5 56.7 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 129.244 3.018 . . . . 0.0 116.663 167.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . 0.253 3.0 m-85 51.97 81.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.14 2.576 . . . . 0.0 112.093 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.81 16.9 79.18 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.8 152.89 22.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.254 1.022 . . . . 0.0 108.324 168.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -87.03 156.97 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.36 138.47 50.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.53 -24.86 67.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -165.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -86.01 -26.9 25.15 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.738 -0.602 . . . . 0.0 110.552 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -67.26 -40.74 86.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.34 -32.32 64.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.85 0.46 . . . . 0.0 111.148 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.41 72.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.274 0.63 . . . . 0.0 111.869 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -98.95 -11.52 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.517 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -54.48 -28.79 47.15 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.509 1.524 . . . . 0.0 111.886 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.16 -44.09 66.2 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.042 1.337 . . . . 0.0 111.309 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -69.41 -29.77 67.59 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.057 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.64 -31.38 64.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.188 1.358 . . . . 0.0 111.225 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.82 -29.17 68.27 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.838 0.855 . . . . 0.0 111.479 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.93 -24.17 35.76 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 111.441 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.1 157.65 34.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 123.013 1.387 . . . . 0.0 112.326 -167.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -92.12 97.01 10.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.766 -2.016 . . . . 0.0 108.778 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -119.34 8.08 11.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.57 120.89 13.21 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -170.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.56 87.0 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.363 1.459 . . . . 0.0 114.287 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -76.99 145.55 37.98 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 117.775 0.787 . . . . 0.0 109.239 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.1 mt -84.27 138.07 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.66 127.39 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 124.722 1.209 . . . . 0.0 108.835 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.48 117.78 34.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.5 mt -89.86 141.76 28.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.182 0.901 . . . . 0.0 111.557 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -137.04 159.58 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.19 0.996 . . . . 0.0 109.289 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.56 173.43 37.11 Favored Glycine 0 N--CA 1.45 -0.392 0 O-C-N 121.268 -0.895 . . . . 0.0 111.857 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.0 154.37 48.24 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.296 1.438 . . . . 0.0 107.632 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.26 -155.6 11.86 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -131.84 121.23 23.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.089 3.356 . . . . 0.0 105.997 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -25.25 15.27 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 119.986 1.266 . . . . 0.0 112.836 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -79.09 -41.22 29.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.196 0.198 . . . . 0.0 110.729 -169.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.53 -34.21 36.37 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 118.539 -1.145 . . . . 0.0 111.501 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.572 ' CE2' ' HB2' ' A' ' 96' ' ' TRP 0.277 0.0 OUTLIER -153.87 41.89 0.53 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.84 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.16 -24.73 5.03 Favored Glycine 0 N--CA 1.475 1.29 0 O-C-N 119.646 -1.909 . . . . 0.0 114.069 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 -27.06 6.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.806 1.242 . . . . 0.0 111.497 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.572 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 19.9 m-90 -119.22 -55.31 2.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 116.173 -1.87 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.8 t80 7.27 122.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 130.066 3.346 . . . . 0.0 115.8 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.85 30.07 16.6 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.536 1.534 . . . . 0.0 111.655 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.57 -39.09 91.25 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.938 -1.101 . . . . 0.0 110.685 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.53 72.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 111.34 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.9 tp -61.28 -47.79 84.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.54 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.47 -39.93 96.99 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 mtm -65.92 -44.66 84.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 117.918 0.859 . . . . 0.0 112.23 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.517 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -64.29 -34.77 78.9 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.494 173.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.4 -42.34 98.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.048 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.59 -42.86 91.2 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.538 1.135 . . . . 0.0 111.695 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.33 -58.6 6.77 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.631 1.172 . . . . 0.0 108.41 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 mt -78.14 -20.7 51.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.434 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 t -61.32 -28.64 69.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.365 0.984 . . . . 0.0 110.502 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -22.73 50.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.873 1.215 . . . . 0.0 109.787 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -83.35 1.26 42.14 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.854 1.662 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.67 34.04 66.93 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.458 0.572 . . . . 0.0 111.731 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.13 169.07 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.705 0.752 . . . . 0.0 109.38 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -116.13 143.85 44.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -112.34 148.01 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.73 1.15 . . . . 0.0 112.138 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.52 -179.39 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.194 0.998 . . . . 0.0 109.589 169.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.95 35.72 38.27 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-O 118.473 -1.182 . . . . 0.0 113.987 172.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -78.55 148.59 33.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.48 1.64 . . . . 0.0 108.587 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -124.91 148.1 58.71 Favored Pre-proline 0 CA--C 1.516 -0.35 0 CA-C-O 117.26 -1.352 . . . . 0.0 108.786 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.82 139.3 43.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 N-CA-C 108.877 -1.24 . . . . 0.0 108.877 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.478 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.4 p -72.41 -15.57 61.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.443 1.497 . . . . 0.0 113.289 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.62 145.32 54.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.956 0.902 . . . . 0.0 109.77 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.23 19.94 79.34 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.367 0.984 . . . . 0.0 112.839 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.45 167.16 22.81 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.129 1.772 . . . . 0.0 108.289 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -126.94 132.22 50.91 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.738 1.615 . . . . 0.0 107.418 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.426 ' CG ' ' N ' ' A' ' 127' ' ' THR . 2.7 p90 -165.11 -69.67 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.426 ' N ' ' CG ' ' A' ' 126' ' ' PHE 0.353 2.8 t 58.62 12.17 2.05 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.11 2.964 . . . . 0.0 114.384 -170.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.3 p -64.59 141.2 98.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.742 -1.224 . . . . 0.0 110.172 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -88.46 -15.28 2.89 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.854 2.37 . . . . 0.0 113.558 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 -49.54 1.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.034 -0.984 . . . . 0.0 113.466 -168.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -91.58 44.37 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.866 1.711 . . . . 0.0 112.266 -168.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 146.56 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 120.944 -1.097 . . . . 0.0 109.467 -168.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -172.7 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.843 1.657 . . . . 0.0 109.819 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.18 -116.3 0.82 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.162 1.385 . . . . 0.0 107.546 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -105.37 7.46 33.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.965 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.84 20.73 18.01 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.779 1.181 . . . . 0.0 112.838 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.55 -17.29 17.17 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.734 1.214 . . . . 0.0 110.857 -173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.15 144.54 50.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.303 0.641 . . . . 0.0 111.155 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 57.7 m-85 -79.33 154.22 29.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.351 1.46 . . . . 0.0 109.866 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.2 m -66.07 -13.74 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.591 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -169.68 -177.56 40.23 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 120.035 1.289 . . . . 0.0 112.206 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 23.1 tp -63.68 125.96 26.0 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.2 121.28 44.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.9 mt -121.29 160.53 23.75 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.9 135.77 41.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 172.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.65 15.4 14.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.129 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -117.63 -22.82 7.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -140.23 -28.66 0.72 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.202 1.001 . . . . 0.0 113.139 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -86.91 8.38 23.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.411 1.005 . . . . 0.0 111.809 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.95 -24.16 22.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.274 0.943 . . . . 0.0 112.589 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.76 -26.27 44.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.286 1.034 . . . . 0.0 111.667 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -124.97 -13.74 6.79 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.3 m -55.55 -28.86 57.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.277 0.944 . . . . 0.0 111.533 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.5 -43.07 71.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.271 1.029 . . . . 0.0 111.318 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.87 -31.68 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.856 0.836 . . . . 0.0 109.677 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -77.42 -25.23 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.275 0.63 . . . . 0.0 109.667 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -55.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -52.65 -47.22 67.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.633 1.173 . . . . 0.0 110.187 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -68.51 -35.49 77.56 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.315 0.384 . . . . 0.0 110.58 -177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 25.3 t90 -65.72 -45.54 82.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.627 0.727 . . . . 0.0 109.816 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -59.1 -34.53 72.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.667 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.49 70.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.051 0.54 . . . . 0.0 110.889 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -85.4 -45.58 11.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.16 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.7 pt -64.34 -37.9 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 120.603 1.547 . . . . 0.0 109.897 -170.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.58 -13.2 28.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -49.67 5.85 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 108.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.91 -28.13 69.85 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.376 0.535 . . . . 0.0 111.051 -169.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 70.5 mtm -89.4 -41.22 12.22 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.46 1.104 . . . . 0.0 111.416 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.93 -44.09 27.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.393 0.677 . . . . 0.0 110.727 -174.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -73.25 -28.44 62.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.331 1.452 . . . . 0.0 109.862 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -60.16 -49.9 75.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -1.0 48.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.853 0.461 . . . . 0.0 110.581 178.188 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' FMN . . . . . 0.436 ' N3 ' ' CE1' ' A' ' 93' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.47 143.89 31.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -132.29 145.77 51.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.381 1.872 . . . . 0.0 108.104 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.63 117.52 4.85 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.26 112.35 21.95 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 118.983 1.391 . . . . 0.0 108.054 169.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -106.42 142.9 35.32 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.525 1.13 . . . . 0.0 111.83 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.27 169.14 25.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 110.163 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.14 137.89 7.91 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 168.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -138.75 135.57 34.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.791 1.636 . . . . 0.0 108.076 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -87.19 -28.9 22.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.8 p -108.74 -90.8 0.45 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.8 m -162.03 -11.79 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.546 2.738 . . . . 0.0 113.21 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -62.78 -46.75 86.56 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.979 -1.701 . . . . 0.0 112.272 -167.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -34.51 77.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.3 -48.25 80.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.07 0.948 . . . . 0.0 110.437 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 70.2 mtm -65.99 -40.35 91.1 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.908 -0.495 . . . . 0.0 110.943 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.59 98.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.873 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.68 -48.12 75.63 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.075 0.95 . . . . 0.0 110.634 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -59.11 -44.92 92.02 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.18 -54.51 39.93 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 124.658 1.224 . . . . 0.0 109.024 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.426 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -53.03 -56.23 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.888 0.767 . . . . 0.0 109.775 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -38.53 78.14 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.59 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.6 -46.73 74.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 122.878 0.471 . . . . 0.0 111.377 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 158' ' ' GLN . 11.5 mt -68.05 -47.18 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.572 1.149 . . . . 0.0 108.504 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -70.61 -50.17 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.722 0.809 . . . . 0.0 110.159 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.29 115.13 0.85 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.19 3.7 3.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.396 2.731 . . . . 0.0 112.945 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.4 -34.67 70.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.132 1.373 . . . . 0.0 108.996 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -21.02 3.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -169.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.51 142.47 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 120.909 1.686 . . . . 0.0 108.727 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -132.86 129.73 38.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.399 1.08 . . . . 0.0 109.528 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.37 146.41 48.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.64 0.776 . . . . 0.0 111.666 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -139.39 121.69 15.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.632 1.973 . . . . 0.0 107.301 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -103.72 90.43 3.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.33 -15.13 22.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.089 1.356 . . . . 0.0 114.392 -167.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -12.83 61.71 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -131.73 -35.28 1.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.016 1.326 . . . . 0.0 112.22 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -81.75 145.34 30.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.044 1.338 . . . . 0.0 109.651 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -83.95 143.54 43.23 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.36 -8.04 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.501 2.134 . . . . 0.0 111.072 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -57.21 -35.54 69.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.763 1.62 . . . . 0.0 111.823 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -21.37 66.76 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.261 -0.9 . . . . 0.0 113.194 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -13.32 23.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.673 1.189 . . . . 0.0 112.034 170.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.33 -27.46 61.53 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.626 -1.296 . . . . 0.0 111.043 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.68 -49.46 16.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.853 0.751 . . . . 0.0 110.167 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -65.4 140.83 58.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.944 1.298 . . . . 0.0 108.86 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.84 -31.07 68.72 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.356 0.662 . . . . 0.0 110.755 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.77 144.54 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -133.7 152.32 51.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.53 0.605 . . . . 0.0 110.246 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.66 121.67 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -120.67 137.44 54.46 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 108.991 -172.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.33 122.3 3.79 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-O 118.02 -1.434 . . . . 0.0 113.236 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.47 126.07 26.62 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 119.15 1.475 . . . . 0.0 111.829 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -78.51 142.95 18.84 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.433 2.755 . . . . 0.0 109.187 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -92.23 110.09 21.47 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -95.63 171.56 8.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.493 1.117 . . . . 0.0 110.37 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 26.89 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.722 2.809 . . . . 0.0 115.647 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 55.11 76.27 0.27 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.928 1.291 . . . . 0.0 112.481 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.18 16.36 79.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.44 154.5 21.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.458 1.123 . . . . 0.0 108.565 168.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -82.75 153.57 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.04 138.37 44.16 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.89 -24.44 67.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -165.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -87.83 -25.92 23.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.986 0.514 . . . . 0.0 110.606 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.8 m95 -68.46 -39.52 81.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.013 -0.429 . . . . 0.0 110.393 170.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -55.56 -32.87 63.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.023 0.529 . . . . 0.0 111.346 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.91 71.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.424 0.69 . . . . 0.0 111.971 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.7 -12.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.745 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.561 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.3 t-105 -54.25 -28.03 38.83 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.529 1.531 . . . . 0.0 112.059 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.44 -46.13 64.47 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.055 1.342 . . . . 0.0 111.227 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -67.56 -32.02 72.5 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.319 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.63 -30.16 62.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.871 1.214 . . . . 0.0 111.445 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.3 -32.41 70.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.634 0.774 . . . . 0.0 111.354 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.85 -22.7 33.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.963 0.905 . . . . 0.0 110.728 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -73.63 159.8 32.53 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.689 1.233 . . . . 0.0 111.341 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -91.52 101.66 14.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.645 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -122.9 3.93 9.41 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.665 1.186 . . . . 0.0 113.215 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -67.03 115.38 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.72 5.12 78.59 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.61 1.576 . . . . 0.0 115.288 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.2 149.98 33.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 118.125 0.963 . . . . 0.0 110.047 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -86.23 139.08 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 167.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.09 129.63 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 124.756 1.222 . . . . 0.0 108.925 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.05 118.0 35.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 mt -90.12 143.01 27.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.975 0.807 . . . . 0.0 111.776 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -135.29 156.33 49.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.898 0.879 . . . . 0.0 108.657 168.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.24 162.46 30.59 Favored Glycine 0 CA--C 1.505 -0.546 0 O-C-N 120.874 -1.141 . . . . 0.0 111.939 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.6 153.28 40.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.01 -145.75 5.84 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -151.73 145.13 24.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.157 2.183 . . . . 0.0 108.149 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.95 -31.59 22.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.752 2.021 . . . . 0.0 114.019 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.82 -32.93 62.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.356 0.98 . . . . 0.0 112.782 -167.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.71 -19.94 23.3 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 124.843 1.211 . . . . 0.0 111.521 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' C ' ' H ' ' A' ' 95' ' ' GLU . 25.5 m-85 -126.44 -88.64 0.57 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.189 0.996 . . . . 0.0 108.872 -169.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.46 -50.26 2.43 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 128.295 2.855 . . . . 0.0 107.812 -167.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.7 mm-40 -69.02 -32.66 72.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.483 1.913 . . . . 0.0 110.533 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -111.89 0.83 16.25 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.793 1.237 . . . . 0.0 111.656 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.11 126.33 22.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.71 -1.243 . . . . 0.0 109.897 169.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.61 24.7 9.09 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.719 1.608 . . . . 0.0 113.46 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.76 -41.65 97.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.791 -1.193 . . . . 0.0 110.426 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.441 0.697 . . . . 0.0 111.368 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.669 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.33 -46.82 88.68 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.544 0.738 . . . . 0.0 110.927 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.1 95.14 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.6 mtm -68.44 -43.39 77.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 117.74 0.77 . . . . 0.0 112.559 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.567 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -63.82 -33.04 74.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.6 1.091 . . . . 0.0 111.28 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -66.0 -41.03 91.57 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.031 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.93 -31.49 66.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.698 1.999 . . . . 0.0 112.155 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -61.86 -61.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.49 -18.83 56.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.761 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -61.87 -31.11 71.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.145 1.339 . . . . 0.0 111.55 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -22.35 56.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.627 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -82.12 4.73 22.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.518 1.927 . . . . 0.0 112.876 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.05 31.49 78.0 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -82.69 169.82 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -116.8 142.27 47.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -110.04 147.45 33.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.57 1.077 . . . . 0.0 111.723 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.6 m -127.82 178.54 4.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.187 0.995 . . . . 0.0 109.24 169.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.15 34.22 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.326 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -75.65 151.69 37.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.837 1.818 . . . . 0.0 108.446 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.71 148.27 67.81 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 117.095 -1.431 . . . . 0.0 108.946 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.922 1.365 . . . . 0.0 109.696 168.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.511 HG22 ' CD1' ' A' ' 139' ' ' PHE . 79.7 p . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.496 1.518 . . . . 0.0 113.692 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -163.53 -59.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.695 0.68 . . . . 0.0 109.283 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.325 3.7 t 54.97 7.73 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.628 2.771 . . . . 0.0 114.173 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.5 p -72.84 146.09 87.48 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.66 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.98 -11.28 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.935 2.423 . . . . 0.0 113.867 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -79.87 -48.07 1.4 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -169.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.61 39.98 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.295 1.997 . . . . 0.0 112.8 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 148.82 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 120.949 -1.094 . . . . 0.0 110.408 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.02 -172.16 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.123 1.769 . . . . 0.0 109.666 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.42 -117.38 0.94 Allowed 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.24 8.36 33.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.016 1.326 . . . . 0.0 112.011 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.36 20.21 20.84 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.352 0.977 . . . . 0.0 112.865 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.31 -17.21 17.39 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.971 1.308 . . . . 0.0 110.779 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.34 144.33 49.56 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.683 0.793 . . . . 0.0 111.026 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.4 m-85 -79.13 154.65 29.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.48 1.512 . . . . 0.0 109.776 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.18 -15.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.492 1.117 . . . . 0.0 112.479 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.35 -178.47 41.19 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.592 1.087 . . . . 0.0 111.698 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.9 tp -65.7 135.39 54.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.08 124.56 47.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.66 159.57 34.3 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.515 1.126 . . . . 0.0 109.9 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.63 139.63 29.71 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.525 1.53 . . . . 0.0 107.254 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.21 4.22 16.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.043 1.337 . . . . 0.0 111.048 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -24.06 15.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.21 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -147.42 -30.35 0.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -81.29 9.93 6.33 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.342 0.974 . . . . 0.0 111.871 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -55.07 -20.67 10.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.977 0.911 . . . . 0.0 112.792 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.78 -27.01 57.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.522 0.729 . . . . 0.0 110.934 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.77 -11.72 6.62 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 p -52.56 -35.82 54.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 110.476 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.04 -39.93 87.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.529 1.532 . . . . 0.0 111.466 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -31.66 59.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 109.667 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.16 -29.81 57.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.856 -0.528 . . . . 0.0 109.812 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.37 -57.23 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.3 pt20 -57.04 -43.83 82.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 122.661 0.384 . . . . 0.0 111.746 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -65.72 -34.15 77.54 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.055 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.6 t90 -66.51 -45.2 80.33 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.812 0.815 . . . . 0.0 109.802 176.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 89.9 m -57.37 -37.17 72.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.813 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -68.5 -26.69 65.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.199 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.13 -43.52 12.98 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.909 -1.044 . . . . 0.0 112.091 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.07 -36.4 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.874 1.67 . . . . 0.0 109.85 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.2 -47.7 6.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.3 -35.44 77.36 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.41 0.55 . . . . 0.0 110.225 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.729 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.4 mtm -77.9 -43.45 30.04 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.322 1.049 . . . . 0.0 110.601 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.68 73.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.922 0.889 . . . . 0.0 111.252 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.75 -30.76 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.94 1.296 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.542 0.737 . . . . 0.0 110.599 169.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.91 -1.65 56.87 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.719 1.608 . . . . 0.0 113.818 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.089 0.556 . . . . 0.0 110.494 -179.84 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttm . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.162 0.506 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 147.31 51.6 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 127.946 2.498 . . . . 0.0 106.978 168.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.41 147.07 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.645 1.578 . . . . 0.0 109.0 -166.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.87 119.09 4.78 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.08 108.1 19.08 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -103.73 143.84 32.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.68 1.192 . . . . 0.0 109.998 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -161.09 174.63 13.43 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.956 0.503 . . . . 0.0 109.826 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.17 142.9 9.93 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -140.81 147.19 38.64 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.607 1.163 . . . . 0.0 108.012 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 -29.54 33.08 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 169.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.8 p -104.29 -77.43 0.58 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p 175.66 -7.78 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.997 2.919 . . . . 0.0 110.891 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.46 -44.06 88.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.01 1.732 . . . . 0.0 110.542 -168.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -31.53 70.07 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -64.53 -47.43 78.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.453 1.101 . . . . 0.0 110.207 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.7 mtm -64.11 -40.27 95.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.193 0.451 . . . . 0.0 110.875 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.23 96.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.056 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -47.9 73.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.015 0.926 . . . . 0.0 110.713 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -60.3 -43.78 95.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -63.9 -54.22 38.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.502 1.121 . . . . 0.0 108.974 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -51.52 -56.18 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.039 0.836 . . . . 0.0 109.769 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -39.52 82.6 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.732 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.17 -46.92 69.4 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.424 0.453 . . . . 0.0 111.226 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.45 -48.24 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.25 1.42 . . . . 0.0 108.488 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 164' ' ' ILE . 81.0 mt -72.59 -50.16 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.529 0.731 . . . . 0.0 110.513 -175.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.77 114.11 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.392 0.996 . . . . 0.0 110.855 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 4.09 3.36 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.399 2.732 . . . . 0.0 113.056 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.84 -36.12 64.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.553 1.541 . . . . 0.0 109.262 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.74 -26.1 6.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.434 1.893 . . . . 0.0 110.766 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.33 140.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.114 1.779 . . . . 0.0 109.683 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -130.59 129.56 42.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.676 1.19 . . . . 0.0 109.718 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.47 149.87 45.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.072 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -144.88 112.79 6.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.083 1.753 . . . . 0.0 107.393 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -87.21 108.47 18.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.2 mt -66.38 -7.53 19.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -61.92 -27.54 68.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.9 1.227 . . . . 0.0 111.47 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.36 -33.3 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.677 1.191 . . . . 0.0 112.278 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -83.13 140.51 32.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -82.95 142.21 44.55 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -74.07 -8.79 21.5 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.787 1.658 . . . . 0.0 111.037 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -56.3 -36.68 68.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.879 1.672 . . . . 0.0 111.599 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.34 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -11.52 13.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 112.169 170.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.66 -30.83 63.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.589 -1.32 . . . . 0.0 111.24 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -75.19 -47.92 26.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.88 0.764 . . . . 0.0 110.904 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -63.37 146.55 53.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.77 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -71.43 -24.99 62.13 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.852 0.861 . . . . 0.0 110.402 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.5 t -150.47 151.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.687 1.995 . . . . 0.0 106.166 -168.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.19 155.28 50.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.195 0.907 . . . . 0.0 110.219 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.28 122.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 168.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.48 139.76 51.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.62 0.768 . . . . 0.0 109.046 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.07 121.69 2.8 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.802 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.689 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.39 136.67 27.38 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 118.49 1.145 . . . . 0.0 110.972 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.13 153.87 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.244 1.963 . . . . 0.0 108.921 166.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.466 HG21 ' H ' ' A' ' 99' ' ' ASP . 90.1 m -108.94 94.77 5.23 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -83.13 168.67 16.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.324 1.05 . . . . 0.0 111.509 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t0 18.36 69.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 129.395 3.078 . . . . 0.0 115.251 166.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 56.48 67.6 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.581 1.153 . . . . 0.0 111.861 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.6 23.04 77.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -83.21 154.7 24.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.598 1.159 . . . . 0.0 110.12 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.5 mt -96.18 149.14 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -66.78 143.85 56.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.52 -26.77 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.532 0.733 . . . . 0.0 112.119 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -30.45 71.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.418 0.687 . . . . 0.0 110.898 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.476 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.6 m95 -82.05 -42.14 19.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.48 1.112 . . . . 0.0 110.404 173.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.3 -34.91 64.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.388 0.54 . . . . 0.0 110.956 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.49 72.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.05 -13.27 8.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.697 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.1 t-105 -53.81 -28.68 36.86 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.624 1.57 . . . . 0.0 111.933 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.57 -45.28 59.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.887 1.275 . . . . 0.0 111.055 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.55 -29.86 68.51 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.336 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -56.18 -31.93 63.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.187 1.358 . . . . 0.0 111.111 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.33 -32.58 74.07 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.604 0.762 . . . . 0.0 111.811 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.93 -27.29 43.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.32 0.648 . . . . 0.0 110.518 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.47 157.24 37.99 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.659 1.219 . . . . 0.0 111.376 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -89.9 97.1 10.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.009 -1.905 . . . . 0.0 108.265 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -117.74 3.02 12.31 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 122.194 0.997 . . . . 0.0 113.197 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -68.6 113.01 5.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.23 49.7 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.768 -1.018 . . . . 0.0 115.053 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.57 156.17 29.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.969 1.385 . . . . 0.0 109.282 169.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.686 HG21 ' HG2' ' A' ' 168' ' ' MET . 7.0 mt -85.49 145.78 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.1 129.36 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.346 1.458 . . . . 0.0 109.658 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -107.99 119.53 39.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 166.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.24 141.44 28.7 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.338 0.972 . . . . 0.0 111.49 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -134.7 160.72 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.093 0.957 . . . . 0.0 108.456 168.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.79 40.08 Favored Glycine 0 N--CA 1.442 -0.919 0 O-C-N 120.939 -1.1 . . . . 0.0 111.074 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.54 148.65 48.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.168 -1.016 . . . . 0.0 108.401 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.44 -155.31 8.81 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.15 138.5 13.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.204 1.802 . . . . 0.0 106.437 168.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -94.03 -24.54 17.58 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 124.02 0.928 . . . . 0.0 112.164 -175.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.72 -51.87 67.54 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.905 0.775 . . . . 0.0 110.946 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.68 -27.13 7.69 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.694 1.14 . . . . 0.0 113.202 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.3 29.37 5.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -168.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.3 -43.1 42.89 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.17 1.35 . . . . 0.0 110.866 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -64.81 -16.46 63.11 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.381 -1.07 . . . . 0.0 112.348 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -130.02 14.03 5.74 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.09 1.756 . . . . 0.0 111.899 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -47.24 127.3 10.51 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.795 2.038 . . . . 0.0 110.56 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 47.36 28.98 1.17 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.902 1.281 . . . . 0.0 112.606 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.466 ' H ' HG21 ' A' ' 55' ' ' THR . 7.3 t70 -63.83 -37.94 89.26 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.804 -1.185 . . . . 0.0 109.815 -169.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.94 74.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.594 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.689 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -59.88 -46.03 90.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.888 0.875 . . . . 0.0 110.342 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.54 -41.88 99.65 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.0 mtm -64.86 -43.83 91.71 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.113 0.957 . . . . 0.0 111.463 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -64.43 -35.72 81.83 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 119.623 1.101 . . . . 0.0 111.143 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -64.47 -41.6 96.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.145 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.88 -42.71 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.93 -59.33 4.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.695 1.198 . . . . 0.0 108.406 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.83 -19.83 57.07 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.627 -0.671 . . . . 0.0 110.855 -170.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.3 t -62.39 -29.79 70.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.31 0.959 . . . . 0.0 110.386 169.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.94 -23.58 52.43 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.305 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -81.94 4.38 22.79 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.104 1.762 . . . . 0.0 113.172 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.24 33.84 86.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.519 0.6 . . . . 0.0 111.749 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.45 170.45 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 123.522 0.729 . . . . 0.0 109.224 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -115.83 140.07 49.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.82 149.0 30.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.797 1.181 . . . . 0.0 112.213 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 13.9 m -129.51 -179.63 3.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.218 1.007 . . . . 0.0 109.995 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.35 39.35 26.65 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.085 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -82.67 149.86 27.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.426 1.613 . . . . 0.0 109.339 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.47 146.36 49.58 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.376 -1.297 . . . . 0.0 108.696 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.6 135.06 25.41 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.395 1.397 . . . . 0.0 110.248 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.557 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.4 p . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 126.219 1.808 . . . . 0.0 112.993 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -164.52 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 109.482 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.302 3.0 t 58.5 8.48 0.88 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.757 2.823 . . . . 0.0 114.956 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 148.3 47.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.398 1.479 . . . . 0.0 111.468 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.31 -14.57 3.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.836 2.357 . . . . 0.0 114.644 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -80.46 -50.02 1.13 Allowed Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.31 37.35 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 CA-C-N 122.008 1.753 . . . . 0.0 112.674 -168.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 148.3 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.414 1.086 . . . . 0.0 110.207 -167.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -172.23 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 126.217 1.807 . . . . 0.0 109.514 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.52 -117.31 0.92 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.041 1.336 . . . . 0.0 107.549 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.26 8.33 33.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.775 1.23 . . . . 0.0 111.918 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.59 20.08 20.68 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.483 1.04 . . . . 0.0 112.713 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.62 -16.84 17.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.889 1.276 . . . . 0.0 110.594 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.94 145.09 50.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.457 0.703 . . . . 0.0 110.98 174.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.557 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -80.13 154.24 28.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.429 1.492 . . . . 0.0 109.608 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -66.15 -12.39 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.681 1.193 . . . . 0.0 112.621 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.12 -177.37 44.15 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.682 1.128 . . . . 0.0 111.889 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.3 tp -67.05 133.0 49.03 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.11 56.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.8 mt -117.13 154.52 30.9 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 108.597 170.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.52 101.1 4.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -0.64 54.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.835 0.854 . . . . 0.0 112.548 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.03 -26.01 14.37 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.451 0.569 . . . . 0.0 111.134 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -139.84 -27.78 0.76 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -87.94 11.63 15.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.942 0.792 . . . . 0.0 111.449 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -53.66 -25.97 20.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.888 1.222 . . . . 0.0 112.525 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.07 -26.15 56.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 110.954 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 pp -130.61 -6.43 4.13 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 112.957 -169.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.4 m -55.59 -29.65 59.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.084 1.311 . . . . 0.0 109.772 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.28 -41.04 78.99 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.445 1.098 . . . . 0.0 111.743 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -75.88 -31.77 59.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.461 1.104 . . . . 0.0 109.738 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -74.73 -30.84 61.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.32 -59.52 4.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.69 -39.42 80.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.7 m -62.53 -38.95 91.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.943 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -66.74 -44.45 81.51 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.9 m -57.05 -34.82 68.61 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.937 0.895 . . . . 0.0 109.548 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -31.7 72.65 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.618 0.573 . . . . 0.0 110.582 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.38 -45.95 12.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.504 173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 25' ' ' ILE . 5.9 pt -64.18 -38.43 82.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 120.994 1.725 . . . . 0.0 109.833 -170.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.43 -12.26 29.66 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -49.15 5.9 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 125.797 1.639 . . . . 0.0 108.266 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.4 -23.49 67.3 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.252 -170.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.686 ' HG2' HG21 ' A' ' 81' ' ' ILE . 66.9 mtm -94.09 -45.25 7.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.434 1.094 . . . . 0.0 110.979 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.64 49.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.477 0.711 . . . . 0.0 110.823 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -69.4 -28.06 65.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.98 1.312 . . . . 0.0 109.679 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -70.78 -45.71 64.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.814 1.245 . . . . 0.0 110.443 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -22.34 62.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.017 -175.556 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.56 142.78 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -131.67 148.16 52.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.776 2.03 . . . . 0.0 108.488 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.49 118.81 4.93 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.013 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 108.98 19.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.212 1.506 . . . . 0.0 109.838 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -105.57 145.81 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.537 1.535 . . . . 0.0 110.979 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -163.47 175.7 10.5 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.736 0.814 . . . . 0.0 110.231 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.49 141.97 9.2 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 106.502 -2.639 . . . . 0.0 106.502 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -150.03 140.29 22.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.528 1.164 . . . . 0.0 110.891 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -36.37 13.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.692 1.197 . . . . 0.0 110.015 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 p -93.99 -6.64 44.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.217 1.407 . . . . 0.0 112.009 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m 68.05 9.98 7.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.588 1.955 . . . . 0.0 113.091 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -63.83 -45.43 89.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.33 1.423 . . . . 0.0 110.386 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -33.28 74.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.665 0.786 . . . . 0.0 108.918 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.54 -49.55 70.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 109.397 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.45 -38.89 92.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.895 0.316 . . . . 0.0 110.809 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.01 98.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.866 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.09 76.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.956 0.902 . . . . 0.0 110.491 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -59.1 -45.97 89.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.6 mttm -62.21 -55.79 25.0 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 125.106 1.363 . . . . 0.0 108.831 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.6 mt -52.59 -56.48 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 118.458 0.572 . . . . 0.0 109.967 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -38.5 72.78 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.258 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.47 -46.87 74.92 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.902 0.481 . . . . 0.0 111.339 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -66.24 -47.85 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.567 1.147 . . . . 0.0 108.854 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 164' ' ' ILE . 71.7 mt -72.13 -49.69 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.702 0.801 . . . . 0.0 110.048 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 115.69 0.86 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.64 3.74 4.06 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.256 2.637 . . . . 0.0 112.689 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.76 -34.53 67.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.11 1.364 . . . . 0.0 109.027 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 -22.7 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.552 1.541 . . . . 0.0 111.641 -169.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.3 140.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 120.479 1.491 . . . . 0.0 108.924 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -131.26 128.96 40.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.206 1.003 . . . . 0.0 109.824 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.19 149.1 47.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.636 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.6 111.67 5.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.193 1.797 . . . . 0.0 107.144 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.43 111.26 20.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.96 -8.19 35.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -60.24 -27.99 67.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.248 0.931 . . . . 0.0 111.584 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -132.42 -33.82 1.25 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.495 1.118 . . . . 0.0 112.122 -171.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -83.05 140.45 32.68 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.177 0.991 . . . . 0.0 108.585 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -83.44 142.23 43.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.23 -4.75 15.79 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.774 1.649 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -55.21 -35.42 64.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.723 1.601 . . . . 0.0 111.977 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -19.34 65.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -12.15 19.6 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.324 1.049 . . . . 0.0 112.326 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 95.7 mt-10 -78.09 -23.35 48.0 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.828 -1.17 . . . . 0.0 111.543 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -75.4 -48.96 20.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -68.98 150.28 47.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.21 1.404 . . . . 0.0 108.381 -170.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -81.96 -23.78 35.92 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 110.502 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.27 144.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.71 156.11 48.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.398 0.679 . . . . 0.0 110.205 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.61 123.59 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.7 138.6 54.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -133.3 124.79 3.82 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.442 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -127.49 135.32 27.27 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 118.84 1.32 . . . . 0.0 110.842 178.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.11 145.44 12.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.793 1.662 . . . . 0.0 108.511 166.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.9 m -90.46 123.49 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -108.11 170.73 7.82 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.455 1.902 . . . . 0.0 110.249 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t0 15.37 69.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 129.542 3.137 . . . . 0.0 115.217 168.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 58.59 67.79 0.9 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.427 1.491 . . . . 0.0 110.401 172.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.66 32.61 70.91 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.354 0.5 OUTLIER -99.15 153.83 18.61 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.625 1.17 . . . . 0.0 109.827 168.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.96 148.87 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -62.38 142.67 57.71 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.85 -28.14 69.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.14 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.69 -29.48 70.03 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.646 0.778 . . . . 0.0 110.509 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.9 m95 -81.94 -42.51 19.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.745 0.818 . . . . 0.0 110.785 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.62 -33.99 64.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.408 0.549 . . . . 0.0 110.872 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.91 73.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.464 1.105 . . . . 0.0 111.838 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.09 -11.31 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.547 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.9 t-105 -53.04 -28.8 26.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.846 1.658 . . . . 0.0 111.817 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.71 -45.87 67.28 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.189 1.396 . . . . 0.0 111.414 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.67 -31.97 73.27 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.005 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.5 mt -56.66 -32.47 65.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.709 1.14 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.42 -31.77 71.34 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.47 0.708 . . . . 0.0 111.166 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.95 -16.72 35.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.675 0.79 . . . . 0.0 111.448 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.98 156.3 39.32 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 122.227 1.013 . . . . 0.0 113.47 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -89.12 75.19 7.92 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.766 2.427 . . . . 0.0 106.335 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.301 56.1 tp -118.11 7.32 12.15 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 125.514 1.526 . . . . 0.0 113.606 -165.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -74.15 138.04 43.57 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.406 1.882 . . . . 0.0 109.656 -172.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.69 8.49 86.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 125.599 1.571 . . . . 0.0 114.489 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 54.8 mttm -90.69 148.81 22.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.953 1.301 . . . . 0.0 109.37 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -84.2 139.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.96 127.95 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 C-N-CA 125.052 1.341 . . . . 0.0 108.828 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.95 115.33 30.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 167.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 mt -86.73 143.19 27.66 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.127 0.876 . . . . 0.0 111.184 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 24.4 p90 -136.86 158.76 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.77 0.828 . . . . 0.0 109.034 168.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.63 176.96 41.05 Favored Glycine 0 CA--C 1.508 -0.385 0 O-C-N 120.944 -1.098 . . . . 0.0 112.441 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.36 145.16 50.9 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.29 32.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.93 139.12 23.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.151 1.476 . . . . 0.0 108.625 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.62 -20.24 23.94 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.969 1.308 . . . . 0.0 114.403 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.55 -47.43 69.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.045 1.293 . . . . 0.0 111.25 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.67 -21.03 10.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.086 0.851 . . . . 0.0 112.195 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 41.77 2.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.116 0.967 . . . . 0.0 111.307 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.95 -43.54 72.79 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 125.007 1.289 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.8 mm-40 -67.33 -26.12 66.35 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -94.0 -10.5 33.38 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.957 2.503 . . . . 0.0 112.628 -171.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -49.57 130.09 20.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.505 2.722 . . . . 0.0 110.913 -169.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 48.91 27.92 1.79 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.228 1.011 . . . . 0.0 112.599 172.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.46 -36.48 84.32 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.03 -1.044 . . . . 0.0 110.023 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.08 77.14 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.641 0.376 . . . . 0.0 111.515 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -60.95 -48.15 83.15 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 110.009 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.09 97.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.62 -44.65 89.86 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.043 0.922 . . . . 0.0 111.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.58 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -63.9 -34.54 78.19 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.508 1.049 . . . . 0.0 111.158 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -64.06 -41.91 97.19 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.222 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.59 -31.22 66.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.966 2.106 . . . . 0.0 112.249 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -62.73 -61.87 2.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.2 mt -76.32 -19.75 57.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.39 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -61.15 -31.08 70.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.022 1.283 . . . . 0.0 111.427 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -21.16 54.19 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -83.9 6.02 23.2 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.407 1.883 . . . . 0.0 112.46 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.15 32.2 76.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.41 170.13 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.713 0.805 . . . . 0.0 108.908 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -119.96 142.63 48.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.95 148.73 31.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.916 1.235 . . . . 0.0 111.911 -169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 22.1 m -129.06 179.56 3.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.275 1.03 . . . . 0.0 108.992 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 36.37 40.0 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-O 118.398 -1.223 . . . . 0.0 113.894 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -79.83 151.55 30.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 119.556 1.678 . . . . 0.0 108.83 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 152.52 73.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.264 172.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 135.12 33.16 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.292 1.328 . . . . 0.0 109.98 169.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.563 HG22 ' CD1' ' A' ' 139' ' ' PHE . 55.1 p . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 125.935 1.694 . . . . 0.0 112.902 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.457 -0.106 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -168.54 -48.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 0.0 109.466 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.32 3.3 t 59.74 7.53 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.075 2.95 . . . . 0.0 114.639 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 149.03 56.9 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.954 1.302 . . . . 0.0 112.624 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -90.04 -13.67 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.889 2.393 . . . . 0.0 114.025 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.54 -52.29 2.93 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 117.965 -1.017 . . . . 0.0 113.297 -169.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -85.96 40.07 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 121.695 1.641 . . . . 0.0 112.053 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 121' ' ' THR . 0.1 OUTLIER -137.19 145.91 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.607 1.163 . . . . 0.0 109.227 -168.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.418 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.4 -176.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.78 1.232 . . . . 0.0 112.074 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.94 -110.58 0.53 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 127.026 2.131 . . . . 0.0 109.155 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -99.41 -0.71 40.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.552 1.541 . . . . 0.0 111.958 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.0 26.06 9.95 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.146 -0.971 . . . . 0.0 111.798 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -20.48 13.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.142 1.377 . . . . 0.0 108.444 -175.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.98 138.9 51.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.993 1.317 . . . . 0.0 110.863 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 121' ' ' THR . 43.2 m-85 -78.47 151.8 32.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' A' ' 101' ' ' LEU . 14.4 m -63.12 -13.71 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.827 1.251 . . . . 0.0 112.201 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.8 -174.08 42.04 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 119.458 1.026 . . . . 0.0 111.737 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.29 128.63 36.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.07 123.36 47.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 142' ' ' LEU . 74.9 mt -122.18 156.59 33.39 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.039 1.335 . . . . 0.0 108.363 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.08 123.98 16.24 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -100.78 14.32 32.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.429 1.092 . . . . 0.0 110.824 -169.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.42 -24.3 5.44 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.49 -48.72 3.06 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.605 1.093 . . . . 0.0 108.39 172.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -104.4 21.88 15.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.434 1.494 . . . . 0.0 112.659 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -53.47 -24.69 13.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.58 -26.01 41.4 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.83 -12.95 8.35 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.043 0.937 . . . . 0.0 112.244 -170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -58.85 -27.48 65.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.84 1.2 . . . . 0.0 110.781 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.87 -47.07 81.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.326 1.05 . . . . 0.0 110.967 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.99 -32.38 72.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.753 0.787 . . . . 0.0 109.485 -171.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -75.18 -27.52 59.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.875 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.34 -55.2 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -51.67 -47.98 63.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.922 0.889 . . . . 0.0 109.853 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -68.08 -35.91 78.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.561 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -64.92 -44.37 89.75 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.452 0.644 . . . . 0.0 109.778 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.3 m -58.88 -36.59 74.88 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.664 0.786 . . . . 0.0 109.474 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -69.72 -29.26 66.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.31 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.73 -46.64 16.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.355 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.75 -38.5 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 120.872 1.669 . . . . 0.0 110.21 -170.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.19 -15.34 59.69 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.227 0.611 . . . . 0.0 111.94 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -96.4 -46.16 6.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.15 -41.95 89.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.909 0.777 . . . . 0.0 109.503 -173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.696 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.2 mtm -75.67 -37.24 59.74 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.561 0.744 . . . . 0.0 110.938 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.01 -47.15 60.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.926 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.41 -30.72 71.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 110.021 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -63.17 -47.27 83.35 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.463 0.574 . . . . 0.0 110.391 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -3.01 49.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.592 1.157 . . . . 0.0 113.765 -175.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.249 0.477 . . . . 0.0 110.647 178.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.05 144.67 47.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.156 1.382 . . . . 0.0 108.427 169.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.4 mtm -124.01 150.65 44.63 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.935 2.494 . . . . 0.0 108.741 -167.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.43 120.32 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.11 102.98 15.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.621 1.211 . . . . 0.0 110.101 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -102.7 145.57 29.5 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.044 1.338 . . . . 0.0 111.467 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -164.14 172.61 13.48 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.981 0.912 . . . . 0.0 109.897 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.69 137.4 8.23 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 169.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -135.61 130.69 34.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.149 1.38 . . . . 0.0 109.978 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -91.26 -38.33 12.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.93 0.492 . . . . 0.0 110.016 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 p -93.99 -85.69 0.28 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.18 -3.9 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.491 2.717 . . . . 0.0 111.867 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -68.85 -42.83 76.57 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 119.729 -1.857 . . . . 0.0 112.171 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -35.97 82.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -64.68 -49.35 71.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 109.921 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.5 mtm -64.87 -38.71 91.89 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.093 -0.379 . . . . 0.0 111.465 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.15 98.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.0 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.21 79.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.031 0.932 . . . . 0.0 110.61 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -57.64 -47.1 83.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -61.68 -54.41 43.02 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 124.733 1.271 . . . . 0.0 108.995 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.97 -57.02 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.83 0.741 . . . . 0.0 109.691 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -39.11 70.29 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 123.431 0.693 . . . . 0.0 110.339 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.68 -47.7 68.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.801 0.44 . . . . 0.0 111.486 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 158' ' ' GLN . 12.7 mt -65.79 -45.5 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 108.51 -174.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.77 -52.1 27.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.913 0.885 . . . . 0.0 110.546 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.72 115.45 0.85 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.83 3.15 4.64 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.451 2.767 . . . . 0.0 112.686 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.09 -34.39 68.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.451 1.5 . . . . 0.0 109.556 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -4.34 4.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.157 1.783 . . . . 0.0 111.95 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.77 144.46 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 120.955 1.707 . . . . 0.0 109.3 167.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -134.91 130.67 36.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.856 1.263 . . . . 0.0 110.31 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.78 149.62 45.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -146.9 108.76 4.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.182 1.793 . . . . 0.0 108.345 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -82.64 112.92 19.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.73 -9.82 22.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -58.95 -29.02 66.84 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.261 0.937 . . . . 0.0 111.624 168.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -129.95 -33.8 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.544 1.138 . . . . 0.0 111.728 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -87.57 142.04 28.15 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.314 1.046 . . . . 0.0 109.192 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -83.78 143.15 43.08 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -74.65 -2.19 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.706 1.604 . . . . 0.0 111.412 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -56.82 -33.83 67.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.094 2.225 . . . . 0.0 112.459 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -18.59 65.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 44.2 ttm -59.17 -14.31 10.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.973 2.109 . . . . 0.0 111.654 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 65.4 mt-10 -74.36 -30.4 61.98 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.83 -1.169 . . . . 0.0 110.699 173.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.48 -48.84 16.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.775 0.716 . . . . 0.0 109.721 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -67.74 134.28 50.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.95 -6.57 48.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 81' ' ' ILE . 77.1 t -135.27 140.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 156.47 48.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 118.206 0.457 . . . . 0.0 109.865 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.26 122.56 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 168.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.73 132.66 55.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.12 115.98 2.82 Favored Glycine 0 CA--C 1.511 -0.158 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.484 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -118.48 125.15 28.0 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 118.775 1.288 . . . . 0.0 109.347 176.057 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.27 143.34 7.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.912 2.408 . . . . 0.0 107.925 168.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -88.56 128.36 35.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -117.65 170.11 9.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.875 1.67 . . . . 0.0 109.688 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 28.21 58.68 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.117 2.567 . . . . 0.0 115.325 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 56.58 73.64 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.666 1.187 . . . . 0.0 112.427 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.98 15.54 76.32 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -82.3 152.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.451 1.12 . . . . 0.0 109.095 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -83.97 153.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.752 -1.574 . . . . 0.0 106.752 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -60.5 141.73 56.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.912 0.863 . . . . 0.0 108.835 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.93 -28.09 68.66 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -79.66 -22.77 43.11 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.822 -0.549 . . . . 0.0 110.289 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' ILE . 11.5 m95 -76.63 -43.79 36.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.211 0.604 . . . . 0.0 111.234 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -53.5 -34.9 59.76 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.126 0.57 . . . . 0.0 110.943 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.21 71.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.099 0.96 . . . . 0.0 112.149 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -109.11 -9.32 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.557 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.8 t-105 -53.08 -28.93 27.44 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.457 1.503 . . . . 0.0 111.69 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.51 -45.35 72.49 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.825 1.25 . . . . 0.0 111.623 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.9 -27.74 66.91 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.105 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.26 -32.02 67.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.726 1.148 . . . . 0.0 111.062 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.2 -30.36 69.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.536 0.734 . . . . 0.0 111.148 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.53 -11.35 37.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.18 0.992 . . . . 0.0 111.631 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.97 174.02 9.17 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.142 0.973 . . . . 0.0 110.783 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.436 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 5.1 t30 -114.92 103.77 11.26 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.115 1.766 . . . . 0.0 107.582 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.8 8.47 7.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.778 1.231 . . . . 0.0 113.068 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -67.32 116.52 8.18 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.22 9.99 85.33 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.305 1.431 . . . . 0.0 114.847 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -80.59 152.58 28.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.006 0.903 . . . . 0.0 109.693 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.721 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.2 mt -87.16 141.49 14.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 168.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.11 131.61 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.851 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -111.14 116.37 30.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.08 142.75 27.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.99 0.814 . . . . 0.0 111.792 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -136.83 159.09 42.9 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.28 175.88 37.87 Favored Glycine 0 N--CA 1.447 -0.573 0 O-C-N 120.884 -1.135 . . . . 0.0 111.934 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -125.44 153.66 43.15 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.82 -155.39 8.96 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -155.69 137.64 14.5 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.081 1.352 . . . . 0.0 108.433 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -22.58 24.89 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 113.845 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.9 mt -67.15 -48.01 69.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.823 1.192 . . . . 0.0 110.638 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.66 -26.28 9.27 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.759 1.171 . . . . 0.0 112.328 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.13 33.55 3.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.57 -42.89 58.61 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.659 1.572 . . . . 0.0 111.131 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -61.63 -18.54 59.89 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 117.694 0.747 . . . . 0.0 112.538 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.67 11.83 7.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.081 1.752 . . . . 0.0 112.563 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.12 122.96 4.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.34 1.456 . . . . 0.0 108.682 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 52.33 28.72 5.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.133 0.973 . . . . 0.0 112.959 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.62 -39.66 94.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.519 -1.363 . . . . 0.0 110.72 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.32 73.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.113 0.565 . . . . 0.0 111.485 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.1 tp -59.91 -47.0 87.54 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.067 0.947 . . . . 0.0 110.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.85 97.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.9 mtm -66.47 -43.89 84.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.946 0.873 . . . . 0.0 111.717 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.557 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.6 mt -64.93 -34.58 78.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.455 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.7 -41.97 98.03 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.927 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.16 -42.28 89.22 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.536 1.134 . . . . 0.0 111.578 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.67 -58.44 7.5 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.798 1.239 . . . . 0.0 108.292 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.4 mt -78.17 -19.62 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.453 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 t -61.58 -28.8 69.6 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 110.298 168.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -22.94 52.58 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.628 -1.295 . . . . 0.0 109.608 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -83.64 4.66 27.54 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.236 1.814 . . . . 0.0 112.371 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.0 33.42 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.624 0.647 . . . . 0.0 112.032 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.87 170.91 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -115.5 143.18 45.69 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.43 147.01 33.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.936 0.789 . . . . 0.0 111.358 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.2 m -128.0 178.02 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.255 1.022 . . . . 0.0 109.081 170.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.49 37.26 31.57 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-O 118.615 -1.103 . . . . 0.0 114.126 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -79.32 144.2 34.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.647 1.724 . . . . 0.0 108.628 171.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -121.81 147.32 48.13 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 117.326 -1.321 . . . . 0.0 108.922 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.39 138.59 39.37 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 120.804 1.323 . . . . 0.0 109.596 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.0 p . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.806 1.643 . . . . 0.0 113.383 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 127' ' ' THR . 13.3 p90 -163.94 -58.88 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 O-C-N 121.767 -0.583 . . . . 0.0 109.709 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 126' ' ' PHE 0.327 2.7 t 58.83 10.15 1.41 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.505 2.722 . . . . 0.0 114.648 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -67.11 139.84 95.46 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.733 -1.229 . . . . 0.0 108.885 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.45 -13.28 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.504 2.136 . . . . 0.0 113.735 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -80.35 -48.84 1.23 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.7 37.65 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.017 1.756 . . . . 0.0 112.737 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 146.52 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 124.243 1.017 . . . . 0.0 109.74 -166.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.41 -172.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 126.024 1.73 . . . . 0.0 109.636 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.73 -116.53 0.86 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.173 1.389 . . . . 0.0 107.528 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.36 8.33 33.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.822 1.249 . . . . 0.0 112.068 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.53 20.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.73 1.157 . . . . 0.0 112.823 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -100.55 -17.33 17.14 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.744 1.218 . . . . 0.0 110.775 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.49 145.26 51.03 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.308 0.643 . . . . 0.0 111.088 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.1 m-85 -80.84 155.07 26.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.205 1.402 . . . . 0.0 110.005 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.1 m -66.86 -12.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.802 1.241 . . . . 0.0 112.869 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.11 -179.03 43.53 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 119.659 1.118 . . . . 0.0 112.454 -170.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.428 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 25.1 tp -66.06 128.52 36.39 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.68 119.86 40.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -120.4 159.36 25.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.652 1.181 . . . . 0.0 108.728 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.69 122.6 12.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 173.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.36 18.42 16.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.673 -169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 -20.49 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.878 0.871 . . . . 0.0 112.873 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.97 -53.51 2.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.198 1.363 . . . . 0.0 108.652 170.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.53 16.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -168.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.72 -26.28 9.07 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.933 0.893 . . . . 0.0 112.504 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.91 -26.81 54.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.175 0.99 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.13 -7.66 9.83 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.414 1.086 . . . . 0.0 112.257 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 m -50.47 -33.82 22.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.761 1.164 . . . . 0.0 110.31 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.49 -41.39 85.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.303 1.041 . . . . 0.0 111.742 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -33.43 65.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.866 1.266 . . . . 0.0 109.796 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -22.9 41.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.769 0.828 . . . . 0.0 110.363 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.16 -60.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.424 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.7 pt20 -55.78 -41.81 74.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.366 0.53 . . . . 0.0 112.331 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 60.0 p -66.56 -35.69 80.82 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.053 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 45.5 t90 -65.46 -43.26 90.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 109.528 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.1 m -58.74 -36.66 74.68 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 123.717 0.807 . . . . 0.0 109.575 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.29 -32.8 73.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.359 0.412 . . . . 0.0 111.175 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -77.14 -45.84 25.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.476 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -65.28 -38.28 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 120.878 1.672 . . . . 0.0 110.415 -173.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.26 -12.32 50.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.54 0.609 . . . . 0.0 112.267 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -95.02 -47.86 6.22 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.45 -35.69 78.32 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.846 0.748 . . . . 0.0 110.69 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.721 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.9 mtm -81.48 -39.83 24.18 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.249 1.019 . . . . 0.0 110.518 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.83 63.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.933 0.893 . . . . 0.0 110.916 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.64 -32.08 69.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.872 1.269 . . . . 0.0 109.436 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.46 ' CD2' HD11 ' A' ' 81' ' ' ILE . 61.6 t60 -62.78 -49.86 73.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -3.26 29.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.521 1.129 . . . . 0.0 113.555 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.511 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.92 146.15 51.54 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 126.504 1.922 . . . . 0.0 108.196 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -136.57 146.99 46.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.548 1.539 . . . . 0.0 109.271 -166.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.0 119.45 4.88 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.22 111.46 21.68 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.627 1.213 . . . . 0.0 108.315 169.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -107.3 144.68 33.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 111.167 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -161.79 175.91 11.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.548 0.739 . . . . 0.0 110.716 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.9 11.91 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -140.99 143.78 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.131 1.372 . . . . 0.0 110.58 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -93.29 -39.19 11.11 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.675 1.19 . . . . 0.0 109.857 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -96.56 -85.86 0.33 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 p -173.91 -4.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.97 2.508 . . . . 0.0 112.336 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -66.39 -43.38 86.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.956 -1.715 . . . . 0.0 111.402 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -34.74 76.77 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.61 -49.33 77.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.166 0.986 . . . . 0.0 109.985 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.2 mtm -66.33 -41.21 89.93 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.917 -0.489 . . . . 0.0 110.837 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.33 93.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.687 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.8 77.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.01 0.924 . . . . 0.0 110.553 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -59.13 -44.32 92.02 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.71 -55.04 30.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 124.762 1.288 . . . . 0.0 108.7 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.05 -56.08 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.07 0.85 . . . . 0.0 109.79 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -39.14 82.66 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.814 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.48 -47.76 69.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.042 0.537 . . . . 0.0 111.227 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.31 -47.53 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.014 1.326 . . . . 0.0 108.424 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -73.22 -48.99 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.669 0.788 . . . . 0.0 110.324 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.49 114.97 0.88 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.25 3.66 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.432 2.755 . . . . 0.0 112.875 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -73.8 -35.62 64.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.334 1.454 . . . . 0.0 109.18 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.96 -27.19 5.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.282 1.833 . . . . 0.0 110.872 -172.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 141.68 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 120.705 1.593 . . . . 0.0 109.569 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 m -133.38 129.83 37.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.572 1.149 . . . . 0.0 109.648 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.38 150.44 45.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.559 0.744 . . . . 0.0 111.921 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -145.64 112.23 5.88 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.423 1.889 . . . . 0.0 107.087 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -87.12 110.86 20.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.17 -8.76 26.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -58.35 -29.24 65.81 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.162 0.892 . . . . 0.0 111.538 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.93 -33.84 1.15 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -82.86 141.43 32.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.121 0.969 . . . . 0.0 108.756 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 m -84.74 141.69 38.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.79 -6.59 18.86 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.651 1.567 . . . . 0.0 111.734 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -55.42 -37.19 67.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.894 1.679 . . . . 0.0 111.706 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -19.3 65.8 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -11.8 16.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 112.534 170.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.61 -31.08 66.52 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 111.376 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.3 -46.29 42.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.722 0.772 . . . . 0.0 110.431 -169.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.99 149.36 50.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.912 1.285 . . . . 0.0 108.719 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -73.61 -25.05 60.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.872 0.869 . . . . 0.0 110.337 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 49' ' ' LEU . 41.0 t -151.93 147.55 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.684 1.993 . . . . 0.0 105.929 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.36 158.69 35.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.288 0.949 . . . . 0.0 111.034 168.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.58 121.53 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.38 136.13 54.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.45 120.16 3.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.3 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.5 131.47 24.44 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 119.091 1.445 . . . . 0.0 111.129 176.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.98 149.25 15.64 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.134 1.89 . . . . 0.0 108.331 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -96.09 128.38 42.94 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -121.11 171.28 8.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 109.84 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 30.65 54.89 0.19 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.983 2.513 . . . . 0.0 115.616 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 56.74 75.78 0.34 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 112.267 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 31.19 68.94 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.458 0.543 . . . . 0.0 114.458 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.19 156.13 17.38 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.727 1.611 . . . . 0.0 109.571 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.93 151.19 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -65.78 142.99 57.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.03 -27.16 68.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.226 -169.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -66.89 -26.15 66.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.883 0.873 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.506 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.4 m95 -84.45 -42.85 15.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.165 0.986 . . . . 0.0 110.782 171.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.42 -34.69 64.65 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.45 0.568 . . . . 0.0 110.978 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.57 71.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.576 1.15 . . . . 0.0 112.237 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.05 -10.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.541 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.1 t-105 -53.75 -28.85 36.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.476 1.51 . . . . 0.0 111.668 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.42 -44.51 67.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.81 1.244 . . . . 0.0 111.338 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.53 -27.94 66.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.438 1.095 . . . . 0.0 112.355 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.7 mt -57.24 -30.06 64.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.755 1.161 . . . . 0.0 111.409 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.95 -32.04 71.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.59 0.756 . . . . 0.0 111.366 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.96 -27.94 39.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 110.805 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.24 160.21 32.6 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.571 1.177 . . . . 0.0 111.431 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.3 96.27 10.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.163 -1.835 . . . . 0.0 108.572 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.0 4.73 13.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.131 0.967 . . . . 0.0 113.132 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -69.37 113.97 7.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.6 55.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.623 -1.098 . . . . 0.0 115.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.89 160.78 25.4 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.25 1.525 . . . . 0.0 109.697 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.529 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.5 mt -94.03 150.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 118.365 0.53 . . . . 0.0 109.993 -169.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.8 t -135.45 127.9 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.59 116.94 32.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.65 141.51 28.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.231 0.923 . . . . 0.0 111.327 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -137.39 162.21 34.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 177.76 38.62 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 121.037 -1.039 . . . . 0.0 111.931 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 mt -122.84 150.04 43.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.89 -157.9 11.49 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -157.33 137.31 12.51 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.031 1.332 . . . . 0.0 107.879 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -21.43 26.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.54 -45.47 65.44 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.622 1.101 . . . . 0.0 110.776 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.94 -29.13 9.33 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.302 0.953 . . . . 0.0 112.423 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.09 33.83 3.87 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.07 -42.61 61.66 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 120.155 1.343 . . . . 0.0 111.29 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.46 -17.42 62.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.825 0.812 . . . . 0.0 112.728 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -127.06 10.45 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.915 1.686 . . . . 0.0 112.342 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -41.96 124.36 2.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.476 1.91 . . . . 0.0 110.393 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 49.47 29.01 2.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.322 1.049 . . . . 0.0 112.72 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.751 -1.218 . . . . 0.0 110.255 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.35 73.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.407 0.283 . . . . 0.0 111.094 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.662 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.0 tp -61.69 -46.57 89.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.186 0.994 . . . . 0.0 110.633 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.25 -41.92 98.51 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.2 mtm -65.6 -44.72 85.7 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.616 0.708 . . . . 0.0 111.783 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -64.74 -35.09 79.94 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.161 175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.77 -42.01 97.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.946 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.77 -43.45 88.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.615 1.166 . . . . 0.0 111.69 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -54.19 -58.97 5.37 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.516 1.126 . . . . 0.0 108.486 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.25 -19.05 57.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.741 -170.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 t -62.22 -29.37 70.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.365 0.984 . . . . 0.0 110.51 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -22.16 56.44 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.604 -1.31 . . . . 0.0 109.735 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -84.67 5.5 27.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.089 1.755 . . . . 0.0 112.935 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.05 35.15 90.2 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.25 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 124.326 1.051 . . . . 0.0 109.375 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.54 140.31 52.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -112.49 147.14 37.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 111.206 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -129.22 -178.96 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 109.335 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.6 34.01 41.0 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.006 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.97 146.17 39.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 119.694 1.747 . . . . 0.0 108.354 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 144.82 40.57 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-O 117.319 -1.324 . . . . 0.0 108.467 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.26 138.78 40.27 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 120.691 1.282 . . . . 0.0 109.22 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.479 HG22 ' CD1' ' A' ' 139' ' ' PHE . 68.0 p . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 125.985 1.714 . . . . 0.0 113.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.22 -46.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.438 1.017 . . . . 0.0 110.453 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.3 3.4 t 59.77 8.6 1.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.764 2.826 . . . . 0.0 115.179 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -90.15 147.86 37.99 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.975 1.31 . . . . 0.0 111.458 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.63 -9.33 5.77 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.955 2.436 . . . . 0.0 114.162 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -72.93 -55.01 4.25 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.26 40.52 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 121.553 1.59 . . . . 0.0 112.413 -168.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.68 149.24 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.588 1.085 . . . . 0.0 110.748 -166.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.27 -172.39 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 126.209 1.803 . . . . 0.0 109.86 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.95 -116.54 0.85 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.099 1.359 . . . . 0.0 107.81 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.28 8.24 33.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.974 1.309 . . . . 0.0 111.89 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.92 20.56 20.95 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.724 1.154 . . . . 0.0 112.618 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -99.43 -18.06 17.65 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.752 1.221 . . . . 0.0 110.782 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 143.35 50.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.231 0.612 . . . . 0.0 110.927 174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.0 m-85 -77.68 155.28 31.43 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.232 1.413 . . . . 0.0 109.64 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.8 m -65.18 -14.94 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 112.422 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.91 -178.15 42.72 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 119.763 1.165 . . . . 0.0 111.968 -173.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 13.9 tp -64.76 129.68 40.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.66 110.14 18.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.31 151.32 24.99 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.374 0.669 . . . . 0.0 109.716 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.87 138.02 25.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -107.87 30.84 5.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.132 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 t -133.09 -39.04 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.04 -53.21 4.84 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.937 1.695 . . . . 0.0 106.76 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.7 16.89 23.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.015 1.326 . . . . 0.0 112.763 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -52.42 -27.92 17.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.214 0.915 . . . . 0.0 112.562 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.86 -19.57 30.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.996 0.518 . . . . 0.0 111.896 -173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.21 -2.96 7.54 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.968 1.307 . . . . 0.0 112.542 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 p -55.62 -32.39 63.09 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.869 1.213 . . . . 0.0 110.297 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.31 -42.03 90.43 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.401 1.08 . . . . 0.0 111.502 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -33.54 57.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.626 1.17 . . . . 0.0 109.941 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -70.01 -32.88 71.27 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.306 1.042 . . . . 0.0 108.413 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 52.8 mt -67.27 -59.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -58.37 -38.47 77.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.6 m -64.08 -37.8 88.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.667 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 36.2 t90 -66.5 -44.95 81.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.87 0.843 . . . . 0.0 110.168 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.1 m -56.93 -35.37 68.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.946 0.898 . . . . 0.0 109.72 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -70.76 -30.53 67.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.546 0.529 . . . . 0.0 109.852 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.77 -47.22 15.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.518 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.08 -39.71 86.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 CA-C-N 121.132 1.787 . . . . 0.0 110.36 -169.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.62 -14.11 56.54 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.369 0.667 . . . . 0.0 112.136 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.64 -45.98 6.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.37 -42.97 88.17 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.758 0.708 . . . . 0.0 109.525 -173.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.529 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -76.9 -36.31 56.75 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -174.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.45 63.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.133 0.973 . . . . 0.0 109.959 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.52 -32.02 73.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.23 1.412 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.55 -47.78 80.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.161 0.584 . . . . 0.0 110.382 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -6.13 48.03 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.208 1.003 . . . . 0.0 113.707 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 118.785 0.72 . . . . 0.0 110.645 -178.572 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.85 140.29 29.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.99 148.25 47.13 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.632 2.373 . . . . 0.0 108.815 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.55 118.66 4.7 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.01 112.49 23.43 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.945 1.373 . . . . 0.0 108.928 170.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.0 144.86 34.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.159 1.384 . . . . 0.0 111.219 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.51 175.6 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.949 0.899 . . . . 0.0 110.74 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.22 140.51 7.91 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.592 -2.603 . . . . 0.0 106.592 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 141.24 43.3 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.727 1.264 . . . . 0.0 109.444 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -83.25 -40.34 19.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.442 1.097 . . . . 0.0 109.723 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.6 p -96.7 -82.26 0.4 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.622 1.569 . . . . 0.0 107.271 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 p -177.71 -6.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 128.781 2.832 . . . . 0.0 111.619 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.22 -41.26 86.05 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 119.769 -1.832 . . . . 0.0 111.806 -168.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -35.05 74.95 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -63.32 -46.46 86.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.991 0.917 . . . . 0.0 110.326 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.9 -38.85 87.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.011 -0.431 . . . . 0.0 111.044 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.69 93.89 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.683 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.65 -47.22 77.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.041 0.936 . . . . 0.0 110.621 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.64 -44.52 93.49 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.81 -55.43 26.48 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 124.546 1.154 . . . . 0.0 109.112 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.11 -56.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 118.974 0.806 . . . . 0.0 109.719 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.17 77.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.636 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.28 -46.58 73.19 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.013 0.525 . . . . 0.0 111.347 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 158' ' ' GLN . 14.4 mt -67.39 -45.76 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.826 1.25 . . . . 0.0 108.417 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 164' ' ' ILE . 77.4 mt -71.95 -50.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.765 0.826 . . . . 0.0 110.241 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.51 114.27 0.79 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.489 1.042 . . . . 0.0 110.607 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.56 3.79 3.98 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.532 2.821 . . . . 0.0 112.681 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.8 -34.61 69.52 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.178 1.391 . . . . 0.0 109.194 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 -20.27 4.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.553 1.541 . . . . 0.0 111.602 -169.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.98 143.12 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.958 1.708 . . . . 0.0 109.083 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.6 m -133.68 129.24 36.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.562 1.145 . . . . 0.0 109.76 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.06 149.1 46.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.85 0.86 . . . . 0.0 111.687 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -144.09 112.32 6.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.445 1.898 . . . . 0.0 106.929 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -87.71 110.71 20.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.19 -8.39 31.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -59.77 -28.88 67.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.225 0.92 . . . . 0.0 111.476 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.36 -33.44 1.28 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.418 1.087 . . . . 0.0 112.285 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -83.34 140.6 32.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.218 1.007 . . . . 0.0 108.672 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m -84.88 141.63 38.27 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.05 -5.33 16.89 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.674 1.583 . . . . 0.0 111.764 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -54.06 -38.21 65.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.489 1.495 . . . . 0.0 111.338 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -20.55 66.27 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.116 -0.99 . . . . 0.0 113.16 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -12.23 27.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.331 1.053 . . . . 0.0 112.514 169.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -74.01 -26.26 60.34 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.941 -1.099 . . . . 0.0 110.581 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.31 -50.28 13.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.942 0.792 . . . . 0.0 110.106 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.89 146.16 55.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.575 1.15 . . . . 0.0 108.666 -169.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.72 -25.84 54.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.486 0.66 . . . . 0.0 110.648 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -145.54 140.36 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.09 155.77 41.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.648 0.658 . . . . 0.0 110.769 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.28 121.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 168.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 138.25 54.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.03 122.93 3.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-O 118.076 -1.402 . . . . 0.0 112.687 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.75 130.14 24.56 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.66 1.184 . . . . 0.0 110.307 177.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.04 146.69 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.352 2.035 . . . . 0.0 108.368 167.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -93.53 129.35 39.78 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -122.74 172.23 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.228 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 26.25 57.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 128.796 2.838 . . . . 0.0 115.702 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 57.84 76.11 0.34 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.412 1.485 . . . . 0.0 111.722 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.29 73.57 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.75 158.33 21.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.809 1.244 . . . . 0.0 109.68 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.56 151.6 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.02 143.59 57.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.47 -26.74 68.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.141 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -66.67 -26.7 67.17 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.525 0.73 . . . . 0.0 110.74 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -84.64 -42.36 15.43 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.16 0.984 . . . . 0.0 110.702 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.34 -34.34 64.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.206 0.457 . . . . 0.0 111.039 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.257 1.023 . . . . 0.0 112.16 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.04 -10.86 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.548 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.1 t-105 -53.62 -29.02 36.01 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.639 1.576 . . . . 0.0 111.849 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.57 -43.32 69.7 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.989 1.316 . . . . 0.0 111.302 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.62 -29.34 66.82 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.549 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.74 -33.31 68.32 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.17 1.35 . . . . 0.0 110.747 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.84 -29.15 68.99 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.927 0.891 . . . . 0.0 111.795 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -80.96 -24.52 38.03 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.976 0.511 . . . . 0.0 111.256 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -74.21 162.61 28.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.919 1.342 . . . . 0.0 112.23 -168.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -98.41 99.02 10.16 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.568 1.947 . . . . 0.0 108.842 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.8 10.48 15.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.9 121.22 12.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -169.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.75 -0.88 89.38 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.572 1.558 . . . . 0.0 115.17 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -73.75 154.21 39.69 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 118.239 1.019 . . . . 0.0 109.681 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.702 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.2 mt -91.28 140.67 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.46 130.15 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 124.706 1.202 . . . . 0.0 109.012 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -109.57 115.5 30.03 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 mt -86.95 143.02 27.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.869 0.759 . . . . 0.0 111.455 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -137.7 161.27 36.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.24 176.5 39.44 Favored Glycine 0 CA--C 1.506 -0.488 0 O-C-N 120.844 -1.16 . . . . 0.0 112.558 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.6 mt -121.0 153.33 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.91 -153.9 9.22 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -154.02 142.48 20.69 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.973 1.709 . . . . 0.0 108.099 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.58 -23.38 20.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.14 -36.97 80.53 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.805 1.184 . . . . 0.0 112.027 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.7 -27.51 58.79 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -69.07 0.25 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.674 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.31 -39.54 3.09 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.576 1.56 . . . . 0.0 110.385 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.9 mm-40 -76.71 -35.35 57.91 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.59 -13.43 56.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.879 1.672 . . . . 0.0 111.528 -173.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -50.92 123.87 10.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 126.614 1.966 . . . . 0.0 109.322 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.0 26.71 4.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.259 1.023 . . . . 0.0 112.597 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.88 -37.33 86.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.688 -1.257 . . . . 0.0 110.622 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -32.74 73.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.825 0.45 . . . . 0.0 111.761 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.675 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -60.93 -47.72 85.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.86 -40.83 97.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.7 mtm -65.61 -43.83 88.41 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.829 0.814 . . . . 0.0 112.376 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 53' ' ' ILE . 3.7 mt -63.84 -33.82 76.55 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.567 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.55 -38.27 86.74 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.265 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.46 -30.54 64.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.091 2.156 . . . . 0.0 112.019 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -63.46 -62.01 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.07 -19.1 58.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.028 -0.986 . . . . 0.0 112.577 -166.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.1 p -60.23 -31.35 70.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.75 1.159 . . . . 0.0 111.125 169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -23.11 47.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -77.96 2.16 18.43 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.671 1.188 . . . . 0.0 112.414 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.79 32.88 66.54 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.999 0.818 . . . . 0.0 112.113 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.49 176.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.843 0.857 . . . . 0.0 109.743 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 146.92 47.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 166.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.6 149.01 31.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.991 0.814 . . . . 0.0 111.8 -169.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.5 m -127.39 -179.76 3.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.326 1.05 . . . . 0.0 108.977 169.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.83 33.5 46.18 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.986 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.6 m-30 -78.09 144.04 36.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.765 1.783 . . . . 0.0 108.47 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -119.32 145.43 38.56 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-O 117.344 -1.312 . . . . 0.0 108.662 171.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.16 138.33 43.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.708 1.289 . . . . 0.0 109.215 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.462 HG22 ' CD1' ' A' ' 139' ' ' PHE . 69.0 p . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 125.661 1.585 . . . . 0.0 113.582 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -164.68 -54.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.867 0.758 . . . . 0.0 109.696 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 3.8 t 57.96 8.18 0.7 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.19 2.596 . . . . 0.0 114.624 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -63.97 140.49 97.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 121.113 -0.992 . . . . 0.0 109.531 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.84 -11.5 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.834 2.356 . . . . 0.0 112.863 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -75.64 -52.35 2.84 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.922 1.237 . . . . 0.0 114.112 -168.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.04 42.02 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.944 1.73 . . . . 0.0 111.609 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.58 150.5 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.815 -1.178 . . . . 0.0 110.147 -167.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.84 -172.38 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 126.11 1.764 . . . . 0.0 109.913 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.4 -116.58 0.81 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.566 1.547 . . . . 0.0 107.487 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.1 8.93 34.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.844 1.257 . . . . 0.0 111.764 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.72 21.13 22.34 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.808 1.194 . . . . 0.0 112.486 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.24 -18.4 17.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.865 1.266 . . . . 0.0 110.586 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.71 142.49 49.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 111.311 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 121' ' ' THR . 60.3 m-85 -77.38 155.5 31.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.182 1.393 . . . . 0.0 109.923 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.97 -12.87 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.601 1.16 . . . . 0.0 112.428 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.22 -178.85 43.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 119.907 1.23 . . . . 0.0 112.322 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 18.9 tp -65.46 130.26 42.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.09 117.71 33.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.9 mt -113.9 152.08 31.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.92 0.888 . . . . 0.0 108.723 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.59 128.22 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -102.47 17.89 22.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.59 1.156 . . . . 0.0 110.408 -171.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.62 -21.55 5.65 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 -49.02 2.96 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.03 1.332 . . . . 0.0 108.25 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.55 19.31 20.59 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.107 1.363 . . . . 0.0 113.664 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -52.96 -22.99 6.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.58 -25.35 30.99 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.857 0.863 . . . . 0.0 111.864 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -120.56 -10.13 9.29 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -55.36 -32.41 62.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.096 1.316 . . . . 0.0 110.854 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.59 -40.42 83.13 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.603 1.161 . . . . 0.0 111.731 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -31.75 62.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.291 1.037 . . . . 0.0 109.786 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -78.88 -28.97 44.16 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.7 mt -63.12 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -58.0 -41.58 83.37 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.2 m -63.23 -37.05 85.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.772 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 42.4 t90 -67.12 -44.37 80.07 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.716 0.77 . . . . 0.0 110.22 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.3 m -57.11 -36.13 70.26 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.087 0.955 . . . . 0.0 109.506 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.78 -29.02 66.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.338 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.03 -46.55 16.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.318 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 25' ' ' ILE . 4.7 pt -64.43 -38.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.961 1.709 . . . . 0.0 110.271 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.2 -15.59 60.24 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.228 0.611 . . . . 0.0 112.036 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -95.92 -46.39 6.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.66 -40.43 83.47 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.711 0.687 . . . . 0.0 109.755 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.702 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -79.19 -37.99 36.92 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.737 0.815 . . . . 0.0 110.983 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.01 -46.77 70.32 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.008 0.923 . . . . 0.0 109.901 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.62 -29.88 69.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.106 1.362 . . . . 0.0 109.777 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -63.6 -48.47 77.21 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.553 0.615 . . . . 0.0 110.506 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.52 50.1 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.414 1.086 . . . . 0.0 113.741 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.485 178.822 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 119.704 -0.188 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.56 140.62 30.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -129.27 146.78 51.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.648 1.979 . . . . 0.0 108.947 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.27 117.63 4.77 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.597 -1.113 . . . . 0.0 110.445 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.82 113.32 23.37 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 119.254 1.527 . . . . 0.0 108.354 169.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -108.87 145.04 35.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.913 1.285 . . . . 0.0 111.442 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -159.96 173.35 16.02 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.652 0.781 . . . . 0.0 109.927 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.49 139.95 8.66 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -141.48 131.85 25.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.395 1.478 . . . . 0.0 108.837 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.7 m -84.29 -28.93 26.79 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.741 0.246 . . . . 0.0 110.739 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.1 p -112.47 -79.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.448 1.099 . . . . 0.0 108.165 -172.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.8 p -173.04 -13.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.18 -42.64 79.65 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 119.711 -1.868 . . . . 0.0 113.333 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -34.38 77.77 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.48 -49.25 76.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.454 1.102 . . . . 0.0 109.866 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.3 mtm -66.34 -41.83 89.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.346 0.521 . . . . 0.0 111.182 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.19 94.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.005 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.48 77.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 123.863 0.865 . . . . 0.0 110.436 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.88 -44.26 91.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -63.39 -54.93 29.1 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 124.79 1.306 . . . . 0.0 108.996 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.07 -56.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.956 0.798 . . . . 0.0 109.716 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -39.11 83.02 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.3 -46.92 72.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.939 0.496 . . . . 0.0 111.227 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -66.17 -46.62 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.962 1.305 . . . . 0.0 108.596 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 164' ' ' ILE . 83.3 mt -72.66 -50.23 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.93 114.34 0.78 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.399 1.0 . . . . 0.0 110.67 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.12 4.03 3.57 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.494 2.796 . . . . 0.0 112.814 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.56 -34.05 64.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.505 1.522 . . . . 0.0 109.149 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.26 -22.77 3.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.772 1.629 . . . . 0.0 111.409 -169.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.16 140.73 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.657 1.571 . . . . 0.0 109.091 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.5 m -130.17 129.09 43.0 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.485 1.114 . . . . 0.0 109.679 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.42 148.96 46.39 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.481 0.712 . . . . 0.0 111.942 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -142.88 110.46 5.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.429 1.892 . . . . 0.0 106.621 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -86.74 110.65 20.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.0 -8.07 20.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -60.62 -28.04 68.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.25 0.932 . . . . 0.0 111.729 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -132.33 -33.97 1.25 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.77 1.228 . . . . 0.0 111.886 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -82.73 140.77 32.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.091 0.957 . . . . 0.0 108.565 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 m -83.96 140.82 40.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -74.13 -1.9 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.163 1.451 . . . . 0.0 110.983 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -56.36 -33.97 66.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.246 2.293 . . . . 0.0 111.921 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -19.36 64.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.428 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.0 ttm -58.17 -16.34 13.13 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.266 2.226 . . . . 0.0 111.702 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -73.65 -31.14 63.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.056 -1.027 . . . . 0.0 110.795 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -78.16 -47.07 18.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.341 0.591 . . . . 0.0 110.019 -169.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -65.84 140.33 58.38 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.58 -169.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.5 -17.16 56.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.41 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.55 149.9 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 126.434 1.893 . . . . 0.0 106.069 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.428 HD13 ' CG ' ' A' ' 43' ' ' MET . 8.1 mt -138.34 151.31 47.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.667 0.787 . . . . 0.0 109.218 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.36 121.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.0 135.75 54.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.19 122.79 4.37 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-O 117.773 -1.57 . . . . 0.0 113.12 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.5 126.61 25.78 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 119.286 1.543 . . . . 0.0 110.63 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.44 144.66 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.689 2.259 . . . . 0.0 107.799 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -87.81 131.27 34.59 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.98 169.47 10.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.22 1.808 . . . . 0.0 109.62 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 28.85 54.67 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.275 2.63 . . . . 0.0 115.319 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 55.98 78.73 0.19 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.312 1.445 . . . . 0.0 112.23 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 13.49 76.11 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.07 160.8 19.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.555 1.142 . . . . 0.0 109.125 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 mt -92.18 154.64 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -59.13 140.82 55.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.99 0.916 . . . . 0.0 108.787 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.83 -28.92 69.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -80.33 -20.95 43.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.642 -0.661 . . . . 0.0 110.58 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.497 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.1 m95 -77.0 -44.31 31.44 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.83 169.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -53.33 -35.85 60.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.473 0.709 . . . . 0.0 110.751 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.4 71.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.008 0.923 . . . . 0.0 112.209 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.44 -9.78 11.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.56 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.6 t-105 -53.32 -29.46 33.84 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 111.71 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.32 -44.76 74.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.959 1.304 . . . . 0.0 111.459 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -68.48 -29.67 68.34 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.113 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.5 mt -57.65 -31.06 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.995 1.27 . . . . 0.0 111.122 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.56 -28.95 65.3 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.499 0.72 . . . . 0.0 111.205 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.02 -23.34 38.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.139 0.576 . . . . 0.0 111.173 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 mt -72.94 157.84 36.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 123.038 1.399 . . . . 0.0 112.878 -167.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -90.94 91.53 8.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.738 -2.028 . . . . 0.0 107.978 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -111.38 11.63 21.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.84 128.33 35.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.06 30.86 69.57 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.294 0.95 . . . . 0.0 114.469 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.91 156.68 34.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.59 1.195 . . . . 0.0 109.633 169.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.656 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.4 mt -88.63 146.81 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.37 130.17 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.084 1.354 . . . . 0.0 109.263 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.06 117.93 35.07 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.05 143.13 27.05 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.389 0.995 . . . . 0.0 112.085 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -136.38 156.04 49.19 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.229 1.011 . . . . 0.0 109.13 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.55 164.54 35.16 Favored Glycine 0 CA--C 1.506 -0.475 0 O-C-N 120.801 -1.187 . . . . 0.0 112.154 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.4 158.63 36.79 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.57 -137.75 3.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.5 150.81 21.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.535 1.934 . . . . 0.0 108.046 168.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.08 -31.29 18.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.919 1.688 . . . . 0.0 114.149 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.6 -33.25 62.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.487 1.04 . . . . 0.0 113.082 -167.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.52 -19.33 35.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 124.788 1.185 . . . . 0.0 111.206 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 95' ' ' GLU . 26.8 m-85 -126.85 -90.07 0.54 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.547 1.139 . . . . 0.0 108.721 -170.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.59 -50.8 2.55 Favored Glycine 0 N--CA 1.464 0.555 0 C-N-CA 128.517 2.96 . . . . 0.0 107.755 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' TYR . 12.3 mm-40 -69.65 -30.63 68.38 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.67 1.988 . . . . 0.0 110.536 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -115.14 0.73 13.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.75 1.22 . . . . 0.0 112.021 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.91 127.04 24.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.883 1.273 . . . . 0.0 109.545 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 56.28 23.8 7.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.57 1.548 . . . . 0.0 113.666 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.74 -36.78 78.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.551 -1.343 . . . . 0.0 110.698 -171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.64 72.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.104 0.561 . . . . 0.0 111.467 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.656 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.38 -46.76 88.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.799 0.84 . . . . 0.0 110.756 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.52 96.44 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.8 mtm -66.07 -44.94 83.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 117.712 0.756 . . . . 0.0 112.152 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.56 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.2 mt -64.33 -32.82 74.58 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.606 1.094 . . . . 0.0 111.807 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -63.53 -40.11 96.17 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.109 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.0 -36.13 69.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.758 1.623 . . . . 0.0 112.204 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.4 tptt -57.42 -47.03 82.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.688 0.795 . . . . 0.0 109.894 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -93.76 -20.65 19.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.037 -0.983 . . . . 0.0 112.33 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.2 p -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.748 1.613 . . . . 0.0 111.665 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -79.15 -17.43 55.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.071 0.548 . . . . 0.0 110.059 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -79.54 1.42 25.96 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.114 1.366 . . . . 0.0 111.943 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.01 34.79 58.34 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.941 0.792 . . . . 0.0 111.908 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.43 171.9 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.961 0.904 . . . . 0.0 109.787 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -121.09 142.91 49.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.44 150.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.903 1.229 . . . . 0.0 111.999 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.8 m -129.88 -178.66 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.649 1.179 . . . . 0.0 109.157 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 33.9 43.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-O 118.417 -1.213 . . . . 0.0 113.977 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -71.8 147.32 47.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.437 1.619 . . . . 0.0 107.784 170.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.66 144.98 51.69 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.236 169.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -69.58 140.12 42.57 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-N 121.012 1.397 . . . . 0.0 109.472 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.509 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 125.568 1.547 . . . . 0.0 113.555 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -167.15 -57.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -170.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 2.9 t 56.2 7.52 0.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.844 2.858 . . . . 0.0 114.364 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -69.61 144.17 93.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 120.991 -1.068 . . . . 0.0 110.515 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.84 -14.5 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.722 2.281 . . . . 0.0 113.76 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -80.53 -48.98 1.18 Allowed Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.26 39.33 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.383 2.056 . . . . 0.0 112.579 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 148.43 21.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 109.589 -167.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -172.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.998 1.719 . . . . 0.0 109.666 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.85 -116.37 0.84 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.135 1.374 . . . . 0.0 107.306 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.38 7.8 33.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 112.202 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.28 20.13 18.85 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.996 1.284 . . . . 0.0 112.475 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.02 -17.11 17.66 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.686 1.194 . . . . 0.0 110.668 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 144.04 50.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 110.879 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.509 ' CD1' HG22 ' A' ' 121' ' ' THR . 50.4 m-85 -78.26 154.87 30.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.953 1.301 . . . . 0.0 109.246 174.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.42 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.1 m -65.44 -14.91 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.15 -176.31 40.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.561 1.073 . . . . 0.0 111.901 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 16.3 tp -65.66 129.55 40.17 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.22 129.66 55.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.9 mt -130.47 158.68 39.24 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.724 1.61 . . . . 0.0 109.215 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.0 125.6 23.71 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.025 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -98.91 6.35 46.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.534 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -20.7 11.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.244 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.23 -42.33 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 112.675 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.13 7.2 19.6 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.091 0.86 . . . . 0.0 112.808 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -55.58 -21.55 17.89 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.522 1.056 . . . . 0.0 113.088 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.57 -25.61 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 111.536 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.0 pp -129.26 3.8 5.19 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.08 0.952 . . . . 0.0 112.446 -169.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -50.96 -29.4 12.11 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.81 -1.181 . . . . 0.0 110.842 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.36 -39.29 94.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.747 1.619 . . . . 0.0 110.604 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.28 -46.35 56.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 129.374 3.07 . . . . 0.0 108.194 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -25.39 62.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.841 -1.981 . . . . 0.0 108.273 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.28 -62.33 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -57.17 -37.34 71.96 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.2 m -63.53 -38.39 90.93 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.428 0.455 . . . . 0.0 110.751 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -66.52 -44.56 82.13 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.438 -0.788 . . . . 0.0 110.179 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 72.8 m -55.89 -35.53 66.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.553 0.741 . . . . 0.0 109.809 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -33.58 76.28 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.485 0.491 . . . . 0.0 110.259 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -81.93 -46.14 14.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.498 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 25' ' ' ILE . 5.3 pt -64.55 -39.47 85.69 Favored 'Isoleucine or valine' 0 C--N 1.337 0.061 0 CA-C-N 121.417 1.917 . . . . 0.0 109.977 -169.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.6 -14.25 57.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -96.44 -45.65 6.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.885 1.274 . . . . 0.0 107.888 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.29 -41.08 88.13 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.886 0.767 . . . . 0.0 109.724 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.656 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -77.37 -35.65 54.32 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.169 0.988 . . . . 0.0 110.951 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.48 -47.32 42.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.335 1.054 . . . . 0.0 110.004 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.53 -29.56 68.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.405 1.482 . . . . 0.0 110.129 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -60.66 -45.78 92.82 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.266 0.485 . . . . 0.0 110.302 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.78 -1.63 58.09 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 114.055 -174.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.422 177.934 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 145.26 30.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.876 1.27 . . . . 0.0 108.636 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 48' ' ' VAL . 13.8 mtm -130.45 147.25 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.127 1.771 . . . . 0.0 108.984 -168.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.4 118.63 5.07 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 118.81 -0.995 . . . . 0.0 110.947 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.09 105.9 18.12 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.86 1.33 . . . . 0.0 109.952 171.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -105.0 145.74 30.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.47 1.508 . . . . 0.0 111.301 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -164.93 175.47 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.007 0.923 . . . . 0.0 110.431 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.91 142.33 10.02 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 168.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -146.52 147.69 31.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.25 1.025 . . . . 0.0 111.401 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -95.79 -45.89 6.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.543 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.5 p -90.19 -10.93 42.6 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.006 1.722 . . . . 0.0 111.41 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.276 44.5 m 73.64 13.67 4.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.2 2.2 . . . . 0.0 113.697 -168.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.6 -44.2 94.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.593 1.542 . . . . 0.0 110.764 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -34.29 77.28 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -64.45 -49.07 72.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.409 1.084 . . . . 0.0 109.99 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.8 -38.89 92.51 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.94 -0.475 . . . . 0.0 111.151 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.76 97.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.848 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.13 79.03 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.776 0.83 . . . . 0.0 110.611 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.37 -46.74 83.06 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.903 0.481 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.32 -54.86 34.44 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 124.732 1.27 . . . . 0.0 108.923 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.413 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.41 -56.87 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 118.447 0.567 . . . . 0.0 109.584 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -38.99 72.81 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.343 0.657 . . . . 0.0 110.539 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.62 -48.1 67.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.992 0.517 . . . . 0.0 111.201 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 158' ' ' GLN . 17.8 mt -64.64 -47.11 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.996 1.318 . . . . 0.0 108.8 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.5 mt -72.58 -51.55 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.783 0.833 . . . . 0.0 110.52 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.67 115.59 0.76 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.44 3.54 4.11 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.29 2.66 . . . . 0.0 112.98 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.73 -35.12 65.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.25 1.42 . . . . 0.0 108.966 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -26.96 5.57 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.067 1.747 . . . . 0.0 111.369 -173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.47 140.43 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 120.781 1.628 . . . . 0.0 109.088 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.7 m -129.91 129.62 44.1 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.54 1.136 . . . . 0.0 110.073 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.79 148.99 47.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.875 0.87 . . . . 0.0 112.154 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -145.21 108.84 4.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.697 1.599 . . . . 0.0 107.762 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -82.31 112.03 18.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.77 -9.44 36.92 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -59.12 -28.49 66.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.422 1.01 . . . . 0.0 111.509 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.64 -34.22 1.56 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.473 1.109 . . . . 0.0 112.112 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.26 140.2 33.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 m -82.95 139.72 42.97 Favored Pre-proline 0 N--CA 1.452 -0.358 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.81 -1.62 11.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 121.172 1.454 . . . . 0.0 111.425 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 122.153 2.251 . . . . 0.0 111.713 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -18.78 64.68 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.431 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.2 ttm -58.91 -15.62 13.66 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.993 2.117 . . . . 0.0 111.971 169.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.1 -32.99 63.45 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.191 -0.943 . . . . 0.0 110.601 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.62 -48.11 28.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.58 0.705 . . . . 0.0 110.04 -170.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -70.86 131.86 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.94 -3.34 58.9 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 3' ' ' MET . 74.8 t -140.57 146.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.6 mt -140.63 153.86 46.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.999 0.52 . . . . 0.0 109.789 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -129.32 122.84 56.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 mp -119.73 136.71 54.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -130.2 119.71 2.87 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 117.957 -1.468 . . . . 0.0 112.785 -171.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.698 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -125.03 133.64 25.0 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.046 1.423 . . . . 0.0 110.309 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.74 157.07 15.97 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.222 1.948 . . . . 0.0 108.717 166.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -101.22 125.26 47.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -113.71 172.18 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.802 1.641 . . . . 0.0 109.829 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.96 62.5 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.793 2.837 . . . . 0.0 115.225 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 55.93 71.52 0.55 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 112.363 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.27 79.34 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.27 155.39 24.87 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.548 1.139 . . . . 0.0 109.948 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.25 151.61 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -65.8 143.5 57.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.91 -26.67 68.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.035 -169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.03 -26.7 66.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.674 0.789 . . . . 0.0 110.761 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.1 m95 -83.99 -42.74 15.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.108 0.963 . . . . 0.0 110.71 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.41 -34.92 64.82 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.581 0.628 . . . . 0.0 110.819 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.7 71.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.359 1.064 . . . . 0.0 112.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.31 -11.46 10.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t-105 -53.52 -28.98 34.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.653 1.581 . . . . 0.0 111.724 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.29 -44.68 64.73 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.006 1.322 . . . . 0.0 111.384 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.73 -30.37 70.58 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.568 -1.206 . . . . 0.0 111.95 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.703 1.138 . . . . 0.0 111.096 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.14 -31.33 70.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 111.421 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.41 -26.44 38.46 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.355 0.662 . . . . 0.0 110.887 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.24 159.79 33.37 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.565 1.174 . . . . 0.0 112.062 -169.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.68 96.85 10.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 112.832 -1.986 . . . . 0.0 108.215 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -118.92 6.6 11.4 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.122 0.969 . . . . 0.0 113.141 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.0 118.35 11.8 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -168.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.79 70.5 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.943 1.259 . . . . 0.0 115.687 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -110.68 154.74 23.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.083 1.441 . . . . 0.0 109.106 171.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.5 mt -85.21 143.78 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 118.87 0.759 . . . . 0.0 109.283 -172.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.5 t -132.44 134.13 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.526 1.53 . . . . 0.0 109.854 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.77 120.6 41.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.1 143.68 26.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 119.145 0.884 . . . . 0.0 111.644 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 21.2 p90 -137.13 159.39 42.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.37 178.13 39.08 Favored Glycine 0 N--CA 1.448 -0.555 0 O-C-N 121.044 -1.035 . . . . 0.0 112.524 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -127.67 151.12 49.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.73 -157.76 9.85 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -155.12 137.68 15.11 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.606 1.562 . . . . 0.0 108.333 168.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.57 -20.76 22.24 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.74 -49.33 68.81 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.781 1.173 . . . . 0.0 110.836 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.53 -27.36 8.6 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.189 0.9 . . . . 0.0 112.149 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -131.4 33.07 4.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -166.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.45 -42.66 57.55 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-N 120.354 1.434 . . . . 0.0 111.012 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.82 -19.75 60.35 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 117.986 0.893 . . . . 0.0 112.318 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -125.84 12.56 7.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.871 1.668 . . . . 0.0 112.432 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -45.61 122.05 3.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.487 1.515 . . . . 0.0 108.679 170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 52.86 28.2 6.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.033 0.933 . . . . 0.0 112.971 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.91 -40.29 94.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 120.648 -1.282 . . . . 0.0 110.113 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.94 -33.75 76.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 111.709 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.698 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.6 tp -59.96 -47.72 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 110.456 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.11 97.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.3 mtm -65.02 -44.56 88.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.01 0.905 . . . . 0.0 111.78 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 53' ' ' ILE . 3.9 mt -64.43 -35.44 80.93 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.295 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -64.24 -41.46 96.98 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.387 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.34 -42.6 92.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -55.06 -59.49 4.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.267 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.26 -20.84 57.01 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.628 -0.67 . . . . 0.0 110.794 -170.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.8 t -62.2 -30.29 70.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.165 0.893 . . . . 0.0 110.304 168.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -24.12 48.66 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.7 -1.25 . . . . 0.0 109.279 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -81.19 2.38 27.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.025 1.73 . . . . 0.0 112.59 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.69 33.15 79.83 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 118.643 0.656 . . . . 0.0 112.102 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.18 169.51 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 117.619 0.709 . . . . 0.0 109.468 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -113.61 140.25 48.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.45 148.08 32.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.072 1.305 . . . . 0.0 112.43 -168.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.8 m -128.6 -179.98 3.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.817 1.247 . . . . 0.0 109.577 168.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.77 33.41 33.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 118.342 -1.254 . . . . 0.0 114.741 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -78.86 139.6 38.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.933 1.866 . . . . 0.0 108.784 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 148.96 42.1 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.59 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.33 138.99 37.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 120.949 1.375 . . . . 0.0 109.108 168.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 139' ' ' PHE . 60.2 p . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 113.441 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 127' ' ' THR . 12.9 p90 -162.49 -61.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.167 0.894 . . . . 0.0 110.07 -172.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 126' ' ' PHE 0.333 2.1 t 58.74 11.13 1.69 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.575 2.75 . . . . 0.0 114.801 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 p -66.47 142.87 97.94 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.851 -1.156 . . . . 0.0 109.095 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.75 -15.36 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.283 1.989 . . . . 0.0 113.852 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -80.81 -48.21 1.15 Allowed Pre-proline 0 C--N 1.344 0.344 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.34 36.63 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.705 1.603 . . . . 0.0 112.484 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.093 0.957 . . . . 0.0 109.843 -166.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.77 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 109.456 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.94 -116.83 0.86 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.959 1.304 . . . . 0.0 107.62 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.14 7.82 33.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.761 1.224 . . . . 0.0 111.831 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.68 20.1 20.4 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.724 1.154 . . . . 0.0 112.575 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -100.36 -17.25 17.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.852 1.261 . . . . 0.0 110.859 -172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 145.29 51.25 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.286 0.634 . . . . 0.0 110.876 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.2 m-85 -81.27 155.45 26.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 110.221 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.02 -12.44 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.725 1.21 . . . . 0.0 112.755 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.67 -178.28 42.64 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.612 1.097 . . . . 0.0 111.879 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 22.2 tp -65.54 127.92 33.81 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.55 116.02 29.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.15 157.57 24.6 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.98 15.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -98.97 17.26 20.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.883 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.94 -23.57 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.17 -52.6 2.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.702 1.137 . . . . 0.0 109.18 172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -98.16 14.46 27.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.52 1.128 . . . . 0.0 113.896 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -52.07 -26.13 10.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.906 0.882 . . . . 0.0 112.485 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.37 -27.9 46.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 111.38 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -7.03 13.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.045 0.938 . . . . 0.0 111.218 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.2 m -53.07 -26.91 17.7 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.719 -1.238 . . . . 0.0 110.862 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.16 -40.18 90.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 122.035 0.921 . . . . 0.0 110.269 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -70.92 -46.2 62.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 129.827 3.251 . . . . 0.0 107.825 -177.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -69.49 -28.12 65.79 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.199 -1.819 . . . . 0.0 108.322 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.34 -61.05 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.493 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -56.88 -41.19 77.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 118.908 0.776 . . . . 0.0 112.259 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 m -65.59 -35.68 81.52 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.635 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 49.0 t90 -66.65 -43.95 83.26 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.464 -0.772 . . . . 0.0 109.79 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 92.7 m -57.55 -35.49 70.4 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.903 0.881 . . . . 0.0 109.644 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.12 -27.99 63.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.014 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -80.2 -46.41 16.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.148 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.2 -39.54 85.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 121.308 1.867 . . . . 0.0 110.614 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.11 -15.37 59.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -96.53 -45.11 6.87 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 124.683 1.193 . . . . 0.0 107.799 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.31 -42.02 90.41 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.122 0.874 . . . . 0.0 109.574 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.653 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.9 mtm -74.36 -41.92 60.23 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.142 0.977 . . . . 0.0 110.081 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.94 -44.41 80.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.286 1.035 . . . . 0.0 110.647 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -69.81 -32.2 70.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.082 1.353 . . . . 0.0 109.785 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -61.53 -42.44 98.82 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.474 0.654 . . . . 0.0 109.913 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -2.16 35.6 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.02 1.728 . . . . 0.0 113.758 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-N 118.406 0.548 . . . . 0.0 110.567 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.14 142.54 33.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 mtm -131.14 146.43 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.648 1.979 . . . . 0.0 108.276 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.55 117.94 5.0 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 118.637 -1.091 . . . . 0.0 110.397 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.72 113.12 24.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.268 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -109.92 147.36 33.57 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.77 1.628 . . . . 0.0 111.451 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -164.13 175.25 10.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.748 1.219 . . . . 0.0 109.704 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.54 142.95 11.16 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 168.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -148.87 144.61 27.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.303 1.051 . . . . 0.0 111.452 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 m -96.07 -37.87 10.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 111.389 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -95.09 -8.9 35.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 111.594 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.264 56.9 m 71.5 15.01 6.22 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.745 2.018 . . . . 0.0 114.121 -170.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -65.28 -42.94 92.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.434 1.47 . . . . 0.0 110.353 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.18 -33.66 75.88 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -64.3 -46.93 81.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.0 110.096 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 -40.85 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.592 -0.692 . . . . 0.0 111.548 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.4 94.02 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.638 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.37 79.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.902 0.881 . . . . 0.0 110.788 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.34 -45.3 88.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -61.73 -54.33 43.92 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 124.701 1.251 . . . . 0.0 108.725 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.1 mt -53.58 -56.73 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.852 0.751 . . . . 0.0 109.958 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.22 76.75 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.0 0.52 . . . . 0.0 110.484 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.92 -48.01 69.96 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.995 0.518 . . . . 0.0 111.21 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -65.27 -47.28 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.133 0.973 . . . . 0.0 108.533 -176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.83 -50.49 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.383 0.673 . . . . 0.0 110.402 -175.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.29 113.69 0.73 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 171.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.15 4.08 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.357 2.705 . . . . 0.0 112.69 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.89 -34.4 66.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.022 1.329 . . . . 0.0 109.228 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.86 -21.33 4.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.558 1.543 . . . . 0.0 111.814 -169.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -94.04 141.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 120.659 1.572 . . . . 0.0 109.028 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 m -130.44 128.23 40.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 110.006 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.41 148.66 48.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.932 0.893 . . . . 0.0 112.163 174.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.25 109.7 4.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.094 1.758 . . . . 0.0 107.41 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -83.82 112.11 19.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.16 -10.53 42.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -58.06 -29.11 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.19 0.905 . . . . 0.0 111.542 169.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.34 -34.37 1.62 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.573 1.149 . . . . 0.0 112.08 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.26 140.27 33.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -84.01 139.98 39.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.97 -4.46 15.18 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.087 1.424 . . . . 0.0 111.643 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -54.16 -36.96 63.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.08 1.764 . . . . 0.0 111.524 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -20.59 66.24 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.224 -0.923 . . . . 0.0 113.449 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -11.9 26.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.329 1.052 . . . . 0.0 112.185 169.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -74.57 -25.7 59.46 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.866 -1.146 . . . . 0.0 110.961 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.79 -51.57 11.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.183 0.901 . . . . 0.0 110.195 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -66.72 142.13 57.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.288 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.44 -27.56 61.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 110.694 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.26 144.27 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -135.33 152.77 51.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.546 0.612 . . . . 0.0 110.293 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.88 121.32 54.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -120.72 137.8 54.3 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.145 0.978 . . . . 0.0 108.473 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.71 2.57 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-O 117.543 -1.698 . . . . 0.0 111.85 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.14 127.69 26.45 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 119.476 1.638 . . . . 0.0 111.405 176.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.47 145.45 13.27 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.818 1.679 . . . . 0.0 108.16 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 m -89.6 137.43 32.33 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -133.02 173.37 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.884 2.074 . . . . 0.0 109.406 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.7 t0 36.13 51.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.331 2.252 . . . . 0.0 114.47 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 56.05 80.71 0.14 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.271 1.429 . . . . 0.0 112.483 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 75.25 10.27 84.31 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 172.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.33 163.88 14.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.708 1.603 . . . . 0.0 110.509 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mt -89.84 152.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -68.47 144.44 54.66 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.39 -29.62 70.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.185 0.594 . . . . 0.0 112.193 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.59 -23.6 65.4 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.943 -0.473 . . . . 0.0 111.169 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.459 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.9 m95 -86.12 -41.98 14.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.301 1.04 . . . . 0.0 110.937 170.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.72 -34.66 65.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.586 0.63 . . . . 0.0 111.016 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.27 -30.36 70.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.752 1.221 . . . . 0.0 111.874 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.19 -12.97 10.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.605 ' CH2' HD13 ' A' ' 104' ' ' LEU . 2.9 t-105 -53.31 -29.42 33.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.007 1.323 . . . . 0.0 111.801 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.27 -43.33 70.69 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.147 1.379 . . . . 0.0 111.387 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.23 -31.23 70.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.936 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.1 mt -56.59 -31.03 63.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.936 1.244 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.73 -28.49 65.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.665 0.786 . . . . 0.0 111.545 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.9 -24.97 32.91 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.417 0.687 . . . . 0.0 111.038 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 mt -72.95 158.62 35.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 123.046 1.403 . . . . 0.0 112.679 -167.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.53 95.98 10.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.549 174.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mt -118.23 8.09 12.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.61 121.21 13.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.4 8.05 88.04 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.284 1.421 . . . . 0.0 114.495 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -76.2 147.89 38.08 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 117.743 0.771 . . . . 0.0 109.203 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.746 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.3 mt -86.64 138.41 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 167.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.98 129.63 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.765 1.226 . . . . 0.0 108.589 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.69 117.61 34.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -90.92 141.38 28.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.941 0.791 . . . . 0.0 111.93 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -137.85 161.91 35.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.894 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.25 174.72 36.2 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 121.295 -0.878 . . . . 0.0 112.389 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 mt -124.21 148.5 47.24 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.396 1.079 . . . . 0.0 108.755 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.45 27.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.332 0.492 . . . . 0.0 112.241 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -133.45 112.69 11.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -29.44 28.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.459 0.171 . . . . 0.0 111.271 -172.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.96 -46.25 58.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.148 0.579 . . . . 0.0 110.395 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.08 -34.65 12.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.04 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.39 28.95 4.91 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.54 -34.34 60.03 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 120.33 1.423 . . . . 0.0 112.411 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.2 -24.32 63.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.063 0.932 . . . . 0.0 112.369 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -113.15 -47.5 3.02 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.521 1.528 . . . . 0.0 110.089 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.265 1.6 t80 43.97 -131.36 0.77 Allowed 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 128.478 2.711 . . . . 0.0 109.514 -172.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.58 39.38 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 130.697 3.599 . . . . 0.0 113.787 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 5.9 t70 -58.14 -43.05 87.09 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 119.437 -2.039 . . . . 0.0 111.123 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.98 -32.1 71.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.946 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.0 tp -63.13 -47.39 82.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.478 0.711 . . . . 0.0 110.189 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.27 99.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.1 mtm -62.97 -48.15 80.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 117.556 0.678 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.605 HD13 ' CH2' ' A' ' 69' ' ' TRP . 13.0 tp -67.06 -30.86 71.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.651 -0.656 . . . . 0.0 111.201 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -60.83 -46.29 91.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.3 0.5 . . . . 0.0 109.826 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.72 -41.2 92.54 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.448 1.099 . . . . 0.0 111.657 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 7.0 tptt -55.6 -62.27 1.79 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.553 1.141 . . . . 0.0 107.936 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.16 -21.04 62.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.536 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -61.65 -29.4 70.04 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.649 1.113 . . . . 0.0 110.729 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.48 -22.1 54.96 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.819 -1.176 . . . . 0.0 109.799 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.73 1.61 37.87 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.636 1.574 . . . . 0.0 112.541 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.32 33.66 68.62 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.477 0.58 . . . . 0.0 111.842 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.25 170.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.622 0.769 . . . . 0.0 109.319 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -117.26 143.14 46.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -110.33 148.05 32.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.56 1.073 . . . . 0.0 111.899 -170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.3 m -128.42 178.17 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.664 1.185 . . . . 0.0 108.439 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.78 34.21 39.62 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 118.52 -1.155 . . . . 0.0 114.368 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -71.95 155.72 40.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.613 1.707 . . . . 0.0 107.948 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.45 142.05 33.48 Favored Pre-proline 0 CA--C 1.514 -0.437 0 CA-C-O 116.939 -1.505 . . . . 0.0 109.227 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.45 143.08 56.31 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.038 1.406 . . . . 0.0 109.618 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.521 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 73.9 p . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.899 1.68 . . . . 0.0 113.776 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.4 p90 -163.01 -53.88 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 118.752 0.705 . . . . 0.0 109.454 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.361 3.1 t 61.66 8.12 2.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.066 2.547 . . . . 0.0 114.939 176.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.2 t -67.85 138.13 92.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -84.7 -10.56 8.42 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.251 2.634 . . . . 0.0 112.77 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -78.42 -49.93 1.72 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -88.46 39.84 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.381 2.054 . . . . 0.0 112.593 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 148.43 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.509 1.124 . . . . 0.0 109.612 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.02 -171.98 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 C-N-CA 126.369 1.867 . . . . 0.0 109.861 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.39 -116.11 0.86 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.203 1.401 . . . . 0.0 107.443 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.55 8.34 33.28 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.059 1.344 . . . . 0.0 112.222 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.99 21.12 19.13 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.76 1.171 . . . . 0.0 112.506 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -100.69 -18.32 16.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.793 1.237 . . . . 0.0 110.8 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.14 144.23 51.24 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.887 0.475 . . . . 0.0 110.876 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.78 156.58 30.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.7 m -65.2 -18.11 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.478 0.711 . . . . 0.0 112.108 174.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.07 -178.76 39.66 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.403 1.001 . . . . 0.0 111.114 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.23 128.26 35.5 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.15 125.5 53.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.1 mt -121.99 150.23 42.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.65 132.4 38.91 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -111.57 10.67 21.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.705 -170.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.258 0.5 OUTLIER -108.21 -31.17 8.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 176.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -136.14 -27.33 1.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.096 0.862 . . . . 0.0 113.267 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -89.5 12.08 17.57 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.914 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -57.69 -21.77 42.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.874 1.215 . . . . 0.0 113.475 -170.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.54 -19.29 28.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.647 0.779 . . . . 0.0 112.141 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.0 mt -113.49 -24.48 9.25 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 126.702 2.001 . . . . 0.0 111.4 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.5 p -51.43 -35.77 40.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.366 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.395 0.678 . . . . 0.0 110.26 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.88 -29.63 66.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.547 0.339 . . . . 0.0 111.744 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -78.97 -28.11 43.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.704 0.802 . . . . 0.0 110.039 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 mt -66.05 -54.26 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.698 ' HA ' HD13 ' A' ' 24' ' ' ILE . 3.6 pt20 -56.97 -44.77 82.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.588 0.755 . . . . 0.0 112.257 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.4 p -67.19 -35.64 80.06 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.933 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -64.63 -45.12 88.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.844 0.83 . . . . 0.0 109.553 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.7 m -57.53 -35.42 70.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.134 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -34.7 77.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.83 0.452 . . . . 0.0 110.273 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.24 -46.27 18.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.373 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -65.18 -38.61 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 120.858 1.663 . . . . 0.0 110.002 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.28 -14.3 60.41 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.286 0.494 . . . . 0.0 112.016 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -95.03 -46.14 6.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 107.871 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.46 -36.02 77.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.841 0.746 . . . . 0.0 110.209 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.746 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.1 mtm -77.67 -44.19 28.84 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.329 1.052 . . . . 0.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -42.45 78.18 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.819 0.848 . . . . 0.0 111.052 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.18 -31.11 68.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.91 1.284 . . . . 0.0 109.791 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -41.91 97.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.297 0.639 . . . . 0.0 110.487 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -1.25 56.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.901 1.681 . . . . 0.0 113.919 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.318 179.239 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.2 143.86 30.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.0 mtm -132.12 146.51 52.09 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.773 2.029 . . . . 0.0 108.187 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.75 118.42 4.94 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-O 118.622 -1.099 . . . . 0.0 110.51 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 111.54 22.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.986 1.393 . . . . 0.0 108.885 169.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.88 146.44 36.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.988 1.315 . . . . 0.0 111.047 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -161.91 174.88 12.49 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.234 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.2 10.2 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.578 -2.609 . . . . 0.0 106.578 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.4 p -146.38 122.47 10.78 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.326 1.063 . . . . 0.0 111.614 -169.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 m -80.83 -37.87 29.28 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.205 0.457 . . . . 0.0 111.638 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.9 p -107.93 8.55 28.55 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.866 1.266 . . . . 0.0 112.092 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.7 m 65.35 11.71 7.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.85 2.06 . . . . 0.0 114.192 -171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -66.63 -46.94 74.2 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.318 -1.489 . . . . 0.0 111.224 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -33.44 75.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.88 -46.56 87.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 110.312 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.4 mtm -65.49 -43.37 90.38 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.774 -0.578 . . . . 0.0 111.384 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.55 -39.81 89.29 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 122.005 -0.434 . . . . 0.0 110.886 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.74 81.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.206 1.002 . . . . 0.0 110.53 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.5 -44.77 85.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.93 -53.88 47.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.721 1.263 . . . . 0.0 108.997 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 5.9 mt -53.55 -56.82 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.724 0.693 . . . . 0.0 109.768 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -38.49 78.63 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.574 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.57 -47.78 71.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.004 0.522 . . . . 0.0 111.121 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.2 mt -65.27 -48.0 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.682 1.193 . . . . 0.0 108.697 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 164' ' ' ILE . 77.0 mt -71.96 -50.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.502 0.721 . . . . 0.0 110.54 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.59 114.34 0.75 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.5 1.048 . . . . 0.0 110.707 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.39 3.76 3.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.625 2.883 . . . . 0.0 112.677 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -73.49 -34.12 65.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.206 1.403 . . . . 0.0 109.226 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -22.53 3.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.4 1.48 . . . . 0.0 111.824 -169.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 120.333 1.424 . . . . 0.0 108.752 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 m -129.17 129.58 45.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.539 1.136 . . . . 0.0 110.022 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.05 146.28 45.97 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.299 1.039 . . . . 0.0 112.068 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -144.09 107.97 4.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.616 1.567 . . . . 0.0 107.313 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -83.29 112.42 19.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.31 -8.95 20.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.94 0.896 . . . . 0.0 113.155 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.91 -29.14 66.83 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.209 0.913 . . . . 0.0 111.753 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -130.82 -34.25 1.52 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.714 1.206 . . . . 0.0 111.842 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -82.16 141.78 32.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.982 0.913 . . . . 0.0 108.756 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -81.35 147.97 61.7 Favored Pre-proline 0 N--CA 1.45 -0.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -78.19 -2.95 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.177 1.251 . . . . 0.0 111.36 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -55.75 -35.3 66.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 122.101 2.228 . . . . 0.0 112.011 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -20.09 66.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.414 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.7 ttm -59.28 -15.51 16.21 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.674 1.99 . . . . 0.0 111.477 171.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -73.2 -30.83 63.8 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.194 -0.941 . . . . 0.0 110.913 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -76.01 -46.28 30.24 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.976 0.807 . . . . 0.0 110.834 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.98 141.87 56.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.1 -168.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -74.54 -19.96 60.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.318 0.647 . . . . 0.0 110.509 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.7 t -145.41 148.7 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 43' ' ' MET . 11.2 mt -138.27 150.3 46.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.99 0.916 . . . . 0.0 109.183 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.5 120.65 51.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.7 132.59 55.7 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.89 118.33 3.67 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-O 117.541 -1.699 . . . . 0.0 112.757 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -119.35 126.01 27.24 Favored Pre-proline 0 N--CA 1.472 0.625 0 CA-C-N 119.608 1.704 . . . . 0.0 111.45 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -80.27 144.82 16.63 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.351 2.701 . . . . 0.0 108.987 167.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 m -94.96 131.54 40.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -121.91 171.33 9.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.524 1.93 . . . . 0.0 109.442 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 20.12 67.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.921 2.888 . . . . 0.0 115.459 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 54.0 70.05 0.65 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.689 1.196 . . . . 0.0 112.112 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 21.11 79.65 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.165 0.826 . . . . 0.0 115.165 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.305 0.4 OUTLIER -88.34 156.4 19.19 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 166.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.21 150.36 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -55.34 139.59 42.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.181 0.991 . . . . 0.0 108.545 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.63 -28.22 69.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -78.47 -19.51 52.95 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.726 -0.609 . . . . 0.0 110.434 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 53' ' ' ILE . 14.0 m95 -81.08 -43.06 20.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.377 0.671 . . . . 0.0 111.192 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.26 -33.44 58.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.531 0.605 . . . . 0.0 111.008 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.24 71.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.252 1.021 . . . . 0.0 112.33 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.86 -8.92 12.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.558 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.9 t-105 -53.2 -28.96 29.35 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.31 1.444 . . . . 0.0 111.902 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.72 -44.71 76.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.992 1.317 . . . . 0.0 111.635 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -68.58 -29.01 67.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.05 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.75 -29.84 65.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 111.114 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.33 -29.47 66.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.515 0.726 . . . . 0.0 111.452 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.87 -24.62 38.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.391 0.676 . . . . 0.0 111.366 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.4 159.91 33.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.808 1.289 . . . . 0.0 112.998 -168.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.4 92.31 7.59 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 126.663 1.985 . . . . 0.0 108.539 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -113.5 10.15 18.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.66 126.43 28.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.98 21.66 79.01 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.818 1.199 . . . . 0.0 115.678 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.21 155.8 21.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.802 1.301 . . . . 0.0 108.828 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.637 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.7 mt -87.25 145.79 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.01 130.2 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.046 1.338 . . . . 0.0 109.29 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.86 118.07 35.84 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -90.45 141.73 28.45 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.227 0.921 . . . . 0.0 111.554 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -136.78 160.58 38.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.205 1.002 . . . . 0.0 108.43 168.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.13 170.81 36.29 Favored Glycine 0 N--CA 1.446 -0.641 0 O-C-N 121.005 -1.06 . . . . 0.0 111.82 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.8 mt -129.32 153.14 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.42 -154.87 11.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -149.77 137.52 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.101 1.36 . . . . 0.0 108.074 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.62 -22.83 21.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.306 1.443 . . . . 0.0 113.44 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.28 -39.55 53.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.054 1.297 . . . . 0.0 111.627 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.42 -26.28 16.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.418 1.008 . . . . 0.0 112.232 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.36 35.46 2.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -167.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.66 52.54 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.186 1.357 . . . . 0.0 110.973 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -62.71 -15.02 50.86 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.067 0.947 . . . . 0.0 112.133 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -126.22 8.89 7.28 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.351 1.86 . . . . 0.0 112.128 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -48.93 124.86 9.33 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.496 1.518 . . . . 0.0 109.389 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.17 28.63 9.29 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.182 0.993 . . . . 0.0 112.855 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.1 -36.89 82.91 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 120.444 -1.41 . . . . 0.0 110.684 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 111.325 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.68 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -60.41 -48.11 83.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.016 0.926 . . . . 0.0 110.535 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.45 98.13 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mtm -65.16 -44.54 88.22 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.849 0.825 . . . . 0.0 112.101 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.558 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.3 mt -65.29 -35.31 80.61 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.365 0.984 . . . . 0.0 111.169 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -62.94 -42.14 99.72 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.656 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.12 -43.1 88.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.29 -59.11 5.11 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.848 1.259 . . . . 0.0 108.4 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.69 -22.19 54.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.241 -169.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 t -62.02 -28.77 69.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.975 0.807 . . . . 0.0 110.534 169.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.92 -24.36 44.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.588 -1.32 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -80.57 -0.95 39.98 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.409 1.484 . . . . 0.0 112.489 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.1 59.95 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.814 0.734 . . . . 0.0 111.895 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.57 172.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.764 0.782 . . . . 0.0 109.696 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -118.09 145.41 44.86 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.89 151.71 33.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 120.289 1.404 . . . . 0.0 112.994 -168.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.5 m -131.67 -178.97 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.821 1.248 . . . . 0.0 109.46 169.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.76 29.92 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.202 -1.332 . . . . 0.0 115.091 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -75.49 152.32 37.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.909 1.854 . . . . 0.0 109.008 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.31 148.15 69.02 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 117.16 -1.4 . . . . 0.0 109.088 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.87 140.02 41.24 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 121.11 1.432 . . . . 0.0 110.429 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 139' ' ' PHE . 66.6 p . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.364 1.866 . . . . 0.0 113.296 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 127' ' ' THR . 11.9 p90 -161.75 -58.76 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 126' ' ' PHE 0.328 1.9 t 58.64 11.71 1.88 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.103 2.561 . . . . 0.0 114.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 p -66.56 133.28 94.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.864 -1.148 . . . . 0.0 107.908 167.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.13 -14.26 5.07 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.16 1.907 . . . . 0.0 113.326 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -80.6 -47.41 1.24 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 117.756 -1.116 . . . . 0.0 114.007 -169.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.15 39.37 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.078 1.852 . . . . 0.0 112.428 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.37 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.333 -167.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -172.55 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 126.069 1.748 . . . . 0.0 109.968 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.08 -116.52 0.84 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.054 1.342 . . . . 0.0 107.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.21 8.0 33.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.828 1.251 . . . . 0.0 111.885 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.42 20.3 20.43 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.129 1.347 . . . . 0.0 112.803 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.25 -16.83 17.59 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.877 1.271 . . . . 0.0 110.944 -172.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 144.53 50.44 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.279 0.631 . . . . 0.0 111.186 173.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.2 m-85 -78.78 154.37 30.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.698 1.599 . . . . 0.0 109.676 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -14.32 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.157 . . . . 0.0 112.707 173.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.45 -179.62 40.89 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 119.69 1.132 . . . . 0.0 111.968 -170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 14.5 tp -65.7 129.78 40.97 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.09 124.15 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.71 160.16 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.981 0.912 . . . . 0.0 108.879 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.13 124.93 31.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -105.29 10.24 33.65 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.779 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -25.65 11.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.207 1.003 . . . . 0.0 110.862 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.06 -46.93 1.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.703 1.138 . . . . 0.0 111.169 174.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -89.74 15.35 9.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -53.67 -22.05 8.16 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.71 -26.55 31.91 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.258 1.023 . . . . 0.0 111.291 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -116.14 -13.73 11.16 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.293 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.7 p -57.3 -27.41 62.13 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.129 1.331 . . . . 0.0 112.381 -171.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -52.76 -39.1 61.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.781 1.632 . . . . 0.0 111.788 173.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.36 -30.47 68.49 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.701 1.6 . . . . 0.0 111.003 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -92.46 -18.16 23.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.037 1.335 . . . . 0.0 110.484 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.84 -60.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.733 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.6 pt20 -51.82 -44.8 63.67 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.128 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 p -67.59 -35.22 78.57 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.077 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.7 t90 -65.35 -44.87 86.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.026 0.917 . . . . 0.0 109.656 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 96.6 m -57.82 -35.9 71.49 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.808 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.74 -29.78 66.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.404 0.547 . . . . 0.0 111.173 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -79.07 -45.76 19.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.931 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 25' ' ' ILE . 5.2 pt -64.89 -39.27 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 120.865 1.666 . . . . 0.0 109.862 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.49 -14.64 58.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.2 0.6 . . . . 0.0 111.984 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -96.2 -45.94 6.65 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.64 -42.47 88.37 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.968 0.804 . . . . 0.0 109.387 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.637 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.3 mtm -77.29 -35.51 55.02 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.706 0.802 . . . . 0.0 110.716 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -48.4 56.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.351 1.06 . . . . 0.0 109.678 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.49 -31.15 72.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.216 1.406 . . . . 0.0 109.951 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -63.96 -49.04 74.13 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.487 0.585 . . . . 0.0 110.447 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.23 -3.84 44.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.586 179.325 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 140.23 30.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 168.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 mtm -123.13 148.67 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.574 2.349 . . . . 0.0 108.386 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.29 118.47 4.69 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.48 114.44 25.1 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.944 1.372 . . . . 0.0 108.754 170.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.15 146.32 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.635 1.574 . . . . 0.0 110.535 172.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.01 172.74 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.189 0.996 . . . . 0.0 109.814 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.72 140.56 9.3 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -153.3 164.66 37.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.11 0.955 . . . . 0.0 112.007 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -132.08 -41.32 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.192 1.397 . . . . 0.0 110.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.2 p -76.5 -15.52 59.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.502 0.721 . . . . 0.0 110.551 169.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.261 57.5 m 73.57 16.15 3.99 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.479 2.311 . . . . 0.0 113.831 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -63.24 -43.6 97.57 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.371 -1.456 . . . . 0.0 110.584 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -33.72 73.24 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.45 -47.38 84.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.454 0.702 . . . . 0.0 109.644 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -65.51 -39.54 91.97 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.186 0.448 . . . . 0.0 111.145 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.64 93.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.846 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.43 79.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.038 0.935 . . . . 0.0 110.674 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -57.2 -44.95 84.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.34 -56.46 16.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.804 1.315 . . . . 0.0 108.94 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.2 mt -51.88 -56.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 118.274 0.488 . . . . 0.0 110.099 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.24 -36.4 73.14 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.877 0.871 . . . . 0.0 111.122 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.32 -45.74 62.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.682 0.393 . . . . 0.0 111.084 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.67 -47.11 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.292 1.037 . . . . 0.0 108.802 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 164' ' ' ILE . 72.8 mt -73.34 -50.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.539 0.736 . . . . 0.0 110.279 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.36 112.25 0.41 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.79 -4.29 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.443 2.762 . . . . 0.0 112.29 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.1 -33.68 59.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.057 1.743 . . . . 0.0 109.387 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.44 -21.42 4.18 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.708 1.603 . . . . 0.0 111.417 -169.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.82 139.17 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 120.397 1.453 . . . . 0.0 109.108 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -128.25 129.09 45.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.606 1.163 . . . . 0.0 110.056 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.66 147.9 43.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.726 1.21 . . . . 0.0 112.049 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.09 111.94 5.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.987 1.715 . . . . 0.0 107.121 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.14 109.98 19.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.5 -7.57 26.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -62.43 -26.49 68.53 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.597 1.09 . . . . 0.0 111.669 169.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -132.83 -33.59 1.18 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 112.184 -171.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -84.04 141.16 31.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.49 1.116 . . . . 0.0 108.286 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -86.73 141.64 33.97 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -71.86 -4.24 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.079 1.853 . . . . 0.0 111.186 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -54.97 -35.76 64.63 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 120.347 1.43 . . . . 0.0 112.179 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -20.58 66.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 175.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -65.34 -10.96 37.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 112.539 169.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.02 -30.19 68.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.514 1.052 . . . . 0.0 110.159 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.62 -51.46 9.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.422 0.63 . . . . 0.0 110.295 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.99 143.55 57.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.616 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -76.15 -24.49 54.83 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.543 0.687 . . . . 0.0 110.766 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.8 t -145.18 139.18 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -169.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 153.49 43.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.612 0.642 . . . . 0.0 110.875 174.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 125.41 67.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.32 136.55 54.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.947 0.899 . . . . 0.0 109.886 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.05 116.52 2.99 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.006 -1.996 . . . . 0.0 111.689 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.51 130.1 24.9 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-N 120.229 2.014 . . . . 0.0 112.409 170.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.83 141.69 10.88 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.453 2.102 . . . . 0.0 107.792 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 m -89.45 124.35 34.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -115.24 174.7 5.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.526 1.93 . . . . 0.0 109.351 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 31.06 55.64 0.22 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.085 2.554 . . . . 0.0 115.253 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 55.69 78.84 0.18 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.71 1.204 . . . . 0.0 112.71 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 76.09 9.85 85.37 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.86 159.67 17.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.15 1.38 . . . . 0.0 110.803 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -91.05 152.9 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.04 144.5 55.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.68 -28.88 69.71 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.113 0.965 . . . . 0.0 112.4 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.262 0.625 . . . . 0.0 111.012 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.441 ' CD1' HG22 ' A' ' 53' ' ' ILE . 6.4 m95 -79.98 -43.49 21.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 110.195 173.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.46 -34.39 61.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.28 0.632 . . . . 0.0 111.024 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.379 1.072 . . . . 0.0 112.174 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.27 -10.41 9.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.513 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.9 t-105 -53.37 -27.73 25.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.505 1.522 . . . . 0.0 112.166 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.23 -45.56 66.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.209 1.404 . . . . 0.0 111.524 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -64.91 -33.05 75.1 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.929 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 44.3 mt -57.63 -31.68 66.5 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.725 1.148 . . . . 0.0 111.393 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.29 -27.49 61.58 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.345 0.658 . . . . 0.0 111.178 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.64 -19.29 31.18 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.832 0.853 . . . . 0.0 111.482 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.99 171.65 12.45 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.053 0.93 . . . . 0.0 110.721 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.47 112.22 24.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.22 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.02 10.3 6.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.838 0.855 . . . . 0.0 112.945 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.62 119.41 10.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -170.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.83 85.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 124.822 1.201 . . . . 0.0 114.148 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -79.17 149.37 32.0 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.002 0.901 . . . . 0.0 108.86 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.739 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.3 mt -86.38 140.35 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.52 131.38 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 109.447 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -112.53 112.91 24.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 166.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.39 143.99 26.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.799 0.727 . . . . 0.0 111.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -141.87 164.22 30.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.948 1.299 . . . . 0.0 109.03 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.48 38.88 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 121.195 -0.94 . . . . 0.0 113.218 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -128.56 153.76 46.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.437 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.71 -153.9 9.17 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.07 138.83 10.56 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 126.75 2.02 . . . . 0.0 107.775 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.39 -21.74 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.864 1.265 . . . . 0.0 114.267 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.51 -48.11 65.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.756 1.162 . . . . 0.0 110.664 -173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.93 -26.27 19.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.034 0.826 . . . . 0.0 112.33 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -130.92 27.75 4.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.44 58.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-N 121.116 1.78 . . . . 0.0 112.524 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.12 -15.92 58.3 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.033 -1.275 . . . . 0.0 113.222 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -125.16 -49.65 1.7 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.745 1.618 . . . . 0.0 111.433 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.261 2.0 t80 43.82 -133.59 0.61 Allowed 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.204 2.602 . . . . 0.0 109.844 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.98 40.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.816 3.646 . . . . 0.0 113.188 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 6.6 t70 -58.75 -43.08 90.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.554 -1.966 . . . . 0.0 111.42 -169.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.72 71.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.276 0.63 . . . . 0.0 110.584 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.585 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -62.75 -47.98 81.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.649 0.78 . . . . 0.0 110.384 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.44 99.19 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.6 mtm -62.0 -46.3 89.81 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 117.765 0.782 . . . . 0.0 111.218 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.513 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -67.99 -31.43 71.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.735 -0.603 . . . . 0.0 111.7 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.36 -49.97 75.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.011 0.434 . . . . 0.0 109.927 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.45 -40.17 92.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.419 1.088 . . . . 0.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 72' ' ' LEU . 17.9 tptt -54.2 -58.8 6.0 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.397 1.479 . . . . 0.0 108.444 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.9 -18.59 55.97 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.544 -0.723 . . . . 0.0 110.672 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -60.91 -26.93 67.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.985 0.811 . . . . 0.0 110.557 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -24.19 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.771 -1.206 . . . . 0.0 109.849 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -82.94 1.66 38.49 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.576 1.55 . . . . 0.0 112.627 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.06 34.27 70.33 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 118.633 0.651 . . . . 0.0 111.982 172.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.53 171.24 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 117.823 0.812 . . . . 0.0 109.89 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -116.23 140.6 49.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -108.53 147.6 31.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.55 1.068 . . . . 0.0 111.756 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 14.3 m -128.75 179.07 4.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 108.982 169.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.25 33.52 44.23 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-O 118.65 -1.084 . . . . 0.0 114.344 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.17 149.69 46.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.589 1.694 . . . . 0.0 108.044 169.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.37 135.65 27.75 Favored Pre-proline 0 CA--C 1.516 -0.334 0 CA-C-O 116.917 -1.516 . . . . 0.0 108.578 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.63 138.76 50.67 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 121.36 1.521 . . . . 0.0 109.776 169.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 67.3 p . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 126.522 1.929 . . . . 0.0 113.191 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -166.43 -52.98 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.477 1.035 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.326 3.1 t 57.45 10.64 1.0 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.237 2.615 . . . . 0.0 114.536 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 141.81 88.0 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.509 1.523 . . . . 0.0 109.783 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.24 -13.37 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.214 1.943 . . . . 0.0 114.114 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -80.0 -50.33 1.2 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.87 38.65 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.0 1.8 . . . . 0.0 112.827 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 149.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -166.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -172.28 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 125.906 1.683 . . . . 0.0 110.005 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.6 -116.89 0.89 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.65 8.0 32.92 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.016 1.326 . . . . 0.0 112.161 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.61 20.35 19.79 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.613 1.102 . . . . 0.0 112.591 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -100.15 -16.97 17.63 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.735 1.214 . . . . 0.0 110.713 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.02 142.45 49.58 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.445 0.698 . . . . 0.0 110.404 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.0 m-85 -77.47 157.7 30.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.863 1.265 . . . . 0.0 108.725 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.453 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -65.19 -18.69 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.915 173.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.04 -179.83 40.31 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 119.604 1.093 . . . . 0.0 112.066 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.483 HD11 HD21 ' A' ' 144' ' ' LEU . 12.8 tp -61.01 129.26 40.53 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.03 119.13 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 142' ' ' LEU . 85.9 mt -117.15 156.61 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.134 0.974 . . . . 0.0 109.223 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.97 122.15 12.21 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -97.56 18.15 16.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.843 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 -20.92 4.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.879 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.72 -53.95 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.239 1.381 . . . . 0.0 108.547 169.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.78 17.71 17.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -52.0 -25.2 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.036 0.934 . . . . 0.0 112.496 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.99 -26.65 54.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 0.0 111.426 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.46 -8.47 9.11 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.111 0.965 . . . . 0.0 112.331 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.6 m -51.59 -34.17 35.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.982 1.264 . . . . 0.0 110.554 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.54 -49.14 75.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.65 0.78 . . . . 0.0 110.238 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.11 -32.12 73.04 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.27 1.028 . . . . 0.0 109.892 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -74.98 -29.31 60.86 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 118.256 -0.878 . . . . 0.0 108.982 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.15 -58.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.44 -45.05 65.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.495 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.1 m -69.69 -35.23 74.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.587 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 34.6 t90 -67.08 -45.32 77.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.628 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 86.5 m -58.73 -33.88 70.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.823 0.849 . . . . 0.0 109.765 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -70.88 -32.33 69.27 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -78.63 -47.41 17.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.271 -1.347 . . . . 0.0 112.257 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.24 -37.19 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 121.23 1.832 . . . . 0.0 109.838 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.3 -13.0 33.7 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -51.07 5.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.649 1.58 . . . . 0.0 107.875 169.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.93 -22.8 67.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.355 0.662 . . . . 0.0 111.46 -169.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.739 ' HG2' HG21 ' A' ' 81' ' ' ILE . 69.5 mtm -94.43 -44.08 8.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 111.472 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.39 57.44 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.506 0.722 . . . . 0.0 110.709 -172.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.49 -27.69 66.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.897 1.279 . . . . 0.0 109.51 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -70.33 -48.27 57.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 110.378 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.42 -17.23 60.23 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.791 -179.205 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 142.68 29.83 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 mtm -130.94 147.96 52.65 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.447 1.899 . . . . 0.0 108.516 -169.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.25 117.63 4.77 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-O 118.824 -0.987 . . . . 0.0 110.807 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 98.02 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.879 1.339 . . . . 0.0 109.548 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -95.88 146.41 24.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.506 1.122 . . . . 0.0 110.447 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 36.3 p90 -165.36 174.6 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.686 0.794 . . . . 0.0 109.024 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.28 133.8 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 106.188 -2.765 . . . . 0.0 106.188 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 147.77 28.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.8 t -126.23 -27.56 3.21 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.944 1.298 . . . . 0.0 109.834 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.9 p -81.45 -74.28 0.34 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 169.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.0 p 175.7 -14.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.163 1.785 . . . . 0.0 113.839 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -63.44 -48.2 78.74 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.646 -1.284 . . . . 0.0 114.359 -164.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -33.71 74.93 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 6.5 tt0 -62.98 -47.79 81.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.2 mtm -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 118.004 0.365 . . . . 0.0 111.444 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.45 -41.65 90.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.69 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.76 82.25 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.995 0.918 . . . . 0.0 110.754 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.82 -44.96 90.97 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.2 -56.64 16.62 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 124.616 1.198 . . . . 0.0 108.43 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.403 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.0 mt -51.58 -56.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 118.821 0.737 . . . . 0.0 109.966 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -38.96 71.71 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.428 0.691 . . . . 0.0 110.514 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.88 -46.9 73.53 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.792 0.437 . . . . 0.0 111.442 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.66 -47.85 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.517 1.127 . . . . 0.0 108.727 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 164' ' ' ILE . 68.3 mt -72.32 -50.97 32.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 123.876 0.87 . . . . 0.0 110.309 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.28 114.92 0.7 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 170.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.86 2.83 4.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.374 2.716 . . . . 0.0 112.812 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.91 -34.01 66.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 -23.89 3.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.672 1.589 . . . . 0.0 111.549 -169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.81 140.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.45 1.477 . . . . 0.0 109.278 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.7 m -129.36 128.66 43.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.689 1.195 . . . . 0.0 110.477 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.12 148.07 49.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 112.094 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -148.87 110.26 4.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.61 1.564 . . . . 0.0 107.618 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -86.92 113.14 22.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.23 -10.45 42.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -58.68 -26.91 64.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.981 0.809 . . . . 0.0 111.88 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.74 -28.72 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.889 0.875 . . . . 0.0 112.005 -167.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -87.63 145.36 26.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.377 1.471 . . . . 0.0 108.614 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -83.63 148.42 54.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.633 0.773 . . . . 0.0 108.976 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -79.27 -11.21 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.793 2.329 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -56.68 -36.6 69.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.446 1.476 . . . . 0.0 111.488 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -20.23 66.17 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.332 -0.855 . . . . 0.0 113.023 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -13.82 25.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.403 1.081 . . . . 0.0 112.156 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.94 -26.7 60.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.079 -1.013 . . . . 0.0 110.897 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.35 -50.65 13.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.786 0.803 . . . . 0.0 110.107 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -65.29 144.03 57.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.093 1.357 . . . . 0.0 108.248 -169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -75.52 -25.13 56.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.753 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 49' ' ' LEU . 42.2 t -144.15 140.24 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -168.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.8 158.65 36.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.659 0.663 . . . . 0.0 110.757 173.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.23 123.31 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.9 135.65 55.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.832 0.853 . . . . 0.0 108.872 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.24 3.67 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.697 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.83 130.09 24.89 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 118.824 1.312 . . . . 0.0 110.558 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.24 138.31 7.6 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.289 2.659 . . . . 0.0 107.887 168.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 m -87.19 126.32 34.72 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -113.19 172.77 6.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.253 1.821 . . . . 0.0 109.89 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 21.94 63.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.241 3.017 . . . . 0.0 115.469 169.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.17 71.39 0.54 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.713 1.205 . . . . 0.0 112.151 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.89 13.35 80.8 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.97 151.14 35.8 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.662 1.22 . . . . 0.0 109.302 168.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.63 148.84 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -64.35 144.75 56.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.44 -27.65 68.71 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.162 -172.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -64.82 -27.75 69.09 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.806 0.842 . . . . 0.0 112.401 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -88.53 -40.5 13.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.832 1.253 . . . . 0.0 110.59 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.12 -35.83 65.07 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.726 0.694 . . . . 0.0 111.009 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.11 71.33 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.165 0.986 . . . . 0.0 112.139 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.99 -12.4 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.727 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.0 t-105 -54.85 -28.76 52.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.114 1.366 . . . . 0.0 111.804 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.51 -44.86 61.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.681 1.192 . . . . 0.0 110.876 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.24 -29.6 67.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.22 -1.371 . . . . 0.0 112.559 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 mt -55.66 -32.86 63.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.228 1.376 . . . . 0.0 110.895 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.07 -33.68 76.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.69 0.796 . . . . 0.0 111.819 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.99 -26.62 48.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.277 0.631 . . . . 0.0 110.767 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.95 152.82 40.01 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.88 1.324 . . . . 0.0 110.511 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -85.11 103.59 14.25 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.558 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.5 mt -124.75 4.41 8.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.767 1.227 . . . . 0.0 113.032 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -68.48 113.14 5.76 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.74 79.86 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.34 1.447 . . . . 0.0 115.094 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -82.76 153.0 25.48 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.324 1.062 . . . . 0.0 109.914 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -87.99 141.59 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.53 129.1 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.163 1.385 . . . . 0.0 108.632 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.71 117.81 35.02 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.92 142.26 27.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.082 0.856 . . . . 0.0 111.524 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -140.37 161.33 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.006 0.922 . . . . 0.0 108.95 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.04 179.53 39.58 Favored Glycine 0 N--CA 1.45 -0.415 0 O-C-N 120.841 -1.162 . . . . 0.0 112.338 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.46 153.96 42.72 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 109.233 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.44 -157.86 13.33 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -148.88 141.94 24.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.486 1.514 . . . . 0.0 109.254 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 -21.03 23.75 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.79 -40.94 68.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.874 1.216 . . . . 0.0 111.804 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.91 -22.93 19.22 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 124.592 1.091 . . . . 0.0 111.512 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.6 m-85 -121.38 -84.8 0.66 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.764 1.225 . . . . 0.0 108.071 -170.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.0 -50.27 2.64 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 128.237 2.827 . . . . 0.0 108.6 -168.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' TYR . 1.3 mp0 -71.74 -36.21 70.39 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 126.613 1.965 . . . . 0.0 110.169 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -106.66 1.27 24.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.334 1.054 . . . . 0.0 112.085 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.29 120.83 2.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.587 1.555 . . . . 0.0 109.009 168.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 55.46 25.7 8.06 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.13 0.972 . . . . 0.0 113.465 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.88 -38.57 91.4 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 120.855 -1.153 . . . . 0.0 110.743 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.61 -32.99 73.14 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.074 -0.391 . . . . 0.0 111.795 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.697 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.8 tp -60.75 -46.29 91.04 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.116 0.966 . . . . 0.0 110.797 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.66 -40.35 96.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.5 mtm -68.52 -43.1 77.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.875 0.837 . . . . 0.0 112.461 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.585 HD12 HD12 ' A' ' 53' ' ' ILE . 4.7 mt -63.5 -33.27 75.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.3 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -65.35 -42.46 92.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.969 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.33 -42.46 92.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.675 1.19 . . . . 0.0 111.743 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -55.19 -59.33 4.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.619 1.168 . . . . 0.0 108.403 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 mt -76.95 -20.17 56.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.445 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -62.31 -28.81 70.0 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.234 0.924 . . . . 0.0 110.425 168.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.09 -24.07 47.7 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.646 -1.284 . . . . 0.0 109.572 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 18.8 mmmt -80.83 3.64 21.84 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.295 1.838 . . . . 0.0 113.08 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.17 80.4 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 118.593 0.633 . . . . 0.0 111.635 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.74 171.67 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.674 0.79 . . . . 0.0 109.046 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -117.98 141.9 47.95 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.51 147.69 32.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.487 1.039 . . . . 0.0 111.514 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.9 m -128.27 178.4 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.315 1.046 . . . . 0.0 108.802 169.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 35.94 37.57 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 118.608 -1.107 . . . . 0.0 114.286 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -77.87 152.82 33.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.667 1.733 . . . . 0.0 109.201 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -128.18 147.44 63.51 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 117.411 -1.281 . . . . 0.0 108.45 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.52 140.53 40.05 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.132 1.221 . . . . 0.0 109.651 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 139' ' ' PHE . 78.8 p . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 125.878 1.671 . . . . 0.0 113.822 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -163.52 -53.01 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.218 0.607 . . . . 0.0 109.711 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 2.9 t 58.64 8.81 0.97 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.969 2.508 . . . . 0.0 114.616 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -68.46 139.74 92.03 Favored Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 120.835 -1.166 . . . . 0.0 108.817 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -85.03 -11.3 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.9 2.4 . . . . 0.0 113.085 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -77.85 -50.61 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -168.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -88.39 42.54 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.179 1.919 . . . . 0.0 112.163 -169.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 147.66 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.771 -1.206 . . . . 0.0 109.806 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 -172.47 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 125.968 1.707 . . . . 0.0 110.182 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.07 -116.49 0.84 Allowed 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.1 1.36 . . . . 0.0 107.579 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.25 8.56 33.96 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.839 1.256 . . . . 0.0 111.871 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.25 21.56 19.73 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.986 1.279 . . . . 0.0 112.504 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -99.77 -18.32 17.27 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.693 1.197 . . . . 0.0 110.764 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.5 144.35 51.07 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.257 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -78.13 154.98 30.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.114 1.366 . . . . 0.0 109.826 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' A' ' 101' ' ' LEU . 16.1 m -65.61 -12.49 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.587 1.155 . . . . 0.0 112.618 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.84 -177.21 44.69 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 119.763 1.165 . . . . 0.0 112.475 -172.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 24.7 tp -65.77 131.26 45.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.08 112.88 20.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.9 mt -110.96 154.2 24.45 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.268 1.027 . . . . 0.0 109.59 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.47 128.27 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -102.5 13.79 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.399 1.079 . . . . 0.0 110.793 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -22.44 5.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.1 -49.24 2.98 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.765 1.226 . . . . 0.0 108.153 172.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.48 22.38 15.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.36 1.464 . . . . 0.0 112.809 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -52.52 -26.86 14.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.138 0.575 . . . . 0.0 112.411 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.75 -25.19 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.43 0.692 . . . . 0.0 111.677 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -125.13 -11.31 7.03 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.121 0.969 . . . . 0.0 112.153 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.0 m -56.94 -29.77 63.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.017 1.28 . . . . 0.0 109.351 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.83 -37.78 77.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.219 1.408 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.8 -37.49 27.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.577 1.151 . . . . 0.0 110.039 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -67.89 -31.06 70.6 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.33 -54.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -52.67 -47.73 66.98 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.061 1.344 . . . . 0.0 110.411 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.3 m -66.41 -36.31 82.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.256 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.411 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 31.2 t90 -66.27 -44.67 82.94 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.547 0.689 . . . . 0.0 109.963 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.5 m -58.18 -36.1 72.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.794 0.838 . . . . 0.0 109.691 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -69.62 -31.33 69.39 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.597 0.561 . . . . 0.0 109.854 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -79.59 -47.58 15.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.674 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.32 -38.85 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 121.018 1.735 . . . . 0.0 110.349 -169.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.94 -14.28 59.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.104 0.561 . . . . 0.0 111.976 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.23 -46.54 6.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.57 -39.5 80.46 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.292 0.637 . . . . 0.0 110.062 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.5 mtm -78.49 -38.3 41.17 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 -176.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.3 62.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.145 0.978 . . . . 0.0 109.96 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.15 -29.68 70.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.036 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -64.36 -47.63 78.58 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 110.58 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -2.12 51.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.601 1.161 . . . . 0.0 113.649 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.49 178.738 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.604 ' SD ' HG21 ' A' ' 48' ' ' VAL . 27.2 ttm . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.58 144.24 51.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.943 2.097 . . . . 0.0 106.344 169.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.95 146.4 50.33 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 -166.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.29 114.27 3.93 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.09 101.32 13.98 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.816 1.308 . . . . 0.0 110.665 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.84 146.65 26.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.773 1.229 . . . . 0.0 111.57 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 39.0 p90 -163.84 173.86 12.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.364 1.066 . . . . 0.0 109.61 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.23 139.85 8.66 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 169.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -136.83 133.18 35.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.763 1.225 . . . . 0.0 110.551 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.48 -42.24 13.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.806 0.843 . . . . 0.0 109.307 174.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.3 p -97.27 -84.24 0.38 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 p -174.83 -5.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.189 2.596 . . . . 0.0 112.104 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -67.73 -40.91 84.18 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 119.796 -1.815 . . . . 0.0 111.449 -168.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -34.86 78.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 5.6 tt0 -64.74 -48.48 74.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.016 0.926 . . . . 0.0 109.918 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.3 mtm -66.76 -36.86 83.42 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.644 -0.66 . . . . 0.0 111.452 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.99 97.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.646 -0.659 . . . . 0.0 110.69 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.07 85.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.544 1.137 . . . . 0.0 111.278 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.82 -48.52 81.04 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.182 0.993 . . . . 0.0 109.238 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -59.71 -56.44 21.88 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.35 -56.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.066 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -53.78 -43.19 69.04 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.129 0.971 . . . . 0.0 110.349 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.91 -42.5 69.86 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.024 0.53 . . . . 0.0 111.144 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.8 mt -65.25 -49.83 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 108.822 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 164' ' ' ILE . 61.0 mt -71.87 -52.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.143 0.977 . . . . 0.0 110.254 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.07 112.56 0.4 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.65 -3.99 11.3 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.243 2.628 . . . . 0.0 112.639 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.98 -34.46 59.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.693 1.597 . . . . 0.0 109.546 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -27.71 6.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.152 1.781 . . . . 0.0 109.99 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.5 140.08 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.953 1.706 . . . . 0.0 109.428 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 m -132.69 129.73 39.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.28 1.7 pt? -101.39 156.78 17.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.549 1.068 . . . . 0.0 113.044 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -147.93 113.93 5.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.164 1.386 . . . . 0.0 109.142 -166.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.9 112.38 19.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.74 -10.53 20.13 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.973 0.909 . . . . 0.0 113.309 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -57.88 -29.19 64.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.115 0.871 . . . . 0.0 111.798 168.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -130.05 -33.93 1.72 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.785 1.234 . . . . 0.0 111.708 -172.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -84.04 141.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.12 0.968 . . . . 0.0 108.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.0 m -85.09 143.15 39.25 Favored Pre-proline 0 C--O 1.225 -0.218 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.79 -6.51 18.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.781 1.654 . . . . 0.0 111.736 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -54.92 -37.4 66.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.781 1.628 . . . . 0.0 111.313 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -21.22 66.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -13.65 22.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 169.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.72 -26.0 61.42 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.89 -1.131 . . . . 0.0 110.669 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -77.6 -50.3 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.062 0.847 . . . . 0.0 110.273 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.09 139.44 58.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.89 -21.93 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.23 0.538 . . . . 0.0 111.399 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG21 ' SD ' ' A' ' 1' ' ' MET . 57.6 t -140.38 141.96 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -172.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -129.74 158.14 40.21 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.892 0.377 . . . . 0.0 110.755 174.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.63 122.49 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.87 134.28 55.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -127.77 119.11 3.08 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 117.826 -1.541 . . . . 0.0 112.725 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.89 132.54 24.22 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 119.114 1.457 . . . . 0.0 110.864 178.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.46 149.1 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.427 2.085 . . . . 0.0 108.297 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 m -94.52 130.15 41.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -124.54 170.93 10.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.881 1.673 . . . . 0.0 109.472 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 31.92 54.89 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.736 2.414 . . . . 0.0 115.313 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 57.23 76.65 0.31 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.111 1.364 . . . . 0.0 112.755 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.42 25.42 75.5 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.791 -0.568 . . . . 0.0 114.482 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -97.37 164.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.72 1.608 . . . . 0.0 110.318 169.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.8 mt -101.73 151.85 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 126.153 1.781 . . . . 0.0 106.461 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.1 144.08 56.91 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.65 -27.2 68.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.114 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -66.77 -26.49 66.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.806 0.843 . . . . 0.0 110.642 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.9 m95 -84.55 -43.05 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.27 1.028 . . . . 0.0 110.819 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.26 -36.09 63.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.443 0.565 . . . . 0.0 110.746 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -31.07 71.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.49 1.116 . . . . 0.0 112.174 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.12 -10.8 10.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.4 t-105 -53.57 -29.29 36.52 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.604 . . . . 0.0 111.621 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.8 -43.64 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.004 1.322 . . . . 0.0 111.154 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -69.24 -29.71 67.7 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.114 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.99 -31.1 64.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.086 1.312 . . . . 0.0 111.055 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.48 -28.17 64.78 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.625 0.77 . . . . 0.0 111.22 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.96 -23.59 36.01 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.511 0.724 . . . . 0.0 111.114 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.68 158.22 32.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.937 1.351 . . . . 0.0 111.961 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -91.72 99.87 12.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.866 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.77 9.08 11.96 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.17 122.16 15.94 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.98 84.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.93 1.252 . . . . 0.0 114.564 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -83.05 147.35 28.19 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.206 1.003 . . . . 0.0 110.274 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -80.99 139.11 18.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.73 123.98 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 125.016 1.326 . . . . 0.0 109.127 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -104.44 115.43 30.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 mt -88.78 141.58 28.38 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 118.828 0.74 . . . . 0.0 111.572 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 18.2 p90 -140.2 163.36 32.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.431 1.093 . . . . 0.0 108.5 169.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 179.24 38.59 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.115 -0.99 . . . . 0.0 112.519 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.8 mt -123.67 152.76 41.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.148 0.979 . . . . 0.0 108.809 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 -163.04 13.27 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.834 0.73 . . . . 0.0 111.306 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.77 117.21 7.46 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.753 2.021 . . . . 0.0 105.99 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.42 -28.75 24.9 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.992 0.36 . . . . 0.0 111.397 -171.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.93 -45.86 55.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.164 0.585 . . . . 0.0 110.284 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.36 -36.29 17.76 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.727 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -135.24 37.8 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.75 -39.75 68.72 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 119.687 1.13 . . . . 0.0 111.322 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.41 -17.15 58.5 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 117.962 0.881 . . . . 0.0 112.626 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -129.54 13.19 5.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.031 1.732 . . . . 0.0 112.342 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -44.6 126.38 5.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.796 1.638 . . . . 0.0 110.013 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.87 25.83 2.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.186 1.395 . . . . 0.0 113.34 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.03 -37.2 84.04 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 120.402 -1.436 . . . . 0.0 110.707 -170.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.72 73.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.24 0.616 . . . . 0.0 111.961 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.8 tp -60.92 -46.26 91.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.199 0.999 . . . . 0.0 110.771 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.64 99.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.9 mtm -62.08 -45.67 92.48 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 117.578 0.689 . . . . 0.0 111.607 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -65.54 -33.44 75.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.84 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -62.01 -39.53 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.246 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.11 -36.23 66.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.796 1.638 . . . . 0.0 112.192 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.9 tptt -57.51 -46.05 84.24 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.726 0.81 . . . . 0.0 109.98 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.39 -19.07 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.623 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p -61.4 -31.94 71.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.663 1.574 . . . . 0.0 111.88 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -78.36 -18.35 55.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.794 -0.566 . . . . 0.0 110.368 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -78.96 1.39 23.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.134 1.373 . . . . 0.0 112.031 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.96 65.01 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.79 0.723 . . . . 0.0 111.908 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.38 170.32 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.738 0.815 . . . . 0.0 109.603 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -118.33 135.09 54.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -102.81 147.1 27.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -127.3 175.61 8.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.58 39.09 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.822 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -72.98 150.78 42.19 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.124 1.962 . . . . 0.0 108.008 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.53 145.12 56.15 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.009 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.04 141.89 45.29 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 121.177 1.456 . . . . 0.0 109.238 168.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 ' CD1' ' A' ' 139' ' ' PHE . 81.9 p . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 125.81 1.644 . . . . 0.0 113.894 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -160.09 -57.0 0.06 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.799 0.727 . . . . 0.0 110.265 -169.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.353 4.3 t 58.59 10.81 1.52 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.935 2.494 . . . . 0.0 114.572 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.6 t -62.96 131.52 94.69 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.28 -13.41 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.397 2.065 . . . . 0.0 112.836 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -80.64 -48.03 1.2 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -169.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -88.04 39.06 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.089 1.859 . . . . 0.0 112.212 -168.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.32 147.04 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 119.212 0.914 . . . . 0.0 109.4 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.852 1.661 . . . . 0.0 109.794 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.81 -116.29 0.84 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.318 1.447 . . . . 0.0 107.491 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -105.21 7.89 33.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.791 1.237 . . . . 0.0 112.111 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.16 20.23 18.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.639 1.114 . . . . 0.0 112.463 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.05 -17.86 17.28 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 110.863 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.96 143.96 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.897 0.479 . . . . 0.0 110.706 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.505 ' CD1' HG22 ' A' ' 121' ' ' THR . 63.1 m-85 -77.9 156.09 30.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.818 1.247 . . . . 0.0 109.111 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.01 -15.65 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.087 0.955 . . . . 0.0 112.315 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.02 -176.63 40.35 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 119.985 1.266 . . . . 0.0 111.763 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.8 tp -63.81 126.86 28.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.0 119.79 40.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.5 mt -113.5 146.09 40.17 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.39 131.11 55.62 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 170.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.57 30.23 7.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.243 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.47 -34.52 0.84 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -116.91 -30.77 5.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 120.131 1.332 . . . . 0.0 111.788 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.95 3.5 52.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.872 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -58.28 -21.88 50.51 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.298 0.954 . . . . 0.0 112.137 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.29 -24.43 42.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.277 1.031 . . . . 0.0 111.508 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -126.29 -5.8 6.58 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.735 0.814 . . . . 0.0 112.864 -170.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -56.72 -29.89 62.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.078 0.854 . . . . 0.0 110.482 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.73 -38.18 64.08 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.849 1.66 . . . . 0.0 111.731 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -36.6 23.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.745 1.218 . . . . 0.0 109.945 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -67.44 -26.37 66.37 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.986 0.915 . . . . 0.0 109.52 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.38 -57.58 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -49.78 -48.26 50.6 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 110.563 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -65.35 -37.46 87.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.385 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 33.8 t90 -66.36 -43.43 86.04 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -58.18 -35.44 71.6 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.568 0.747 . . . . 0.0 109.426 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -33.78 76.42 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.433 0.458 . . . . 0.0 110.047 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.79 -46.13 15.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.56 -1.21 . . . . 0.0 111.85 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 25' ' ' ILE . 6.5 pt -65.02 -39.78 86.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.375 1.898 . . . . 0.0 109.959 -169.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.87 -21.93 66.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.819 -0.551 . . . . 0.0 110.749 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -89.63 -42.66 11.25 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.75 -31.26 68.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.807 0.73 . . . . 0.0 109.979 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.9 mtm -86.01 -44.03 12.66 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.889 1.275 . . . . 0.0 109.029 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.5 83.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.317 1.047 . . . . 0.0 111.961 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.52 -27.54 63.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.959 1.304 . . . . 0.0 109.766 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -67.63 -31.77 72.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.558 0.617 . . . . 0.0 111.52 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.443 ' CE1' ' CE ' ' A' ' 1' ' ' MET . 2.8 m-30 -58.43 -29.91 66.48 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 O-C-N 123.745 0.653 . . . . 0.0 111.084 -167.617 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.56 140.83 30.31 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.78 146.65 48.18 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.995 2.118 . . . . 0.0 108.769 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.29 116.49 4.41 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-O 118.49 -1.172 . . . . 0.0 111.215 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 100.2 12.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.339 1.569 . . . . 0.0 110.051 172.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -98.96 145.31 27.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.454 1.502 . . . . 0.0 111.551 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -165.87 173.13 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.742 1.217 . . . . 0.0 109.014 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.22 127.88 2.89 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 172.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -128.85 131.73 47.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.714 1.606 . . . . 0.0 109.148 -170.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -84.59 -36.47 22.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.9 p -103.7 -81.65 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -177.6 -4.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.621 2.768 . . . . 0.0 112.111 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.46 -43.44 73.22 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 122.088 2.222 . . . . 0.0 111.054 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -67.89 -30.94 70.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.757 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.86 -46.41 75.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.962 0.905 . . . . 0.0 110.594 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.12 -35.67 81.53 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.42 98.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.029 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.52 74.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.808 0.843 . . . . 0.0 110.666 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.54 -47.14 85.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 122.89 0.476 . . . . 0.0 110.031 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 24' ' ' ILE . 57.0 mttm -61.3 -55.04 36.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.788 1.235 . . . . 0.0 108.905 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.55 -56.49 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.99 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.66 70.84 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.117 0.567 . . . . 0.0 110.372 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.42 -47.01 74.61 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.827 0.451 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LYS . 6.9 mt -66.21 -47.98 82.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.299 1.04 . . . . 0.0 108.898 -175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 164' ' ' ILE . 69.5 mt -71.03 -50.5 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.765 0.826 . . . . 0.0 110.415 -176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.55 114.55 0.76 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.63 2.97 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.454 2.769 . . . . 0.0 112.889 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.4 -34.36 67.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.056 1.342 . . . . 0.0 109.09 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.46 -21.43 3.83 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.44 1.496 . . . . 0.0 111.509 -169.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -93.93 142.05 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 120.828 1.649 . . . . 0.0 108.992 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.4 m -132.58 129.47 39.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.437 1.095 . . . . 0.0 110.054 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 147.77 49.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 111.539 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.91 107.16 4.35 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 107.604 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.96 112.79 20.06 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.23 -10.24 22.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.795 1.238 . . . . 0.0 112.999 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -59.93 -28.33 67.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.08 0.855 . . . . 0.0 111.847 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -129.15 -33.96 1.91 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.9 1.28 . . . . 0.0 111.882 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.21 141.71 29.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.29 1.036 . . . . 0.0 109.05 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -84.78 142.53 39.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.0 -6.28 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.481 1.454 . . . . 0.0 111.419 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -54.15 -37.84 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.986 1.721 . . . . 0.0 111.422 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -21.86 66.53 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -14.7 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.061 1.344 . . . . 0.0 112.235 169.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -72.7 -26.14 61.49 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.942 -1.099 . . . . 0.0 110.775 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -78.15 -49.21 14.3 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.869 0.759 . . . . 0.0 110.092 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -65.27 140.0 58.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.74 1.216 . . . . 0.0 108.436 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -73.04 -29.32 62.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.656 0.741 . . . . 0.0 110.827 -174.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.0 t -142.52 143.81 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.66 155.5 49.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.597 0.635 . . . . 0.0 109.512 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.76 122.21 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.37 145.58 47.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 147.3 15.79 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.754 -1.212 . . . . 0.0 115.759 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -134.72 134.35 22.03 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.67 1.988 . . . . 0.0 109.582 -169.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -84.92 140.69 8.04 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 107.274 165.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -88.58 103.99 16.42 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -88.07 169.13 12.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.832 0.853 . . . . 0.0 110.709 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 22.97 66.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.886 2.875 . . . . 0.0 115.602 167.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.63 71.29 0.56 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.367 1.067 . . . . 0.0 112.096 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.42 15.7 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.01 148.41 32.53 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.632 1.206 . . . . 0.0 109.737 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.97 153.08 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -60.98 142.84 56.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.773 0.829 . . . . 0.0 108.941 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.37 -27.85 68.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -166.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.07 -24.31 35.32 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.732 -0.605 . . . . 0.0 110.468 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 53' ' ' ILE . 13.1 m95 -72.91 -43.76 62.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.914 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.34 -35.51 60.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.661 0.664 . . . . 0.0 110.973 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.76 71.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.538 0.735 . . . . 0.0 111.9 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.1 -11.46 10.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.98 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.8 t-105 -53.46 -28.9 32.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.73 1.612 . . . . 0.0 111.6 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.59 -43.88 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.093 1.357 . . . . 0.0 111.346 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.45 -30.01 67.82 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.092 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.6 mt -57.28 -30.46 64.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.945 1.248 . . . . 0.0 111.236 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.32 -28.47 65.19 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.689 0.796 . . . . 0.0 111.467 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.88 -24.33 35.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.184 0.594 . . . . 0.0 111.275 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.61 158.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 123.169 1.462 . . . . 0.0 112.205 -168.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -92.2 98.51 11.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.931 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -119.64 8.81 11.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.83 120.75 13.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.22 12.32 84.25 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.12 1.343 . . . . 0.0 114.12 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -79.52 148.53 31.77 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 117.659 0.729 . . . . 0.0 109.143 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -85.15 141.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 166.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.02 119.6 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 125.758 1.623 . . . . 0.0 107.167 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -98.85 116.63 31.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.127 -0.983 . . . . 0.0 108.617 168.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.08 141.89 29.1 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.19 0.904 . . . . 0.0 112.242 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -137.36 155.43 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.995 0.918 . . . . 0.0 109.162 168.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.81 172.17 36.3 Favored Glycine 0 N--CA 1.451 -0.345 0 O-C-N 120.698 -1.251 . . . . 0.0 112.296 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.78 155.83 40.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.389 1.076 . . . . 0.0 108.443 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.19 -155.64 12.96 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -149.23 140.28 22.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -24.6 20.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.002 1.321 . . . . 0.0 113.811 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -33.24 43.22 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.164 1.347 . . . . 0.0 112.862 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.5 -20.73 36.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.454 1.026 . . . . 0.0 111.266 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -122.37 -86.36 0.65 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.689 1.196 . . . . 0.0 108.051 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.42 -53.3 3.15 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 128.719 3.056 . . . . 0.0 107.703 -168.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.6 -28.0 69.33 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.605 1.962 . . . . 0.0 110.776 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -118.34 6.63 11.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.971 1.308 . . . . 0.0 112.228 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.56 122.22 5.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.976 1.31 . . . . 0.0 109.905 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.41 26.8 7.42 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.195 1.398 . . . . 0.0 113.056 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.47 -38.81 92.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 120.928 -1.108 . . . . 0.0 110.443 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.22 75.28 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.209 0.604 . . . . 0.0 111.907 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.653 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.4 tp -60.34 -45.93 91.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.996 0.918 . . . . 0.0 110.403 175.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.34 97.5 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.6 mtm -66.46 -42.6 87.34 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 118.0 0.9 . . . . 0.0 111.971 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 53' ' ' ILE . 4.1 mt -63.16 -35.11 79.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.546 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -65.31 -42.44 93.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.18 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.7 -42.57 95.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.347 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -55.35 -60.67 3.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.719 1.208 . . . . 0.0 108.224 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.75 -20.36 56.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.906 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -60.96 -29.26 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.579 1.081 . . . . 0.0 110.499 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -22.21 55.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.875 -1.14 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -85.09 2.54 42.95 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 112.458 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.67 36.44 82.87 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.37 0.532 . . . . 0.0 112.12 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.8 169.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.838 0.855 . . . . 0.0 110.076 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -104.3 136.36 44.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -106.76 146.8 30.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.881 1.219 . . . . 0.0 110.658 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.7 m -129.85 178.09 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 123.786 0.834 . . . . 0.0 108.799 169.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.95 38.96 34.35 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-O 118.767 -1.019 . . . . 0.0 113.855 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -79.59 153.99 29.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.462 1.631 . . . . 0.0 109.085 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.21 149.95 75.14 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.635 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.47 140.39 39.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.44 1.426 . . . . 0.0 110.158 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 126.472 1.909 . . . . 0.0 113.503 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 12.3 p90 -162.03 -60.43 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 126' ' ' PHE 0.315 1.9 t 56.95 9.4 0.62 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.276 2.63 . . . . 0.0 114.19 -179.416 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 p -66.82 135.97 94.41 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.832 -1.168 . . . . 0.0 108.974 169.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.98 -13.9 5.38 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.431 2.087 . . . . 0.0 113.671 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.99 -48.41 1.09 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.2 36.96 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.983 1.789 . . . . 0.0 112.965 -168.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.66 147.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.131 0.972 . . . . 0.0 109.529 -167.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.76 -172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.7 . . . . 0.0 109.372 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.01 -117.12 0.87 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.062 1.345 . . . . 0.0 107.518 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -104.88 7.45 34.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.667 1.187 . . . . 0.0 112.003 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.57 20.15 18.12 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.56 1.076 . . . . 0.0 112.787 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.36 -17.26 17.33 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.831 1.252 . . . . 0.0 111.007 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.06 145.25 50.61 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.512 0.725 . . . . 0.0 110.809 174.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.4 m-85 -79.84 154.61 28.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.209 1.404 . . . . 0.0 109.845 177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.98 -12.41 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.813 1.245 . . . . 0.0 112.829 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.29 -176.23 41.65 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.617 1.099 . . . . 0.0 111.863 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 144' ' ' LEU . 34.4 tp -63.0 126.8 28.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.28 121.21 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 153' ' ' SER . 55.8 mt -123.05 155.69 36.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.085 0.954 . . . . 0.0 109.512 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.49 120.82 16.96 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.07 3.66 44.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.553 -172.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -30.84 10.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.537 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.9 -46.61 2.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.257 0.935 . . . . 0.0 110.637 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -99.57 24.01 8.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.334 1.054 . . . . 0.0 111.31 -171.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -53.48 -29.27 35.18 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.712 0.687 . . . . 0.0 111.841 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.97 -22.85 48.82 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.922 0.889 . . . . 0.0 111.213 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.69 -31.04 11.41 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 126.497 1.919 . . . . 0.0 110.245 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.613 ' HA ' HD22 ' A' ' 144' ' ' LEU . 70.6 m -55.92 -26.11 46.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.993 169.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.56 -54.71 11.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.071 0.85 . . . . 0.0 109.959 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -62.55 -32.68 73.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.092 0.949 . . . . 0.0 111.793 -170.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -83.94 -24.07 30.85 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.435 1.494 . . . . 0.0 109.692 -170.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.9 mt -60.73 -52.83 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -54.84 -44.99 74.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.861 0.864 . . . . 0.0 110.582 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -71.3 -33.64 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.686 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CZ2' ' HB1' ' A' ' 83' ' ' ALA . 35.4 t90 -65.45 -44.39 87.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.747 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.0 m -59.52 -36.24 75.73 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.995 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -68.79 -32.5 72.27 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 122.789 0.435 . . . . 0.0 110.564 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -79.11 -46.42 18.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.741 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 25' ' ' ILE . 7.0 pt -65.0 -38.0 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 120.597 1.544 . . . . 0.0 109.838 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.46 -12.26 50.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.477 0.581 . . . . 0.0 112.187 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -95.29 -46.6 6.67 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.28 -36.23 79.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.947 0.794 . . . . 0.0 110.637 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -82.04 -37.38 26.57 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.209 1.003 . . . . 0.0 110.834 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.24 -45.28 56.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 110.228 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.79 -30.07 68.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 110.084 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 81' ' ' ILE . 68.0 t60 -63.98 -53.11 55.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.068 0.547 . . . . 0.0 109.822 169.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -9.3 58.83 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.681 178.224 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.53 143.49 31.98 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mtm -132.18 149.56 52.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 107.55 -170.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.16 121.23 5.24 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.759 -1.023 . . . . 0.0 110.671 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.61 113.59 25.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.826 1.313 . . . . 0.0 109.07 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 43' ' ' MET . 73.8 m-85 -109.69 145.93 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.395 1.478 . . . . 0.0 111.748 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -162.67 172.23 15.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.237 1.015 . . . . 0.0 109.602 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.36 136.58 7.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 168.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -134.52 128.82 34.09 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.813 1.245 . . . . 0.0 110.871 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.1 m -89.79 -42.26 11.38 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.933 0.493 . . . . 0.0 110.014 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -92.62 -82.33 0.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.7 p -177.13 -6.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.464 2.306 . . . . 0.0 112.559 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.42 -44.47 91.1 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 119.817 -1.802 . . . . 0.0 112.062 -168.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -37.99 88.16 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.3 -46.58 89.72 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.632 0.773 . . . . 0.0 110.316 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.6 mtm -67.34 -43.23 82.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.158 0.436 . . . . 0.0 110.979 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.5 87.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.709 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.72 80.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.776 0.83 . . . . 0.0 110.823 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.65 -44.13 93.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -63.2 -53.86 46.63 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.004 1.321 . . . . 0.0 108.992 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -53.24 -56.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.843 0.747 . . . . 0.0 110.091 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -38.29 79.75 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.385 -178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.36 -47.9 71.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.056 0.542 . . . . 0.0 111.033 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.6 mt -65.75 -48.24 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.437 1.095 . . . . 0.0 108.674 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 164' ' ' ILE . 79.5 mt -71.1 -49.9 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 123.461 0.704 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.97 114.31 0.77 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.19 4.15 3.52 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.48 2.787 . . . . 0.0 112.577 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.59 -34.38 67.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.225 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 -21.24 3.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.424 1.49 . . . . 0.0 111.694 -169.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.13 141.63 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.583 1.538 . . . . 0.0 108.995 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.3 m -131.56 128.91 40.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.328 1.051 . . . . 0.0 109.817 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.55 149.12 47.44 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.521 0.729 . . . . 0.0 112.048 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -146.97 111.85 5.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.995 1.718 . . . . 0.0 106.926 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.82 112.48 21.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.23 -8.79 19.15 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -59.27 -28.64 66.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.255 0.934 . . . . 0.0 111.762 168.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -132.26 -33.64 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.545 1.138 . . . . 0.0 111.973 -171.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.66 140.5 30.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 109.019 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -86.03 141.66 35.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 75' ' ' LEU . 18.4 Cg_endo -72.57 1.41 6.3 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.666 2.244 . . . . 0.0 111.695 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -59.6 -34.79 73.2 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 119.057 -2.277 . . . . 0.0 111.576 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -17.97 63.29 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.442 ' HG3' ' CZ ' ' A' ' 6' ' ' PHE . 15.7 mtm -59.09 -15.84 16.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 0.0 111.791 168.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 54.6 mt-10 -72.3 -26.53 62.0 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.976 -1.078 . . . . 0.0 111.529 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.96 -50.33 11.32 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.984 0.811 . . . . 0.0 110.347 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -67.68 147.19 53.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.124 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -79.13 -23.41 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.968 -0.457 . . . . 0.0 110.938 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.4 t -143.21 138.49 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.91 152.4 47.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.15 125.4 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.29 134.47 52.25 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.686 0.794 . . . . 0.0 109.321 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.54 117.54 3.64 Favored Glycine 0 N--CA 1.463 0.436 0 CA-C-O 116.989 -2.006 . . . . 0.0 111.705 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -115.32 126.74 27.46 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 120.168 1.984 . . . . 0.0 110.932 172.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.98 141.79 10.74 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.548 2.832 . . . . 0.0 108.354 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -91.23 112.03 23.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -98.53 170.46 8.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.476 1.111 . . . . 0.0 110.592 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.74 62.92 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.783 2.833 . . . . 0.0 115.449 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 57.09 74.87 0.39 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.762 1.225 . . . . 0.0 112.626 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.11 71.08 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.12 164.28 23.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.564 1.173 . . . . 0.0 108.762 168.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.12 153.27 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -59.85 141.61 55.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.57 -29.36 69.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -166.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.64 -21.17 52.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.614 -0.679 . . . . 0.0 110.283 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.0 m95 -77.84 -45.27 24.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.497 168.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -53.76 -36.0 61.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.182 0.593 . . . . 0.0 110.886 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.73 70.99 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.299 1.04 . . . . 0.0 112.061 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.9 -8.69 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.569 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.0 t-105 -54.31 -28.95 45.74 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 111.677 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -45.11 71.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.771 1.228 . . . . 0.0 111.646 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.43 -26.11 66.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 117.727 -1.13 . . . . 0.0 112.388 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.16 -30.95 68.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.055 1.298 . . . . 0.0 111.042 -176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -70.12 -26.92 64.18 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.238 0.615 . . . . 0.0 111.583 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.09 -23.16 33.22 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.289 0.635 . . . . 0.0 111.484 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 40' ' ' PRO . 21.3 mt -72.14 171.83 11.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.504 1.145 . . . . 0.0 111.073 -170.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 13.7 t30 -111.78 103.26 11.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.029 1.732 . . . . 0.0 108.442 173.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -121.83 10.79 10.3 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.67 121.95 15.18 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.9 8.91 86.8 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.169 1.366 . . . . 0.0 114.605 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.79 151.19 32.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 117.976 0.888 . . . . 0.0 109.032 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.733 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.0 mt -88.99 141.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.34 126.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.002 1.321 . . . . 0.0 108.328 176.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.39 110.29 22.58 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 105' ' ' HIS . 58.0 mt -88.5 142.76 27.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.925 0.784 . . . . 0.0 110.637 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -137.62 162.37 33.98 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.168 1.387 . . . . 0.0 108.163 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.1 173.64 36.77 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 121.369 -0.832 . . . . 0.0 112.119 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.8 mt -128.99 154.6 46.45 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.97 1.308 . . . . 0.0 108.087 -172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.67 -152.4 9.43 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -157.22 142.76 17.41 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.739 2.016 . . . . 0.0 107.142 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -91.98 -26.78 18.23 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.81 -32.93 63.98 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.894 1.224 . . . . 0.0 112.835 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.7 -16.52 48.45 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 124.251 0.929 . . . . 0.0 111.795 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -127.54 -88.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.49 1.516 . . . . 0.0 108.761 -168.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.26 -50.74 2.8 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 129.247 3.308 . . . . 0.0 108.364 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.22 -25.78 65.38 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 125.636 1.574 . . . . 0.0 110.885 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -119.12 8.09 11.48 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.949 1.3 . . . . 0.0 112.449 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -46.7 123.08 4.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.191 1.397 . . . . 0.0 110.399 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 52.36 27.52 4.93 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.011 1.324 . . . . 0.0 113.122 173.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.22 -34.75 78.14 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.529 -170.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.27 71.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.453 0.701 . . . . 0.0 111.606 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.624 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -62.42 -47.17 85.27 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.133 0.973 . . . . 0.0 109.972 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.87 -40.87 97.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.2 mtm -66.58 -45.31 79.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.156 0.978 . . . . 0.0 112.214 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.569 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -66.48 -32.0 73.09 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.552 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' HD12 ' A' ' 84' ' ' LEU . 2.1 m-70 -59.12 -47.93 83.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.064 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.02 -41.26 95.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.286 1.035 . . . . 0.0 111.427 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -55.4 -57.99 9.57 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 108.883 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.8 -19.63 48.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.446 -169.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -61.27 -29.13 69.66 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.109 0.868 . . . . 0.0 110.246 169.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -22.48 56.28 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.68 -1.263 . . . . 0.0 109.769 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -84.48 1.19 46.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.555 1.542 . . . . 0.0 112.36 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.95 34.87 71.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 112.155 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.74 173.02 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.956 0.902 . . . . 0.0 109.85 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -118.28 143.74 46.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.37 147.71 34.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.823 1.192 . . . . 0.0 111.62 -170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 15.3 m -128.82 -179.79 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.661 0.784 . . . . 0.0 109.945 171.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 38.41 30.64 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.807 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -77.98 151.94 33.38 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.521 1.66 . . . . 0.0 108.368 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.62 146.56 60.97 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-O 116.968 -1.491 . . . . 0.0 109.461 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.49 139.48 45.1 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 CA-C-N 120.953 1.376 . . . . 0.0 110.186 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 139' ' ' PHE . 74.0 p . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 126.228 1.811 . . . . 0.0 113.931 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -164.57 -49.45 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.679 0.672 . . . . 0.0 110.09 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.305 2.5 t 58.7 9.05 1.03 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.149 2.58 . . . . 0.0 114.391 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.98 134.91 52.1 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 109.449 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -86.42 -11.37 6.09 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.53 2.154 . . . . 0.0 113.948 -172.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.46 -48.86 3.04 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -89.77 38.32 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.708 1.646 . . . . 0.0 112.113 -169.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.44 150.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.632 1.173 . . . . 0.0 110.166 -166.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.413 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -127.96 -172.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 126.322 1.849 . . . . 0.0 109.805 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.02 -116.64 0.85 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.123 1.369 . . . . 0.0 107.606 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.22 8.38 33.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.964 1.306 . . . . 0.0 111.957 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.17 21.0 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.875 1.226 . . . . 0.0 112.593 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -99.58 -17.36 17.88 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.781 1.232 . . . . 0.0 110.573 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.93 142.71 49.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.043 0.537 . . . . 0.0 111.305 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.3 m-85 -77.4 155.8 31.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.375 1.47 . . . . 0.0 108.926 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.413 HG12 HG23 ' A' ' 133' ' ' ILE . 30.9 m -68.24 -14.56 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.356 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -162.46 179.83 37.52 Favored Glycine 0 N--CA 1.47 0.948 0 O-C-N 119.974 -1.704 . . . . 0.0 111.987 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.9 tp -63.31 128.1 34.29 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.91 126.44 55.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.28 156.37 37.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.77 115.36 15.87 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -93.0 26.17 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.934 -168.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.7 -25.87 3.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.778 168.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.39 -36.05 3.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.343 1.429 . . . . 0.0 111.654 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -84.26 -2.82 57.63 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.863 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -55.29 -24.63 29.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.056 1.753 . . . . 0.0 112.376 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.97 -20.84 28.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.038 1.335 . . . . 0.0 112.83 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 -6.78 8.91 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.957 1.303 . . . . 0.0 113.025 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -54.23 -28.63 42.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.46 1.482 . . . . 0.0 111.329 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -52.35 -40.49 62.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.843 1.257 . . . . 0.0 111.611 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -31.49 69.25 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.33 1.852 . . . . 0.0 111.318 -177.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -92.46 -19.4 22.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.765 1.226 . . . . 0.0 110.606 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.46 -58.53 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.2 pt20 -54.04 -42.57 69.33 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.861 0.864 . . . . 0.0 112.617 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 p -68.16 -35.22 77.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 35.9 t90 -65.64 -45.02 84.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.041 0.924 . . . . 0.0 109.604 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 91.2 m -58.0 -34.59 70.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.336 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.42 -28.19 63.82 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.947 0.499 . . . . 0.0 110.386 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -83.55 -45.92 13.01 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.67 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 25' ' ' ILE . 6.3 pt -63.64 -36.96 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.945 1.702 . . . . 0.0 109.75 -171.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.9 -12.31 35.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.51 -51.23 5.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.679 1.592 . . . . 0.0 107.795 169.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.77 -22.61 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.161 0.584 . . . . 0.0 111.752 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.733 ' HG2' HG21 ' A' ' 81' ' ' ILE . 68.7 mtm -93.78 -42.11 9.3 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 124.926 1.29 . . . . 0.0 111.514 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.45 -43.8 38.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.584 0.753 . . . . 0.0 110.854 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.03 -28.86 65.82 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.217 1.407 . . . . 0.0 109.603 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -61.57 -43.54 98.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.97 -1.59 57.98 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 113.454 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.384 178.217 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.19 142.98 30.79 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 mtm -131.62 147.35 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.383 1.873 . . . . 0.0 107.858 -170.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.74 119.24 5.02 Favored Glycine 0 N--CA 1.46 0.28 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 99.49 12.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.799 1.3 . . . . 0.0 109.326 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -97.86 146.79 25.09 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.704 1.202 . . . . 0.0 109.979 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -165.27 173.11 11.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.49 132.45 6.21 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 105.889 -2.885 . . . . 0.0 105.889 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -152.52 147.86 26.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -125.23 -31.98 3.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.294 1.438 . . . . 0.0 108.876 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 p -88.36 -6.51 57.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.348 1.859 . . . . 0.0 111.618 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.25 43.8 m 71.69 10.13 6.34 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 127.754 2.422 . . . . 0.0 115.144 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -65.87 -44.79 84.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.807 1.64 . . . . 0.0 111.016 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -34.96 79.57 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -65.45 -46.97 77.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.014 0.926 . . . . 0.0 110.422 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.0 mtm -63.89 -39.4 94.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.388 0.54 . . . . 0.0 110.9 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.02 99.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.739 172.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.39 76.83 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.928 0.891 . . . . 0.0 110.539 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -57.21 -47.32 81.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.013 0.525 . . . . 0.0 109.69 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.61 -54.02 45.82 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 124.598 1.186 . . . . 0.0 108.525 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -52.94 -56.78 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 118.733 0.697 . . . . 0.0 109.562 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -38.98 72.68 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.262 0.625 . . . . 0.0 110.529 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -46.69 73.05 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.745 0.418 . . . . 0.0 111.275 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 158' ' ' GLN . 16.0 mt -66.17 -48.15 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.785 1.234 . . . . 0.0 108.704 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.97 -50.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.768 0.827 . . . . 0.0 110.415 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.98 115.22 0.73 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 170.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.06 3.47 3.95 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.479 2.786 . . . . 0.0 112.788 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.12 -34.35 66.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.036 1.334 . . . . 0.0 109.236 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 -23.49 3.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.838 1.655 . . . . 0.0 111.422 -169.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.55 141.04 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.696 1.589 . . . . 0.0 109.352 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -130.23 128.61 42.01 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.216 1.007 . . . . 0.0 110.043 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.38 145.26 51.24 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.98 0.912 . . . . 0.0 111.216 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -148.66 112.71 5.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -93.3 116.59 29.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -67.15 -11.12 56.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.768 -174.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -58.72 -25.82 63.32 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.6 . . . . 0.0 111.618 168.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -134.8 -31.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.804 0.842 . . . . 0.0 111.85 -167.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.12 154.12 18.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.658 1.183 . . . . 0.0 112.05 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -96.28 134.39 23.64 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 125.153 1.381 . . . . 0.0 109.715 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.45 -6.62 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 112.366 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -49.22 -40.03 32.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.441 1.473 . . . . 0.0 111.526 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -23.09 67.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -14.6 31.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.374 1.07 . . . . 0.0 112.378 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.97 -25.51 61.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.053 -1.029 . . . . 0.0 110.615 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -75.89 -49.89 16.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.23 0.923 . . . . 0.0 110.24 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -66.73 147.68 52.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.436 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.0 -28.06 60.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.829 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 49' ' ' LEU . 38.7 t -144.95 142.56 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -168.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -127.84 160.28 32.27 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.681 0.673 . . . . 0.0 111.133 173.474 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.26 123.66 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 166.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -121.53 145.69 47.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.04 150.66 22.23 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.668 -1.253 . . . . 0.0 114.855 173.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -133.26 135.11 24.93 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.382 1.873 . . . . 0.0 109.453 -169.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.11 141.45 9.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 N-CA-C 107.64 -1.716 . . . . 0.0 107.64 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.0 m -86.33 104.92 16.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -86.89 168.77 13.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.926 1.29 . . . . 0.0 109.613 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 19.72 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.483 3.113 . . . . 0.0 115.878 166.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 56.24 72.39 0.5 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.338 1.055 . . . . 0.0 112.279 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.79 11.58 78.01 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.46 149.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.61 1.195 . . . . 0.0 110.635 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mt -84.72 153.51 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 172.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -62.19 143.47 56.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.72 -27.23 68.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.39 -28.94 31.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.635 -0.666 . . . . 0.0 110.653 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.2 m95 -65.55 -44.02 88.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 169.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -55.92 -37.78 69.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.37 0.532 . . . . 0.0 110.92 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.8 73.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.947 0.499 . . . . 0.0 111.761 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 m -99.64 -11.85 8.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.727 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.567 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -53.87 -28.81 38.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.184 1.793 . . . . 0.0 111.606 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.34 -43.22 64.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.267 1.427 . . . . 0.0 111.125 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.33 -31.03 70.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 117.772 -1.108 . . . . 0.0 111.843 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.1 mt -56.5 -32.76 65.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.863 1.21 . . . . 0.0 110.923 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.94 -28.53 66.73 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.375 0.67 . . . . 0.0 111.43 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.02 -25.58 34.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.327 0.651 . . . . 0.0 111.193 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 159.6 34.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.972 1.367 . . . . 0.0 112.511 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.5 98.3 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.678 -2.056 . . . . 0.0 108.694 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.09 8.8 11.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.4 120.52 12.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.4 12.85 83.93 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.984 1.278 . . . . 0.0 113.88 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -81.45 150.76 28.17 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 117.796 0.798 . . . . 0.0 109.309 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.749 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.8 mt -87.13 141.03 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.52 121.29 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 124.87 1.268 . . . . 0.0 108.052 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -97.95 115.73 28.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.93 -1.106 . . . . 0.0 108.328 168.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.54 HD12 ' ND1' ' A' ' 105' ' ' HIS . 51.1 mt -91.2 140.4 29.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.195 0.907 . . . . 0.0 112.448 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -139.73 157.83 45.1 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.455 1.502 . . . . 0.0 109.405 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.02 179.53 35.5 Favored Glycine 0 CA--C 1.512 -0.129 0 O-C-N 120.668 -1.27 . . . . 0.0 112.619 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.83 153.58 40.83 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.949 0.9 . . . . 0.0 109.35 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.41 -167.98 28.89 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.85 136.19 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.18 -24.25 26.19 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.052 0.941 . . . . 0.0 113.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.8 mt -81.14 -33.25 33.29 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.779 1.172 . . . . 0.0 112.71 -169.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.1 -22.5 32.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.102 0.858 . . . . 0.0 111.039 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -125.23 -87.88 0.6 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.0 -47.95 1.98 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 128.41 2.91 . . . . 0.0 108.866 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.72 -28.84 69.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.837 1.655 . . . . 0.0 110.725 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -117.46 9.14 13.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.205 1.402 . . . . 0.0 112.133 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -47.65 122.61 5.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.034 1.334 . . . . 0.0 109.582 169.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.22 25.62 5.95 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.403 1.481 . . . . 0.0 113.379 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.95 -36.97 86.09 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.98 -30.95 71.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.886 -0.509 . . . . 0.0 112.043 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -63.0 -45.69 91.22 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.146 0.978 . . . . 0.0 111.009 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.13 96.11 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.9 mtm -67.01 -44.39 80.44 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.132 0.966 . . . . 0.0 112.115 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.567 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -64.64 -33.04 75.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.924 0.784 . . . . 0.0 111.55 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.54 ' ND1' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -60.23 -47.49 85.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.22 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.21 -40.8 94.65 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.581 1.153 . . . . 0.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 14.1 tptt -55.21 -60.07 3.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.784 1.234 . . . . 0.0 108.795 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.29 -19.21 54.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.063 -169.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 t -61.2 -28.73 69.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.088 0.858 . . . . 0.0 110.274 169.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -21.84 55.59 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.733 -1.229 . . . . 0.0 109.992 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -85.24 1.59 47.56 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.642 1.577 . . . . 0.0 112.659 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.14 34.36 75.64 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.419 0.554 . . . . 0.0 111.897 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -86.26 170.33 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.979 0.912 . . . . 0.0 109.449 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.48 140.8 48.97 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 168.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -105.16 148.25 27.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.598 0.635 . . . . 0.0 110.531 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.1 m -126.97 177.43 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.22 39.18 27.59 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-O 118.441 -1.199 . . . . 0.0 113.983 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -76.35 151.7 36.57 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.704 1.752 . . . . 0.0 108.182 169.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.48 146.25 61.1 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.653 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.56 139.41 37.41 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.128 1.439 . . . . 0.0 109.52 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 139' ' ' PHE . 64.4 p . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.019 1.728 . . . . 0.0 113.334 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.1 p90 -164.02 -60.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.002 0.819 . . . . 0.0 109.611 -174.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.337 2.0 t 58.06 9.94 1.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.671 2.788 . . . . 0.0 114.768 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.9 p -66.02 139.16 96.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.785 -1.197 . . . . 0.0 108.953 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.9 -15.54 3.82 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.444 2.096 . . . . 0.0 113.383 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -80.55 -47.33 1.26 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -86.88 35.94 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.072 1.848 . . . . 0.0 112.165 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.65 148.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.92 1.288 . . . . 0.0 109.556 -167.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.49 -172.95 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 125.978 1.711 . . . . 0.0 110.128 176.115 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.88 -116.22 0.83 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.302 1.441 . . . . 0.0 107.531 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.99 7.55 34.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.995 1.318 . . . . 0.0 111.879 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.45 18.85 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.998 1.285 . . . . 0.0 112.455 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.65 -17.59 17.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.645 1.178 . . . . 0.0 110.934 -172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.93 143.07 50.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.925 0.49 . . . . 0.0 111.212 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.458 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.3 m-85 -77.56 155.8 31.32 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.169 1.388 . . . . 0.0 108.658 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 133' ' ' ILE . 35.0 m -69.12 -16.35 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.763 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.88 -176.64 38.61 Favored Glycine 0 C--N 1.338 0.669 0 O-C-N 120.572 -1.33 . . . . 0.0 111.65 -172.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.2 tp -65.96 130.13 42.2 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.38 117.63 32.97 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.289 1.035 . . . . 0.0 108.27 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.03 153.66 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.317 1.047 . . . . 0.0 109.71 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.79 122.83 16.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -105.23 7.97 33.78 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.263 1.025 . . . . 0.0 110.716 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 -27.41 12.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.494 1.118 . . . . 0.0 110.39 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -124.9 -47.08 1.81 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.302 0.955 . . . . 0.0 111.025 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.18 17.14 7.37 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.7 0.8 . . . . 0.0 112.493 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -51.76 -22.88 3.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.043 0.937 . . . . 0.0 112.952 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -79.72 -25.85 41.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.846 0.858 . . . . 0.0 111.472 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -122.74 -13.12 7.98 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.241 1.017 . . . . 0.0 112.623 -171.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.1 p -55.71 -31.37 62.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.655 1.116 . . . . 0.0 110.681 -175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.58 -38.69 75.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.096 1.358 . . . . 0.0 111.476 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.46 -34.01 60.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.442 1.097 . . . . 0.0 109.414 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.72 60.26 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.676 0.79 . . . . 0.0 109.651 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.23 -60.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.1 pt20 -56.09 -40.21 73.32 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.4 m -68.65 -33.3 73.76 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.017 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 44.5 t90 -66.28 -43.37 86.57 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 174.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.6 m -58.98 -34.75 72.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.794 0.837 . . . . 0.0 110.062 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.75 -31.35 68.13 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.93 0.492 . . . . 0.0 109.989 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -79.47 -45.82 18.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.515 171.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 pt -64.69 -38.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 120.944 1.702 . . . . 0.0 110.032 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.4 -12.17 49.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.216 0.462 . . . . 0.0 112.18 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.92 -46.27 6.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.742 1.217 . . . . 0.0 107.893 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.3 -36.36 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.114 0.87 . . . . 0.0 110.719 -172.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.749 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.4 mtm -80.94 -35.15 32.66 Favored 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.941 0.896 . . . . 0.0 110.972 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -46.42 33.89 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.382 1.073 . . . . 0.0 110.335 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.1 -30.21 70.17 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.259 1.424 . . . . 0.0 110.253 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.44 ' CD2' HD11 ' A' ' 81' ' ' ILE . 64.4 t60 -63.25 -54.31 39.24 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.95 0.5 . . . . 0.0 110.293 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.31 -7.21 55.63 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -169.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 C-N-CA 123.159 0.583 . . . . 0.0 110.632 179.189 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 142.99 31.23 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -130.92 147.06 52.52 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.49 1.916 . . . . 0.0 108.18 -170.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 118.37 5.07 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-O 118.563 -1.132 . . . . 0.0 110.409 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.39 109.96 19.93 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.026 1.413 . . . . 0.0 108.573 169.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -103.25 143.91 32.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.933 1.293 . . . . 0.0 111.398 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.8 172.86 17.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.162 0.585 . . . . 0.0 110.79 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.18 139.34 8.06 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -160.52 135.29 7.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.942 1.297 . . . . 0.0 108.207 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -99.86 -27.7 13.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.226 1.011 . . . . 0.0 110.909 169.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 p -99.37 -3.15 34.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.887 1.675 . . . . 0.0 111.753 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.7 m 70.87 8.55 6.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.657 2.383 . . . . 0.0 115.126 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -63.66 -45.3 90.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.365 1.438 . . . . 0.0 110.76 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 -35.67 79.57 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.0 -46.0 91.13 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 123.463 0.705 . . . . 0.0 110.085 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.7 mtm -64.71 -39.37 93.52 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.96 -0.462 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.26 95.45 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.013 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.69 -47.69 73.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.951 0.9 . . . . 0.0 110.641 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.89 -44.23 94.33 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -63.41 -54.2 40.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 124.596 1.185 . . . . 0.0 109.321 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -52.53 -55.83 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.973 0.806 . . . . 0.0 109.614 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -39.04 79.26 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.966 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.62 -46.72 74.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.102 0.477 . . . . 0.0 111.21 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.23 -46.89 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.152 1.381 . . . . 0.0 108.484 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.37 -49.56 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.604 0.762 . . . . 0.0 110.286 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.99 115.99 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.46 1.029 . . . . 0.0 110.548 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.22 3.18 4.25 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.427 2.751 . . . . 0.0 112.48 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.82 -34.74 69.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.28 1.432 . . . . 0.0 109.253 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.84 -23.06 3.74 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.641 1.576 . . . . 0.0 111.484 -169.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.48 139.95 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 120.509 1.504 . . . . 0.0 108.652 173.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -129.14 129.54 45.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.223 1.009 . . . . 0.0 109.349 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.65 146.26 51.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.29 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -145.4 99.67 3.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -81.49 124.47 29.5 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.61 -8.62 58.15 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -37.38 62.25 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.411 1.085 . . . . 0.0 108.986 169.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -98.55 -31.48 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.884 1.673 . . . . 0.0 112.822 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.13 172.17 13.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.305 1.442 . . . . 0.0 111.299 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.0 m -92.59 155.47 42.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -79.71 -9.73 14.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.779 2.319 . . . . 0.0 111.368 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -57.1 -36.87 71.13 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.962 1.71 . . . . 0.0 111.203 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -13.15 21.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.404 1.081 . . . . 0.0 112.355 170.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -73.37 -26.4 60.99 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.798 -1.188 . . . . 0.0 111.176 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.09 -51.33 12.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.097 0.862 . . . . 0.0 110.206 -171.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -66.16 142.99 57.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.301 1.44 . . . . 0.0 109.246 -169.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.05 -27.6 61.84 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.41 144.19 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.79 152.54 51.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.2 119.65 53.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.79 144.56 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.82 148.56 19.55 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.461 -1.352 . . . . 0.0 115.839 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.17 136.67 26.52 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.94 2.096 . . . . 0.0 109.502 -169.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.04 141.21 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 N-CA-C 107.839 -1.639 . . . . 0.0 107.839 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.7 m -87.82 116.35 25.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -99.43 167.79 10.4 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.104 1.762 . . . . 0.0 110.164 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 13.16 75.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 130.093 3.357 . . . . 0.0 115.272 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 56.54 65.03 1.51 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.842 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.16 70.15 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.358 0.5 OUTLIER -94.28 152.92 18.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.381 1.073 . . . . 0.0 109.956 168.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mt -95.86 151.21 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.582 1.553 . . . . 0.0 106.812 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -59.78 140.41 56.56 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.39 -27.46 69.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.134 0.574 . . . . 0.0 111.947 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -28.92 64.69 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.979 0.511 . . . . 0.0 111.207 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.3 m95 -77.76 -42.85 32.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.676 0.79 . . . . 0.0 110.268 170.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -55.78 -35.9 66.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.597 0.635 . . . . 0.0 110.909 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.98 -31.56 72.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.89 0.876 . . . . 0.0 111.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.9 -12.37 8.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.689 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.542 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -54.25 -28.86 44.32 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.551 1.541 . . . . 0.0 111.656 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.49 -44.08 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.97 1.308 . . . . 0.0 111.025 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -69.21 -30.13 68.25 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.457 -1.259 . . . . 0.0 112.675 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.85 -31.55 64.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.186 1.357 . . . . 0.0 110.685 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.3 -28.56 67.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.878 0.871 . . . . 0.0 111.566 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.45 -24.42 36.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.642 0.777 . . . . 0.0 111.254 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.89 157.33 33.38 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 123.122 1.439 . . . . 0.0 112.503 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -90.64 95.88 10.37 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.53 7.78 12.77 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.06 120.94 13.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.83 -0.39 89.14 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 125.393 1.473 . . . . 0.0 114.824 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -72.35 150.48 43.44 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.035 0.918 . . . . 0.0 109.46 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.4 mt -88.98 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.3 t -132.67 128.03 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.427 1.091 . . . . 0.0 108.655 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.98 118.45 36.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -90.06 142.85 27.31 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.966 0.803 . . . . 0.0 111.692 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -140.59 158.76 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.079 0.952 . . . . 0.0 108.875 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.45 -179.93 39.5 Favored Glycine 0 CA--C 1.508 -0.367 0 O-C-N 120.678 -1.264 . . . . 0.0 112.125 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.39 145.2 45.36 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.71 11.79 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 169.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -159.63 135.0 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.463 1.505 . . . . 0.0 107.224 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.85 -20.81 24.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.57 -47.84 68.62 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.655 1.116 . . . . 0.0 110.608 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.88 -29.13 7.43 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.491 1.043 . . . . 0.0 112.391 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -132.27 33.95 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -166.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.43 -38.77 63.47 Favored Glycine 0 N--CA 1.47 0.939 0 CA-C-N 120.024 1.284 . . . . 0.0 111.725 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.91 -17.01 62.79 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.362 1.081 . . . . 0.0 112.737 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -128.52 14.37 6.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 112.079 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.65 123.17 2.16 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.717 1.607 . . . . 0.0 109.762 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.52 27.85 2.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.939 1.296 . . . . 0.0 112.978 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.16 -37.82 86.69 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.68 -1.263 . . . . 0.0 110.628 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.92 76.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.527 0.331 . . . . 0.0 111.454 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.681 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.2 tp -60.1 -47.41 86.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.366 1.066 . . . . 0.0 110.505 174.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.78 98.58 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.1 mtm -64.15 -45.03 90.29 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.927 0.864 . . . . 0.0 111.829 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.584 HD12 HD12 ' A' ' 53' ' ' ILE . 4.9 mt -63.3 -35.14 79.37 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.345 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.23 -43.38 95.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.202 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.82 -42.1 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.776 1.23 . . . . 0.0 111.571 175.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.89 -59.85 4.17 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.679 1.191 . . . . 0.0 108.311 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.39 -20.45 54.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.871 -169.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 t -60.98 -29.09 69.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.256 0.934 . . . . 0.0 110.499 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -22.15 53.55 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.012 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -83.66 1.6 41.62 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 125.582 1.553 . . . . 0.0 112.583 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.47 31.88 68.16 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.641 0.655 . . . . 0.0 112.207 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.22 173.12 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.004 0.922 . . . . 0.0 109.193 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.51 148.6 44.25 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.32 150.49 30.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.098 0.863 . . . . 0.0 112.275 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.1 m -128.01 -179.7 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.718 1.207 . . . . 0.0 109.059 169.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.03 35.75 37.78 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-O 118.463 -1.187 . . . . 0.0 114.165 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -79.05 145.92 33.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.711 1.755 . . . . 0.0 108.713 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -120.53 148.29 47.5 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.363 170.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.41 139.16 37.35 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 CA-C-N 120.703 1.287 . . . . 0.0 109.187 168.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.488 HG22 ' CD1' ' A' ' 139' ' ' PHE . 72.8 p . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 125.774 1.63 . . . . 0.0 113.161 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.49 -57.74 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.364 0.984 . . . . 0.0 110.487 -171.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 4.0 t 58.17 11.07 1.41 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.282 2.633 . . . . 0.0 114.567 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -63.94 132.71 95.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -83.92 -12.23 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.718 2.278 . . . . 0.0 112.694 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -80.51 -48.83 1.19 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -88.3 38.81 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.314 2.009 . . . . 0.0 112.643 -168.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 146.72 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.205 -0.934 . . . . 0.0 110.056 -167.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.2 -172.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.107 1.763 . . . . 0.0 109.594 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.47 -117.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.988 1.315 . . . . 0.0 107.588 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -104.97 7.74 34.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.753 1.221 . . . . 0.0 112.011 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.02 20.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.572 1.082 . . . . 0.0 112.749 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -100.04 -17.47 17.48 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.746 1.218 . . . . 0.0 110.767 -172.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.55 144.67 50.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.306 0.642 . . . . 0.0 110.88 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.1 m-85 -79.93 154.64 28.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.147 1.379 . . . . 0.0 110.048 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.79 -12.61 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.7 1.2 . . . . 0.0 112.654 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.75 -177.69 44.06 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 119.479 1.036 . . . . 0.0 111.83 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.3 tp -64.67 127.84 33.24 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.71 107.55 16.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.48 155.21 17.03 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.56 115.89 8.51 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.55 27.13 2.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.489 -168.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 t -133.31 -19.89 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 -45.02 2.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.428 1.467 . . . . 0.0 109.309 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -79.62 -0.44 33.75 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.416 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.18 -25.27 21.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.018 1.735 . . . . 0.0 112.787 -171.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.7 -20.68 25.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.76 1.224 . . . . 0.0 112.738 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pp -124.48 -6.98 7.52 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.215 1.406 . . . . 0.0 113.088 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.7 m -53.49 -32.12 48.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.037 1.289 . . . . 0.0 110.24 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.94 -40.79 81.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.125 0.57 . . . . 0.0 111.455 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.68 -34.53 67.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.134 1.374 . . . . 0.0 109.564 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -78.83 -28.58 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.143 0.977 . . . . 0.0 109.224 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.71 -60.62 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -57.1 -41.08 78.27 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 118.727 0.694 . . . . 0.0 112.479 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -64.77 -36.22 83.61 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.536 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 39.9 t90 -66.35 -45.02 81.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 110.037 176.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.1 m -56.53 -37.06 69.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.168 0.987 . . . . 0.0 109.506 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.71 -29.06 66.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.474 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -80.74 -45.76 16.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.044 -0.979 . . . . 0.0 111.22 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 25' ' ' ILE . 4.9 pt -64.6 -38.7 83.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 CA-C-N 120.84 1.654 . . . . 0.0 110.238 -171.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.17 -15.2 59.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.304 0.642 . . . . 0.0 112.034 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.16 -45.88 6.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.06 -41.59 88.31 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 118.704 0.684 . . . . 0.0 109.574 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.4 mtm -76.27 -38.01 56.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.706 0.803 . . . . 0.0 110.837 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.76 66.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.813 0.845 . . . . 0.0 109.927 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.58 -30.38 70.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.452 1.501 . . . . 0.0 109.921 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -63.28 -47.46 82.23 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 118.558 0.617 . . . . 0.0 110.502 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -2.74 47.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.775 1.23 . . . . 0.0 113.688 -175.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.418 179.519 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.95 141.46 44.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.138 1.375 . . . . 0.0 108.652 169.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 48' ' ' VAL . 15.3 mtm -120.68 147.59 45.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.291 2.237 . . . . 0.0 108.657 -169.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.84 120.1 5.61 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.666 -1.075 . . . . 0.0 110.711 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 116.03 27.28 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 118.828 1.314 . . . . 0.0 108.601 169.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.37 147.25 35.59 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.807 1.643 . . . . 0.0 111.403 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -161.99 173.88 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.023 0.929 . . . . 0.0 110.81 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.35 138.51 7.98 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -140.68 131.61 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.34 1.456 . . . . 0.0 108.715 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.4 m -90.33 -36.85 14.42 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -94.58 -84.99 0.31 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.2 p -174.68 -6.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.739 2.016 . . . . 0.0 113.106 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -68.85 -42.39 77.18 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 119.839 -1.788 . . . . 0.0 112.249 -168.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -35.78 82.28 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.25 -47.55 83.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.4 mtm -66.69 -41.06 88.63 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.906 -0.496 . . . . 0.0 111.295 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.19 92.33 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 118.835 -0.603 . . . . 0.0 110.655 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.41 79.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.979 0.912 . . . . 0.0 110.872 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -58.68 -43.97 90.09 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.09 -55.32 26.42 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.813 1.245 . . . . 0.0 108.81 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -52.51 -56.66 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 119.018 0.826 . . . . 0.0 109.832 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -38.98 77.12 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.759 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.51 -47.22 70.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 122.737 0.415 . . . . 0.0 111.553 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -66.12 -45.56 90.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.743 1.217 . . . . 0.0 108.456 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 164' ' ' ILE . 78.1 mt -72.35 -51.81 27.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.636 0.774 . . . . 0.0 110.484 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.3 114.06 0.75 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.432 1.015 . . . . 0.0 110.592 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.28 3.61 3.97 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.351 2.701 . . . . 0.0 112.693 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.97 -35.05 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.222 1.409 . . . . 0.0 109.118 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -24.7 5.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.876 1.67 . . . . 0.0 111.438 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.77 140.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 121.103 1.774 . . . . 0.0 109.242 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 m -130.69 130.13 43.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.541 1.137 . . . . 0.0 109.788 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.79 148.53 46.18 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.734 0.814 . . . . 0.0 112.06 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.56 115.14 10.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.872 1.669 . . . . 0.0 108.666 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.16 100.57 9.15 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.96 -21.65 66.43 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.844 1.656 . . . . 0.0 112.847 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -60.41 -28.84 68.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 112.468 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -109.89 -32.51 7.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.339 1.056 . . . . 0.0 112.993 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.63 167.62 16.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.636 1.175 . . . . 0.0 111.476 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -93.46 147.41 33.62 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.812 1.645 . . . . 0.0 109.07 -170.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -76.0 -1.52 11.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.588 1.525 . . . . 0.0 111.107 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -55.97 -33.74 65.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 122.346 2.339 . . . . 0.0 111.908 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.39 -19.87 65.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.425 ' CG ' HD13 ' A' ' 49' ' ' LEU . 47.5 ttm -58.91 -16.04 15.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.913 2.085 . . . . 0.0 111.627 169.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.37 -27.69 56.51 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.241 -0.912 . . . . 0.0 110.753 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.88 -51.55 12.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.751 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.36 133.18 47.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.01 -10.2 53.71 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.22 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 3' ' ' MET . 71.4 t -134.09 143.84 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.9 mt -140.34 149.05 42.24 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.8 121.63 56.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.63 147.08 44.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 85' ' ' TYR . . . -151.93 147.49 17.36 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 119.589 -1.291 . . . . 0.0 115.66 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -135.5 135.93 23.13 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 126.894 2.078 . . . . 0.0 109.602 -171.56 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.97 144.02 7.07 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 165.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.9 m -88.73 117.21 27.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -98.77 169.95 9.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.592 1.157 . . . . 0.0 110.561 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 22.72 64.99 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.915 2.886 . . . . 0.0 115.517 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.75 70.8 0.6 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.586 1.154 . . . . 0.0 112.097 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.42 17.3 79.77 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.81 151.26 27.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.314 1.054 . . . . 0.0 109.555 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.31 153.03 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -61.14 141.02 57.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.862 0.839 . . . . 0.0 108.774 170.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.62 -27.4 68.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -166.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.11 -23.63 35.58 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.063 0.545 . . . . 0.0 110.391 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.529 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.5 m95 -73.44 -43.95 59.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 169.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -53.51 -34.24 57.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.336 0.655 . . . . 0.0 111.084 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.18 71.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 111.862 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 m -104.98 -9.36 9.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.59 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.6 t-105 -53.09 -29.49 30.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.708 1.603 . . . . 0.0 111.932 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.42 -43.81 76.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.33 -29.76 66.55 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.247 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -58.02 -31.03 66.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.828 1.194 . . . . 0.0 111.157 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.77 -26.92 62.63 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.549 0.74 . . . . 0.0 111.558 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.22 -22.34 35.96 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.316 0.646 . . . . 0.0 110.934 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.1 mt -73.93 156.89 37.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.982 1.372 . . . . 0.0 112.313 -167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.08 97.45 11.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.666 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -119.26 8.92 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.08 123.9 20.25 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.36 9.0 87.08 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.494 1.521 . . . . 0.0 114.329 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.48 146.94 34.12 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.646 0.723 . . . . 0.0 109.617 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.9 mt -85.62 139.02 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 167.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.41 132.43 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 124.867 1.267 . . . . 0.0 109.143 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.03 119.46 37.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.69 143.82 26.49 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.122 0.874 . . . . 0.0 112.032 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 24.0 p90 -139.94 157.81 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.095 0.958 . . . . 0.0 109.253 169.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.68 177.04 38.1 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 120.452 -1.405 . . . . 0.0 112.849 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.69 157.24 36.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.195 0.998 . . . . 0.0 108.478 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.12 -152.75 9.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -154.73 135.13 13.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.548 1.539 . . . . 0.0 107.493 166.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -22.83 24.7 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.733 1.213 . . . . 0.0 113.277 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.5 mt -77.59 -40.19 43.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 120.016 1.28 . . . . 0.0 111.556 -171.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.43 -28.4 11.57 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.814 1.197 . . . . 0.0 112.166 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.78 34.61 3.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -168.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.06 61.11 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 119.99 1.268 . . . . 0.0 111.381 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.53 -16.4 55.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.757 0.778 . . . . 0.0 112.169 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.7 10.01 7.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.506 1.922 . . . . 0.0 112.112 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -47.5 124.01 6.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.38 1.472 . . . . 0.0 109.411 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.55 27.48 5.13 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 124.42 1.075 . . . . 0.0 112.781 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.09 -37.39 87.34 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.505 -1.372 . . . . 0.0 110.605 -172.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.36 75.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.917 0.487 . . . . 0.0 111.696 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.657 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -59.72 -47.62 84.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.167 0.987 . . . . 0.0 110.29 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.78 97.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.4 mtm -64.97 -42.76 94.3 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 117.853 0.827 . . . . 0.0 111.864 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.659 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 mt -66.0 -33.78 76.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.814 1.188 . . . . 0.0 111.856 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -62.3 -40.64 96.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.741 -0.599 . . . . 0.0 110.334 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.81 -35.07 69.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.432 1.493 . . . . 0.0 111.813 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HB3' HD23 ' A' ' 104' ' ' LEU . 20.6 tptt -58.11 -43.98 87.48 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.614 0.765 . . . . 0.0 109.916 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.4 mt -98.58 -18.16 18.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.917 -1.039 . . . . 0.0 112.446 -170.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p -60.64 -32.23 71.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 111.611 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -79.8 -18.74 50.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.1 0.56 . . . . 0.0 110.23 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -79.33 1.42 25.18 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.408 1.483 . . . . 0.0 111.969 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.83 63.86 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 118.601 0.637 . . . . 0.0 111.883 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.2 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.827 0.851 . . . . 0.0 109.376 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -118.27 141.33 48.63 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -106.15 147.14 29.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.336 0.971 . . . . 0.0 111.526 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.2 m -127.35 177.76 5.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.715 1.206 . . . . 0.0 108.921 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.35 35.73 32.63 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.389 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -79.86 146.87 31.97 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.888 1.844 . . . . 0.0 109.138 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -122.82 148.57 54.09 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 124.986 1.314 . . . . 0.0 108.488 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.71 138.07 31.18 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.585 1.524 . . . . 0.0 110.465 169.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.526 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.0 p . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 126.381 1.872 . . . . 0.0 112.939 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 127' ' ' THR . 11.2 p90 -165.2 -57.57 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.907 0.883 . . . . 0.0 108.929 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 126' ' ' PHE 0.339 2.1 t 59.71 10.52 2.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.873 2.869 . . . . 0.0 114.895 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.7 p -67.33 139.12 94.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.867 -1.146 . . . . 0.0 108.683 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -86.91 -14.79 4.08 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.245 1.963 . . . . 0.0 113.532 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -81.7 -46.68 1.05 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -86.31 38.35 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.979 1.786 . . . . 0.0 112.395 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 146.52 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.183 0.993 . . . . 0.0 108.988 -167.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -172.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.737 1.615 . . . . 0.0 109.708 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.98 -116.01 0.82 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.479 1.512 . . . . 0.0 107.371 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.03 7.63 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.886 1.274 . . . . 0.0 111.881 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.72 20.84 17.97 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.94 1.257 . . . . 0.0 112.601 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.56 -16.8 17.36 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.945 1.298 . . . . 0.0 110.844 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.99 145.3 50.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.427 0.691 . . . . 0.0 110.882 174.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.7 m-85 -80.18 153.91 28.31 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.715 1.606 . . . . 0.0 109.295 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.4 m -66.7 -12.55 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 112.599 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.99 -177.42 43.16 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.523 1.056 . . . . 0.0 112.019 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 20.0 tp -66.15 129.64 40.52 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.99 123.53 48.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 157.63 27.76 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.478 1.111 . . . . 0.0 108.136 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.93 120.04 11.43 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -98.19 12.8 33.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -21.5 11.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.196 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.4 -40.7 1.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.366 1.439 . . . . 0.0 113.249 172.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -80.63 4.92 17.02 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.386 0.994 . . . . 0.0 112.57 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.12 -25.02 28.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.439 1.472 . . . . 0.0 112.663 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.77 -26.05 49.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.749 1.22 . . . . 0.0 111.5 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.21 -6.49 6.56 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.321 1.049 . . . . 0.0 112.753 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.1 m -51.76 -33.8 36.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.208 1.367 . . . . 0.0 110.172 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.48 -42.65 78.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.836 1.255 . . . . 0.0 111.516 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -75.08 -33.43 61.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.797 1.239 . . . . 0.0 109.817 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -76.26 -30.98 58.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.704 -0.623 . . . . 0.0 109.651 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.9 -55.96 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.403 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.8 pt20 -58.18 -43.1 87.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -65.21 -35.19 80.28 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.971 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.45 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.3 t90 -66.05 -45.3 81.9 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.841 0.829 . . . . 0.0 110.247 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 84.5 m -57.09 -36.48 70.64 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.161 0.985 . . . . 0.0 109.416 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.44 -28.65 66.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.323 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -81.27 -45.36 16.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.407 171.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 25' ' ' ILE . 4.5 pt -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 120.923 1.692 . . . . 0.0 110.008 -172.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.58 -14.14 56.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.835 -0.541 . . . . 0.0 112.108 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -94.47 -46.9 6.8 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.7 -34.79 76.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.681 0.673 . . . . 0.0 110.477 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -81.39 -43.12 19.44 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.32 1.048 . . . . 0.0 110.182 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.12 72.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.054 0.942 . . . . 0.0 111.222 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.06 -30.51 66.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.802 1.241 . . . . 0.0 109.607 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.41 ' CD2' HD11 ' A' ' 81' ' ' ILE . 67.5 t60 -66.45 -47.61 72.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -12.0 61.23 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.506 1.122 . . . . 0.0 113.388 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 C-N-CA 122.962 0.505 . . . . 0.0 110.793 -178.49 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.48 144.08 29.8 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 mtm -131.21 146.11 52.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.621 1.969 . . . . 0.0 107.854 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.42 117.22 4.98 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-O 118.478 -1.179 . . . . 0.0 110.628 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.63 115.41 26.14 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.245 1.522 . . . . 0.0 108.461 169.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.39 146.36 37.27 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.198 1.399 . . . . 0.0 111.382 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -161.93 176.44 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.166 0.986 . . . . 0.0 110.755 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.7 144.51 12.53 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 p -152.67 139.82 19.32 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.64 1.22 . . . . 0.0 112.647 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.7 m -99.87 -34.72 10.02 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.7 p -93.59 0.59 56.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.133 0.973 . . . . 0.0 111.86 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m 65.4 13.36 8.78 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.869 2.068 . . . . 0.0 113.538 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.37 -48.43 77.96 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.217 -1.552 . . . . 0.0 111.149 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -32.82 74.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.27 -48.75 80.46 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 109.679 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -65.35 -40.41 93.59 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.05 -0.406 . . . . 0.0 111.133 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.52 98.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.872 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.03 -47.42 77.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.279 1.032 . . . . 0.0 110.764 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.89 -45.23 90.74 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HD12 ' A' ' 24' ' ' ILE . 58.9 mttm -61.77 -56.5 18.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 124.825 1.328 . . . . 0.0 108.994 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -51.96 -56.08 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 118.649 0.659 . . . . 0.0 110.108 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.93 78.31 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.27 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.06 -47.47 74.22 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.802 0.441 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -65.74 -47.42 85.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.502 1.121 . . . . 0.0 108.966 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 164' ' ' ILE . 78.8 mt -72.35 -49.26 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.605 0.762 . . . . 0.0 110.173 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.09 115.57 0.89 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.599 1.095 . . . . 0.0 110.47 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.38 3.85 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.412 2.742 . . . . 0.0 112.814 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.68 -34.55 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.943 1.297 . . . . 0.0 109.054 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.99 -21.35 4.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 111.639 -169.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.21 141.33 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.592 1.542 . . . . 0.0 108.944 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -131.56 128.83 40.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.436 1.094 . . . . 0.0 109.974 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.49 148.78 46.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.932 0.893 . . . . 0.0 112.034 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.73 110.89 6.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.582 1.953 . . . . 0.0 107.081 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.55 109.97 19.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.0 mt -66.17 -8.54 24.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -58.93 -29.14 66.88 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.113 0.87 . . . . 0.0 111.425 169.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -132.45 -33.79 1.24 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 111.995 -172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -80.95 139.96 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 m -84.27 139.94 39.18 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -74.31 -0.39 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.256 1.484 . . . . 0.0 111.107 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -56.84 -33.16 66.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.939 2.154 . . . . 0.0 112.208 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -19.45 65.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.421 ' HG2' HD13 ' A' ' 49' ' ' LEU . 42.9 ttm -58.59 -16.22 14.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.752 2.021 . . . . 0.0 111.435 169.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 69.0 mt-10 -74.1 -29.29 61.78 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.028 -1.045 . . . . 0.0 111.095 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -76.75 -47.15 22.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.852 0.751 . . . . 0.0 109.974 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.26 139.23 57.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.601 -1.181 . . . . 0.0 107.968 -169.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.54 -26.96 61.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.228 0.537 . . . . 0.0 110.272 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -141.35 147.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.421 HD13 ' HG2' ' A' ' 43' ' ' MET . 6.3 mt -139.29 150.59 45.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.964 0.505 . . . . 0.0 109.985 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.4 120.48 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 170.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.29 138.61 53.59 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 108.629 -172.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.23 122.56 3.5 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-O 118.239 -1.312 . . . . 0.0 112.442 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.692 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -124.99 130.93 24.04 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 118.613 1.206 . . . . 0.0 109.963 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -84.84 146.63 10.47 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 108.387 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 m -88.33 129.57 35.35 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -119.7 170.65 9.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.091 1.757 . . . . 0.0 109.618 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 27.36 57.65 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.255 2.622 . . . . 0.0 115.265 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 56.85 76.99 0.28 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.983 1.313 . . . . 0.0 112.247 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.42 14.23 71.68 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.41 160.07 21.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.603 1.161 . . . . 0.0 109.666 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -97.4 152.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.55 144.0 55.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 171.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.54 -28.59 69.96 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.164 0.586 . . . . 0.0 112.354 -168.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.73 -24.33 63.54 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.925 -0.484 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.492 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.0 m95 -83.37 -42.8 16.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.933 0.893 . . . . 0.0 110.866 170.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.55 -35.49 65.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.624 0.647 . . . . 0.0 110.818 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.02 71.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.596 1.158 . . . . 0.0 111.88 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 m -106.07 -11.64 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.68 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.544 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -52.89 -29.06 26.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.693 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.79 -46.56 65.47 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.15 1.38 . . . . 0.0 111.248 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.79 -29.53 69.5 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 117.435 -1.269 . . . . 0.0 112.14 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 mt -56.36 -35.91 68.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.798 1.181 . . . . 0.0 110.867 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.48 -33.14 75.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.384 0.674 . . . . 0.0 111.701 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.78 -12.92 43.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 111.184 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.28 171.38 12.24 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.381 1.086 . . . . 0.0 110.65 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 6.2 t30 -111.02 98.82 7.82 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.812 1.645 . . . . 0.0 107.641 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -118.77 6.29 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -65.12 112.86 3.58 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.48 -3.21 68.5 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.849 1.69 . . . . 0.0 116.076 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -75.36 155.12 36.8 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.537 1.168 . . . . 0.0 110.115 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.684 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.0 mt -89.41 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.44 133.33 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.676 1.19 . . . . 0.0 109.416 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.8 117.41 33.34 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.11 142.75 27.41 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 119.023 0.829 . . . . 0.0 111.752 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.75 159.89 41.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.222 1.009 . . . . 0.0 108.878 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.02 177.51 39.05 Favored Glycine 0 N--CA 1.447 -0.578 0 O-C-N 121.14 -0.975 . . . . 0.0 112.207 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.77 153.67 42.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.17 -158.15 10.75 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -152.2 141.08 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.094 1.358 . . . . 0.0 109.141 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.35 -22.36 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.37 -39.92 70.95 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.931 1.241 . . . . 0.0 112.265 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.97 -18.44 31.86 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.171 0.891 . . . . 0.0 111.512 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.93 -89.91 0.54 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.939 1.296 . . . . 0.0 108.13 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.58 -50.21 2.47 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 128.497 2.951 . . . . 0.0 107.936 -168.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.77 -28.42 67.6 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.365 1.866 . . . . 0.0 110.767 -175.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -117.53 6.61 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.651 1.181 . . . . 0.0 112.349 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -43.96 121.87 2.61 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.496 1.518 . . . . 0.0 109.592 168.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 52.85 25.88 4.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.588 1.155 . . . . 0.0 113.512 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.47 -36.0 82.59 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.516 -1.365 . . . . 0.0 110.603 -172.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.69 74.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.255 0.622 . . . . 0.0 112.06 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.692 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -60.48 -46.49 89.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.141 0.976 . . . . 0.0 110.413 176.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.21 97.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 mtm -67.14 -42.73 83.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.841 0.821 . . . . 0.0 112.239 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.577 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -63.49 -36.15 82.82 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.201 172.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -63.6 -41.25 98.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.973 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.18 -43.19 92.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -55.6 -58.44 7.8 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.427 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.97 -20.27 58.03 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.728 -0.608 . . . . 0.0 110.385 -169.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t -62.95 -29.66 70.97 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.846 0.748 . . . . 0.0 110.022 167.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.0 -27.38 39.58 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.047 1.294 . . . . 0.0 108.427 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 14.8 mmmt -73.58 2.47 7.91 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.503 1.121 . . . . 0.0 113.176 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.35 85.96 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.427 1.012 . . . . 0.0 112.378 169.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.66 173.75 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.795 0.838 . . . . 0.0 109.304 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 145.75 45.2 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 165.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.96 150.1 28.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.854 0.752 . . . . 0.0 111.878 -169.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.7 m -127.47 179.59 3.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 109.304 169.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 36.24 43.4 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.532 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -71.73 153.52 41.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.091 1.445 . . . . 0.0 108.139 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.23 145.87 58.56 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-O 116.944 -1.503 . . . . 0.0 108.835 169.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.68 140.46 39.29 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 CA-C-N 120.895 1.355 . . . . 0.0 109.618 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.499 HG22 ' CD1' ' A' ' 139' ' ' PHE . 80.6 p . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 113.583 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -163.9 -50.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.952 0.796 . . . . 0.0 110.275 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.303 2.8 t 57.79 8.93 0.77 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.479 2.712 . . . . 0.0 114.512 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -83.55 144.51 46.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.977 1.311 . . . . 0.0 110.861 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -88.94 -12.52 3.4 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.895 2.397 . . . . 0.0 113.775 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -50.91 3.77 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 117.916 -1.04 . . . . 0.0 113.402 -168.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -88.29 38.98 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.751 1.634 . . . . 0.0 112.091 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 148.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.083 -1.011 . . . . 0.0 110.241 -166.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.37 -172.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 126.361 1.864 . . . . 0.0 109.981 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.03 -116.03 0.81 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.486 1.515 . . . . 0.0 107.327 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.09 8.14 34.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.579 1.152 . . . . 0.0 111.889 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.87 21.03 19.69 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.993 1.282 . . . . 0.0 112.506 -173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -100.06 -18.16 17.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 110.837 -172.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.86 143.31 50.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.303 0.641 . . . . 0.0 111.328 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.8 m-85 -78.14 155.39 30.5 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.076 1.35 . . . . 0.0 109.457 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.5 -14.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.546 1.138 . . . . 0.0 112.804 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.32 -178.3 42.4 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 119.65 1.114 . . . . 0.0 112.184 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.97 130.29 42.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.33 117.96 31.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 142' ' ' LEU . 71.6 mt -117.13 152.52 34.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.433 1.093 . . . . 0.0 109.164 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.72 124.06 13.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -99.26 15.05 27.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.235 1.014 . . . . 0.0 110.576 -169.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 t -123.04 -22.27 5.25 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 -48.54 2.96 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.759 1.223 . . . . 0.0 108.041 171.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -105.21 22.64 15.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.641 1.577 . . . . 0.0 112.474 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -52.6 -25.78 11.62 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.826 0.739 . . . . 0.0 112.279 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.09 -25.32 52.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.781 . . . . 0.0 111.478 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -125.02 -14.44 6.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.5 m -57.67 -28.95 64.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.098 1.317 . . . . 0.0 109.769 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.23 -49.21 78.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.595 0.758 . . . . 0.0 111.06 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -66.7 -33.17 75.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.081 0.943 . . . . 0.0 109.329 -171.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -79.13 -23.46 44.01 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.219 -174.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.59 -53.71 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -53.64 -47.07 70.67 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 123.636 0.775 . . . . 0.0 110.136 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.9 m -66.83 -36.79 83.17 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.146 0.278 . . . . 0.0 110.521 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 29.5 t90 -65.79 -46.06 80.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.716 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -58.04 -34.55 70.2 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -31.81 71.9 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.028 0.531 . . . . 0.0 110.601 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -83.03 -45.52 13.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.942 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 25' ' ' ILE . 5.7 pt -64.24 -37.82 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 120.849 1.658 . . . . 0.0 110.048 -170.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.83 -11.8 30.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -49.82 5.72 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 125.704 1.601 . . . . 0.0 108.088 169.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.33 -28.44 70.01 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.951 -0.468 . . . . 0.0 110.913 -169.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.684 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.2 mtm -89.34 -40.71 12.59 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 124.132 0.973 . . . . 0.0 111.429 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.28 33.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.575 0.75 . . . . 0.0 110.784 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.0 -29.72 63.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.233 1.413 . . . . 0.0 109.452 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -63.06 -49.79 73.16 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.227 0.467 . . . . 0.0 109.914 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -2.4 34.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.332 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.648 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.5 141.5 31.6 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtm -129.17 145.05 51.4 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.582 1.953 . . . . 0.0 108.489 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.48 115.52 4.09 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.99 121.63 28.05 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -115.63 144.7 43.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.335 1.054 . . . . 0.0 111.679 171.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -156.62 169.88 23.67 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.762 1.225 . . . . 0.0 110.29 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.33 138.57 8.02 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 p -142.05 136.47 30.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.707 1.203 . . . . 0.0 109.814 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -92.75 -39.23 11.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.14 0.976 . . . . 0.0 110.09 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -85.99 -86.34 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 p -177.76 4.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.04 3.336 . . . . 0.0 110.763 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -67.27 -45.43 76.66 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.091 -1.631 . . . . 0.0 111.59 -166.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -34.28 77.11 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -60.98 -47.67 85.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.302 0.641 . . . . 0.0 110.151 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -64.89 -40.43 95.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 122.217 -0.302 . . . . 0.0 111.035 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.07 97.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.824 -0.607 . . . . 0.0 110.623 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.97 -45.7 78.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.085 0.954 . . . . 0.0 110.971 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.86 -45.21 93.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.7 mttm -63.43 -57.55 9.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.699 1.249 . . . . 0.0 108.84 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -51.92 -55.53 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 118.248 0.476 . . . . 0.0 110.015 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -38.23 74.52 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.868 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.77 -48.79 65.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.826 0.451 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.6 mt -65.76 -46.32 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 108.788 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 164' ' ' ILE . 72.3 mt -71.14 -50.14 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 110.038 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.08 114.9 0.8 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.57 1.33 5.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.326 2.684 . . . . 0.0 112.458 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.22 -33.83 65.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 109.404 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.04 -19.63 3.94 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.43 -169.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.63 141.61 15.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.702 1.592 . . . . 0.0 108.755 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.6 m -131.66 129.03 40.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.75 145.53 25.56 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.17 127.55 30.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.007 2.123 . . . . 0.0 107.935 -168.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.26 88.2 3.07 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.724 1.609 . . . . 0.0 107.373 -168.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.45 -16.11 21.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.925 1.29 . . . . 0.0 114.352 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -13.55 62.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.721 -0.612 . . . . 0.0 112.45 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -129.75 -35.43 1.68 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.313 1.445 . . . . 0.0 112.145 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -81.56 145.08 30.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.054 1.342 . . . . 0.0 109.553 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.82 147.69 59.26 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -76.1 -8.95 19.12 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.431 2.087 . . . . 0.0 111.029 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -55.05 -36.54 65.67 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.699 1.59 . . . . 0.0 111.325 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -22.94 67.13 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.119 -0.988 . . . . 0.0 113.397 176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -14.15 31.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -73.06 -26.65 61.36 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.767 -1.208 . . . . 0.0 110.716 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -76.75 -51.11 12.02 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.524 1.056 . . . . 0.0 109.97 -171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -66.01 142.02 57.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.615 -169.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.73 -24.0 56.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.806 0.812 . . . . 0.0 111.611 -172.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.31 144.18 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -172.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.56 153.21 51.83 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.672 0.669 . . . . 0.0 110.47 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.54 120.03 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -118.84 132.4 56.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -172.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -122.18 116.32 3.02 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-O 117.793 -1.56 . . . . 0.0 112.571 -173.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.49 121.45 32.04 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 119.314 1.557 . . . . 0.0 110.758 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -76.8 146.41 26.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.941 2.427 . . . . 0.0 108.941 168.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -94.06 139.81 30.5 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -133.05 167.73 19.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.624 2.37 . . . . 0.0 109.905 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 27.5 56.7 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 129.244 3.018 . . . . 0.0 116.663 167.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . 0.253 3.0 m-85 51.97 81.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.14 2.576 . . . . 0.0 112.093 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.81 16.9 79.18 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.8 152.89 22.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.254 1.022 . . . . 0.0 108.324 168.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -87.03 156.97 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.36 138.47 50.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.53 -24.86 67.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -165.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -86.01 -26.9 25.15 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.738 -0.602 . . . . 0.0 110.552 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -67.26 -40.74 86.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.34 -32.32 64.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.85 0.46 . . . . 0.0 111.148 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.41 72.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.274 0.63 . . . . 0.0 111.869 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -98.95 -11.52 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -54.48 -28.79 47.15 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.509 1.524 . . . . 0.0 111.886 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.16 -44.09 66.2 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.042 1.337 . . . . 0.0 111.309 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -69.41 -29.77 67.59 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.057 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.64 -31.38 64.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.188 1.358 . . . . 0.0 111.225 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.82 -29.17 68.27 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.838 0.855 . . . . 0.0 111.479 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.93 -24.17 35.76 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 111.441 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.1 157.65 34.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 123.013 1.387 . . . . 0.0 112.326 -167.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -92.12 97.01 10.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.766 -2.016 . . . . 0.0 108.778 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -119.34 8.08 11.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.57 120.89 13.21 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -170.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.56 87.0 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.363 1.459 . . . . 0.0 114.287 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -76.99 145.55 37.98 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 117.775 0.787 . . . . 0.0 109.239 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.703 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.1 mt -84.27 138.07 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.66 127.39 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 124.722 1.209 . . . . 0.0 108.835 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.48 117.78 34.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 167.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.5 mt -89.86 141.76 28.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.182 0.901 . . . . 0.0 111.557 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 27.2 p90 -137.04 159.58 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.19 0.996 . . . . 0.0 109.289 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.56 173.43 37.11 Favored Glycine 0 N--CA 1.45 -0.392 0 O-C-N 121.268 -0.895 . . . . 0.0 111.857 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.0 154.37 48.24 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.296 1.438 . . . . 0.0 107.632 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.26 -155.6 11.86 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -131.84 121.23 23.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.089 3.356 . . . . 0.0 105.997 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -25.25 15.27 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 119.986 1.266 . . . . 0.0 112.836 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -79.09 -41.22 29.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.196 0.198 . . . . 0.0 110.729 -169.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.53 -34.21 36.37 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 118.539 -1.145 . . . . 0.0 111.501 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.725 ' CE2' ' HB2' ' A' ' 96' ' ' TRP 0.277 0.0 OUTLIER -153.87 41.89 0.53 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.84 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.16 -24.73 5.03 Favored Glycine 0 N--CA 1.475 1.29 0 O-C-N 119.646 -1.909 . . . . 0.0 114.069 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 -27.06 6.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.806 1.242 . . . . 0.0 111.497 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TRP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 19.9 m-90 -119.22 -55.31 2.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 116.173 -1.87 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.8 t80 7.27 122.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 130.066 3.346 . . . . 0.0 115.8 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.85 30.07 16.6 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.536 1.534 . . . . 0.0 111.655 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.57 -39.09 91.25 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.938 -1.101 . . . . 0.0 110.685 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.53 72.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 111.34 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -61.28 -47.79 84.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.54 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.47 -39.93 96.99 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 mtm -65.92 -44.66 84.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 117.918 0.859 . . . . 0.0 112.23 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -64.29 -34.77 78.9 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.494 173.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.4 -42.34 98.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.048 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.59 -42.86 91.2 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.538 1.135 . . . . 0.0 111.695 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.33 -58.6 6.77 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.631 1.172 . . . . 0.0 108.41 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 mt -78.14 -20.7 51.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.434 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 t -61.32 -28.64 69.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.365 0.984 . . . . 0.0 110.502 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -22.73 50.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.873 1.215 . . . . 0.0 109.787 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -83.35 1.26 42.14 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.854 1.662 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.67 34.04 66.93 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.458 0.572 . . . . 0.0 111.731 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.13 169.07 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.705 0.752 . . . . 0.0 109.38 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -116.13 143.85 44.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -112.34 148.01 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.73 1.15 . . . . 0.0 112.138 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.1 m -128.52 -179.39 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.194 0.998 . . . . 0.0 109.589 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.95 35.72 38.27 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-O 118.473 -1.182 . . . . 0.0 113.987 172.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -78.55 148.59 33.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.48 1.64 . . . . 0.0 108.587 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -124.91 148.1 58.71 Favored Pre-proline 0 CA--C 1.516 -0.35 0 CA-C-O 117.26 -1.352 . . . . 0.0 108.786 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.82 139.3 43.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 N-CA-C 108.877 -1.24 . . . . 0.0 108.877 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.479 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.4 p . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.443 1.497 . . . . 0.0 113.289 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 127' ' ' THR . 2.7 p90 -165.11 -69.67 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 126' ' ' PHE 0.353 2.8 t 58.62 12.17 2.05 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.11 2.964 . . . . 0.0 114.384 -170.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.3 p -64.59 141.2 98.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.742 -1.224 . . . . 0.0 110.172 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -88.46 -15.28 2.89 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.854 2.37 . . . . 0.0 113.558 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 -49.54 1.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.034 -0.984 . . . . 0.0 113.466 -168.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -91.58 44.37 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.866 1.711 . . . . 0.0 112.266 -168.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 146.56 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 120.944 -1.097 . . . . 0.0 109.467 -168.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -172.7 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.843 1.657 . . . . 0.0 109.819 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.18 -116.3 0.82 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.162 1.385 . . . . 0.0 107.546 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -105.37 7.46 33.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.965 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.84 20.73 18.01 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.779 1.181 . . . . 0.0 112.838 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.55 -17.29 17.17 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.734 1.214 . . . . 0.0 110.857 -173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.15 144.54 50.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.303 0.641 . . . . 0.0 111.155 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 57.7 m-85 -79.33 154.22 29.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.351 1.46 . . . . 0.0 109.866 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.07 -13.74 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.591 174.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -169.68 -177.56 40.23 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 120.035 1.289 . . . . 0.0 112.206 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 144' ' ' LEU . 23.1 tp -63.68 125.96 26.0 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.2 121.28 44.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 142' ' ' LEU . 69.9 mt -121.29 160.53 23.75 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.9 135.77 41.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 172.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.65 15.4 14.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.129 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -117.63 -22.82 7.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -140.23 -28.66 0.72 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.202 1.001 . . . . 0.0 113.139 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -86.91 8.38 23.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.411 1.005 . . . . 0.0 111.809 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.95 -24.16 22.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.274 0.943 . . . . 0.0 112.589 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.76 -26.27 44.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.286 1.034 . . . . 0.0 111.667 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -124.97 -13.74 6.79 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.3 m -55.55 -28.86 57.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.277 0.944 . . . . 0.0 111.533 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.5 -43.07 71.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.271 1.029 . . . . 0.0 111.318 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.87 -31.68 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.856 0.836 . . . . 0.0 109.677 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -77.42 -25.23 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.275 0.63 . . . . 0.0 109.667 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -55.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -52.65 -47.22 67.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.633 1.173 . . . . 0.0 110.187 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -68.51 -35.49 77.56 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.315 0.384 . . . . 0.0 110.58 -177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 25.3 t90 -65.72 -45.54 82.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.627 0.727 . . . . 0.0 109.816 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -59.1 -34.53 72.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.667 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.49 70.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.051 0.54 . . . . 0.0 110.889 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -85.4 -45.58 11.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.16 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 25' ' ' ILE . 6.7 pt -64.34 -37.9 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 120.603 1.547 . . . . 0.0 109.897 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.58 -13.2 28.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -49.67 5.85 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 108.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.91 -28.13 69.85 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.376 0.535 . . . . 0.0 111.051 -169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' MET . . . . . 0.703 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -89.4 -41.22 12.22 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.46 1.104 . . . . 0.0 111.416 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.93 -44.09 27.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.393 0.677 . . . . 0.0 110.727 -174.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -73.25 -28.44 62.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.331 1.452 . . . . 0.0 109.862 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -60.16 -49.9 75.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -1.0 48.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.853 0.461 . . . . 0.0 110.581 178.188 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.47 143.89 31.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -132.29 145.77 51.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.381 1.872 . . . . 0.0 108.104 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.63 117.52 4.85 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.26 112.35 21.95 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 118.983 1.391 . . . . 0.0 108.054 169.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -106.42 142.9 35.32 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.525 1.13 . . . . 0.0 111.83 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.27 169.14 25.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 110.163 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.14 137.89 7.91 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 168.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -138.75 135.57 34.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.791 1.636 . . . . 0.0 108.076 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -87.19 -28.9 22.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.8 p -108.74 -90.8 0.45 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.8 m -162.03 -11.79 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.546 2.738 . . . . 0.0 113.21 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -62.78 -46.75 86.56 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.979 -1.701 . . . . 0.0 112.272 -167.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -34.51 77.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.3 -48.25 80.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.07 0.948 . . . . 0.0 110.437 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 70.2 mtm -65.99 -40.35 91.1 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.908 -0.495 . . . . 0.0 110.943 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.59 98.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.873 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.68 -48.12 75.63 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.075 0.95 . . . . 0.0 110.634 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -59.11 -44.92 92.02 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.18 -54.51 39.93 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 124.658 1.224 . . . . 0.0 109.024 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.426 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -53.03 -56.23 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.888 0.767 . . . . 0.0 109.775 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -38.53 78.14 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.59 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.6 -46.73 74.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 122.878 0.471 . . . . 0.0 111.377 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 158' ' ' GLN . 11.5 mt -68.05 -47.18 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.572 1.149 . . . . 0.0 108.504 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -70.61 -50.17 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.722 0.809 . . . . 0.0 110.159 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.29 115.13 0.85 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.19 3.7 3.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.396 2.731 . . . . 0.0 112.945 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.4 -34.67 70.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.132 1.373 . . . . 0.0 108.996 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -21.02 3.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -169.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.51 142.47 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 120.909 1.686 . . . . 0.0 108.727 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -132.86 129.73 38.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.399 1.08 . . . . 0.0 109.528 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.37 146.41 48.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.64 0.776 . . . . 0.0 111.666 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -139.39 121.69 15.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.632 1.973 . . . . 0.0 107.301 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -103.72 90.43 3.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.33 -15.13 22.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.089 1.356 . . . . 0.0 114.392 -167.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -12.83 61.71 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -131.73 -35.28 1.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.016 1.326 . . . . 0.0 112.22 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -81.75 145.34 30.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.044 1.338 . . . . 0.0 109.651 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -83.95 143.54 43.23 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.36 -8.04 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.501 2.134 . . . . 0.0 111.072 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -57.21 -35.54 69.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.763 1.62 . . . . 0.0 111.823 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -21.37 66.76 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.261 -0.9 . . . . 0.0 113.194 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -13.32 23.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.673 1.189 . . . . 0.0 112.034 170.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.33 -27.46 61.53 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.626 -1.296 . . . . 0.0 111.043 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.68 -49.46 16.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.853 0.751 . . . . 0.0 110.167 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -65.4 140.83 58.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.944 1.298 . . . . 0.0 108.86 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.84 -31.07 68.72 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.356 0.662 . . . . 0.0 110.755 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.77 144.54 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -133.7 152.32 51.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.53 0.605 . . . . 0.0 110.246 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.66 121.67 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -120.67 137.44 54.46 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 108.991 -172.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.33 122.3 3.79 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-O 118.02 -1.434 . . . . 0.0 113.236 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.47 126.07 26.62 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 119.15 1.475 . . . . 0.0 111.829 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -78.51 142.95 18.84 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.433 2.755 . . . . 0.0 109.187 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -92.23 110.09 21.47 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -95.63 171.56 8.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.493 1.117 . . . . 0.0 110.37 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 26.89 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.722 2.809 . . . . 0.0 115.647 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 55.11 76.27 0.27 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.928 1.291 . . . . 0.0 112.481 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.18 16.36 79.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.44 154.5 21.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.458 1.123 . . . . 0.0 108.565 168.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -82.75 153.57 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.04 138.37 44.16 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.89 -24.44 67.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -165.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -87.83 -25.92 23.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.986 0.514 . . . . 0.0 110.606 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.8 m95 -68.46 -39.52 81.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.013 -0.429 . . . . 0.0 110.393 170.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -55.56 -32.87 63.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.023 0.529 . . . . 0.0 111.346 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.91 71.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.424 0.69 . . . . 0.0 111.971 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.7 -12.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.745 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.561 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.3 t-105 -54.25 -28.03 38.83 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.529 1.531 . . . . 0.0 112.059 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.44 -46.13 64.47 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.055 1.342 . . . . 0.0 111.227 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -67.56 -32.02 72.5 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.319 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.63 -30.16 62.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.871 1.214 . . . . 0.0 111.445 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.3 -32.41 70.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.634 0.774 . . . . 0.0 111.354 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.85 -22.7 33.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.963 0.905 . . . . 0.0 110.728 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -73.63 159.8 32.53 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.689 1.233 . . . . 0.0 111.341 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -91.52 101.66 14.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.645 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -122.9 3.93 9.41 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.665 1.186 . . . . 0.0 113.215 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -67.03 115.38 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.72 5.12 78.59 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.61 1.576 . . . . 0.0 115.288 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.2 149.98 33.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 118.125 0.963 . . . . 0.0 110.047 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -86.23 139.08 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 167.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.09 129.63 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 124.756 1.222 . . . . 0.0 108.925 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.05 118.0 35.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 mt -90.12 143.01 27.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.975 0.807 . . . . 0.0 111.776 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -135.29 156.33 49.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.898 0.879 . . . . 0.0 108.657 168.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.24 162.46 30.59 Favored Glycine 0 CA--C 1.505 -0.546 0 O-C-N 120.874 -1.141 . . . . 0.0 111.939 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.6 153.28 40.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.01 -145.75 5.84 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -151.73 145.13 24.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.157 2.183 . . . . 0.0 108.149 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.95 -31.59 22.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.752 2.021 . . . . 0.0 114.019 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.82 -32.93 62.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.356 0.98 . . . . 0.0 112.782 -167.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.71 -19.94 23.3 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 124.843 1.211 . . . . 0.0 111.521 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' C ' ' H ' ' A' ' 95' ' ' GLU . 25.5 m-85 -126.44 -88.64 0.57 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.189 0.996 . . . . 0.0 108.872 -169.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.46 -50.26 2.43 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 128.295 2.855 . . . . 0.0 107.812 -167.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.7 mm-40 -69.02 -32.66 72.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.483 1.913 . . . . 0.0 110.533 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -111.89 0.83 16.25 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.793 1.237 . . . . 0.0 111.656 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.11 126.33 22.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.71 -1.243 . . . . 0.0 109.897 169.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.61 24.7 9.09 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.719 1.608 . . . . 0.0 113.46 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.76 -41.65 97.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.791 -1.193 . . . . 0.0 110.426 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.441 0.697 . . . . 0.0 111.368 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.669 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.33 -46.82 88.68 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.544 0.738 . . . . 0.0 110.927 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.1 95.14 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.6 mtm -68.44 -43.39 77.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 117.74 0.77 . . . . 0.0 112.559 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.567 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -63.82 -33.04 74.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.6 1.091 . . . . 0.0 111.28 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -66.0 -41.03 91.57 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.031 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.93 -31.49 66.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.698 1.999 . . . . 0.0 112.155 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -61.86 -61.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.49 -18.83 56.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.761 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -61.87 -31.11 71.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.145 1.339 . . . . 0.0 111.55 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -22.35 56.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.627 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -82.12 4.73 22.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.518 1.927 . . . . 0.0 112.876 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.05 31.49 78.0 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -82.69 169.82 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -116.8 142.27 47.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -110.04 147.45 33.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.57 1.077 . . . . 0.0 111.723 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.6 m -127.82 178.54 4.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.187 0.995 . . . . 0.0 109.24 169.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.15 34.22 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.326 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -75.65 151.69 37.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.837 1.818 . . . . 0.0 108.446 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.71 148.27 67.81 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 117.095 -1.431 . . . . 0.0 108.946 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.922 1.365 . . . . 0.0 109.696 168.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.511 HG22 ' CD1' ' A' ' 139' ' ' PHE . 79.7 p -74.33 -12.9 60.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.496 1.518 . . . . 0.0 113.692 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.08 144.95 56.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.8 0.809 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.54 76.04 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.95 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.73 169.21 18.07 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.976 1.71 . . . . 0.0 108.962 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.15 126.81 40.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.577 1.551 . . . . 0.0 107.916 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -163.53 -59.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.695 0.68 . . . . 0.0 109.283 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.325 3.7 t 54.97 7.73 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.628 2.771 . . . . 0.0 114.173 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.5 p -72.84 146.09 87.48 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.66 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.98 -11.28 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.935 2.423 . . . . 0.0 113.867 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -79.87 -48.07 1.4 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -169.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.61 39.98 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.295 1.997 . . . . 0.0 112.8 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 148.82 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 120.949 -1.094 . . . . 0.0 110.408 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.02 -172.16 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.123 1.769 . . . . 0.0 109.666 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.42 -117.38 0.94 Allowed 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.24 8.36 33.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.016 1.326 . . . . 0.0 112.011 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.36 20.21 20.84 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.352 0.977 . . . . 0.0 112.865 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.31 -17.21 17.39 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.971 1.308 . . . . 0.0 110.779 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.34 144.33 49.56 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.683 0.793 . . . . 0.0 111.026 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.4 m-85 -79.13 154.65 29.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.48 1.512 . . . . 0.0 109.776 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.18 -15.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.492 1.117 . . . . 0.0 112.479 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.35 -178.47 41.19 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.592 1.087 . . . . 0.0 111.698 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.9 tp -65.7 135.39 54.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.08 124.56 47.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.66 159.57 34.3 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.515 1.126 . . . . 0.0 109.9 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.63 139.63 29.71 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.525 1.53 . . . . 0.0 107.254 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.21 4.22 16.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.043 1.337 . . . . 0.0 111.048 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -24.06 15.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.21 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -147.42 -30.35 0.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -81.29 9.93 6.33 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.342 0.974 . . . . 0.0 111.871 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -55.07 -20.67 10.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.977 0.911 . . . . 0.0 112.792 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.78 -27.01 57.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.522 0.729 . . . . 0.0 110.934 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.77 -11.72 6.62 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 p -52.56 -35.82 54.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 110.476 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.04 -39.93 87.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.529 1.532 . . . . 0.0 111.466 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -31.66 59.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 109.667 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.16 -29.81 57.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.856 -0.528 . . . . 0.0 109.812 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.37 -57.23 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.3 pt20 -57.04 -43.83 82.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 122.661 0.384 . . . . 0.0 111.746 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -65.72 -34.15 77.54 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.055 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.6 t90 -66.51 -45.2 80.33 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.812 0.815 . . . . 0.0 109.802 176.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 89.9 m -57.37 -37.17 72.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.813 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -68.5 -26.69 65.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.199 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.13 -43.52 12.98 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.909 -1.044 . . . . 0.0 112.091 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.07 -36.4 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.874 1.67 . . . . 0.0 109.85 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.2 -47.7 6.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.3 -35.44 77.36 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.41 0.55 . . . . 0.0 110.225 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.729 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.4 mtm -77.9 -43.45 30.04 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.322 1.049 . . . . 0.0 110.601 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.68 73.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.922 0.889 . . . . 0.0 111.252 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.75 -30.76 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.94 1.296 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.542 0.737 . . . . 0.0 110.599 169.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.91 -1.65 56.87 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.719 1.608 . . . . 0.0 113.818 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.089 0.556 . . . . 0.0 110.494 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttm . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.162 0.506 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 147.31 51.6 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 127.946 2.498 . . . . 0.0 106.978 168.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.41 147.07 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.645 1.578 . . . . 0.0 109.0 -166.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.87 119.09 4.78 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.08 108.1 19.08 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -103.73 143.84 32.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.68 1.192 . . . . 0.0 109.998 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -161.09 174.63 13.43 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.956 0.503 . . . . 0.0 109.826 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.17 142.9 9.93 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -140.81 147.19 38.64 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.607 1.163 . . . . 0.0 108.012 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 -29.54 33.08 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 169.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.8 p -104.29 -77.43 0.58 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p 175.66 -7.78 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.997 2.919 . . . . 0.0 110.891 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.46 -44.06 88.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.01 1.732 . . . . 0.0 110.542 -168.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -31.53 70.07 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -64.53 -47.43 78.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.453 1.101 . . . . 0.0 110.207 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.7 mtm -64.11 -40.27 95.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.193 0.451 . . . . 0.0 110.875 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.23 96.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.056 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -47.9 73.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.015 0.926 . . . . 0.0 110.713 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -60.3 -43.78 95.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -63.9 -54.22 38.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.502 1.121 . . . . 0.0 108.974 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -51.52 -56.18 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.039 0.836 . . . . 0.0 109.769 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -39.52 82.6 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.732 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.17 -46.92 69.4 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.424 0.453 . . . . 0.0 111.226 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.45 -48.24 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.25 1.42 . . . . 0.0 108.488 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 164' ' ' ILE . 81.0 mt -72.59 -50.16 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.529 0.731 . . . . 0.0 110.513 -175.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.77 114.11 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.392 0.996 . . . . 0.0 110.855 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 4.09 3.36 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.399 2.732 . . . . 0.0 113.056 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.84 -36.12 64.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.553 1.541 . . . . 0.0 109.262 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.74 -26.1 6.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.434 1.893 . . . . 0.0 110.766 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.33 140.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.114 1.779 . . . . 0.0 109.683 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -130.59 129.56 42.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.676 1.19 . . . . 0.0 109.718 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.47 149.87 45.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.072 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -144.88 112.79 6.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.083 1.753 . . . . 0.0 107.393 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -87.21 108.47 18.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.2 mt -66.38 -7.53 19.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -61.92 -27.54 68.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.9 1.227 . . . . 0.0 111.47 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.36 -33.3 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.677 1.191 . . . . 0.0 112.278 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -83.13 140.51 32.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -82.95 142.21 44.55 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -74.07 -8.79 21.5 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.787 1.658 . . . . 0.0 111.037 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -56.3 -36.68 68.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.879 1.672 . . . . 0.0 111.599 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.34 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -11.52 13.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 112.169 170.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.66 -30.83 63.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.589 -1.32 . . . . 0.0 111.24 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -75.19 -47.92 26.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.88 0.764 . . . . 0.0 110.904 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -63.37 146.55 53.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.77 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -71.43 -24.99 62.13 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.852 0.861 . . . . 0.0 110.402 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.5 t -150.47 151.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.687 1.995 . . . . 0.0 106.166 -168.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.19 155.28 50.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.195 0.907 . . . . 0.0 110.219 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.28 122.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 168.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.48 139.76 51.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.62 0.768 . . . . 0.0 109.046 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.07 121.69 2.8 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.802 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.689 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.39 136.67 27.38 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 118.49 1.145 . . . . 0.0 110.972 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.13 153.87 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.244 1.963 . . . . 0.0 108.921 166.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.466 HG21 ' H ' ' A' ' 99' ' ' ASP . 90.1 m -108.94 94.77 5.23 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -83.13 168.67 16.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.324 1.05 . . . . 0.0 111.509 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t0 18.36 69.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 129.395 3.078 . . . . 0.0 115.251 166.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 56.48 67.6 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.581 1.153 . . . . 0.0 111.861 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.6 23.04 77.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -83.21 154.7 24.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.598 1.159 . . . . 0.0 110.12 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.5 mt -96.18 149.14 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -66.78 143.85 56.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.52 -26.77 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.532 0.733 . . . . 0.0 112.119 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -30.45 71.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.418 0.687 . . . . 0.0 110.898 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.476 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.6 m95 -82.05 -42.14 19.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.48 1.112 . . . . 0.0 110.404 173.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.3 -34.91 64.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.388 0.54 . . . . 0.0 110.956 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.49 72.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.05 -13.27 8.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.697 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.1 t-105 -53.81 -28.68 36.86 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.624 1.57 . . . . 0.0 111.933 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.57 -45.28 59.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.887 1.275 . . . . 0.0 111.055 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.55 -29.86 68.51 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.336 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -56.18 -31.93 63.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.187 1.358 . . . . 0.0 111.111 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.33 -32.58 74.07 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.604 0.762 . . . . 0.0 111.811 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.93 -27.29 43.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.32 0.648 . . . . 0.0 110.518 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.47 157.24 37.99 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.659 1.219 . . . . 0.0 111.376 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -89.9 97.1 10.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.009 -1.905 . . . . 0.0 108.265 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -117.74 3.02 12.31 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 122.194 0.997 . . . . 0.0 113.197 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -68.6 113.01 5.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -169.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.23 49.7 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.768 -1.018 . . . . 0.0 115.053 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.57 156.17 29.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.969 1.385 . . . . 0.0 109.282 169.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.686 HG21 ' HG2' ' A' ' 168' ' ' MET . 7.0 mt -85.49 145.78 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.1 129.36 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.346 1.458 . . . . 0.0 109.658 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -107.99 119.53 39.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 166.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.24 141.44 28.7 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.338 0.972 . . . . 0.0 111.49 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -134.7 160.72 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.093 0.957 . . . . 0.0 108.456 168.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.79 40.08 Favored Glycine 0 N--CA 1.442 -0.919 0 O-C-N 120.939 -1.1 . . . . 0.0 111.074 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.54 148.65 48.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.168 -1.016 . . . . 0.0 108.401 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.44 -155.31 8.81 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.15 138.5 13.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.204 1.802 . . . . 0.0 106.437 168.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -94.03 -24.54 17.58 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 124.02 0.928 . . . . 0.0 112.164 -175.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.72 -51.87 67.54 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.905 0.775 . . . . 0.0 110.946 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.68 -27.13 7.69 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.694 1.14 . . . . 0.0 113.202 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.3 29.37 5.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -168.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.3 -43.1 42.89 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.17 1.35 . . . . 0.0 110.866 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -64.81 -16.46 63.11 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.381 -1.07 . . . . 0.0 112.348 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -130.02 14.03 5.74 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.09 1.756 . . . . 0.0 111.899 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -47.24 127.3 10.51 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.795 2.038 . . . . 0.0 110.56 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 47.36 28.98 1.17 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.902 1.281 . . . . 0.0 112.606 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.466 ' H ' HG21 ' A' ' 55' ' ' THR . 7.3 t70 -63.83 -37.94 89.26 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.804 -1.185 . . . . 0.0 109.815 -169.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.94 74.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.594 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.689 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -59.88 -46.03 90.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.888 0.875 . . . . 0.0 110.342 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.54 -41.88 99.65 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.0 mtm -64.86 -43.83 91.71 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.113 0.957 . . . . 0.0 111.463 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -64.43 -35.72 81.83 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 119.623 1.101 . . . . 0.0 111.143 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -64.47 -41.6 96.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.145 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.88 -42.71 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.93 -59.33 4.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.695 1.198 . . . . 0.0 108.406 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.83 -19.83 57.07 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.627 -0.671 . . . . 0.0 110.855 -170.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.3 t -62.39 -29.79 70.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.31 0.959 . . . . 0.0 110.386 169.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.94 -23.58 52.43 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.305 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -81.94 4.38 22.79 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.104 1.762 . . . . 0.0 113.172 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.24 33.84 86.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.519 0.6 . . . . 0.0 111.749 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.45 170.45 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 123.522 0.729 . . . . 0.0 109.224 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -115.83 140.07 49.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.82 149.0 30.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.797 1.181 . . . . 0.0 112.213 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 13.9 m -129.51 -179.63 3.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.218 1.007 . . . . 0.0 109.995 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.35 39.35 26.65 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.085 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -82.67 149.86 27.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.426 1.613 . . . . 0.0 109.339 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.47 146.36 49.58 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.376 -1.297 . . . . 0.0 108.696 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.6 135.06 25.41 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.395 1.397 . . . . 0.0 110.248 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.557 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.4 p -74.26 -14.58 60.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.219 1.808 . . . . 0.0 112.993 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.95 140.49 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.92 0.867 . . . . 0.0 110.87 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.14 -5.85 52.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.736 1.636 . . . . 0.0 113.533 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.03 170.61 9.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.065 1.346 . . . . 0.0 111.154 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.05 130.44 52.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.641 1.576 . . . . 0.0 108.0 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -164.52 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 109.482 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.302 3.0 t 58.5 8.48 0.88 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.757 2.823 . . . . 0.0 114.956 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 148.3 47.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.398 1.479 . . . . 0.0 111.468 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.31 -14.57 3.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.836 2.357 . . . . 0.0 114.644 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -80.46 -50.02 1.13 Allowed Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.31 37.35 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 CA-C-N 122.008 1.753 . . . . 0.0 112.674 -168.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 148.3 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.414 1.086 . . . . 0.0 110.207 -167.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -172.23 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 126.217 1.807 . . . . 0.0 109.514 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.52 -117.31 0.92 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.041 1.336 . . . . 0.0 107.549 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.26 8.33 33.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.775 1.23 . . . . 0.0 111.918 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.59 20.08 20.68 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.483 1.04 . . . . 0.0 112.713 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.62 -16.84 17.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.889 1.276 . . . . 0.0 110.594 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.94 145.09 50.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.457 0.703 . . . . 0.0 110.98 174.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.557 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -80.13 154.24 28.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.429 1.492 . . . . 0.0 109.608 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -66.15 -12.39 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.681 1.193 . . . . 0.0 112.621 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.12 -177.37 44.15 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.682 1.128 . . . . 0.0 111.889 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.3 tp -67.05 133.0 49.03 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.11 56.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.8 mt -117.13 154.52 30.9 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 108.597 170.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.52 101.1 4.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -0.64 54.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.835 0.854 . . . . 0.0 112.548 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.03 -26.01 14.37 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.451 0.569 . . . . 0.0 111.134 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -139.84 -27.78 0.76 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -87.94 11.63 15.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.942 0.792 . . . . 0.0 111.449 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -53.66 -25.97 20.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.888 1.222 . . . . 0.0 112.525 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.07 -26.15 56.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 110.954 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 pp -130.61 -6.43 4.13 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 112.957 -169.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.4 m -55.59 -29.65 59.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.084 1.311 . . . . 0.0 109.772 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.28 -41.04 78.99 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.445 1.098 . . . . 0.0 111.743 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -75.88 -31.77 59.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.461 1.104 . . . . 0.0 109.738 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -74.73 -30.84 61.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.32 -59.52 4.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.69 -39.42 80.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.7 m -62.53 -38.95 91.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.943 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -66.74 -44.45 81.51 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.9 m -57.05 -34.82 68.61 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.937 0.895 . . . . 0.0 109.548 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -31.7 72.65 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.618 0.573 . . . . 0.0 110.582 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.38 -45.95 12.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.504 173.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 25' ' ' ILE . 5.9 pt -64.18 -38.43 82.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 120.994 1.725 . . . . 0.0 109.833 -170.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.43 -12.26 29.66 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -49.15 5.9 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 125.797 1.639 . . . . 0.0 108.266 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.4 -23.49 67.3 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.252 -170.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.686 ' HG2' HG21 ' A' ' 81' ' ' ILE . 66.9 mtm -94.09 -45.25 7.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.434 1.094 . . . . 0.0 110.979 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.64 49.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.477 0.711 . . . . 0.0 110.823 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -69.4 -28.06 65.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.98 1.312 . . . . 0.0 109.679 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -70.78 -45.71 64.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.814 1.245 . . . . 0.0 110.443 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -22.34 62.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.017 -175.556 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.56 142.78 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -131.67 148.16 52.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.776 2.03 . . . . 0.0 108.488 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.49 118.81 4.93 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.013 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 108.98 19.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.212 1.506 . . . . 0.0 109.838 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -105.57 145.81 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.537 1.535 . . . . 0.0 110.979 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -163.47 175.7 10.5 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.736 0.814 . . . . 0.0 110.231 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.49 141.97 9.2 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 106.502 -2.639 . . . . 0.0 106.502 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -150.03 140.29 22.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.528 1.164 . . . . 0.0 110.891 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -36.37 13.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.692 1.197 . . . . 0.0 110.015 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 p -93.99 -6.64 44.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.217 1.407 . . . . 0.0 112.009 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m 68.05 9.98 7.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.588 1.955 . . . . 0.0 113.091 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -63.83 -45.43 89.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.33 1.423 . . . . 0.0 110.386 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -33.28 74.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.665 0.786 . . . . 0.0 108.918 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.54 -49.55 70.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 109.397 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.45 -38.89 92.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.895 0.316 . . . . 0.0 110.809 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.01 98.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.866 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.09 76.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.956 0.902 . . . . 0.0 110.491 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -59.1 -45.97 89.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.6 mttm -62.21 -55.79 25.0 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 125.106 1.363 . . . . 0.0 108.831 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.6 mt -52.59 -56.48 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 118.458 0.572 . . . . 0.0 109.967 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -38.5 72.78 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.258 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.47 -46.87 74.92 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.902 0.481 . . . . 0.0 111.339 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -66.24 -47.85 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.567 1.147 . . . . 0.0 108.854 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 164' ' ' ILE . 71.7 mt -72.13 -49.69 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.702 0.801 . . . . 0.0 110.048 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 115.69 0.86 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.64 3.74 4.06 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.256 2.637 . . . . 0.0 112.689 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.76 -34.53 67.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.11 1.364 . . . . 0.0 109.027 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 -22.7 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.552 1.541 . . . . 0.0 111.641 -169.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.3 140.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 120.479 1.491 . . . . 0.0 108.924 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -131.26 128.96 40.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.206 1.003 . . . . 0.0 109.824 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.19 149.1 47.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.636 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.6 111.67 5.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.193 1.797 . . . . 0.0 107.144 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.43 111.26 20.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.96 -8.19 35.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -60.24 -27.99 67.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.248 0.931 . . . . 0.0 111.584 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -132.42 -33.82 1.25 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.495 1.118 . . . . 0.0 112.122 -171.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -83.05 140.45 32.68 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.177 0.991 . . . . 0.0 108.585 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -83.44 142.23 43.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.23 -4.75 15.79 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.774 1.649 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -55.21 -35.42 64.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.723 1.601 . . . . 0.0 111.977 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -19.34 65.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -12.15 19.6 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.324 1.049 . . . . 0.0 112.326 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 95.7 mt-10 -78.09 -23.35 48.0 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.828 -1.17 . . . . 0.0 111.543 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -75.4 -48.96 20.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -68.98 150.28 47.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.21 1.404 . . . . 0.0 108.381 -170.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -81.96 -23.78 35.92 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 110.502 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.27 144.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.71 156.11 48.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.398 0.679 . . . . 0.0 110.205 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.61 123.59 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.7 138.6 54.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -133.3 124.79 3.82 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.442 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -127.49 135.32 27.27 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 118.84 1.32 . . . . 0.0 110.842 178.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.11 145.44 12.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.793 1.662 . . . . 0.0 108.511 166.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.9 m -90.46 123.49 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -108.11 170.73 7.82 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.455 1.902 . . . . 0.0 110.249 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t0 15.37 69.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 129.542 3.137 . . . . 0.0 115.217 168.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 58.59 67.79 0.9 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.427 1.491 . . . . 0.0 110.401 172.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.66 32.61 70.91 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.354 0.5 OUTLIER -99.15 153.83 18.61 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.625 1.17 . . . . 0.0 109.827 168.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.96 148.87 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -62.38 142.67 57.71 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.85 -28.14 69.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.14 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.69 -29.48 70.03 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.646 0.778 . . . . 0.0 110.509 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.9 m95 -81.94 -42.51 19.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.745 0.818 . . . . 0.0 110.785 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.62 -33.99 64.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.408 0.549 . . . . 0.0 110.872 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.91 73.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.464 1.105 . . . . 0.0 111.838 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.09 -11.31 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.547 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.9 t-105 -53.04 -28.8 26.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.846 1.658 . . . . 0.0 111.817 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.71 -45.87 67.28 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.189 1.396 . . . . 0.0 111.414 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.67 -31.97 73.27 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.005 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.5 mt -56.66 -32.47 65.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.709 1.14 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.42 -31.77 71.34 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.47 0.708 . . . . 0.0 111.166 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.95 -16.72 35.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.675 0.79 . . . . 0.0 111.448 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.98 156.3 39.32 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 122.227 1.013 . . . . 0.0 113.47 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -89.12 75.19 7.92 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.766 2.427 . . . . 0.0 106.335 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.301 56.1 tp -118.11 7.32 12.15 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 125.514 1.526 . . . . 0.0 113.606 -165.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -74.15 138.04 43.57 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.406 1.882 . . . . 0.0 109.656 -172.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.69 8.49 86.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 125.599 1.571 . . . . 0.0 114.489 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 54.8 mttm -90.69 148.81 22.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.953 1.301 . . . . 0.0 109.37 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -84.2 139.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.96 127.95 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 C-N-CA 125.052 1.341 . . . . 0.0 108.828 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.95 115.33 30.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 167.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 mt -86.73 143.19 27.66 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.127 0.876 . . . . 0.0 111.184 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 24.4 p90 -136.86 158.76 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.77 0.828 . . . . 0.0 109.034 168.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.63 176.96 41.05 Favored Glycine 0 CA--C 1.508 -0.385 0 O-C-N 120.944 -1.098 . . . . 0.0 112.441 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.36 145.16 50.9 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.29 32.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.93 139.12 23.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.151 1.476 . . . . 0.0 108.625 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.62 -20.24 23.94 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.969 1.308 . . . . 0.0 114.403 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.55 -47.43 69.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.045 1.293 . . . . 0.0 111.25 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.67 -21.03 10.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.086 0.851 . . . . 0.0 112.195 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 41.77 2.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.116 0.967 . . . . 0.0 111.307 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.95 -43.54 72.79 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 125.007 1.289 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.8 mm-40 -67.33 -26.12 66.35 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -94.0 -10.5 33.38 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.957 2.503 . . . . 0.0 112.628 -171.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -49.57 130.09 20.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.505 2.722 . . . . 0.0 110.913 -169.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 48.91 27.92 1.79 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.228 1.011 . . . . 0.0 112.599 172.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.46 -36.48 84.32 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.03 -1.044 . . . . 0.0 110.023 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.08 77.14 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.641 0.376 . . . . 0.0 111.515 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -60.95 -48.15 83.15 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 110.009 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.09 97.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.62 -44.65 89.86 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.043 0.922 . . . . 0.0 111.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.58 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -63.9 -34.54 78.19 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.508 1.049 . . . . 0.0 111.158 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -64.06 -41.91 97.19 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.222 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.59 -31.22 66.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.966 2.106 . . . . 0.0 112.249 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -62.73 -61.87 2.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.2 mt -76.32 -19.75 57.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.39 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -61.15 -31.08 70.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.022 1.283 . . . . 0.0 111.427 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -21.16 54.19 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -83.9 6.02 23.2 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.407 1.883 . . . . 0.0 112.46 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.15 32.2 76.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.41 170.13 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.713 0.805 . . . . 0.0 108.908 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -119.96 142.63 48.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.95 148.73 31.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.916 1.235 . . . . 0.0 111.911 -169.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 22.1 m -129.06 179.56 3.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.275 1.03 . . . . 0.0 108.992 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 36.37 40.0 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-O 118.398 -1.223 . . . . 0.0 113.894 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -79.83 151.55 30.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 119.556 1.678 . . . . 0.0 108.83 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 152.52 73.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.264 172.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 135.12 33.16 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.292 1.328 . . . . 0.0 109.98 169.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.563 HG22 ' CD1' ' A' ' 139' ' ' PHE . 55.1 p -73.59 -15.03 61.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.935 1.694 . . . . 0.0 112.902 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.22 145.21 56.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.903 0.881 . . . . 0.0 109.152 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.37 18.75 79.46 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.946 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.09 163.7 25.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.694 1.998 . . . . 0.0 109.012 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.33 126.19 40.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 125.627 1.571 . . . . 0.0 107.648 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -168.54 -48.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 0.0 109.466 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.32 3.3 t 59.74 7.53 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.075 2.95 . . . . 0.0 114.639 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 149.03 56.9 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.954 1.302 . . . . 0.0 112.624 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -90.04 -13.67 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.889 2.393 . . . . 0.0 114.025 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.54 -52.29 2.93 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 117.965 -1.017 . . . . 0.0 113.297 -169.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -85.96 40.07 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 121.695 1.641 . . . . 0.0 112.053 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 121' ' ' THR . 0.1 OUTLIER -137.19 145.91 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.607 1.163 . . . . 0.0 109.227 -168.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.418 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.4 -176.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.78 1.232 . . . . 0.0 112.074 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.94 -110.58 0.53 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 127.026 2.131 . . . . 0.0 109.155 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -99.41 -0.71 40.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.552 1.541 . . . . 0.0 111.958 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.0 26.06 9.95 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.146 -0.971 . . . . 0.0 111.798 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -20.48 13.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.142 1.377 . . . . 0.0 108.444 -175.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.98 138.9 51.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.993 1.317 . . . . 0.0 110.863 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 121' ' ' THR . 43.2 m-85 -78.47 151.8 32.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' A' ' 101' ' ' LEU . 14.4 m -63.12 -13.71 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.827 1.251 . . . . 0.0 112.201 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.8 -174.08 42.04 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 119.458 1.026 . . . . 0.0 111.737 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.29 128.63 36.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.07 123.36 47.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 142' ' ' LEU . 74.9 mt -122.18 156.59 33.39 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.039 1.335 . . . . 0.0 108.363 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.08 123.98 16.24 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -100.78 14.32 32.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.429 1.092 . . . . 0.0 110.824 -169.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.42 -24.3 5.44 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.49 -48.72 3.06 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.605 1.093 . . . . 0.0 108.39 172.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -104.4 21.88 15.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.434 1.494 . . . . 0.0 112.659 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -53.47 -24.69 13.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.58 -26.01 41.4 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.83 -12.95 8.35 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.043 0.937 . . . . 0.0 112.244 -170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -58.85 -27.48 65.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.84 1.2 . . . . 0.0 110.781 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.87 -47.07 81.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.326 1.05 . . . . 0.0 110.967 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.99 -32.38 72.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.753 0.787 . . . . 0.0 109.485 -171.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -75.18 -27.52 59.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.875 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.34 -55.2 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -51.67 -47.98 63.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.922 0.889 . . . . 0.0 109.853 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -68.08 -35.91 78.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.561 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -64.92 -44.37 89.75 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.452 0.644 . . . . 0.0 109.778 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.3 m -58.88 -36.59 74.88 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.664 0.786 . . . . 0.0 109.474 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -69.72 -29.26 66.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.31 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.73 -46.64 16.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.355 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.75 -38.5 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 120.872 1.669 . . . . 0.0 110.21 -170.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.19 -15.34 59.69 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.227 0.611 . . . . 0.0 111.94 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -96.4 -46.16 6.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.15 -41.95 89.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.909 0.777 . . . . 0.0 109.503 -173.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.696 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.2 mtm -75.67 -37.24 59.74 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.561 0.744 . . . . 0.0 110.938 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.01 -47.15 60.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.926 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.41 -30.72 71.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 110.021 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -63.17 -47.27 83.35 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.463 0.574 . . . . 0.0 110.391 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -3.01 49.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.592 1.157 . . . . 0.0 113.765 -175.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.249 0.477 . . . . 0.0 110.647 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.05 144.67 47.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.156 1.382 . . . . 0.0 108.427 169.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.4 mtm -124.01 150.65 44.63 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.935 2.494 . . . . 0.0 108.741 -167.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.43 120.32 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.11 102.98 15.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.621 1.211 . . . . 0.0 110.101 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -102.7 145.57 29.5 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.044 1.338 . . . . 0.0 111.467 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -164.14 172.61 13.48 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.981 0.912 . . . . 0.0 109.897 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.69 137.4 8.23 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 169.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -135.61 130.69 34.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.149 1.38 . . . . 0.0 109.978 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -91.26 -38.33 12.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.93 0.492 . . . . 0.0 110.016 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 p -93.99 -85.69 0.28 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.18 -3.9 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.491 2.717 . . . . 0.0 111.867 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -68.85 -42.83 76.57 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 119.729 -1.857 . . . . 0.0 112.171 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -35.97 82.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -64.68 -49.35 71.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 109.921 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.5 mtm -64.87 -38.71 91.89 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.093 -0.379 . . . . 0.0 111.465 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.15 98.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.0 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.21 79.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.031 0.932 . . . . 0.0 110.61 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -57.64 -47.1 83.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -61.68 -54.41 43.02 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 124.733 1.271 . . . . 0.0 108.995 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.97 -57.02 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.83 0.741 . . . . 0.0 109.691 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -39.11 70.29 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 123.431 0.693 . . . . 0.0 110.339 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.68 -47.7 68.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.801 0.44 . . . . 0.0 111.486 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 158' ' ' GLN . 12.7 mt -65.79 -45.5 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 108.51 -174.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.77 -52.1 27.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.913 0.885 . . . . 0.0 110.546 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.72 115.45 0.85 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.83 3.15 4.64 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.451 2.767 . . . . 0.0 112.686 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.09 -34.39 68.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.451 1.5 . . . . 0.0 109.556 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -4.34 4.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.157 1.783 . . . . 0.0 111.95 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.77 144.46 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 120.955 1.707 . . . . 0.0 109.3 167.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -134.91 130.67 36.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.856 1.263 . . . . 0.0 110.31 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.78 149.62 45.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -146.9 108.76 4.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.182 1.793 . . . . 0.0 108.345 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -82.64 112.92 19.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.73 -9.82 22.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -58.95 -29.02 66.84 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.261 0.937 . . . . 0.0 111.624 168.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -129.95 -33.8 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.544 1.138 . . . . 0.0 111.728 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -87.57 142.04 28.15 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.314 1.046 . . . . 0.0 109.192 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -83.78 143.15 43.08 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -74.65 -2.19 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.706 1.604 . . . . 0.0 111.412 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -56.82 -33.83 67.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.094 2.225 . . . . 0.0 112.459 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -18.59 65.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 44.2 ttm -59.17 -14.31 10.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.973 2.109 . . . . 0.0 111.654 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 65.4 mt-10 -74.36 -30.4 61.98 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.83 -1.169 . . . . 0.0 110.699 173.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.48 -48.84 16.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.775 0.716 . . . . 0.0 109.721 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -67.74 134.28 50.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.95 -6.57 48.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 81' ' ' ILE . 77.1 t -135.27 140.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 156.47 48.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 118.206 0.457 . . . . 0.0 109.865 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.26 122.56 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 168.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.73 132.66 55.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.12 115.98 2.82 Favored Glycine 0 CA--C 1.511 -0.158 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.484 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -118.48 125.15 28.0 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 118.775 1.288 . . . . 0.0 109.347 176.057 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.27 143.34 7.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.912 2.408 . . . . 0.0 107.925 168.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -88.56 128.36 35.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -117.65 170.11 9.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.875 1.67 . . . . 0.0 109.688 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 28.21 58.68 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.117 2.567 . . . . 0.0 115.325 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 56.58 73.64 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.666 1.187 . . . . 0.0 112.427 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.98 15.54 76.32 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -82.3 152.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.451 1.12 . . . . 0.0 109.095 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -83.97 153.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.752 -1.574 . . . . 0.0 106.752 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -60.5 141.73 56.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.912 0.863 . . . . 0.0 108.835 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.93 -28.09 68.66 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -79.66 -22.77 43.11 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.822 -0.549 . . . . 0.0 110.289 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' ILE . 11.5 m95 -76.63 -43.79 36.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.211 0.604 . . . . 0.0 111.234 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -53.5 -34.9 59.76 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.126 0.57 . . . . 0.0 110.943 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.21 71.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.099 0.96 . . . . 0.0 112.149 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -109.11 -9.32 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.557 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.8 t-105 -53.08 -28.93 27.44 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.457 1.503 . . . . 0.0 111.69 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.51 -45.35 72.49 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.825 1.25 . . . . 0.0 111.623 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.9 -27.74 66.91 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.105 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.26 -32.02 67.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.726 1.148 . . . . 0.0 111.062 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.2 -30.36 69.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.536 0.734 . . . . 0.0 111.148 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.53 -11.35 37.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.18 0.992 . . . . 0.0 111.631 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.97 174.02 9.17 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.142 0.973 . . . . 0.0 110.783 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.436 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 5.1 t30 -114.92 103.77 11.26 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.115 1.766 . . . . 0.0 107.582 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.8 8.47 7.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.778 1.231 . . . . 0.0 113.068 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -67.32 116.52 8.18 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.22 9.99 85.33 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.305 1.431 . . . . 0.0 114.847 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -80.59 152.58 28.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.006 0.903 . . . . 0.0 109.693 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.721 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.2 mt -87.16 141.49 14.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 168.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.11 131.61 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.851 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -111.14 116.37 30.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.08 142.75 27.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.99 0.814 . . . . 0.0 111.792 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -136.83 159.09 42.9 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.28 175.88 37.87 Favored Glycine 0 N--CA 1.447 -0.573 0 O-C-N 120.884 -1.135 . . . . 0.0 111.934 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -125.44 153.66 43.15 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.82 -155.39 8.96 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -155.69 137.64 14.5 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.081 1.352 . . . . 0.0 108.433 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.43 -22.58 24.89 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 113.845 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.9 mt -67.15 -48.01 69.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.823 1.192 . . . . 0.0 110.638 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.66 -26.28 9.27 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.759 1.171 . . . . 0.0 112.328 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.13 33.55 3.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.57 -42.89 58.61 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.659 1.572 . . . . 0.0 111.131 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -61.63 -18.54 59.89 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 117.694 0.747 . . . . 0.0 112.538 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.67 11.83 7.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.081 1.752 . . . . 0.0 112.563 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.12 122.96 4.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.34 1.456 . . . . 0.0 108.682 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 52.33 28.72 5.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.133 0.973 . . . . 0.0 112.959 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.62 -39.66 94.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.519 -1.363 . . . . 0.0 110.72 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.32 73.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.113 0.565 . . . . 0.0 111.485 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.1 tp -59.91 -47.0 87.54 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.067 0.947 . . . . 0.0 110.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.85 97.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.9 mtm -66.47 -43.89 84.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.946 0.873 . . . . 0.0 111.717 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.557 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.6 mt -64.93 -34.58 78.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.455 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.7 -41.97 98.03 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.927 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.16 -42.28 89.22 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.536 1.134 . . . . 0.0 111.578 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.67 -58.44 7.5 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.798 1.239 . . . . 0.0 108.292 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.4 mt -78.17 -19.62 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.453 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 t -61.58 -28.8 69.6 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 110.298 168.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -22.94 52.58 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.628 -1.295 . . . . 0.0 109.608 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -83.64 4.66 27.54 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.236 1.814 . . . . 0.0 112.371 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.0 33.42 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.624 0.647 . . . . 0.0 112.032 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.87 170.91 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -115.5 143.18 45.69 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.43 147.01 33.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.936 0.789 . . . . 0.0 111.358 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.2 m -128.0 178.02 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.255 1.022 . . . . 0.0 109.081 170.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.49 37.26 31.57 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-O 118.615 -1.103 . . . . 0.0 114.126 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -79.32 144.2 34.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.647 1.724 . . . . 0.0 108.628 171.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -121.81 147.32 48.13 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 117.326 -1.321 . . . . 0.0 108.922 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.39 138.59 39.37 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 120.804 1.323 . . . . 0.0 109.596 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.0 p -74.14 -6.8 49.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.806 1.643 . . . . 0.0 113.383 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.73 140.83 57.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.257 1.027 . . . . 0.0 109.543 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.87 -11.42 59.88 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.556 1.551 . . . . 0.0 113.67 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -92.8 158.97 15.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.815 1.308 . . . . 0.0 111.017 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -128.76 125.82 38.67 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.559 2.344 . . . . 0.0 106.086 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 127' ' ' THR . 13.3 p90 -163.94 -58.88 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 O-C-N 121.767 -0.583 . . . . 0.0 109.709 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 126' ' ' PHE 0.327 2.7 t 58.83 10.15 1.41 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.505 2.722 . . . . 0.0 114.648 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -67.11 139.84 95.46 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.733 -1.229 . . . . 0.0 108.885 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.45 -13.28 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.504 2.136 . . . . 0.0 113.735 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -80.35 -48.84 1.23 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.7 37.65 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.017 1.756 . . . . 0.0 112.737 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 146.52 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 124.243 1.017 . . . . 0.0 109.74 -166.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.41 -172.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 126.024 1.73 . . . . 0.0 109.636 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.73 -116.53 0.86 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.173 1.389 . . . . 0.0 107.528 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.36 8.33 33.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.822 1.249 . . . . 0.0 112.068 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.53 20.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.73 1.157 . . . . 0.0 112.823 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -100.55 -17.33 17.14 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.744 1.218 . . . . 0.0 110.775 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.49 145.26 51.03 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.308 0.643 . . . . 0.0 111.088 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.1 m-85 -80.84 155.07 26.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.205 1.402 . . . . 0.0 110.005 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.1 m -66.86 -12.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.802 1.241 . . . . 0.0 112.869 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.11 -179.03 43.53 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 119.659 1.118 . . . . 0.0 112.454 -170.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.428 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 25.1 tp -66.06 128.52 36.39 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.68 119.86 40.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -120.4 159.36 25.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.652 1.181 . . . . 0.0 108.728 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.69 122.6 12.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 173.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.36 18.42 16.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.673 -169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 -20.49 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.878 0.871 . . . . 0.0 112.873 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.97 -53.51 2.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.198 1.363 . . . . 0.0 108.652 170.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.53 16.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -168.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.72 -26.28 9.07 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.933 0.893 . . . . 0.0 112.504 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.91 -26.81 54.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.175 0.99 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.13 -7.66 9.83 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.414 1.086 . . . . 0.0 112.257 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 m -50.47 -33.82 22.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.761 1.164 . . . . 0.0 110.31 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.49 -41.39 85.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.303 1.041 . . . . 0.0 111.742 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -33.43 65.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.866 1.266 . . . . 0.0 109.796 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -22.9 41.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.769 0.828 . . . . 0.0 110.363 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.16 -60.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.424 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.7 pt20 -55.78 -41.81 74.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.366 0.53 . . . . 0.0 112.331 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 60.0 p -66.56 -35.69 80.82 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.053 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 45.5 t90 -65.46 -43.26 90.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 109.528 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.1 m -58.74 -36.66 74.68 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 123.717 0.807 . . . . 0.0 109.575 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.29 -32.8 73.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.359 0.412 . . . . 0.0 111.175 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -77.14 -45.84 25.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.476 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -65.28 -38.28 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 120.878 1.672 . . . . 0.0 110.415 -173.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.26 -12.32 50.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.54 0.609 . . . . 0.0 112.267 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -95.02 -47.86 6.22 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.45 -35.69 78.32 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.846 0.748 . . . . 0.0 110.69 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.721 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.9 mtm -81.48 -39.83 24.18 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.249 1.019 . . . . 0.0 110.518 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.83 63.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.933 0.893 . . . . 0.0 110.916 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.64 -32.08 69.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.872 1.269 . . . . 0.0 109.436 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.46 ' CD2' HD11 ' A' ' 81' ' ' ILE . 61.6 t60 -62.78 -49.86 73.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -3.26 29.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.521 1.129 . . . . 0.0 113.555 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.511 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.92 146.15 51.54 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 126.504 1.922 . . . . 0.0 108.196 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -136.57 146.99 46.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.548 1.539 . . . . 0.0 109.271 -166.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.0 119.45 4.88 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.22 111.46 21.68 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.627 1.213 . . . . 0.0 108.315 169.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -107.3 144.68 33.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 111.167 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -161.79 175.91 11.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.548 0.739 . . . . 0.0 110.716 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.9 11.91 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -140.99 143.78 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.131 1.372 . . . . 0.0 110.58 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -93.29 -39.19 11.11 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.675 1.19 . . . . 0.0 109.857 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -96.56 -85.86 0.33 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 p -173.91 -4.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.97 2.508 . . . . 0.0 112.336 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -66.39 -43.38 86.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.956 -1.715 . . . . 0.0 111.402 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -34.74 76.77 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.61 -49.33 77.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.166 0.986 . . . . 0.0 109.985 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.2 mtm -66.33 -41.21 89.93 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.917 -0.489 . . . . 0.0 110.837 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.33 93.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.687 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.8 77.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.01 0.924 . . . . 0.0 110.553 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -59.13 -44.32 92.02 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.71 -55.04 30.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 124.762 1.288 . . . . 0.0 108.7 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.05 -56.08 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.07 0.85 . . . . 0.0 109.79 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -39.14 82.66 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.814 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.48 -47.76 69.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.042 0.537 . . . . 0.0 111.227 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.31 -47.53 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.014 1.326 . . . . 0.0 108.424 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -73.22 -48.99 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.669 0.788 . . . . 0.0 110.324 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.49 114.97 0.88 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.25 3.66 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.432 2.755 . . . . 0.0 112.875 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -73.8 -35.62 64.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.334 1.454 . . . . 0.0 109.18 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.96 -27.19 5.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.282 1.833 . . . . 0.0 110.872 -172.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 141.68 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 120.705 1.593 . . . . 0.0 109.569 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 m -133.38 129.83 37.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.572 1.149 . . . . 0.0 109.648 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.38 150.44 45.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.559 0.744 . . . . 0.0 111.921 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -145.64 112.23 5.88 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.423 1.889 . . . . 0.0 107.087 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -87.12 110.86 20.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.17 -8.76 26.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -58.35 -29.24 65.81 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.162 0.892 . . . . 0.0 111.538 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.93 -33.84 1.15 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -82.86 141.43 32.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.121 0.969 . . . . 0.0 108.756 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 m -84.74 141.69 38.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.79 -6.59 18.86 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.651 1.567 . . . . 0.0 111.734 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -55.42 -37.19 67.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.894 1.679 . . . . 0.0 111.706 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -19.3 65.8 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -11.8 16.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 112.534 170.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.61 -31.08 66.52 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 111.376 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.3 -46.29 42.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.722 0.772 . . . . 0.0 110.431 -169.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.99 149.36 50.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.912 1.285 . . . . 0.0 108.719 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -73.61 -25.05 60.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.872 0.869 . . . . 0.0 110.337 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 49' ' ' LEU . 41.0 t -151.93 147.55 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.684 1.993 . . . . 0.0 105.929 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.36 158.69 35.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.288 0.949 . . . . 0.0 111.034 168.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.58 121.53 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.38 136.13 54.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.45 120.16 3.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.3 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.5 131.47 24.44 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 119.091 1.445 . . . . 0.0 111.129 176.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.98 149.25 15.64 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.134 1.89 . . . . 0.0 108.331 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -96.09 128.38 42.94 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -121.11 171.28 8.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 109.84 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 30.65 54.89 0.19 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.983 2.513 . . . . 0.0 115.616 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 56.74 75.78 0.34 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 112.267 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 31.19 68.94 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.458 0.543 . . . . 0.0 114.458 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.19 156.13 17.38 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.727 1.611 . . . . 0.0 109.571 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.93 151.19 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -65.78 142.99 57.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.03 -27.16 68.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.226 -169.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -66.89 -26.15 66.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.883 0.873 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.506 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.4 m95 -84.45 -42.85 15.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.165 0.986 . . . . 0.0 110.782 171.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.42 -34.69 64.65 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.45 0.568 . . . . 0.0 110.978 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.57 71.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.576 1.15 . . . . 0.0 112.237 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.05 -10.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.541 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.1 t-105 -53.75 -28.85 36.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.476 1.51 . . . . 0.0 111.668 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.42 -44.51 67.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.81 1.244 . . . . 0.0 111.338 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.53 -27.94 66.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.438 1.095 . . . . 0.0 112.355 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.7 mt -57.24 -30.06 64.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.755 1.161 . . . . 0.0 111.409 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.95 -32.04 71.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.59 0.756 . . . . 0.0 111.366 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.96 -27.94 39.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 110.805 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.24 160.21 32.6 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.571 1.177 . . . . 0.0 111.431 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.3 96.27 10.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.163 -1.835 . . . . 0.0 108.572 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.0 4.73 13.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.131 0.967 . . . . 0.0 113.132 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -69.37 113.97 7.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -169.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.6 55.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.623 -1.098 . . . . 0.0 115.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.89 160.78 25.4 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.25 1.525 . . . . 0.0 109.697 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.529 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.5 mt -94.03 150.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 118.365 0.53 . . . . 0.0 109.993 -169.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.8 t -135.45 127.9 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.59 116.94 32.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.65 141.51 28.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.231 0.923 . . . . 0.0 111.327 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -137.39 162.21 34.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 177.76 38.62 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 121.037 -1.039 . . . . 0.0 111.931 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 mt -122.84 150.04 43.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.89 -157.9 11.49 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -157.33 137.31 12.51 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.031 1.332 . . . . 0.0 107.879 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -21.43 26.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.54 -45.47 65.44 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.622 1.101 . . . . 0.0 110.776 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.94 -29.13 9.33 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.302 0.953 . . . . 0.0 112.423 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.09 33.83 3.87 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.07 -42.61 61.66 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 120.155 1.343 . . . . 0.0 111.29 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.46 -17.42 62.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.825 0.812 . . . . 0.0 112.728 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -127.06 10.45 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.915 1.686 . . . . 0.0 112.342 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -41.96 124.36 2.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.476 1.91 . . . . 0.0 110.393 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 49.47 29.01 2.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.322 1.049 . . . . 0.0 112.72 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.751 -1.218 . . . . 0.0 110.255 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.35 73.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.407 0.283 . . . . 0.0 111.094 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.662 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.0 tp -61.69 -46.57 89.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.186 0.994 . . . . 0.0 110.633 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.25 -41.92 98.51 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.2 mtm -65.6 -44.72 85.7 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.616 0.708 . . . . 0.0 111.783 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -64.74 -35.09 79.94 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.161 175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.77 -42.01 97.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.946 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.77 -43.45 88.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.615 1.166 . . . . 0.0 111.69 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -54.19 -58.97 5.37 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.516 1.126 . . . . 0.0 108.486 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.25 -19.05 57.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.741 -170.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 t -62.22 -29.37 70.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.365 0.984 . . . . 0.0 110.51 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -22.16 56.44 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.604 -1.31 . . . . 0.0 109.735 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -84.67 5.5 27.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.089 1.755 . . . . 0.0 112.935 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.05 35.15 90.2 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.25 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 124.326 1.051 . . . . 0.0 109.375 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.54 140.31 52.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -112.49 147.14 37.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 111.206 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -129.22 -178.96 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 109.335 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.6 34.01 41.0 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.006 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.97 146.17 39.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 119.694 1.747 . . . . 0.0 108.354 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 144.82 40.57 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-O 117.319 -1.324 . . . . 0.0 108.467 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.26 138.78 40.27 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 120.691 1.282 . . . . 0.0 109.22 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.479 HG22 ' CD1' ' A' ' 139' ' ' PHE . 68.0 p -73.98 -4.32 34.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.985 1.714 . . . . 0.0 113.337 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.59 141.58 57.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.997 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.51 -7.33 58.13 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.625 1.583 . . . . 0.0 113.619 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -94.34 161.29 14.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 0.0 110.097 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.55 131.05 46.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.22 -46.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.438 1.017 . . . . 0.0 110.453 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.3 3.4 t 59.77 8.6 1.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.764 2.826 . . . . 0.0 115.179 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -90.15 147.86 37.99 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.975 1.31 . . . . 0.0 111.458 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.63 -9.33 5.77 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.955 2.436 . . . . 0.0 114.162 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -72.93 -55.01 4.25 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.26 40.52 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 121.553 1.59 . . . . 0.0 112.413 -168.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.68 149.24 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.588 1.085 . . . . 0.0 110.748 -166.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.27 -172.39 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 126.209 1.803 . . . . 0.0 109.86 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.95 -116.54 0.85 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.099 1.359 . . . . 0.0 107.81 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.28 8.24 33.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.974 1.309 . . . . 0.0 111.89 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.92 20.56 20.95 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.724 1.154 . . . . 0.0 112.618 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -99.43 -18.06 17.65 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.752 1.221 . . . . 0.0 110.782 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 143.35 50.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.231 0.612 . . . . 0.0 110.927 174.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.0 m-85 -77.68 155.28 31.43 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.232 1.413 . . . . 0.0 109.64 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.8 m -65.18 -14.94 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 112.422 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.91 -178.15 42.72 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 119.763 1.165 . . . . 0.0 111.968 -173.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 13.9 tp -64.76 129.68 40.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.66 110.14 18.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.31 151.32 24.99 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.374 0.669 . . . . 0.0 109.716 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.87 138.02 25.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -107.87 30.84 5.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.132 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 t -133.09 -39.04 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.04 -53.21 4.84 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.937 1.695 . . . . 0.0 106.76 171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.7 16.89 23.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.015 1.326 . . . . 0.0 112.763 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -52.42 -27.92 17.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.214 0.915 . . . . 0.0 112.562 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.86 -19.57 30.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.996 0.518 . . . . 0.0 111.896 -173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.21 -2.96 7.54 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.968 1.307 . . . . 0.0 112.542 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 p -55.62 -32.39 63.09 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.869 1.213 . . . . 0.0 110.297 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.31 -42.03 90.43 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.401 1.08 . . . . 0.0 111.502 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -33.54 57.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.626 1.17 . . . . 0.0 109.941 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -70.01 -32.88 71.27 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.306 1.042 . . . . 0.0 108.413 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 52.8 mt -67.27 -59.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -58.37 -38.47 77.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.6 m -64.08 -37.8 88.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.667 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 36.2 t90 -66.5 -44.95 81.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.87 0.843 . . . . 0.0 110.168 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.1 m -56.93 -35.37 68.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.946 0.898 . . . . 0.0 109.72 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -70.76 -30.53 67.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.546 0.529 . . . . 0.0 109.852 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.77 -47.22 15.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.518 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.08 -39.71 86.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 CA-C-N 121.132 1.787 . . . . 0.0 110.36 -169.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.62 -14.11 56.54 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.369 0.667 . . . . 0.0 112.136 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.64 -45.98 6.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.37 -42.97 88.17 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.758 0.708 . . . . 0.0 109.525 -173.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.529 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -76.9 -36.31 56.75 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -174.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.45 63.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.133 0.973 . . . . 0.0 109.959 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.52 -32.02 73.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.23 1.412 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.55 -47.78 80.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.161 0.584 . . . . 0.0 110.382 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -6.13 48.03 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.208 1.003 . . . . 0.0 113.707 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 118.785 0.72 . . . . 0.0 110.645 -178.572 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.85 140.29 29.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.99 148.25 47.13 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.632 2.373 . . . . 0.0 108.815 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.55 118.66 4.7 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.01 112.49 23.43 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.945 1.373 . . . . 0.0 108.928 170.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.0 144.86 34.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.159 1.384 . . . . 0.0 111.219 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.51 175.6 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.949 0.899 . . . . 0.0 110.74 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.22 140.51 7.91 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.592 -2.603 . . . . 0.0 106.592 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 141.24 43.3 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.727 1.264 . . . . 0.0 109.444 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -83.25 -40.34 19.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.442 1.097 . . . . 0.0 109.723 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.6 p -96.7 -82.26 0.4 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.622 1.569 . . . . 0.0 107.271 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 p -177.71 -6.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 128.781 2.832 . . . . 0.0 111.619 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.22 -41.26 86.05 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 119.769 -1.832 . . . . 0.0 111.806 -168.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -35.05 74.95 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -63.32 -46.46 86.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.991 0.917 . . . . 0.0 110.326 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.9 -38.85 87.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.011 -0.431 . . . . 0.0 111.044 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.69 93.89 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.683 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.65 -47.22 77.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.041 0.936 . . . . 0.0 110.621 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.64 -44.52 93.49 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.81 -55.43 26.48 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 124.546 1.154 . . . . 0.0 109.112 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.11 -56.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 118.974 0.806 . . . . 0.0 109.719 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.17 77.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.636 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.28 -46.58 73.19 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.013 0.525 . . . . 0.0 111.347 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 158' ' ' GLN . 14.4 mt -67.39 -45.76 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.826 1.25 . . . . 0.0 108.417 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 164' ' ' ILE . 77.4 mt -71.95 -50.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.765 0.826 . . . . 0.0 110.241 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.51 114.27 0.79 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.489 1.042 . . . . 0.0 110.607 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.56 3.79 3.98 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.532 2.821 . . . . 0.0 112.681 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.8 -34.61 69.52 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.178 1.391 . . . . 0.0 109.194 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 -20.27 4.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.553 1.541 . . . . 0.0 111.602 -169.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.98 143.12 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.958 1.708 . . . . 0.0 109.083 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.6 m -133.68 129.24 36.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.562 1.145 . . . . 0.0 109.76 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.06 149.1 46.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.85 0.86 . . . . 0.0 111.687 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -144.09 112.32 6.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.445 1.898 . . . . 0.0 106.929 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -87.71 110.71 20.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.19 -8.39 31.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -59.77 -28.88 67.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.225 0.92 . . . . 0.0 111.476 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.36 -33.44 1.28 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.418 1.087 . . . . 0.0 112.285 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -83.34 140.6 32.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.218 1.007 . . . . 0.0 108.672 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m -84.88 141.63 38.27 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.05 -5.33 16.89 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.674 1.583 . . . . 0.0 111.764 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -54.06 -38.21 65.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.489 1.495 . . . . 0.0 111.338 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -20.55 66.27 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.116 -0.99 . . . . 0.0 113.16 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -12.23 27.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.331 1.053 . . . . 0.0 112.514 169.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -74.01 -26.26 60.34 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.941 -1.099 . . . . 0.0 110.581 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.31 -50.28 13.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.942 0.792 . . . . 0.0 110.106 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.89 146.16 55.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.575 1.15 . . . . 0.0 108.666 -169.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.72 -25.84 54.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.486 0.66 . . . . 0.0 110.648 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -145.54 140.36 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.09 155.77 41.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.648 0.658 . . . . 0.0 110.769 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.28 121.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 168.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 138.25 54.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.03 122.93 3.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-O 118.076 -1.402 . . . . 0.0 112.687 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.75 130.14 24.56 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.66 1.184 . . . . 0.0 110.307 177.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.04 146.69 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.352 2.035 . . . . 0.0 108.368 167.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -93.53 129.35 39.78 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -122.74 172.23 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.228 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 26.25 57.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 128.796 2.838 . . . . 0.0 115.702 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 57.84 76.11 0.34 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.412 1.485 . . . . 0.0 111.722 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.29 73.57 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.75 158.33 21.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.809 1.244 . . . . 0.0 109.68 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.56 151.6 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.02 143.59 57.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.47 -26.74 68.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.141 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -66.67 -26.7 67.17 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.525 0.73 . . . . 0.0 110.74 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -84.64 -42.36 15.43 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.16 0.984 . . . . 0.0 110.702 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.34 -34.34 64.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.206 0.457 . . . . 0.0 111.039 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.257 1.023 . . . . 0.0 112.16 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.04 -10.86 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.548 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.1 t-105 -53.62 -29.02 36.01 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.639 1.576 . . . . 0.0 111.849 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.57 -43.32 69.7 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.989 1.316 . . . . 0.0 111.302 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.62 -29.34 66.82 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.549 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.74 -33.31 68.32 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.17 1.35 . . . . 0.0 110.747 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.84 -29.15 68.99 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.927 0.891 . . . . 0.0 111.795 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -80.96 -24.52 38.03 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.976 0.511 . . . . 0.0 111.256 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -74.21 162.61 28.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.919 1.342 . . . . 0.0 112.23 -168.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -98.41 99.02 10.16 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.568 1.947 . . . . 0.0 108.842 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.8 10.48 15.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.9 121.22 12.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -169.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.75 -0.88 89.38 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.572 1.558 . . . . 0.0 115.17 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -73.75 154.21 39.69 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 118.239 1.019 . . . . 0.0 109.681 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.702 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.2 mt -91.28 140.67 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.46 130.15 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 124.706 1.202 . . . . 0.0 109.012 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -109.57 115.5 30.03 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 mt -86.95 143.02 27.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.869 0.759 . . . . 0.0 111.455 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -137.7 161.27 36.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.24 176.5 39.44 Favored Glycine 0 CA--C 1.506 -0.488 0 O-C-N 120.844 -1.16 . . . . 0.0 112.558 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.6 mt -121.0 153.33 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.91 -153.9 9.22 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -154.02 142.48 20.69 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.973 1.709 . . . . 0.0 108.099 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.58 -23.38 20.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.14 -36.97 80.53 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.805 1.184 . . . . 0.0 112.027 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.7 -27.51 58.79 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -69.07 0.25 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.674 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.31 -39.54 3.09 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.576 1.56 . . . . 0.0 110.385 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.9 mm-40 -76.71 -35.35 57.91 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.59 -13.43 56.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.879 1.672 . . . . 0.0 111.528 -173.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -50.92 123.87 10.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 126.614 1.966 . . . . 0.0 109.322 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.0 26.71 4.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.259 1.023 . . . . 0.0 112.597 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.88 -37.33 86.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.688 -1.257 . . . . 0.0 110.622 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -32.74 73.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.825 0.45 . . . . 0.0 111.761 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.675 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -60.93 -47.72 85.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.86 -40.83 97.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.7 mtm -65.61 -43.83 88.41 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.829 0.814 . . . . 0.0 112.376 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 53' ' ' ILE . 3.7 mt -63.84 -33.82 76.55 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.567 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.55 -38.27 86.74 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.265 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.46 -30.54 64.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.091 2.156 . . . . 0.0 112.019 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -63.46 -62.01 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.07 -19.1 58.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.028 -0.986 . . . . 0.0 112.577 -166.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.1 p -60.23 -31.35 70.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.75 1.159 . . . . 0.0 111.125 169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -23.11 47.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -77.96 2.16 18.43 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.671 1.188 . . . . 0.0 112.414 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.79 32.88 66.54 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.999 0.818 . . . . 0.0 112.113 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.49 176.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.843 0.857 . . . . 0.0 109.743 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 146.92 47.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 166.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.6 149.01 31.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.991 0.814 . . . . 0.0 111.8 -169.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.5 m -127.39 -179.76 3.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.326 1.05 . . . . 0.0 108.977 169.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.83 33.5 46.18 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.986 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.6 m-30 -78.09 144.04 36.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.765 1.783 . . . . 0.0 108.47 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -119.32 145.43 38.56 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-O 117.344 -1.312 . . . . 0.0 108.662 171.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.16 138.33 43.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.708 1.289 . . . . 0.0 109.215 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.462 HG22 ' CD1' ' A' ' 139' ' ' PHE . 69.0 p -73.94 -6.88 49.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.661 1.585 . . . . 0.0 113.582 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.51 141.93 55.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.04 0.924 . . . . 0.0 109.868 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.64 59.93 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.499 1.523 . . . . 0.0 113.75 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -88.99 163.44 15.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.591 1.195 . . . . 0.0 110.639 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -127.56 124.81 39.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -164.68 -54.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.867 0.758 . . . . 0.0 109.696 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 3.8 t 57.96 8.18 0.7 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.19 2.596 . . . . 0.0 114.624 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -63.97 140.49 97.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 121.113 -0.992 . . . . 0.0 109.531 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.84 -11.5 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.834 2.356 . . . . 0.0 112.863 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -75.64 -52.35 2.84 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.922 1.237 . . . . 0.0 114.112 -168.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.04 42.02 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.944 1.73 . . . . 0.0 111.609 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.58 150.5 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.815 -1.178 . . . . 0.0 110.147 -167.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.84 -172.38 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 126.11 1.764 . . . . 0.0 109.913 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.4 -116.58 0.81 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.566 1.547 . . . . 0.0 107.487 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.1 8.93 34.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.844 1.257 . . . . 0.0 111.764 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.72 21.13 22.34 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.808 1.194 . . . . 0.0 112.486 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.24 -18.4 17.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.865 1.266 . . . . 0.0 110.586 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.71 142.49 49.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 111.311 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 121' ' ' THR . 60.3 m-85 -77.38 155.5 31.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.182 1.393 . . . . 0.0 109.923 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.97 -12.87 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.601 1.16 . . . . 0.0 112.428 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.22 -178.85 43.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 119.907 1.23 . . . . 0.0 112.322 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 18.9 tp -65.46 130.26 42.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.09 117.71 33.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.9 mt -113.9 152.08 31.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.92 0.888 . . . . 0.0 108.723 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.59 128.22 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -102.47 17.89 22.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.59 1.156 . . . . 0.0 110.408 -171.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.62 -21.55 5.65 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 -49.02 2.96 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.03 1.332 . . . . 0.0 108.25 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.55 19.31 20.59 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.107 1.363 . . . . 0.0 113.664 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -52.96 -22.99 6.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.58 -25.35 30.99 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.857 0.863 . . . . 0.0 111.864 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -120.56 -10.13 9.29 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -55.36 -32.41 62.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.096 1.316 . . . . 0.0 110.854 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.59 -40.42 83.13 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.603 1.161 . . . . 0.0 111.731 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -31.75 62.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.291 1.037 . . . . 0.0 109.786 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -78.88 -28.97 44.16 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.7 mt -63.12 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -58.0 -41.58 83.37 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.2 m -63.23 -37.05 85.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.772 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 42.4 t90 -67.12 -44.37 80.07 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.716 0.77 . . . . 0.0 110.22 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.3 m -57.11 -36.13 70.26 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.087 0.955 . . . . 0.0 109.506 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.78 -29.02 66.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.338 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.03 -46.55 16.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.318 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 25' ' ' ILE . 4.7 pt -64.43 -38.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.961 1.709 . . . . 0.0 110.271 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.2 -15.59 60.24 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.228 0.611 . . . . 0.0 112.036 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -95.92 -46.39 6.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.66 -40.43 83.47 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.711 0.687 . . . . 0.0 109.755 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.702 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -79.19 -37.99 36.92 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.737 0.815 . . . . 0.0 110.983 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.01 -46.77 70.32 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.008 0.923 . . . . 0.0 109.901 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.62 -29.88 69.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.106 1.362 . . . . 0.0 109.777 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -63.6 -48.47 77.21 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.553 0.615 . . . . 0.0 110.506 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.52 50.1 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.414 1.086 . . . . 0.0 113.741 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.485 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 119.704 -0.188 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.56 140.62 30.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -129.27 146.78 51.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.648 1.979 . . . . 0.0 108.947 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.27 117.63 4.77 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.597 -1.113 . . . . 0.0 110.445 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.82 113.32 23.37 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 119.254 1.527 . . . . 0.0 108.354 169.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -108.87 145.04 35.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.913 1.285 . . . . 0.0 111.442 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -159.96 173.35 16.02 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.652 0.781 . . . . 0.0 109.927 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.49 139.95 8.66 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -141.48 131.85 25.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.395 1.478 . . . . 0.0 108.837 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.7 m -84.29 -28.93 26.79 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.741 0.246 . . . . 0.0 110.739 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.1 p -112.47 -79.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.448 1.099 . . . . 0.0 108.165 -172.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.8 p -173.04 -13.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.18 -42.64 79.65 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 119.711 -1.868 . . . . 0.0 113.333 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -34.38 77.77 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.48 -49.25 76.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.454 1.102 . . . . 0.0 109.866 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.3 mtm -66.34 -41.83 89.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.346 0.521 . . . . 0.0 111.182 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.19 94.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.005 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.48 77.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 123.863 0.865 . . . . 0.0 110.436 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.88 -44.26 91.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -63.39 -54.93 29.1 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 124.79 1.306 . . . . 0.0 108.996 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.07 -56.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.956 0.798 . . . . 0.0 109.716 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -39.11 83.02 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.3 -46.92 72.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.939 0.496 . . . . 0.0 111.227 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -66.17 -46.62 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.962 1.305 . . . . 0.0 108.596 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 164' ' ' ILE . 83.3 mt -72.66 -50.23 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.93 114.34 0.78 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.399 1.0 . . . . 0.0 110.67 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.12 4.03 3.57 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.494 2.796 . . . . 0.0 112.814 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.56 -34.05 64.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.505 1.522 . . . . 0.0 109.149 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.26 -22.77 3.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.772 1.629 . . . . 0.0 111.409 -169.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.16 140.73 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.657 1.571 . . . . 0.0 109.091 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.5 m -130.17 129.09 43.0 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.485 1.114 . . . . 0.0 109.679 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.42 148.96 46.39 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.481 0.712 . . . . 0.0 111.942 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -142.88 110.46 5.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.429 1.892 . . . . 0.0 106.621 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -86.74 110.65 20.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.0 -8.07 20.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -60.62 -28.04 68.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.25 0.932 . . . . 0.0 111.729 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -132.33 -33.97 1.25 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.77 1.228 . . . . 0.0 111.886 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -82.73 140.77 32.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.091 0.957 . . . . 0.0 108.565 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 m -83.96 140.82 40.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -74.13 -1.9 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.163 1.451 . . . . 0.0 110.983 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -56.36 -33.97 66.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.246 2.293 . . . . 0.0 111.921 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -19.36 64.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.428 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.0 ttm -58.17 -16.34 13.13 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.266 2.226 . . . . 0.0 111.702 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -73.65 -31.14 63.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.056 -1.027 . . . . 0.0 110.795 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -78.16 -47.07 18.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.341 0.591 . . . . 0.0 110.019 -169.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -65.84 140.33 58.38 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.58 -169.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.5 -17.16 56.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.41 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.55 149.9 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 126.434 1.893 . . . . 0.0 106.069 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.428 HD13 ' CG ' ' A' ' 43' ' ' MET . 8.1 mt -138.34 151.31 47.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.667 0.787 . . . . 0.0 109.218 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.36 121.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.0 135.75 54.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.19 122.79 4.37 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-O 117.773 -1.57 . . . . 0.0 113.12 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.5 126.61 25.78 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 119.286 1.543 . . . . 0.0 110.63 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.44 144.66 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.689 2.259 . . . . 0.0 107.799 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -87.81 131.27 34.59 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.98 169.47 10.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.22 1.808 . . . . 0.0 109.62 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 28.85 54.67 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.275 2.63 . . . . 0.0 115.319 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 55.98 78.73 0.19 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.312 1.445 . . . . 0.0 112.23 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 13.49 76.11 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.07 160.8 19.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.555 1.142 . . . . 0.0 109.125 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 mt -92.18 154.64 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -59.13 140.82 55.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.99 0.916 . . . . 0.0 108.787 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.83 -28.92 69.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -80.33 -20.95 43.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.642 -0.661 . . . . 0.0 110.58 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.497 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.1 m95 -77.0 -44.31 31.44 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.83 169.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -53.33 -35.85 60.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.473 0.709 . . . . 0.0 110.751 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.4 71.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.008 0.923 . . . . 0.0 112.209 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.44 -9.78 11.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.56 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.6 t-105 -53.32 -29.46 33.84 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 111.71 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.32 -44.76 74.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.959 1.304 . . . . 0.0 111.459 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -68.48 -29.67 68.34 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.113 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.5 mt -57.65 -31.06 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.995 1.27 . . . . 0.0 111.122 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.56 -28.95 65.3 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.499 0.72 . . . . 0.0 111.205 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.02 -23.34 38.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.139 0.576 . . . . 0.0 111.173 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 mt -72.94 157.84 36.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 123.038 1.399 . . . . 0.0 112.878 -167.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -90.94 91.53 8.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.738 -2.028 . . . . 0.0 107.978 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -111.38 11.63 21.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.84 128.33 35.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.06 30.86 69.57 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.294 0.95 . . . . 0.0 114.469 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.91 156.68 34.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.59 1.195 . . . . 0.0 109.633 169.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.656 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.4 mt -88.63 146.81 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.37 130.17 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.084 1.354 . . . . 0.0 109.263 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.06 117.93 35.07 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.05 143.13 27.05 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.389 0.995 . . . . 0.0 112.085 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -136.38 156.04 49.19 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.229 1.011 . . . . 0.0 109.13 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.55 164.54 35.16 Favored Glycine 0 CA--C 1.506 -0.475 0 O-C-N 120.801 -1.187 . . . . 0.0 112.154 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.4 158.63 36.79 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.57 -137.75 3.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.5 150.81 21.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.535 1.934 . . . . 0.0 108.046 168.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.08 -31.29 18.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.919 1.688 . . . . 0.0 114.149 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.6 -33.25 62.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.487 1.04 . . . . 0.0 113.082 -167.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.52 -19.33 35.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 124.788 1.185 . . . . 0.0 111.206 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 95' ' ' GLU . 26.8 m-85 -126.85 -90.07 0.54 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.547 1.139 . . . . 0.0 108.721 -170.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.59 -50.8 2.55 Favored Glycine 0 N--CA 1.464 0.555 0 C-N-CA 128.517 2.96 . . . . 0.0 107.755 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' TYR . 12.3 mm-40 -69.65 -30.63 68.38 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.67 1.988 . . . . 0.0 110.536 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -115.14 0.73 13.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.75 1.22 . . . . 0.0 112.021 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.91 127.04 24.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.883 1.273 . . . . 0.0 109.545 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 56.28 23.8 7.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.57 1.548 . . . . 0.0 113.666 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.74 -36.78 78.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.551 -1.343 . . . . 0.0 110.698 -171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.64 72.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.104 0.561 . . . . 0.0 111.467 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.656 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.38 -46.76 88.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.799 0.84 . . . . 0.0 110.756 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.52 96.44 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.8 mtm -66.07 -44.94 83.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 117.712 0.756 . . . . 0.0 112.152 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.56 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.2 mt -64.33 -32.82 74.58 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.606 1.094 . . . . 0.0 111.807 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -63.53 -40.11 96.17 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.109 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.0 -36.13 69.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.758 1.623 . . . . 0.0 112.204 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.4 tptt -57.42 -47.03 82.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.688 0.795 . . . . 0.0 109.894 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -93.76 -20.65 19.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.037 -0.983 . . . . 0.0 112.33 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.2 p -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.748 1.613 . . . . 0.0 111.665 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -79.15 -17.43 55.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.071 0.548 . . . . 0.0 110.059 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -79.54 1.42 25.96 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.114 1.366 . . . . 0.0 111.943 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.01 34.79 58.34 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.941 0.792 . . . . 0.0 111.908 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.43 171.9 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.961 0.904 . . . . 0.0 109.787 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -121.09 142.91 49.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.44 150.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.903 1.229 . . . . 0.0 111.999 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.8 m -129.88 -178.66 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.649 1.179 . . . . 0.0 109.157 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 33.9 43.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-O 118.417 -1.213 . . . . 0.0 113.977 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -71.8 147.32 47.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.437 1.619 . . . . 0.0 107.784 170.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.66 144.98 51.69 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.236 169.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -69.58 140.12 42.57 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-N 121.012 1.397 . . . . 0.0 109.472 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.509 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p -73.77 -11.01 60.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.568 1.547 . . . . 0.0 113.555 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.48 144.8 55.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.902 0.858 . . . . 0.0 109.338 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.83 19.2 79.29 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.123 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.4 165.49 27.36 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.868 2.067 . . . . 0.0 108.317 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -140.28 133.53 29.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.339 1.856 . . . . 0.0 108.485 -173.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -167.15 -57.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -170.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 2.9 t 56.2 7.52 0.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.844 2.858 . . . . 0.0 114.364 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -69.61 144.17 93.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 120.991 -1.068 . . . . 0.0 110.515 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.84 -14.5 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.722 2.281 . . . . 0.0 113.76 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -80.53 -48.98 1.18 Allowed Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.26 39.33 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.383 2.056 . . . . 0.0 112.579 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 148.43 21.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 109.589 -167.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -172.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.998 1.719 . . . . 0.0 109.666 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.85 -116.37 0.84 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.135 1.374 . . . . 0.0 107.306 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.38 7.8 33.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 112.202 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.28 20.13 18.85 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.996 1.284 . . . . 0.0 112.475 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.02 -17.11 17.66 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.686 1.194 . . . . 0.0 110.668 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 144.04 50.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 110.879 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.509 ' CD1' HG22 ' A' ' 121' ' ' THR . 50.4 m-85 -78.26 154.87 30.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.953 1.301 . . . . 0.0 109.246 174.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.42 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.1 m -65.44 -14.91 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.15 -176.31 40.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.561 1.073 . . . . 0.0 111.901 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 16.3 tp -65.66 129.55 40.17 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.22 129.66 55.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.9 mt -130.47 158.68 39.24 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.724 1.61 . . . . 0.0 109.215 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.0 125.6 23.71 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.025 176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -98.91 6.35 46.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.534 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -20.7 11.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.244 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.23 -42.33 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 112.675 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.13 7.2 19.6 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.091 0.86 . . . . 0.0 112.808 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -55.58 -21.55 17.89 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.522 1.056 . . . . 0.0 113.088 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.57 -25.61 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 111.536 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.0 pp -129.26 3.8 5.19 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.08 0.952 . . . . 0.0 112.446 -169.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -50.96 -29.4 12.11 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.81 -1.181 . . . . 0.0 110.842 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.36 -39.29 94.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.747 1.619 . . . . 0.0 110.604 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.28 -46.35 56.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 129.374 3.07 . . . . 0.0 108.194 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -25.39 62.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.841 -1.981 . . . . 0.0 108.273 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.28 -62.33 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -57.17 -37.34 71.96 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.2 m -63.53 -38.39 90.93 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.428 0.455 . . . . 0.0 110.751 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -66.52 -44.56 82.13 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.438 -0.788 . . . . 0.0 110.179 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 72.8 m -55.89 -35.53 66.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.553 0.741 . . . . 0.0 109.809 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -33.58 76.28 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.485 0.491 . . . . 0.0 110.259 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -81.93 -46.14 14.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.498 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 25' ' ' ILE . 5.3 pt -64.55 -39.47 85.69 Favored 'Isoleucine or valine' 0 C--N 1.337 0.061 0 CA-C-N 121.417 1.917 . . . . 0.0 109.977 -169.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.6 -14.25 57.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -96.44 -45.65 6.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.885 1.274 . . . . 0.0 107.888 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.29 -41.08 88.13 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.886 0.767 . . . . 0.0 109.724 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.656 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -77.37 -35.65 54.32 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.169 0.988 . . . . 0.0 110.951 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.48 -47.32 42.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.335 1.054 . . . . 0.0 110.004 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.53 -29.56 68.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.405 1.482 . . . . 0.0 110.129 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -60.66 -45.78 92.82 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.266 0.485 . . . . 0.0 110.302 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.78 -1.63 58.09 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 114.055 -174.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.422 177.934 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 145.26 30.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.876 1.27 . . . . 0.0 108.636 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 48' ' ' VAL . 13.8 mtm -130.45 147.25 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.127 1.771 . . . . 0.0 108.984 -168.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.4 118.63 5.07 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 118.81 -0.995 . . . . 0.0 110.947 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.09 105.9 18.12 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.86 1.33 . . . . 0.0 109.952 171.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -105.0 145.74 30.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.47 1.508 . . . . 0.0 111.301 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -164.93 175.47 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.007 0.923 . . . . 0.0 110.431 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.91 142.33 10.02 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 168.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -146.52 147.69 31.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.25 1.025 . . . . 0.0 111.401 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -95.79 -45.89 6.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.543 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.5 p -90.19 -10.93 42.6 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.006 1.722 . . . . 0.0 111.41 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.276 44.5 m 73.64 13.67 4.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.2 2.2 . . . . 0.0 113.697 -168.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.6 -44.2 94.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.593 1.542 . . . . 0.0 110.764 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -34.29 77.28 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -64.45 -49.07 72.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.409 1.084 . . . . 0.0 109.99 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.8 -38.89 92.51 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.94 -0.475 . . . . 0.0 111.151 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.76 97.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.848 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.13 79.03 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.776 0.83 . . . . 0.0 110.611 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.37 -46.74 83.06 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.903 0.481 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.32 -54.86 34.44 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 124.732 1.27 . . . . 0.0 108.923 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.413 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.41 -56.87 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 118.447 0.567 . . . . 0.0 109.584 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -38.99 72.81 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.343 0.657 . . . . 0.0 110.539 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.62 -48.1 67.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.992 0.517 . . . . 0.0 111.201 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 158' ' ' GLN . 17.8 mt -64.64 -47.11 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.996 1.318 . . . . 0.0 108.8 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.5 mt -72.58 -51.55 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.783 0.833 . . . . 0.0 110.52 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.67 115.59 0.76 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.44 3.54 4.11 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.29 2.66 . . . . 0.0 112.98 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.73 -35.12 65.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.25 1.42 . . . . 0.0 108.966 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -26.96 5.57 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.067 1.747 . . . . 0.0 111.369 -173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.47 140.43 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 120.781 1.628 . . . . 0.0 109.088 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.7 m -129.91 129.62 44.1 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.54 1.136 . . . . 0.0 110.073 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.79 148.99 47.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.875 0.87 . . . . 0.0 112.154 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -145.21 108.84 4.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.697 1.599 . . . . 0.0 107.762 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -82.31 112.03 18.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.77 -9.44 36.92 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -59.12 -28.49 66.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.422 1.01 . . . . 0.0 111.509 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.64 -34.22 1.56 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.473 1.109 . . . . 0.0 112.112 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.26 140.2 33.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 m -82.95 139.72 42.97 Favored Pre-proline 0 N--CA 1.452 -0.358 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.81 -1.62 11.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 121.172 1.454 . . . . 0.0 111.425 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 122.153 2.251 . . . . 0.0 111.713 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -18.78 64.68 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.431 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.2 ttm -58.91 -15.62 13.66 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.993 2.117 . . . . 0.0 111.971 169.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.1 -32.99 63.45 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.191 -0.943 . . . . 0.0 110.601 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.62 -48.11 28.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.58 0.705 . . . . 0.0 110.04 -170.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -70.86 131.86 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.94 -3.34 58.9 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 3' ' ' MET . 74.8 t -140.57 146.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.6 mt -140.63 153.86 46.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.999 0.52 . . . . 0.0 109.789 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -129.32 122.84 56.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 mp -119.73 136.71 54.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -130.2 119.71 2.87 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 117.957 -1.468 . . . . 0.0 112.785 -171.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.698 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -125.03 133.64 25.0 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.046 1.423 . . . . 0.0 110.309 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.74 157.07 15.97 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.222 1.948 . . . . 0.0 108.717 166.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -101.22 125.26 47.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -113.71 172.18 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.802 1.641 . . . . 0.0 109.829 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.96 62.5 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.793 2.837 . . . . 0.0 115.225 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 55.93 71.52 0.55 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 112.363 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.27 79.34 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.27 155.39 24.87 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.548 1.139 . . . . 0.0 109.948 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.25 151.61 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -65.8 143.5 57.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.91 -26.67 68.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.035 -169.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.03 -26.7 66.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.674 0.789 . . . . 0.0 110.761 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.1 m95 -83.99 -42.74 15.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.108 0.963 . . . . 0.0 110.71 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.41 -34.92 64.82 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.581 0.628 . . . . 0.0 110.819 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.7 71.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.359 1.064 . . . . 0.0 112.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.31 -11.46 10.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t-105 -53.52 -28.98 34.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.653 1.581 . . . . 0.0 111.724 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.29 -44.68 64.73 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.006 1.322 . . . . 0.0 111.384 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.73 -30.37 70.58 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.568 -1.206 . . . . 0.0 111.95 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.703 1.138 . . . . 0.0 111.096 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.14 -31.33 70.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 111.421 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.41 -26.44 38.46 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.355 0.662 . . . . 0.0 110.887 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.24 159.79 33.37 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.565 1.174 . . . . 0.0 112.062 -169.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.68 96.85 10.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 112.832 -1.986 . . . . 0.0 108.215 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -118.92 6.6 11.4 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.122 0.969 . . . . 0.0 113.141 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.0 118.35 11.8 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -168.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.79 70.5 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.943 1.259 . . . . 0.0 115.687 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -110.68 154.74 23.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.083 1.441 . . . . 0.0 109.106 171.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.5 mt -85.21 143.78 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 118.87 0.759 . . . . 0.0 109.283 -172.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.5 t -132.44 134.13 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.526 1.53 . . . . 0.0 109.854 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.77 120.6 41.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.1 143.68 26.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 119.145 0.884 . . . . 0.0 111.644 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 21.2 p90 -137.13 159.39 42.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.37 178.13 39.08 Favored Glycine 0 N--CA 1.448 -0.555 0 O-C-N 121.044 -1.035 . . . . 0.0 112.524 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -127.67 151.12 49.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.73 -157.76 9.85 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -155.12 137.68 15.11 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.606 1.562 . . . . 0.0 108.333 168.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.57 -20.76 22.24 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.74 -49.33 68.81 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.781 1.173 . . . . 0.0 110.836 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.53 -27.36 8.6 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.189 0.9 . . . . 0.0 112.149 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -131.4 33.07 4.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -166.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.45 -42.66 57.55 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-N 120.354 1.434 . . . . 0.0 111.012 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.82 -19.75 60.35 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 117.986 0.893 . . . . 0.0 112.318 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -125.84 12.56 7.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.871 1.668 . . . . 0.0 112.432 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -45.61 122.05 3.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.487 1.515 . . . . 0.0 108.679 170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 52.86 28.2 6.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.033 0.933 . . . . 0.0 112.971 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.91 -40.29 94.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 120.648 -1.282 . . . . 0.0 110.113 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.94 -33.75 76.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 111.709 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.698 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.6 tp -59.96 -47.72 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 110.456 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.11 97.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.3 mtm -65.02 -44.56 88.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.01 0.905 . . . . 0.0 111.78 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 53' ' ' ILE . 3.9 mt -64.43 -35.44 80.93 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.295 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -64.24 -41.46 96.98 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.387 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.34 -42.6 92.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -55.06 -59.49 4.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.267 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.26 -20.84 57.01 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.628 -0.67 . . . . 0.0 110.794 -170.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.8 t -62.2 -30.29 70.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.165 0.893 . . . . 0.0 110.304 168.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -24.12 48.66 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.7 -1.25 . . . . 0.0 109.279 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -81.19 2.38 27.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.025 1.73 . . . . 0.0 112.59 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.69 33.15 79.83 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 118.643 0.656 . . . . 0.0 112.102 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.18 169.51 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 117.619 0.709 . . . . 0.0 109.468 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -113.61 140.25 48.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.45 148.08 32.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.072 1.305 . . . . 0.0 112.43 -168.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.8 m -128.6 -179.98 3.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.817 1.247 . . . . 0.0 109.577 168.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.77 33.41 33.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 118.342 -1.254 . . . . 0.0 114.741 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -78.86 139.6 38.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.933 1.866 . . . . 0.0 108.784 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 148.96 42.1 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.59 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.33 138.99 37.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 120.949 1.375 . . . . 0.0 109.108 168.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 139' ' ' PHE . 60.2 p -74.08 -6.78 49.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 113.441 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.15 140.58 57.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.207 1.004 . . . . 0.0 109.724 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.15 -10.02 62.04 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.541 1.543 . . . . 0.0 113.881 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -88.94 162.4 16.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.79 1.295 . . . . 0.0 110.752 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -127.64 125.33 39.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 127' ' ' THR . 12.9 p90 -162.49 -61.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.167 0.894 . . . . 0.0 110.07 -172.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 126' ' ' PHE 0.333 2.1 t 58.74 11.13 1.69 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.575 2.75 . . . . 0.0 114.801 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 p -66.47 142.87 97.94 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.851 -1.156 . . . . 0.0 109.095 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.75 -15.36 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.283 1.989 . . . . 0.0 113.852 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -80.81 -48.21 1.15 Allowed Pre-proline 0 C--N 1.344 0.344 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.34 36.63 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.705 1.603 . . . . 0.0 112.484 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.093 0.957 . . . . 0.0 109.843 -166.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.77 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 109.456 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.94 -116.83 0.86 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.959 1.304 . . . . 0.0 107.62 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.14 7.82 33.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.761 1.224 . . . . 0.0 111.831 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.68 20.1 20.4 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.724 1.154 . . . . 0.0 112.575 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -100.36 -17.25 17.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.852 1.261 . . . . 0.0 110.859 -172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 145.29 51.25 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.286 0.634 . . . . 0.0 110.876 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.2 m-85 -81.27 155.45 26.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 110.221 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.02 -12.44 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.725 1.21 . . . . 0.0 112.755 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.67 -178.28 42.64 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.612 1.097 . . . . 0.0 111.879 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 22.2 tp -65.54 127.92 33.81 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.55 116.02 29.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.15 157.57 24.6 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.13 121.98 15.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -98.97 17.26 20.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.883 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.94 -23.57 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.17 -52.6 2.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.702 1.137 . . . . 0.0 109.18 172.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -98.16 14.46 27.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.52 1.128 . . . . 0.0 113.896 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -52.07 -26.13 10.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.906 0.882 . . . . 0.0 112.485 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.37 -27.9 46.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 111.38 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -7.03 13.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.045 0.938 . . . . 0.0 111.218 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.2 m -53.07 -26.91 17.7 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.719 -1.238 . . . . 0.0 110.862 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.16 -40.18 90.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 122.035 0.921 . . . . 0.0 110.269 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -70.92 -46.2 62.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 129.827 3.251 . . . . 0.0 107.825 -177.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -69.49 -28.12 65.79 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.199 -1.819 . . . . 0.0 108.322 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.34 -61.05 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.493 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -56.88 -41.19 77.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 118.908 0.776 . . . . 0.0 112.259 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 m -65.59 -35.68 81.52 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.635 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 49.0 t90 -66.65 -43.95 83.26 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.464 -0.772 . . . . 0.0 109.79 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 92.7 m -57.55 -35.49 70.4 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.903 0.881 . . . . 0.0 109.644 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.12 -27.99 63.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.014 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -80.2 -46.41 16.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.148 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.2 -39.54 85.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 121.308 1.867 . . . . 0.0 110.614 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.11 -15.37 59.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -96.53 -45.11 6.87 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 124.683 1.193 . . . . 0.0 107.799 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.31 -42.02 90.41 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.122 0.874 . . . . 0.0 109.574 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.653 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.9 mtm -74.36 -41.92 60.23 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.142 0.977 . . . . 0.0 110.081 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.94 -44.41 80.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.286 1.035 . . . . 0.0 110.647 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -69.81 -32.2 70.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.082 1.353 . . . . 0.0 109.785 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -61.53 -42.44 98.82 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.474 0.654 . . . . 0.0 109.913 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -2.16 35.6 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.02 1.728 . . . . 0.0 113.758 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-N 118.406 0.548 . . . . 0.0 110.567 -179.204 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.14 142.54 33.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 mtm -131.14 146.43 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.648 1.979 . . . . 0.0 108.276 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.55 117.94 5.0 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 118.637 -1.091 . . . . 0.0 110.397 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.72 113.12 24.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.268 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -109.92 147.36 33.57 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.77 1.628 . . . . 0.0 111.451 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -164.13 175.25 10.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.748 1.219 . . . . 0.0 109.704 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.54 142.95 11.16 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 168.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -148.87 144.61 27.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.303 1.051 . . . . 0.0 111.452 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 m -96.07 -37.87 10.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 111.389 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -95.09 -8.9 35.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 111.594 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.264 56.9 m 71.5 15.01 6.22 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.745 2.018 . . . . 0.0 114.121 -170.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -65.28 -42.94 92.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.434 1.47 . . . . 0.0 110.353 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.18 -33.66 75.88 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -64.3 -46.93 81.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.0 110.096 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 -40.85 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.592 -0.692 . . . . 0.0 111.548 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.4 94.02 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.638 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.37 79.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.902 0.881 . . . . 0.0 110.788 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.34 -45.3 88.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -61.73 -54.33 43.92 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 124.701 1.251 . . . . 0.0 108.725 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.1 mt -53.58 -56.73 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.852 0.751 . . . . 0.0 109.958 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.22 76.75 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.0 0.52 . . . . 0.0 110.484 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.92 -48.01 69.96 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.995 0.518 . . . . 0.0 111.21 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -65.27 -47.28 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.133 0.973 . . . . 0.0 108.533 -176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.83 -50.49 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.383 0.673 . . . . 0.0 110.402 -175.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.29 113.69 0.73 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 171.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.15 4.08 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.357 2.705 . . . . 0.0 112.69 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.89 -34.4 66.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.022 1.329 . . . . 0.0 109.228 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.86 -21.33 4.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.558 1.543 . . . . 0.0 111.814 -169.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -94.04 141.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 120.659 1.572 . . . . 0.0 109.028 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 m -130.44 128.23 40.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 110.006 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.41 148.66 48.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.932 0.893 . . . . 0.0 112.163 174.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.25 109.7 4.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.094 1.758 . . . . 0.0 107.41 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -83.82 112.11 19.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.16 -10.53 42.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -58.06 -29.11 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.19 0.905 . . . . 0.0 111.542 169.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.34 -34.37 1.62 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.573 1.149 . . . . 0.0 112.08 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.26 140.27 33.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -84.01 139.98 39.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.97 -4.46 15.18 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.087 1.424 . . . . 0.0 111.643 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -54.16 -36.96 63.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.08 1.764 . . . . 0.0 111.524 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -20.59 66.24 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.224 -0.923 . . . . 0.0 113.449 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -11.9 26.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.329 1.052 . . . . 0.0 112.185 169.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -74.57 -25.7 59.46 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.866 -1.146 . . . . 0.0 110.961 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.79 -51.57 11.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.183 0.901 . . . . 0.0 110.195 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -66.72 142.13 57.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.288 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.44 -27.56 61.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 110.694 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.26 144.27 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -135.33 152.77 51.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.546 0.612 . . . . 0.0 110.293 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.88 121.32 54.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -120.72 137.8 54.3 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.145 0.978 . . . . 0.0 108.473 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.71 2.57 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-O 117.543 -1.698 . . . . 0.0 111.85 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.14 127.69 26.45 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 119.476 1.638 . . . . 0.0 111.405 176.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.47 145.45 13.27 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.818 1.679 . . . . 0.0 108.16 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 m -89.6 137.43 32.33 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -133.02 173.37 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.884 2.074 . . . . 0.0 109.406 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.7 t0 36.13 51.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.331 2.252 . . . . 0.0 114.47 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 56.05 80.71 0.14 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.271 1.429 . . . . 0.0 112.483 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 75.25 10.27 84.31 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 172.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.33 163.88 14.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.708 1.603 . . . . 0.0 110.509 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mt -89.84 152.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -68.47 144.44 54.66 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.39 -29.62 70.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.185 0.594 . . . . 0.0 112.193 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.59 -23.6 65.4 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.943 -0.473 . . . . 0.0 111.169 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.459 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.9 m95 -86.12 -41.98 14.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.301 1.04 . . . . 0.0 110.937 170.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.72 -34.66 65.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.586 0.63 . . . . 0.0 111.016 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.27 -30.36 70.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.752 1.221 . . . . 0.0 111.874 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.19 -12.97 10.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.605 ' CH2' HD13 ' A' ' 104' ' ' LEU . 2.9 t-105 -53.31 -29.42 33.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.007 1.323 . . . . 0.0 111.801 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.27 -43.33 70.69 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.147 1.379 . . . . 0.0 111.387 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.23 -31.23 70.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.936 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.1 mt -56.59 -31.03 63.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.936 1.244 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.73 -28.49 65.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.665 0.786 . . . . 0.0 111.545 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.9 -24.97 32.91 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.417 0.687 . . . . 0.0 111.038 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 mt -72.95 158.62 35.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 123.046 1.403 . . . . 0.0 112.679 -167.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.53 95.98 10.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.549 174.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mt -118.23 8.09 12.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.61 121.21 13.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.4 8.05 88.04 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.284 1.421 . . . . 0.0 114.495 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -76.2 147.89 38.08 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 117.743 0.771 . . . . 0.0 109.203 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.746 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.3 mt -86.64 138.41 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 167.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.98 129.63 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.765 1.226 . . . . 0.0 108.589 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.69 117.61 34.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -90.92 141.38 28.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.941 0.791 . . . . 0.0 111.93 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -137.85 161.91 35.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.894 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.25 174.72 36.2 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 121.295 -0.878 . . . . 0.0 112.389 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 mt -124.21 148.5 47.24 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.396 1.079 . . . . 0.0 108.755 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.45 27.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.332 0.492 . . . . 0.0 112.241 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -133.45 112.69 11.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -29.44 28.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.459 0.171 . . . . 0.0 111.271 -172.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.96 -46.25 58.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.148 0.579 . . . . 0.0 110.395 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.08 -34.65 12.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.04 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.39 28.95 4.91 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.54 -34.34 60.03 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 120.33 1.423 . . . . 0.0 112.411 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.2 -24.32 63.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.063 0.932 . . . . 0.0 112.369 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -113.15 -47.5 3.02 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.521 1.528 . . . . 0.0 110.089 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.265 1.6 t80 43.97 -131.36 0.77 Allowed 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 128.478 2.711 . . . . 0.0 109.514 -172.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.58 39.38 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 130.697 3.599 . . . . 0.0 113.787 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 5.9 t70 -58.14 -43.05 87.09 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 119.437 -2.039 . . . . 0.0 111.123 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.98 -32.1 71.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.946 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.0 tp -63.13 -47.39 82.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.478 0.711 . . . . 0.0 110.189 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.27 99.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.1 mtm -62.97 -48.15 80.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 117.556 0.678 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.605 HD13 ' CH2' ' A' ' 69' ' ' TRP . 13.0 tp -67.06 -30.86 71.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.651 -0.656 . . . . 0.0 111.201 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -60.83 -46.29 91.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.3 0.5 . . . . 0.0 109.826 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.72 -41.2 92.54 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.448 1.099 . . . . 0.0 111.657 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 7.0 tptt -55.6 -62.27 1.79 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.553 1.141 . . . . 0.0 107.936 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.16 -21.04 62.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.536 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -61.65 -29.4 70.04 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.649 1.113 . . . . 0.0 110.729 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.48 -22.1 54.96 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.819 -1.176 . . . . 0.0 109.799 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.73 1.61 37.87 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.636 1.574 . . . . 0.0 112.541 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.32 33.66 68.62 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.477 0.58 . . . . 0.0 111.842 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.25 170.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.622 0.769 . . . . 0.0 109.319 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -117.26 143.14 46.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -110.33 148.05 32.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.56 1.073 . . . . 0.0 111.899 -170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.3 m -128.42 178.17 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.664 1.185 . . . . 0.0 108.439 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.78 34.21 39.62 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 118.52 -1.155 . . . . 0.0 114.368 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -71.95 155.72 40.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.613 1.707 . . . . 0.0 107.948 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.45 142.05 33.48 Favored Pre-proline 0 CA--C 1.514 -0.437 0 CA-C-O 116.939 -1.505 . . . . 0.0 109.227 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.45 143.08 56.31 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.038 1.406 . . . . 0.0 109.618 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.521 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 73.9 p -74.69 -0.01 16.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.899 1.68 . . . . 0.0 113.776 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.27 146.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.04 0.936 . . . . 0.0 109.948 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.29 22.83 75.28 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.216 0.913 . . . . 0.0 112.967 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.15 152.45 40.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.838 . . . . 0.0 109.459 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -122.75 133.13 54.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 128.732 2.813 . . . . 0.0 104.682 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.4 p90 -163.01 -53.88 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 118.752 0.705 . . . . 0.0 109.454 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.361 3.1 t 61.66 8.12 2.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.066 2.547 . . . . 0.0 114.939 176.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.2 t -67.85 138.13 92.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -84.7 -10.56 8.42 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.251 2.634 . . . . 0.0 112.77 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -78.42 -49.93 1.72 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -88.46 39.84 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.381 2.054 . . . . 0.0 112.593 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 148.43 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.509 1.124 . . . . 0.0 109.612 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.02 -171.98 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 C-N-CA 126.369 1.867 . . . . 0.0 109.861 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.39 -116.11 0.86 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.203 1.401 . . . . 0.0 107.443 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.55 8.34 33.28 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.059 1.344 . . . . 0.0 112.222 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.99 21.12 19.13 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.76 1.171 . . . . 0.0 112.506 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -100.69 -18.32 16.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.793 1.237 . . . . 0.0 110.8 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.14 144.23 51.24 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.887 0.475 . . . . 0.0 110.876 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.78 156.58 30.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.7 m -65.2 -18.11 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.478 0.711 . . . . 0.0 112.108 174.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.07 -178.76 39.66 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.403 1.001 . . . . 0.0 111.114 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.23 128.26 35.5 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.15 125.5 53.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.1 mt -121.99 150.23 42.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.65 132.4 38.91 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -111.57 10.67 21.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.705 -170.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.258 0.5 OUTLIER -108.21 -31.17 8.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 176.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -136.14 -27.33 1.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.096 0.862 . . . . 0.0 113.267 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -89.5 12.08 17.57 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.914 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -57.69 -21.77 42.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.874 1.215 . . . . 0.0 113.475 -170.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.54 -19.29 28.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.647 0.779 . . . . 0.0 112.141 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.0 mt -113.49 -24.48 9.25 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 126.702 2.001 . . . . 0.0 111.4 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.5 p -51.43 -35.77 40.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.366 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.395 0.678 . . . . 0.0 110.26 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.88 -29.63 66.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.547 0.339 . . . . 0.0 111.744 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -78.97 -28.11 43.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.704 0.802 . . . . 0.0 110.039 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 mt -66.05 -54.26 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.698 ' HA ' HD13 ' A' ' 24' ' ' ILE . 3.6 pt20 -56.97 -44.77 82.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.588 0.755 . . . . 0.0 112.257 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.4 p -67.19 -35.64 80.06 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.933 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -64.63 -45.12 88.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.844 0.83 . . . . 0.0 109.553 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.7 m -57.53 -35.42 70.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.134 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -34.7 77.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.83 0.452 . . . . 0.0 110.273 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.24 -46.27 18.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.373 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -65.18 -38.61 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 120.858 1.663 . . . . 0.0 110.002 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.28 -14.3 60.41 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.286 0.494 . . . . 0.0 112.016 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -95.03 -46.14 6.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 107.871 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.46 -36.02 77.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.841 0.746 . . . . 0.0 110.209 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.746 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.1 mtm -77.67 -44.19 28.84 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.329 1.052 . . . . 0.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -42.45 78.18 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.819 0.848 . . . . 0.0 111.052 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.18 -31.11 68.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.91 1.284 . . . . 0.0 109.791 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -41.91 97.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.297 0.639 . . . . 0.0 110.487 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -1.25 56.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.901 1.681 . . . . 0.0 113.919 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.318 179.239 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.2 143.86 30.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.0 mtm -132.12 146.51 52.09 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.773 2.029 . . . . 0.0 108.187 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.75 118.42 4.94 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-O 118.622 -1.099 . . . . 0.0 110.51 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 111.54 22.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.986 1.393 . . . . 0.0 108.885 169.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.88 146.44 36.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.988 1.315 . . . . 0.0 111.047 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -161.91 174.88 12.49 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.234 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.2 10.2 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.578 -2.609 . . . . 0.0 106.578 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.4 p -146.38 122.47 10.78 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.326 1.063 . . . . 0.0 111.614 -169.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 m -80.83 -37.87 29.28 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.205 0.457 . . . . 0.0 111.638 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.9 p -107.93 8.55 28.55 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.866 1.266 . . . . 0.0 112.092 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.7 m 65.35 11.71 7.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.85 2.06 . . . . 0.0 114.192 -171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -66.63 -46.94 74.2 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.318 -1.489 . . . . 0.0 111.224 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -33.44 75.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.88 -46.56 87.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 110.312 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.4 mtm -65.49 -43.37 90.38 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.774 -0.578 . . . . 0.0 111.384 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.55 -39.81 89.29 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 122.005 -0.434 . . . . 0.0 110.886 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.74 81.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.206 1.002 . . . . 0.0 110.53 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.5 -44.77 85.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.93 -53.88 47.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.721 1.263 . . . . 0.0 108.997 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 5.9 mt -53.55 -56.82 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.724 0.693 . . . . 0.0 109.768 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -38.49 78.63 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.574 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.57 -47.78 71.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.004 0.522 . . . . 0.0 111.121 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.2 mt -65.27 -48.0 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.682 1.193 . . . . 0.0 108.697 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 164' ' ' ILE . 77.0 mt -71.96 -50.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.502 0.721 . . . . 0.0 110.54 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.59 114.34 0.75 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.5 1.048 . . . . 0.0 110.707 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.39 3.76 3.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.625 2.883 . . . . 0.0 112.677 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -73.49 -34.12 65.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.206 1.403 . . . . 0.0 109.226 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -22.53 3.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.4 1.48 . . . . 0.0 111.824 -169.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 120.333 1.424 . . . . 0.0 108.752 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 m -129.17 129.58 45.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.539 1.136 . . . . 0.0 110.022 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.05 146.28 45.97 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.299 1.039 . . . . 0.0 112.068 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -144.09 107.97 4.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.616 1.567 . . . . 0.0 107.313 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -83.29 112.42 19.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.31 -8.95 20.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.94 0.896 . . . . 0.0 113.155 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.91 -29.14 66.83 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.209 0.913 . . . . 0.0 111.753 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -130.82 -34.25 1.52 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.714 1.206 . . . . 0.0 111.842 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -82.16 141.78 32.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.982 0.913 . . . . 0.0 108.756 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -81.35 147.97 61.7 Favored Pre-proline 0 N--CA 1.45 -0.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -78.19 -2.95 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.177 1.251 . . . . 0.0 111.36 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -55.75 -35.3 66.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 122.101 2.228 . . . . 0.0 112.011 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -20.09 66.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.414 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.7 ttm -59.28 -15.51 16.21 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.674 1.99 . . . . 0.0 111.477 171.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -73.2 -30.83 63.8 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.194 -0.941 . . . . 0.0 110.913 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -76.01 -46.28 30.24 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.976 0.807 . . . . 0.0 110.834 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.98 141.87 56.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.1 -168.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -74.54 -19.96 60.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.318 0.647 . . . . 0.0 110.509 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.7 t -145.41 148.7 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 43' ' ' MET . 11.2 mt -138.27 150.3 46.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.99 0.916 . . . . 0.0 109.183 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.5 120.65 51.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.7 132.59 55.7 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.89 118.33 3.67 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-O 117.541 -1.699 . . . . 0.0 112.757 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -119.35 126.01 27.24 Favored Pre-proline 0 N--CA 1.472 0.625 0 CA-C-N 119.608 1.704 . . . . 0.0 111.45 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -80.27 144.82 16.63 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.351 2.701 . . . . 0.0 108.987 167.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 m -94.96 131.54 40.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -121.91 171.33 9.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.524 1.93 . . . . 0.0 109.442 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 20.12 67.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.921 2.888 . . . . 0.0 115.459 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 54.0 70.05 0.65 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.689 1.196 . . . . 0.0 112.112 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 21.11 79.65 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.165 0.826 . . . . 0.0 115.165 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.305 0.4 OUTLIER -88.34 156.4 19.19 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 166.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.21 150.36 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -55.34 139.59 42.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.181 0.991 . . . . 0.0 108.545 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.63 -28.22 69.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -78.47 -19.51 52.95 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.726 -0.609 . . . . 0.0 110.434 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 53' ' ' ILE . 14.0 m95 -81.08 -43.06 20.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.377 0.671 . . . . 0.0 111.192 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.26 -33.44 58.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.531 0.605 . . . . 0.0 111.008 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.24 71.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.252 1.021 . . . . 0.0 112.33 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.86 -8.92 12.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.558 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.9 t-105 -53.2 -28.96 29.35 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.31 1.444 . . . . 0.0 111.902 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.72 -44.71 76.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.992 1.317 . . . . 0.0 111.635 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -68.58 -29.01 67.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.05 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.75 -29.84 65.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 111.114 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.33 -29.47 66.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.515 0.726 . . . . 0.0 111.452 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.87 -24.62 38.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.391 0.676 . . . . 0.0 111.366 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.4 159.91 33.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.808 1.289 . . . . 0.0 112.998 -168.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.4 92.31 7.59 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 126.663 1.985 . . . . 0.0 108.539 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -113.5 10.15 18.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.66 126.43 28.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.98 21.66 79.01 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.818 1.199 . . . . 0.0 115.678 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.21 155.8 21.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.802 1.301 . . . . 0.0 108.828 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.637 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.7 mt -87.25 145.79 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.01 130.2 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.046 1.338 . . . . 0.0 109.29 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.86 118.07 35.84 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -90.45 141.73 28.45 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.227 0.921 . . . . 0.0 111.554 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -136.78 160.58 38.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.205 1.002 . . . . 0.0 108.43 168.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.13 170.81 36.29 Favored Glycine 0 N--CA 1.446 -0.641 0 O-C-N 121.005 -1.06 . . . . 0.0 111.82 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.8 mt -129.32 153.14 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.42 -154.87 11.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -149.77 137.52 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.101 1.36 . . . . 0.0 108.074 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.62 -22.83 21.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.306 1.443 . . . . 0.0 113.44 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.28 -39.55 53.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.054 1.297 . . . . 0.0 111.627 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.42 -26.28 16.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.418 1.008 . . . . 0.0 112.232 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.36 35.46 2.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -167.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.66 52.54 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.186 1.357 . . . . 0.0 110.973 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -62.71 -15.02 50.86 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.067 0.947 . . . . 0.0 112.133 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -126.22 8.89 7.28 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.351 1.86 . . . . 0.0 112.128 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -48.93 124.86 9.33 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.496 1.518 . . . . 0.0 109.389 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.17 28.63 9.29 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.182 0.993 . . . . 0.0 112.855 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.1 -36.89 82.91 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 120.444 -1.41 . . . . 0.0 110.684 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 111.325 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.68 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -60.41 -48.11 83.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.016 0.926 . . . . 0.0 110.535 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.45 98.13 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mtm -65.16 -44.54 88.22 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.849 0.825 . . . . 0.0 112.101 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.558 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.3 mt -65.29 -35.31 80.61 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.365 0.984 . . . . 0.0 111.169 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -62.94 -42.14 99.72 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.656 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.12 -43.1 88.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.29 -59.11 5.11 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.848 1.259 . . . . 0.0 108.4 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.69 -22.19 54.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.241 -169.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 t -62.02 -28.77 69.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.975 0.807 . . . . 0.0 110.534 169.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.92 -24.36 44.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.588 -1.32 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -80.57 -0.95 39.98 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.409 1.484 . . . . 0.0 112.489 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.1 59.95 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.814 0.734 . . . . 0.0 111.895 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.57 172.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.764 0.782 . . . . 0.0 109.696 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -118.09 145.41 44.86 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.89 151.71 33.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 120.289 1.404 . . . . 0.0 112.994 -168.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.5 m -131.67 -178.97 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.821 1.248 . . . . 0.0 109.46 169.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.76 29.92 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.202 -1.332 . . . . 0.0 115.091 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -75.49 152.32 37.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.909 1.854 . . . . 0.0 109.008 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.31 148.15 69.02 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 117.16 -1.4 . . . . 0.0 109.088 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.87 140.02 41.24 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 121.11 1.432 . . . . 0.0 110.429 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 139' ' ' PHE . 66.6 p -76.2 -4.05 39.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.364 1.866 . . . . 0.0 113.296 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.17 141.42 57.49 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.49 -9.54 61.52 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.445 1.497 . . . . 0.0 113.677 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.28 156.16 16.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.896 1.348 . . . . 0.0 110.986 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.52 126.29 44.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 127' ' ' THR . 11.9 p90 -161.75 -58.76 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 126' ' ' PHE 0.328 1.9 t 58.64 11.71 1.88 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.103 2.561 . . . . 0.0 114.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 p -66.56 133.28 94.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.864 -1.148 . . . . 0.0 107.908 167.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.13 -14.26 5.07 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.16 1.907 . . . . 0.0 113.326 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -80.6 -47.41 1.24 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 117.756 -1.116 . . . . 0.0 114.007 -169.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.15 39.37 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.078 1.852 . . . . 0.0 112.428 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.37 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.333 -167.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -172.55 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 126.069 1.748 . . . . 0.0 109.968 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.08 -116.52 0.84 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.054 1.342 . . . . 0.0 107.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.21 8.0 33.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.828 1.251 . . . . 0.0 111.885 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.42 20.3 20.43 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.129 1.347 . . . . 0.0 112.803 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.25 -16.83 17.59 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.877 1.271 . . . . 0.0 110.944 -172.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 144.53 50.44 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.279 0.631 . . . . 0.0 111.186 173.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.2 m-85 -78.78 154.37 30.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.698 1.599 . . . . 0.0 109.676 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -14.32 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.157 . . . . 0.0 112.707 173.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.45 -179.62 40.89 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 119.69 1.132 . . . . 0.0 111.968 -170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 14.5 tp -65.7 129.78 40.97 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.09 124.15 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.71 160.16 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.981 0.912 . . . . 0.0 108.879 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.13 124.93 31.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -105.29 10.24 33.65 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.779 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -25.65 11.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.207 1.003 . . . . 0.0 110.862 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.06 -46.93 1.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.703 1.138 . . . . 0.0 111.169 174.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -89.74 15.35 9.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -53.67 -22.05 8.16 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.71 -26.55 31.91 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.258 1.023 . . . . 0.0 111.291 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -116.14 -13.73 11.16 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.293 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.7 p -57.3 -27.41 62.13 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.129 1.331 . . . . 0.0 112.381 -171.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -52.76 -39.1 61.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.781 1.632 . . . . 0.0 111.788 173.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.36 -30.47 68.49 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.701 1.6 . . . . 0.0 111.003 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -92.46 -18.16 23.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.037 1.335 . . . . 0.0 110.484 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.84 -60.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.733 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.6 pt20 -51.82 -44.8 63.67 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.128 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 p -67.59 -35.22 78.57 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.077 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.7 t90 -65.35 -44.87 86.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.026 0.917 . . . . 0.0 109.656 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 96.6 m -57.82 -35.9 71.49 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.808 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.74 -29.78 66.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.404 0.547 . . . . 0.0 111.173 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -79.07 -45.76 19.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.931 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 25' ' ' ILE . 5.2 pt -64.89 -39.27 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 120.865 1.666 . . . . 0.0 109.862 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.49 -14.64 58.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.2 0.6 . . . . 0.0 111.984 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -96.2 -45.94 6.65 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.64 -42.47 88.37 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.968 0.804 . . . . 0.0 109.387 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.637 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.3 mtm -77.29 -35.51 55.02 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.706 0.802 . . . . 0.0 110.716 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -48.4 56.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.351 1.06 . . . . 0.0 109.678 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.49 -31.15 72.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.216 1.406 . . . . 0.0 109.951 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -63.96 -49.04 74.13 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.487 0.585 . . . . 0.0 110.447 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.23 -3.84 44.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.586 179.325 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 140.23 30.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 168.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 mtm -123.13 148.67 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.574 2.349 . . . . 0.0 108.386 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.29 118.47 4.69 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.48 114.44 25.1 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.944 1.372 . . . . 0.0 108.754 170.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.15 146.32 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.635 1.574 . . . . 0.0 110.535 172.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.01 172.74 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.189 0.996 . . . . 0.0 109.814 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.72 140.56 9.3 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -153.3 164.66 37.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.11 0.955 . . . . 0.0 112.007 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -132.08 -41.32 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.192 1.397 . . . . 0.0 110.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.2 p -76.5 -15.52 59.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.502 0.721 . . . . 0.0 110.551 169.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.261 57.5 m 73.57 16.15 3.99 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.479 2.311 . . . . 0.0 113.831 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -63.24 -43.6 97.57 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.371 -1.456 . . . . 0.0 110.584 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -33.72 73.24 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.45 -47.38 84.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.454 0.702 . . . . 0.0 109.644 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -65.51 -39.54 91.97 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.186 0.448 . . . . 0.0 111.145 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.64 93.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.846 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.43 79.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.038 0.935 . . . . 0.0 110.674 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -57.2 -44.95 84.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.34 -56.46 16.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.804 1.315 . . . . 0.0 108.94 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.2 mt -51.88 -56.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 118.274 0.488 . . . . 0.0 110.099 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.24 -36.4 73.14 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.877 0.871 . . . . 0.0 111.122 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.32 -45.74 62.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.682 0.393 . . . . 0.0 111.084 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.67 -47.11 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.292 1.037 . . . . 0.0 108.802 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 164' ' ' ILE . 72.8 mt -73.34 -50.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.539 0.736 . . . . 0.0 110.279 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.36 112.25 0.41 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.79 -4.29 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.443 2.762 . . . . 0.0 112.29 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.1 -33.68 59.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.057 1.743 . . . . 0.0 109.387 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.44 -21.42 4.18 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.708 1.603 . . . . 0.0 111.417 -169.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.82 139.17 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 120.397 1.453 . . . . 0.0 109.108 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -128.25 129.09 45.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.606 1.163 . . . . 0.0 110.056 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.66 147.9 43.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.726 1.21 . . . . 0.0 112.049 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.09 111.94 5.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.987 1.715 . . . . 0.0 107.121 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.14 109.98 19.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.5 -7.57 26.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -62.43 -26.49 68.53 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.597 1.09 . . . . 0.0 111.669 169.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -132.83 -33.59 1.18 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 112.184 -171.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -84.04 141.16 31.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.49 1.116 . . . . 0.0 108.286 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -86.73 141.64 33.97 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -71.86 -4.24 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.079 1.853 . . . . 0.0 111.186 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -54.97 -35.76 64.63 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 120.347 1.43 . . . . 0.0 112.179 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -20.58 66.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 175.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -65.34 -10.96 37.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 112.539 169.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.02 -30.19 68.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.514 1.052 . . . . 0.0 110.159 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.62 -51.46 9.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.422 0.63 . . . . 0.0 110.295 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.99 143.55 57.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.616 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -76.15 -24.49 54.83 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.543 0.687 . . . . 0.0 110.766 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.8 t -145.18 139.18 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -169.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 153.49 43.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.612 0.642 . . . . 0.0 110.875 174.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 125.41 67.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.32 136.55 54.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.947 0.899 . . . . 0.0 109.886 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.05 116.52 2.99 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.006 -1.996 . . . . 0.0 111.689 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.51 130.1 24.9 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-N 120.229 2.014 . . . . 0.0 112.409 170.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.83 141.69 10.88 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.453 2.102 . . . . 0.0 107.792 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 m -89.45 124.35 34.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -115.24 174.7 5.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.526 1.93 . . . . 0.0 109.351 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 31.06 55.64 0.22 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.085 2.554 . . . . 0.0 115.253 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 55.69 78.84 0.18 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.71 1.204 . . . . 0.0 112.71 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 76.09 9.85 85.37 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.86 159.67 17.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.15 1.38 . . . . 0.0 110.803 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -91.05 152.9 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.04 144.5 55.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.68 -28.88 69.71 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.113 0.965 . . . . 0.0 112.4 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.262 0.625 . . . . 0.0 111.012 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.441 ' CD1' HG22 ' A' ' 53' ' ' ILE . 6.4 m95 -79.98 -43.49 21.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 110.195 173.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.46 -34.39 61.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.28 0.632 . . . . 0.0 111.024 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.379 1.072 . . . . 0.0 112.174 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.27 -10.41 9.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.513 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.9 t-105 -53.37 -27.73 25.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.505 1.522 . . . . 0.0 112.166 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.23 -45.56 66.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.209 1.404 . . . . 0.0 111.524 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -64.91 -33.05 75.1 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.929 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 44.3 mt -57.63 -31.68 66.5 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.725 1.148 . . . . 0.0 111.393 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.29 -27.49 61.58 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.345 0.658 . . . . 0.0 111.178 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.64 -19.29 31.18 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.832 0.853 . . . . 0.0 111.482 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.99 171.65 12.45 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.053 0.93 . . . . 0.0 110.721 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.47 112.22 24.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.22 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.02 10.3 6.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.838 0.855 . . . . 0.0 112.945 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.62 119.41 10.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -170.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.83 85.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 124.822 1.201 . . . . 0.0 114.148 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -79.17 149.37 32.0 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.002 0.901 . . . . 0.0 108.86 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.739 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.3 mt -86.38 140.35 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.52 131.38 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 109.447 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -112.53 112.91 24.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 166.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.39 143.99 26.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.799 0.727 . . . . 0.0 111.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -141.87 164.22 30.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.948 1.299 . . . . 0.0 109.03 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.48 38.88 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 121.195 -0.94 . . . . 0.0 113.218 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -128.56 153.76 46.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.437 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.71 -153.9 9.17 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.07 138.83 10.56 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 126.75 2.02 . . . . 0.0 107.775 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.39 -21.74 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.864 1.265 . . . . 0.0 114.267 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.51 -48.11 65.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.756 1.162 . . . . 0.0 110.664 -173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.93 -26.27 19.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.034 0.826 . . . . 0.0 112.33 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -130.92 27.75 4.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.44 58.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-N 121.116 1.78 . . . . 0.0 112.524 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.12 -15.92 58.3 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.033 -1.275 . . . . 0.0 113.222 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -125.16 -49.65 1.7 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.745 1.618 . . . . 0.0 111.433 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.261 2.0 t80 43.82 -133.59 0.61 Allowed 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.204 2.602 . . . . 0.0 109.844 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.98 40.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.816 3.646 . . . . 0.0 113.188 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 6.6 t70 -58.75 -43.08 90.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.554 -1.966 . . . . 0.0 111.42 -169.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.72 71.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.276 0.63 . . . . 0.0 110.584 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.585 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -62.75 -47.98 81.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.649 0.78 . . . . 0.0 110.384 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.44 99.19 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.6 mtm -62.0 -46.3 89.81 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 117.765 0.782 . . . . 0.0 111.218 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.513 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -67.99 -31.43 71.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.735 -0.603 . . . . 0.0 111.7 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.36 -49.97 75.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.011 0.434 . . . . 0.0 109.927 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.45 -40.17 92.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.419 1.088 . . . . 0.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 72' ' ' LEU . 17.9 tptt -54.2 -58.8 6.0 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.397 1.479 . . . . 0.0 108.444 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.9 -18.59 55.97 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.544 -0.723 . . . . 0.0 110.672 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -60.91 -26.93 67.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.985 0.811 . . . . 0.0 110.557 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -24.19 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.771 -1.206 . . . . 0.0 109.849 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -82.94 1.66 38.49 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.576 1.55 . . . . 0.0 112.627 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.06 34.27 70.33 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 118.633 0.651 . . . . 0.0 111.982 172.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.53 171.24 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 117.823 0.812 . . . . 0.0 109.89 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -116.23 140.6 49.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -108.53 147.6 31.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.55 1.068 . . . . 0.0 111.756 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 14.3 m -128.75 179.07 4.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 108.982 169.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.25 33.52 44.23 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-O 118.65 -1.084 . . . . 0.0 114.344 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.17 149.69 46.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.589 1.694 . . . . 0.0 108.044 169.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.37 135.65 27.75 Favored Pre-proline 0 CA--C 1.516 -0.334 0 CA-C-O 116.917 -1.516 . . . . 0.0 108.578 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.63 138.76 50.67 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 121.36 1.521 . . . . 0.0 109.776 169.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 67.3 p -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.522 1.929 . . . . 0.0 113.191 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.09 139.87 57.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.056 -1.028 . . . . 0.0 109.885 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.78 66.2 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.768 1.651 . . . . 0.0 114.023 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.5 163.19 13.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.179 1.49 . . . . 0.0 110.717 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -129.17 130.39 46.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -166.43 -52.98 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.477 1.035 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.326 3.1 t 57.45 10.64 1.0 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.237 2.615 . . . . 0.0 114.536 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 141.81 88.0 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.509 1.523 . . . . 0.0 109.783 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.24 -13.37 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.214 1.943 . . . . 0.0 114.114 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -80.0 -50.33 1.2 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.87 38.65 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.0 1.8 . . . . 0.0 112.827 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 149.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -166.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -172.28 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 125.906 1.683 . . . . 0.0 110.005 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.6 -116.89 0.89 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.65 8.0 32.92 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.016 1.326 . . . . 0.0 112.161 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.61 20.35 19.79 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.613 1.102 . . . . 0.0 112.591 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -100.15 -16.97 17.63 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.735 1.214 . . . . 0.0 110.713 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.02 142.45 49.58 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.445 0.698 . . . . 0.0 110.404 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.0 m-85 -77.47 157.7 30.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.863 1.265 . . . . 0.0 108.725 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.453 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -65.19 -18.69 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.915 173.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.04 -179.83 40.31 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 119.604 1.093 . . . . 0.0 112.066 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.483 HD11 HD21 ' A' ' 144' ' ' LEU . 12.8 tp -61.01 129.26 40.53 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.03 119.13 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 142' ' ' LEU . 85.9 mt -117.15 156.61 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.134 0.974 . . . . 0.0 109.223 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.97 122.15 12.21 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -97.56 18.15 16.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.843 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 -20.92 4.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.879 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.72 -53.95 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.239 1.381 . . . . 0.0 108.547 169.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.78 17.71 17.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -52.0 -25.2 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.036 0.934 . . . . 0.0 112.496 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.99 -26.65 54.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 0.0 111.426 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.46 -8.47 9.11 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.111 0.965 . . . . 0.0 112.331 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.6 m -51.59 -34.17 35.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.982 1.264 . . . . 0.0 110.554 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.54 -49.14 75.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.65 0.78 . . . . 0.0 110.238 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.11 -32.12 73.04 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.27 1.028 . . . . 0.0 109.892 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -74.98 -29.31 60.86 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 118.256 -0.878 . . . . 0.0 108.982 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.15 -58.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.44 -45.05 65.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.495 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.1 m -69.69 -35.23 74.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.587 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 34.6 t90 -67.08 -45.32 77.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.628 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 86.5 m -58.73 -33.88 70.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.823 0.849 . . . . 0.0 109.765 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -70.88 -32.33 69.27 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -78.63 -47.41 17.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.271 -1.347 . . . . 0.0 112.257 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.24 -37.19 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 121.23 1.832 . . . . 0.0 109.838 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.3 -13.0 33.7 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -51.07 5.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.649 1.58 . . . . 0.0 107.875 169.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.93 -22.8 67.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.355 0.662 . . . . 0.0 111.46 -169.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.739 ' HG2' HG21 ' A' ' 81' ' ' ILE . 69.5 mtm -94.43 -44.08 8.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 111.472 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.39 57.44 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.506 0.722 . . . . 0.0 110.709 -172.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.49 -27.69 66.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.897 1.279 . . . . 0.0 109.51 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -70.33 -48.27 57.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 110.378 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.42 -17.23 60.23 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.791 -179.205 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 142.68 29.83 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 mtm -130.94 147.96 52.65 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.447 1.899 . . . . 0.0 108.516 -169.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.25 117.63 4.77 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-O 118.824 -0.987 . . . . 0.0 110.807 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 98.02 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.879 1.339 . . . . 0.0 109.548 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -95.88 146.41 24.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.506 1.122 . . . . 0.0 110.447 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 36.3 p90 -165.36 174.6 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.686 0.794 . . . . 0.0 109.024 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.28 133.8 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 106.188 -2.765 . . . . 0.0 106.188 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 147.77 28.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.8 t -126.23 -27.56 3.21 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.944 1.298 . . . . 0.0 109.834 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.9 p -81.45 -74.28 0.34 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 169.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.0 p 175.7 -14.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.163 1.785 . . . . 0.0 113.839 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -63.44 -48.2 78.74 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.646 -1.284 . . . . 0.0 114.359 -164.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -33.71 74.93 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 6.5 tt0 -62.98 -47.79 81.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.2 mtm -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 118.004 0.365 . . . . 0.0 111.444 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.45 -41.65 90.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.69 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.76 82.25 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.995 0.918 . . . . 0.0 110.754 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.82 -44.96 90.97 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.2 -56.64 16.62 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 124.616 1.198 . . . . 0.0 108.43 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.403 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.0 mt -51.58 -56.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 118.821 0.737 . . . . 0.0 109.966 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -38.96 71.71 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.428 0.691 . . . . 0.0 110.514 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.88 -46.9 73.53 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.792 0.437 . . . . 0.0 111.442 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.66 -47.85 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.517 1.127 . . . . 0.0 108.727 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 164' ' ' ILE . 68.3 mt -72.32 -50.97 32.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 123.876 0.87 . . . . 0.0 110.309 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.28 114.92 0.7 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 170.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.86 2.83 4.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.374 2.716 . . . . 0.0 112.812 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.91 -34.01 66.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 -23.89 3.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.672 1.589 . . . . 0.0 111.549 -169.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.81 140.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.45 1.477 . . . . 0.0 109.278 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.7 m -129.36 128.66 43.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.689 1.195 . . . . 0.0 110.477 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.12 148.07 49.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 112.094 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -148.87 110.26 4.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.61 1.564 . . . . 0.0 107.618 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -86.92 113.14 22.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.23 -10.45 42.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -58.68 -26.91 64.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.981 0.809 . . . . 0.0 111.88 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.74 -28.72 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.889 0.875 . . . . 0.0 112.005 -167.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -87.63 145.36 26.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.377 1.471 . . . . 0.0 108.614 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -83.63 148.42 54.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.633 0.773 . . . . 0.0 108.976 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -79.27 -11.21 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.793 2.329 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -56.68 -36.6 69.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.446 1.476 . . . . 0.0 111.488 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -20.23 66.17 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.332 -0.855 . . . . 0.0 113.023 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -13.82 25.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.403 1.081 . . . . 0.0 112.156 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.94 -26.7 60.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.079 -1.013 . . . . 0.0 110.897 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.35 -50.65 13.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.786 0.803 . . . . 0.0 110.107 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -65.29 144.03 57.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.093 1.357 . . . . 0.0 108.248 -169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -75.52 -25.13 56.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.753 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 49' ' ' LEU . 42.2 t -144.15 140.24 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -168.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.8 158.65 36.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.659 0.663 . . . . 0.0 110.757 173.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.23 123.31 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.9 135.65 55.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.832 0.853 . . . . 0.0 108.872 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.24 3.67 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.697 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.83 130.09 24.89 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 118.824 1.312 . . . . 0.0 110.558 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.24 138.31 7.6 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.289 2.659 . . . . 0.0 107.887 168.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 m -87.19 126.32 34.72 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -113.19 172.77 6.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.253 1.821 . . . . 0.0 109.89 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 21.94 63.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.241 3.017 . . . . 0.0 115.469 169.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.17 71.39 0.54 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.713 1.205 . . . . 0.0 112.151 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.89 13.35 80.8 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.97 151.14 35.8 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.662 1.22 . . . . 0.0 109.302 168.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.63 148.84 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -64.35 144.75 56.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.44 -27.65 68.71 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.162 -172.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -64.82 -27.75 69.09 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.806 0.842 . . . . 0.0 112.401 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -88.53 -40.5 13.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.832 1.253 . . . . 0.0 110.59 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.12 -35.83 65.07 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.726 0.694 . . . . 0.0 111.009 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.11 71.33 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.165 0.986 . . . . 0.0 112.139 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.99 -12.4 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.727 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.0 t-105 -54.85 -28.76 52.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.114 1.366 . . . . 0.0 111.804 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.51 -44.86 61.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.681 1.192 . . . . 0.0 110.876 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.24 -29.6 67.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.22 -1.371 . . . . 0.0 112.559 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 mt -55.66 -32.86 63.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.228 1.376 . . . . 0.0 110.895 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.07 -33.68 76.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.69 0.796 . . . . 0.0 111.819 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.99 -26.62 48.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.277 0.631 . . . . 0.0 110.767 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.95 152.82 40.01 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.88 1.324 . . . . 0.0 110.511 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -85.11 103.59 14.25 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.558 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.5 mt -124.75 4.41 8.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.767 1.227 . . . . 0.0 113.032 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -68.48 113.14 5.76 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.74 79.86 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.34 1.447 . . . . 0.0 115.094 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -82.76 153.0 25.48 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.324 1.062 . . . . 0.0 109.914 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -87.99 141.59 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.53 129.1 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.163 1.385 . . . . 0.0 108.632 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.71 117.81 35.02 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.92 142.26 27.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.082 0.856 . . . . 0.0 111.524 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -140.37 161.33 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.006 0.922 . . . . 0.0 108.95 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.04 179.53 39.58 Favored Glycine 0 N--CA 1.45 -0.415 0 O-C-N 120.841 -1.162 . . . . 0.0 112.338 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.46 153.96 42.72 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 109.233 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.44 -157.86 13.33 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -148.88 141.94 24.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.486 1.514 . . . . 0.0 109.254 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.96 -21.03 23.75 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.79 -40.94 68.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.874 1.216 . . . . 0.0 111.804 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.91 -22.93 19.22 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 124.592 1.091 . . . . 0.0 111.512 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.6 m-85 -121.38 -84.8 0.66 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.764 1.225 . . . . 0.0 108.071 -170.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.0 -50.27 2.64 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 128.237 2.827 . . . . 0.0 108.6 -168.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' TYR . 1.3 mp0 -71.74 -36.21 70.39 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 126.613 1.965 . . . . 0.0 110.169 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -106.66 1.27 24.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.334 1.054 . . . . 0.0 112.085 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.29 120.83 2.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.587 1.555 . . . . 0.0 109.009 168.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 55.46 25.7 8.06 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.13 0.972 . . . . 0.0 113.465 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.88 -38.57 91.4 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 120.855 -1.153 . . . . 0.0 110.743 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.61 -32.99 73.14 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.074 -0.391 . . . . 0.0 111.795 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.697 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.8 tp -60.75 -46.29 91.04 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.116 0.966 . . . . 0.0 110.797 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.66 -40.35 96.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.5 mtm -68.52 -43.1 77.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.875 0.837 . . . . 0.0 112.461 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.585 HD12 HD12 ' A' ' 53' ' ' ILE . 4.7 mt -63.5 -33.27 75.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.3 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -65.35 -42.46 92.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.969 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.33 -42.46 92.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.675 1.19 . . . . 0.0 111.743 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -55.19 -59.33 4.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.619 1.168 . . . . 0.0 108.403 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 mt -76.95 -20.17 56.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.445 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -62.31 -28.81 70.0 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.234 0.924 . . . . 0.0 110.425 168.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.09 -24.07 47.7 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.646 -1.284 . . . . 0.0 109.572 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 18.8 mmmt -80.83 3.64 21.84 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.295 1.838 . . . . 0.0 113.08 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.17 80.4 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 118.593 0.633 . . . . 0.0 111.635 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.74 171.67 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.674 0.79 . . . . 0.0 109.046 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -117.98 141.9 47.95 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.51 147.69 32.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.487 1.039 . . . . 0.0 111.514 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.9 m -128.27 178.4 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.315 1.046 . . . . 0.0 108.802 169.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 35.94 37.57 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 118.608 -1.107 . . . . 0.0 114.286 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -77.87 152.82 33.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.667 1.733 . . . . 0.0 109.201 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -128.18 147.44 63.51 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 117.411 -1.281 . . . . 0.0 108.45 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.52 140.53 40.05 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.132 1.221 . . . . 0.0 109.651 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 139' ' ' PHE . 78.8 p -74.37 -7.73 53.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.878 1.671 . . . . 0.0 113.822 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.95 142.7 57.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.065 0.936 . . . . 0.0 110.273 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.93 -5.4 62.28 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.675 1.607 . . . . 0.0 114.038 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -100.69 155.15 18.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.635 1.574 . . . . 0.0 109.904 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -124.11 126.93 47.05 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.998 1.719 . . . . 0.0 106.592 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -163.52 -53.01 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.218 0.607 . . . . 0.0 109.711 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 2.9 t 58.64 8.81 0.97 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.969 2.508 . . . . 0.0 114.616 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -68.46 139.74 92.03 Favored Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 120.835 -1.166 . . . . 0.0 108.817 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -85.03 -11.3 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.9 2.4 . . . . 0.0 113.085 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -77.85 -50.61 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -168.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -88.39 42.54 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.179 1.919 . . . . 0.0 112.163 -169.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 147.66 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.771 -1.206 . . . . 0.0 109.806 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 -172.47 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 125.968 1.707 . . . . 0.0 110.182 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.07 -116.49 0.84 Allowed 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.1 1.36 . . . . 0.0 107.579 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.25 8.56 33.96 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.839 1.256 . . . . 0.0 111.871 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.25 21.56 19.73 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.986 1.279 . . . . 0.0 112.504 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -99.77 -18.32 17.27 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.693 1.197 . . . . 0.0 110.764 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.5 144.35 51.07 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.257 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -78.13 154.98 30.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.114 1.366 . . . . 0.0 109.826 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' A' ' 101' ' ' LEU . 16.1 m -65.61 -12.49 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.587 1.155 . . . . 0.0 112.618 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.84 -177.21 44.69 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 119.763 1.165 . . . . 0.0 112.475 -172.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 24.7 tp -65.77 131.26 45.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.08 112.88 20.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.9 mt -110.96 154.2 24.45 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.268 1.027 . . . . 0.0 109.59 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.47 128.27 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -102.5 13.79 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.399 1.079 . . . . 0.0 110.793 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -22.44 5.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.1 -49.24 2.98 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.765 1.226 . . . . 0.0 108.153 172.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.48 22.38 15.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.36 1.464 . . . . 0.0 112.809 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -52.52 -26.86 14.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.138 0.575 . . . . 0.0 112.411 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.75 -25.19 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.43 0.692 . . . . 0.0 111.677 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -125.13 -11.31 7.03 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.121 0.969 . . . . 0.0 112.153 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.0 m -56.94 -29.77 63.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.017 1.28 . . . . 0.0 109.351 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.83 -37.78 77.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.219 1.408 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.8 -37.49 27.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.577 1.151 . . . . 0.0 110.039 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -67.89 -31.06 70.6 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.33 -54.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -52.67 -47.73 66.98 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.061 1.344 . . . . 0.0 110.411 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.3 m -66.41 -36.31 82.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.256 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.411 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 31.2 t90 -66.27 -44.67 82.94 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.547 0.689 . . . . 0.0 109.963 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.5 m -58.18 -36.1 72.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.794 0.838 . . . . 0.0 109.691 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -69.62 -31.33 69.39 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.597 0.561 . . . . 0.0 109.854 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -79.59 -47.58 15.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.674 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.32 -38.85 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 121.018 1.735 . . . . 0.0 110.349 -169.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.94 -14.28 59.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.104 0.561 . . . . 0.0 111.976 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.23 -46.54 6.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.57 -39.5 80.46 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.292 0.637 . . . . 0.0 110.062 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.5 mtm -78.49 -38.3 41.17 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 -176.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.3 62.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.145 0.978 . . . . 0.0 109.96 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.15 -29.68 70.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.036 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -64.36 -47.63 78.58 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 110.58 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -2.12 51.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.601 1.161 . . . . 0.0 113.649 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.49 178.738 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.604 ' SD ' HG21 ' A' ' 48' ' ' VAL . 27.2 ttm . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.58 144.24 51.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.943 2.097 . . . . 0.0 106.344 169.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.95 146.4 50.33 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 -166.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.29 114.27 3.93 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.09 101.32 13.98 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.816 1.308 . . . . 0.0 110.665 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.84 146.65 26.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.773 1.229 . . . . 0.0 111.57 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 39.0 p90 -163.84 173.86 12.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.364 1.066 . . . . 0.0 109.61 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.23 139.85 8.66 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 169.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -136.83 133.18 35.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.763 1.225 . . . . 0.0 110.551 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.48 -42.24 13.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.806 0.843 . . . . 0.0 109.307 174.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.3 p -97.27 -84.24 0.38 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 p -174.83 -5.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.189 2.596 . . . . 0.0 112.104 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -67.73 -40.91 84.18 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 119.796 -1.815 . . . . 0.0 111.449 -168.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -34.86 78.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 5.6 tt0 -64.74 -48.48 74.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.016 0.926 . . . . 0.0 109.918 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.3 mtm -66.76 -36.86 83.42 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.644 -0.66 . . . . 0.0 111.452 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.99 97.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.646 -0.659 . . . . 0.0 110.69 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.07 85.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.544 1.137 . . . . 0.0 111.278 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.82 -48.52 81.04 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.182 0.993 . . . . 0.0 109.238 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -59.71 -56.44 21.88 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.35 -56.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.066 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -53.78 -43.19 69.04 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.129 0.971 . . . . 0.0 110.349 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.91 -42.5 69.86 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.024 0.53 . . . . 0.0 111.144 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.8 mt -65.25 -49.83 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 108.822 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 164' ' ' ILE . 61.0 mt -71.87 -52.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.143 0.977 . . . . 0.0 110.254 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.07 112.56 0.4 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.65 -3.99 11.3 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.243 2.628 . . . . 0.0 112.639 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.98 -34.46 59.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.693 1.597 . . . . 0.0 109.546 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -27.71 6.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.152 1.781 . . . . 0.0 109.99 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.5 140.08 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.953 1.706 . . . . 0.0 109.428 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 m -132.69 129.73 39.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.28 1.7 pt? -101.39 156.78 17.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.549 1.068 . . . . 0.0 113.044 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -147.93 113.93 5.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.164 1.386 . . . . 0.0 109.142 -166.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.9 112.38 19.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.74 -10.53 20.13 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.973 0.909 . . . . 0.0 113.309 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -57.88 -29.19 64.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.115 0.871 . . . . 0.0 111.798 168.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -130.05 -33.93 1.72 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.785 1.234 . . . . 0.0 111.708 -172.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -84.04 141.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.12 0.968 . . . . 0.0 108.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.0 m -85.09 143.15 39.25 Favored Pre-proline 0 C--O 1.225 -0.218 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.79 -6.51 18.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.781 1.654 . . . . 0.0 111.736 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -54.92 -37.4 66.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.781 1.628 . . . . 0.0 111.313 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -21.22 66.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -13.65 22.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 169.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.72 -26.0 61.42 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.89 -1.131 . . . . 0.0 110.669 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -77.6 -50.3 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.062 0.847 . . . . 0.0 110.273 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.09 139.44 58.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.89 -21.93 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.23 0.538 . . . . 0.0 111.399 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG21 ' SD ' ' A' ' 1' ' ' MET . 57.6 t -140.38 141.96 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -172.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -129.74 158.14 40.21 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.892 0.377 . . . . 0.0 110.755 174.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.63 122.49 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.87 134.28 55.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -127.77 119.11 3.08 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 117.826 -1.541 . . . . 0.0 112.725 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.89 132.54 24.22 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 119.114 1.457 . . . . 0.0 110.864 178.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.46 149.1 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.427 2.085 . . . . 0.0 108.297 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 m -94.52 130.15 41.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -124.54 170.93 10.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.881 1.673 . . . . 0.0 109.472 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 31.92 54.89 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.736 2.414 . . . . 0.0 115.313 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 57.23 76.65 0.31 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.111 1.364 . . . . 0.0 112.755 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.42 25.42 75.5 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.791 -0.568 . . . . 0.0 114.482 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -97.37 164.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.72 1.608 . . . . 0.0 110.318 169.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.8 mt -101.73 151.85 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 126.153 1.781 . . . . 0.0 106.461 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.1 144.08 56.91 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.65 -27.2 68.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.114 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -66.77 -26.49 66.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.806 0.843 . . . . 0.0 110.642 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.9 m95 -84.55 -43.05 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.27 1.028 . . . . 0.0 110.819 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.26 -36.09 63.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.443 0.565 . . . . 0.0 110.746 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -31.07 71.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.49 1.116 . . . . 0.0 112.174 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.12 -10.8 10.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.4 t-105 -53.57 -29.29 36.52 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.604 . . . . 0.0 111.621 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.8 -43.64 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.004 1.322 . . . . 0.0 111.154 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -69.24 -29.71 67.7 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.114 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.99 -31.1 64.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.086 1.312 . . . . 0.0 111.055 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.48 -28.17 64.78 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.625 0.77 . . . . 0.0 111.22 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.96 -23.59 36.01 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.511 0.724 . . . . 0.0 111.114 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.68 158.22 32.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.937 1.351 . . . . 0.0 111.961 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -91.72 99.87 12.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.866 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.77 9.08 11.96 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.17 122.16 15.94 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.98 84.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.93 1.252 . . . . 0.0 114.564 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -83.05 147.35 28.19 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.206 1.003 . . . . 0.0 110.274 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -80.99 139.11 18.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.73 123.98 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 125.016 1.326 . . . . 0.0 109.127 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -104.44 115.43 30.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 mt -88.78 141.58 28.38 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 118.828 0.74 . . . . 0.0 111.572 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 18.2 p90 -140.2 163.36 32.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.431 1.093 . . . . 0.0 108.5 169.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 179.24 38.59 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.115 -0.99 . . . . 0.0 112.519 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.8 mt -123.67 152.76 41.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.148 0.979 . . . . 0.0 108.809 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 -163.04 13.27 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.834 0.73 . . . . 0.0 111.306 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.77 117.21 7.46 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.753 2.021 . . . . 0.0 105.99 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.42 -28.75 24.9 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.992 0.36 . . . . 0.0 111.397 -171.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.93 -45.86 55.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.164 0.585 . . . . 0.0 110.284 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.36 -36.29 17.76 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.727 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -135.24 37.8 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.75 -39.75 68.72 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 119.687 1.13 . . . . 0.0 111.322 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.41 -17.15 58.5 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 117.962 0.881 . . . . 0.0 112.626 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -129.54 13.19 5.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.031 1.732 . . . . 0.0 112.342 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -44.6 126.38 5.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.796 1.638 . . . . 0.0 110.013 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.87 25.83 2.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.186 1.395 . . . . 0.0 113.34 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.03 -37.2 84.04 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 120.402 -1.436 . . . . 0.0 110.707 -170.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.72 73.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.24 0.616 . . . . 0.0 111.961 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.8 tp -60.92 -46.26 91.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.199 0.999 . . . . 0.0 110.771 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.64 99.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.9 mtm -62.08 -45.67 92.48 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 117.578 0.689 . . . . 0.0 111.607 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -65.54 -33.44 75.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.84 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -62.01 -39.53 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.246 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.11 -36.23 66.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.796 1.638 . . . . 0.0 112.192 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.9 tptt -57.51 -46.05 84.24 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.726 0.81 . . . . 0.0 109.98 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.39 -19.07 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.623 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p -61.4 -31.94 71.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.663 1.574 . . . . 0.0 111.88 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -78.36 -18.35 55.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.794 -0.566 . . . . 0.0 110.368 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -78.96 1.39 23.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.134 1.373 . . . . 0.0 112.031 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.96 65.01 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.79 0.723 . . . . 0.0 111.908 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.38 170.32 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.738 0.815 . . . . 0.0 109.603 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -118.33 135.09 54.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -102.81 147.1 27.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -127.3 175.61 8.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.58 39.09 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.822 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -72.98 150.78 42.19 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.124 1.962 . . . . 0.0 108.008 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.53 145.12 56.15 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.009 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.04 141.89 45.29 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 121.177 1.456 . . . . 0.0 109.238 168.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 ' CD1' ' A' ' 139' ' ' PHE . 81.9 p -75.49 -3.82 36.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.81 1.644 . . . . 0.0 113.894 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.37 146.12 45.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.747 0.819 . . . . 0.0 109.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.88 17.17 78.99 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.478 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.53 156.18 49.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.238 1.815 . . . . 0.0 109.491 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.89 129.08 48.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -160.09 -57.0 0.06 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.799 0.727 . . . . 0.0 110.265 -169.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.353 4.3 t 58.59 10.81 1.52 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.935 2.494 . . . . 0.0 114.572 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.6 t -62.96 131.52 94.69 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.28 -13.41 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.397 2.065 . . . . 0.0 112.836 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -80.64 -48.03 1.2 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -169.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -88.04 39.06 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.089 1.859 . . . . 0.0 112.212 -168.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.32 147.04 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 119.212 0.914 . . . . 0.0 109.4 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.852 1.661 . . . . 0.0 109.794 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.81 -116.29 0.84 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.318 1.447 . . . . 0.0 107.491 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -105.21 7.89 33.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.791 1.237 . . . . 0.0 112.111 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.16 20.23 18.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.639 1.114 . . . . 0.0 112.463 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.05 -17.86 17.28 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 110.863 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.96 143.96 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.897 0.479 . . . . 0.0 110.706 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.505 ' CD1' HG22 ' A' ' 121' ' ' THR . 63.1 m-85 -77.9 156.09 30.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.818 1.247 . . . . 0.0 109.111 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.01 -15.65 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.087 0.955 . . . . 0.0 112.315 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.02 -176.63 40.35 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 119.985 1.266 . . . . 0.0 111.763 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.8 tp -63.81 126.86 28.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.0 119.79 40.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.5 mt -113.5 146.09 40.17 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.39 131.11 55.62 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 170.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.57 30.23 7.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.243 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.47 -34.52 0.84 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -116.91 -30.77 5.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 120.131 1.332 . . . . 0.0 111.788 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -89.95 3.5 52.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.872 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -58.28 -21.88 50.51 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.298 0.954 . . . . 0.0 112.137 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.29 -24.43 42.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.277 1.031 . . . . 0.0 111.508 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -126.29 -5.8 6.58 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.735 0.814 . . . . 0.0 112.864 -170.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -56.72 -29.89 62.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.078 0.854 . . . . 0.0 110.482 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.73 -38.18 64.08 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.849 1.66 . . . . 0.0 111.731 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -36.6 23.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.745 1.218 . . . . 0.0 109.945 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -67.44 -26.37 66.37 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.986 0.915 . . . . 0.0 109.52 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.38 -57.58 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -49.78 -48.26 50.6 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 110.563 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -65.35 -37.46 87.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.385 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 33.8 t90 -66.36 -43.43 86.04 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -58.18 -35.44 71.6 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.568 0.747 . . . . 0.0 109.426 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -33.78 76.42 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.433 0.458 . . . . 0.0 110.047 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.79 -46.13 15.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.56 -1.21 . . . . 0.0 111.85 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 25' ' ' ILE . 6.5 pt -65.02 -39.78 86.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.375 1.898 . . . . 0.0 109.959 -169.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.87 -21.93 66.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.819 -0.551 . . . . 0.0 110.749 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -89.63 -42.66 11.25 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.75 -31.26 68.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.807 0.73 . . . . 0.0 109.979 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.9 mtm -86.01 -44.03 12.66 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.889 1.275 . . . . 0.0 109.029 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.5 83.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.317 1.047 . . . . 0.0 111.961 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.52 -27.54 63.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.959 1.304 . . . . 0.0 109.766 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -67.63 -31.77 72.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.558 0.617 . . . . 0.0 111.52 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.443 ' CE1' ' CE ' ' A' ' 1' ' ' MET . 2.8 m-30 -58.43 -29.91 66.48 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 O-C-N 123.745 0.653 . . . . 0.0 111.084 -167.617 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.56 140.83 30.31 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.78 146.65 48.18 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.995 2.118 . . . . 0.0 108.769 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.29 116.49 4.41 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-O 118.49 -1.172 . . . . 0.0 111.215 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 100.2 12.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.339 1.569 . . . . 0.0 110.051 172.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -98.96 145.31 27.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.454 1.502 . . . . 0.0 111.551 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -165.87 173.13 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.742 1.217 . . . . 0.0 109.014 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.22 127.88 2.89 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 172.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -128.85 131.73 47.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.714 1.606 . . . . 0.0 109.148 -170.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -84.59 -36.47 22.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.9 p -103.7 -81.65 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -177.6 -4.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.621 2.768 . . . . 0.0 112.111 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.46 -43.44 73.22 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 122.088 2.222 . . . . 0.0 111.054 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -67.89 -30.94 70.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.757 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.86 -46.41 75.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.962 0.905 . . . . 0.0 110.594 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.12 -35.67 81.53 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.42 98.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.029 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.52 74.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.808 0.843 . . . . 0.0 110.666 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.54 -47.14 85.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 122.89 0.476 . . . . 0.0 110.031 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 24' ' ' ILE . 57.0 mttm -61.3 -55.04 36.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.788 1.235 . . . . 0.0 108.905 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.55 -56.49 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.99 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.66 70.84 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.117 0.567 . . . . 0.0 110.372 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.42 -47.01 74.61 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.827 0.451 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LYS . 6.9 mt -66.21 -47.98 82.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.299 1.04 . . . . 0.0 108.898 -175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 164' ' ' ILE . 69.5 mt -71.03 -50.5 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.765 0.826 . . . . 0.0 110.415 -176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.55 114.55 0.76 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.63 2.97 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.454 2.769 . . . . 0.0 112.889 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.4 -34.36 67.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.056 1.342 . . . . 0.0 109.09 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.46 -21.43 3.83 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.44 1.496 . . . . 0.0 111.509 -169.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -93.93 142.05 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 120.828 1.649 . . . . 0.0 108.992 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.4 m -132.58 129.47 39.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.437 1.095 . . . . 0.0 110.054 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 147.77 49.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 111.539 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.91 107.16 4.35 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 107.604 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.96 112.79 20.06 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.23 -10.24 22.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.795 1.238 . . . . 0.0 112.999 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -59.93 -28.33 67.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.08 0.855 . . . . 0.0 111.847 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -129.15 -33.96 1.91 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.9 1.28 . . . . 0.0 111.882 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.21 141.71 29.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.29 1.036 . . . . 0.0 109.05 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -84.78 142.53 39.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.0 -6.28 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.481 1.454 . . . . 0.0 111.419 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -54.15 -37.84 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.986 1.721 . . . . 0.0 111.422 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -21.86 66.53 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -14.7 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.061 1.344 . . . . 0.0 112.235 169.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -72.7 -26.14 61.49 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.942 -1.099 . . . . 0.0 110.775 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -78.15 -49.21 14.3 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.869 0.759 . . . . 0.0 110.092 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -65.27 140.0 58.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.74 1.216 . . . . 0.0 108.436 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -73.04 -29.32 62.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.656 0.741 . . . . 0.0 110.827 -174.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.0 t -142.52 143.81 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.66 155.5 49.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.597 0.635 . . . . 0.0 109.512 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.76 122.21 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.37 145.58 47.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 147.3 15.79 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.754 -1.212 . . . . 0.0 115.759 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -134.72 134.35 22.03 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.67 1.988 . . . . 0.0 109.582 -169.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -84.92 140.69 8.04 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 107.274 165.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -88.58 103.99 16.42 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -88.07 169.13 12.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.832 0.853 . . . . 0.0 110.709 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 22.97 66.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.886 2.875 . . . . 0.0 115.602 167.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.63 71.29 0.56 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.367 1.067 . . . . 0.0 112.096 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.42 15.7 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.01 148.41 32.53 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.632 1.206 . . . . 0.0 109.737 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.97 153.08 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -60.98 142.84 56.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.773 0.829 . . . . 0.0 108.941 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.37 -27.85 68.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -166.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.07 -24.31 35.32 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.732 -0.605 . . . . 0.0 110.468 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 53' ' ' ILE . 13.1 m95 -72.91 -43.76 62.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.914 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.34 -35.51 60.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.661 0.664 . . . . 0.0 110.973 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.76 71.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.538 0.735 . . . . 0.0 111.9 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.1 -11.46 10.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.98 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.8 t-105 -53.46 -28.9 32.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.73 1.612 . . . . 0.0 111.6 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.59 -43.88 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.093 1.357 . . . . 0.0 111.346 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.45 -30.01 67.82 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.092 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.6 mt -57.28 -30.46 64.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.945 1.248 . . . . 0.0 111.236 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.32 -28.47 65.19 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.689 0.796 . . . . 0.0 111.467 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.88 -24.33 35.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.184 0.594 . . . . 0.0 111.275 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.61 158.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 123.169 1.462 . . . . 0.0 112.205 -168.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -92.2 98.51 11.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.931 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -119.64 8.81 11.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.83 120.75 13.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.22 12.32 84.25 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.12 1.343 . . . . 0.0 114.12 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -79.52 148.53 31.77 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 117.659 0.729 . . . . 0.0 109.143 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -85.15 141.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 166.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.02 119.6 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 125.758 1.623 . . . . 0.0 107.167 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -98.85 116.63 31.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.127 -0.983 . . . . 0.0 108.617 168.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.08 141.89 29.1 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.19 0.904 . . . . 0.0 112.242 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -137.36 155.43 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.995 0.918 . . . . 0.0 109.162 168.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.81 172.17 36.3 Favored Glycine 0 N--CA 1.451 -0.345 0 O-C-N 120.698 -1.251 . . . . 0.0 112.296 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.78 155.83 40.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.389 1.076 . . . . 0.0 108.443 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.19 -155.64 12.96 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -149.23 140.28 22.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -24.6 20.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.002 1.321 . . . . 0.0 113.811 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -33.24 43.22 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.164 1.347 . . . . 0.0 112.862 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.5 -20.73 36.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.454 1.026 . . . . 0.0 111.266 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -122.37 -86.36 0.65 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.689 1.196 . . . . 0.0 108.051 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.42 -53.3 3.15 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 128.719 3.056 . . . . 0.0 107.703 -168.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.6 -28.0 69.33 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.605 1.962 . . . . 0.0 110.776 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -118.34 6.63 11.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.971 1.308 . . . . 0.0 112.228 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.56 122.22 5.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.976 1.31 . . . . 0.0 109.905 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.41 26.8 7.42 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.195 1.398 . . . . 0.0 113.056 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.47 -38.81 92.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 120.928 -1.108 . . . . 0.0 110.443 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.22 75.28 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.209 0.604 . . . . 0.0 111.907 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.653 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.4 tp -60.34 -45.93 91.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.996 0.918 . . . . 0.0 110.403 175.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.34 97.5 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.6 mtm -66.46 -42.6 87.34 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 118.0 0.9 . . . . 0.0 111.971 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 53' ' ' ILE . 4.1 mt -63.16 -35.11 79.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.546 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -65.31 -42.44 93.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.18 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.7 -42.57 95.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.347 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -55.35 -60.67 3.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.719 1.208 . . . . 0.0 108.224 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.75 -20.36 56.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.906 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -60.96 -29.26 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.579 1.081 . . . . 0.0 110.499 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -22.21 55.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.875 -1.14 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -85.09 2.54 42.95 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 112.458 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.67 36.44 82.87 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.37 0.532 . . . . 0.0 112.12 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.8 169.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.838 0.855 . . . . 0.0 110.076 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -104.3 136.36 44.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -106.76 146.8 30.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.881 1.219 . . . . 0.0 110.658 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.7 m -129.85 178.09 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 123.786 0.834 . . . . 0.0 108.799 169.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.95 38.96 34.35 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-O 118.767 -1.019 . . . . 0.0 113.855 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -79.59 153.99 29.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.462 1.631 . . . . 0.0 109.085 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.21 149.95 75.14 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.635 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.47 140.39 39.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.44 1.426 . . . . 0.0 110.158 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p -75.51 -4.69 41.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.472 1.909 . . . . 0.0 113.503 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.16 140.81 57.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.99 -1.069 . . . . 0.0 109.961 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.42 -9.43 61.58 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.508 1.528 . . . . 0.0 113.515 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -93.81 150.17 20.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.096 1.448 . . . . 0.0 111.389 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -111.36 126.15 54.61 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 127.529 2.332 . . . . 0.0 105.308 167.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 12.3 p90 -162.03 -60.43 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 126' ' ' PHE 0.315 1.9 t 56.95 9.4 0.62 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.276 2.63 . . . . 0.0 114.19 -179.416 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 p -66.82 135.97 94.41 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.832 -1.168 . . . . 0.0 108.974 169.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.98 -13.9 5.38 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.431 2.087 . . . . 0.0 113.671 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.99 -48.41 1.09 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.2 36.96 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.983 1.789 . . . . 0.0 112.965 -168.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.66 147.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.131 0.972 . . . . 0.0 109.529 -167.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.76 -172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.7 . . . . 0.0 109.372 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.01 -117.12 0.87 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.062 1.345 . . . . 0.0 107.518 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -104.88 7.45 34.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.667 1.187 . . . . 0.0 112.003 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.57 20.15 18.12 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.56 1.076 . . . . 0.0 112.787 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.36 -17.26 17.33 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.831 1.252 . . . . 0.0 111.007 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.06 145.25 50.61 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.512 0.725 . . . . 0.0 110.809 174.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.4 m-85 -79.84 154.61 28.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.209 1.404 . . . . 0.0 109.845 177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.98 -12.41 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.813 1.245 . . . . 0.0 112.829 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.29 -176.23 41.65 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.617 1.099 . . . . 0.0 111.863 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 144' ' ' LEU . 34.4 tp -63.0 126.8 28.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.28 121.21 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 153' ' ' SER . 55.8 mt -123.05 155.69 36.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.085 0.954 . . . . 0.0 109.512 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.49 120.82 16.96 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.07 3.66 44.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.553 -172.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -30.84 10.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.537 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.9 -46.61 2.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.257 0.935 . . . . 0.0 110.637 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -99.57 24.01 8.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.334 1.054 . . . . 0.0 111.31 -171.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -53.48 -29.27 35.18 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.712 0.687 . . . . 0.0 111.841 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.97 -22.85 48.82 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.922 0.889 . . . . 0.0 111.213 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.69 -31.04 11.41 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 126.497 1.919 . . . . 0.0 110.245 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.613 ' HA ' HD22 ' A' ' 144' ' ' LEU . 70.6 m -55.92 -26.11 46.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.993 169.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.56 -54.71 11.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.071 0.85 . . . . 0.0 109.959 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -62.55 -32.68 73.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.092 0.949 . . . . 0.0 111.793 -170.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -83.94 -24.07 30.85 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.435 1.494 . . . . 0.0 109.692 -170.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.9 mt -60.73 -52.83 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -54.84 -44.99 74.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.861 0.864 . . . . 0.0 110.582 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -71.3 -33.64 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.686 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CZ2' ' HB1' ' A' ' 83' ' ' ALA . 35.4 t90 -65.45 -44.39 87.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.747 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.0 m -59.52 -36.24 75.73 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.995 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -68.79 -32.5 72.27 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 122.789 0.435 . . . . 0.0 110.564 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -79.11 -46.42 18.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.741 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 25' ' ' ILE . 7.0 pt -65.0 -38.0 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 120.597 1.544 . . . . 0.0 109.838 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.46 -12.26 50.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.477 0.581 . . . . 0.0 112.187 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -95.29 -46.6 6.67 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.28 -36.23 79.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.947 0.794 . . . . 0.0 110.637 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -82.04 -37.38 26.57 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.209 1.003 . . . . 0.0 110.834 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.24 -45.28 56.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 110.228 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.79 -30.07 68.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 110.084 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 81' ' ' ILE . 68.0 t60 -63.98 -53.11 55.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.068 0.547 . . . . 0.0 109.822 169.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -9.3 58.83 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.681 178.224 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.53 143.49 31.98 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mtm -132.18 149.56 52.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 107.55 -170.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.16 121.23 5.24 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.759 -1.023 . . . . 0.0 110.671 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.61 113.59 25.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.826 1.313 . . . . 0.0 109.07 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 43' ' ' MET . 73.8 m-85 -109.69 145.93 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.395 1.478 . . . . 0.0 111.748 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -162.67 172.23 15.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.237 1.015 . . . . 0.0 109.602 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.36 136.58 7.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 168.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -134.52 128.82 34.09 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.813 1.245 . . . . 0.0 110.871 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.1 m -89.79 -42.26 11.38 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.933 0.493 . . . . 0.0 110.014 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -92.62 -82.33 0.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.7 p -177.13 -6.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.464 2.306 . . . . 0.0 112.559 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.42 -44.47 91.1 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 119.817 -1.802 . . . . 0.0 112.062 -168.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -37.99 88.16 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.3 -46.58 89.72 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.632 0.773 . . . . 0.0 110.316 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.6 mtm -67.34 -43.23 82.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.158 0.436 . . . . 0.0 110.979 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.5 87.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.709 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.72 80.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.776 0.83 . . . . 0.0 110.823 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.65 -44.13 93.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -63.2 -53.86 46.63 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.004 1.321 . . . . 0.0 108.992 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -53.24 -56.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.843 0.747 . . . . 0.0 110.091 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -38.29 79.75 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.385 -178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.36 -47.9 71.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.056 0.542 . . . . 0.0 111.033 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.6 mt -65.75 -48.24 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.437 1.095 . . . . 0.0 108.674 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 164' ' ' ILE . 79.5 mt -71.1 -49.9 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 123.461 0.704 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.97 114.31 0.77 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.19 4.15 3.52 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.48 2.787 . . . . 0.0 112.577 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.59 -34.38 67.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.225 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 -21.24 3.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.424 1.49 . . . . 0.0 111.694 -169.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.13 141.63 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.583 1.538 . . . . 0.0 108.995 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.3 m -131.56 128.91 40.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.328 1.051 . . . . 0.0 109.817 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.55 149.12 47.44 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.521 0.729 . . . . 0.0 112.048 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -146.97 111.85 5.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.995 1.718 . . . . 0.0 106.926 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.82 112.48 21.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.23 -8.79 19.15 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -59.27 -28.64 66.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.255 0.934 . . . . 0.0 111.762 168.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -132.26 -33.64 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.545 1.138 . . . . 0.0 111.973 -171.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.66 140.5 30.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 109.019 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -86.03 141.66 35.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 75' ' ' LEU . 18.4 Cg_endo -72.57 1.41 6.3 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.666 2.244 . . . . 0.0 111.695 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -59.6 -34.79 73.2 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 119.057 -2.277 . . . . 0.0 111.576 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -17.97 63.29 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.442 ' HG3' ' CZ ' ' A' ' 6' ' ' PHE . 15.7 mtm -59.09 -15.84 16.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 0.0 111.791 168.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 54.6 mt-10 -72.3 -26.53 62.0 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.976 -1.078 . . . . 0.0 111.529 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.96 -50.33 11.32 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.984 0.811 . . . . 0.0 110.347 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -67.68 147.19 53.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.124 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -79.13 -23.41 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.968 -0.457 . . . . 0.0 110.938 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.4 t -143.21 138.49 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.91 152.4 47.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.15 125.4 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.29 134.47 52.25 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.686 0.794 . . . . 0.0 109.321 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.54 117.54 3.64 Favored Glycine 0 N--CA 1.463 0.436 0 CA-C-O 116.989 -2.006 . . . . 0.0 111.705 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -115.32 126.74 27.46 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 120.168 1.984 . . . . 0.0 110.932 172.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.98 141.79 10.74 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.548 2.832 . . . . 0.0 108.354 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -91.23 112.03 23.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -98.53 170.46 8.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.476 1.111 . . . . 0.0 110.592 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.74 62.92 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.783 2.833 . . . . 0.0 115.449 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 57.09 74.87 0.39 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.762 1.225 . . . . 0.0 112.626 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.11 71.08 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.12 164.28 23.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.564 1.173 . . . . 0.0 108.762 168.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.12 153.27 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -59.85 141.61 55.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.57 -29.36 69.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -166.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.64 -21.17 52.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.614 -0.679 . . . . 0.0 110.283 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.0 m95 -77.84 -45.27 24.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.497 168.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -53.76 -36.0 61.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.182 0.593 . . . . 0.0 110.886 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.73 70.99 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.299 1.04 . . . . 0.0 112.061 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.9 -8.69 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.569 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.0 t-105 -54.31 -28.95 45.74 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 111.677 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -45.11 71.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.771 1.228 . . . . 0.0 111.646 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.43 -26.11 66.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 117.727 -1.13 . . . . 0.0 112.388 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.16 -30.95 68.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.055 1.298 . . . . 0.0 111.042 -176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -70.12 -26.92 64.18 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.238 0.615 . . . . 0.0 111.583 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.09 -23.16 33.22 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.289 0.635 . . . . 0.0 111.484 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 40' ' ' PRO . 21.3 mt -72.14 171.83 11.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.504 1.145 . . . . 0.0 111.073 -170.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 13.7 t30 -111.78 103.26 11.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.029 1.732 . . . . 0.0 108.442 173.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -121.83 10.79 10.3 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.67 121.95 15.18 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.9 8.91 86.8 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.169 1.366 . . . . 0.0 114.605 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.79 151.19 32.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 117.976 0.888 . . . . 0.0 109.032 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.733 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.0 mt -88.99 141.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.34 126.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.002 1.321 . . . . 0.0 108.328 176.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.39 110.29 22.58 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 105' ' ' HIS . 58.0 mt -88.5 142.76 27.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.925 0.784 . . . . 0.0 110.637 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -137.62 162.37 33.98 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.168 1.387 . . . . 0.0 108.163 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.1 173.64 36.77 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 121.369 -0.832 . . . . 0.0 112.119 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.8 mt -128.99 154.6 46.45 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.97 1.308 . . . . 0.0 108.087 -172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.67 -152.4 9.43 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -157.22 142.76 17.41 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.739 2.016 . . . . 0.0 107.142 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -91.98 -26.78 18.23 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.81 -32.93 63.98 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.894 1.224 . . . . 0.0 112.835 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.7 -16.52 48.45 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 124.251 0.929 . . . . 0.0 111.795 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -127.54 -88.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.49 1.516 . . . . 0.0 108.761 -168.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.26 -50.74 2.8 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 129.247 3.308 . . . . 0.0 108.364 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.22 -25.78 65.38 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 125.636 1.574 . . . . 0.0 110.885 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -119.12 8.09 11.48 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.949 1.3 . . . . 0.0 112.449 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -46.7 123.08 4.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.191 1.397 . . . . 0.0 110.399 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 52.36 27.52 4.93 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.011 1.324 . . . . 0.0 113.122 173.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.22 -34.75 78.14 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.529 -170.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.27 71.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.453 0.701 . . . . 0.0 111.606 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.624 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -62.42 -47.17 85.27 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.133 0.973 . . . . 0.0 109.972 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.87 -40.87 97.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.2 mtm -66.58 -45.31 79.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.156 0.978 . . . . 0.0 112.214 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.569 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -66.48 -32.0 73.09 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.552 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' HD12 ' A' ' 84' ' ' LEU . 2.1 m-70 -59.12 -47.93 83.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.064 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.02 -41.26 95.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.286 1.035 . . . . 0.0 111.427 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -55.4 -57.99 9.57 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 108.883 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.8 -19.63 48.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.446 -169.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -61.27 -29.13 69.66 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.109 0.868 . . . . 0.0 110.246 169.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -22.48 56.28 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.68 -1.263 . . . . 0.0 109.769 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -84.48 1.19 46.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.555 1.542 . . . . 0.0 112.36 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.95 34.87 71.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 112.155 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.74 173.02 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.956 0.902 . . . . 0.0 109.85 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -118.28 143.74 46.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.37 147.71 34.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.823 1.192 . . . . 0.0 111.62 -170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 15.3 m -128.82 -179.79 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.661 0.784 . . . . 0.0 109.945 171.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 38.41 30.64 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.807 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -77.98 151.94 33.38 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.521 1.66 . . . . 0.0 108.368 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.62 146.56 60.97 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-O 116.968 -1.491 . . . . 0.0 109.461 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.49 139.48 45.1 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 CA-C-N 120.953 1.376 . . . . 0.0 110.186 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 139' ' ' PHE . 74.0 p -74.8 -6.27 48.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.228 1.811 . . . . 0.0 113.931 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.87 141.3 53.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.03 0.919 . . . . 0.0 110.033 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.04 -10.33 68.9 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.191 1.377 . . . . 0.0 113.628 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -100.82 150.04 23.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.149 1.475 . . . . 0.0 111.107 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.86 128.55 55.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.874 2.469 . . . . 0.0 105.143 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -164.57 -49.45 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.679 0.672 . . . . 0.0 110.09 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.305 2.5 t 58.7 9.05 1.03 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.149 2.58 . . . . 0.0 114.391 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.98 134.91 52.1 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 109.449 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -86.42 -11.37 6.09 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.53 2.154 . . . . 0.0 113.948 -172.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.46 -48.86 3.04 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -89.77 38.32 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.708 1.646 . . . . 0.0 112.113 -169.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.44 150.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.632 1.173 . . . . 0.0 110.166 -166.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.413 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -127.96 -172.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 126.322 1.849 . . . . 0.0 109.805 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.02 -116.64 0.85 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.123 1.369 . . . . 0.0 107.606 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.22 8.38 33.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.964 1.306 . . . . 0.0 111.957 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.17 21.0 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.875 1.226 . . . . 0.0 112.593 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -99.58 -17.36 17.88 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.781 1.232 . . . . 0.0 110.573 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.93 142.71 49.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.043 0.537 . . . . 0.0 111.305 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.3 m-85 -77.4 155.8 31.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.375 1.47 . . . . 0.0 108.926 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.413 HG12 HG23 ' A' ' 133' ' ' ILE . 30.9 m -68.24 -14.56 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.356 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -162.46 179.83 37.52 Favored Glycine 0 N--CA 1.47 0.948 0 O-C-N 119.974 -1.704 . . . . 0.0 111.987 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.9 tp -63.31 128.1 34.29 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.91 126.44 55.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.28 156.37 37.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.77 115.36 15.87 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -93.0 26.17 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.934 -168.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.7 -25.87 3.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.778 168.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.39 -36.05 3.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.343 1.429 . . . . 0.0 111.654 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -84.26 -2.82 57.63 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.863 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -55.29 -24.63 29.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.056 1.753 . . . . 0.0 112.376 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.97 -20.84 28.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.038 1.335 . . . . 0.0 112.83 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 -6.78 8.91 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.957 1.303 . . . . 0.0 113.025 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -54.23 -28.63 42.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.46 1.482 . . . . 0.0 111.329 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -52.35 -40.49 62.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.843 1.257 . . . . 0.0 111.611 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -31.49 69.25 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.33 1.852 . . . . 0.0 111.318 -177.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -92.46 -19.4 22.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.765 1.226 . . . . 0.0 110.606 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.46 -58.53 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.2 pt20 -54.04 -42.57 69.33 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.861 0.864 . . . . 0.0 112.617 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 p -68.16 -35.22 77.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 35.9 t90 -65.64 -45.02 84.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.041 0.924 . . . . 0.0 109.604 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 91.2 m -58.0 -34.59 70.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.336 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.42 -28.19 63.82 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.947 0.499 . . . . 0.0 110.386 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -83.55 -45.92 13.01 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.67 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 25' ' ' ILE . 6.3 pt -63.64 -36.96 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.945 1.702 . . . . 0.0 109.75 -171.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.9 -12.31 35.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.51 -51.23 5.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.679 1.592 . . . . 0.0 107.795 169.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.77 -22.61 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.161 0.584 . . . . 0.0 111.752 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.733 ' HG2' HG21 ' A' ' 81' ' ' ILE . 68.7 mtm -93.78 -42.11 9.3 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 124.926 1.29 . . . . 0.0 111.514 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.45 -43.8 38.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.584 0.753 . . . . 0.0 110.854 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.03 -28.86 65.82 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.217 1.407 . . . . 0.0 109.603 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -61.57 -43.54 98.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.97 -1.59 57.98 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 113.454 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.384 178.217 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.19 142.98 30.79 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 mtm -131.62 147.35 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.383 1.873 . . . . 0.0 107.858 -170.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.74 119.24 5.02 Favored Glycine 0 N--CA 1.46 0.28 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 99.49 12.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.799 1.3 . . . . 0.0 109.326 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -97.86 146.79 25.09 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.704 1.202 . . . . 0.0 109.979 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -165.27 173.11 11.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.49 132.45 6.21 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 105.889 -2.885 . . . . 0.0 105.889 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -152.52 147.86 26.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -125.23 -31.98 3.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.294 1.438 . . . . 0.0 108.876 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 p -88.36 -6.51 57.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.348 1.859 . . . . 0.0 111.618 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.25 43.8 m 71.69 10.13 6.34 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 127.754 2.422 . . . . 0.0 115.144 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -65.87 -44.79 84.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.807 1.64 . . . . 0.0 111.016 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -34.96 79.57 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -65.45 -46.97 77.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.014 0.926 . . . . 0.0 110.422 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.0 mtm -63.89 -39.4 94.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.388 0.54 . . . . 0.0 110.9 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.02 99.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.739 172.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.39 76.83 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.928 0.891 . . . . 0.0 110.539 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -57.21 -47.32 81.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.013 0.525 . . . . 0.0 109.69 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.61 -54.02 45.82 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 124.598 1.186 . . . . 0.0 108.525 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -52.94 -56.78 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 118.733 0.697 . . . . 0.0 109.562 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -38.98 72.68 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.262 0.625 . . . . 0.0 110.529 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -46.69 73.05 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.745 0.418 . . . . 0.0 111.275 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 158' ' ' GLN . 16.0 mt -66.17 -48.15 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.785 1.234 . . . . 0.0 108.704 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.97 -50.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.768 0.827 . . . . 0.0 110.415 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.98 115.22 0.73 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 170.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.06 3.47 3.95 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.479 2.786 . . . . 0.0 112.788 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.12 -34.35 66.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.036 1.334 . . . . 0.0 109.236 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 -23.49 3.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.838 1.655 . . . . 0.0 111.422 -169.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.55 141.04 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.696 1.589 . . . . 0.0 109.352 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -130.23 128.61 42.01 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.216 1.007 . . . . 0.0 110.043 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.38 145.26 51.24 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.98 0.912 . . . . 0.0 111.216 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -148.66 112.71 5.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -93.3 116.59 29.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -67.15 -11.12 56.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.768 -174.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -58.72 -25.82 63.32 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.6 . . . . 0.0 111.618 168.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -134.8 -31.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.804 0.842 . . . . 0.0 111.85 -167.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.12 154.12 18.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.658 1.183 . . . . 0.0 112.05 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -96.28 134.39 23.64 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 125.153 1.381 . . . . 0.0 109.715 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.45 -6.62 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 112.366 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -49.22 -40.03 32.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.441 1.473 . . . . 0.0 111.526 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -23.09 67.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -14.6 31.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.374 1.07 . . . . 0.0 112.378 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.97 -25.51 61.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.053 -1.029 . . . . 0.0 110.615 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -75.89 -49.89 16.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.23 0.923 . . . . 0.0 110.24 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -66.73 147.68 52.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.436 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.0 -28.06 60.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.829 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 49' ' ' LEU . 38.7 t -144.95 142.56 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -168.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -127.84 160.28 32.27 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.681 0.673 . . . . 0.0 111.133 173.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.26 123.66 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 166.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -121.53 145.69 47.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.04 150.66 22.23 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.668 -1.253 . . . . 0.0 114.855 173.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -133.26 135.11 24.93 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.382 1.873 . . . . 0.0 109.453 -169.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.11 141.45 9.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 N-CA-C 107.64 -1.716 . . . . 0.0 107.64 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.0 m -86.33 104.92 16.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -86.89 168.77 13.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.926 1.29 . . . . 0.0 109.613 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 19.72 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.483 3.113 . . . . 0.0 115.878 166.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 56.24 72.39 0.5 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.338 1.055 . . . . 0.0 112.279 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.79 11.58 78.01 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.46 149.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.61 1.195 . . . . 0.0 110.635 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mt -84.72 153.51 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 172.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -62.19 143.47 56.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.72 -27.23 68.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.39 -28.94 31.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.635 -0.666 . . . . 0.0 110.653 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.2 m95 -65.55 -44.02 88.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 169.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -55.92 -37.78 69.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.37 0.532 . . . . 0.0 110.92 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.8 73.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.947 0.499 . . . . 0.0 111.761 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 m -99.64 -11.85 8.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.727 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.567 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -53.87 -28.81 38.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.184 1.793 . . . . 0.0 111.606 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.34 -43.22 64.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.267 1.427 . . . . 0.0 111.125 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.33 -31.03 70.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 117.772 -1.108 . . . . 0.0 111.843 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.1 mt -56.5 -32.76 65.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.863 1.21 . . . . 0.0 110.923 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.94 -28.53 66.73 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.375 0.67 . . . . 0.0 111.43 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.02 -25.58 34.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.327 0.651 . . . . 0.0 111.193 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 159.6 34.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.972 1.367 . . . . 0.0 112.511 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.5 98.3 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.678 -2.056 . . . . 0.0 108.694 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.09 8.8 11.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.4 120.52 12.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.4 12.85 83.93 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.984 1.278 . . . . 0.0 113.88 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -81.45 150.76 28.17 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 117.796 0.798 . . . . 0.0 109.309 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.749 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.8 mt -87.13 141.03 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.52 121.29 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 124.87 1.268 . . . . 0.0 108.052 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -97.95 115.73 28.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.93 -1.106 . . . . 0.0 108.328 168.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.54 HD12 ' ND1' ' A' ' 105' ' ' HIS . 51.1 mt -91.2 140.4 29.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.195 0.907 . . . . 0.0 112.448 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -139.73 157.83 45.1 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.455 1.502 . . . . 0.0 109.405 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.02 179.53 35.5 Favored Glycine 0 CA--C 1.512 -0.129 0 O-C-N 120.668 -1.27 . . . . 0.0 112.619 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.83 153.58 40.83 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.949 0.9 . . . . 0.0 109.35 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.41 -167.98 28.89 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.85 136.19 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.18 -24.25 26.19 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.052 0.941 . . . . 0.0 113.356 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.8 mt -81.14 -33.25 33.29 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.779 1.172 . . . . 0.0 112.71 -169.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.1 -22.5 32.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.102 0.858 . . . . 0.0 111.039 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -125.23 -87.88 0.6 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.0 -47.95 1.98 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 128.41 2.91 . . . . 0.0 108.866 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.72 -28.84 69.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.837 1.655 . . . . 0.0 110.725 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -117.46 9.14 13.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.205 1.402 . . . . 0.0 112.133 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -47.65 122.61 5.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.034 1.334 . . . . 0.0 109.582 169.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.22 25.62 5.95 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.403 1.481 . . . . 0.0 113.379 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.95 -36.97 86.09 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.98 -30.95 71.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.886 -0.509 . . . . 0.0 112.043 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -63.0 -45.69 91.22 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.146 0.978 . . . . 0.0 111.009 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.13 96.11 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.9 mtm -67.01 -44.39 80.44 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.132 0.966 . . . . 0.0 112.115 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.567 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -64.64 -33.04 75.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.924 0.784 . . . . 0.0 111.55 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.54 ' ND1' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -60.23 -47.49 85.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.22 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.21 -40.8 94.65 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.581 1.153 . . . . 0.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 14.1 tptt -55.21 -60.07 3.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.784 1.234 . . . . 0.0 108.795 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.29 -19.21 54.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.063 -169.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 t -61.2 -28.73 69.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.088 0.858 . . . . 0.0 110.274 169.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -21.84 55.59 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.733 -1.229 . . . . 0.0 109.992 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -85.24 1.59 47.56 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.642 1.577 . . . . 0.0 112.659 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.14 34.36 75.64 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.419 0.554 . . . . 0.0 111.897 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -86.26 170.33 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.979 0.912 . . . . 0.0 109.449 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.48 140.8 48.97 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 168.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -105.16 148.25 27.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.598 0.635 . . . . 0.0 110.531 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.1 m -126.97 177.43 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.22 39.18 27.59 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-O 118.441 -1.199 . . . . 0.0 113.983 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -76.35 151.7 36.57 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.704 1.752 . . . . 0.0 108.182 169.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.48 146.25 61.1 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.653 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.56 139.41 37.41 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.128 1.439 . . . . 0.0 109.52 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 139' ' ' PHE . 64.4 p -76.28 -5.06 45.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.019 1.728 . . . . 0.0 113.334 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.43 140.04 58.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.178 0.99 . . . . 0.0 109.703 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.14 -8.95 61.97 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.378 1.466 . . . . 0.0 113.891 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.44 161.94 16.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.915 1.357 . . . . 0.0 110.661 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.1 p90 -164.02 -60.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.002 0.819 . . . . 0.0 109.611 -174.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.337 2.0 t 58.06 9.94 1.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.671 2.788 . . . . 0.0 114.768 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.9 p -66.02 139.16 96.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.785 -1.197 . . . . 0.0 108.953 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.9 -15.54 3.82 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.444 2.096 . . . . 0.0 113.383 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -80.55 -47.33 1.26 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -86.88 35.94 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.072 1.848 . . . . 0.0 112.165 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.65 148.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.92 1.288 . . . . 0.0 109.556 -167.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.49 -172.95 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 125.978 1.711 . . . . 0.0 110.128 176.115 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.88 -116.22 0.83 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.302 1.441 . . . . 0.0 107.531 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.99 7.55 34.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.995 1.318 . . . . 0.0 111.879 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.45 18.85 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.998 1.285 . . . . 0.0 112.455 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.65 -17.59 17.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.645 1.178 . . . . 0.0 110.934 -172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.93 143.07 50.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.925 0.49 . . . . 0.0 111.212 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.458 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.3 m-85 -77.56 155.8 31.32 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.169 1.388 . . . . 0.0 108.658 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 133' ' ' ILE . 35.0 m -69.12 -16.35 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.763 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.88 -176.64 38.61 Favored Glycine 0 C--N 1.338 0.669 0 O-C-N 120.572 -1.33 . . . . 0.0 111.65 -172.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.2 tp -65.96 130.13 42.2 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.38 117.63 32.97 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.289 1.035 . . . . 0.0 108.27 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.03 153.66 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.317 1.047 . . . . 0.0 109.71 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.79 122.83 16.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -105.23 7.97 33.78 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.263 1.025 . . . . 0.0 110.716 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 -27.41 12.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.494 1.118 . . . . 0.0 110.39 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -124.9 -47.08 1.81 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.302 0.955 . . . . 0.0 111.025 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.18 17.14 7.37 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.7 0.8 . . . . 0.0 112.493 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -51.76 -22.88 3.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.043 0.937 . . . . 0.0 112.952 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -79.72 -25.85 41.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.846 0.858 . . . . 0.0 111.472 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -122.74 -13.12 7.98 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.241 1.017 . . . . 0.0 112.623 -171.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.1 p -55.71 -31.37 62.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.655 1.116 . . . . 0.0 110.681 -175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.58 -38.69 75.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.096 1.358 . . . . 0.0 111.476 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.46 -34.01 60.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.442 1.097 . . . . 0.0 109.414 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.72 60.26 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.676 0.79 . . . . 0.0 109.651 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.23 -60.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.1 pt20 -56.09 -40.21 73.32 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.4 m -68.65 -33.3 73.76 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.017 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 44.5 t90 -66.28 -43.37 86.57 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 174.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.6 m -58.98 -34.75 72.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.794 0.837 . . . . 0.0 110.062 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.75 -31.35 68.13 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.93 0.492 . . . . 0.0 109.989 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -79.47 -45.82 18.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.515 171.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 pt -64.69 -38.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 120.944 1.702 . . . . 0.0 110.032 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.4 -12.17 49.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.216 0.462 . . . . 0.0 112.18 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.92 -46.27 6.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.742 1.217 . . . . 0.0 107.893 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.3 -36.36 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.114 0.87 . . . . 0.0 110.719 -172.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.749 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.4 mtm -80.94 -35.15 32.66 Favored 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.941 0.896 . . . . 0.0 110.972 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -46.42 33.89 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.382 1.073 . . . . 0.0 110.335 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.1 -30.21 70.17 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.259 1.424 . . . . 0.0 110.253 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.44 ' CD2' HD11 ' A' ' 81' ' ' ILE . 64.4 t60 -63.25 -54.31 39.24 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.95 0.5 . . . . 0.0 110.293 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.31 -7.21 55.63 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -169.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 C-N-CA 123.159 0.583 . . . . 0.0 110.632 179.189 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 142.99 31.23 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -130.92 147.06 52.52 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.49 1.916 . . . . 0.0 108.18 -170.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 118.37 5.07 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-O 118.563 -1.132 . . . . 0.0 110.409 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.39 109.96 19.93 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.026 1.413 . . . . 0.0 108.573 169.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -103.25 143.91 32.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.933 1.293 . . . . 0.0 111.398 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.8 172.86 17.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.162 0.585 . . . . 0.0 110.79 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.18 139.34 8.06 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -160.52 135.29 7.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.942 1.297 . . . . 0.0 108.207 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -99.86 -27.7 13.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.226 1.011 . . . . 0.0 110.909 169.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 p -99.37 -3.15 34.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.887 1.675 . . . . 0.0 111.753 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.7 m 70.87 8.55 6.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.657 2.383 . . . . 0.0 115.126 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -63.66 -45.3 90.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.365 1.438 . . . . 0.0 110.76 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 -35.67 79.57 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.0 -46.0 91.13 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 123.463 0.705 . . . . 0.0 110.085 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.7 mtm -64.71 -39.37 93.52 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.96 -0.462 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.26 95.45 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.013 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.69 -47.69 73.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.951 0.9 . . . . 0.0 110.641 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.89 -44.23 94.33 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -63.41 -54.2 40.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 124.596 1.185 . . . . 0.0 109.321 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -52.53 -55.83 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.973 0.806 . . . . 0.0 109.614 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -39.04 79.26 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.966 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.62 -46.72 74.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.102 0.477 . . . . 0.0 111.21 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.23 -46.89 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.152 1.381 . . . . 0.0 108.484 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.37 -49.56 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.604 0.762 . . . . 0.0 110.286 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.99 115.99 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.46 1.029 . . . . 0.0 110.548 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.22 3.18 4.25 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.427 2.751 . . . . 0.0 112.48 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.82 -34.74 69.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.28 1.432 . . . . 0.0 109.253 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.84 -23.06 3.74 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.641 1.576 . . . . 0.0 111.484 -169.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.48 139.95 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 120.509 1.504 . . . . 0.0 108.652 173.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -129.14 129.54 45.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.223 1.009 . . . . 0.0 109.349 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.65 146.26 51.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.29 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -145.4 99.67 3.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -81.49 124.47 29.5 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.61 -8.62 58.15 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -37.38 62.25 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.411 1.085 . . . . 0.0 108.986 169.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -98.55 -31.48 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.884 1.673 . . . . 0.0 112.822 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.13 172.17 13.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.305 1.442 . . . . 0.0 111.299 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.0 m -92.59 155.47 42.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -79.71 -9.73 14.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.779 2.319 . . . . 0.0 111.368 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -57.1 -36.87 71.13 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.962 1.71 . . . . 0.0 111.203 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -13.15 21.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.404 1.081 . . . . 0.0 112.355 170.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -73.37 -26.4 60.99 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.798 -1.188 . . . . 0.0 111.176 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.09 -51.33 12.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.097 0.862 . . . . 0.0 110.206 -171.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -66.16 142.99 57.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.301 1.44 . . . . 0.0 109.246 -169.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.05 -27.6 61.84 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.41 144.19 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.79 152.54 51.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.2 119.65 53.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.79 144.56 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.82 148.56 19.55 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.461 -1.352 . . . . 0.0 115.839 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.17 136.67 26.52 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.94 2.096 . . . . 0.0 109.502 -169.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.04 141.21 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 N-CA-C 107.839 -1.639 . . . . 0.0 107.839 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.7 m -87.82 116.35 25.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -99.43 167.79 10.4 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.104 1.762 . . . . 0.0 110.164 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 13.16 75.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 130.093 3.357 . . . . 0.0 115.272 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 56.54 65.03 1.51 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.842 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.16 70.15 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.358 0.5 OUTLIER -94.28 152.92 18.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.381 1.073 . . . . 0.0 109.956 168.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mt -95.86 151.21 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.582 1.553 . . . . 0.0 106.812 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -59.78 140.41 56.56 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.39 -27.46 69.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.134 0.574 . . . . 0.0 111.947 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -28.92 64.69 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.979 0.511 . . . . 0.0 111.207 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.3 m95 -77.76 -42.85 32.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.676 0.79 . . . . 0.0 110.268 170.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -55.78 -35.9 66.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.597 0.635 . . . . 0.0 110.909 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.98 -31.56 72.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.89 0.876 . . . . 0.0 111.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.9 -12.37 8.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.689 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.542 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -54.25 -28.86 44.32 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.551 1.541 . . . . 0.0 111.656 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.49 -44.08 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.97 1.308 . . . . 0.0 111.025 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -69.21 -30.13 68.25 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.457 -1.259 . . . . 0.0 112.675 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.85 -31.55 64.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.186 1.357 . . . . 0.0 110.685 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.3 -28.56 67.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.878 0.871 . . . . 0.0 111.566 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.45 -24.42 36.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.642 0.777 . . . . 0.0 111.254 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.89 157.33 33.38 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 123.122 1.439 . . . . 0.0 112.503 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -90.64 95.88 10.37 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.53 7.78 12.77 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.06 120.94 13.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.83 -0.39 89.14 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 125.393 1.473 . . . . 0.0 114.824 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -72.35 150.48 43.44 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.035 0.918 . . . . 0.0 109.46 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.4 mt -88.98 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.3 t -132.67 128.03 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.427 1.091 . . . . 0.0 108.655 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.98 118.45 36.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -90.06 142.85 27.31 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.966 0.803 . . . . 0.0 111.692 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -140.59 158.76 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.079 0.952 . . . . 0.0 108.875 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.45 -179.93 39.5 Favored Glycine 0 CA--C 1.508 -0.367 0 O-C-N 120.678 -1.264 . . . . 0.0 112.125 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.39 145.2 45.36 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.71 11.79 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 169.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -159.63 135.0 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.463 1.505 . . . . 0.0 107.224 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.85 -20.81 24.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.57 -47.84 68.62 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.655 1.116 . . . . 0.0 110.608 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.88 -29.13 7.43 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.491 1.043 . . . . 0.0 112.391 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -132.27 33.95 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -166.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.43 -38.77 63.47 Favored Glycine 0 N--CA 1.47 0.939 0 CA-C-N 120.024 1.284 . . . . 0.0 111.725 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.91 -17.01 62.79 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.362 1.081 . . . . 0.0 112.737 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -128.52 14.37 6.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 112.079 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.65 123.17 2.16 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.717 1.607 . . . . 0.0 109.762 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.52 27.85 2.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.939 1.296 . . . . 0.0 112.978 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.16 -37.82 86.69 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.68 -1.263 . . . . 0.0 110.628 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.92 76.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.527 0.331 . . . . 0.0 111.454 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.681 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.2 tp -60.1 -47.41 86.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.366 1.066 . . . . 0.0 110.505 174.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.78 98.58 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.1 mtm -64.15 -45.03 90.29 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.927 0.864 . . . . 0.0 111.829 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.584 HD12 HD12 ' A' ' 53' ' ' ILE . 4.9 mt -63.3 -35.14 79.37 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.345 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.23 -43.38 95.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.202 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.82 -42.1 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.776 1.23 . . . . 0.0 111.571 175.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.89 -59.85 4.17 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.679 1.191 . . . . 0.0 108.311 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.39 -20.45 54.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.871 -169.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 t -60.98 -29.09 69.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.256 0.934 . . . . 0.0 110.499 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -22.15 53.55 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.012 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -83.66 1.6 41.62 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 125.582 1.553 . . . . 0.0 112.583 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.47 31.88 68.16 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.641 0.655 . . . . 0.0 112.207 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.22 173.12 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.004 0.922 . . . . 0.0 109.193 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.51 148.6 44.25 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.32 150.49 30.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.098 0.863 . . . . 0.0 112.275 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.1 m -128.01 -179.7 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.718 1.207 . . . . 0.0 109.059 169.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.03 35.75 37.78 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-O 118.463 -1.187 . . . . 0.0 114.165 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -79.05 145.92 33.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.711 1.755 . . . . 0.0 108.713 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -120.53 148.29 47.5 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.363 170.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.41 139.16 37.35 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 CA-C-N 120.703 1.287 . . . . 0.0 109.187 168.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.488 HG22 ' CD1' ' A' ' 139' ' ' PHE . 72.8 p -73.5 -5.7 41.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.774 1.63 . . . . 0.0 113.161 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.91 140.79 57.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.173 -0.955 . . . . 0.0 109.463 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.79 -10.34 57.15 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.307 1.432 . . . . 0.0 113.735 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.06 160.31 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.969 1.384 . . . . 0.0 110.377 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -129.15 127.62 41.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.49 -57.74 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.364 0.984 . . . . 0.0 110.487 -171.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 4.0 t 58.17 11.07 1.41 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.282 2.633 . . . . 0.0 114.567 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -63.94 132.71 95.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -83.92 -12.23 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.718 2.278 . . . . 0.0 112.694 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -80.51 -48.83 1.19 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -88.3 38.81 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.314 2.009 . . . . 0.0 112.643 -168.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 146.72 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.205 -0.934 . . . . 0.0 110.056 -167.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.2 -172.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.107 1.763 . . . . 0.0 109.594 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.47 -117.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.988 1.315 . . . . 0.0 107.588 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -104.97 7.74 34.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.753 1.221 . . . . 0.0 112.011 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.02 20.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.572 1.082 . . . . 0.0 112.749 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -100.04 -17.47 17.48 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.746 1.218 . . . . 0.0 110.767 -172.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.55 144.67 50.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.306 0.642 . . . . 0.0 110.88 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.1 m-85 -79.93 154.64 28.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.147 1.379 . . . . 0.0 110.048 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.79 -12.61 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.7 1.2 . . . . 0.0 112.654 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.75 -177.69 44.06 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 119.479 1.036 . . . . 0.0 111.83 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.3 tp -64.67 127.84 33.24 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.71 107.55 16.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.48 155.21 17.03 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.56 115.89 8.51 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.55 27.13 2.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.489 -168.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 t -133.31 -19.89 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 -45.02 2.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.428 1.467 . . . . 0.0 109.309 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -79.62 -0.44 33.75 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.416 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.18 -25.27 21.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.018 1.735 . . . . 0.0 112.787 -171.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.7 -20.68 25.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.76 1.224 . . . . 0.0 112.738 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pp -124.48 -6.98 7.52 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.215 1.406 . . . . 0.0 113.088 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.7 m -53.49 -32.12 48.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.037 1.289 . . . . 0.0 110.24 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.94 -40.79 81.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.125 0.57 . . . . 0.0 111.455 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.68 -34.53 67.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.134 1.374 . . . . 0.0 109.564 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -78.83 -28.58 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.143 0.977 . . . . 0.0 109.224 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.71 -60.62 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -57.1 -41.08 78.27 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 118.727 0.694 . . . . 0.0 112.479 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -64.77 -36.22 83.61 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.536 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 39.9 t90 -66.35 -45.02 81.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 110.037 176.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.1 m -56.53 -37.06 69.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.168 0.987 . . . . 0.0 109.506 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.71 -29.06 66.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.474 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -80.74 -45.76 16.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.044 -0.979 . . . . 0.0 111.22 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 25' ' ' ILE . 4.9 pt -64.6 -38.7 83.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 CA-C-N 120.84 1.654 . . . . 0.0 110.238 -171.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.17 -15.2 59.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.304 0.642 . . . . 0.0 112.034 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.16 -45.88 6.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.06 -41.59 88.31 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 118.704 0.684 . . . . 0.0 109.574 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.4 mtm -76.27 -38.01 56.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.706 0.803 . . . . 0.0 110.837 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.76 66.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.813 0.845 . . . . 0.0 109.927 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.58 -30.38 70.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.452 1.501 . . . . 0.0 109.921 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -63.28 -47.46 82.23 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 118.558 0.617 . . . . 0.0 110.502 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -2.74 47.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.775 1.23 . . . . 0.0 113.688 -175.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.418 179.519 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.95 141.46 44.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.138 1.375 . . . . 0.0 108.652 169.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 48' ' ' VAL . 15.3 mtm -120.68 147.59 45.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.291 2.237 . . . . 0.0 108.657 -169.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.84 120.1 5.61 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.666 -1.075 . . . . 0.0 110.711 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 116.03 27.28 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 118.828 1.314 . . . . 0.0 108.601 169.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.37 147.25 35.59 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.807 1.643 . . . . 0.0 111.403 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -161.99 173.88 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.023 0.929 . . . . 0.0 110.81 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.35 138.51 7.98 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -140.68 131.61 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.34 1.456 . . . . 0.0 108.715 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.4 m -90.33 -36.85 14.42 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -94.58 -84.99 0.31 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.2 p -174.68 -6.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.739 2.016 . . . . 0.0 113.106 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -68.85 -42.39 77.18 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 119.839 -1.788 . . . . 0.0 112.249 -168.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -35.78 82.28 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.25 -47.55 83.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.4 mtm -66.69 -41.06 88.63 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.906 -0.496 . . . . 0.0 111.295 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.19 92.33 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 118.835 -0.603 . . . . 0.0 110.655 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.41 79.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.979 0.912 . . . . 0.0 110.872 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -58.68 -43.97 90.09 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.09 -55.32 26.42 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.813 1.245 . . . . 0.0 108.81 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -52.51 -56.66 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 119.018 0.826 . . . . 0.0 109.832 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -38.98 77.12 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.759 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.51 -47.22 70.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 122.737 0.415 . . . . 0.0 111.553 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -66.12 -45.56 90.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.743 1.217 . . . . 0.0 108.456 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 164' ' ' ILE . 78.1 mt -72.35 -51.81 27.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.636 0.774 . . . . 0.0 110.484 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.3 114.06 0.75 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.432 1.015 . . . . 0.0 110.592 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.28 3.61 3.97 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.351 2.701 . . . . 0.0 112.693 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.97 -35.05 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.222 1.409 . . . . 0.0 109.118 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -24.7 5.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.876 1.67 . . . . 0.0 111.438 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.77 140.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 121.103 1.774 . . . . 0.0 109.242 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 m -130.69 130.13 43.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.541 1.137 . . . . 0.0 109.788 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.79 148.53 46.18 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.734 0.814 . . . . 0.0 112.06 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.56 115.14 10.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.872 1.669 . . . . 0.0 108.666 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.16 100.57 9.15 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.96 -21.65 66.43 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.844 1.656 . . . . 0.0 112.847 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -60.41 -28.84 68.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 112.468 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -109.89 -32.51 7.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.339 1.056 . . . . 0.0 112.993 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.63 167.62 16.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.636 1.175 . . . . 0.0 111.476 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -93.46 147.41 33.62 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.812 1.645 . . . . 0.0 109.07 -170.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -76.0 -1.52 11.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.588 1.525 . . . . 0.0 111.107 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -55.97 -33.74 65.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 122.346 2.339 . . . . 0.0 111.908 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.39 -19.87 65.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.425 ' CG ' HD13 ' A' ' 49' ' ' LEU . 47.5 ttm -58.91 -16.04 15.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.913 2.085 . . . . 0.0 111.627 169.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.37 -27.69 56.51 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.241 -0.912 . . . . 0.0 110.753 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.88 -51.55 12.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.751 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.36 133.18 47.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.01 -10.2 53.71 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.22 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 3' ' ' MET . 71.4 t -134.09 143.84 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.9 mt -140.34 149.05 42.24 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.8 121.63 56.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.63 147.08 44.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 85' ' ' TYR . . . -151.93 147.49 17.36 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 119.589 -1.291 . . . . 0.0 115.66 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -135.5 135.93 23.13 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 126.894 2.078 . . . . 0.0 109.602 -171.56 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.97 144.02 7.07 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 165.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.9 m -88.73 117.21 27.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -98.77 169.95 9.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.592 1.157 . . . . 0.0 110.561 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 22.72 64.99 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.915 2.886 . . . . 0.0 115.517 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.75 70.8 0.6 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.586 1.154 . . . . 0.0 112.097 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.42 17.3 79.77 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.81 151.26 27.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.314 1.054 . . . . 0.0 109.555 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.31 153.03 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -61.14 141.02 57.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.862 0.839 . . . . 0.0 108.774 170.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.62 -27.4 68.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -166.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.11 -23.63 35.58 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.063 0.545 . . . . 0.0 110.391 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.529 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.5 m95 -73.44 -43.95 59.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 169.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -53.51 -34.24 57.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.336 0.655 . . . . 0.0 111.084 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.18 71.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 111.862 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 m -104.98 -9.36 9.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.59 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.6 t-105 -53.09 -29.49 30.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.708 1.603 . . . . 0.0 111.932 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.42 -43.81 76.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.33 -29.76 66.55 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.247 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -58.02 -31.03 66.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.828 1.194 . . . . 0.0 111.157 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.77 -26.92 62.63 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.549 0.74 . . . . 0.0 111.558 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.22 -22.34 35.96 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.316 0.646 . . . . 0.0 110.934 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.1 mt -73.93 156.89 37.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.982 1.372 . . . . 0.0 112.313 -167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.08 97.45 11.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.666 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -119.26 8.92 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.08 123.9 20.25 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -172.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.36 9.0 87.08 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.494 1.521 . . . . 0.0 114.329 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.48 146.94 34.12 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.646 0.723 . . . . 0.0 109.617 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.9 mt -85.62 139.02 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 167.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.41 132.43 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 124.867 1.267 . . . . 0.0 109.143 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.03 119.46 37.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.69 143.82 26.49 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.122 0.874 . . . . 0.0 112.032 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 24.0 p90 -139.94 157.81 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.095 0.958 . . . . 0.0 109.253 169.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.68 177.04 38.1 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 120.452 -1.405 . . . . 0.0 112.849 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.69 157.24 36.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.195 0.998 . . . . 0.0 108.478 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.12 -152.75 9.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -154.73 135.13 13.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.548 1.539 . . . . 0.0 107.493 166.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -22.83 24.7 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.733 1.213 . . . . 0.0 113.277 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.5 mt -77.59 -40.19 43.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 120.016 1.28 . . . . 0.0 111.556 -171.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.43 -28.4 11.57 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.814 1.197 . . . . 0.0 112.166 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.78 34.61 3.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -168.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.06 61.11 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 119.99 1.268 . . . . 0.0 111.381 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.53 -16.4 55.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.757 0.778 . . . . 0.0 112.169 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.7 10.01 7.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.506 1.922 . . . . 0.0 112.112 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -47.5 124.01 6.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.38 1.472 . . . . 0.0 109.411 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.55 27.48 5.13 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 124.42 1.075 . . . . 0.0 112.781 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.09 -37.39 87.34 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.505 -1.372 . . . . 0.0 110.605 -172.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.36 75.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.917 0.487 . . . . 0.0 111.696 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.657 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -59.72 -47.62 84.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.167 0.987 . . . . 0.0 110.29 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.78 97.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.4 mtm -64.97 -42.76 94.3 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 117.853 0.827 . . . . 0.0 111.864 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.659 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 mt -66.0 -33.78 76.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.814 1.188 . . . . 0.0 111.856 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -62.3 -40.64 96.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.741 -0.599 . . . . 0.0 110.334 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.81 -35.07 69.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.432 1.493 . . . . 0.0 111.813 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HB3' HD23 ' A' ' 104' ' ' LEU . 20.6 tptt -58.11 -43.98 87.48 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.614 0.765 . . . . 0.0 109.916 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.4 mt -98.58 -18.16 18.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.917 -1.039 . . . . 0.0 112.446 -170.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p -60.64 -32.23 71.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 111.611 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -79.8 -18.74 50.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.1 0.56 . . . . 0.0 110.23 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -79.33 1.42 25.18 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.408 1.483 . . . . 0.0 111.969 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.83 63.86 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 118.601 0.637 . . . . 0.0 111.883 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.2 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.827 0.851 . . . . 0.0 109.376 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -118.27 141.33 48.63 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -106.15 147.14 29.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.336 0.971 . . . . 0.0 111.526 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.2 m -127.35 177.76 5.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.715 1.206 . . . . 0.0 108.921 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.35 35.73 32.63 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.389 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -79.86 146.87 31.97 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.888 1.844 . . . . 0.0 109.138 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -122.82 148.57 54.09 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 124.986 1.314 . . . . 0.0 108.488 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.71 138.07 31.18 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.585 1.524 . . . . 0.0 110.465 169.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.526 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.0 p -77.99 -6.6 54.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.381 1.872 . . . . 0.0 112.939 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.33 139.19 58.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.21 1.005 . . . . 0.0 110.201 -173.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.9 -3.46 50.73 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.454 1.502 . . . . 0.0 113.519 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.94 164.14 13.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.092 1.357 . . . . 0.0 110.799 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -128.89 124.7 35.9 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.105 1.762 . . . . 0.0 107.568 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 127' ' ' THR . 11.2 p90 -165.2 -57.57 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.907 0.883 . . . . 0.0 108.929 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 126' ' ' PHE 0.339 2.1 t 59.71 10.52 2.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.873 2.869 . . . . 0.0 114.895 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.7 p -67.33 139.12 94.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.867 -1.146 . . . . 0.0 108.683 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -86.91 -14.79 4.08 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.245 1.963 . . . . 0.0 113.532 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -81.7 -46.68 1.05 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -86.31 38.35 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.979 1.786 . . . . 0.0 112.395 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 146.52 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.183 0.993 . . . . 0.0 108.988 -167.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -172.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.737 1.615 . . . . 0.0 109.708 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.98 -116.01 0.82 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.479 1.512 . . . . 0.0 107.371 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.03 7.63 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.886 1.274 . . . . 0.0 111.881 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.72 20.84 17.97 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.94 1.257 . . . . 0.0 112.601 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.56 -16.8 17.36 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.945 1.298 . . . . 0.0 110.844 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.99 145.3 50.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.427 0.691 . . . . 0.0 110.882 174.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.7 m-85 -80.18 153.91 28.31 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.715 1.606 . . . . 0.0 109.295 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.4 m -66.7 -12.55 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 112.599 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.99 -177.42 43.16 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.523 1.056 . . . . 0.0 112.019 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 20.0 tp -66.15 129.64 40.52 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.99 123.53 48.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 157.63 27.76 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.478 1.111 . . . . 0.0 108.136 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.93 120.04 11.43 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -98.19 12.8 33.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -21.5 11.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.196 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.4 -40.7 1.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.366 1.439 . . . . 0.0 113.249 172.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -80.63 4.92 17.02 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.386 0.994 . . . . 0.0 112.57 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.12 -25.02 28.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.439 1.472 . . . . 0.0 112.663 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.77 -26.05 49.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.749 1.22 . . . . 0.0 111.5 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.21 -6.49 6.56 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.321 1.049 . . . . 0.0 112.753 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.1 m -51.76 -33.8 36.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.208 1.367 . . . . 0.0 110.172 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.48 -42.65 78.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.836 1.255 . . . . 0.0 111.516 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -75.08 -33.43 61.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.797 1.239 . . . . 0.0 109.817 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -76.26 -30.98 58.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.704 -0.623 . . . . 0.0 109.651 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.9 -55.96 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.403 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.8 pt20 -58.18 -43.1 87.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -65.21 -35.19 80.28 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.971 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.45 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.3 t90 -66.05 -45.3 81.9 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.841 0.829 . . . . 0.0 110.247 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 84.5 m -57.09 -36.48 70.64 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.161 0.985 . . . . 0.0 109.416 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.44 -28.65 66.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.323 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -81.27 -45.36 16.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.407 171.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 25' ' ' ILE . 4.5 pt -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 120.923 1.692 . . . . 0.0 110.008 -172.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.58 -14.14 56.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.835 -0.541 . . . . 0.0 112.108 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -94.47 -46.9 6.8 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.7 -34.79 76.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.681 0.673 . . . . 0.0 110.477 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -81.39 -43.12 19.44 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.32 1.048 . . . . 0.0 110.182 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.12 72.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.054 0.942 . . . . 0.0 111.222 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.06 -30.51 66.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.802 1.241 . . . . 0.0 109.607 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.41 ' CD2' HD11 ' A' ' 81' ' ' ILE . 67.5 t60 -66.45 -47.61 72.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -12.0 61.23 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.506 1.122 . . . . 0.0 113.388 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 C-N-CA 122.962 0.505 . . . . 0.0 110.793 -178.49 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.48 144.08 29.8 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 mtm -131.21 146.11 52.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.621 1.969 . . . . 0.0 107.854 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.42 117.22 4.98 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-O 118.478 -1.179 . . . . 0.0 110.628 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.63 115.41 26.14 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.245 1.522 . . . . 0.0 108.461 169.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.39 146.36 37.27 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.198 1.399 . . . . 0.0 111.382 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -161.93 176.44 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.166 0.986 . . . . 0.0 110.755 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.7 144.51 12.53 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 p -152.67 139.82 19.32 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.64 1.22 . . . . 0.0 112.647 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.7 m -99.87 -34.72 10.02 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.7 p -93.59 0.59 56.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.133 0.973 . . . . 0.0 111.86 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m 65.4 13.36 8.78 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.869 2.068 . . . . 0.0 113.538 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.37 -48.43 77.96 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.217 -1.552 . . . . 0.0 111.149 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -32.82 74.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.27 -48.75 80.46 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 109.679 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -65.35 -40.41 93.59 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.05 -0.406 . . . . 0.0 111.133 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.52 98.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.872 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.03 -47.42 77.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.279 1.032 . . . . 0.0 110.764 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.89 -45.23 90.74 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HD12 ' A' ' 24' ' ' ILE . 58.9 mttm -61.77 -56.5 18.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 124.825 1.328 . . . . 0.0 108.994 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -51.96 -56.08 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 118.649 0.659 . . . . 0.0 110.108 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.93 78.31 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.27 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.06 -47.47 74.22 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.802 0.441 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -65.74 -47.42 85.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.502 1.121 . . . . 0.0 108.966 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 164' ' ' ILE . 78.8 mt -72.35 -49.26 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.605 0.762 . . . . 0.0 110.173 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.09 115.57 0.89 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.599 1.095 . . . . 0.0 110.47 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.38 3.85 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.412 2.742 . . . . 0.0 112.814 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.68 -34.55 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.943 1.297 . . . . 0.0 109.054 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.99 -21.35 4.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 111.639 -169.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.21 141.33 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.592 1.542 . . . . 0.0 108.944 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -131.56 128.83 40.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.436 1.094 . . . . 0.0 109.974 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.49 148.78 46.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.932 0.893 . . . . 0.0 112.034 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.73 110.89 6.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.582 1.953 . . . . 0.0 107.081 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.55 109.97 19.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.0 mt -66.17 -8.54 24.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -58.93 -29.14 66.88 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.113 0.87 . . . . 0.0 111.425 169.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -132.45 -33.79 1.24 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 111.995 -172.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -80.95 139.96 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 m -84.27 139.94 39.18 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -74.31 -0.39 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.256 1.484 . . . . 0.0 111.107 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -56.84 -33.16 66.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.939 2.154 . . . . 0.0 112.208 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -19.45 65.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.421 ' HG2' HD13 ' A' ' 49' ' ' LEU . 42.9 ttm -58.59 -16.22 14.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.752 2.021 . . . . 0.0 111.435 169.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 69.0 mt-10 -74.1 -29.29 61.78 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.028 -1.045 . . . . 0.0 111.095 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -76.75 -47.15 22.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.852 0.751 . . . . 0.0 109.974 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.26 139.23 57.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.601 -1.181 . . . . 0.0 107.968 -169.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.54 -26.96 61.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.228 0.537 . . . . 0.0 110.272 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -141.35 147.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.421 HD13 ' HG2' ' A' ' 43' ' ' MET . 6.3 mt -139.29 150.59 45.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.964 0.505 . . . . 0.0 109.985 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.4 120.48 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 170.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.29 138.61 53.59 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 108.629 -172.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.23 122.56 3.5 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-O 118.239 -1.312 . . . . 0.0 112.442 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.692 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -124.99 130.93 24.04 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 118.613 1.206 . . . . 0.0 109.963 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -84.84 146.63 10.47 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 108.387 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 m -88.33 129.57 35.35 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -119.7 170.65 9.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.091 1.757 . . . . 0.0 109.618 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 27.36 57.65 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.255 2.622 . . . . 0.0 115.265 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 56.85 76.99 0.28 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.983 1.313 . . . . 0.0 112.247 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.42 14.23 71.68 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.41 160.07 21.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.603 1.161 . . . . 0.0 109.666 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -97.4 152.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.55 144.0 55.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 171.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.54 -28.59 69.96 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.164 0.586 . . . . 0.0 112.354 -168.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.73 -24.33 63.54 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.925 -0.484 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.492 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.0 m95 -83.37 -42.8 16.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.933 0.893 . . . . 0.0 110.866 170.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.55 -35.49 65.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.624 0.647 . . . . 0.0 110.818 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.02 71.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.596 1.158 . . . . 0.0 111.88 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 m -106.07 -11.64 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.68 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.544 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -52.89 -29.06 26.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.693 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.79 -46.56 65.47 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.15 1.38 . . . . 0.0 111.248 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.79 -29.53 69.5 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 117.435 -1.269 . . . . 0.0 112.14 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 mt -56.36 -35.91 68.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.798 1.181 . . . . 0.0 110.867 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.48 -33.14 75.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.384 0.674 . . . . 0.0 111.701 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.78 -12.92 43.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 111.184 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.28 171.38 12.24 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.381 1.086 . . . . 0.0 110.65 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 6.2 t30 -111.02 98.82 7.82 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.812 1.645 . . . . 0.0 107.641 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -118.77 6.29 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -65.12 112.86 3.58 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.48 -3.21 68.5 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.849 1.69 . . . . 0.0 116.076 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -75.36 155.12 36.8 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.537 1.168 . . . . 0.0 110.115 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.684 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.0 mt -89.41 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.44 133.33 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.676 1.19 . . . . 0.0 109.416 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.8 117.41 33.34 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.11 142.75 27.41 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 119.023 0.829 . . . . 0.0 111.752 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.75 159.89 41.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.222 1.009 . . . . 0.0 108.878 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.02 177.51 39.05 Favored Glycine 0 N--CA 1.447 -0.578 0 O-C-N 121.14 -0.975 . . . . 0.0 112.207 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.77 153.67 42.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.17 -158.15 10.75 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -152.2 141.08 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.094 1.358 . . . . 0.0 109.141 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.35 -22.36 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.37 -39.92 70.95 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.931 1.241 . . . . 0.0 112.265 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.97 -18.44 31.86 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.171 0.891 . . . . 0.0 111.512 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.93 -89.91 0.54 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.939 1.296 . . . . 0.0 108.13 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.58 -50.21 2.47 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 128.497 2.951 . . . . 0.0 107.936 -168.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.77 -28.42 67.6 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.365 1.866 . . . . 0.0 110.767 -175.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -117.53 6.61 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.651 1.181 . . . . 0.0 112.349 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -43.96 121.87 2.61 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.496 1.518 . . . . 0.0 109.592 168.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 52.85 25.88 4.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.588 1.155 . . . . 0.0 113.512 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.47 -36.0 82.59 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.516 -1.365 . . . . 0.0 110.603 -172.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.69 74.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.255 0.622 . . . . 0.0 112.06 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.692 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -60.48 -46.49 89.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.141 0.976 . . . . 0.0 110.413 176.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.21 97.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 mtm -67.14 -42.73 83.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.841 0.821 . . . . 0.0 112.239 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.577 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -63.49 -36.15 82.82 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.201 172.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -63.6 -41.25 98.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.973 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.18 -43.19 92.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -55.6 -58.44 7.8 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.97 -20.27 58.03 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.728 -0.608 . . . . 0.0 110.385 -169.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t -62.95 -29.66 70.97 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.846 0.748 . . . . 0.0 110.022 167.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.0 -27.38 39.58 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.047 1.294 . . . . 0.0 108.427 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 14.8 mmmt -73.58 2.47 7.91 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.503 1.121 . . . . 0.0 113.176 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.35 85.96 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.427 1.012 . . . . 0.0 112.378 169.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.66 173.75 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.795 0.838 . . . . 0.0 109.304 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 145.75 45.2 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 165.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.96 150.1 28.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.854 0.752 . . . . 0.0 111.878 -169.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.7 m -127.47 179.59 3.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 109.304 169.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 36.24 43.4 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.532 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -71.73 153.52 41.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.091 1.445 . . . . 0.0 108.139 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.23 145.87 58.56 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-O 116.944 -1.503 . . . . 0.0 108.835 169.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.68 140.46 39.29 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 CA-C-N 120.895 1.355 . . . . 0.0 109.618 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.499 HG22 ' CD1' ' A' ' 139' ' ' PHE . 80.6 p -74.98 -6.48 49.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 113.583 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.1 141.06 57.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.053 0.93 . . . . 0.0 110.246 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.55 -8.83 66.93 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.005 1.764 . . . . 0.0 113.816 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -89.76 163.17 15.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.746 1.273 . . . . 0.0 110.622 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -126.48 123.96 39.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 169.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -163.9 -50.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.952 0.796 . . . . 0.0 110.275 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.303 2.8 t 57.79 8.93 0.77 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.479 2.712 . . . . 0.0 114.512 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -83.55 144.51 46.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.977 1.311 . . . . 0.0 110.861 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -88.94 -12.52 3.4 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.895 2.397 . . . . 0.0 113.775 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -50.91 3.77 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 117.916 -1.04 . . . . 0.0 113.402 -168.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -88.29 38.98 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.751 1.634 . . . . 0.0 112.091 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 148.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.083 -1.011 . . . . 0.0 110.241 -166.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.37 -172.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 126.361 1.864 . . . . 0.0 109.981 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.03 -116.03 0.81 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.486 1.515 . . . . 0.0 107.327 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.09 8.14 34.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.579 1.152 . . . . 0.0 111.889 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.87 21.03 19.69 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.993 1.282 . . . . 0.0 112.506 -173.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -100.06 -18.16 17.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 110.837 -172.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.86 143.31 50.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.303 0.641 . . . . 0.0 111.328 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.8 m-85 -78.14 155.39 30.5 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.076 1.35 . . . . 0.0 109.457 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.5 -14.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.546 1.138 . . . . 0.0 112.804 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.32 -178.3 42.4 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 119.65 1.114 . . . . 0.0 112.184 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.97 130.29 42.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.33 117.96 31.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 142' ' ' LEU . 71.6 mt -117.13 152.52 34.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.433 1.093 . . . . 0.0 109.164 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.72 124.06 13.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -99.26 15.05 27.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.235 1.014 . . . . 0.0 110.576 -169.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 t -123.04 -22.27 5.25 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 -48.54 2.96 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.759 1.223 . . . . 0.0 108.041 171.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -105.21 22.64 15.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.641 1.577 . . . . 0.0 112.474 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -52.6 -25.78 11.62 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.826 0.739 . . . . 0.0 112.279 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.09 -25.32 52.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.781 . . . . 0.0 111.478 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -125.02 -14.44 6.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.5 m -57.67 -28.95 64.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.098 1.317 . . . . 0.0 109.769 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.23 -49.21 78.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.595 0.758 . . . . 0.0 111.06 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -66.7 -33.17 75.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.081 0.943 . . . . 0.0 109.329 -171.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -79.13 -23.46 44.01 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.219 -174.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.59 -53.71 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -53.64 -47.07 70.67 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 123.636 0.775 . . . . 0.0 110.136 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.9 m -66.83 -36.79 83.17 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.146 0.278 . . . . 0.0 110.521 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 29.5 t90 -65.79 -46.06 80.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.716 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -58.04 -34.55 70.2 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -31.81 71.9 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.028 0.531 . . . . 0.0 110.601 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -83.03 -45.52 13.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.942 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 25' ' ' ILE . 5.7 pt -64.24 -37.82 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 120.849 1.658 . . . . 0.0 110.048 -170.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.83 -11.8 30.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -49.82 5.72 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 125.704 1.601 . . . . 0.0 108.088 169.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.33 -28.44 70.01 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.951 -0.468 . . . . 0.0 110.913 -169.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.684 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.2 mtm -89.34 -40.71 12.59 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 124.132 0.973 . . . . 0.0 111.429 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.28 33.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.575 0.75 . . . . 0.0 110.784 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.0 -29.72 63.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.233 1.413 . . . . 0.0 109.452 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -63.06 -49.79 73.16 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.227 0.467 . . . . 0.0 109.914 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -2.4 34.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.332 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.648 179.824 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.5 141.5 31.6 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtm -129.17 145.05 51.4 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.582 1.953 . . . . 0.0 108.489 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.48 115.52 4.09 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.99 121.63 28.05 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -115.63 144.7 43.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.335 1.054 . . . . 0.0 111.679 171.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -156.62 169.88 23.67 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.762 1.225 . . . . 0.0 110.29 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.33 138.57 8.02 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 p -142.05 136.47 30.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.707 1.203 . . . . 0.0 109.814 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -92.75 -39.23 11.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.14 0.976 . . . . 0.0 110.09 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -85.99 -86.34 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 p -177.76 4.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.04 3.336 . . . . 0.0 110.763 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -67.27 -45.43 76.66 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.091 -1.631 . . . . 0.0 111.59 -166.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -34.28 77.11 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -60.98 -47.67 85.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.302 0.641 . . . . 0.0 110.151 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -64.89 -40.43 95.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 122.217 -0.302 . . . . 0.0 111.035 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.07 97.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.824 -0.607 . . . . 0.0 110.623 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.97 -45.7 78.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.085 0.954 . . . . 0.0 110.971 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.86 -45.21 93.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.7 mttm -63.43 -57.55 9.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.699 1.249 . . . . 0.0 108.84 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -51.92 -55.53 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 118.248 0.476 . . . . 0.0 110.015 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -38.23 74.52 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.868 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.77 -48.79 65.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.826 0.451 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.6 mt -65.76 -46.32 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 108.788 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 164' ' ' ILE . 72.3 mt -71.14 -50.14 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 110.038 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.08 114.9 0.8 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.57 1.33 5.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.326 2.684 . . . . 0.0 112.458 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.22 -33.83 65.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 109.404 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.04 -19.63 3.94 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.43 -169.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.63 141.61 15.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.702 1.592 . . . . 0.0 108.755 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.6 m -131.66 129.03 40.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.75 145.53 25.56 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.17 127.55 30.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.007 2.123 . . . . 0.0 107.935 -168.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.26 88.2 3.07 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.724 1.609 . . . . 0.0 107.373 -168.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.45 -16.11 21.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.925 1.29 . . . . 0.0 114.352 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -13.55 62.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.721 -0.612 . . . . 0.0 112.45 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -129.75 -35.43 1.68 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.313 1.445 . . . . 0.0 112.145 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -81.56 145.08 30.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.054 1.342 . . . . 0.0 109.553 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.82 147.69 59.26 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -76.1 -8.95 19.12 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.431 2.087 . . . . 0.0 111.029 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -55.05 -36.54 65.67 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.699 1.59 . . . . 0.0 111.325 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -22.94 67.13 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.119 -0.988 . . . . 0.0 113.397 176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -14.15 31.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -73.06 -26.65 61.36 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.767 -1.208 . . . . 0.0 110.716 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -76.75 -51.11 12.02 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.524 1.056 . . . . 0.0 109.97 -171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -66.01 142.02 57.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.615 -169.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.73 -24.0 56.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.806 0.812 . . . . 0.0 111.611 -172.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.31 144.18 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -172.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.56 153.21 51.83 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.672 0.669 . . . . 0.0 110.47 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.54 120.03 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -118.84 132.4 56.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -172.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -122.18 116.32 3.02 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-O 117.793 -1.56 . . . . 0.0 112.571 -173.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.49 121.45 32.04 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 119.314 1.557 . . . . 0.0 110.758 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -76.8 146.41 26.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.941 2.427 . . . . 0.0 108.941 168.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -94.06 139.81 30.5 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -133.05 167.73 19.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.624 2.37 . . . . 0.0 109.905 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 27.5 56.7 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 129.244 3.018 . . . . 0.0 116.663 167.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . 0.253 3.0 m-85 51.97 81.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.14 2.576 . . . . 0.0 112.093 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.81 16.9 79.18 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.8 152.89 22.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.254 1.022 . . . . 0.0 108.324 168.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -87.03 156.97 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.36 138.47 50.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.53 -24.86 67.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -165.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -86.01 -26.9 25.15 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.738 -0.602 . . . . 0.0 110.552 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -67.26 -40.74 86.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.34 -32.32 64.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.85 0.46 . . . . 0.0 111.148 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.41 72.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.274 0.63 . . . . 0.0 111.869 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -98.95 -11.52 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -54.48 -28.79 47.15 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.509 1.524 . . . . 0.0 111.886 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.16 -44.09 66.2 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.042 1.337 . . . . 0.0 111.309 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -69.41 -29.77 67.59 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.057 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.64 -31.38 64.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.188 1.358 . . . . 0.0 111.225 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.82 -29.17 68.27 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.838 0.855 . . . . 0.0 111.479 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.93 -24.17 35.76 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 111.441 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.1 157.65 34.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 123.013 1.387 . . . . 0.0 112.326 -167.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -92.12 97.01 10.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.766 -2.016 . . . . 0.0 108.778 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -119.34 8.08 11.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.57 120.89 13.21 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -170.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.56 87.0 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.363 1.459 . . . . 0.0 114.287 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -76.99 145.55 37.98 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 117.775 0.787 . . . . 0.0 109.239 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.703 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.1 mt -84.27 138.07 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.66 127.39 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 124.722 1.209 . . . . 0.0 108.835 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.48 117.78 34.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 167.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.5 mt -89.86 141.76 28.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.182 0.901 . . . . 0.0 111.557 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 27.2 p90 -137.04 159.58 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.19 0.996 . . . . 0.0 109.289 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.56 173.43 37.11 Favored Glycine 0 N--CA 1.45 -0.392 0 O-C-N 121.268 -0.895 . . . . 0.0 111.857 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.0 154.37 48.24 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.296 1.438 . . . . 0.0 107.632 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.26 -155.6 11.86 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -131.84 121.23 23.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.089 3.356 . . . . 0.0 105.997 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -25.25 15.27 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 119.986 1.266 . . . . 0.0 112.836 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -79.09 -41.22 29.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.196 0.198 . . . . 0.0 110.729 -169.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.53 -34.21 36.37 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 118.539 -1.145 . . . . 0.0 111.501 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.725 ' CE2' ' HB2' ' A' ' 96' ' ' TRP 0.277 0.0 OUTLIER -153.87 41.89 0.53 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.84 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.16 -24.73 5.03 Favored Glycine 0 N--CA 1.475 1.29 0 O-C-N 119.646 -1.909 . . . . 0.0 114.069 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 -27.06 6.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.806 1.242 . . . . 0.0 111.497 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 19.9 m-90 -119.22 -55.31 2.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 116.173 -1.87 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.8 t80 7.27 122.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 130.066 3.346 . . . . 0.0 115.8 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.85 30.07 16.6 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.536 1.534 . . . . 0.0 111.655 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.57 -39.09 91.25 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.938 -1.101 . . . . 0.0 110.685 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.53 72.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 111.34 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -61.28 -47.79 84.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.54 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.47 -39.93 96.99 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 mtm -65.92 -44.66 84.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 117.918 0.859 . . . . 0.0 112.23 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -64.29 -34.77 78.9 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.494 173.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.4 -42.34 98.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.048 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.59 -42.86 91.2 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.538 1.135 . . . . 0.0 111.695 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.33 -58.6 6.77 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.631 1.172 . . . . 0.0 108.41 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 mt -78.14 -20.7 51.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.434 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 t -61.32 -28.64 69.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.365 0.984 . . . . 0.0 110.502 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -22.73 50.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.873 1.215 . . . . 0.0 109.787 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -83.35 1.26 42.14 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.854 1.662 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.67 34.04 66.93 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.458 0.572 . . . . 0.0 111.731 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.13 169.07 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.705 0.752 . . . . 0.0 109.38 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -116.13 143.85 44.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -112.34 148.01 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.73 1.15 . . . . 0.0 112.138 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.1 m -128.52 -179.39 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.194 0.998 . . . . 0.0 109.589 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.95 35.72 38.27 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-O 118.473 -1.182 . . . . 0.0 113.987 172.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -78.55 148.59 33.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.48 1.64 . . . . 0.0 108.587 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -124.91 148.1 58.71 Favored Pre-proline 0 CA--C 1.516 -0.35 0 CA-C-O 117.26 -1.352 . . . . 0.0 108.786 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.82 139.3 43.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 N-CA-C 108.877 -1.24 . . . . 0.0 108.877 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.479 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.4 p -72.41 -15.57 61.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.443 1.497 . . . . 0.0 113.289 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.62 145.32 54.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.956 0.902 . . . . 0.0 109.77 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.23 19.94 79.34 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.367 0.984 . . . . 0.0 112.839 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.45 167.16 22.81 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.129 1.772 . . . . 0.0 108.289 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -126.94 132.22 50.91 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.738 1.615 . . . . 0.0 107.418 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 127' ' ' THR . 2.7 p90 -165.11 -69.67 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 126' ' ' PHE 0.353 2.8 t 58.62 12.17 2.05 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.11 2.964 . . . . 0.0 114.384 -170.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.3 p -64.59 141.2 98.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.742 -1.224 . . . . 0.0 110.172 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -88.46 -15.28 2.89 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.854 2.37 . . . . 0.0 113.558 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 -49.54 1.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.034 -0.984 . . . . 0.0 113.466 -168.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -91.58 44.37 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.866 1.711 . . . . 0.0 112.266 -168.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 146.56 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 120.944 -1.097 . . . . 0.0 109.467 -168.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -172.7 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.843 1.657 . . . . 0.0 109.819 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.18 -116.3 0.82 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.162 1.385 . . . . 0.0 107.546 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -105.37 7.46 33.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.965 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.84 20.73 18.01 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.779 1.181 . . . . 0.0 112.838 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.55 -17.29 17.17 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.734 1.214 . . . . 0.0 110.857 -173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.15 144.54 50.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.303 0.641 . . . . 0.0 111.155 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 57.7 m-85 -79.33 154.22 29.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.351 1.46 . . . . 0.0 109.866 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.07 -13.74 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.591 174.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -169.68 -177.56 40.23 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 120.035 1.289 . . . . 0.0 112.206 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 144' ' ' LEU . 23.1 tp -63.68 125.96 26.0 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.2 121.28 44.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 142' ' ' LEU . 69.9 mt -121.29 160.53 23.75 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.9 135.77 41.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 172.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.65 15.4 14.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.129 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -117.63 -22.82 7.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -140.23 -28.66 0.72 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.202 1.001 . . . . 0.0 113.139 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -86.91 8.38 23.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.411 1.005 . . . . 0.0 111.809 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.95 -24.16 22.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.274 0.943 . . . . 0.0 112.589 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.76 -26.27 44.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.286 1.034 . . . . 0.0 111.667 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -124.97 -13.74 6.79 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.3 m -55.55 -28.86 57.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.277 0.944 . . . . 0.0 111.533 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.5 -43.07 71.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.271 1.029 . . . . 0.0 111.318 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.87 -31.68 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.856 0.836 . . . . 0.0 109.677 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -77.42 -25.23 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.275 0.63 . . . . 0.0 109.667 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -55.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -52.65 -47.22 67.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.633 1.173 . . . . 0.0 110.187 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -68.51 -35.49 77.56 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.315 0.384 . . . . 0.0 110.58 -177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 25.3 t90 -65.72 -45.54 82.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.627 0.727 . . . . 0.0 109.816 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -59.1 -34.53 72.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.667 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.49 70.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.051 0.54 . . . . 0.0 110.889 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -85.4 -45.58 11.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.16 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 25' ' ' ILE . 6.7 pt -64.34 -37.9 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 120.603 1.547 . . . . 0.0 109.897 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.58 -13.2 28.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -49.67 5.85 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 108.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.91 -28.13 69.85 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.376 0.535 . . . . 0.0 111.051 -169.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.703 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -89.4 -41.22 12.22 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.46 1.104 . . . . 0.0 111.416 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.93 -44.09 27.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.393 0.677 . . . . 0.0 110.727 -174.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -73.25 -28.44 62.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.331 1.452 . . . . 0.0 109.862 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -60.16 -49.9 75.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -1.0 48.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.853 0.461 . . . . 0.0 110.581 178.188 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' FMN . . . . . 0.468 ' N3 ' ' CZ ' ' A' ' 93' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.47 143.89 31.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -132.29 145.77 51.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.381 1.872 . . . . 0.0 108.104 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.63 117.52 4.85 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.26 112.35 21.95 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 118.983 1.391 . . . . 0.0 108.054 169.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -106.42 142.9 35.32 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.525 1.13 . . . . 0.0 111.83 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.27 169.14 25.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 110.163 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.14 137.89 7.91 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 168.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -138.75 135.57 34.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.791 1.636 . . . . 0.0 108.076 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -87.19 -28.9 22.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.8 p -108.74 -90.8 0.45 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.8 m -162.03 -11.79 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.546 2.738 . . . . 0.0 113.21 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -62.78 -46.75 86.56 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.979 -1.701 . . . . 0.0 112.272 -167.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -34.51 77.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.3 -48.25 80.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.07 0.948 . . . . 0.0 110.437 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 70.2 mtm -65.99 -40.35 91.1 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.908 -0.495 . . . . 0.0 110.943 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.59 98.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.873 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.68 -48.12 75.63 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.075 0.95 . . . . 0.0 110.634 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -59.11 -44.92 92.02 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.18 -54.51 39.93 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 124.658 1.224 . . . . 0.0 109.024 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.426 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -53.03 -56.23 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.888 0.767 . . . . 0.0 109.775 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -38.53 78.14 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.59 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.6 -46.73 74.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 122.878 0.471 . . . . 0.0 111.377 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 158' ' ' GLN . 11.5 mt -68.05 -47.18 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.572 1.149 . . . . 0.0 108.504 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -70.61 -50.17 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.722 0.809 . . . . 0.0 110.159 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.29 115.13 0.85 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.19 3.7 3.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.396 2.731 . . . . 0.0 112.945 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.4 -34.67 70.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.132 1.373 . . . . 0.0 108.996 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -21.02 3.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -169.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.51 142.47 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 120.909 1.686 . . . . 0.0 108.727 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -132.86 129.73 38.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.399 1.08 . . . . 0.0 109.528 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.37 146.41 48.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.64 0.776 . . . . 0.0 111.666 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -139.39 121.69 15.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.632 1.973 . . . . 0.0 107.301 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -103.72 90.43 3.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.33 -15.13 22.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.089 1.356 . . . . 0.0 114.392 -167.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -12.83 61.71 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -131.73 -35.28 1.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.016 1.326 . . . . 0.0 112.22 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -81.75 145.34 30.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.044 1.338 . . . . 0.0 109.651 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -83.95 143.54 43.23 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.36 -8.04 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.501 2.134 . . . . 0.0 111.072 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -57.21 -35.54 69.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.763 1.62 . . . . 0.0 111.823 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -21.37 66.76 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.261 -0.9 . . . . 0.0 113.194 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -13.32 23.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.673 1.189 . . . . 0.0 112.034 170.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.33 -27.46 61.53 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.626 -1.296 . . . . 0.0 111.043 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.68 -49.46 16.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.853 0.751 . . . . 0.0 110.167 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -65.4 140.83 58.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.944 1.298 . . . . 0.0 108.86 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.84 -31.07 68.72 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.356 0.662 . . . . 0.0 110.755 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.77 144.54 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -133.7 152.32 51.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.53 0.605 . . . . 0.0 110.246 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.66 121.67 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -120.67 137.44 54.46 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 108.991 -172.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.33 122.3 3.79 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-O 118.02 -1.434 . . . . 0.0 113.236 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.47 126.07 26.62 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 119.15 1.475 . . . . 0.0 111.829 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -78.51 142.95 18.84 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.433 2.755 . . . . 0.0 109.187 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -92.23 110.09 21.47 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -95.63 171.56 8.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.493 1.117 . . . . 0.0 110.37 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 26.89 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.722 2.809 . . . . 0.0 115.647 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 55.11 76.27 0.27 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.928 1.291 . . . . 0.0 112.481 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.18 16.36 79.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.44 154.5 21.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.458 1.123 . . . . 0.0 108.565 168.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -82.75 153.57 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.04 138.37 44.16 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.89 -24.44 67.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -165.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -87.83 -25.92 23.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.986 0.514 . . . . 0.0 110.606 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.8 m95 -68.46 -39.52 81.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.013 -0.429 . . . . 0.0 110.393 170.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -55.56 -32.87 63.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.023 0.529 . . . . 0.0 111.346 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.91 71.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.424 0.69 . . . . 0.0 111.971 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.7 -12.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.745 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.561 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.3 t-105 -54.25 -28.03 38.83 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.529 1.531 . . . . 0.0 112.059 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.44 -46.13 64.47 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.055 1.342 . . . . 0.0 111.227 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -67.56 -32.02 72.5 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.319 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.63 -30.16 62.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.871 1.214 . . . . 0.0 111.445 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.3 -32.41 70.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.634 0.774 . . . . 0.0 111.354 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.85 -22.7 33.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.963 0.905 . . . . 0.0 110.728 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -73.63 159.8 32.53 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.689 1.233 . . . . 0.0 111.341 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -91.52 101.66 14.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.645 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -122.9 3.93 9.41 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.665 1.186 . . . . 0.0 113.215 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -67.03 115.38 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.72 5.12 78.59 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.61 1.576 . . . . 0.0 115.288 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.2 149.98 33.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 118.125 0.963 . . . . 0.0 110.047 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -86.23 139.08 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 167.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.09 129.63 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 124.756 1.222 . . . . 0.0 108.925 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.05 118.0 35.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 mt -90.12 143.01 27.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.975 0.807 . . . . 0.0 111.776 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -135.29 156.33 49.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.898 0.879 . . . . 0.0 108.657 168.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.24 162.46 30.59 Favored Glycine 0 CA--C 1.505 -0.546 0 O-C-N 120.874 -1.141 . . . . 0.0 111.939 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.6 153.28 40.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.01 -145.75 5.84 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -151.73 145.13 24.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.157 2.183 . . . . 0.0 108.149 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.635 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -85.95 -31.59 22.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.752 2.021 . . . . 0.0 114.019 172.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.82 -32.93 62.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.356 0.98 . . . . 0.0 112.782 -167.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.71 -19.94 23.3 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 124.843 1.211 . . . . 0.0 111.521 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' C ' ' H ' ' A' ' 95' ' ' GLU . 25.5 m-85 -126.44 -88.64 0.57 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.189 0.996 . . . . 0.0 108.872 -169.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.46 -50.26 2.43 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 128.295 2.855 . . . . 0.0 107.812 -167.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.7 mm-40 -69.02 -32.66 72.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.483 1.913 . . . . 0.0 110.533 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -111.89 0.83 16.25 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.793 1.237 . . . . 0.0 111.656 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.11 126.33 22.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.71 -1.243 . . . . 0.0 109.897 169.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.61 24.7 9.09 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.719 1.608 . . . . 0.0 113.46 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.76 -41.65 97.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.791 -1.193 . . . . 0.0 110.426 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.441 0.697 . . . . 0.0 111.368 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.669 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.33 -46.82 88.68 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.544 0.738 . . . . 0.0 110.927 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.1 95.14 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.6 mtm -68.44 -43.39 77.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 117.74 0.77 . . . . 0.0 112.559 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.567 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -63.82 -33.04 74.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.6 1.091 . . . . 0.0 111.28 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -66.0 -41.03 91.57 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.031 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.93 -31.49 66.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.698 1.999 . . . . 0.0 112.155 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -61.86 -61.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.49 -18.83 56.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.761 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -61.87 -31.11 71.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.145 1.339 . . . . 0.0 111.55 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -22.35 56.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.627 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -82.12 4.73 22.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.518 1.927 . . . . 0.0 112.876 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.05 31.49 78.0 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -82.69 169.82 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -116.8 142.27 47.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -110.04 147.45 33.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.57 1.077 . . . . 0.0 111.723 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.6 m -127.82 178.54 4.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.187 0.995 . . . . 0.0 109.24 169.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.15 34.22 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.326 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -75.65 151.69 37.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.837 1.818 . . . . 0.0 108.446 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.71 148.27 67.81 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 117.095 -1.431 . . . . 0.0 108.946 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.922 1.365 . . . . 0.0 109.696 168.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.511 HG22 ' CD1' ' A' ' 139' ' ' PHE . 79.7 p . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 125.496 1.518 . . . . 0.0 113.692 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -163.53 -59.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.695 0.68 . . . . 0.0 109.283 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.325 3.7 t 54.97 7.73 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.628 2.771 . . . . 0.0 114.173 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.5 p -72.84 146.09 87.48 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.66 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.98 -11.28 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.935 2.423 . . . . 0.0 113.867 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -79.87 -48.07 1.4 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -169.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.61 39.98 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.295 1.997 . . . . 0.0 112.8 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 148.82 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 120.949 -1.094 . . . . 0.0 110.408 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.02 -172.16 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.123 1.769 . . . . 0.0 109.666 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.42 -117.38 0.94 Allowed 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.24 8.36 33.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.016 1.326 . . . . 0.0 112.011 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.36 20.21 20.84 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.352 0.977 . . . . 0.0 112.865 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.31 -17.21 17.39 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.971 1.308 . . . . 0.0 110.779 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.34 144.33 49.56 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.683 0.793 . . . . 0.0 111.026 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.4 m-85 -79.13 154.65 29.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.48 1.512 . . . . 0.0 109.776 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.18 -15.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.492 1.117 . . . . 0.0 112.479 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.35 -178.47 41.19 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.592 1.087 . . . . 0.0 111.698 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.9 tp -65.7 135.39 54.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.08 124.56 47.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.66 159.57 34.3 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.515 1.126 . . . . 0.0 109.9 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.63 139.63 29.71 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.525 1.53 . . . . 0.0 107.254 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.21 4.22 16.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.043 1.337 . . . . 0.0 111.048 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -24.06 15.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.21 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -147.42 -30.35 0.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -81.29 9.93 6.33 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.342 0.974 . . . . 0.0 111.871 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -55.07 -20.67 10.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.977 0.911 . . . . 0.0 112.792 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.78 -27.01 57.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.522 0.729 . . . . 0.0 110.934 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.77 -11.72 6.62 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 p -52.56 -35.82 54.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 110.476 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.04 -39.93 87.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.529 1.532 . . . . 0.0 111.466 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -31.66 59.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 109.667 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.16 -29.81 57.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.856 -0.528 . . . . 0.0 109.812 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.37 -57.23 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.3 pt20 -57.04 -43.83 82.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 122.661 0.384 . . . . 0.0 111.746 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -65.72 -34.15 77.54 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.055 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.6 t90 -66.51 -45.2 80.33 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.812 0.815 . . . . 0.0 109.802 176.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 89.9 m -57.37 -37.17 72.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.813 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -68.5 -26.69 65.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.199 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.13 -43.52 12.98 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.909 -1.044 . . . . 0.0 112.091 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.07 -36.4 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.874 1.67 . . . . 0.0 109.85 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.2 -47.7 6.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.3 -35.44 77.36 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.41 0.55 . . . . 0.0 110.225 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.729 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.4 mtm -77.9 -43.45 30.04 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.322 1.049 . . . . 0.0 110.601 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.68 73.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.922 0.889 . . . . 0.0 111.252 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.75 -30.76 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.94 1.296 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.542 0.737 . . . . 0.0 110.599 169.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.91 -1.65 56.87 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.719 1.608 . . . . 0.0 113.818 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.089 0.556 . . . . 0.0 110.494 -179.84 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttm . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.162 0.506 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 147.31 51.6 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 127.946 2.498 . . . . 0.0 106.978 168.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.41 147.07 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.645 1.578 . . . . 0.0 109.0 -166.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.87 119.09 4.78 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.08 108.1 19.08 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -103.73 143.84 32.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.68 1.192 . . . . 0.0 109.998 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -161.09 174.63 13.43 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.956 0.503 . . . . 0.0 109.826 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.17 142.9 9.93 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -140.81 147.19 38.64 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.607 1.163 . . . . 0.0 108.012 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 -29.54 33.08 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 169.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.8 p -104.29 -77.43 0.58 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p 175.66 -7.78 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.997 2.919 . . . . 0.0 110.891 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.46 -44.06 88.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.01 1.732 . . . . 0.0 110.542 -168.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -31.53 70.07 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -64.53 -47.43 78.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.453 1.101 . . . . 0.0 110.207 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.7 mtm -64.11 -40.27 95.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.193 0.451 . . . . 0.0 110.875 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.23 96.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.056 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -47.9 73.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.015 0.926 . . . . 0.0 110.713 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -60.3 -43.78 95.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -63.9 -54.22 38.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.502 1.121 . . . . 0.0 108.974 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -51.52 -56.18 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.039 0.836 . . . . 0.0 109.769 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -39.52 82.6 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.732 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.17 -46.92 69.4 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.424 0.453 . . . . 0.0 111.226 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.45 -48.24 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.25 1.42 . . . . 0.0 108.488 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 164' ' ' ILE . 81.0 mt -72.59 -50.16 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.529 0.731 . . . . 0.0 110.513 -175.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.77 114.11 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.392 0.996 . . . . 0.0 110.855 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 4.09 3.36 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.399 2.732 . . . . 0.0 113.056 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.84 -36.12 64.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.553 1.541 . . . . 0.0 109.262 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.74 -26.1 6.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.434 1.893 . . . . 0.0 110.766 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.33 140.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.114 1.779 . . . . 0.0 109.683 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -130.59 129.56 42.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.676 1.19 . . . . 0.0 109.718 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.47 149.87 45.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.072 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -144.88 112.79 6.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.083 1.753 . . . . 0.0 107.393 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -87.21 108.47 18.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.2 mt -66.38 -7.53 19.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -61.92 -27.54 68.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.9 1.227 . . . . 0.0 111.47 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.36 -33.3 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.677 1.191 . . . . 0.0 112.278 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -83.13 140.51 32.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -82.95 142.21 44.55 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -74.07 -8.79 21.5 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.787 1.658 . . . . 0.0 111.037 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -56.3 -36.68 68.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.879 1.672 . . . . 0.0 111.599 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.34 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -11.52 13.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 112.169 170.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.66 -30.83 63.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.589 -1.32 . . . . 0.0 111.24 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -75.19 -47.92 26.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.88 0.764 . . . . 0.0 110.904 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -63.37 146.55 53.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.77 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -71.43 -24.99 62.13 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.852 0.861 . . . . 0.0 110.402 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.5 t -150.47 151.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.687 1.995 . . . . 0.0 106.166 -168.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.19 155.28 50.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.195 0.907 . . . . 0.0 110.219 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.28 122.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 168.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.48 139.76 51.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.62 0.768 . . . . 0.0 109.046 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.07 121.69 2.8 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.802 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.689 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.39 136.67 27.38 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 118.49 1.145 . . . . 0.0 110.972 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.13 153.87 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.244 1.963 . . . . 0.0 108.921 166.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.466 HG21 ' H ' ' A' ' 99' ' ' ASP . 90.1 m -108.94 94.77 5.23 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -83.13 168.67 16.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.324 1.05 . . . . 0.0 111.509 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t0 18.36 69.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 129.395 3.078 . . . . 0.0 115.251 166.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 56.48 67.6 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.581 1.153 . . . . 0.0 111.861 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.6 23.04 77.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -83.21 154.7 24.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.598 1.159 . . . . 0.0 110.12 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.5 mt -96.18 149.14 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -66.78 143.85 56.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.52 -26.77 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.532 0.733 . . . . 0.0 112.119 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -30.45 71.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.418 0.687 . . . . 0.0 110.898 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.476 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.6 m95 -82.05 -42.14 19.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.48 1.112 . . . . 0.0 110.404 173.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.3 -34.91 64.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.388 0.54 . . . . 0.0 110.956 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.49 72.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.05 -13.27 8.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.697 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.1 t-105 -53.81 -28.68 36.86 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.624 1.57 . . . . 0.0 111.933 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.57 -45.28 59.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.887 1.275 . . . . 0.0 111.055 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.55 -29.86 68.51 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.336 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -56.18 -31.93 63.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.187 1.358 . . . . 0.0 111.111 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.33 -32.58 74.07 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.604 0.762 . . . . 0.0 111.811 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.93 -27.29 43.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.32 0.648 . . . . 0.0 110.518 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.47 157.24 37.99 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.659 1.219 . . . . 0.0 111.376 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -89.9 97.1 10.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.009 -1.905 . . . . 0.0 108.265 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -117.74 3.02 12.31 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 122.194 0.997 . . . . 0.0 113.197 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -68.6 113.01 5.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.23 49.7 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.768 -1.018 . . . . 0.0 115.053 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.57 156.17 29.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.969 1.385 . . . . 0.0 109.282 169.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.686 HG21 ' HG2' ' A' ' 168' ' ' MET . 7.0 mt -85.49 145.78 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.1 129.36 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.346 1.458 . . . . 0.0 109.658 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -107.99 119.53 39.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 166.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.24 141.44 28.7 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.338 0.972 . . . . 0.0 111.49 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -134.7 160.72 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.093 0.957 . . . . 0.0 108.456 168.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.79 40.08 Favored Glycine 0 N--CA 1.442 -0.919 0 O-C-N 120.939 -1.1 . . . . 0.0 111.074 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.54 148.65 48.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.168 -1.016 . . . . 0.0 108.401 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.44 -155.31 8.81 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.15 138.5 13.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.204 1.802 . . . . 0.0 106.437 168.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.654 HE22 HD21 ' A' ' 148' ' ' ASN . 0.0 OUTLIER -94.03 -24.54 17.58 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 124.02 0.928 . . . . 0.0 112.164 -175.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.72 -51.87 67.54 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.905 0.775 . . . . 0.0 110.946 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.68 -27.13 7.69 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.694 1.14 . . . . 0.0 113.202 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.3 29.37 5.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -168.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.3 -43.1 42.89 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.17 1.35 . . . . 0.0 110.866 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -64.81 -16.46 63.11 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.381 -1.07 . . . . 0.0 112.348 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -130.02 14.03 5.74 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.09 1.756 . . . . 0.0 111.899 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -47.24 127.3 10.51 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.795 2.038 . . . . 0.0 110.56 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 47.36 28.98 1.17 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.902 1.281 . . . . 0.0 112.606 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.466 ' H ' HG21 ' A' ' 55' ' ' THR . 7.3 t70 -63.83 -37.94 89.26 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.804 -1.185 . . . . 0.0 109.815 -169.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.94 74.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.594 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.689 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -59.88 -46.03 90.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.888 0.875 . . . . 0.0 110.342 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.54 -41.88 99.65 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.0 mtm -64.86 -43.83 91.71 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.113 0.957 . . . . 0.0 111.463 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -64.43 -35.72 81.83 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 119.623 1.101 . . . . 0.0 111.143 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -64.47 -41.6 96.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.145 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.88 -42.71 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.93 -59.33 4.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.695 1.198 . . . . 0.0 108.406 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.83 -19.83 57.07 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.627 -0.671 . . . . 0.0 110.855 -170.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.3 t -62.39 -29.79 70.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.31 0.959 . . . . 0.0 110.386 169.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.94 -23.58 52.43 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.305 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -81.94 4.38 22.79 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.104 1.762 . . . . 0.0 113.172 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.24 33.84 86.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.519 0.6 . . . . 0.0 111.749 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.45 170.45 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 123.522 0.729 . . . . 0.0 109.224 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -115.83 140.07 49.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.82 149.0 30.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.797 1.181 . . . . 0.0 112.213 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 13.9 m -129.51 -179.63 3.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.218 1.007 . . . . 0.0 109.995 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.35 39.35 26.65 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.085 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -82.67 149.86 27.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.426 1.613 . . . . 0.0 109.339 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.47 146.36 49.58 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.376 -1.297 . . . . 0.0 108.696 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.6 135.06 25.41 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.395 1.397 . . . . 0.0 110.248 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.557 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.4 p . . . . . 0 CA--C 1.54 0.589 0 C-N-CA 126.219 1.808 . . . . 0.0 112.993 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -164.52 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 109.482 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.302 3.0 t 58.5 8.48 0.88 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.757 2.823 . . . . 0.0 114.956 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 148.3 47.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.398 1.479 . . . . 0.0 111.468 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.31 -14.57 3.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.836 2.357 . . . . 0.0 114.644 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -80.46 -50.02 1.13 Allowed Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.31 37.35 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 CA-C-N 122.008 1.753 . . . . 0.0 112.674 -168.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 148.3 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.414 1.086 . . . . 0.0 110.207 -167.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -172.23 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 126.217 1.807 . . . . 0.0 109.514 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.52 -117.31 0.92 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.041 1.336 . . . . 0.0 107.549 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.26 8.33 33.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.775 1.23 . . . . 0.0 111.918 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.59 20.08 20.68 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.483 1.04 . . . . 0.0 112.713 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.62 -16.84 17.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.889 1.276 . . . . 0.0 110.594 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.94 145.09 50.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.457 0.703 . . . . 0.0 110.98 174.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.557 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -80.13 154.24 28.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.429 1.492 . . . . 0.0 109.608 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -66.15 -12.39 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.681 1.193 . . . . 0.0 112.621 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.12 -177.37 44.15 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.682 1.128 . . . . 0.0 111.889 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.3 tp -67.05 133.0 49.03 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.11 56.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.8 mt -117.13 154.52 30.9 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 108.597 170.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.52 101.1 4.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -0.64 54.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.835 0.854 . . . . 0.0 112.548 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.03 -26.01 14.37 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.451 0.569 . . . . 0.0 111.134 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.654 HD21 HE22 ' A' ' 90' ' ' GLN . 8.5 p30 -139.84 -27.78 0.76 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -87.94 11.63 15.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.942 0.792 . . . . 0.0 111.449 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -53.66 -25.97 20.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.888 1.222 . . . . 0.0 112.525 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.07 -26.15 56.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 110.954 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 pp -130.61 -6.43 4.13 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 112.957 -169.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.4 m -55.59 -29.65 59.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.084 1.311 . . . . 0.0 109.772 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.28 -41.04 78.99 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.445 1.098 . . . . 0.0 111.743 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -75.88 -31.77 59.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.461 1.104 . . . . 0.0 109.738 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -74.73 -30.84 61.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.32 -59.52 4.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.69 -39.42 80.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.7 m -62.53 -38.95 91.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.943 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -66.74 -44.45 81.51 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.9 m -57.05 -34.82 68.61 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.937 0.895 . . . . 0.0 109.548 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -31.7 72.65 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.618 0.573 . . . . 0.0 110.582 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.38 -45.95 12.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.504 173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 25' ' ' ILE . 5.9 pt -64.18 -38.43 82.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 120.994 1.725 . . . . 0.0 109.833 -170.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.43 -12.26 29.66 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -49.15 5.9 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 125.797 1.639 . . . . 0.0 108.266 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.4 -23.49 67.3 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.252 -170.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.686 ' HG2' HG21 ' A' ' 81' ' ' ILE . 66.9 mtm -94.09 -45.25 7.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.434 1.094 . . . . 0.0 110.979 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.64 49.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.477 0.711 . . . . 0.0 110.823 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -69.4 -28.06 65.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.98 1.312 . . . . 0.0 109.679 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -70.78 -45.71 64.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.814 1.245 . . . . 0.0 110.443 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -22.34 62.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.017 -175.556 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.56 142.78 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -131.67 148.16 52.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.776 2.03 . . . . 0.0 108.488 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.49 118.81 4.93 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.013 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 108.98 19.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.212 1.506 . . . . 0.0 109.838 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -105.57 145.81 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.537 1.535 . . . . 0.0 110.979 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -163.47 175.7 10.5 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.736 0.814 . . . . 0.0 110.231 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.49 141.97 9.2 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 106.502 -2.639 . . . . 0.0 106.502 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -150.03 140.29 22.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.528 1.164 . . . . 0.0 110.891 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -36.37 13.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.692 1.197 . . . . 0.0 110.015 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 p -93.99 -6.64 44.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.217 1.407 . . . . 0.0 112.009 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m 68.05 9.98 7.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.588 1.955 . . . . 0.0 113.091 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -63.83 -45.43 89.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.33 1.423 . . . . 0.0 110.386 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -33.28 74.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.665 0.786 . . . . 0.0 108.918 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.54 -49.55 70.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 109.397 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.45 -38.89 92.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.895 0.316 . . . . 0.0 110.809 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.01 98.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.866 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.09 76.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.956 0.902 . . . . 0.0 110.491 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -59.1 -45.97 89.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.6 mttm -62.21 -55.79 25.0 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 125.106 1.363 . . . . 0.0 108.831 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.6 mt -52.59 -56.48 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 118.458 0.572 . . . . 0.0 109.967 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -38.5 72.78 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.258 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.47 -46.87 74.92 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.902 0.481 . . . . 0.0 111.339 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -66.24 -47.85 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.567 1.147 . . . . 0.0 108.854 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 164' ' ' ILE . 71.7 mt -72.13 -49.69 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.702 0.801 . . . . 0.0 110.048 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 115.69 0.86 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.64 3.74 4.06 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.256 2.637 . . . . 0.0 112.689 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.76 -34.53 67.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.11 1.364 . . . . 0.0 109.027 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 -22.7 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.552 1.541 . . . . 0.0 111.641 -169.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.3 140.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 120.479 1.491 . . . . 0.0 108.924 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -131.26 128.96 40.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.206 1.003 . . . . 0.0 109.824 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.19 149.1 47.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.636 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.6 111.67 5.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.193 1.797 . . . . 0.0 107.144 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.43 111.26 20.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.96 -8.19 35.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -60.24 -27.99 67.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.248 0.931 . . . . 0.0 111.584 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -132.42 -33.82 1.25 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.495 1.118 . . . . 0.0 112.122 -171.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -83.05 140.45 32.68 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.177 0.991 . . . . 0.0 108.585 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -83.44 142.23 43.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.23 -4.75 15.79 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.774 1.649 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -55.21 -35.42 64.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.723 1.601 . . . . 0.0 111.977 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -19.34 65.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -12.15 19.6 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.324 1.049 . . . . 0.0 112.326 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 95.7 mt-10 -78.09 -23.35 48.0 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.828 -1.17 . . . . 0.0 111.543 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -75.4 -48.96 20.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -68.98 150.28 47.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.21 1.404 . . . . 0.0 108.381 -170.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -81.96 -23.78 35.92 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 110.502 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.27 144.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.71 156.11 48.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.398 0.679 . . . . 0.0 110.205 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.61 123.59 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.7 138.6 54.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -133.3 124.79 3.82 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.442 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -127.49 135.32 27.27 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 118.84 1.32 . . . . 0.0 110.842 178.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.11 145.44 12.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.793 1.662 . . . . 0.0 108.511 166.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.9 m -90.46 123.49 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -108.11 170.73 7.82 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.455 1.902 . . . . 0.0 110.249 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t0 15.37 69.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 129.542 3.137 . . . . 0.0 115.217 168.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 58.59 67.79 0.9 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.427 1.491 . . . . 0.0 110.401 172.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.66 32.61 70.91 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.354 0.5 OUTLIER -99.15 153.83 18.61 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.625 1.17 . . . . 0.0 109.827 168.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.96 148.87 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -62.38 142.67 57.71 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.85 -28.14 69.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.14 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.69 -29.48 70.03 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.646 0.778 . . . . 0.0 110.509 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.9 m95 -81.94 -42.51 19.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.745 0.818 . . . . 0.0 110.785 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.62 -33.99 64.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.408 0.549 . . . . 0.0 110.872 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.91 73.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.464 1.105 . . . . 0.0 111.838 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.09 -11.31 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.547 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.9 t-105 -53.04 -28.8 26.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.846 1.658 . . . . 0.0 111.817 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.71 -45.87 67.28 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.189 1.396 . . . . 0.0 111.414 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.67 -31.97 73.27 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.005 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.5 mt -56.66 -32.47 65.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.709 1.14 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.42 -31.77 71.34 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.47 0.708 . . . . 0.0 111.166 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.95 -16.72 35.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.675 0.79 . . . . 0.0 111.448 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.98 156.3 39.32 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 122.227 1.013 . . . . 0.0 113.47 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -89.12 75.19 7.92 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.766 2.427 . . . . 0.0 106.335 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.301 56.1 tp -118.11 7.32 12.15 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 125.514 1.526 . . . . 0.0 113.606 -165.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -74.15 138.04 43.57 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.406 1.882 . . . . 0.0 109.656 -172.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.69 8.49 86.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 125.599 1.571 . . . . 0.0 114.489 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 54.8 mttm -90.69 148.81 22.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.953 1.301 . . . . 0.0 109.37 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -84.2 139.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.96 127.95 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 C-N-CA 125.052 1.341 . . . . 0.0 108.828 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.95 115.33 30.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 167.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 mt -86.73 143.19 27.66 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.127 0.876 . . . . 0.0 111.184 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 24.4 p90 -136.86 158.76 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.77 0.828 . . . . 0.0 109.034 168.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.63 176.96 41.05 Favored Glycine 0 CA--C 1.508 -0.385 0 O-C-N 120.944 -1.098 . . . . 0.0 112.441 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.36 145.16 50.9 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.29 32.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.93 139.12 23.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.151 1.476 . . . . 0.0 108.625 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.48 HE22 ' CG ' ' A' ' 145' ' ' ASP . 0.3 OUTLIER -89.62 -20.24 23.94 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.969 1.308 . . . . 0.0 114.403 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.55 -47.43 69.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.045 1.293 . . . . 0.0 111.25 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.67 -21.03 10.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.086 0.851 . . . . 0.0 112.195 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 41.77 2.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.116 0.967 . . . . 0.0 111.307 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.95 -43.54 72.79 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 125.007 1.289 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.8 mm-40 -67.33 -26.12 66.35 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -94.0 -10.5 33.38 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.957 2.503 . . . . 0.0 112.628 -171.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -49.57 130.09 20.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.505 2.722 . . . . 0.0 110.913 -169.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 48.91 27.92 1.79 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.228 1.011 . . . . 0.0 112.599 172.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.46 -36.48 84.32 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.03 -1.044 . . . . 0.0 110.023 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.08 77.14 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.641 0.376 . . . . 0.0 111.515 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -60.95 -48.15 83.15 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 110.009 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.09 97.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.62 -44.65 89.86 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.043 0.922 . . . . 0.0 111.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.58 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -63.9 -34.54 78.19 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.508 1.049 . . . . 0.0 111.158 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -64.06 -41.91 97.19 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.222 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.59 -31.22 66.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.966 2.106 . . . . 0.0 112.249 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -62.73 -61.87 2.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.2 mt -76.32 -19.75 57.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.39 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -61.15 -31.08 70.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.022 1.283 . . . . 0.0 111.427 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -21.16 54.19 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -83.9 6.02 23.2 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.407 1.883 . . . . 0.0 112.46 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.15 32.2 76.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.41 170.13 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.713 0.805 . . . . 0.0 108.908 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -119.96 142.63 48.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.95 148.73 31.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.916 1.235 . . . . 0.0 111.911 -169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 22.1 m -129.06 179.56 3.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.275 1.03 . . . . 0.0 108.992 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 36.37 40.0 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-O 118.398 -1.223 . . . . 0.0 113.894 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -79.83 151.55 30.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 119.556 1.678 . . . . 0.0 108.83 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 152.52 73.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.264 172.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 135.12 33.16 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.292 1.328 . . . . 0.0 109.98 169.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.563 HG22 ' CD1' ' A' ' 139' ' ' PHE . 55.1 p . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 125.935 1.694 . . . . 0.0 112.902 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 N--CA 1.457 -0.106 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -168.54 -48.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 0.0 109.466 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.32 3.3 t 59.74 7.53 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.075 2.95 . . . . 0.0 114.639 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 149.03 56.9 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.954 1.302 . . . . 0.0 112.624 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -90.04 -13.67 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.889 2.393 . . . . 0.0 114.025 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.54 -52.29 2.93 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 117.965 -1.017 . . . . 0.0 113.297 -169.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -85.96 40.07 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 121.695 1.641 . . . . 0.0 112.053 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 121' ' ' THR . 0.1 OUTLIER -137.19 145.91 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.607 1.163 . . . . 0.0 109.227 -168.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.418 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.4 -176.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.78 1.232 . . . . 0.0 112.074 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.94 -110.58 0.53 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 127.026 2.131 . . . . 0.0 109.155 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -99.41 -0.71 40.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.552 1.541 . . . . 0.0 111.958 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.0 26.06 9.95 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.146 -0.971 . . . . 0.0 111.798 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -20.48 13.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.142 1.377 . . . . 0.0 108.444 -175.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.98 138.9 51.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.993 1.317 . . . . 0.0 110.863 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 121' ' ' THR . 43.2 m-85 -78.47 151.8 32.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' A' ' 101' ' ' LEU . 14.4 m -63.12 -13.71 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.827 1.251 . . . . 0.0 112.201 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.8 -174.08 42.04 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 119.458 1.026 . . . . 0.0 111.737 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.29 128.63 36.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.07 123.36 47.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 142' ' ' LEU . 74.9 mt -122.18 156.59 33.39 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.039 1.335 . . . . 0.0 108.363 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.48 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -141.08 123.98 16.24 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -100.78 14.32 32.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.429 1.092 . . . . 0.0 110.824 -169.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.42 -24.3 5.44 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.49 -48.72 3.06 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.605 1.093 . . . . 0.0 108.39 172.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -104.4 21.88 15.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.434 1.494 . . . . 0.0 112.659 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -53.47 -24.69 13.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.58 -26.01 41.4 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.83 -12.95 8.35 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.043 0.937 . . . . 0.0 112.244 -170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -58.85 -27.48 65.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.84 1.2 . . . . 0.0 110.781 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.87 -47.07 81.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.326 1.05 . . . . 0.0 110.967 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.99 -32.38 72.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.753 0.787 . . . . 0.0 109.485 -171.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -75.18 -27.52 59.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.875 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.34 -55.2 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -51.67 -47.98 63.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.922 0.889 . . . . 0.0 109.853 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -68.08 -35.91 78.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.561 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -64.92 -44.37 89.75 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.452 0.644 . . . . 0.0 109.778 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.3 m -58.88 -36.59 74.88 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.664 0.786 . . . . 0.0 109.474 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -69.72 -29.26 66.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.31 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.73 -46.64 16.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.355 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.75 -38.5 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 120.872 1.669 . . . . 0.0 110.21 -170.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.19 -15.34 59.69 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.227 0.611 . . . . 0.0 111.94 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -96.4 -46.16 6.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.15 -41.95 89.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.909 0.777 . . . . 0.0 109.503 -173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.696 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.2 mtm -75.67 -37.24 59.74 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.561 0.744 . . . . 0.0 110.938 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.01 -47.15 60.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.926 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.41 -30.72 71.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 110.021 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -63.17 -47.27 83.35 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.463 0.574 . . . . 0.0 110.391 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -3.01 49.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.592 1.157 . . . . 0.0 113.765 -175.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.249 0.477 . . . . 0.0 110.647 178.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.05 144.67 47.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.156 1.382 . . . . 0.0 108.427 169.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.4 mtm -124.01 150.65 44.63 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.935 2.494 . . . . 0.0 108.741 -167.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.43 120.32 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.11 102.98 15.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.621 1.211 . . . . 0.0 110.101 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -102.7 145.57 29.5 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.044 1.338 . . . . 0.0 111.467 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -164.14 172.61 13.48 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.981 0.912 . . . . 0.0 109.897 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.69 137.4 8.23 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 169.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -135.61 130.69 34.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.149 1.38 . . . . 0.0 109.978 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -91.26 -38.33 12.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.93 0.492 . . . . 0.0 110.016 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 p -93.99 -85.69 0.28 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.18 -3.9 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.491 2.717 . . . . 0.0 111.867 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -68.85 -42.83 76.57 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 119.729 -1.857 . . . . 0.0 112.171 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -35.97 82.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -64.68 -49.35 71.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 109.921 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.5 mtm -64.87 -38.71 91.89 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.093 -0.379 . . . . 0.0 111.465 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.15 98.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.0 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.21 79.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.031 0.932 . . . . 0.0 110.61 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -57.64 -47.1 83.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -61.68 -54.41 43.02 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 124.733 1.271 . . . . 0.0 108.995 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.97 -57.02 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.83 0.741 . . . . 0.0 109.691 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -39.11 70.29 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 123.431 0.693 . . . . 0.0 110.339 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.68 -47.7 68.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.801 0.44 . . . . 0.0 111.486 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 158' ' ' GLN . 12.7 mt -65.79 -45.5 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 108.51 -174.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.77 -52.1 27.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.913 0.885 . . . . 0.0 110.546 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.72 115.45 0.85 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.83 3.15 4.64 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.451 2.767 . . . . 0.0 112.686 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.09 -34.39 68.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.451 1.5 . . . . 0.0 109.556 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -4.34 4.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.157 1.783 . . . . 0.0 111.95 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.77 144.46 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 120.955 1.707 . . . . 0.0 109.3 167.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -134.91 130.67 36.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.856 1.263 . . . . 0.0 110.31 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.78 149.62 45.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -146.9 108.76 4.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.182 1.793 . . . . 0.0 108.345 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -82.64 112.92 19.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.73 -9.82 22.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -58.95 -29.02 66.84 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.261 0.937 . . . . 0.0 111.624 168.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -129.95 -33.8 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.544 1.138 . . . . 0.0 111.728 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -87.57 142.04 28.15 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.314 1.046 . . . . 0.0 109.192 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -83.78 143.15 43.08 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -74.65 -2.19 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.706 1.604 . . . . 0.0 111.412 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -56.82 -33.83 67.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.094 2.225 . . . . 0.0 112.459 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -18.59 65.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 44.2 ttm -59.17 -14.31 10.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.973 2.109 . . . . 0.0 111.654 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 65.4 mt-10 -74.36 -30.4 61.98 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.83 -1.169 . . . . 0.0 110.699 173.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.48 -48.84 16.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.775 0.716 . . . . 0.0 109.721 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -67.74 134.28 50.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.95 -6.57 48.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 81' ' ' ILE . 77.1 t -135.27 140.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 156.47 48.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 118.206 0.457 . . . . 0.0 109.865 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.26 122.56 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 168.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.73 132.66 55.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.12 115.98 2.82 Favored Glycine 0 CA--C 1.511 -0.158 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.484 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -118.48 125.15 28.0 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 118.775 1.288 . . . . 0.0 109.347 176.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.27 143.34 7.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.912 2.408 . . . . 0.0 107.925 168.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -88.56 128.36 35.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -117.65 170.11 9.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.875 1.67 . . . . 0.0 109.688 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 28.21 58.68 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.117 2.567 . . . . 0.0 115.325 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 56.58 73.64 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.666 1.187 . . . . 0.0 112.427 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.98 15.54 76.32 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -82.3 152.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.451 1.12 . . . . 0.0 109.095 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -83.97 153.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.752 -1.574 . . . . 0.0 106.752 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -60.5 141.73 56.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.912 0.863 . . . . 0.0 108.835 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.93 -28.09 68.66 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -79.66 -22.77 43.11 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.822 -0.549 . . . . 0.0 110.289 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' ILE . 11.5 m95 -76.63 -43.79 36.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.211 0.604 . . . . 0.0 111.234 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -53.5 -34.9 59.76 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.126 0.57 . . . . 0.0 110.943 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.21 71.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.099 0.96 . . . . 0.0 112.149 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -109.11 -9.32 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.557 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.8 t-105 -53.08 -28.93 27.44 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.457 1.503 . . . . 0.0 111.69 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.51 -45.35 72.49 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.825 1.25 . . . . 0.0 111.623 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.9 -27.74 66.91 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.105 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.26 -32.02 67.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.726 1.148 . . . . 0.0 111.062 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.2 -30.36 69.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.536 0.734 . . . . 0.0 111.148 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.53 -11.35 37.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.18 0.992 . . . . 0.0 111.631 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.97 174.02 9.17 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.142 0.973 . . . . 0.0 110.783 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.436 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 5.1 t30 -114.92 103.77 11.26 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.115 1.766 . . . . 0.0 107.582 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.8 8.47 7.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.778 1.231 . . . . 0.0 113.068 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -67.32 116.52 8.18 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.22 9.99 85.33 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.305 1.431 . . . . 0.0 114.847 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -80.59 152.58 28.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.006 0.903 . . . . 0.0 109.693 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.721 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.2 mt -87.16 141.49 14.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 168.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.11 131.61 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.851 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -111.14 116.37 30.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.08 142.75 27.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.99 0.814 . . . . 0.0 111.792 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -136.83 159.09 42.9 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.28 175.88 37.87 Favored Glycine 0 N--CA 1.447 -0.573 0 O-C-N 120.884 -1.135 . . . . 0.0 111.934 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -125.44 153.66 43.15 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.82 -155.39 8.96 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -155.69 137.64 14.5 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.081 1.352 . . . . 0.0 108.433 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.478 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -87.43 -22.58 24.89 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 113.845 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.9 mt -67.15 -48.01 69.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.823 1.192 . . . . 0.0 110.638 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.66 -26.28 9.27 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.759 1.171 . . . . 0.0 112.328 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.13 33.55 3.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.57 -42.89 58.61 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.659 1.572 . . . . 0.0 111.131 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -61.63 -18.54 59.89 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 117.694 0.747 . . . . 0.0 112.538 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.67 11.83 7.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.081 1.752 . . . . 0.0 112.563 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.12 122.96 4.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.34 1.456 . . . . 0.0 108.682 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 52.33 28.72 5.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.133 0.973 . . . . 0.0 112.959 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.62 -39.66 94.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.519 -1.363 . . . . 0.0 110.72 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.32 73.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.113 0.565 . . . . 0.0 111.485 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.1 tp -59.91 -47.0 87.54 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.067 0.947 . . . . 0.0 110.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.85 97.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.9 mtm -66.47 -43.89 84.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.946 0.873 . . . . 0.0 111.717 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.557 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.6 mt -64.93 -34.58 78.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.455 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.7 -41.97 98.03 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.927 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.16 -42.28 89.22 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.536 1.134 . . . . 0.0 111.578 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.67 -58.44 7.5 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.798 1.239 . . . . 0.0 108.292 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.4 mt -78.17 -19.62 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.453 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 t -61.58 -28.8 69.6 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 110.298 168.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -22.94 52.58 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.628 -1.295 . . . . 0.0 109.608 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -83.64 4.66 27.54 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.236 1.814 . . . . 0.0 112.371 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.0 33.42 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.624 0.647 . . . . 0.0 112.032 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.87 170.91 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -115.5 143.18 45.69 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.43 147.01 33.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.936 0.789 . . . . 0.0 111.358 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.2 m -128.0 178.02 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.255 1.022 . . . . 0.0 109.081 170.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.49 37.26 31.57 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-O 118.615 -1.103 . . . . 0.0 114.126 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -79.32 144.2 34.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.647 1.724 . . . . 0.0 108.628 171.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -121.81 147.32 48.13 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 117.326 -1.321 . . . . 0.0 108.922 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.39 138.59 39.37 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 120.804 1.323 . . . . 0.0 109.596 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.0 p . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.806 1.643 . . . . 0.0 113.383 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 127' ' ' THR . 13.3 p90 -163.94 -58.88 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 O-C-N 121.767 -0.583 . . . . 0.0 109.709 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 126' ' ' PHE 0.327 2.7 t 58.83 10.15 1.41 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.505 2.722 . . . . 0.0 114.648 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -67.11 139.84 95.46 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.733 -1.229 . . . . 0.0 108.885 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.45 -13.28 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.504 2.136 . . . . 0.0 113.735 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -80.35 -48.84 1.23 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.7 37.65 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.017 1.756 . . . . 0.0 112.737 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 146.52 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 124.243 1.017 . . . . 0.0 109.74 -166.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.41 -172.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 126.024 1.73 . . . . 0.0 109.636 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.73 -116.53 0.86 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.173 1.389 . . . . 0.0 107.528 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.36 8.33 33.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.822 1.249 . . . . 0.0 112.068 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.53 20.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.73 1.157 . . . . 0.0 112.823 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -100.55 -17.33 17.14 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.744 1.218 . . . . 0.0 110.775 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.49 145.26 51.03 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.308 0.643 . . . . 0.0 111.088 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.1 m-85 -80.84 155.07 26.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.205 1.402 . . . . 0.0 110.005 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.1 m -66.86 -12.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.802 1.241 . . . . 0.0 112.869 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.11 -179.03 43.53 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 119.659 1.118 . . . . 0.0 112.454 -170.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.428 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 25.1 tp -66.06 128.52 36.39 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.68 119.86 40.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -120.4 159.36 25.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.652 1.181 . . . . 0.0 108.728 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.464 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -143.69 122.6 12.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.36 18.42 16.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.673 -169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 -20.49 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.878 0.871 . . . . 0.0 112.873 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.97 -53.51 2.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.198 1.363 . . . . 0.0 108.652 170.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.53 16.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -168.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.72 -26.28 9.07 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.933 0.893 . . . . 0.0 112.504 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.91 -26.81 54.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.175 0.99 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.13 -7.66 9.83 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.414 1.086 . . . . 0.0 112.257 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 m -50.47 -33.82 22.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.761 1.164 . . . . 0.0 110.31 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.49 -41.39 85.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.303 1.041 . . . . 0.0 111.742 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -33.43 65.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.866 1.266 . . . . 0.0 109.796 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -22.9 41.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.769 0.828 . . . . 0.0 110.363 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.16 -60.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.424 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.7 pt20 -55.78 -41.81 74.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.366 0.53 . . . . 0.0 112.331 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 60.0 p -66.56 -35.69 80.82 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.053 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 45.5 t90 -65.46 -43.26 90.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 109.528 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.1 m -58.74 -36.66 74.68 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 123.717 0.807 . . . . 0.0 109.575 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.29 -32.8 73.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.359 0.412 . . . . 0.0 111.175 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -77.14 -45.84 25.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.476 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -65.28 -38.28 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 120.878 1.672 . . . . 0.0 110.415 -173.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.26 -12.32 50.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.54 0.609 . . . . 0.0 112.267 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -95.02 -47.86 6.22 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.45 -35.69 78.32 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.846 0.748 . . . . 0.0 110.69 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.721 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.9 mtm -81.48 -39.83 24.18 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.249 1.019 . . . . 0.0 110.518 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.83 63.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.933 0.893 . . . . 0.0 110.916 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.64 -32.08 69.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.872 1.269 . . . . 0.0 109.436 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.46 ' CD2' HD11 ' A' ' 81' ' ' ILE . 61.6 t60 -62.78 -49.86 73.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -3.26 29.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.521 1.129 . . . . 0.0 113.555 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.511 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.92 146.15 51.54 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 126.504 1.922 . . . . 0.0 108.196 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -136.57 146.99 46.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.548 1.539 . . . . 0.0 109.271 -166.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.0 119.45 4.88 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.22 111.46 21.68 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.627 1.213 . . . . 0.0 108.315 169.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -107.3 144.68 33.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 111.167 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -161.79 175.91 11.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.548 0.739 . . . . 0.0 110.716 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.9 11.91 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -140.99 143.78 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.131 1.372 . . . . 0.0 110.58 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -93.29 -39.19 11.11 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.675 1.19 . . . . 0.0 109.857 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -96.56 -85.86 0.33 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 p -173.91 -4.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.97 2.508 . . . . 0.0 112.336 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -66.39 -43.38 86.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.956 -1.715 . . . . 0.0 111.402 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -34.74 76.77 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.61 -49.33 77.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.166 0.986 . . . . 0.0 109.985 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.2 mtm -66.33 -41.21 89.93 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.917 -0.489 . . . . 0.0 110.837 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.33 93.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.687 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.8 77.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.01 0.924 . . . . 0.0 110.553 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -59.13 -44.32 92.02 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.71 -55.04 30.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 124.762 1.288 . . . . 0.0 108.7 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.05 -56.08 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.07 0.85 . . . . 0.0 109.79 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -39.14 82.66 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.814 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.48 -47.76 69.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.042 0.537 . . . . 0.0 111.227 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.31 -47.53 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.014 1.326 . . . . 0.0 108.424 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -73.22 -48.99 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.669 0.788 . . . . 0.0 110.324 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.49 114.97 0.88 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.25 3.66 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.432 2.755 . . . . 0.0 112.875 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -73.8 -35.62 64.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.334 1.454 . . . . 0.0 109.18 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.96 -27.19 5.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.282 1.833 . . . . 0.0 110.872 -172.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 141.68 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 120.705 1.593 . . . . 0.0 109.569 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 m -133.38 129.83 37.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.572 1.149 . . . . 0.0 109.648 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.38 150.44 45.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.559 0.744 . . . . 0.0 111.921 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -145.64 112.23 5.88 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.423 1.889 . . . . 0.0 107.087 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -87.12 110.86 20.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.17 -8.76 26.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -58.35 -29.24 65.81 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.162 0.892 . . . . 0.0 111.538 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.93 -33.84 1.15 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -82.86 141.43 32.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.121 0.969 . . . . 0.0 108.756 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 m -84.74 141.69 38.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.79 -6.59 18.86 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.651 1.567 . . . . 0.0 111.734 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -55.42 -37.19 67.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.894 1.679 . . . . 0.0 111.706 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -19.3 65.8 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -11.8 16.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 112.534 170.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.61 -31.08 66.52 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 111.376 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.3 -46.29 42.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.722 0.772 . . . . 0.0 110.431 -169.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.99 149.36 50.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.912 1.285 . . . . 0.0 108.719 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -73.61 -25.05 60.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.872 0.869 . . . . 0.0 110.337 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 49' ' ' LEU . 41.0 t -151.93 147.55 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.684 1.993 . . . . 0.0 105.929 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.36 158.69 35.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.288 0.949 . . . . 0.0 111.034 168.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.58 121.53 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.38 136.13 54.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.45 120.16 3.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.3 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.5 131.47 24.44 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 119.091 1.445 . . . . 0.0 111.129 176.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.98 149.25 15.64 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.134 1.89 . . . . 0.0 108.331 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -96.09 128.38 42.94 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -121.11 171.28 8.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 109.84 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 30.65 54.89 0.19 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.983 2.513 . . . . 0.0 115.616 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 56.74 75.78 0.34 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 112.267 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 31.19 68.94 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.458 0.543 . . . . 0.0 114.458 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.19 156.13 17.38 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.727 1.611 . . . . 0.0 109.571 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.93 151.19 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -65.78 142.99 57.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.03 -27.16 68.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.226 -169.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -66.89 -26.15 66.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.883 0.873 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.506 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.4 m95 -84.45 -42.85 15.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.165 0.986 . . . . 0.0 110.782 171.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.42 -34.69 64.65 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.45 0.568 . . . . 0.0 110.978 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.57 71.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.576 1.15 . . . . 0.0 112.237 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.05 -10.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.541 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.1 t-105 -53.75 -28.85 36.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.476 1.51 . . . . 0.0 111.668 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.42 -44.51 67.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.81 1.244 . . . . 0.0 111.338 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.53 -27.94 66.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.438 1.095 . . . . 0.0 112.355 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.7 mt -57.24 -30.06 64.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.755 1.161 . . . . 0.0 111.409 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.95 -32.04 71.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.59 0.756 . . . . 0.0 111.366 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.96 -27.94 39.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 110.805 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.24 160.21 32.6 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.571 1.177 . . . . 0.0 111.431 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.3 96.27 10.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.163 -1.835 . . . . 0.0 108.572 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.0 4.73 13.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.131 0.967 . . . . 0.0 113.132 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -69.37 113.97 7.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.6 55.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.623 -1.098 . . . . 0.0 115.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.89 160.78 25.4 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.25 1.525 . . . . 0.0 109.697 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.529 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.5 mt -94.03 150.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 118.365 0.53 . . . . 0.0 109.993 -169.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.8 t -135.45 127.9 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.59 116.94 32.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.65 141.51 28.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.231 0.923 . . . . 0.0 111.327 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -137.39 162.21 34.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 177.76 38.62 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 121.037 -1.039 . . . . 0.0 111.931 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 mt -122.84 150.04 43.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.89 -157.9 11.49 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -157.33 137.31 12.51 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.031 1.332 . . . . 0.0 107.879 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.474 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -86.86 -21.43 26.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.54 -45.47 65.44 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.622 1.101 . . . . 0.0 110.776 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.94 -29.13 9.33 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.302 0.953 . . . . 0.0 112.423 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.09 33.83 3.87 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.07 -42.61 61.66 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 120.155 1.343 . . . . 0.0 111.29 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.46 -17.42 62.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.825 0.812 . . . . 0.0 112.728 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -127.06 10.45 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.915 1.686 . . . . 0.0 112.342 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -41.96 124.36 2.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.476 1.91 . . . . 0.0 110.393 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 49.47 29.01 2.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.322 1.049 . . . . 0.0 112.72 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.751 -1.218 . . . . 0.0 110.255 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.35 73.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.407 0.283 . . . . 0.0 111.094 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.662 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.0 tp -61.69 -46.57 89.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.186 0.994 . . . . 0.0 110.633 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.25 -41.92 98.51 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.2 mtm -65.6 -44.72 85.7 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.616 0.708 . . . . 0.0 111.783 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -64.74 -35.09 79.94 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.161 175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.77 -42.01 97.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.946 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.77 -43.45 88.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.615 1.166 . . . . 0.0 111.69 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -54.19 -58.97 5.37 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.516 1.126 . . . . 0.0 108.486 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.25 -19.05 57.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.741 -170.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 t -62.22 -29.37 70.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.365 0.984 . . . . 0.0 110.51 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -22.16 56.44 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.604 -1.31 . . . . 0.0 109.735 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -84.67 5.5 27.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.089 1.755 . . . . 0.0 112.935 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.05 35.15 90.2 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.25 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 124.326 1.051 . . . . 0.0 109.375 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.54 140.31 52.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -112.49 147.14 37.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 111.206 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -129.22 -178.96 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 109.335 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.6 34.01 41.0 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.006 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.97 146.17 39.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 119.694 1.747 . . . . 0.0 108.354 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 144.82 40.57 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-O 117.319 -1.324 . . . . 0.0 108.467 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.26 138.78 40.27 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 120.691 1.282 . . . . 0.0 109.22 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.479 HG22 ' CD1' ' A' ' 139' ' ' PHE . 68.0 p . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 125.985 1.714 . . . . 0.0 113.337 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.22 -46.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.438 1.017 . . . . 0.0 110.453 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.3 3.4 t 59.77 8.6 1.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.764 2.826 . . . . 0.0 115.179 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -90.15 147.86 37.99 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.975 1.31 . . . . 0.0 111.458 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.63 -9.33 5.77 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.955 2.436 . . . . 0.0 114.162 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -72.93 -55.01 4.25 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.26 40.52 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 121.553 1.59 . . . . 0.0 112.413 -168.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.68 149.24 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.588 1.085 . . . . 0.0 110.748 -166.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.27 -172.39 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 126.209 1.803 . . . . 0.0 109.86 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.95 -116.54 0.85 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.099 1.359 . . . . 0.0 107.81 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.28 8.24 33.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.974 1.309 . . . . 0.0 111.89 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.92 20.56 20.95 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.724 1.154 . . . . 0.0 112.618 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -99.43 -18.06 17.65 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.752 1.221 . . . . 0.0 110.782 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 143.35 50.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.231 0.612 . . . . 0.0 110.927 174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.0 m-85 -77.68 155.28 31.43 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.232 1.413 . . . . 0.0 109.64 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.8 m -65.18 -14.94 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 112.422 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.91 -178.15 42.72 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 119.763 1.165 . . . . 0.0 111.968 -173.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 13.9 tp -64.76 129.68 40.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.66 110.14 18.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.31 151.32 24.99 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.374 0.669 . . . . 0.0 109.716 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.87 138.02 25.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -107.87 30.84 5.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.132 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 t -133.09 -39.04 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.474 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.6 OUTLIER -88.04 -53.21 4.84 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.937 1.695 . . . . 0.0 106.76 171.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.7 16.89 23.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.015 1.326 . . . . 0.0 112.763 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -52.42 -27.92 17.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.214 0.915 . . . . 0.0 112.562 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.86 -19.57 30.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.996 0.518 . . . . 0.0 111.896 -173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.21 -2.96 7.54 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.968 1.307 . . . . 0.0 112.542 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 p -55.62 -32.39 63.09 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.869 1.213 . . . . 0.0 110.297 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.31 -42.03 90.43 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.401 1.08 . . . . 0.0 111.502 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -33.54 57.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.626 1.17 . . . . 0.0 109.941 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -70.01 -32.88 71.27 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.306 1.042 . . . . 0.0 108.413 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 52.8 mt -67.27 -59.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -58.37 -38.47 77.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.6 m -64.08 -37.8 88.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.667 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 36.2 t90 -66.5 -44.95 81.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.87 0.843 . . . . 0.0 110.168 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.1 m -56.93 -35.37 68.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.946 0.898 . . . . 0.0 109.72 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -70.76 -30.53 67.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.546 0.529 . . . . 0.0 109.852 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.77 -47.22 15.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.518 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.08 -39.71 86.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 CA-C-N 121.132 1.787 . . . . 0.0 110.36 -169.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.62 -14.11 56.54 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.369 0.667 . . . . 0.0 112.136 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.64 -45.98 6.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.37 -42.97 88.17 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.758 0.708 . . . . 0.0 109.525 -173.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.529 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -76.9 -36.31 56.75 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -174.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.45 63.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.133 0.973 . . . . 0.0 109.959 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.52 -32.02 73.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.23 1.412 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.55 -47.78 80.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.161 0.584 . . . . 0.0 110.382 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -6.13 48.03 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.208 1.003 . . . . 0.0 113.707 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 118.785 0.72 . . . . 0.0 110.645 -178.572 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.85 140.29 29.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.99 148.25 47.13 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.632 2.373 . . . . 0.0 108.815 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.55 118.66 4.7 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.01 112.49 23.43 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.945 1.373 . . . . 0.0 108.928 170.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.0 144.86 34.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.159 1.384 . . . . 0.0 111.219 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.51 175.6 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.949 0.899 . . . . 0.0 110.74 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.22 140.51 7.91 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.592 -2.603 . . . . 0.0 106.592 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 141.24 43.3 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.727 1.264 . . . . 0.0 109.444 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -83.25 -40.34 19.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.442 1.097 . . . . 0.0 109.723 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.6 p -96.7 -82.26 0.4 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.622 1.569 . . . . 0.0 107.271 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 p -177.71 -6.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 128.781 2.832 . . . . 0.0 111.619 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.22 -41.26 86.05 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 119.769 -1.832 . . . . 0.0 111.806 -168.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -35.05 74.95 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -63.32 -46.46 86.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.991 0.917 . . . . 0.0 110.326 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.9 -38.85 87.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.011 -0.431 . . . . 0.0 111.044 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.69 93.89 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.683 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.65 -47.22 77.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.041 0.936 . . . . 0.0 110.621 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.64 -44.52 93.49 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.81 -55.43 26.48 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 124.546 1.154 . . . . 0.0 109.112 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.11 -56.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 118.974 0.806 . . . . 0.0 109.719 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.17 77.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.636 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.28 -46.58 73.19 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.013 0.525 . . . . 0.0 111.347 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 158' ' ' GLN . 14.4 mt -67.39 -45.76 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.826 1.25 . . . . 0.0 108.417 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 164' ' ' ILE . 77.4 mt -71.95 -50.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.765 0.826 . . . . 0.0 110.241 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.51 114.27 0.79 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.489 1.042 . . . . 0.0 110.607 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.56 3.79 3.98 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.532 2.821 . . . . 0.0 112.681 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.8 -34.61 69.52 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.178 1.391 . . . . 0.0 109.194 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 -20.27 4.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.553 1.541 . . . . 0.0 111.602 -169.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.98 143.12 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.958 1.708 . . . . 0.0 109.083 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.6 m -133.68 129.24 36.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.562 1.145 . . . . 0.0 109.76 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.06 149.1 46.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.85 0.86 . . . . 0.0 111.687 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -144.09 112.32 6.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.445 1.898 . . . . 0.0 106.929 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -87.71 110.71 20.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.19 -8.39 31.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -59.77 -28.88 67.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.225 0.92 . . . . 0.0 111.476 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.36 -33.44 1.28 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.418 1.087 . . . . 0.0 112.285 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -83.34 140.6 32.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.218 1.007 . . . . 0.0 108.672 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m -84.88 141.63 38.27 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.05 -5.33 16.89 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.674 1.583 . . . . 0.0 111.764 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -54.06 -38.21 65.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.489 1.495 . . . . 0.0 111.338 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -20.55 66.27 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.116 -0.99 . . . . 0.0 113.16 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -12.23 27.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.331 1.053 . . . . 0.0 112.514 169.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -74.01 -26.26 60.34 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.941 -1.099 . . . . 0.0 110.581 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.31 -50.28 13.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.942 0.792 . . . . 0.0 110.106 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.89 146.16 55.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.575 1.15 . . . . 0.0 108.666 -169.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.72 -25.84 54.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.486 0.66 . . . . 0.0 110.648 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -145.54 140.36 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.09 155.77 41.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.648 0.658 . . . . 0.0 110.769 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.28 121.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 168.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 138.25 54.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.03 122.93 3.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-O 118.076 -1.402 . . . . 0.0 112.687 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.75 130.14 24.56 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.66 1.184 . . . . 0.0 110.307 177.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.04 146.69 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.352 2.035 . . . . 0.0 108.368 167.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -93.53 129.35 39.78 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -122.74 172.23 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.228 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 26.25 57.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 128.796 2.838 . . . . 0.0 115.702 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 57.84 76.11 0.34 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.412 1.485 . . . . 0.0 111.722 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.29 73.57 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.75 158.33 21.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.809 1.244 . . . . 0.0 109.68 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.56 151.6 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.02 143.59 57.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.47 -26.74 68.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.141 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -66.67 -26.7 67.17 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.525 0.73 . . . . 0.0 110.74 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -84.64 -42.36 15.43 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.16 0.984 . . . . 0.0 110.702 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.34 -34.34 64.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.206 0.457 . . . . 0.0 111.039 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.257 1.023 . . . . 0.0 112.16 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.04 -10.86 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.548 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.1 t-105 -53.62 -29.02 36.01 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.639 1.576 . . . . 0.0 111.849 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.57 -43.32 69.7 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.989 1.316 . . . . 0.0 111.302 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.62 -29.34 66.82 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.549 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.74 -33.31 68.32 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.17 1.35 . . . . 0.0 110.747 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.84 -29.15 68.99 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.927 0.891 . . . . 0.0 111.795 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -80.96 -24.52 38.03 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.976 0.511 . . . . 0.0 111.256 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -74.21 162.61 28.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.919 1.342 . . . . 0.0 112.23 -168.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -98.41 99.02 10.16 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.568 1.947 . . . . 0.0 108.842 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.8 10.48 15.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.9 121.22 12.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -169.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.75 -0.88 89.38 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.572 1.558 . . . . 0.0 115.17 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -73.75 154.21 39.69 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 118.239 1.019 . . . . 0.0 109.681 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.702 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.2 mt -91.28 140.67 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.46 130.15 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 124.706 1.202 . . . . 0.0 109.012 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -109.57 115.5 30.03 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 mt -86.95 143.02 27.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.869 0.759 . . . . 0.0 111.455 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -137.7 161.27 36.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.24 176.5 39.44 Favored Glycine 0 CA--C 1.506 -0.488 0 O-C-N 120.844 -1.16 . . . . 0.0 112.558 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.6 mt -121.0 153.33 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.91 -153.9 9.22 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -154.02 142.48 20.69 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.973 1.709 . . . . 0.0 108.099 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.425 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -90.58 -23.38 20.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 175.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.14 -36.97 80.53 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.805 1.184 . . . . 0.0 112.027 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.7 -27.51 58.79 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -69.07 0.25 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.674 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.31 -39.54 3.09 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.576 1.56 . . . . 0.0 110.385 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.9 mm-40 -76.71 -35.35 57.91 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.59 -13.43 56.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.879 1.672 . . . . 0.0 111.528 -173.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -50.92 123.87 10.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 126.614 1.966 . . . . 0.0 109.322 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.0 26.71 4.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.259 1.023 . . . . 0.0 112.597 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.88 -37.33 86.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.688 -1.257 . . . . 0.0 110.622 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -32.74 73.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.825 0.45 . . . . 0.0 111.761 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.675 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -60.93 -47.72 85.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.86 -40.83 97.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.7 mtm -65.61 -43.83 88.41 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.829 0.814 . . . . 0.0 112.376 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 53' ' ' ILE . 3.7 mt -63.84 -33.82 76.55 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.567 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.55 -38.27 86.74 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.265 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.46 -30.54 64.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.091 2.156 . . . . 0.0 112.019 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -63.46 -62.01 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.07 -19.1 58.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.028 -0.986 . . . . 0.0 112.577 -166.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.1 p -60.23 -31.35 70.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.75 1.159 . . . . 0.0 111.125 169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -23.11 47.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -77.96 2.16 18.43 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.671 1.188 . . . . 0.0 112.414 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.79 32.88 66.54 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.999 0.818 . . . . 0.0 112.113 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.49 176.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.843 0.857 . . . . 0.0 109.743 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 146.92 47.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 166.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.6 149.01 31.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.991 0.814 . . . . 0.0 111.8 -169.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.5 m -127.39 -179.76 3.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.326 1.05 . . . . 0.0 108.977 169.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.83 33.5 46.18 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.986 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.6 m-30 -78.09 144.04 36.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.765 1.783 . . . . 0.0 108.47 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -119.32 145.43 38.56 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-O 117.344 -1.312 . . . . 0.0 108.662 171.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.16 138.33 43.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.708 1.289 . . . . 0.0 109.215 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.462 HG22 ' CD1' ' A' ' 139' ' ' PHE . 69.0 p . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 125.661 1.585 . . . . 0.0 113.582 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -164.68 -54.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.867 0.758 . . . . 0.0 109.696 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 3.8 t 57.96 8.18 0.7 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.19 2.596 . . . . 0.0 114.624 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -63.97 140.49 97.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 121.113 -0.992 . . . . 0.0 109.531 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.84 -11.5 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.834 2.356 . . . . 0.0 112.863 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -75.64 -52.35 2.84 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.922 1.237 . . . . 0.0 114.112 -168.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.04 42.02 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.944 1.73 . . . . 0.0 111.609 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.58 150.5 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.815 -1.178 . . . . 0.0 110.147 -167.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.84 -172.38 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 126.11 1.764 . . . . 0.0 109.913 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.4 -116.58 0.81 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.566 1.547 . . . . 0.0 107.487 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.1 8.93 34.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.844 1.257 . . . . 0.0 111.764 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.72 21.13 22.34 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.808 1.194 . . . . 0.0 112.486 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.24 -18.4 17.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.865 1.266 . . . . 0.0 110.586 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.71 142.49 49.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 111.311 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 121' ' ' THR . 60.3 m-85 -77.38 155.5 31.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.182 1.393 . . . . 0.0 109.923 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.97 -12.87 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.601 1.16 . . . . 0.0 112.428 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.22 -178.85 43.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 119.907 1.23 . . . . 0.0 112.322 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 18.9 tp -65.46 130.26 42.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.09 117.71 33.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.9 mt -113.9 152.08 31.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.92 0.888 . . . . 0.0 108.723 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -145.59 128.22 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -102.47 17.89 22.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.59 1.156 . . . . 0.0 110.408 -171.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.62 -21.55 5.65 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.425 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.4 OUTLIER -112.71 -49.02 2.96 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.03 1.332 . . . . 0.0 108.25 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.55 19.31 20.59 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.107 1.363 . . . . 0.0 113.664 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -52.96 -22.99 6.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.58 -25.35 30.99 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.857 0.863 . . . . 0.0 111.864 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -120.56 -10.13 9.29 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -55.36 -32.41 62.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.096 1.316 . . . . 0.0 110.854 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.59 -40.42 83.13 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.603 1.161 . . . . 0.0 111.731 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -31.75 62.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.291 1.037 . . . . 0.0 109.786 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -78.88 -28.97 44.16 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.7 mt -63.12 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -58.0 -41.58 83.37 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.2 m -63.23 -37.05 85.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.772 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 42.4 t90 -67.12 -44.37 80.07 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.716 0.77 . . . . 0.0 110.22 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.3 m -57.11 -36.13 70.26 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.087 0.955 . . . . 0.0 109.506 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.78 -29.02 66.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.338 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.03 -46.55 16.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.318 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 25' ' ' ILE . 4.7 pt -64.43 -38.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.961 1.709 . . . . 0.0 110.271 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.2 -15.59 60.24 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.228 0.611 . . . . 0.0 112.036 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -95.92 -46.39 6.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.66 -40.43 83.47 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.711 0.687 . . . . 0.0 109.755 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.702 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -79.19 -37.99 36.92 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.737 0.815 . . . . 0.0 110.983 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.01 -46.77 70.32 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.008 0.923 . . . . 0.0 109.901 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.62 -29.88 69.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.106 1.362 . . . . 0.0 109.777 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -63.6 -48.47 77.21 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.553 0.615 . . . . 0.0 110.506 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.52 50.1 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.414 1.086 . . . . 0.0 113.741 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.485 178.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 119.704 -0.188 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.56 140.62 30.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -129.27 146.78 51.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.648 1.979 . . . . 0.0 108.947 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.27 117.63 4.77 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.597 -1.113 . . . . 0.0 110.445 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.82 113.32 23.37 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 119.254 1.527 . . . . 0.0 108.354 169.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -108.87 145.04 35.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.913 1.285 . . . . 0.0 111.442 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -159.96 173.35 16.02 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.652 0.781 . . . . 0.0 109.927 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.49 139.95 8.66 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -141.48 131.85 25.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.395 1.478 . . . . 0.0 108.837 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.7 m -84.29 -28.93 26.79 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.741 0.246 . . . . 0.0 110.739 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.1 p -112.47 -79.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.448 1.099 . . . . 0.0 108.165 -172.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.8 p -173.04 -13.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.18 -42.64 79.65 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 119.711 -1.868 . . . . 0.0 113.333 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -34.38 77.77 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.48 -49.25 76.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.454 1.102 . . . . 0.0 109.866 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.3 mtm -66.34 -41.83 89.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.346 0.521 . . . . 0.0 111.182 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.19 94.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.005 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.48 77.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 123.863 0.865 . . . . 0.0 110.436 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.88 -44.26 91.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -63.39 -54.93 29.1 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 124.79 1.306 . . . . 0.0 108.996 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.07 -56.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.956 0.798 . . . . 0.0 109.716 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -39.11 83.02 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.3 -46.92 72.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.939 0.496 . . . . 0.0 111.227 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -66.17 -46.62 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.962 1.305 . . . . 0.0 108.596 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 164' ' ' ILE . 83.3 mt -72.66 -50.23 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.93 114.34 0.78 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.399 1.0 . . . . 0.0 110.67 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.12 4.03 3.57 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.494 2.796 . . . . 0.0 112.814 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.56 -34.05 64.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.505 1.522 . . . . 0.0 109.149 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.26 -22.77 3.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.772 1.629 . . . . 0.0 111.409 -169.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.16 140.73 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.657 1.571 . . . . 0.0 109.091 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.5 m -130.17 129.09 43.0 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.485 1.114 . . . . 0.0 109.679 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.42 148.96 46.39 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.481 0.712 . . . . 0.0 111.942 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -142.88 110.46 5.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.429 1.892 . . . . 0.0 106.621 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -86.74 110.65 20.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.0 -8.07 20.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -60.62 -28.04 68.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.25 0.932 . . . . 0.0 111.729 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -132.33 -33.97 1.25 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.77 1.228 . . . . 0.0 111.886 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -82.73 140.77 32.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.091 0.957 . . . . 0.0 108.565 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 m -83.96 140.82 40.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -74.13 -1.9 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.163 1.451 . . . . 0.0 110.983 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -56.36 -33.97 66.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.246 2.293 . . . . 0.0 111.921 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -19.36 64.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.428 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.0 ttm -58.17 -16.34 13.13 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.266 2.226 . . . . 0.0 111.702 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -73.65 -31.14 63.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.056 -1.027 . . . . 0.0 110.795 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -78.16 -47.07 18.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.341 0.591 . . . . 0.0 110.019 -169.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -65.84 140.33 58.38 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.58 -169.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.5 -17.16 56.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.41 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.55 149.9 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 126.434 1.893 . . . . 0.0 106.069 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.428 HD13 ' CG ' ' A' ' 43' ' ' MET . 8.1 mt -138.34 151.31 47.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.667 0.787 . . . . 0.0 109.218 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.36 121.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.0 135.75 54.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.19 122.79 4.37 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-O 117.773 -1.57 . . . . 0.0 113.12 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.5 126.61 25.78 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 119.286 1.543 . . . . 0.0 110.63 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.44 144.66 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.689 2.259 . . . . 0.0 107.799 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -87.81 131.27 34.59 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.98 169.47 10.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.22 1.808 . . . . 0.0 109.62 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 28.85 54.67 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.275 2.63 . . . . 0.0 115.319 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 55.98 78.73 0.19 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.312 1.445 . . . . 0.0 112.23 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 13.49 76.11 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.07 160.8 19.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.555 1.142 . . . . 0.0 109.125 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 mt -92.18 154.64 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -59.13 140.82 55.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.99 0.916 . . . . 0.0 108.787 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.83 -28.92 69.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -80.33 -20.95 43.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.642 -0.661 . . . . 0.0 110.58 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.497 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.1 m95 -77.0 -44.31 31.44 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.83 169.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -53.33 -35.85 60.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.473 0.709 . . . . 0.0 110.751 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.4 71.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.008 0.923 . . . . 0.0 112.209 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.44 -9.78 11.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.56 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.6 t-105 -53.32 -29.46 33.84 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 111.71 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.32 -44.76 74.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.959 1.304 . . . . 0.0 111.459 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -68.48 -29.67 68.34 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.113 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.5 mt -57.65 -31.06 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.995 1.27 . . . . 0.0 111.122 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.56 -28.95 65.3 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.499 0.72 . . . . 0.0 111.205 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.02 -23.34 38.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.139 0.576 . . . . 0.0 111.173 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 mt -72.94 157.84 36.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 123.038 1.399 . . . . 0.0 112.878 -167.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -90.94 91.53 8.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.738 -2.028 . . . . 0.0 107.978 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -111.38 11.63 21.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.84 128.33 35.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.06 30.86 69.57 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.294 0.95 . . . . 0.0 114.469 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.91 156.68 34.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.59 1.195 . . . . 0.0 109.633 169.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.656 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.4 mt -88.63 146.81 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.37 130.17 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.084 1.354 . . . . 0.0 109.263 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.06 117.93 35.07 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.05 143.13 27.05 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.389 0.995 . . . . 0.0 112.085 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -136.38 156.04 49.19 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.229 1.011 . . . . 0.0 109.13 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.55 164.54 35.16 Favored Glycine 0 CA--C 1.506 -0.475 0 O-C-N 120.801 -1.187 . . . . 0.0 112.154 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.4 158.63 36.79 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.57 -137.75 3.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.5 150.81 21.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.535 1.934 . . . . 0.0 108.046 168.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.593 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -89.08 -31.29 18.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.919 1.688 . . . . 0.0 114.149 173.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.6 -33.25 62.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.487 1.04 . . . . 0.0 113.082 -167.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.52 -19.33 35.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 124.788 1.185 . . . . 0.0 111.206 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 95' ' ' GLU . 26.8 m-85 -126.85 -90.07 0.54 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.547 1.139 . . . . 0.0 108.721 -170.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.59 -50.8 2.55 Favored Glycine 0 N--CA 1.464 0.555 0 C-N-CA 128.517 2.96 . . . . 0.0 107.755 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' TYR . 12.3 mm-40 -69.65 -30.63 68.38 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.67 1.988 . . . . 0.0 110.536 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -115.14 0.73 13.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.75 1.22 . . . . 0.0 112.021 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.91 127.04 24.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.883 1.273 . . . . 0.0 109.545 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 56.28 23.8 7.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.57 1.548 . . . . 0.0 113.666 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.74 -36.78 78.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.551 -1.343 . . . . 0.0 110.698 -171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.64 72.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.104 0.561 . . . . 0.0 111.467 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.656 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.38 -46.76 88.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.799 0.84 . . . . 0.0 110.756 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.52 96.44 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.8 mtm -66.07 -44.94 83.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 117.712 0.756 . . . . 0.0 112.152 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.56 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.2 mt -64.33 -32.82 74.58 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.606 1.094 . . . . 0.0 111.807 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -63.53 -40.11 96.17 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.109 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.0 -36.13 69.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.758 1.623 . . . . 0.0 112.204 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.4 tptt -57.42 -47.03 82.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.688 0.795 . . . . 0.0 109.894 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -93.76 -20.65 19.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.037 -0.983 . . . . 0.0 112.33 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.2 p -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.748 1.613 . . . . 0.0 111.665 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -79.15 -17.43 55.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.071 0.548 . . . . 0.0 110.059 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -79.54 1.42 25.96 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.114 1.366 . . . . 0.0 111.943 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.01 34.79 58.34 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.941 0.792 . . . . 0.0 111.908 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.43 171.9 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.961 0.904 . . . . 0.0 109.787 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -121.09 142.91 49.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.44 150.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.903 1.229 . . . . 0.0 111.999 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.8 m -129.88 -178.66 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.649 1.179 . . . . 0.0 109.157 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 33.9 43.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-O 118.417 -1.213 . . . . 0.0 113.977 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -71.8 147.32 47.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.437 1.619 . . . . 0.0 107.784 170.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.66 144.98 51.69 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.236 169.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -69.58 140.12 42.57 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-N 121.012 1.397 . . . . 0.0 109.472 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.509 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p . . . . . 0 CA--C 1.539 0.556 0 C-N-CA 125.568 1.547 . . . . 0.0 113.555 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -167.15 -57.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -170.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 2.9 t 56.2 7.52 0.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.844 2.858 . . . . 0.0 114.364 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -69.61 144.17 93.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 120.991 -1.068 . . . . 0.0 110.515 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.84 -14.5 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.722 2.281 . . . . 0.0 113.76 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -80.53 -48.98 1.18 Allowed Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.26 39.33 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.383 2.056 . . . . 0.0 112.579 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 148.43 21.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 109.589 -167.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -172.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.998 1.719 . . . . 0.0 109.666 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.85 -116.37 0.84 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.135 1.374 . . . . 0.0 107.306 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.38 7.8 33.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 112.202 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.28 20.13 18.85 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.996 1.284 . . . . 0.0 112.475 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.02 -17.11 17.66 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.686 1.194 . . . . 0.0 110.668 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 144.04 50.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 110.879 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.509 ' CD1' HG22 ' A' ' 121' ' ' THR . 50.4 m-85 -78.26 154.87 30.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.953 1.301 . . . . 0.0 109.246 174.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.42 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.1 m -65.44 -14.91 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.15 -176.31 40.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.561 1.073 . . . . 0.0 111.901 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 16.3 tp -65.66 129.55 40.17 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.22 129.66 55.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.9 mt -130.47 158.68 39.24 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.724 1.61 . . . . 0.0 109.215 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.466 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -137.0 125.6 23.71 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.025 176.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -98.91 6.35 46.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.534 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -20.7 11.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.244 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.23 -42.33 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 112.675 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.13 7.2 19.6 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.091 0.86 . . . . 0.0 112.808 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -55.58 -21.55 17.89 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.522 1.056 . . . . 0.0 113.088 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.57 -25.61 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 111.536 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.0 pp -129.26 3.8 5.19 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.08 0.952 . . . . 0.0 112.446 -169.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -50.96 -29.4 12.11 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.81 -1.181 . . . . 0.0 110.842 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.36 -39.29 94.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.747 1.619 . . . . 0.0 110.604 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.28 -46.35 56.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 129.374 3.07 . . . . 0.0 108.194 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -25.39 62.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.841 -1.981 . . . . 0.0 108.273 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.28 -62.33 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -57.17 -37.34 71.96 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.2 m -63.53 -38.39 90.93 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.428 0.455 . . . . 0.0 110.751 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -66.52 -44.56 82.13 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.438 -0.788 . . . . 0.0 110.179 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 72.8 m -55.89 -35.53 66.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.553 0.741 . . . . 0.0 109.809 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -33.58 76.28 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.485 0.491 . . . . 0.0 110.259 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -81.93 -46.14 14.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.498 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 25' ' ' ILE . 5.3 pt -64.55 -39.47 85.69 Favored 'Isoleucine or valine' 0 C--N 1.337 0.061 0 CA-C-N 121.417 1.917 . . . . 0.0 109.977 -169.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.6 -14.25 57.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -96.44 -45.65 6.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.885 1.274 . . . . 0.0 107.888 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.29 -41.08 88.13 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.886 0.767 . . . . 0.0 109.724 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.656 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -77.37 -35.65 54.32 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.169 0.988 . . . . 0.0 110.951 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.48 -47.32 42.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.335 1.054 . . . . 0.0 110.004 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.53 -29.56 68.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.405 1.482 . . . . 0.0 110.129 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -60.66 -45.78 92.82 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.266 0.485 . . . . 0.0 110.302 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.78 -1.63 58.09 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 114.055 -174.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.422 177.934 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 145.26 30.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.876 1.27 . . . . 0.0 108.636 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 48' ' ' VAL . 13.8 mtm -130.45 147.25 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.127 1.771 . . . . 0.0 108.984 -168.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.4 118.63 5.07 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 118.81 -0.995 . . . . 0.0 110.947 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.09 105.9 18.12 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.86 1.33 . . . . 0.0 109.952 171.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -105.0 145.74 30.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.47 1.508 . . . . 0.0 111.301 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -164.93 175.47 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.007 0.923 . . . . 0.0 110.431 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.91 142.33 10.02 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 168.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -146.52 147.69 31.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.25 1.025 . . . . 0.0 111.401 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -95.79 -45.89 6.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.543 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.5 p -90.19 -10.93 42.6 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.006 1.722 . . . . 0.0 111.41 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.276 44.5 m 73.64 13.67 4.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.2 2.2 . . . . 0.0 113.697 -168.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.6 -44.2 94.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.593 1.542 . . . . 0.0 110.764 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -34.29 77.28 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -64.45 -49.07 72.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.409 1.084 . . . . 0.0 109.99 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.8 -38.89 92.51 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.94 -0.475 . . . . 0.0 111.151 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.76 97.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.848 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.13 79.03 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.776 0.83 . . . . 0.0 110.611 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.37 -46.74 83.06 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.903 0.481 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.32 -54.86 34.44 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 124.732 1.27 . . . . 0.0 108.923 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.413 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.41 -56.87 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 118.447 0.567 . . . . 0.0 109.584 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -38.99 72.81 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.343 0.657 . . . . 0.0 110.539 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.62 -48.1 67.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.992 0.517 . . . . 0.0 111.201 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 158' ' ' GLN . 17.8 mt -64.64 -47.11 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.996 1.318 . . . . 0.0 108.8 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.5 mt -72.58 -51.55 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.783 0.833 . . . . 0.0 110.52 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.67 115.59 0.76 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.44 3.54 4.11 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.29 2.66 . . . . 0.0 112.98 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.73 -35.12 65.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.25 1.42 . . . . 0.0 108.966 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -26.96 5.57 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.067 1.747 . . . . 0.0 111.369 -173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.47 140.43 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 120.781 1.628 . . . . 0.0 109.088 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.7 m -129.91 129.62 44.1 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.54 1.136 . . . . 0.0 110.073 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.79 148.99 47.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.875 0.87 . . . . 0.0 112.154 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -145.21 108.84 4.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.697 1.599 . . . . 0.0 107.762 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -82.31 112.03 18.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.77 -9.44 36.92 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -59.12 -28.49 66.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.422 1.01 . . . . 0.0 111.509 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.64 -34.22 1.56 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.473 1.109 . . . . 0.0 112.112 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.26 140.2 33.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 m -82.95 139.72 42.97 Favored Pre-proline 0 N--CA 1.452 -0.358 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.81 -1.62 11.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 121.172 1.454 . . . . 0.0 111.425 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 122.153 2.251 . . . . 0.0 111.713 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -18.78 64.68 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.431 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.2 ttm -58.91 -15.62 13.66 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.993 2.117 . . . . 0.0 111.971 169.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.1 -32.99 63.45 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.191 -0.943 . . . . 0.0 110.601 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.62 -48.11 28.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.58 0.705 . . . . 0.0 110.04 -170.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -70.86 131.86 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.94 -3.34 58.9 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 3' ' ' MET . 74.8 t -140.57 146.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.6 mt -140.63 153.86 46.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.999 0.52 . . . . 0.0 109.789 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -129.32 122.84 56.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 mp -119.73 136.71 54.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -130.2 119.71 2.87 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 117.957 -1.468 . . . . 0.0 112.785 -171.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.698 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -125.03 133.64 25.0 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.046 1.423 . . . . 0.0 110.309 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.74 157.07 15.97 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.222 1.948 . . . . 0.0 108.717 166.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -101.22 125.26 47.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -113.71 172.18 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.802 1.641 . . . . 0.0 109.829 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.96 62.5 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.793 2.837 . . . . 0.0 115.225 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 55.93 71.52 0.55 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 112.363 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.27 79.34 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.27 155.39 24.87 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.548 1.139 . . . . 0.0 109.948 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.25 151.61 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -65.8 143.5 57.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.91 -26.67 68.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.035 -169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.03 -26.7 66.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.674 0.789 . . . . 0.0 110.761 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.1 m95 -83.99 -42.74 15.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.108 0.963 . . . . 0.0 110.71 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.41 -34.92 64.82 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.581 0.628 . . . . 0.0 110.819 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.7 71.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.359 1.064 . . . . 0.0 112.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.31 -11.46 10.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t-105 -53.52 -28.98 34.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.653 1.581 . . . . 0.0 111.724 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.29 -44.68 64.73 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.006 1.322 . . . . 0.0 111.384 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.73 -30.37 70.58 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.568 -1.206 . . . . 0.0 111.95 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.703 1.138 . . . . 0.0 111.096 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.14 -31.33 70.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 111.421 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.41 -26.44 38.46 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.355 0.662 . . . . 0.0 110.887 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.24 159.79 33.37 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.565 1.174 . . . . 0.0 112.062 -169.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.68 96.85 10.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 112.832 -1.986 . . . . 0.0 108.215 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -118.92 6.6 11.4 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.122 0.969 . . . . 0.0 113.141 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.0 118.35 11.8 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -168.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.79 70.5 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.943 1.259 . . . . 0.0 115.687 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -110.68 154.74 23.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.083 1.441 . . . . 0.0 109.106 171.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.5 mt -85.21 143.78 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 118.87 0.759 . . . . 0.0 109.283 -172.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.5 t -132.44 134.13 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.526 1.53 . . . . 0.0 109.854 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.77 120.6 41.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.1 143.68 26.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 119.145 0.884 . . . . 0.0 111.644 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 21.2 p90 -137.13 159.39 42.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.37 178.13 39.08 Favored Glycine 0 N--CA 1.448 -0.555 0 O-C-N 121.044 -1.035 . . . . 0.0 112.524 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -127.67 151.12 49.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.73 -157.76 9.85 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -155.12 137.68 15.11 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.606 1.562 . . . . 0.0 108.333 168.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.443 HE22 ' CG ' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -90.57 -20.76 22.24 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.74 -49.33 68.81 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.781 1.173 . . . . 0.0 110.836 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.53 -27.36 8.6 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.189 0.9 . . . . 0.0 112.149 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -131.4 33.07 4.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -166.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.45 -42.66 57.55 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-N 120.354 1.434 . . . . 0.0 111.012 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.82 -19.75 60.35 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 117.986 0.893 . . . . 0.0 112.318 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -125.84 12.56 7.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.871 1.668 . . . . 0.0 112.432 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -45.61 122.05 3.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.487 1.515 . . . . 0.0 108.679 170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 52.86 28.2 6.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.033 0.933 . . . . 0.0 112.971 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.91 -40.29 94.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 120.648 -1.282 . . . . 0.0 110.113 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.94 -33.75 76.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 111.709 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.698 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.6 tp -59.96 -47.72 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 110.456 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.11 97.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.3 mtm -65.02 -44.56 88.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.01 0.905 . . . . 0.0 111.78 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 53' ' ' ILE . 3.9 mt -64.43 -35.44 80.93 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.295 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -64.24 -41.46 96.98 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.387 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.34 -42.6 92.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -55.06 -59.49 4.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.267 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.26 -20.84 57.01 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.628 -0.67 . . . . 0.0 110.794 -170.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.8 t -62.2 -30.29 70.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.165 0.893 . . . . 0.0 110.304 168.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -24.12 48.66 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.7 -1.25 . . . . 0.0 109.279 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -81.19 2.38 27.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.025 1.73 . . . . 0.0 112.59 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.69 33.15 79.83 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 118.643 0.656 . . . . 0.0 112.102 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.18 169.51 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 117.619 0.709 . . . . 0.0 109.468 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -113.61 140.25 48.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.45 148.08 32.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.072 1.305 . . . . 0.0 112.43 -168.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.8 m -128.6 -179.98 3.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.817 1.247 . . . . 0.0 109.577 168.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.77 33.41 33.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 118.342 -1.254 . . . . 0.0 114.741 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -78.86 139.6 38.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.933 1.866 . . . . 0.0 108.784 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 148.96 42.1 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.59 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.33 138.99 37.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 120.949 1.375 . . . . 0.0 109.108 168.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 139' ' ' PHE . 60.2 p . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 113.441 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 127' ' ' THR . 12.9 p90 -162.49 -61.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.167 0.894 . . . . 0.0 110.07 -172.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 126' ' ' PHE 0.333 2.1 t 58.74 11.13 1.69 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.575 2.75 . . . . 0.0 114.801 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 p -66.47 142.87 97.94 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.851 -1.156 . . . . 0.0 109.095 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.75 -15.36 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.283 1.989 . . . . 0.0 113.852 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -80.81 -48.21 1.15 Allowed Pre-proline 0 C--N 1.344 0.344 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.34 36.63 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.705 1.603 . . . . 0.0 112.484 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.093 0.957 . . . . 0.0 109.843 -166.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.77 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 109.456 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.94 -116.83 0.86 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.959 1.304 . . . . 0.0 107.62 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.14 7.82 33.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.761 1.224 . . . . 0.0 111.831 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.68 20.1 20.4 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.724 1.154 . . . . 0.0 112.575 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -100.36 -17.25 17.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.852 1.261 . . . . 0.0 110.859 -172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 145.29 51.25 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.286 0.634 . . . . 0.0 110.876 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.2 m-85 -81.27 155.45 26.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 110.221 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.02 -12.44 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.725 1.21 . . . . 0.0 112.755 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.67 -178.28 42.64 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.612 1.097 . . . . 0.0 111.879 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 22.2 tp -65.54 127.92 33.81 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.55 116.02 29.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.15 157.57 24.6 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.443 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -140.13 121.98 15.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -98.97 17.26 20.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.883 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.94 -23.57 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.17 -52.6 2.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.702 1.137 . . . . 0.0 109.18 172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -98.16 14.46 27.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.52 1.128 . . . . 0.0 113.896 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -52.07 -26.13 10.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.906 0.882 . . . . 0.0 112.485 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.37 -27.9 46.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 111.38 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -7.03 13.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.045 0.938 . . . . 0.0 111.218 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.2 m -53.07 -26.91 17.7 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.719 -1.238 . . . . 0.0 110.862 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.16 -40.18 90.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 122.035 0.921 . . . . 0.0 110.269 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -70.92 -46.2 62.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 129.827 3.251 . . . . 0.0 107.825 -177.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -69.49 -28.12 65.79 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.199 -1.819 . . . . 0.0 108.322 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.34 -61.05 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.493 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -56.88 -41.19 77.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 118.908 0.776 . . . . 0.0 112.259 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 m -65.59 -35.68 81.52 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.635 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 49.0 t90 -66.65 -43.95 83.26 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.464 -0.772 . . . . 0.0 109.79 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 92.7 m -57.55 -35.49 70.4 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.903 0.881 . . . . 0.0 109.644 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.12 -27.99 63.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.014 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -80.2 -46.41 16.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.148 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.2 -39.54 85.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 121.308 1.867 . . . . 0.0 110.614 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.11 -15.37 59.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -96.53 -45.11 6.87 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 124.683 1.193 . . . . 0.0 107.799 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.31 -42.02 90.41 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.122 0.874 . . . . 0.0 109.574 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.653 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.9 mtm -74.36 -41.92 60.23 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.142 0.977 . . . . 0.0 110.081 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.94 -44.41 80.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.286 1.035 . . . . 0.0 110.647 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -69.81 -32.2 70.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.082 1.353 . . . . 0.0 109.785 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -61.53 -42.44 98.82 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.474 0.654 . . . . 0.0 109.913 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -2.16 35.6 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.02 1.728 . . . . 0.0 113.758 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-N 118.406 0.548 . . . . 0.0 110.567 -179.204 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.14 142.54 33.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 mtm -131.14 146.43 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.648 1.979 . . . . 0.0 108.276 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.55 117.94 5.0 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 118.637 -1.091 . . . . 0.0 110.397 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.72 113.12 24.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.268 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -109.92 147.36 33.57 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.77 1.628 . . . . 0.0 111.451 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -164.13 175.25 10.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.748 1.219 . . . . 0.0 109.704 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.54 142.95 11.16 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 168.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -148.87 144.61 27.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.303 1.051 . . . . 0.0 111.452 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 m -96.07 -37.87 10.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 111.389 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -95.09 -8.9 35.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 111.594 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.264 56.9 m 71.5 15.01 6.22 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.745 2.018 . . . . 0.0 114.121 -170.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -65.28 -42.94 92.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.434 1.47 . . . . 0.0 110.353 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.18 -33.66 75.88 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -64.3 -46.93 81.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.0 110.096 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 -40.85 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.592 -0.692 . . . . 0.0 111.548 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.4 94.02 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.638 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.37 79.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.902 0.881 . . . . 0.0 110.788 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.34 -45.3 88.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -61.73 -54.33 43.92 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 124.701 1.251 . . . . 0.0 108.725 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.1 mt -53.58 -56.73 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.852 0.751 . . . . 0.0 109.958 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.22 76.75 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.0 0.52 . . . . 0.0 110.484 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.92 -48.01 69.96 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.995 0.518 . . . . 0.0 111.21 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -65.27 -47.28 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.133 0.973 . . . . 0.0 108.533 -176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.83 -50.49 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.383 0.673 . . . . 0.0 110.402 -175.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.29 113.69 0.73 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 171.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.15 4.08 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.357 2.705 . . . . 0.0 112.69 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.89 -34.4 66.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.022 1.329 . . . . 0.0 109.228 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.86 -21.33 4.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.558 1.543 . . . . 0.0 111.814 -169.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -94.04 141.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 120.659 1.572 . . . . 0.0 109.028 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 m -130.44 128.23 40.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 110.006 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.41 148.66 48.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.932 0.893 . . . . 0.0 112.163 174.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.25 109.7 4.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.094 1.758 . . . . 0.0 107.41 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -83.82 112.11 19.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.16 -10.53 42.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -58.06 -29.11 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.19 0.905 . . . . 0.0 111.542 169.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.34 -34.37 1.62 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.573 1.149 . . . . 0.0 112.08 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.26 140.27 33.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -84.01 139.98 39.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.97 -4.46 15.18 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.087 1.424 . . . . 0.0 111.643 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -54.16 -36.96 63.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.08 1.764 . . . . 0.0 111.524 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -20.59 66.24 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.224 -0.923 . . . . 0.0 113.449 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -11.9 26.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.329 1.052 . . . . 0.0 112.185 169.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -74.57 -25.7 59.46 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.866 -1.146 . . . . 0.0 110.961 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.79 -51.57 11.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.183 0.901 . . . . 0.0 110.195 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -66.72 142.13 57.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.288 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.44 -27.56 61.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 110.694 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.26 144.27 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -135.33 152.77 51.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.546 0.612 . . . . 0.0 110.293 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.88 121.32 54.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -120.72 137.8 54.3 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.145 0.978 . . . . 0.0 108.473 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.71 2.57 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-O 117.543 -1.698 . . . . 0.0 111.85 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.14 127.69 26.45 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 119.476 1.638 . . . . 0.0 111.405 176.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.47 145.45 13.27 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.818 1.679 . . . . 0.0 108.16 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 m -89.6 137.43 32.33 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -133.02 173.37 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.884 2.074 . . . . 0.0 109.406 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.7 t0 36.13 51.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.331 2.252 . . . . 0.0 114.47 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 56.05 80.71 0.14 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.271 1.429 . . . . 0.0 112.483 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 75.25 10.27 84.31 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 172.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.33 163.88 14.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.708 1.603 . . . . 0.0 110.509 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mt -89.84 152.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -68.47 144.44 54.66 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.39 -29.62 70.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.185 0.594 . . . . 0.0 112.193 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.59 -23.6 65.4 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.943 -0.473 . . . . 0.0 111.169 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.459 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.9 m95 -86.12 -41.98 14.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.301 1.04 . . . . 0.0 110.937 170.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.72 -34.66 65.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.586 0.63 . . . . 0.0 111.016 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.27 -30.36 70.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.752 1.221 . . . . 0.0 111.874 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.19 -12.97 10.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.605 ' CH2' HD13 ' A' ' 104' ' ' LEU . 2.9 t-105 -53.31 -29.42 33.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.007 1.323 . . . . 0.0 111.801 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.27 -43.33 70.69 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.147 1.379 . . . . 0.0 111.387 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.23 -31.23 70.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.936 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.1 mt -56.59 -31.03 63.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.936 1.244 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.73 -28.49 65.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.665 0.786 . . . . 0.0 111.545 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.9 -24.97 32.91 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.417 0.687 . . . . 0.0 111.038 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 mt -72.95 158.62 35.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 123.046 1.403 . . . . 0.0 112.679 -167.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.53 95.98 10.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.549 174.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mt -118.23 8.09 12.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.61 121.21 13.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.4 8.05 88.04 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.284 1.421 . . . . 0.0 114.495 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -76.2 147.89 38.08 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 117.743 0.771 . . . . 0.0 109.203 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.746 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.3 mt -86.64 138.41 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 167.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.98 129.63 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.765 1.226 . . . . 0.0 108.589 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.69 117.61 34.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -90.92 141.38 28.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.941 0.791 . . . . 0.0 111.93 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -137.85 161.91 35.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.894 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.25 174.72 36.2 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 121.295 -0.878 . . . . 0.0 112.389 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 mt -124.21 148.5 47.24 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.396 1.079 . . . . 0.0 108.755 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.45 27.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.332 0.492 . . . . 0.0 112.241 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -133.45 112.69 11.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.44 HE22 ' HG2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -83.18 -29.44 28.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.459 0.171 . . . . 0.0 111.271 -172.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.96 -46.25 58.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.148 0.579 . . . . 0.0 110.395 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.08 -34.65 12.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.04 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.39 28.95 4.91 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.54 -34.34 60.03 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 120.33 1.423 . . . . 0.0 112.411 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.2 -24.32 63.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.063 0.932 . . . . 0.0 112.369 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -113.15 -47.5 3.02 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.521 1.528 . . . . 0.0 110.089 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.265 1.6 t80 43.97 -131.36 0.77 Allowed 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 128.478 2.711 . . . . 0.0 109.514 -172.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.58 39.38 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 130.697 3.599 . . . . 0.0 113.787 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 5.9 t70 -58.14 -43.05 87.09 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 119.437 -2.039 . . . . 0.0 111.123 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.98 -32.1 71.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.946 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.0 tp -63.13 -47.39 82.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.478 0.711 . . . . 0.0 110.189 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.27 99.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.1 mtm -62.97 -48.15 80.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 117.556 0.678 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.605 HD13 ' CH2' ' A' ' 69' ' ' TRP . 13.0 tp -67.06 -30.86 71.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.651 -0.656 . . . . 0.0 111.201 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -60.83 -46.29 91.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.3 0.5 . . . . 0.0 109.826 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.72 -41.2 92.54 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.448 1.099 . . . . 0.0 111.657 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 7.0 tptt -55.6 -62.27 1.79 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.553 1.141 . . . . 0.0 107.936 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.16 -21.04 62.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.536 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -61.65 -29.4 70.04 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.649 1.113 . . . . 0.0 110.729 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.48 -22.1 54.96 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.819 -1.176 . . . . 0.0 109.799 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.73 1.61 37.87 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.636 1.574 . . . . 0.0 112.541 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.32 33.66 68.62 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.477 0.58 . . . . 0.0 111.842 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.25 170.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.622 0.769 . . . . 0.0 109.319 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -117.26 143.14 46.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -110.33 148.05 32.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.56 1.073 . . . . 0.0 111.899 -170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.3 m -128.42 178.17 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.664 1.185 . . . . 0.0 108.439 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.78 34.21 39.62 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 118.52 -1.155 . . . . 0.0 114.368 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -71.95 155.72 40.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.613 1.707 . . . . 0.0 107.948 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.45 142.05 33.48 Favored Pre-proline 0 CA--C 1.514 -0.437 0 CA-C-O 116.939 -1.505 . . . . 0.0 109.227 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.45 143.08 56.31 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.038 1.406 . . . . 0.0 109.618 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.521 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 73.9 p . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.899 1.68 . . . . 0.0 113.776 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.4 p90 -163.01 -53.88 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 118.752 0.705 . . . . 0.0 109.454 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.361 3.1 t 61.66 8.12 2.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.066 2.547 . . . . 0.0 114.939 176.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.2 t -67.85 138.13 92.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -84.7 -10.56 8.42 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.251 2.634 . . . . 0.0 112.77 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -78.42 -49.93 1.72 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -88.46 39.84 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.381 2.054 . . . . 0.0 112.593 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 148.43 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.509 1.124 . . . . 0.0 109.612 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.02 -171.98 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 C-N-CA 126.369 1.867 . . . . 0.0 109.861 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.39 -116.11 0.86 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.203 1.401 . . . . 0.0 107.443 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.55 8.34 33.28 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.059 1.344 . . . . 0.0 112.222 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.99 21.12 19.13 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.76 1.171 . . . . 0.0 112.506 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -100.69 -18.32 16.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.793 1.237 . . . . 0.0 110.8 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.14 144.23 51.24 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.887 0.475 . . . . 0.0 110.876 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.78 156.58 30.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.7 m -65.2 -18.11 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.478 0.711 . . . . 0.0 112.108 174.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.07 -178.76 39.66 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.403 1.001 . . . . 0.0 111.114 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.23 128.26 35.5 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.15 125.5 53.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.1 mt -121.99 150.23 42.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.65 132.4 38.91 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -111.57 10.67 21.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.705 -170.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.258 0.5 OUTLIER -108.21 -31.17 8.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 176.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -136.14 -27.33 1.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.096 0.862 . . . . 0.0 113.267 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.44 ' HG2' HE22 ' A' ' 90' ' ' GLN . 46.2 mm-40 -89.5 12.08 17.57 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.914 172.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -57.69 -21.77 42.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.874 1.215 . . . . 0.0 113.475 -170.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.54 -19.29 28.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.647 0.779 . . . . 0.0 112.141 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.0 mt -113.49 -24.48 9.25 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 126.702 2.001 . . . . 0.0 111.4 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.5 p -51.43 -35.77 40.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.366 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.395 0.678 . . . . 0.0 110.26 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.88 -29.63 66.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.547 0.339 . . . . 0.0 111.744 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -78.97 -28.11 43.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.704 0.802 . . . . 0.0 110.039 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 mt -66.05 -54.26 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.698 ' HA ' HD13 ' A' ' 24' ' ' ILE . 3.6 pt20 -56.97 -44.77 82.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.588 0.755 . . . . 0.0 112.257 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.4 p -67.19 -35.64 80.06 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.933 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -64.63 -45.12 88.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.844 0.83 . . . . 0.0 109.553 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.7 m -57.53 -35.42 70.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.134 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -34.7 77.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.83 0.452 . . . . 0.0 110.273 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.24 -46.27 18.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.373 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -65.18 -38.61 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 120.858 1.663 . . . . 0.0 110.002 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.28 -14.3 60.41 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.286 0.494 . . . . 0.0 112.016 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -95.03 -46.14 6.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 107.871 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.46 -36.02 77.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.841 0.746 . . . . 0.0 110.209 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.746 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.1 mtm -77.67 -44.19 28.84 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.329 1.052 . . . . 0.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -42.45 78.18 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.819 0.848 . . . . 0.0 111.052 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.18 -31.11 68.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.91 1.284 . . . . 0.0 109.791 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -41.91 97.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.297 0.639 . . . . 0.0 110.487 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -1.25 56.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.901 1.681 . . . . 0.0 113.919 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.318 179.239 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.2 143.86 30.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.0 mtm -132.12 146.51 52.09 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.773 2.029 . . . . 0.0 108.187 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.75 118.42 4.94 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-O 118.622 -1.099 . . . . 0.0 110.51 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 111.54 22.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.986 1.393 . . . . 0.0 108.885 169.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.88 146.44 36.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.988 1.315 . . . . 0.0 111.047 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -161.91 174.88 12.49 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.234 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.2 10.2 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.578 -2.609 . . . . 0.0 106.578 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.4 p -146.38 122.47 10.78 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.326 1.063 . . . . 0.0 111.614 -169.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 m -80.83 -37.87 29.28 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.205 0.457 . . . . 0.0 111.638 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.9 p -107.93 8.55 28.55 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.866 1.266 . . . . 0.0 112.092 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.7 m 65.35 11.71 7.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.85 2.06 . . . . 0.0 114.192 -171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -66.63 -46.94 74.2 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.318 -1.489 . . . . 0.0 111.224 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -33.44 75.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.88 -46.56 87.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 110.312 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.4 mtm -65.49 -43.37 90.38 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.774 -0.578 . . . . 0.0 111.384 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.55 -39.81 89.29 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 122.005 -0.434 . . . . 0.0 110.886 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.74 81.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.206 1.002 . . . . 0.0 110.53 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.5 -44.77 85.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.93 -53.88 47.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.721 1.263 . . . . 0.0 108.997 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 5.9 mt -53.55 -56.82 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.724 0.693 . . . . 0.0 109.768 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -38.49 78.63 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.574 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.57 -47.78 71.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.004 0.522 . . . . 0.0 111.121 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.2 mt -65.27 -48.0 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.682 1.193 . . . . 0.0 108.697 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 164' ' ' ILE . 77.0 mt -71.96 -50.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.502 0.721 . . . . 0.0 110.54 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.59 114.34 0.75 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.5 1.048 . . . . 0.0 110.707 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.39 3.76 3.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.625 2.883 . . . . 0.0 112.677 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -73.49 -34.12 65.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.206 1.403 . . . . 0.0 109.226 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -22.53 3.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.4 1.48 . . . . 0.0 111.824 -169.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 120.333 1.424 . . . . 0.0 108.752 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 m -129.17 129.58 45.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.539 1.136 . . . . 0.0 110.022 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.05 146.28 45.97 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.299 1.039 . . . . 0.0 112.068 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -144.09 107.97 4.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.616 1.567 . . . . 0.0 107.313 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -83.29 112.42 19.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.31 -8.95 20.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.94 0.896 . . . . 0.0 113.155 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.91 -29.14 66.83 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.209 0.913 . . . . 0.0 111.753 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -130.82 -34.25 1.52 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.714 1.206 . . . . 0.0 111.842 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -82.16 141.78 32.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.982 0.913 . . . . 0.0 108.756 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -81.35 147.97 61.7 Favored Pre-proline 0 N--CA 1.45 -0.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -78.19 -2.95 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.177 1.251 . . . . 0.0 111.36 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -55.75 -35.3 66.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 122.101 2.228 . . . . 0.0 112.011 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -20.09 66.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.414 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.7 ttm -59.28 -15.51 16.21 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.674 1.99 . . . . 0.0 111.477 171.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -73.2 -30.83 63.8 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.194 -0.941 . . . . 0.0 110.913 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -76.01 -46.28 30.24 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.976 0.807 . . . . 0.0 110.834 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.98 141.87 56.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.1 -168.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -74.54 -19.96 60.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.318 0.647 . . . . 0.0 110.509 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.7 t -145.41 148.7 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 43' ' ' MET . 11.2 mt -138.27 150.3 46.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.99 0.916 . . . . 0.0 109.183 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.5 120.65 51.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.7 132.59 55.7 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.89 118.33 3.67 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-O 117.541 -1.699 . . . . 0.0 112.757 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -119.35 126.01 27.24 Favored Pre-proline 0 N--CA 1.472 0.625 0 CA-C-N 119.608 1.704 . . . . 0.0 111.45 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -80.27 144.82 16.63 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.351 2.701 . . . . 0.0 108.987 167.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 m -94.96 131.54 40.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -121.91 171.33 9.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.524 1.93 . . . . 0.0 109.442 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 20.12 67.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.921 2.888 . . . . 0.0 115.459 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 54.0 70.05 0.65 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.689 1.196 . . . . 0.0 112.112 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 21.11 79.65 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.165 0.826 . . . . 0.0 115.165 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.305 0.4 OUTLIER -88.34 156.4 19.19 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 166.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.21 150.36 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -55.34 139.59 42.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.181 0.991 . . . . 0.0 108.545 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.63 -28.22 69.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -78.47 -19.51 52.95 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.726 -0.609 . . . . 0.0 110.434 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 53' ' ' ILE . 14.0 m95 -81.08 -43.06 20.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.377 0.671 . . . . 0.0 111.192 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.26 -33.44 58.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.531 0.605 . . . . 0.0 111.008 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.24 71.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.252 1.021 . . . . 0.0 112.33 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.86 -8.92 12.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.558 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.9 t-105 -53.2 -28.96 29.35 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.31 1.444 . . . . 0.0 111.902 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.72 -44.71 76.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.992 1.317 . . . . 0.0 111.635 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -68.58 -29.01 67.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.05 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.75 -29.84 65.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 111.114 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.33 -29.47 66.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.515 0.726 . . . . 0.0 111.452 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.87 -24.62 38.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.391 0.676 . . . . 0.0 111.366 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.4 159.91 33.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.808 1.289 . . . . 0.0 112.998 -168.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.4 92.31 7.59 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 126.663 1.985 . . . . 0.0 108.539 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -113.5 10.15 18.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.66 126.43 28.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.98 21.66 79.01 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.818 1.199 . . . . 0.0 115.678 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.21 155.8 21.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.802 1.301 . . . . 0.0 108.828 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.637 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.7 mt -87.25 145.79 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.01 130.2 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.046 1.338 . . . . 0.0 109.29 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.86 118.07 35.84 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -90.45 141.73 28.45 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.227 0.921 . . . . 0.0 111.554 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -136.78 160.58 38.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.205 1.002 . . . . 0.0 108.43 168.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.13 170.81 36.29 Favored Glycine 0 N--CA 1.446 -0.641 0 O-C-N 121.005 -1.06 . . . . 0.0 111.82 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.8 mt -129.32 153.14 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.42 -154.87 11.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -149.77 137.52 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.101 1.36 . . . . 0.0 108.074 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.613 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -90.62 -22.83 21.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.306 1.443 . . . . 0.0 113.44 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.28 -39.55 53.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.054 1.297 . . . . 0.0 111.627 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.42 -26.28 16.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.418 1.008 . . . . 0.0 112.232 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.36 35.46 2.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -167.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.66 52.54 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.186 1.357 . . . . 0.0 110.973 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -62.71 -15.02 50.86 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.067 0.947 . . . . 0.0 112.133 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -126.22 8.89 7.28 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.351 1.86 . . . . 0.0 112.128 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -48.93 124.86 9.33 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.496 1.518 . . . . 0.0 109.389 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.17 28.63 9.29 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.182 0.993 . . . . 0.0 112.855 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.1 -36.89 82.91 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 120.444 -1.41 . . . . 0.0 110.684 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 111.325 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.68 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -60.41 -48.11 83.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.016 0.926 . . . . 0.0 110.535 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.45 98.13 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mtm -65.16 -44.54 88.22 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.849 0.825 . . . . 0.0 112.101 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.558 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.3 mt -65.29 -35.31 80.61 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.365 0.984 . . . . 0.0 111.169 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -62.94 -42.14 99.72 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.656 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.12 -43.1 88.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.29 -59.11 5.11 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.848 1.259 . . . . 0.0 108.4 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.69 -22.19 54.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.241 -169.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 t -62.02 -28.77 69.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.975 0.807 . . . . 0.0 110.534 169.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.92 -24.36 44.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.588 -1.32 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -80.57 -0.95 39.98 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.409 1.484 . . . . 0.0 112.489 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.1 59.95 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.814 0.734 . . . . 0.0 111.895 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.57 172.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.764 0.782 . . . . 0.0 109.696 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -118.09 145.41 44.86 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.89 151.71 33.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 120.289 1.404 . . . . 0.0 112.994 -168.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.5 m -131.67 -178.97 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.821 1.248 . . . . 0.0 109.46 169.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.76 29.92 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.202 -1.332 . . . . 0.0 115.091 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -75.49 152.32 37.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.909 1.854 . . . . 0.0 109.008 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.31 148.15 69.02 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 117.16 -1.4 . . . . 0.0 109.088 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.87 140.02 41.24 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 121.11 1.432 . . . . 0.0 110.429 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 139' ' ' PHE . 66.6 p . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.364 1.866 . . . . 0.0 113.296 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 127' ' ' THR . 11.9 p90 -161.75 -58.76 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 126' ' ' PHE 0.328 1.9 t 58.64 11.71 1.88 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.103 2.561 . . . . 0.0 114.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 p -66.56 133.28 94.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.864 -1.148 . . . . 0.0 107.908 167.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.13 -14.26 5.07 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.16 1.907 . . . . 0.0 113.326 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -80.6 -47.41 1.24 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 117.756 -1.116 . . . . 0.0 114.007 -169.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.15 39.37 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.078 1.852 . . . . 0.0 112.428 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.37 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.333 -167.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -172.55 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 126.069 1.748 . . . . 0.0 109.968 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.08 -116.52 0.84 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.054 1.342 . . . . 0.0 107.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.21 8.0 33.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.828 1.251 . . . . 0.0 111.885 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.42 20.3 20.43 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.129 1.347 . . . . 0.0 112.803 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.25 -16.83 17.59 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.877 1.271 . . . . 0.0 110.944 -172.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 144.53 50.44 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.279 0.631 . . . . 0.0 111.186 173.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.2 m-85 -78.78 154.37 30.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.698 1.599 . . . . 0.0 109.676 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -14.32 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.157 . . . . 0.0 112.707 173.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.45 -179.62 40.89 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 119.69 1.132 . . . . 0.0 111.968 -170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 14.5 tp -65.7 129.78 40.97 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.09 124.15 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.71 160.16 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.981 0.912 . . . . 0.0 108.879 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.584 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.13 124.93 31.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -105.29 10.24 33.65 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.779 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -25.65 11.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.207 1.003 . . . . 0.0 110.862 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.06 -46.93 1.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.703 1.138 . . . . 0.0 111.169 174.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 145' ' ' ASP . 35.6 mt-30 -89.74 15.35 9.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -53.67 -22.05 8.16 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.71 -26.55 31.91 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.258 1.023 . . . . 0.0 111.291 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -116.14 -13.73 11.16 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.293 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.7 p -57.3 -27.41 62.13 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.129 1.331 . . . . 0.0 112.381 -171.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -52.76 -39.1 61.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.781 1.632 . . . . 0.0 111.788 173.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.36 -30.47 68.49 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.701 1.6 . . . . 0.0 111.003 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -92.46 -18.16 23.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.037 1.335 . . . . 0.0 110.484 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.84 -60.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.733 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.6 pt20 -51.82 -44.8 63.67 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.128 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 p -67.59 -35.22 78.57 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.077 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.7 t90 -65.35 -44.87 86.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.026 0.917 . . . . 0.0 109.656 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 96.6 m -57.82 -35.9 71.49 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.808 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.74 -29.78 66.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.404 0.547 . . . . 0.0 111.173 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -79.07 -45.76 19.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.931 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 25' ' ' ILE . 5.2 pt -64.89 -39.27 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 120.865 1.666 . . . . 0.0 109.862 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.49 -14.64 58.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.2 0.6 . . . . 0.0 111.984 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -96.2 -45.94 6.65 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.64 -42.47 88.37 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.968 0.804 . . . . 0.0 109.387 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.637 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.3 mtm -77.29 -35.51 55.02 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.706 0.802 . . . . 0.0 110.716 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -48.4 56.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.351 1.06 . . . . 0.0 109.678 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.49 -31.15 72.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.216 1.406 . . . . 0.0 109.951 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -63.96 -49.04 74.13 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.487 0.585 . . . . 0.0 110.447 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.23 -3.84 44.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.586 179.325 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 140.23 30.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 168.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 mtm -123.13 148.67 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.574 2.349 . . . . 0.0 108.386 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.29 118.47 4.69 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.48 114.44 25.1 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.944 1.372 . . . . 0.0 108.754 170.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.15 146.32 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.635 1.574 . . . . 0.0 110.535 172.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.01 172.74 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.189 0.996 . . . . 0.0 109.814 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.72 140.56 9.3 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -153.3 164.66 37.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.11 0.955 . . . . 0.0 112.007 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -132.08 -41.32 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.192 1.397 . . . . 0.0 110.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.2 p -76.5 -15.52 59.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.502 0.721 . . . . 0.0 110.551 169.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.261 57.5 m 73.57 16.15 3.99 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.479 2.311 . . . . 0.0 113.831 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -63.24 -43.6 97.57 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.371 -1.456 . . . . 0.0 110.584 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -33.72 73.24 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.45 -47.38 84.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.454 0.702 . . . . 0.0 109.644 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -65.51 -39.54 91.97 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.186 0.448 . . . . 0.0 111.145 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.64 93.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.846 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.43 79.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.038 0.935 . . . . 0.0 110.674 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -57.2 -44.95 84.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.34 -56.46 16.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.804 1.315 . . . . 0.0 108.94 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.2 mt -51.88 -56.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 118.274 0.488 . . . . 0.0 110.099 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.24 -36.4 73.14 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.877 0.871 . . . . 0.0 111.122 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.32 -45.74 62.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.682 0.393 . . . . 0.0 111.084 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.67 -47.11 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.292 1.037 . . . . 0.0 108.802 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 164' ' ' ILE . 72.8 mt -73.34 -50.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.539 0.736 . . . . 0.0 110.279 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.36 112.25 0.41 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.79 -4.29 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.443 2.762 . . . . 0.0 112.29 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.1 -33.68 59.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.057 1.743 . . . . 0.0 109.387 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.44 -21.42 4.18 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.708 1.603 . . . . 0.0 111.417 -169.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.82 139.17 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 120.397 1.453 . . . . 0.0 109.108 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -128.25 129.09 45.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.606 1.163 . . . . 0.0 110.056 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.66 147.9 43.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.726 1.21 . . . . 0.0 112.049 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.09 111.94 5.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.987 1.715 . . . . 0.0 107.121 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.14 109.98 19.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.5 -7.57 26.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -62.43 -26.49 68.53 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.597 1.09 . . . . 0.0 111.669 169.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -132.83 -33.59 1.18 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 112.184 -171.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -84.04 141.16 31.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.49 1.116 . . . . 0.0 108.286 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -86.73 141.64 33.97 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -71.86 -4.24 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.079 1.853 . . . . 0.0 111.186 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -54.97 -35.76 64.63 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 120.347 1.43 . . . . 0.0 112.179 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -20.58 66.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 175.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -65.34 -10.96 37.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 112.539 169.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.02 -30.19 68.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.514 1.052 . . . . 0.0 110.159 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.62 -51.46 9.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.422 0.63 . . . . 0.0 110.295 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.99 143.55 57.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.616 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -76.15 -24.49 54.83 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.543 0.687 . . . . 0.0 110.766 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.8 t -145.18 139.18 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -169.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 153.49 43.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.612 0.642 . . . . 0.0 110.875 174.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 125.41 67.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.32 136.55 54.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.947 0.899 . . . . 0.0 109.886 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.05 116.52 2.99 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.006 -1.996 . . . . 0.0 111.689 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.51 130.1 24.9 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-N 120.229 2.014 . . . . 0.0 112.409 170.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.83 141.69 10.88 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.453 2.102 . . . . 0.0 107.792 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 m -89.45 124.35 34.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -115.24 174.7 5.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.526 1.93 . . . . 0.0 109.351 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 31.06 55.64 0.22 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.085 2.554 . . . . 0.0 115.253 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 55.69 78.84 0.18 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.71 1.204 . . . . 0.0 112.71 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 76.09 9.85 85.37 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.86 159.67 17.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.15 1.38 . . . . 0.0 110.803 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -91.05 152.9 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.04 144.5 55.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.68 -28.88 69.71 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.113 0.965 . . . . 0.0 112.4 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.262 0.625 . . . . 0.0 111.012 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.441 ' CD1' HG22 ' A' ' 53' ' ' ILE . 6.4 m95 -79.98 -43.49 21.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 110.195 173.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.46 -34.39 61.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.28 0.632 . . . . 0.0 111.024 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.379 1.072 . . . . 0.0 112.174 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.27 -10.41 9.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.513 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.9 t-105 -53.37 -27.73 25.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.505 1.522 . . . . 0.0 112.166 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.23 -45.56 66.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.209 1.404 . . . . 0.0 111.524 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -64.91 -33.05 75.1 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.929 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 44.3 mt -57.63 -31.68 66.5 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.725 1.148 . . . . 0.0 111.393 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.29 -27.49 61.58 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.345 0.658 . . . . 0.0 111.178 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.64 -19.29 31.18 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.832 0.853 . . . . 0.0 111.482 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.99 171.65 12.45 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.053 0.93 . . . . 0.0 110.721 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.47 112.22 24.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.22 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.02 10.3 6.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.838 0.855 . . . . 0.0 112.945 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.62 119.41 10.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -170.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.83 85.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 124.822 1.201 . . . . 0.0 114.148 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -79.17 149.37 32.0 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.002 0.901 . . . . 0.0 108.86 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.739 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.3 mt -86.38 140.35 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.52 131.38 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 109.447 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -112.53 112.91 24.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 166.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.39 143.99 26.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.799 0.727 . . . . 0.0 111.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -141.87 164.22 30.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.948 1.299 . . . . 0.0 109.03 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.48 38.88 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 121.195 -0.94 . . . . 0.0 113.218 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -128.56 153.76 46.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.437 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.71 -153.9 9.17 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.07 138.83 10.56 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 126.75 2.02 . . . . 0.0 107.775 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -89.39 -21.74 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.864 1.265 . . . . 0.0 114.267 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.51 -48.11 65.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.756 1.162 . . . . 0.0 110.664 -173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.93 -26.27 19.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.034 0.826 . . . . 0.0 112.33 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -130.92 27.75 4.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.44 58.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-N 121.116 1.78 . . . . 0.0 112.524 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.12 -15.92 58.3 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.033 -1.275 . . . . 0.0 113.222 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -125.16 -49.65 1.7 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.745 1.618 . . . . 0.0 111.433 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.261 2.0 t80 43.82 -133.59 0.61 Allowed 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.204 2.602 . . . . 0.0 109.844 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.98 40.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.816 3.646 . . . . 0.0 113.188 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 6.6 t70 -58.75 -43.08 90.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.554 -1.966 . . . . 0.0 111.42 -169.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.72 71.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.276 0.63 . . . . 0.0 110.584 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.585 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -62.75 -47.98 81.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.649 0.78 . . . . 0.0 110.384 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.44 99.19 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.6 mtm -62.0 -46.3 89.81 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 117.765 0.782 . . . . 0.0 111.218 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.513 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -67.99 -31.43 71.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.735 -0.603 . . . . 0.0 111.7 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.36 -49.97 75.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.011 0.434 . . . . 0.0 109.927 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.45 -40.17 92.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.419 1.088 . . . . 0.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 72' ' ' LEU . 17.9 tptt -54.2 -58.8 6.0 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.397 1.479 . . . . 0.0 108.444 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.9 -18.59 55.97 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.544 -0.723 . . . . 0.0 110.672 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -60.91 -26.93 67.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.985 0.811 . . . . 0.0 110.557 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -24.19 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.771 -1.206 . . . . 0.0 109.849 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -82.94 1.66 38.49 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.576 1.55 . . . . 0.0 112.627 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.06 34.27 70.33 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 118.633 0.651 . . . . 0.0 111.982 172.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.53 171.24 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 117.823 0.812 . . . . 0.0 109.89 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -116.23 140.6 49.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -108.53 147.6 31.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.55 1.068 . . . . 0.0 111.756 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 14.3 m -128.75 179.07 4.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 108.982 169.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.25 33.52 44.23 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-O 118.65 -1.084 . . . . 0.0 114.344 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.17 149.69 46.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.589 1.694 . . . . 0.0 108.044 169.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.37 135.65 27.75 Favored Pre-proline 0 CA--C 1.516 -0.334 0 CA-C-O 116.917 -1.516 . . . . 0.0 108.578 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.63 138.76 50.67 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 121.36 1.521 . . . . 0.0 109.776 169.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 67.3 p . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 126.522 1.929 . . . . 0.0 113.191 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -166.43 -52.98 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.477 1.035 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.326 3.1 t 57.45 10.64 1.0 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.237 2.615 . . . . 0.0 114.536 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 141.81 88.0 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.509 1.523 . . . . 0.0 109.783 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.24 -13.37 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.214 1.943 . . . . 0.0 114.114 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -80.0 -50.33 1.2 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.87 38.65 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.0 1.8 . . . . 0.0 112.827 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 149.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -166.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -172.28 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 125.906 1.683 . . . . 0.0 110.005 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.6 -116.89 0.89 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.65 8.0 32.92 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.016 1.326 . . . . 0.0 112.161 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.61 20.35 19.79 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.613 1.102 . . . . 0.0 112.591 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -100.15 -16.97 17.63 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.735 1.214 . . . . 0.0 110.713 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.02 142.45 49.58 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.445 0.698 . . . . 0.0 110.404 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.0 m-85 -77.47 157.7 30.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.863 1.265 . . . . 0.0 108.725 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.453 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -65.19 -18.69 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.915 173.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.04 -179.83 40.31 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 119.604 1.093 . . . . 0.0 112.066 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.483 HD11 HD21 ' A' ' 144' ' ' LEU . 12.8 tp -61.01 129.26 40.53 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.03 119.13 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 142' ' ' LEU . 85.9 mt -117.15 156.61 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.134 0.974 . . . . 0.0 109.223 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.423 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -143.97 122.15 12.21 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -97.56 18.15 16.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.843 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 -20.92 4.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.879 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.72 -53.95 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.239 1.381 . . . . 0.0 108.547 169.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.78 17.71 17.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -52.0 -25.2 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.036 0.934 . . . . 0.0 112.496 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.99 -26.65 54.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 0.0 111.426 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.46 -8.47 9.11 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.111 0.965 . . . . 0.0 112.331 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.6 m -51.59 -34.17 35.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.982 1.264 . . . . 0.0 110.554 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.54 -49.14 75.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.65 0.78 . . . . 0.0 110.238 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.11 -32.12 73.04 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.27 1.028 . . . . 0.0 109.892 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -74.98 -29.31 60.86 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 118.256 -0.878 . . . . 0.0 108.982 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.15 -58.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.44 -45.05 65.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.495 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.1 m -69.69 -35.23 74.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.587 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 34.6 t90 -67.08 -45.32 77.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.628 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 86.5 m -58.73 -33.88 70.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.823 0.849 . . . . 0.0 109.765 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -70.88 -32.33 69.27 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -78.63 -47.41 17.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.271 -1.347 . . . . 0.0 112.257 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.24 -37.19 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 121.23 1.832 . . . . 0.0 109.838 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.3 -13.0 33.7 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -51.07 5.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.649 1.58 . . . . 0.0 107.875 169.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.93 -22.8 67.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.355 0.662 . . . . 0.0 111.46 -169.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.739 ' HG2' HG21 ' A' ' 81' ' ' ILE . 69.5 mtm -94.43 -44.08 8.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 111.472 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.39 57.44 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.506 0.722 . . . . 0.0 110.709 -172.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.49 -27.69 66.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.897 1.279 . . . . 0.0 109.51 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -70.33 -48.27 57.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 110.378 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.42 -17.23 60.23 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.791 -179.205 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 142.68 29.83 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 mtm -130.94 147.96 52.65 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.447 1.899 . . . . 0.0 108.516 -169.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.25 117.63 4.77 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-O 118.824 -0.987 . . . . 0.0 110.807 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 98.02 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.879 1.339 . . . . 0.0 109.548 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -95.88 146.41 24.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.506 1.122 . . . . 0.0 110.447 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 36.3 p90 -165.36 174.6 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.686 0.794 . . . . 0.0 109.024 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.28 133.8 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 106.188 -2.765 . . . . 0.0 106.188 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 147.77 28.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.8 t -126.23 -27.56 3.21 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.944 1.298 . . . . 0.0 109.834 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.9 p -81.45 -74.28 0.34 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 169.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.0 p 175.7 -14.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.163 1.785 . . . . 0.0 113.839 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -63.44 -48.2 78.74 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.646 -1.284 . . . . 0.0 114.359 -164.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -33.71 74.93 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 6.5 tt0 -62.98 -47.79 81.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.2 mtm -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 118.004 0.365 . . . . 0.0 111.444 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.45 -41.65 90.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.69 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.76 82.25 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.995 0.918 . . . . 0.0 110.754 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.82 -44.96 90.97 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.2 -56.64 16.62 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 124.616 1.198 . . . . 0.0 108.43 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.403 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.0 mt -51.58 -56.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 118.821 0.737 . . . . 0.0 109.966 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -38.96 71.71 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.428 0.691 . . . . 0.0 110.514 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.88 -46.9 73.53 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.792 0.437 . . . . 0.0 111.442 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.66 -47.85 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.517 1.127 . . . . 0.0 108.727 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 164' ' ' ILE . 68.3 mt -72.32 -50.97 32.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 123.876 0.87 . . . . 0.0 110.309 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.28 114.92 0.7 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 170.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.86 2.83 4.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.374 2.716 . . . . 0.0 112.812 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.91 -34.01 66.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 -23.89 3.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.672 1.589 . . . . 0.0 111.549 -169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.81 140.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.45 1.477 . . . . 0.0 109.278 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.7 m -129.36 128.66 43.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.689 1.195 . . . . 0.0 110.477 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.12 148.07 49.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 112.094 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -148.87 110.26 4.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.61 1.564 . . . . 0.0 107.618 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -86.92 113.14 22.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.23 -10.45 42.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -58.68 -26.91 64.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.981 0.809 . . . . 0.0 111.88 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.74 -28.72 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.889 0.875 . . . . 0.0 112.005 -167.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -87.63 145.36 26.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.377 1.471 . . . . 0.0 108.614 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -83.63 148.42 54.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.633 0.773 . . . . 0.0 108.976 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -79.27 -11.21 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.793 2.329 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -56.68 -36.6 69.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.446 1.476 . . . . 0.0 111.488 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -20.23 66.17 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.332 -0.855 . . . . 0.0 113.023 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -13.82 25.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.403 1.081 . . . . 0.0 112.156 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.94 -26.7 60.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.079 -1.013 . . . . 0.0 110.897 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.35 -50.65 13.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.786 0.803 . . . . 0.0 110.107 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -65.29 144.03 57.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.093 1.357 . . . . 0.0 108.248 -169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -75.52 -25.13 56.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.753 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 49' ' ' LEU . 42.2 t -144.15 140.24 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -168.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.8 158.65 36.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.659 0.663 . . . . 0.0 110.757 173.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.23 123.31 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.9 135.65 55.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.832 0.853 . . . . 0.0 108.872 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.24 3.67 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.697 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.83 130.09 24.89 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 118.824 1.312 . . . . 0.0 110.558 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.24 138.31 7.6 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.289 2.659 . . . . 0.0 107.887 168.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 m -87.19 126.32 34.72 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -113.19 172.77 6.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.253 1.821 . . . . 0.0 109.89 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 21.94 63.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.241 3.017 . . . . 0.0 115.469 169.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.17 71.39 0.54 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.713 1.205 . . . . 0.0 112.151 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.89 13.35 80.8 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.97 151.14 35.8 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.662 1.22 . . . . 0.0 109.302 168.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.63 148.84 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -64.35 144.75 56.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.44 -27.65 68.71 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.162 -172.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -64.82 -27.75 69.09 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.806 0.842 . . . . 0.0 112.401 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -88.53 -40.5 13.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.832 1.253 . . . . 0.0 110.59 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.12 -35.83 65.07 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.726 0.694 . . . . 0.0 111.009 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.11 71.33 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.165 0.986 . . . . 0.0 112.139 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.99 -12.4 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.727 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.0 t-105 -54.85 -28.76 52.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.114 1.366 . . . . 0.0 111.804 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.51 -44.86 61.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.681 1.192 . . . . 0.0 110.876 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.24 -29.6 67.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.22 -1.371 . . . . 0.0 112.559 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 mt -55.66 -32.86 63.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.228 1.376 . . . . 0.0 110.895 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.07 -33.68 76.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.69 0.796 . . . . 0.0 111.819 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.99 -26.62 48.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.277 0.631 . . . . 0.0 110.767 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.95 152.82 40.01 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.88 1.324 . . . . 0.0 110.511 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -85.11 103.59 14.25 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.558 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.5 mt -124.75 4.41 8.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.767 1.227 . . . . 0.0 113.032 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -68.48 113.14 5.76 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.74 79.86 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.34 1.447 . . . . 0.0 115.094 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -82.76 153.0 25.48 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.324 1.062 . . . . 0.0 109.914 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -87.99 141.59 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.53 129.1 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.163 1.385 . . . . 0.0 108.632 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.71 117.81 35.02 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.92 142.26 27.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.082 0.856 . . . . 0.0 111.524 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -140.37 161.33 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.006 0.922 . . . . 0.0 108.95 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.04 179.53 39.58 Favored Glycine 0 N--CA 1.45 -0.415 0 O-C-N 120.841 -1.162 . . . . 0.0 112.338 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.46 153.96 42.72 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 109.233 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.44 -157.86 13.33 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -148.88 141.94 24.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.486 1.514 . . . . 0.0 109.254 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.443 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -88.96 -21.03 23.75 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.79 -40.94 68.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.874 1.216 . . . . 0.0 111.804 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.91 -22.93 19.22 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 124.592 1.091 . . . . 0.0 111.512 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.6 m-85 -121.38 -84.8 0.66 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.764 1.225 . . . . 0.0 108.071 -170.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.0 -50.27 2.64 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 128.237 2.827 . . . . 0.0 108.6 -168.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' TYR . 1.3 mp0 -71.74 -36.21 70.39 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 126.613 1.965 . . . . 0.0 110.169 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -106.66 1.27 24.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.334 1.054 . . . . 0.0 112.085 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.29 120.83 2.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.587 1.555 . . . . 0.0 109.009 168.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 55.46 25.7 8.06 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.13 0.972 . . . . 0.0 113.465 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.88 -38.57 91.4 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 120.855 -1.153 . . . . 0.0 110.743 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.61 -32.99 73.14 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.074 -0.391 . . . . 0.0 111.795 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.697 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.8 tp -60.75 -46.29 91.04 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.116 0.966 . . . . 0.0 110.797 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.66 -40.35 96.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.5 mtm -68.52 -43.1 77.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.875 0.837 . . . . 0.0 112.461 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.585 HD12 HD12 ' A' ' 53' ' ' ILE . 4.7 mt -63.5 -33.27 75.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.3 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -65.35 -42.46 92.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.969 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.33 -42.46 92.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.675 1.19 . . . . 0.0 111.743 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -55.19 -59.33 4.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.619 1.168 . . . . 0.0 108.403 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 mt -76.95 -20.17 56.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.445 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -62.31 -28.81 70.0 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.234 0.924 . . . . 0.0 110.425 168.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.09 -24.07 47.7 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.646 -1.284 . . . . 0.0 109.572 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 18.8 mmmt -80.83 3.64 21.84 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.295 1.838 . . . . 0.0 113.08 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.17 80.4 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 118.593 0.633 . . . . 0.0 111.635 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.74 171.67 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.674 0.79 . . . . 0.0 109.046 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -117.98 141.9 47.95 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.51 147.69 32.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.487 1.039 . . . . 0.0 111.514 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.9 m -128.27 178.4 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.315 1.046 . . . . 0.0 108.802 169.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 35.94 37.57 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 118.608 -1.107 . . . . 0.0 114.286 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -77.87 152.82 33.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.667 1.733 . . . . 0.0 109.201 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -128.18 147.44 63.51 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 117.411 -1.281 . . . . 0.0 108.45 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.52 140.53 40.05 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.132 1.221 . . . . 0.0 109.651 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 139' ' ' PHE . 78.8 p . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 125.878 1.671 . . . . 0.0 113.822 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 . . . . . 0 CA--C 1.53 0.194 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -163.52 -53.01 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.218 0.607 . . . . 0.0 109.711 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 2.9 t 58.64 8.81 0.97 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.969 2.508 . . . . 0.0 114.616 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -68.46 139.74 92.03 Favored Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 120.835 -1.166 . . . . 0.0 108.817 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -85.03 -11.3 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.9 2.4 . . . . 0.0 113.085 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -77.85 -50.61 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -168.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -88.39 42.54 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.179 1.919 . . . . 0.0 112.163 -169.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 147.66 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.771 -1.206 . . . . 0.0 109.806 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 -172.47 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 125.968 1.707 . . . . 0.0 110.182 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.07 -116.49 0.84 Allowed 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.1 1.36 . . . . 0.0 107.579 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.25 8.56 33.96 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.839 1.256 . . . . 0.0 111.871 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.25 21.56 19.73 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.986 1.279 . . . . 0.0 112.504 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -99.77 -18.32 17.27 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.693 1.197 . . . . 0.0 110.764 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.5 144.35 51.07 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.257 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -78.13 154.98 30.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.114 1.366 . . . . 0.0 109.826 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' A' ' 101' ' ' LEU . 16.1 m -65.61 -12.49 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.587 1.155 . . . . 0.0 112.618 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.84 -177.21 44.69 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 119.763 1.165 . . . . 0.0 112.475 -172.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 24.7 tp -65.77 131.26 45.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.08 112.88 20.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.9 mt -110.96 154.2 24.45 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.268 1.027 . . . . 0.0 109.59 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.422 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -144.47 128.27 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -102.5 13.79 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.399 1.079 . . . . 0.0 110.793 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -22.44 5.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.443 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.1 -49.24 2.98 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.765 1.226 . . . . 0.0 108.153 172.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.48 22.38 15.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.36 1.464 . . . . 0.0 112.809 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -52.52 -26.86 14.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.138 0.575 . . . . 0.0 112.411 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.75 -25.19 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.43 0.692 . . . . 0.0 111.677 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -125.13 -11.31 7.03 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.121 0.969 . . . . 0.0 112.153 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.0 m -56.94 -29.77 63.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.017 1.28 . . . . 0.0 109.351 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.83 -37.78 77.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.219 1.408 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.8 -37.49 27.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.577 1.151 . . . . 0.0 110.039 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -67.89 -31.06 70.6 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.33 -54.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -52.67 -47.73 66.98 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.061 1.344 . . . . 0.0 110.411 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.3 m -66.41 -36.31 82.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.256 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.411 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 31.2 t90 -66.27 -44.67 82.94 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.547 0.689 . . . . 0.0 109.963 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.5 m -58.18 -36.1 72.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.794 0.838 . . . . 0.0 109.691 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -69.62 -31.33 69.39 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.597 0.561 . . . . 0.0 109.854 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -79.59 -47.58 15.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.674 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.32 -38.85 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 121.018 1.735 . . . . 0.0 110.349 -169.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.94 -14.28 59.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.104 0.561 . . . . 0.0 111.976 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.23 -46.54 6.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.57 -39.5 80.46 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.292 0.637 . . . . 0.0 110.062 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.5 mtm -78.49 -38.3 41.17 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 -176.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.3 62.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.145 0.978 . . . . 0.0 109.96 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.15 -29.68 70.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.036 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -64.36 -47.63 78.58 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 110.58 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -2.12 51.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.601 1.161 . . . . 0.0 113.649 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.49 178.738 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.604 ' SD ' HG21 ' A' ' 48' ' ' VAL . 27.2 ttm . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.58 144.24 51.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.943 2.097 . . . . 0.0 106.344 169.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.95 146.4 50.33 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 -166.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.29 114.27 3.93 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.09 101.32 13.98 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.816 1.308 . . . . 0.0 110.665 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.84 146.65 26.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.773 1.229 . . . . 0.0 111.57 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 39.0 p90 -163.84 173.86 12.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.364 1.066 . . . . 0.0 109.61 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.23 139.85 8.66 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 169.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -136.83 133.18 35.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.763 1.225 . . . . 0.0 110.551 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.48 -42.24 13.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.806 0.843 . . . . 0.0 109.307 174.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.3 p -97.27 -84.24 0.38 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 p -174.83 -5.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.189 2.596 . . . . 0.0 112.104 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -67.73 -40.91 84.18 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 119.796 -1.815 . . . . 0.0 111.449 -168.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -34.86 78.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 5.6 tt0 -64.74 -48.48 74.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.016 0.926 . . . . 0.0 109.918 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.3 mtm -66.76 -36.86 83.42 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.644 -0.66 . . . . 0.0 111.452 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.99 97.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.646 -0.659 . . . . 0.0 110.69 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.07 85.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.544 1.137 . . . . 0.0 111.278 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.82 -48.52 81.04 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.182 0.993 . . . . 0.0 109.238 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -59.71 -56.44 21.88 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.35 -56.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.066 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -53.78 -43.19 69.04 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.129 0.971 . . . . 0.0 110.349 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.91 -42.5 69.86 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.024 0.53 . . . . 0.0 111.144 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.8 mt -65.25 -49.83 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 108.822 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 164' ' ' ILE . 61.0 mt -71.87 -52.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.143 0.977 . . . . 0.0 110.254 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.07 112.56 0.4 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.65 -3.99 11.3 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.243 2.628 . . . . 0.0 112.639 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.98 -34.46 59.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.693 1.597 . . . . 0.0 109.546 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -27.71 6.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.152 1.781 . . . . 0.0 109.99 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.5 140.08 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.953 1.706 . . . . 0.0 109.428 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 m -132.69 129.73 39.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.28 1.7 pt? -101.39 156.78 17.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.549 1.068 . . . . 0.0 113.044 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -147.93 113.93 5.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.164 1.386 . . . . 0.0 109.142 -166.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.9 112.38 19.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.74 -10.53 20.13 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.973 0.909 . . . . 0.0 113.309 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -57.88 -29.19 64.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.115 0.871 . . . . 0.0 111.798 168.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -130.05 -33.93 1.72 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.785 1.234 . . . . 0.0 111.708 -172.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -84.04 141.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.12 0.968 . . . . 0.0 108.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.0 m -85.09 143.15 39.25 Favored Pre-proline 0 C--O 1.225 -0.218 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.79 -6.51 18.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.781 1.654 . . . . 0.0 111.736 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -54.92 -37.4 66.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.781 1.628 . . . . 0.0 111.313 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -21.22 66.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -13.65 22.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 169.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.72 -26.0 61.42 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.89 -1.131 . . . . 0.0 110.669 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -77.6 -50.3 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.062 0.847 . . . . 0.0 110.273 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.09 139.44 58.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.89 -21.93 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.23 0.538 . . . . 0.0 111.399 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG21 ' SD ' ' A' ' 1' ' ' MET . 57.6 t -140.38 141.96 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -172.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -129.74 158.14 40.21 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.892 0.377 . . . . 0.0 110.755 174.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.63 122.49 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.87 134.28 55.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -127.77 119.11 3.08 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 117.826 -1.541 . . . . 0.0 112.725 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.89 132.54 24.22 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 119.114 1.457 . . . . 0.0 110.864 178.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.46 149.1 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.427 2.085 . . . . 0.0 108.297 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 m -94.52 130.15 41.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -124.54 170.93 10.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.881 1.673 . . . . 0.0 109.472 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 31.92 54.89 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.736 2.414 . . . . 0.0 115.313 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 57.23 76.65 0.31 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.111 1.364 . . . . 0.0 112.755 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.42 25.42 75.5 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.791 -0.568 . . . . 0.0 114.482 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -97.37 164.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.72 1.608 . . . . 0.0 110.318 169.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.8 mt -101.73 151.85 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 126.153 1.781 . . . . 0.0 106.461 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.1 144.08 56.91 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.65 -27.2 68.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.114 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -66.77 -26.49 66.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.806 0.843 . . . . 0.0 110.642 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.9 m95 -84.55 -43.05 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.27 1.028 . . . . 0.0 110.819 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.26 -36.09 63.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.443 0.565 . . . . 0.0 110.746 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -31.07 71.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.49 1.116 . . . . 0.0 112.174 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.12 -10.8 10.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.4 t-105 -53.57 -29.29 36.52 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.604 . . . . 0.0 111.621 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.8 -43.64 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.004 1.322 . . . . 0.0 111.154 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -69.24 -29.71 67.7 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.114 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.99 -31.1 64.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.086 1.312 . . . . 0.0 111.055 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.48 -28.17 64.78 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.625 0.77 . . . . 0.0 111.22 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.96 -23.59 36.01 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.511 0.724 . . . . 0.0 111.114 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.68 158.22 32.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.937 1.351 . . . . 0.0 111.961 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -91.72 99.87 12.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.866 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.77 9.08 11.96 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.17 122.16 15.94 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.98 84.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.93 1.252 . . . . 0.0 114.564 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -83.05 147.35 28.19 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.206 1.003 . . . . 0.0 110.274 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -80.99 139.11 18.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.73 123.98 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 125.016 1.326 . . . . 0.0 109.127 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -104.44 115.43 30.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 mt -88.78 141.58 28.38 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 118.828 0.74 . . . . 0.0 111.572 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 18.2 p90 -140.2 163.36 32.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.431 1.093 . . . . 0.0 108.5 169.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 179.24 38.59 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.115 -0.99 . . . . 0.0 112.519 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.8 mt -123.67 152.76 41.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.148 0.979 . . . . 0.0 108.809 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 -163.04 13.27 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.834 0.73 . . . . 0.0 111.306 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.77 117.21 7.46 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.753 2.021 . . . . 0.0 105.99 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -28.75 24.9 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.992 0.36 . . . . 0.0 111.397 -171.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.93 -45.86 55.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.164 0.585 . . . . 0.0 110.284 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.36 -36.29 17.76 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.727 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -135.24 37.8 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.75 -39.75 68.72 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 119.687 1.13 . . . . 0.0 111.322 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.41 -17.15 58.5 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 117.962 0.881 . . . . 0.0 112.626 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -129.54 13.19 5.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.031 1.732 . . . . 0.0 112.342 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -44.6 126.38 5.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.796 1.638 . . . . 0.0 110.013 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.87 25.83 2.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.186 1.395 . . . . 0.0 113.34 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.03 -37.2 84.04 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 120.402 -1.436 . . . . 0.0 110.707 -170.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.72 73.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.24 0.616 . . . . 0.0 111.961 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.8 tp -60.92 -46.26 91.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.199 0.999 . . . . 0.0 110.771 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.64 99.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.9 mtm -62.08 -45.67 92.48 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 117.578 0.689 . . . . 0.0 111.607 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -65.54 -33.44 75.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.84 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -62.01 -39.53 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.246 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.11 -36.23 66.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.796 1.638 . . . . 0.0 112.192 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.9 tptt -57.51 -46.05 84.24 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.726 0.81 . . . . 0.0 109.98 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.39 -19.07 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.623 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p -61.4 -31.94 71.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.663 1.574 . . . . 0.0 111.88 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -78.36 -18.35 55.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.794 -0.566 . . . . 0.0 110.368 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -78.96 1.39 23.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.134 1.373 . . . . 0.0 112.031 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.96 65.01 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.79 0.723 . . . . 0.0 111.908 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.38 170.32 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.738 0.815 . . . . 0.0 109.603 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -118.33 135.09 54.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -102.81 147.1 27.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -127.3 175.61 8.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.58 39.09 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.822 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -72.98 150.78 42.19 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.124 1.962 . . . . 0.0 108.008 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.53 145.12 56.15 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.009 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.04 141.89 45.29 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 121.177 1.456 . . . . 0.0 109.238 168.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 ' CD1' ' A' ' 139' ' ' PHE . 81.9 p . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 125.81 1.644 . . . . 0.0 113.894 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -160.09 -57.0 0.06 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.799 0.727 . . . . 0.0 110.265 -169.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.353 4.3 t 58.59 10.81 1.52 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.935 2.494 . . . . 0.0 114.572 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.6 t -62.96 131.52 94.69 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.28 -13.41 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.397 2.065 . . . . 0.0 112.836 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -80.64 -48.03 1.2 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -169.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -88.04 39.06 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.089 1.859 . . . . 0.0 112.212 -168.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.32 147.04 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 119.212 0.914 . . . . 0.0 109.4 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.852 1.661 . . . . 0.0 109.794 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.81 -116.29 0.84 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.318 1.447 . . . . 0.0 107.491 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -105.21 7.89 33.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.791 1.237 . . . . 0.0 112.111 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.16 20.23 18.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.639 1.114 . . . . 0.0 112.463 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.05 -17.86 17.28 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 110.863 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.96 143.96 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.897 0.479 . . . . 0.0 110.706 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.505 ' CD1' HG22 ' A' ' 121' ' ' THR . 63.1 m-85 -77.9 156.09 30.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.818 1.247 . . . . 0.0 109.111 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.01 -15.65 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.087 0.955 . . . . 0.0 112.315 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.02 -176.63 40.35 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 119.985 1.266 . . . . 0.0 111.763 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.8 tp -63.81 126.86 28.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.0 119.79 40.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.5 mt -113.5 146.09 40.17 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.39 131.11 55.62 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 170.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.57 30.23 7.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.243 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.47 -34.52 0.84 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -116.91 -30.77 5.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 120.131 1.332 . . . . 0.0 111.788 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -89.95 3.5 52.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.872 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -58.28 -21.88 50.51 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.298 0.954 . . . . 0.0 112.137 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.29 -24.43 42.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.277 1.031 . . . . 0.0 111.508 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -126.29 -5.8 6.58 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.735 0.814 . . . . 0.0 112.864 -170.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -56.72 -29.89 62.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.078 0.854 . . . . 0.0 110.482 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.73 -38.18 64.08 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.849 1.66 . . . . 0.0 111.731 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -36.6 23.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.745 1.218 . . . . 0.0 109.945 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -67.44 -26.37 66.37 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.986 0.915 . . . . 0.0 109.52 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.38 -57.58 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -49.78 -48.26 50.6 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 110.563 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -65.35 -37.46 87.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.385 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 33.8 t90 -66.36 -43.43 86.04 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -58.18 -35.44 71.6 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.568 0.747 . . . . 0.0 109.426 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -33.78 76.42 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.433 0.458 . . . . 0.0 110.047 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.79 -46.13 15.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.56 -1.21 . . . . 0.0 111.85 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 25' ' ' ILE . 6.5 pt -65.02 -39.78 86.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.375 1.898 . . . . 0.0 109.959 -169.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.87 -21.93 66.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.819 -0.551 . . . . 0.0 110.749 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -89.63 -42.66 11.25 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.75 -31.26 68.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.807 0.73 . . . . 0.0 109.979 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.9 mtm -86.01 -44.03 12.66 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.889 1.275 . . . . 0.0 109.029 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.5 83.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.317 1.047 . . . . 0.0 111.961 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.52 -27.54 63.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.959 1.304 . . . . 0.0 109.766 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -67.63 -31.77 72.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.558 0.617 . . . . 0.0 111.52 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.443 ' CE1' ' CE ' ' A' ' 1' ' ' MET . 2.8 m-30 -58.43 -29.91 66.48 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 O-C-N 123.745 0.653 . . . . 0.0 111.084 -167.617 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.56 140.83 30.31 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.78 146.65 48.18 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.995 2.118 . . . . 0.0 108.769 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.29 116.49 4.41 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-O 118.49 -1.172 . . . . 0.0 111.215 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 100.2 12.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.339 1.569 . . . . 0.0 110.051 172.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -98.96 145.31 27.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.454 1.502 . . . . 0.0 111.551 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -165.87 173.13 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.742 1.217 . . . . 0.0 109.014 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.22 127.88 2.89 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 172.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -128.85 131.73 47.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.714 1.606 . . . . 0.0 109.148 -170.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -84.59 -36.47 22.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.9 p -103.7 -81.65 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -177.6 -4.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.621 2.768 . . . . 0.0 112.111 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.46 -43.44 73.22 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 122.088 2.222 . . . . 0.0 111.054 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -67.89 -30.94 70.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.757 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.86 -46.41 75.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.962 0.905 . . . . 0.0 110.594 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.12 -35.67 81.53 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.42 98.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.029 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.52 74.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.808 0.843 . . . . 0.0 110.666 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.54 -47.14 85.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 122.89 0.476 . . . . 0.0 110.031 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 24' ' ' ILE . 57.0 mttm -61.3 -55.04 36.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.788 1.235 . . . . 0.0 108.905 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.55 -56.49 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.99 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.66 70.84 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.117 0.567 . . . . 0.0 110.372 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.42 -47.01 74.61 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.827 0.451 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LYS . 6.9 mt -66.21 -47.98 82.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.299 1.04 . . . . 0.0 108.898 -175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 164' ' ' ILE . 69.5 mt -71.03 -50.5 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.765 0.826 . . . . 0.0 110.415 -176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.55 114.55 0.76 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.63 2.97 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.454 2.769 . . . . 0.0 112.889 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.4 -34.36 67.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.056 1.342 . . . . 0.0 109.09 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.46 -21.43 3.83 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.44 1.496 . . . . 0.0 111.509 -169.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -93.93 142.05 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 120.828 1.649 . . . . 0.0 108.992 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.4 m -132.58 129.47 39.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.437 1.095 . . . . 0.0 110.054 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 147.77 49.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 111.539 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.91 107.16 4.35 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 107.604 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.96 112.79 20.06 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.23 -10.24 22.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.795 1.238 . . . . 0.0 112.999 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -59.93 -28.33 67.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.08 0.855 . . . . 0.0 111.847 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -129.15 -33.96 1.91 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.9 1.28 . . . . 0.0 111.882 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.21 141.71 29.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.29 1.036 . . . . 0.0 109.05 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -84.78 142.53 39.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.0 -6.28 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.481 1.454 . . . . 0.0 111.419 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -54.15 -37.84 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.986 1.721 . . . . 0.0 111.422 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -21.86 66.53 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -14.7 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.061 1.344 . . . . 0.0 112.235 169.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -72.7 -26.14 61.49 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.942 -1.099 . . . . 0.0 110.775 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -78.15 -49.21 14.3 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.869 0.759 . . . . 0.0 110.092 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -65.27 140.0 58.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.74 1.216 . . . . 0.0 108.436 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -73.04 -29.32 62.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.656 0.741 . . . . 0.0 110.827 -174.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.0 t -142.52 143.81 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.66 155.5 49.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.597 0.635 . . . . 0.0 109.512 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.76 122.21 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.37 145.58 47.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 147.3 15.79 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.754 -1.212 . . . . 0.0 115.759 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -134.72 134.35 22.03 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.67 1.988 . . . . 0.0 109.582 -169.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -84.92 140.69 8.04 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 107.274 165.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -88.58 103.99 16.42 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -88.07 169.13 12.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.832 0.853 . . . . 0.0 110.709 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 22.97 66.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.886 2.875 . . . . 0.0 115.602 167.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.63 71.29 0.56 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.367 1.067 . . . . 0.0 112.096 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.42 15.7 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.01 148.41 32.53 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.632 1.206 . . . . 0.0 109.737 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.97 153.08 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -60.98 142.84 56.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.773 0.829 . . . . 0.0 108.941 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.37 -27.85 68.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -166.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.07 -24.31 35.32 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.732 -0.605 . . . . 0.0 110.468 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 53' ' ' ILE . 13.1 m95 -72.91 -43.76 62.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.914 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.34 -35.51 60.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.661 0.664 . . . . 0.0 110.973 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.76 71.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.538 0.735 . . . . 0.0 111.9 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.1 -11.46 10.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.98 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.8 t-105 -53.46 -28.9 32.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.73 1.612 . . . . 0.0 111.6 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.59 -43.88 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.093 1.357 . . . . 0.0 111.346 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.45 -30.01 67.82 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.092 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.6 mt -57.28 -30.46 64.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.945 1.248 . . . . 0.0 111.236 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.32 -28.47 65.19 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.689 0.796 . . . . 0.0 111.467 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.88 -24.33 35.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.184 0.594 . . . . 0.0 111.275 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.61 158.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 123.169 1.462 . . . . 0.0 112.205 -168.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -92.2 98.51 11.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.931 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -119.64 8.81 11.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.83 120.75 13.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.22 12.32 84.25 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.12 1.343 . . . . 0.0 114.12 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -79.52 148.53 31.77 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 117.659 0.729 . . . . 0.0 109.143 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -85.15 141.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 166.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.02 119.6 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 125.758 1.623 . . . . 0.0 107.167 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -98.85 116.63 31.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.127 -0.983 . . . . 0.0 108.617 168.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.08 141.89 29.1 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.19 0.904 . . . . 0.0 112.242 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -137.36 155.43 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.995 0.918 . . . . 0.0 109.162 168.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.81 172.17 36.3 Favored Glycine 0 N--CA 1.451 -0.345 0 O-C-N 120.698 -1.251 . . . . 0.0 112.296 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.78 155.83 40.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.389 1.076 . . . . 0.0 108.443 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.19 -155.64 12.96 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -149.23 140.28 22.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -90.91 -24.6 20.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.002 1.321 . . . . 0.0 113.811 178.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -33.24 43.22 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.164 1.347 . . . . 0.0 112.862 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.5 -20.73 36.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.454 1.026 . . . . 0.0 111.266 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -122.37 -86.36 0.65 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.689 1.196 . . . . 0.0 108.051 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.42 -53.3 3.15 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 128.719 3.056 . . . . 0.0 107.703 -168.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.6 -28.0 69.33 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.605 1.962 . . . . 0.0 110.776 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -118.34 6.63 11.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.971 1.308 . . . . 0.0 112.228 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.56 122.22 5.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.976 1.31 . . . . 0.0 109.905 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.41 26.8 7.42 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.195 1.398 . . . . 0.0 113.056 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.47 -38.81 92.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 120.928 -1.108 . . . . 0.0 110.443 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.22 75.28 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.209 0.604 . . . . 0.0 111.907 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.653 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.4 tp -60.34 -45.93 91.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.996 0.918 . . . . 0.0 110.403 175.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.34 97.5 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.6 mtm -66.46 -42.6 87.34 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 118.0 0.9 . . . . 0.0 111.971 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 53' ' ' ILE . 4.1 mt -63.16 -35.11 79.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.546 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -65.31 -42.44 93.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.18 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.7 -42.57 95.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.347 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -55.35 -60.67 3.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.719 1.208 . . . . 0.0 108.224 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.75 -20.36 56.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.906 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -60.96 -29.26 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.579 1.081 . . . . 0.0 110.499 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -22.21 55.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.875 -1.14 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -85.09 2.54 42.95 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 112.458 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.67 36.44 82.87 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.37 0.532 . . . . 0.0 112.12 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.8 169.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.838 0.855 . . . . 0.0 110.076 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -104.3 136.36 44.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -106.76 146.8 30.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.881 1.219 . . . . 0.0 110.658 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.7 m -129.85 178.09 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 123.786 0.834 . . . . 0.0 108.799 169.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.95 38.96 34.35 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-O 118.767 -1.019 . . . . 0.0 113.855 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -79.59 153.99 29.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.462 1.631 . . . . 0.0 109.085 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.21 149.95 75.14 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.635 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.47 140.39 39.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.44 1.426 . . . . 0.0 110.158 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 126.472 1.909 . . . . 0.0 113.503 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.44 -0.944 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 12.3 p90 -162.03 -60.43 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 126' ' ' PHE 0.315 1.9 t 56.95 9.4 0.62 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.276 2.63 . . . . 0.0 114.19 -179.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 p -66.82 135.97 94.41 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.832 -1.168 . . . . 0.0 108.974 169.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.98 -13.9 5.38 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.431 2.087 . . . . 0.0 113.671 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.99 -48.41 1.09 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.2 36.96 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.983 1.789 . . . . 0.0 112.965 -168.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.66 147.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.131 0.972 . . . . 0.0 109.529 -167.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.76 -172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.7 . . . . 0.0 109.372 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.01 -117.12 0.87 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.062 1.345 . . . . 0.0 107.518 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -104.88 7.45 34.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.667 1.187 . . . . 0.0 112.003 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.57 20.15 18.12 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.56 1.076 . . . . 0.0 112.787 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.36 -17.26 17.33 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.831 1.252 . . . . 0.0 111.007 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.06 145.25 50.61 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.512 0.725 . . . . 0.0 110.809 174.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.4 m-85 -79.84 154.61 28.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.209 1.404 . . . . 0.0 109.845 177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.98 -12.41 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.813 1.245 . . . . 0.0 112.829 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.29 -176.23 41.65 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.617 1.099 . . . . 0.0 111.863 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 144' ' ' LEU . 34.4 tp -63.0 126.8 28.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.28 121.21 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 153' ' ' SER . 55.8 mt -123.05 155.69 36.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.085 0.954 . . . . 0.0 109.512 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.556 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -137.49 120.82 16.96 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.07 3.66 44.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.553 -172.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -30.84 10.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.537 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.9 -46.61 2.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.257 0.935 . . . . 0.0 110.637 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -99.57 24.01 8.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.334 1.054 . . . . 0.0 111.31 -171.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -53.48 -29.27 35.18 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.712 0.687 . . . . 0.0 111.841 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.97 -22.85 48.82 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.922 0.889 . . . . 0.0 111.213 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.69 -31.04 11.41 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 126.497 1.919 . . . . 0.0 110.245 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.613 ' HA ' HD22 ' A' ' 144' ' ' LEU . 70.6 m -55.92 -26.11 46.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.993 169.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.56 -54.71 11.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.071 0.85 . . . . 0.0 109.959 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -62.55 -32.68 73.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.092 0.949 . . . . 0.0 111.793 -170.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -83.94 -24.07 30.85 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.435 1.494 . . . . 0.0 109.692 -170.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.9 mt -60.73 -52.83 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -54.84 -44.99 74.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.861 0.864 . . . . 0.0 110.582 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -71.3 -33.64 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.686 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CZ2' ' HB1' ' A' ' 83' ' ' ALA . 35.4 t90 -65.45 -44.39 87.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.747 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.0 m -59.52 -36.24 75.73 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.995 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -68.79 -32.5 72.27 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 122.789 0.435 . . . . 0.0 110.564 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -79.11 -46.42 18.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.741 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 25' ' ' ILE . 7.0 pt -65.0 -38.0 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 120.597 1.544 . . . . 0.0 109.838 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.46 -12.26 50.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.477 0.581 . . . . 0.0 112.187 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -95.29 -46.6 6.67 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.28 -36.23 79.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.947 0.794 . . . . 0.0 110.637 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -82.04 -37.38 26.57 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.209 1.003 . . . . 0.0 110.834 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.24 -45.28 56.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 110.228 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.79 -30.07 68.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 110.084 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 81' ' ' ILE . 68.0 t60 -63.98 -53.11 55.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.068 0.547 . . . . 0.0 109.822 169.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -9.3 58.83 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.681 178.224 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.53 143.49 31.98 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mtm -132.18 149.56 52.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 107.55 -170.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.16 121.23 5.24 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.759 -1.023 . . . . 0.0 110.671 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.61 113.59 25.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.826 1.313 . . . . 0.0 109.07 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 43' ' ' MET . 73.8 m-85 -109.69 145.93 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.395 1.478 . . . . 0.0 111.748 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -162.67 172.23 15.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.237 1.015 . . . . 0.0 109.602 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.36 136.58 7.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 168.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -134.52 128.82 34.09 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.813 1.245 . . . . 0.0 110.871 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.1 m -89.79 -42.26 11.38 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.933 0.493 . . . . 0.0 110.014 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -92.62 -82.33 0.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.7 p -177.13 -6.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.464 2.306 . . . . 0.0 112.559 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.42 -44.47 91.1 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 119.817 -1.802 . . . . 0.0 112.062 -168.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -37.99 88.16 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.3 -46.58 89.72 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.632 0.773 . . . . 0.0 110.316 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.6 mtm -67.34 -43.23 82.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.158 0.436 . . . . 0.0 110.979 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.5 87.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.709 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.72 80.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.776 0.83 . . . . 0.0 110.823 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.65 -44.13 93.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -63.2 -53.86 46.63 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.004 1.321 . . . . 0.0 108.992 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -53.24 -56.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.843 0.747 . . . . 0.0 110.091 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -38.29 79.75 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.385 -178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.36 -47.9 71.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.056 0.542 . . . . 0.0 111.033 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.6 mt -65.75 -48.24 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.437 1.095 . . . . 0.0 108.674 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 164' ' ' ILE . 79.5 mt -71.1 -49.9 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 123.461 0.704 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.97 114.31 0.77 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.19 4.15 3.52 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.48 2.787 . . . . 0.0 112.577 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.59 -34.38 67.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.225 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 -21.24 3.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.424 1.49 . . . . 0.0 111.694 -169.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.13 141.63 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.583 1.538 . . . . 0.0 108.995 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.3 m -131.56 128.91 40.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.328 1.051 . . . . 0.0 109.817 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.55 149.12 47.44 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.521 0.729 . . . . 0.0 112.048 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -146.97 111.85 5.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.995 1.718 . . . . 0.0 106.926 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.82 112.48 21.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.23 -8.79 19.15 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -59.27 -28.64 66.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.255 0.934 . . . . 0.0 111.762 168.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -132.26 -33.64 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.545 1.138 . . . . 0.0 111.973 -171.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.66 140.5 30.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 109.019 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -86.03 141.66 35.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 75' ' ' LEU . 18.4 Cg_endo -72.57 1.41 6.3 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.666 2.244 . . . . 0.0 111.695 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -59.6 -34.79 73.2 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 119.057 -2.277 . . . . 0.0 111.576 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -17.97 63.29 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.442 ' HG3' ' CZ ' ' A' ' 6' ' ' PHE . 15.7 mtm -59.09 -15.84 16.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 0.0 111.791 168.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 54.6 mt-10 -72.3 -26.53 62.0 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.976 -1.078 . . . . 0.0 111.529 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.96 -50.33 11.32 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.984 0.811 . . . . 0.0 110.347 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -67.68 147.19 53.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.124 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -79.13 -23.41 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.968 -0.457 . . . . 0.0 110.938 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.4 t -143.21 138.49 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.91 152.4 47.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.15 125.4 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.29 134.47 52.25 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.686 0.794 . . . . 0.0 109.321 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.54 117.54 3.64 Favored Glycine 0 N--CA 1.463 0.436 0 CA-C-O 116.989 -2.006 . . . . 0.0 111.705 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -115.32 126.74 27.46 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 120.168 1.984 . . . . 0.0 110.932 172.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.98 141.79 10.74 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.548 2.832 . . . . 0.0 108.354 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -91.23 112.03 23.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -98.53 170.46 8.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.476 1.111 . . . . 0.0 110.592 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.74 62.92 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.783 2.833 . . . . 0.0 115.449 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 57.09 74.87 0.39 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.762 1.225 . . . . 0.0 112.626 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.11 71.08 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.12 164.28 23.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.564 1.173 . . . . 0.0 108.762 168.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.12 153.27 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -59.85 141.61 55.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.57 -29.36 69.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -166.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.64 -21.17 52.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.614 -0.679 . . . . 0.0 110.283 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.0 m95 -77.84 -45.27 24.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.497 168.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -53.76 -36.0 61.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.182 0.593 . . . . 0.0 110.886 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.73 70.99 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.299 1.04 . . . . 0.0 112.061 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.9 -8.69 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.569 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.0 t-105 -54.31 -28.95 45.74 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 111.677 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -45.11 71.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.771 1.228 . . . . 0.0 111.646 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.43 -26.11 66.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 117.727 -1.13 . . . . 0.0 112.388 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.16 -30.95 68.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.055 1.298 . . . . 0.0 111.042 -176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -70.12 -26.92 64.18 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.238 0.615 . . . . 0.0 111.583 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.09 -23.16 33.22 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.289 0.635 . . . . 0.0 111.484 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 40' ' ' PRO . 21.3 mt -72.14 171.83 11.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.504 1.145 . . . . 0.0 111.073 -170.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 13.7 t30 -111.78 103.26 11.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.029 1.732 . . . . 0.0 108.442 173.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -121.83 10.79 10.3 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.67 121.95 15.18 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.9 8.91 86.8 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.169 1.366 . . . . 0.0 114.605 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.79 151.19 32.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 117.976 0.888 . . . . 0.0 109.032 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.733 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.0 mt -88.99 141.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.34 126.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.002 1.321 . . . . 0.0 108.328 176.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.39 110.29 22.58 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 105' ' ' HIS . 58.0 mt -88.5 142.76 27.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.925 0.784 . . . . 0.0 110.637 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -137.62 162.37 33.98 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.168 1.387 . . . . 0.0 108.163 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.1 173.64 36.77 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 121.369 -0.832 . . . . 0.0 112.119 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.8 mt -128.99 154.6 46.45 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.97 1.308 . . . . 0.0 108.087 -172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.67 -152.4 9.43 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -157.22 142.76 17.41 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.739 2.016 . . . . 0.0 107.142 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.63 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -91.98 -26.78 18.23 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.81 -32.93 63.98 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.894 1.224 . . . . 0.0 112.835 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.7 -16.52 48.45 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 124.251 0.929 . . . . 0.0 111.795 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -127.54 -88.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.49 1.516 . . . . 0.0 108.761 -168.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.26 -50.74 2.8 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 129.247 3.308 . . . . 0.0 108.364 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.22 -25.78 65.38 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 125.636 1.574 . . . . 0.0 110.885 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -119.12 8.09 11.48 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.949 1.3 . . . . 0.0 112.449 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -46.7 123.08 4.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.191 1.397 . . . . 0.0 110.399 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 52.36 27.52 4.93 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.011 1.324 . . . . 0.0 113.122 173.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.22 -34.75 78.14 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.529 -170.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.27 71.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.453 0.701 . . . . 0.0 111.606 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.624 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -62.42 -47.17 85.27 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.133 0.973 . . . . 0.0 109.972 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.87 -40.87 97.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.2 mtm -66.58 -45.31 79.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.156 0.978 . . . . 0.0 112.214 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.569 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -66.48 -32.0 73.09 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.552 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' HD12 ' A' ' 84' ' ' LEU . 2.1 m-70 -59.12 -47.93 83.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.064 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.02 -41.26 95.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.286 1.035 . . . . 0.0 111.427 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -55.4 -57.99 9.57 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 108.883 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.8 -19.63 48.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.446 -169.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -61.27 -29.13 69.66 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.109 0.868 . . . . 0.0 110.246 169.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -22.48 56.28 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.68 -1.263 . . . . 0.0 109.769 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -84.48 1.19 46.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.555 1.542 . . . . 0.0 112.36 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.95 34.87 71.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 112.155 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.74 173.02 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.956 0.902 . . . . 0.0 109.85 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -118.28 143.74 46.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.37 147.71 34.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.823 1.192 . . . . 0.0 111.62 -170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 15.3 m -128.82 -179.79 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.661 0.784 . . . . 0.0 109.945 171.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 38.41 30.64 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.807 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -77.98 151.94 33.38 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.521 1.66 . . . . 0.0 108.368 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.62 146.56 60.97 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-O 116.968 -1.491 . . . . 0.0 109.461 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.49 139.48 45.1 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 CA-C-N 120.953 1.376 . . . . 0.0 110.186 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 139' ' ' PHE . 74.0 p . . . . . 0 CA--C 1.537 0.453 0 C-N-CA 126.228 1.811 . . . . 0.0 113.931 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -164.57 -49.45 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.679 0.672 . . . . 0.0 110.09 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.305 2.5 t 58.7 9.05 1.03 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.149 2.58 . . . . 0.0 114.391 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.98 134.91 52.1 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 109.449 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -86.42 -11.37 6.09 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.53 2.154 . . . . 0.0 113.948 -172.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.46 -48.86 3.04 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -89.77 38.32 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.708 1.646 . . . . 0.0 112.113 -169.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.44 150.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.632 1.173 . . . . 0.0 110.166 -166.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.413 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -127.96 -172.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 126.322 1.849 . . . . 0.0 109.805 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.02 -116.64 0.85 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.123 1.369 . . . . 0.0 107.606 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.22 8.38 33.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.964 1.306 . . . . 0.0 111.957 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.17 21.0 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.875 1.226 . . . . 0.0 112.593 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -99.58 -17.36 17.88 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.781 1.232 . . . . 0.0 110.573 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.93 142.71 49.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.043 0.537 . . . . 0.0 111.305 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.3 m-85 -77.4 155.8 31.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.375 1.47 . . . . 0.0 108.926 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.413 HG12 HG23 ' A' ' 133' ' ' ILE . 30.9 m -68.24 -14.56 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.356 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -162.46 179.83 37.52 Favored Glycine 0 N--CA 1.47 0.948 0 O-C-N 119.974 -1.704 . . . . 0.0 111.987 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.9 tp -63.31 128.1 34.29 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.91 126.44 55.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.28 156.37 37.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.547 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.77 115.36 15.87 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -93.0 26.17 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.934 -168.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.7 -25.87 3.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.778 168.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.39 -36.05 3.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.343 1.429 . . . . 0.0 111.654 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -84.26 -2.82 57.63 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.863 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -55.29 -24.63 29.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.056 1.753 . . . . 0.0 112.376 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.97 -20.84 28.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.038 1.335 . . . . 0.0 112.83 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 -6.78 8.91 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.957 1.303 . . . . 0.0 113.025 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -54.23 -28.63 42.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.46 1.482 . . . . 0.0 111.329 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -52.35 -40.49 62.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.843 1.257 . . . . 0.0 111.611 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -31.49 69.25 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.33 1.852 . . . . 0.0 111.318 -177.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -92.46 -19.4 22.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.765 1.226 . . . . 0.0 110.606 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.46 -58.53 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.2 pt20 -54.04 -42.57 69.33 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.861 0.864 . . . . 0.0 112.617 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 p -68.16 -35.22 77.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 35.9 t90 -65.64 -45.02 84.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.041 0.924 . . . . 0.0 109.604 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 91.2 m -58.0 -34.59 70.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.336 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.42 -28.19 63.82 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.947 0.499 . . . . 0.0 110.386 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -83.55 -45.92 13.01 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.67 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 25' ' ' ILE . 6.3 pt -63.64 -36.96 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.945 1.702 . . . . 0.0 109.75 -171.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.9 -12.31 35.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.51 -51.23 5.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.679 1.592 . . . . 0.0 107.795 169.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.77 -22.61 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.161 0.584 . . . . 0.0 111.752 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.733 ' HG2' HG21 ' A' ' 81' ' ' ILE . 68.7 mtm -93.78 -42.11 9.3 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 124.926 1.29 . . . . 0.0 111.514 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.45 -43.8 38.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.584 0.753 . . . . 0.0 110.854 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.03 -28.86 65.82 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.217 1.407 . . . . 0.0 109.603 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -61.57 -43.54 98.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.97 -1.59 57.98 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 113.454 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.384 178.217 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.19 142.98 30.79 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 mtm -131.62 147.35 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.383 1.873 . . . . 0.0 107.858 -170.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.74 119.24 5.02 Favored Glycine 0 N--CA 1.46 0.28 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 99.49 12.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.799 1.3 . . . . 0.0 109.326 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -97.86 146.79 25.09 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.704 1.202 . . . . 0.0 109.979 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -165.27 173.11 11.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.49 132.45 6.21 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 105.889 -2.885 . . . . 0.0 105.889 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -152.52 147.86 26.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -125.23 -31.98 3.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.294 1.438 . . . . 0.0 108.876 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 p -88.36 -6.51 57.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.348 1.859 . . . . 0.0 111.618 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.25 43.8 m 71.69 10.13 6.34 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 127.754 2.422 . . . . 0.0 115.144 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -65.87 -44.79 84.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.807 1.64 . . . . 0.0 111.016 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -34.96 79.57 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -65.45 -46.97 77.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.014 0.926 . . . . 0.0 110.422 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.0 mtm -63.89 -39.4 94.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.388 0.54 . . . . 0.0 110.9 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.02 99.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.739 172.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.39 76.83 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.928 0.891 . . . . 0.0 110.539 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -57.21 -47.32 81.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.013 0.525 . . . . 0.0 109.69 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.61 -54.02 45.82 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 124.598 1.186 . . . . 0.0 108.525 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -52.94 -56.78 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 118.733 0.697 . . . . 0.0 109.562 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -38.98 72.68 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.262 0.625 . . . . 0.0 110.529 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -46.69 73.05 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.745 0.418 . . . . 0.0 111.275 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 158' ' ' GLN . 16.0 mt -66.17 -48.15 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.785 1.234 . . . . 0.0 108.704 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.97 -50.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.768 0.827 . . . . 0.0 110.415 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.98 115.22 0.73 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 170.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.06 3.47 3.95 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.479 2.786 . . . . 0.0 112.788 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.12 -34.35 66.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.036 1.334 . . . . 0.0 109.236 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 -23.49 3.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.838 1.655 . . . . 0.0 111.422 -169.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.55 141.04 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.696 1.589 . . . . 0.0 109.352 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -130.23 128.61 42.01 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.216 1.007 . . . . 0.0 110.043 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.38 145.26 51.24 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.98 0.912 . . . . 0.0 111.216 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -148.66 112.71 5.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -93.3 116.59 29.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -67.15 -11.12 56.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.768 -174.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -58.72 -25.82 63.32 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.6 . . . . 0.0 111.618 168.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -134.8 -31.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.804 0.842 . . . . 0.0 111.85 -167.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.12 154.12 18.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.658 1.183 . . . . 0.0 112.05 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -96.28 134.39 23.64 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 125.153 1.381 . . . . 0.0 109.715 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.45 -6.62 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 112.366 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -49.22 -40.03 32.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.441 1.473 . . . . 0.0 111.526 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -23.09 67.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -14.6 31.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.374 1.07 . . . . 0.0 112.378 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.97 -25.51 61.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.053 -1.029 . . . . 0.0 110.615 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -75.89 -49.89 16.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.23 0.923 . . . . 0.0 110.24 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -66.73 147.68 52.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.436 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.0 -28.06 60.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.829 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 49' ' ' LEU . 38.7 t -144.95 142.56 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -168.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -127.84 160.28 32.27 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.681 0.673 . . . . 0.0 111.133 173.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.26 123.66 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 166.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -121.53 145.69 47.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.04 150.66 22.23 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.668 -1.253 . . . . 0.0 114.855 173.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -133.26 135.11 24.93 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.382 1.873 . . . . 0.0 109.453 -169.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.11 141.45 9.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 N-CA-C 107.64 -1.716 . . . . 0.0 107.64 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.0 m -86.33 104.92 16.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -86.89 168.77 13.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.926 1.29 . . . . 0.0 109.613 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 19.72 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.483 3.113 . . . . 0.0 115.878 166.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 56.24 72.39 0.5 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.338 1.055 . . . . 0.0 112.279 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.79 11.58 78.01 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.46 149.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.61 1.195 . . . . 0.0 110.635 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mt -84.72 153.51 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 172.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -62.19 143.47 56.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.72 -27.23 68.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.39 -28.94 31.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.635 -0.666 . . . . 0.0 110.653 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.2 m95 -65.55 -44.02 88.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 169.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -55.92 -37.78 69.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.37 0.532 . . . . 0.0 110.92 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.8 73.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.947 0.499 . . . . 0.0 111.761 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 m -99.64 -11.85 8.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.727 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.567 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -53.87 -28.81 38.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.184 1.793 . . . . 0.0 111.606 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.34 -43.22 64.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.267 1.427 . . . . 0.0 111.125 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.33 -31.03 70.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 117.772 -1.108 . . . . 0.0 111.843 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.1 mt -56.5 -32.76 65.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.863 1.21 . . . . 0.0 110.923 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.94 -28.53 66.73 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.375 0.67 . . . . 0.0 111.43 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.02 -25.58 34.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.327 0.651 . . . . 0.0 111.193 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 159.6 34.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.972 1.367 . . . . 0.0 112.511 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.5 98.3 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.678 -2.056 . . . . 0.0 108.694 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.09 8.8 11.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.4 120.52 12.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.4 12.85 83.93 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.984 1.278 . . . . 0.0 113.88 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -81.45 150.76 28.17 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 117.796 0.798 . . . . 0.0 109.309 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.749 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.8 mt -87.13 141.03 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.52 121.29 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 124.87 1.268 . . . . 0.0 108.052 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -97.95 115.73 28.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.93 -1.106 . . . . 0.0 108.328 168.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.74 HD12 ' CD2' ' A' ' 105' ' ' HIS . 51.1 mt -91.2 140.4 29.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.195 0.907 . . . . 0.0 112.448 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -139.73 157.83 45.1 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.455 1.502 . . . . 0.0 109.405 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.02 179.53 35.5 Favored Glycine 0 CA--C 1.512 -0.129 0 O-C-N 120.668 -1.27 . . . . 0.0 112.619 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.83 153.58 40.83 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.949 0.9 . . . . 0.0 109.35 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.41 -167.98 28.89 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.85 136.19 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -86.18 -24.25 26.19 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.052 0.941 . . . . 0.0 113.356 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.8 mt -81.14 -33.25 33.29 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.779 1.172 . . . . 0.0 112.71 -169.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.1 -22.5 32.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.102 0.858 . . . . 0.0 111.039 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -125.23 -87.88 0.6 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.0 -47.95 1.98 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 128.41 2.91 . . . . 0.0 108.866 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.72 -28.84 69.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.837 1.655 . . . . 0.0 110.725 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -117.46 9.14 13.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.205 1.402 . . . . 0.0 112.133 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -47.65 122.61 5.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.034 1.334 . . . . 0.0 109.582 169.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.22 25.62 5.95 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.403 1.481 . . . . 0.0 113.379 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.95 -36.97 86.09 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.98 -30.95 71.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.886 -0.509 . . . . 0.0 112.043 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -63.0 -45.69 91.22 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.146 0.978 . . . . 0.0 111.009 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.13 96.11 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.9 mtm -67.01 -44.39 80.44 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.132 0.966 . . . . 0.0 112.115 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.567 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -64.64 -33.04 75.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.924 0.784 . . . . 0.0 111.55 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.74 ' CD2' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -60.23 -47.49 85.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.22 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.21 -40.8 94.65 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.581 1.153 . . . . 0.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 14.1 tptt -55.21 -60.07 3.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.784 1.234 . . . . 0.0 108.795 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.29 -19.21 54.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.063 -169.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 t -61.2 -28.73 69.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.088 0.858 . . . . 0.0 110.274 169.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -21.84 55.59 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.733 -1.229 . . . . 0.0 109.992 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -85.24 1.59 47.56 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.642 1.577 . . . . 0.0 112.659 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.14 34.36 75.64 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.419 0.554 . . . . 0.0 111.897 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -86.26 170.33 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.979 0.912 . . . . 0.0 109.449 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.48 140.8 48.97 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 168.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -105.16 148.25 27.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.598 0.635 . . . . 0.0 110.531 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.1 m -126.97 177.43 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.22 39.18 27.59 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-O 118.441 -1.199 . . . . 0.0 113.983 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -76.35 151.7 36.57 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.704 1.752 . . . . 0.0 108.182 169.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.48 146.25 61.1 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.653 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.56 139.41 37.41 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.128 1.439 . . . . 0.0 109.52 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 139' ' ' PHE . 64.4 p . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 126.019 1.728 . . . . 0.0 113.334 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.1 p90 -164.02 -60.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.002 0.819 . . . . 0.0 109.611 -174.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.337 2.0 t 58.06 9.94 1.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.671 2.788 . . . . 0.0 114.768 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.9 p -66.02 139.16 96.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.785 -1.197 . . . . 0.0 108.953 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.9 -15.54 3.82 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.444 2.096 . . . . 0.0 113.383 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -80.55 -47.33 1.26 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -86.88 35.94 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.072 1.848 . . . . 0.0 112.165 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.65 148.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.92 1.288 . . . . 0.0 109.556 -167.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.49 -172.95 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 125.978 1.711 . . . . 0.0 110.128 176.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.88 -116.22 0.83 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.302 1.441 . . . . 0.0 107.531 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.99 7.55 34.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.995 1.318 . . . . 0.0 111.879 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.45 18.85 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.998 1.285 . . . . 0.0 112.455 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.65 -17.59 17.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.645 1.178 . . . . 0.0 110.934 -172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.93 143.07 50.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.925 0.49 . . . . 0.0 111.212 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.458 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.3 m-85 -77.56 155.8 31.32 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.169 1.388 . . . . 0.0 108.658 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 133' ' ' ILE . 35.0 m -69.12 -16.35 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.763 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.88 -176.64 38.61 Favored Glycine 0 C--N 1.338 0.669 0 O-C-N 120.572 -1.33 . . . . 0.0 111.65 -172.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.2 tp -65.96 130.13 42.2 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.38 117.63 32.97 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.289 1.035 . . . . 0.0 108.27 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.03 153.66 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.317 1.047 . . . . 0.0 109.71 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.504 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -139.79 122.83 16.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -105.23 7.97 33.78 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.263 1.025 . . . . 0.0 110.716 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 -27.41 12.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.494 1.118 . . . . 0.0 110.39 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -124.9 -47.08 1.81 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.302 0.955 . . . . 0.0 111.025 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.18 17.14 7.37 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.7 0.8 . . . . 0.0 112.493 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -51.76 -22.88 3.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.043 0.937 . . . . 0.0 112.952 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -79.72 -25.85 41.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.846 0.858 . . . . 0.0 111.472 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -122.74 -13.12 7.98 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.241 1.017 . . . . 0.0 112.623 -171.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.1 p -55.71 -31.37 62.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.655 1.116 . . . . 0.0 110.681 -175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.58 -38.69 75.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.096 1.358 . . . . 0.0 111.476 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.46 -34.01 60.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.442 1.097 . . . . 0.0 109.414 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.72 60.26 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.676 0.79 . . . . 0.0 109.651 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.23 -60.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.1 pt20 -56.09 -40.21 73.32 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.4 m -68.65 -33.3 73.76 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.017 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 44.5 t90 -66.28 -43.37 86.57 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 174.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.6 m -58.98 -34.75 72.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.794 0.837 . . . . 0.0 110.062 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.75 -31.35 68.13 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.93 0.492 . . . . 0.0 109.989 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -79.47 -45.82 18.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.515 171.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 pt -64.69 -38.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 120.944 1.702 . . . . 0.0 110.032 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.4 -12.17 49.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.216 0.462 . . . . 0.0 112.18 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.92 -46.27 6.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.742 1.217 . . . . 0.0 107.893 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.3 -36.36 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.114 0.87 . . . . 0.0 110.719 -172.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.749 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.4 mtm -80.94 -35.15 32.66 Favored 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.941 0.896 . . . . 0.0 110.972 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -46.42 33.89 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.382 1.073 . . . . 0.0 110.335 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.1 -30.21 70.17 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.259 1.424 . . . . 0.0 110.253 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.44 ' CD2' HD11 ' A' ' 81' ' ' ILE . 64.4 t60 -63.25 -54.31 39.24 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.95 0.5 . . . . 0.0 110.293 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.31 -7.21 55.63 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -169.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 C-N-CA 123.159 0.583 . . . . 0.0 110.632 179.189 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 142.99 31.23 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -130.92 147.06 52.52 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.49 1.916 . . . . 0.0 108.18 -170.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 118.37 5.07 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-O 118.563 -1.132 . . . . 0.0 110.409 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.39 109.96 19.93 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.026 1.413 . . . . 0.0 108.573 169.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -103.25 143.91 32.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.933 1.293 . . . . 0.0 111.398 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.8 172.86 17.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.162 0.585 . . . . 0.0 110.79 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.18 139.34 8.06 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -160.52 135.29 7.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.942 1.297 . . . . 0.0 108.207 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -99.86 -27.7 13.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.226 1.011 . . . . 0.0 110.909 169.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 p -99.37 -3.15 34.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.887 1.675 . . . . 0.0 111.753 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.7 m 70.87 8.55 6.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.657 2.383 . . . . 0.0 115.126 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -63.66 -45.3 90.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.365 1.438 . . . . 0.0 110.76 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 -35.67 79.57 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.0 -46.0 91.13 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 123.463 0.705 . . . . 0.0 110.085 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.7 mtm -64.71 -39.37 93.52 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.96 -0.462 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.26 95.45 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.013 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.69 -47.69 73.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.951 0.9 . . . . 0.0 110.641 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.89 -44.23 94.33 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -63.41 -54.2 40.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 124.596 1.185 . . . . 0.0 109.321 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -52.53 -55.83 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.973 0.806 . . . . 0.0 109.614 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -39.04 79.26 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.966 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.62 -46.72 74.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.102 0.477 . . . . 0.0 111.21 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.23 -46.89 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.152 1.381 . . . . 0.0 108.484 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.37 -49.56 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.604 0.762 . . . . 0.0 110.286 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.99 115.99 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.46 1.029 . . . . 0.0 110.548 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.22 3.18 4.25 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.427 2.751 . . . . 0.0 112.48 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.82 -34.74 69.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.28 1.432 . . . . 0.0 109.253 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.84 -23.06 3.74 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.641 1.576 . . . . 0.0 111.484 -169.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.48 139.95 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 120.509 1.504 . . . . 0.0 108.652 173.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -129.14 129.54 45.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.223 1.009 . . . . 0.0 109.349 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.65 146.26 51.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.29 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -145.4 99.67 3.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -81.49 124.47 29.5 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.61 -8.62 58.15 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -37.38 62.25 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.411 1.085 . . . . 0.0 108.986 169.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -98.55 -31.48 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.884 1.673 . . . . 0.0 112.822 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.13 172.17 13.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.305 1.442 . . . . 0.0 111.299 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.0 m -92.59 155.47 42.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -79.71 -9.73 14.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.779 2.319 . . . . 0.0 111.368 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -57.1 -36.87 71.13 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.962 1.71 . . . . 0.0 111.203 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -13.15 21.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.404 1.081 . . . . 0.0 112.355 170.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -73.37 -26.4 60.99 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.798 -1.188 . . . . 0.0 111.176 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.09 -51.33 12.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.097 0.862 . . . . 0.0 110.206 -171.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -66.16 142.99 57.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.301 1.44 . . . . 0.0 109.246 -169.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.05 -27.6 61.84 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.41 144.19 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.79 152.54 51.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.2 119.65 53.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.79 144.56 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.82 148.56 19.55 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.461 -1.352 . . . . 0.0 115.839 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.17 136.67 26.52 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.94 2.096 . . . . 0.0 109.502 -169.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.04 141.21 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 N-CA-C 107.839 -1.639 . . . . 0.0 107.839 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.7 m -87.82 116.35 25.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -99.43 167.79 10.4 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.104 1.762 . . . . 0.0 110.164 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 13.16 75.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 130.093 3.357 . . . . 0.0 115.272 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 56.54 65.03 1.51 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.842 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.16 70.15 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.358 0.5 OUTLIER -94.28 152.92 18.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.381 1.073 . . . . 0.0 109.956 168.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mt -95.86 151.21 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.582 1.553 . . . . 0.0 106.812 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -59.78 140.41 56.56 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.39 -27.46 69.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.134 0.574 . . . . 0.0 111.947 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -28.92 64.69 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.979 0.511 . . . . 0.0 111.207 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.3 m95 -77.76 -42.85 32.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.676 0.79 . . . . 0.0 110.268 170.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -55.78 -35.9 66.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.597 0.635 . . . . 0.0 110.909 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.98 -31.56 72.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.89 0.876 . . . . 0.0 111.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.9 -12.37 8.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.689 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.542 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -54.25 -28.86 44.32 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.551 1.541 . . . . 0.0 111.656 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.49 -44.08 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.97 1.308 . . . . 0.0 111.025 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -69.21 -30.13 68.25 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.457 -1.259 . . . . 0.0 112.675 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.85 -31.55 64.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.186 1.357 . . . . 0.0 110.685 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.3 -28.56 67.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.878 0.871 . . . . 0.0 111.566 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.45 -24.42 36.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.642 0.777 . . . . 0.0 111.254 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.89 157.33 33.38 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 123.122 1.439 . . . . 0.0 112.503 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -90.64 95.88 10.37 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.53 7.78 12.77 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.06 120.94 13.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.83 -0.39 89.14 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 125.393 1.473 . . . . 0.0 114.824 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -72.35 150.48 43.44 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.035 0.918 . . . . 0.0 109.46 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.4 mt -88.98 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.3 t -132.67 128.03 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.427 1.091 . . . . 0.0 108.655 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.98 118.45 36.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -90.06 142.85 27.31 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.966 0.803 . . . . 0.0 111.692 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -140.59 158.76 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.079 0.952 . . . . 0.0 108.875 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.45 -179.93 39.5 Favored Glycine 0 CA--C 1.508 -0.367 0 O-C-N 120.678 -1.264 . . . . 0.0 112.125 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.39 145.2 45.36 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.71 11.79 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 169.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -159.63 135.0 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.463 1.505 . . . . 0.0 107.224 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.531 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -88.85 -20.81 24.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.57 -47.84 68.62 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.655 1.116 . . . . 0.0 110.608 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.88 -29.13 7.43 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.491 1.043 . . . . 0.0 112.391 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -132.27 33.95 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -166.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.43 -38.77 63.47 Favored Glycine 0 N--CA 1.47 0.939 0 CA-C-N 120.024 1.284 . . . . 0.0 111.725 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.91 -17.01 62.79 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.362 1.081 . . . . 0.0 112.737 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -128.52 14.37 6.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 112.079 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.65 123.17 2.16 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.717 1.607 . . . . 0.0 109.762 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.52 27.85 2.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.939 1.296 . . . . 0.0 112.978 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.16 -37.82 86.69 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.68 -1.263 . . . . 0.0 110.628 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.92 76.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.527 0.331 . . . . 0.0 111.454 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.681 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.2 tp -60.1 -47.41 86.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.366 1.066 . . . . 0.0 110.505 174.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.78 98.58 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.1 mtm -64.15 -45.03 90.29 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.927 0.864 . . . . 0.0 111.829 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.584 HD12 HD12 ' A' ' 53' ' ' ILE . 4.9 mt -63.3 -35.14 79.37 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.345 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.23 -43.38 95.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.202 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.82 -42.1 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.776 1.23 . . . . 0.0 111.571 175.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.89 -59.85 4.17 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.679 1.191 . . . . 0.0 108.311 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.39 -20.45 54.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.871 -169.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 t -60.98 -29.09 69.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.256 0.934 . . . . 0.0 110.499 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -22.15 53.55 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.012 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -83.66 1.6 41.62 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 125.582 1.553 . . . . 0.0 112.583 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.47 31.88 68.16 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.641 0.655 . . . . 0.0 112.207 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.22 173.12 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.004 0.922 . . . . 0.0 109.193 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.51 148.6 44.25 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.32 150.49 30.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.098 0.863 . . . . 0.0 112.275 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.1 m -128.01 -179.7 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.718 1.207 . . . . 0.0 109.059 169.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.03 35.75 37.78 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-O 118.463 -1.187 . . . . 0.0 114.165 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -79.05 145.92 33.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.711 1.755 . . . . 0.0 108.713 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -120.53 148.29 47.5 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.363 170.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.41 139.16 37.35 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 CA-C-N 120.703 1.287 . . . . 0.0 109.187 168.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.488 HG22 ' CD1' ' A' ' 139' ' ' PHE . 72.8 p . . . . . 0 CA--C 1.538 0.505 0 C-N-CA 125.774 1.63 . . . . 0.0 113.161 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.49 -57.74 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.364 0.984 . . . . 0.0 110.487 -171.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 4.0 t 58.17 11.07 1.41 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.282 2.633 . . . . 0.0 114.567 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -63.94 132.71 95.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -83.92 -12.23 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.718 2.278 . . . . 0.0 112.694 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -80.51 -48.83 1.19 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -88.3 38.81 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.314 2.009 . . . . 0.0 112.643 -168.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 146.72 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.205 -0.934 . . . . 0.0 110.056 -167.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.2 -172.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.107 1.763 . . . . 0.0 109.594 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.47 -117.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.988 1.315 . . . . 0.0 107.588 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -104.97 7.74 34.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.753 1.221 . . . . 0.0 112.011 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.02 20.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.572 1.082 . . . . 0.0 112.749 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -100.04 -17.47 17.48 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.746 1.218 . . . . 0.0 110.767 -172.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.55 144.67 50.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.306 0.642 . . . . 0.0 110.88 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.1 m-85 -79.93 154.64 28.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.147 1.379 . . . . 0.0 110.048 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.79 -12.61 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.7 1.2 . . . . 0.0 112.654 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.75 -177.69 44.06 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 119.479 1.036 . . . . 0.0 111.83 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.3 tp -64.67 127.84 33.24 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.71 107.55 16.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.48 155.21 17.03 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.56 115.89 8.51 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.55 27.13 2.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.489 -168.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 t -133.31 -19.89 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 -45.02 2.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.428 1.467 . . . . 0.0 109.309 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -79.62 -0.44 33.75 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.416 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.18 -25.27 21.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.018 1.735 . . . . 0.0 112.787 -171.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.7 -20.68 25.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.76 1.224 . . . . 0.0 112.738 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pp -124.48 -6.98 7.52 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.215 1.406 . . . . 0.0 113.088 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.7 m -53.49 -32.12 48.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.037 1.289 . . . . 0.0 110.24 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.94 -40.79 81.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.125 0.57 . . . . 0.0 111.455 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.68 -34.53 67.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.134 1.374 . . . . 0.0 109.564 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -78.83 -28.58 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.143 0.977 . . . . 0.0 109.224 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.71 -60.62 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -57.1 -41.08 78.27 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 118.727 0.694 . . . . 0.0 112.479 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -64.77 -36.22 83.61 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.536 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 39.9 t90 -66.35 -45.02 81.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 110.037 176.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.1 m -56.53 -37.06 69.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.168 0.987 . . . . 0.0 109.506 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.71 -29.06 66.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.474 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -80.74 -45.76 16.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.044 -0.979 . . . . 0.0 111.22 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 25' ' ' ILE . 4.9 pt -64.6 -38.7 83.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 CA-C-N 120.84 1.654 . . . . 0.0 110.238 -171.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.17 -15.2 59.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.304 0.642 . . . . 0.0 112.034 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.16 -45.88 6.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.06 -41.59 88.31 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 118.704 0.684 . . . . 0.0 109.574 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.4 mtm -76.27 -38.01 56.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.706 0.803 . . . . 0.0 110.837 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.76 66.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.813 0.845 . . . . 0.0 109.927 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.58 -30.38 70.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.452 1.501 . . . . 0.0 109.921 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -63.28 -47.46 82.23 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 118.558 0.617 . . . . 0.0 110.502 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -2.74 47.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.775 1.23 . . . . 0.0 113.688 -175.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.418 179.519 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.95 141.46 44.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.138 1.375 . . . . 0.0 108.652 169.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 48' ' ' VAL . 15.3 mtm -120.68 147.59 45.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.291 2.237 . . . . 0.0 108.657 -169.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.84 120.1 5.61 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.666 -1.075 . . . . 0.0 110.711 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 116.03 27.28 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 118.828 1.314 . . . . 0.0 108.601 169.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.37 147.25 35.59 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.807 1.643 . . . . 0.0 111.403 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -161.99 173.88 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.023 0.929 . . . . 0.0 110.81 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.35 138.51 7.98 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -140.68 131.61 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.34 1.456 . . . . 0.0 108.715 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.4 m -90.33 -36.85 14.42 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -94.58 -84.99 0.31 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.2 p -174.68 -6.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.739 2.016 . . . . 0.0 113.106 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -68.85 -42.39 77.18 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 119.839 -1.788 . . . . 0.0 112.249 -168.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -35.78 82.28 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.25 -47.55 83.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.4 mtm -66.69 -41.06 88.63 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.906 -0.496 . . . . 0.0 111.295 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.19 92.33 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 118.835 -0.603 . . . . 0.0 110.655 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.41 79.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.979 0.912 . . . . 0.0 110.872 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -58.68 -43.97 90.09 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.09 -55.32 26.42 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.813 1.245 . . . . 0.0 108.81 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -52.51 -56.66 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 119.018 0.826 . . . . 0.0 109.832 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -38.98 77.12 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.759 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.51 -47.22 70.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 122.737 0.415 . . . . 0.0 111.553 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -66.12 -45.56 90.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.743 1.217 . . . . 0.0 108.456 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 164' ' ' ILE . 78.1 mt -72.35 -51.81 27.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.636 0.774 . . . . 0.0 110.484 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.3 114.06 0.75 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.432 1.015 . . . . 0.0 110.592 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.28 3.61 3.97 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.351 2.701 . . . . 0.0 112.693 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.97 -35.05 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.222 1.409 . . . . 0.0 109.118 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -24.7 5.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.876 1.67 . . . . 0.0 111.438 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.77 140.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 121.103 1.774 . . . . 0.0 109.242 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 m -130.69 130.13 43.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.541 1.137 . . . . 0.0 109.788 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.79 148.53 46.18 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.734 0.814 . . . . 0.0 112.06 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.56 115.14 10.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.872 1.669 . . . . 0.0 108.666 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.16 100.57 9.15 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.96 -21.65 66.43 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.844 1.656 . . . . 0.0 112.847 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -60.41 -28.84 68.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 112.468 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -109.89 -32.51 7.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.339 1.056 . . . . 0.0 112.993 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.63 167.62 16.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.636 1.175 . . . . 0.0 111.476 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -93.46 147.41 33.62 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.812 1.645 . . . . 0.0 109.07 -170.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -76.0 -1.52 11.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.588 1.525 . . . . 0.0 111.107 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -55.97 -33.74 65.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 122.346 2.339 . . . . 0.0 111.908 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.39 -19.87 65.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.425 ' CG ' HD13 ' A' ' 49' ' ' LEU . 47.5 ttm -58.91 -16.04 15.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.913 2.085 . . . . 0.0 111.627 169.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.37 -27.69 56.51 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.241 -0.912 . . . . 0.0 110.753 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.88 -51.55 12.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.751 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.36 133.18 47.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.01 -10.2 53.71 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.22 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 3' ' ' MET . 71.4 t -134.09 143.84 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.9 mt -140.34 149.05 42.24 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.8 121.63 56.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.63 147.08 44.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 85' ' ' TYR . . . -151.93 147.49 17.36 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 119.589 -1.291 . . . . 0.0 115.66 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -135.5 135.93 23.13 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 126.894 2.078 . . . . 0.0 109.602 -171.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.97 144.02 7.07 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 165.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.9 m -88.73 117.21 27.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -98.77 169.95 9.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.592 1.157 . . . . 0.0 110.561 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 22.72 64.99 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.915 2.886 . . . . 0.0 115.517 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.75 70.8 0.6 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.586 1.154 . . . . 0.0 112.097 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.42 17.3 79.77 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.81 151.26 27.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.314 1.054 . . . . 0.0 109.555 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.31 153.03 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -61.14 141.02 57.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.862 0.839 . . . . 0.0 108.774 170.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.62 -27.4 68.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -166.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.11 -23.63 35.58 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.063 0.545 . . . . 0.0 110.391 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.529 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.5 m95 -73.44 -43.95 59.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 169.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -53.51 -34.24 57.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.336 0.655 . . . . 0.0 111.084 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.18 71.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 111.862 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 m -104.98 -9.36 9.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.59 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.6 t-105 -53.09 -29.49 30.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.708 1.603 . . . . 0.0 111.932 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.42 -43.81 76.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.33 -29.76 66.55 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.247 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -58.02 -31.03 66.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.828 1.194 . . . . 0.0 111.157 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.77 -26.92 62.63 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.549 0.74 . . . . 0.0 111.558 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.22 -22.34 35.96 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.316 0.646 . . . . 0.0 110.934 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.1 mt -73.93 156.89 37.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.982 1.372 . . . . 0.0 112.313 -167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.08 97.45 11.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.666 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -119.26 8.92 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.08 123.9 20.25 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.36 9.0 87.08 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.494 1.521 . . . . 0.0 114.329 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.48 146.94 34.12 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.646 0.723 . . . . 0.0 109.617 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.9 mt -85.62 139.02 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 167.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.41 132.43 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 124.867 1.267 . . . . 0.0 109.143 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.03 119.46 37.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.69 143.82 26.49 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.122 0.874 . . . . 0.0 112.032 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 24.0 p90 -139.94 157.81 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.095 0.958 . . . . 0.0 109.253 169.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.68 177.04 38.1 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 120.452 -1.405 . . . . 0.0 112.849 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.69 157.24 36.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.195 0.998 . . . . 0.0 108.478 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.12 -152.75 9.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -154.73 135.13 13.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.548 1.539 . . . . 0.0 107.493 166.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.636 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -87.47 -22.83 24.7 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.733 1.213 . . . . 0.0 113.277 -178.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.5 mt -77.59 -40.19 43.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 120.016 1.28 . . . . 0.0 111.556 -171.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.43 -28.4 11.57 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.814 1.197 . . . . 0.0 112.166 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.78 34.61 3.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -168.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.06 61.11 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 119.99 1.268 . . . . 0.0 111.381 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.53 -16.4 55.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.757 0.778 . . . . 0.0 112.169 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.7 10.01 7.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.506 1.922 . . . . 0.0 112.112 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -47.5 124.01 6.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.38 1.472 . . . . 0.0 109.411 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.55 27.48 5.13 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 124.42 1.075 . . . . 0.0 112.781 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.09 -37.39 87.34 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.505 -1.372 . . . . 0.0 110.605 -172.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.36 75.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.917 0.487 . . . . 0.0 111.696 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.657 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -59.72 -47.62 84.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.167 0.987 . . . . 0.0 110.29 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.78 97.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.4 mtm -64.97 -42.76 94.3 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 117.853 0.827 . . . . 0.0 111.864 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.659 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 mt -66.0 -33.78 76.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.814 1.188 . . . . 0.0 111.856 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -62.3 -40.64 96.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.741 -0.599 . . . . 0.0 110.334 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.81 -35.07 69.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.432 1.493 . . . . 0.0 111.813 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HB3' HD23 ' A' ' 104' ' ' LEU . 20.6 tptt -58.11 -43.98 87.48 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.614 0.765 . . . . 0.0 109.916 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.4 mt -98.58 -18.16 18.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.917 -1.039 . . . . 0.0 112.446 -170.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p -60.64 -32.23 71.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 111.611 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -79.8 -18.74 50.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.1 0.56 . . . . 0.0 110.23 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -79.33 1.42 25.18 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.408 1.483 . . . . 0.0 111.969 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.83 63.86 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 118.601 0.637 . . . . 0.0 111.883 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.2 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.827 0.851 . . . . 0.0 109.376 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -118.27 141.33 48.63 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -106.15 147.14 29.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.336 0.971 . . . . 0.0 111.526 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.2 m -127.35 177.76 5.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.715 1.206 . . . . 0.0 108.921 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.35 35.73 32.63 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.389 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -79.86 146.87 31.97 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.888 1.844 . . . . 0.0 109.138 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -122.82 148.57 54.09 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 124.986 1.314 . . . . 0.0 108.488 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.71 138.07 31.18 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.585 1.524 . . . . 0.0 110.465 169.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.526 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.0 p . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 126.381 1.872 . . . . 0.0 112.939 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 127' ' ' THR . 11.2 p90 -165.2 -57.57 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.907 0.883 . . . . 0.0 108.929 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 126' ' ' PHE 0.339 2.1 t 59.71 10.52 2.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.873 2.869 . . . . 0.0 114.895 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.7 p -67.33 139.12 94.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.867 -1.146 . . . . 0.0 108.683 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -86.91 -14.79 4.08 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.245 1.963 . . . . 0.0 113.532 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -81.7 -46.68 1.05 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -86.31 38.35 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.979 1.786 . . . . 0.0 112.395 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 146.52 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.183 0.993 . . . . 0.0 108.988 -167.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -172.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.737 1.615 . . . . 0.0 109.708 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.98 -116.01 0.82 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.479 1.512 . . . . 0.0 107.371 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.03 7.63 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.886 1.274 . . . . 0.0 111.881 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.72 20.84 17.97 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.94 1.257 . . . . 0.0 112.601 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.56 -16.8 17.36 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.945 1.298 . . . . 0.0 110.844 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.99 145.3 50.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.427 0.691 . . . . 0.0 110.882 174.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.7 m-85 -80.18 153.91 28.31 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.715 1.606 . . . . 0.0 109.295 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.4 m -66.7 -12.55 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 112.599 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.99 -177.42 43.16 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.523 1.056 . . . . 0.0 112.019 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 20.0 tp -66.15 129.64 40.52 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.99 123.53 48.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 157.63 27.76 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.478 1.111 . . . . 0.0 108.136 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.475 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -142.93 120.04 11.43 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -98.19 12.8 33.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -21.5 11.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.196 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.4 -40.7 1.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.366 1.439 . . . . 0.0 113.249 172.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -80.63 4.92 17.02 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.386 0.994 . . . . 0.0 112.57 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.12 -25.02 28.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.439 1.472 . . . . 0.0 112.663 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.77 -26.05 49.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.749 1.22 . . . . 0.0 111.5 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.21 -6.49 6.56 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.321 1.049 . . . . 0.0 112.753 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.1 m -51.76 -33.8 36.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.208 1.367 . . . . 0.0 110.172 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.48 -42.65 78.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.836 1.255 . . . . 0.0 111.516 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -75.08 -33.43 61.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.797 1.239 . . . . 0.0 109.817 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -76.26 -30.98 58.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.704 -0.623 . . . . 0.0 109.651 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.9 -55.96 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.403 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.8 pt20 -58.18 -43.1 87.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -65.21 -35.19 80.28 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.971 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.45 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.3 t90 -66.05 -45.3 81.9 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.841 0.829 . . . . 0.0 110.247 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 84.5 m -57.09 -36.48 70.64 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.161 0.985 . . . . 0.0 109.416 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.44 -28.65 66.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.323 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -81.27 -45.36 16.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.407 171.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 25' ' ' ILE . 4.5 pt -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 120.923 1.692 . . . . 0.0 110.008 -172.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.58 -14.14 56.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.835 -0.541 . . . . 0.0 112.108 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -94.47 -46.9 6.8 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.7 -34.79 76.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.681 0.673 . . . . 0.0 110.477 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -81.39 -43.12 19.44 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.32 1.048 . . . . 0.0 110.182 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.12 72.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.054 0.942 . . . . 0.0 111.222 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.06 -30.51 66.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.802 1.241 . . . . 0.0 109.607 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.41 ' CD2' HD11 ' A' ' 81' ' ' ILE . 67.5 t60 -66.45 -47.61 72.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -12.0 61.23 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.506 1.122 . . . . 0.0 113.388 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 C-N-CA 122.962 0.505 . . . . 0.0 110.793 -178.49 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.48 144.08 29.8 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 mtm -131.21 146.11 52.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.621 1.969 . . . . 0.0 107.854 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.42 117.22 4.98 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-O 118.478 -1.179 . . . . 0.0 110.628 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.63 115.41 26.14 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.245 1.522 . . . . 0.0 108.461 169.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.39 146.36 37.27 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.198 1.399 . . . . 0.0 111.382 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -161.93 176.44 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.166 0.986 . . . . 0.0 110.755 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.7 144.51 12.53 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 p -152.67 139.82 19.32 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.64 1.22 . . . . 0.0 112.647 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.7 m -99.87 -34.72 10.02 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.7 p -93.59 0.59 56.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.133 0.973 . . . . 0.0 111.86 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m 65.4 13.36 8.78 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.869 2.068 . . . . 0.0 113.538 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.37 -48.43 77.96 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.217 -1.552 . . . . 0.0 111.149 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -32.82 74.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.27 -48.75 80.46 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 109.679 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -65.35 -40.41 93.59 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.05 -0.406 . . . . 0.0 111.133 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.52 98.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.872 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.03 -47.42 77.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.279 1.032 . . . . 0.0 110.764 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.89 -45.23 90.74 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HD12 ' A' ' 24' ' ' ILE . 58.9 mttm -61.77 -56.5 18.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 124.825 1.328 . . . . 0.0 108.994 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -51.96 -56.08 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 118.649 0.659 . . . . 0.0 110.108 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.93 78.31 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.27 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.06 -47.47 74.22 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.802 0.441 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -65.74 -47.42 85.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.502 1.121 . . . . 0.0 108.966 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 164' ' ' ILE . 78.8 mt -72.35 -49.26 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.605 0.762 . . . . 0.0 110.173 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.09 115.57 0.89 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.599 1.095 . . . . 0.0 110.47 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.38 3.85 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.412 2.742 . . . . 0.0 112.814 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.68 -34.55 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.943 1.297 . . . . 0.0 109.054 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.99 -21.35 4.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 111.639 -169.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.21 141.33 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.592 1.542 . . . . 0.0 108.944 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -131.56 128.83 40.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.436 1.094 . . . . 0.0 109.974 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.49 148.78 46.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.932 0.893 . . . . 0.0 112.034 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.73 110.89 6.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.582 1.953 . . . . 0.0 107.081 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.55 109.97 19.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.0 mt -66.17 -8.54 24.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -58.93 -29.14 66.88 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.113 0.87 . . . . 0.0 111.425 169.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -132.45 -33.79 1.24 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 111.995 -172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -80.95 139.96 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 m -84.27 139.94 39.18 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -74.31 -0.39 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.256 1.484 . . . . 0.0 111.107 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -56.84 -33.16 66.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.939 2.154 . . . . 0.0 112.208 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -19.45 65.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.421 ' HG2' HD13 ' A' ' 49' ' ' LEU . 42.9 ttm -58.59 -16.22 14.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.752 2.021 . . . . 0.0 111.435 169.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 69.0 mt-10 -74.1 -29.29 61.78 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.028 -1.045 . . . . 0.0 111.095 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -76.75 -47.15 22.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.852 0.751 . . . . 0.0 109.974 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.26 139.23 57.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.601 -1.181 . . . . 0.0 107.968 -169.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.54 -26.96 61.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.228 0.537 . . . . 0.0 110.272 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -141.35 147.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.421 HD13 ' HG2' ' A' ' 43' ' ' MET . 6.3 mt -139.29 150.59 45.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.964 0.505 . . . . 0.0 109.985 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.4 120.48 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 170.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.29 138.61 53.59 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 108.629 -172.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.23 122.56 3.5 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-O 118.239 -1.312 . . . . 0.0 112.442 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.692 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -124.99 130.93 24.04 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 118.613 1.206 . . . . 0.0 109.963 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -84.84 146.63 10.47 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 108.387 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 m -88.33 129.57 35.35 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -119.7 170.65 9.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.091 1.757 . . . . 0.0 109.618 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 27.36 57.65 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.255 2.622 . . . . 0.0 115.265 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 56.85 76.99 0.28 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.983 1.313 . . . . 0.0 112.247 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.42 14.23 71.68 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.41 160.07 21.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.603 1.161 . . . . 0.0 109.666 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -97.4 152.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.55 144.0 55.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 171.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.54 -28.59 69.96 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.164 0.586 . . . . 0.0 112.354 -168.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.73 -24.33 63.54 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.925 -0.484 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.492 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.0 m95 -83.37 -42.8 16.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.933 0.893 . . . . 0.0 110.866 170.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.55 -35.49 65.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.624 0.647 . . . . 0.0 110.818 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.02 71.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.596 1.158 . . . . 0.0 111.88 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 m -106.07 -11.64 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.68 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.544 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -52.89 -29.06 26.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.693 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.79 -46.56 65.47 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.15 1.38 . . . . 0.0 111.248 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.79 -29.53 69.5 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 117.435 -1.269 . . . . 0.0 112.14 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 mt -56.36 -35.91 68.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.798 1.181 . . . . 0.0 110.867 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.48 -33.14 75.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.384 0.674 . . . . 0.0 111.701 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.78 -12.92 43.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 111.184 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.28 171.38 12.24 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.381 1.086 . . . . 0.0 110.65 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 6.2 t30 -111.02 98.82 7.82 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.812 1.645 . . . . 0.0 107.641 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -118.77 6.29 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -65.12 112.86 3.58 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.48 -3.21 68.5 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.849 1.69 . . . . 0.0 116.076 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -75.36 155.12 36.8 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.537 1.168 . . . . 0.0 110.115 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.684 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.0 mt -89.41 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.44 133.33 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.676 1.19 . . . . 0.0 109.416 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.8 117.41 33.34 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.11 142.75 27.41 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 119.023 0.829 . . . . 0.0 111.752 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.75 159.89 41.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.222 1.009 . . . . 0.0 108.878 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.02 177.51 39.05 Favored Glycine 0 N--CA 1.447 -0.578 0 O-C-N 121.14 -0.975 . . . . 0.0 112.207 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.77 153.67 42.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.17 -158.15 10.75 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -152.2 141.08 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.094 1.358 . . . . 0.0 109.141 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.446 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -87.35 -22.36 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.37 -39.92 70.95 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.931 1.241 . . . . 0.0 112.265 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.97 -18.44 31.86 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.171 0.891 . . . . 0.0 111.512 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.93 -89.91 0.54 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.939 1.296 . . . . 0.0 108.13 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.58 -50.21 2.47 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 128.497 2.951 . . . . 0.0 107.936 -168.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.77 -28.42 67.6 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.365 1.866 . . . . 0.0 110.767 -175.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -117.53 6.61 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.651 1.181 . . . . 0.0 112.349 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -43.96 121.87 2.61 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.496 1.518 . . . . 0.0 109.592 168.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 52.85 25.88 4.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.588 1.155 . . . . 0.0 113.512 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.47 -36.0 82.59 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.516 -1.365 . . . . 0.0 110.603 -172.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.69 74.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.255 0.622 . . . . 0.0 112.06 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.692 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -60.48 -46.49 89.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.141 0.976 . . . . 0.0 110.413 176.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.21 97.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 mtm -67.14 -42.73 83.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.841 0.821 . . . . 0.0 112.239 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.577 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -63.49 -36.15 82.82 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.201 172.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -63.6 -41.25 98.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.973 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.18 -43.19 92.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -55.6 -58.44 7.8 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.97 -20.27 58.03 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.728 -0.608 . . . . 0.0 110.385 -169.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t -62.95 -29.66 70.97 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.846 0.748 . . . . 0.0 110.022 167.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.0 -27.38 39.58 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.047 1.294 . . . . 0.0 108.427 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 14.8 mmmt -73.58 2.47 7.91 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.503 1.121 . . . . 0.0 113.176 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.35 85.96 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.427 1.012 . . . . 0.0 112.378 169.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.66 173.75 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.795 0.838 . . . . 0.0 109.304 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 145.75 45.2 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 165.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.96 150.1 28.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.854 0.752 . . . . 0.0 111.878 -169.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.7 m -127.47 179.59 3.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 109.304 169.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 36.24 43.4 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.532 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -71.73 153.52 41.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.091 1.445 . . . . 0.0 108.139 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.23 145.87 58.56 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-O 116.944 -1.503 . . . . 0.0 108.835 169.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.68 140.46 39.29 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 CA-C-N 120.895 1.355 . . . . 0.0 109.618 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.499 HG22 ' CD1' ' A' ' 139' ' ' PHE . 80.6 p . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 113.583 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -163.9 -50.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.952 0.796 . . . . 0.0 110.275 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.303 2.8 t 57.79 8.93 0.77 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.479 2.712 . . . . 0.0 114.512 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -83.55 144.51 46.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.977 1.311 . . . . 0.0 110.861 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -88.94 -12.52 3.4 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.895 2.397 . . . . 0.0 113.775 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -50.91 3.77 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 117.916 -1.04 . . . . 0.0 113.402 -168.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -88.29 38.98 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.751 1.634 . . . . 0.0 112.091 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 148.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.083 -1.011 . . . . 0.0 110.241 -166.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.37 -172.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 126.361 1.864 . . . . 0.0 109.981 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.03 -116.03 0.81 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.486 1.515 . . . . 0.0 107.327 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.09 8.14 34.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.579 1.152 . . . . 0.0 111.889 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.87 21.03 19.69 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.993 1.282 . . . . 0.0 112.506 -173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -100.06 -18.16 17.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 110.837 -172.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.86 143.31 50.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.303 0.641 . . . . 0.0 111.328 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.8 m-85 -78.14 155.39 30.5 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.076 1.35 . . . . 0.0 109.457 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.5 -14.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.546 1.138 . . . . 0.0 112.804 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.32 -178.3 42.4 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 119.65 1.114 . . . . 0.0 112.184 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.97 130.29 42.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.33 117.96 31.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 142' ' ' LEU . 71.6 mt -117.13 152.52 34.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.433 1.093 . . . . 0.0 109.164 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -144.72 124.06 13.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -99.26 15.05 27.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.235 1.014 . . . . 0.0 110.576 -169.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 t -123.04 -22.27 5.25 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.446 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.2 -48.54 2.96 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.759 1.223 . . . . 0.0 108.041 171.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -105.21 22.64 15.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.641 1.577 . . . . 0.0 112.474 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -52.6 -25.78 11.62 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.826 0.739 . . . . 0.0 112.279 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.09 -25.32 52.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.781 . . . . 0.0 111.478 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -125.02 -14.44 6.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.5 m -57.67 -28.95 64.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.098 1.317 . . . . 0.0 109.769 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.23 -49.21 78.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.595 0.758 . . . . 0.0 111.06 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -66.7 -33.17 75.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.081 0.943 . . . . 0.0 109.329 -171.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -79.13 -23.46 44.01 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.219 -174.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.59 -53.71 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -53.64 -47.07 70.67 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 123.636 0.775 . . . . 0.0 110.136 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.9 m -66.83 -36.79 83.17 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.146 0.278 . . . . 0.0 110.521 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 29.5 t90 -65.79 -46.06 80.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.716 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -58.04 -34.55 70.2 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -31.81 71.9 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.028 0.531 . . . . 0.0 110.601 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -83.03 -45.52 13.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.942 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 25' ' ' ILE . 5.7 pt -64.24 -37.82 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 120.849 1.658 . . . . 0.0 110.048 -170.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.83 -11.8 30.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -49.82 5.72 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 125.704 1.601 . . . . 0.0 108.088 169.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.33 -28.44 70.01 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.951 -0.468 . . . . 0.0 110.913 -169.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.684 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.2 mtm -89.34 -40.71 12.59 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 124.132 0.973 . . . . 0.0 111.429 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.28 33.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.575 0.75 . . . . 0.0 110.784 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.0 -29.72 63.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.233 1.413 . . . . 0.0 109.452 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -63.06 -49.79 73.16 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.227 0.467 . . . . 0.0 109.914 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -2.4 34.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.332 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.648 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.5 141.5 31.6 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtm -129.17 145.05 51.4 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.582 1.953 . . . . 0.0 108.489 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.48 115.52 4.09 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.99 121.63 28.05 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -115.63 144.7 43.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.335 1.054 . . . . 0.0 111.679 171.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -156.62 169.88 23.67 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.762 1.225 . . . . 0.0 110.29 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.33 138.57 8.02 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 p -142.05 136.47 30.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.707 1.203 . . . . 0.0 109.814 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -92.75 -39.23 11.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.14 0.976 . . . . 0.0 110.09 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -85.99 -86.34 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 p -177.76 4.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.04 3.336 . . . . 0.0 110.763 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -67.27 -45.43 76.66 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.091 -1.631 . . . . 0.0 111.59 -166.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -34.28 77.11 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -60.98 -47.67 85.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.302 0.641 . . . . 0.0 110.151 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -64.89 -40.43 95.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 122.217 -0.302 . . . . 0.0 111.035 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.07 97.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.824 -0.607 . . . . 0.0 110.623 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.97 -45.7 78.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.085 0.954 . . . . 0.0 110.971 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.86 -45.21 93.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.7 mttm -63.43 -57.55 9.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.699 1.249 . . . . 0.0 108.84 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -51.92 -55.53 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 118.248 0.476 . . . . 0.0 110.015 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -38.23 74.52 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.868 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.77 -48.79 65.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.826 0.451 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.6 mt -65.76 -46.32 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 108.788 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 164' ' ' ILE . 72.3 mt -71.14 -50.14 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 110.038 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.08 114.9 0.8 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.57 1.33 5.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.326 2.684 . . . . 0.0 112.458 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.22 -33.83 65.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 109.404 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.04 -19.63 3.94 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.43 -169.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.63 141.61 15.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.702 1.592 . . . . 0.0 108.755 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.6 m -131.66 129.03 40.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.75 145.53 25.56 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.17 127.55 30.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.007 2.123 . . . . 0.0 107.935 -168.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.26 88.2 3.07 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.724 1.609 . . . . 0.0 107.373 -168.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.45 -16.11 21.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.925 1.29 . . . . 0.0 114.352 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -13.55 62.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.721 -0.612 . . . . 0.0 112.45 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -129.75 -35.43 1.68 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.313 1.445 . . . . 0.0 112.145 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -81.56 145.08 30.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.054 1.342 . . . . 0.0 109.553 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.82 147.69 59.26 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -76.1 -8.95 19.12 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.431 2.087 . . . . 0.0 111.029 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -55.05 -36.54 65.67 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.699 1.59 . . . . 0.0 111.325 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -22.94 67.13 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.119 -0.988 . . . . 0.0 113.397 176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -14.15 31.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -73.06 -26.65 61.36 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.767 -1.208 . . . . 0.0 110.716 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -76.75 -51.11 12.02 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.524 1.056 . . . . 0.0 109.97 -171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -66.01 142.02 57.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.615 -169.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.73 -24.0 56.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.806 0.812 . . . . 0.0 111.611 -172.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.31 144.18 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -172.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.56 153.21 51.83 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.672 0.669 . . . . 0.0 110.47 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.54 120.03 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -118.84 132.4 56.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -172.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -122.18 116.32 3.02 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-O 117.793 -1.56 . . . . 0.0 112.571 -173.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.49 121.45 32.04 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 119.314 1.557 . . . . 0.0 110.758 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -76.8 146.41 26.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.941 2.427 . . . . 0.0 108.941 168.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -94.06 139.81 30.5 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -133.05 167.73 19.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.624 2.37 . . . . 0.0 109.905 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 27.5 56.7 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 129.244 3.018 . . . . 0.0 116.663 167.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . 0.253 3.0 m-85 51.97 81.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.14 2.576 . . . . 0.0 112.093 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.81 16.9 79.18 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.8 152.89 22.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.254 1.022 . . . . 0.0 108.324 168.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -87.03 156.97 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.36 138.47 50.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.53 -24.86 67.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -165.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -86.01 -26.9 25.15 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.738 -0.602 . . . . 0.0 110.552 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -67.26 -40.74 86.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.34 -32.32 64.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.85 0.46 . . . . 0.0 111.148 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.41 72.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.274 0.63 . . . . 0.0 111.869 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -98.95 -11.52 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -54.48 -28.79 47.15 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.509 1.524 . . . . 0.0 111.886 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.16 -44.09 66.2 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.042 1.337 . . . . 0.0 111.309 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -69.41 -29.77 67.59 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.057 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.64 -31.38 64.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.188 1.358 . . . . 0.0 111.225 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.82 -29.17 68.27 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.838 0.855 . . . . 0.0 111.479 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.93 -24.17 35.76 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 111.441 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.1 157.65 34.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 123.013 1.387 . . . . 0.0 112.326 -167.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -92.12 97.01 10.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.766 -2.016 . . . . 0.0 108.778 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -119.34 8.08 11.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.57 120.89 13.21 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -170.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.56 87.0 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.363 1.459 . . . . 0.0 114.287 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -76.99 145.55 37.98 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 117.775 0.787 . . . . 0.0 109.239 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.703 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.1 mt -84.27 138.07 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.66 127.39 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 124.722 1.209 . . . . 0.0 108.835 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.48 117.78 34.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 167.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.5 mt -89.86 141.76 28.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.182 0.901 . . . . 0.0 111.557 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 27.2 p90 -137.04 159.58 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.19 0.996 . . . . 0.0 109.289 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.56 173.43 37.11 Favored Glycine 0 N--CA 1.45 -0.392 0 O-C-N 121.268 -0.895 . . . . 0.0 111.857 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.0 154.37 48.24 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.296 1.438 . . . . 0.0 107.632 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.26 -155.6 11.86 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -131.84 121.23 23.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.089 3.356 . . . . 0.0 105.997 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.497 HE22 ' HG2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.43 -25.25 15.27 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 119.986 1.266 . . . . 0.0 112.836 178.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -79.09 -41.22 29.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.196 0.198 . . . . 0.0 110.729 -169.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.53 -34.21 36.37 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 118.539 -1.145 . . . . 0.0 111.501 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.725 ' CE2' ' HB2' ' A' ' 96' ' ' TRP 0.277 0.0 OUTLIER -153.87 41.89 0.53 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.84 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.16 -24.73 5.03 Favored Glycine 0 N--CA 1.475 1.29 0 O-C-N 119.646 -1.909 . . . . 0.0 114.069 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 -27.06 6.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.806 1.242 . . . . 0.0 111.497 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TRP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 19.9 m-90 -119.22 -55.31 2.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 116.173 -1.87 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.8 t80 7.27 122.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 130.066 3.346 . . . . 0.0 115.8 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.85 30.07 16.6 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.536 1.534 . . . . 0.0 111.655 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.57 -39.09 91.25 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.938 -1.101 . . . . 0.0 110.685 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.53 72.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 111.34 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -61.28 -47.79 84.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.54 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.47 -39.93 96.99 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 mtm -65.92 -44.66 84.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 117.918 0.859 . . . . 0.0 112.23 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -64.29 -34.77 78.9 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.494 173.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.4 -42.34 98.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.048 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.59 -42.86 91.2 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.538 1.135 . . . . 0.0 111.695 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.33 -58.6 6.77 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.631 1.172 . . . . 0.0 108.41 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 mt -78.14 -20.7 51.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.434 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 t -61.32 -28.64 69.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.365 0.984 . . . . 0.0 110.502 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -22.73 50.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.873 1.215 . . . . 0.0 109.787 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -83.35 1.26 42.14 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.854 1.662 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.67 34.04 66.93 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.458 0.572 . . . . 0.0 111.731 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.13 169.07 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.705 0.752 . . . . 0.0 109.38 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -116.13 143.85 44.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -112.34 148.01 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.73 1.15 . . . . 0.0 112.138 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.1 m -128.52 -179.39 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.194 0.998 . . . . 0.0 109.589 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.95 35.72 38.27 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-O 118.473 -1.182 . . . . 0.0 113.987 172.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -78.55 148.59 33.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.48 1.64 . . . . 0.0 108.587 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -124.91 148.1 58.71 Favored Pre-proline 0 CA--C 1.516 -0.35 0 CA-C-O 117.26 -1.352 . . . . 0.0 108.786 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.82 139.3 43.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 N-CA-C 108.877 -1.24 . . . . 0.0 108.877 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.479 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.4 p . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 125.443 1.497 . . . . 0.0 113.289 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 127' ' ' THR . 2.7 p90 -165.11 -69.67 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 126' ' ' PHE 0.353 2.8 t 58.62 12.17 2.05 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.11 2.964 . . . . 0.0 114.384 -170.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.3 p -64.59 141.2 98.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.742 -1.224 . . . . 0.0 110.172 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -88.46 -15.28 2.89 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.854 2.37 . . . . 0.0 113.558 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 -49.54 1.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.034 -0.984 . . . . 0.0 113.466 -168.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -91.58 44.37 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.866 1.711 . . . . 0.0 112.266 -168.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 146.56 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 120.944 -1.097 . . . . 0.0 109.467 -168.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -172.7 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.843 1.657 . . . . 0.0 109.819 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.18 -116.3 0.82 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.162 1.385 . . . . 0.0 107.546 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -105.37 7.46 33.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.965 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.84 20.73 18.01 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.779 1.181 . . . . 0.0 112.838 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.55 -17.29 17.17 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.734 1.214 . . . . 0.0 110.857 -173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.15 144.54 50.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.303 0.641 . . . . 0.0 111.155 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 57.7 m-85 -79.33 154.22 29.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.351 1.46 . . . . 0.0 109.866 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.07 -13.74 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.591 174.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -169.68 -177.56 40.23 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 120.035 1.289 . . . . 0.0 112.206 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 144' ' ' LEU . 23.1 tp -63.68 125.96 26.0 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.2 121.28 44.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 142' ' ' LEU . 69.9 mt -121.29 160.53 23.75 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.9 135.77 41.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 172.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.65 15.4 14.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.129 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -117.63 -22.82 7.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -140.23 -28.66 0.72 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.202 1.001 . . . . 0.0 113.139 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.497 ' HG2' HE22 ' A' ' 90' ' ' GLN . 35.4 mm-40 -86.91 8.38 23.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.411 1.005 . . . . 0.0 111.809 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.95 -24.16 22.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.274 0.943 . . . . 0.0 112.589 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.76 -26.27 44.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.286 1.034 . . . . 0.0 111.667 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -124.97 -13.74 6.79 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.3 m -55.55 -28.86 57.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.277 0.944 . . . . 0.0 111.533 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.5 -43.07 71.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.271 1.029 . . . . 0.0 111.318 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.87 -31.68 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.856 0.836 . . . . 0.0 109.677 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -77.42 -25.23 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.275 0.63 . . . . 0.0 109.667 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -55.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -52.65 -47.22 67.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.633 1.173 . . . . 0.0 110.187 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -68.51 -35.49 77.56 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.315 0.384 . . . . 0.0 110.58 -177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 25.3 t90 -65.72 -45.54 82.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.627 0.727 . . . . 0.0 109.816 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -59.1 -34.53 72.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.667 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.49 70.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.051 0.54 . . . . 0.0 110.889 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -85.4 -45.58 11.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.16 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 25' ' ' ILE . 6.7 pt -64.34 -37.9 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 120.603 1.547 . . . . 0.0 109.897 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.58 -13.2 28.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -49.67 5.85 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 108.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.91 -28.13 69.85 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.376 0.535 . . . . 0.0 111.051 -169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' MET . . . . . 0.703 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -89.4 -41.22 12.22 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.46 1.104 . . . . 0.0 111.416 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.93 -44.09 27.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.393 0.677 . . . . 0.0 110.727 -174.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -73.25 -28.44 62.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.331 1.452 . . . . 0.0 109.862 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -60.16 -49.9 75.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -1.0 48.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.853 0.461 . . . . 0.0 110.581 178.188 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 119.815 -0.136 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.47 143.89 31.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 168.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -132.29 145.77 51.52 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.381 1.872 . . . . 0.0 108.104 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.63 117.52 4.85 Favored Glycine 0 C--O 1.228 -0.277 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.26 112.35 21.95 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 118.983 1.391 . . . . 0.0 108.054 169.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -106.42 142.9 35.32 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.525 1.13 . . . . 0.0 111.83 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.27 169.14 25.17 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.801 0.84 . . . . 0.0 110.163 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.14 137.89 7.91 Favored Glycine 0 C--N 1.333 0.391 0 N-CA-C 105.965 -2.854 . . . . 0.0 105.965 168.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 p -138.75 135.57 34.84 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.791 1.636 . . . . 0.0 108.076 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.7 m -87.19 -28.9 22.13 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 173.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.8 p -108.74 -90.8 0.45 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.8 m -162.03 -11.79 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.546 2.738 . . . . 0.0 113.21 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -62.78 -46.75 86.56 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.979 -1.701 . . . . 0.0 112.272 -167.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -34.51 77.76 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -62.3 -48.25 80.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.07 0.948 . . . . 0.0 110.437 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 70.2 mtm -65.99 -40.35 91.1 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.908 -0.495 . . . . 0.0 110.943 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.93 -42.59 98.45 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.873 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.68 -48.12 75.63 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.075 0.95 . . . . 0.0 110.634 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -59.11 -44.92 92.02 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -62.18 -54.51 39.93 Favored 'General case' 0 CA--C 1.502 -0.871 0 O-C-N 124.658 1.224 . . . . 0.0 109.024 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.426 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -53.03 -56.23 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.888 0.767 . . . . 0.0 109.775 -177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -38.53 78.14 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.59 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.6 -46.73 74.97 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 122.878 0.471 . . . . 0.0 111.377 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 158' ' ' GLN . 11.5 mt -68.05 -47.18 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.572 1.149 . . . . 0.0 108.504 -174.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -70.61 -50.17 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.722 0.809 . . . . 0.0 110.159 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.29 115.13 0.85 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 170.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.19 3.7 3.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.396 2.731 . . . . 0.0 112.945 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.4 -34.67 70.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.132 1.373 . . . . 0.0 108.996 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -21.02 3.54 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.342 1.457 . . . . 0.0 111.587 -169.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.0 t -93.51 142.47 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 120.909 1.686 . . . . 0.0 108.727 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.6 m -132.86 129.73 38.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.399 1.08 . . . . 0.0 109.528 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.37 146.41 48.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.64 0.776 . . . . 0.0 111.666 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -139.39 121.69 15.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.632 1.973 . . . . 0.0 107.301 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -103.72 90.43 3.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.33 -15.13 22.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.089 1.356 . . . . 0.0 114.392 -167.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -12.83 61.71 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 170.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -131.73 -35.28 1.28 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.016 1.326 . . . . 0.0 112.22 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -81.75 145.34 30.53 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.044 1.338 . . . . 0.0 109.651 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -83.95 143.54 43.23 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -74.36 -8.04 20.31 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.501 2.134 . . . . 0.0 111.072 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -57.21 -35.54 69.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.763 1.62 . . . . 0.0 111.823 -176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.79 -21.37 66.76 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.261 -0.9 . . . . 0.0 113.194 175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -13.32 23.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.673 1.189 . . . . 0.0 112.034 170.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -73.33 -27.46 61.53 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.626 -1.296 . . . . 0.0 111.043 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.68 -49.46 16.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.853 0.751 . . . . 0.0 110.167 -172.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -65.4 140.83 58.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.944 1.298 . . . . 0.0 108.86 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -69.84 -31.07 68.72 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.356 0.662 . . . . 0.0 110.755 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -142.77 144.54 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mt -133.7 152.32 51.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.53 0.605 . . . . 0.0 110.246 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.66 121.67 57.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -120.67 137.44 54.46 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 108.991 -172.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.33 122.3 3.79 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-O 118.02 -1.434 . . . . 0.0 113.236 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.669 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.47 126.07 26.62 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 119.15 1.475 . . . . 0.0 111.829 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -78.51 142.95 18.84 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.433 2.755 . . . . 0.0 109.187 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.1 m -92.23 110.09 21.47 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -95.63 171.56 8.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.493 1.117 . . . . 0.0 110.37 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 26.89 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.722 2.809 . . . . 0.0 115.647 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 55.11 76.27 0.27 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.928 1.291 . . . . 0.0 112.481 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.18 16.36 79.72 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 115.087 0.795 . . . . 0.0 115.087 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -86.44 154.5 21.1 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.458 1.123 . . . . 0.0 108.565 168.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.3 mt -82.75 153.57 3.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.04 138.37 44.16 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.89 -24.44 67.74 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -165.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -87.83 -25.92 23.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 122.986 0.514 . . . . 0.0 110.606 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.8 m95 -68.46 -39.52 81.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.013 -0.429 . . . . 0.0 110.393 170.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -55.56 -32.87 63.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.023 0.529 . . . . 0.0 111.346 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.97 -31.91 71.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.424 0.69 . . . . 0.0 111.971 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.7 -12.33 8.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-O 118.733 -0.651 . . . . 0.0 112.745 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.561 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.3 t-105 -54.25 -28.03 38.83 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.529 1.531 . . . . 0.0 112.059 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.44 -46.13 64.47 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.055 1.342 . . . . 0.0 111.227 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -67.56 -32.02 72.5 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.319 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.63 -30.16 62.99 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.871 1.214 . . . . 0.0 111.445 -175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -70.3 -32.41 70.17 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.634 0.774 . . . . 0.0 111.354 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.85 -22.7 33.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.963 0.905 . . . . 0.0 110.728 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -73.63 159.8 32.53 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 122.689 1.233 . . . . 0.0 111.341 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -91.52 101.66 14.32 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.645 173.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -122.9 3.93 9.41 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.665 1.186 . . . . 0.0 113.215 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.4 mp0 -67.03 115.38 6.67 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.72 5.12 78.59 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.61 1.576 . . . . 0.0 115.288 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -78.2 149.98 33.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 118.125 0.963 . . . . 0.0 110.047 176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.729 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -86.23 139.08 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 167.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.09 129.63 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 124.756 1.222 . . . . 0.0 108.925 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.05 118.0 35.6 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.6 mt -90.12 143.01 27.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 118.975 0.807 . . . . 0.0 111.776 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -135.29 156.33 49.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.898 0.879 . . . . 0.0 108.657 168.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.24 162.46 30.59 Favored Glycine 0 CA--C 1.505 -0.546 0 O-C-N 120.874 -1.141 . . . . 0.0 111.939 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.3 mt -123.6 153.28 40.91 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.01 -145.75 5.84 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -151.73 145.13 24.79 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.157 2.183 . . . . 0.0 108.149 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.635 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -85.95 -31.59 22.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.752 2.021 . . . . 0.0 114.019 172.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.0 mt -74.82 -32.93 62.1 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.356 0.98 . . . . 0.0 112.782 -167.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.71 -19.94 23.3 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 124.843 1.211 . . . . 0.0 111.521 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' C ' ' H ' ' A' ' 95' ' ' GLU . 25.5 m-85 -126.44 -88.64 0.57 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.189 0.996 . . . . 0.0 108.872 -169.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.46 -50.26 2.43 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 128.295 2.855 . . . . 0.0 107.812 -167.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 93' ' ' TYR . 9.7 mm-40 -69.02 -32.66 72.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.483 1.913 . . . . 0.0 110.533 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -111.89 0.83 16.25 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.793 1.237 . . . . 0.0 111.656 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -54.11 126.33 22.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.71 -1.243 . . . . 0.0 109.897 169.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.61 24.7 9.09 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 125.719 1.608 . . . . 0.0 113.46 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.76 -41.65 97.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.791 -1.193 . . . . 0.0 110.426 -175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.441 0.697 . . . . 0.0 111.368 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.669 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.33 -46.82 88.68 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.544 0.738 . . . . 0.0 110.927 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.95 -39.1 95.14 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 27.6 mtm -68.44 -43.39 77.19 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 117.74 0.77 . . . . 0.0 112.559 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.567 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -63.82 -33.04 74.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 119.6 1.091 . . . . 0.0 111.28 172.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -66.0 -41.03 91.57 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.031 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.93 -31.49 66.41 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.698 1.999 . . . . 0.0 112.155 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -61.86 -61.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 169.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.5 mt -77.49 -18.83 56.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.761 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 88.0 p -61.87 -31.11 71.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 120.145 1.339 . . . . 0.0 111.55 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.73 -22.35 56.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.521 -0.737 . . . . 0.0 109.627 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -82.12 4.73 22.02 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.518 1.927 . . . . 0.0 112.876 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.05 31.49 78.0 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -82.69 169.82 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -116.8 142.27 47.13 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -110.04 147.45 33.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 119.57 1.077 . . . . 0.0 111.723 -169.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.519 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.6 m -127.82 178.54 4.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.187 0.995 . . . . 0.0 109.24 169.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.63 36.15 34.22 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.326 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -75.65 151.69 37.7 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.837 1.818 . . . . 0.0 108.446 169.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -128.71 148.27 67.81 Favored Pre-proline 0 N--CA 1.466 0.363 0 CA-C-O 117.095 -1.431 . . . . 0.0 108.946 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.43 139.93 42.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 120.922 1.365 . . . . 0.0 109.696 168.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.511 HG22 ' CD1' ' A' ' 139' ' ' PHE . 79.7 p -74.33 -12.9 60.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.496 1.518 . . . . 0.0 113.692 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -63.08 144.95 56.45 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.8 0.809 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.54 76.04 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.95 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.73 169.21 18.07 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.976 1.71 . . . . 0.0 108.962 175.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -129.15 126.81 40.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 125.577 1.551 . . . . 0.0 107.916 -175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -163.53 -59.45 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.695 0.68 . . . . 0.0 109.283 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.325 3.7 t 54.97 7.73 0.19 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 128.628 2.771 . . . . 0.0 114.173 -175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.5 p -72.84 146.09 87.48 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.018 -1.051 . . . . 0.0 110.66 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -87.98 -11.28 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.935 2.423 . . . . 0.0 113.867 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -79.87 -48.07 1.4 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -169.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -91.61 39.98 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.295 1.997 . . . . 0.0 112.8 -168.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.06 148.82 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 120.949 -1.094 . . . . 0.0 110.408 -167.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.02 -172.16 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.123 1.769 . . . . 0.0 109.666 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.42 -117.38 0.94 Allowed 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -105.24 8.36 33.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.016 1.326 . . . . 0.0 112.011 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.36 20.21 20.84 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.352 0.977 . . . . 0.0 112.865 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -100.31 -17.21 17.39 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.971 1.308 . . . . 0.0 110.779 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.34 144.33 49.56 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.683 0.793 . . . . 0.0 111.026 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.511 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.4 m-85 -79.13 154.65 29.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.48 1.512 . . . . 0.0 109.776 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.18 -15.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 124.492 1.117 . . . . 0.0 112.479 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -170.35 -178.47 41.19 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 119.592 1.087 . . . . 0.0 111.698 -170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.9 tp -65.7 135.39 54.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 170.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -119.08 124.56 47.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.6 mt -127.66 159.57 34.3 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.515 1.126 . . . . 0.0 109.9 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -143.63 139.63 29.71 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.525 1.53 . . . . 0.0 107.254 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -113.21 4.22 16.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.043 1.337 . . . . 0.0 111.048 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.51 -24.06 15.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.21 -177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -147.42 -30.35 0.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -81.29 9.93 6.33 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.342 0.974 . . . . 0.0 111.871 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -55.07 -20.67 10.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.977 0.911 . . . . 0.0 112.792 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.78 -27.01 57.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.522 0.729 . . . . 0.0 110.934 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 pp -125.77 -11.72 6.62 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 p -52.56 -35.82 54.5 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 110.476 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -60.04 -39.93 87.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.529 1.532 . . . . 0.0 111.466 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -31.66 59.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.765 0.826 . . . . 0.0 109.667 -176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -76.16 -29.81 57.89 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 121.856 -0.528 . . . . 0.0 109.812 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.37 -57.23 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.3 pt20 -57.04 -43.83 82.33 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 122.661 0.384 . . . . 0.0 111.746 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -65.72 -34.15 77.54 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.904 -0.718 . . . . 0.0 111.055 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.413 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.6 t90 -66.51 -45.2 80.33 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.812 0.815 . . . . 0.0 109.802 176.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 89.9 m -57.37 -37.17 72.2 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.813 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -68.5 -26.69 65.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.199 -176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -86.13 -43.52 12.98 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.909 -1.044 . . . . 0.0 112.091 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.541 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.07 -36.4 76.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.874 1.67 . . . . 0.0 109.85 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.22 0.608 . . . . 0.0 112.182 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.2 -47.7 6.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.3 -35.44 77.36 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.41 0.55 . . . . 0.0 110.225 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.729 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.4 mtm -77.9 -43.45 30.04 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 124.322 1.049 . . . . 0.0 110.601 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.68 73.14 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.922 0.889 . . . . 0.0 111.252 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -69.75 -30.76 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.94 1.296 . . . . 0.0 109.9 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -42.23 98.65 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.542 0.737 . . . . 0.0 110.599 169.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.91 -1.65 56.87 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.719 1.608 . . . . 0.0 113.818 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.089 0.556 . . . . 0.0 110.494 -179.84 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttm . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.162 0.506 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 147.31 51.6 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 127.946 2.498 . . . . 0.0 106.978 168.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.5 mtm -135.41 147.07 48.87 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.645 1.578 . . . . 0.0 109.0 -166.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.87 119.09 4.78 Favored Glycine 0 CA--C 1.518 0.228 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.08 108.1 19.08 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -103.73 143.84 32.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.68 1.192 . . . . 0.0 109.998 172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -161.09 174.63 13.43 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.956 0.503 . . . . 0.0 109.826 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.17 142.9 9.93 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 169.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 t -140.81 147.19 38.64 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 124.607 1.163 . . . . 0.0 108.012 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.66 -29.54 33.08 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 169.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.8 p -104.29 -77.43 0.58 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -172.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p 175.66 -7.78 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.997 2.919 . . . . 0.0 110.891 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -65.46 -44.06 88.37 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 121.01 1.732 . . . . 0.0 110.542 -168.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -31.53 70.07 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -64.53 -47.43 78.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.453 1.101 . . . . 0.0 110.207 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.7 mtm -64.11 -40.27 95.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.193 0.451 . . . . 0.0 110.875 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.23 96.64 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.056 174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.73 -47.9 73.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.015 0.926 . . . . 0.0 110.713 177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -60.3 -43.78 95.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -63.9 -54.22 38.14 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 124.502 1.121 . . . . 0.0 108.974 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.5 mt -51.52 -56.18 6.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 119.039 0.836 . . . . 0.0 109.769 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -39.52 82.6 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 119.048 -0.501 . . . . 0.0 110.732 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -68.17 -46.92 69.4 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.424 0.453 . . . . 0.0 111.226 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.45 -48.24 85.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.25 1.42 . . . . 0.0 108.488 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 164' ' ' ILE . 81.0 mt -72.59 -50.16 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.529 0.731 . . . . 0.0 110.513 -175.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.77 114.11 0.77 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 124.392 0.996 . . . . 0.0 110.855 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.79 4.09 3.36 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 123.399 2.732 . . . . 0.0 113.056 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.84 -36.12 64.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.553 1.541 . . . . 0.0 109.262 174.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.74 -26.1 6.19 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.434 1.893 . . . . 0.0 110.766 -172.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -94.33 140.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 121.114 1.779 . . . . 0.0 109.683 176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -130.59 129.56 42.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.676 1.19 . . . . 0.0 109.718 175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.47 149.87 45.44 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.072 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -144.88 112.79 6.35 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.083 1.753 . . . . 0.0 107.393 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -87.21 108.47 18.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.2 mt -66.38 -7.53 19.77 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -172.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -61.92 -27.54 68.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.9 1.227 . . . . 0.0 111.47 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.36 -33.3 1.12 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.677 1.191 . . . . 0.0 112.278 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -83.13 140.51 32.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -82.95 142.21 44.55 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -74.07 -8.79 21.5 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.787 1.658 . . . . 0.0 111.037 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -56.3 -36.68 68.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.879 1.672 . . . . 0.0 111.599 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.93 -19.34 65.83 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 176.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -11.52 13.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.733 1.213 . . . . 0.0 112.169 170.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -73.66 -30.83 63.15 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.589 -1.32 . . . . 0.0 111.24 173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -75.19 -47.92 26.01 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.88 0.764 . . . . 0.0 110.904 -169.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -63.37 146.55 53.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.77 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -71.43 -24.99 62.13 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.852 0.861 . . . . 0.0 110.402 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 56.5 t -150.47 151.35 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 126.687 1.995 . . . . 0.0 106.166 -168.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.2 mt -135.19 155.28 50.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 119.195 0.907 . . . . 0.0 110.219 175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -129.28 122.0 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 168.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.48 139.76 51.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.62 0.768 . . . . 0.0 109.046 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -134.07 121.69 2.8 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.802 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.689 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.39 136.67 27.38 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 118.49 1.145 . . . . 0.0 110.972 178.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.13 153.87 32.34 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.244 1.963 . . . . 0.0 108.921 166.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.466 HG21 ' H ' ' A' ' 99' ' ' ASP . 90.1 m -108.94 94.77 5.23 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -83.13 168.67 16.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.324 1.05 . . . . 0.0 111.509 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t0 18.36 69.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 129.395 3.078 . . . . 0.0 115.251 166.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 56.48 67.6 0.97 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.581 1.153 . . . . 0.0 111.861 177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.6 23.04 77.77 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 116.194 1.238 . . . . 0.0 116.194 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -83.21 154.7 24.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.598 1.159 . . . . 0.0 110.12 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.5 mt -96.18 149.14 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 171.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -66.78 143.85 56.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.52 -26.77 68.86 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.532 0.733 . . . . 0.0 112.119 -170.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -30.45 71.44 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.418 0.687 . . . . 0.0 110.898 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.476 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.6 m95 -82.05 -42.14 19.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.48 1.112 . . . . 0.0 110.404 173.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.3 -34.91 64.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.388 0.54 . . . . 0.0 110.956 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 -31.49 72.67 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.814 0.846 . . . . 0.0 112.056 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.8 m -102.05 -13.27 8.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.697 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.1 t-105 -53.81 -28.68 36.86 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.624 1.57 . . . . 0.0 111.933 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -72.57 -45.28 59.95 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.887 1.275 . . . . 0.0 111.055 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.55 -29.86 68.51 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.336 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.4 mt -56.18 -31.93 63.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 120.187 1.358 . . . . 0.0 111.111 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.33 -32.58 74.07 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.604 0.762 . . . . 0.0 111.811 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -78.93 -27.29 43.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.32 0.648 . . . . 0.0 110.518 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.47 157.24 37.99 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 122.659 1.219 . . . . 0.0 111.376 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -89.9 97.1 10.99 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.009 -1.905 . . . . 0.0 108.265 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -117.74 3.02 12.31 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 122.194 0.997 . . . . 0.0 113.197 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -68.6 113.01 5.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 -169.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.23 28.23 49.7 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.768 -1.018 . . . . 0.0 115.053 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -118.57 156.17 29.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.969 1.385 . . . . 0.0 109.282 169.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.686 HG21 ' HG2' ' A' ' 168' ' ' MET . 7.0 mt -85.49 145.78 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.1 129.36 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 125.346 1.458 . . . . 0.0 109.658 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -107.99 119.53 39.72 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 166.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.4 mt -90.24 141.44 28.7 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.338 0.972 . . . . 0.0 111.49 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -134.7 160.72 37.25 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.093 0.957 . . . . 0.0 108.456 168.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -166.21 179.79 40.08 Favored Glycine 0 N--CA 1.442 -0.919 0 O-C-N 120.939 -1.1 . . . . 0.0 111.074 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.7 mt -125.54 148.65 48.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.168 -1.016 . . . . 0.0 108.401 -170.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.44 -155.31 8.81 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.15 138.5 13.79 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.204 1.802 . . . . 0.0 106.437 168.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.654 HE22 HD21 ' A' ' 148' ' ' ASN . 0.0 OUTLIER -94.03 -24.54 17.58 Favored 'General case' 0 N--CA 1.422 -1.866 0 C-N-CA 124.02 0.928 . . . . 0.0 112.164 -175.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.72 -51.87 67.54 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.905 0.775 . . . . 0.0 110.946 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -100.68 -27.13 7.69 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 124.694 1.14 . . . . 0.0 113.202 -171.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.3 29.37 5.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -168.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -50.3 -43.1 42.89 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 120.17 1.35 . . . . 0.0 110.866 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -64.81 -16.46 63.11 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.381 -1.07 . . . . 0.0 112.348 -175.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -130.02 14.03 5.74 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.09 1.756 . . . . 0.0 111.899 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -47.24 127.3 10.51 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.795 2.038 . . . . 0.0 110.56 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 47.36 28.98 1.17 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.902 1.281 . . . . 0.0 112.606 171.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.466 ' H ' HG21 ' A' ' 55' ' ' THR . 7.3 t70 -63.83 -37.94 89.26 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.804 -1.185 . . . . 0.0 109.815 -169.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 -32.94 74.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.874 0.47 . . . . 0.0 111.594 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.689 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -59.88 -46.03 90.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 123.888 0.875 . . . . 0.0 110.342 172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.54 -41.88 99.65 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 39.0 mtm -64.86 -43.83 91.71 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 118.113 0.957 . . . . 0.0 111.463 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -64.43 -35.72 81.83 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 119.623 1.101 . . . . 0.0 111.143 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -64.47 -41.6 96.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.145 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.88 -42.71 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.492 1.117 . . . . 0.0 111.524 175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.93 -59.33 4.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 124.695 1.198 . . . . 0.0 108.406 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.83 -19.83 57.07 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.627 -0.671 . . . . 0.0 110.855 -170.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.3 t -62.39 -29.79 70.74 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.31 0.959 . . . . 0.0 110.386 169.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.94 -23.58 52.43 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.704 -1.248 . . . . 0.0 109.305 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -81.94 4.38 22.79 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.104 1.762 . . . . 0.0 113.172 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.24 33.84 86.31 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.519 0.6 . . . . 0.0 111.749 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -83.45 170.45 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 123.522 0.729 . . . . 0.0 109.224 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -115.83 140.07 49.58 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -109.82 149.0 30.47 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.797 1.181 . . . . 0.0 112.213 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.502 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 13.9 m -129.51 -179.63 3.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.218 1.007 . . . . 0.0 109.995 169.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.35 39.35 26.65 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-O 118.721 -1.044 . . . . 0.0 114.085 170.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -82.67 149.86 27.11 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.426 1.613 . . . . 0.0 109.339 171.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -123.47 146.36 49.58 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-O 117.376 -1.297 . . . . 0.0 108.696 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.6 135.06 25.41 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.395 1.397 . . . . 0.0 110.248 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.557 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.4 p -74.26 -14.58 60.93 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.219 1.808 . . . . 0.0 112.993 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.95 140.49 58.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.92 0.867 . . . . 0.0 110.87 -169.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.14 -5.85 52.72 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.736 1.636 . . . . 0.0 113.533 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.03 170.61 9.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.065 1.346 . . . . 0.0 111.154 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -125.05 130.44 52.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.641 1.576 . . . . 0.0 108.0 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -164.52 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 109.482 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.302 3.0 t 58.5 8.48 0.88 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 128.757 2.823 . . . . 0.0 114.956 175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.08 148.3 47.41 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.398 1.479 . . . . 0.0 111.468 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.31 -14.57 3.21 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.836 2.357 . . . . 0.0 114.644 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -80.46 -50.02 1.13 Allowed Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.31 37.35 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 CA-C-N 122.008 1.753 . . . . 0.0 112.674 -168.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 148.3 24.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 124.414 1.086 . . . . 0.0 110.207 -167.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -172.23 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 126.217 1.807 . . . . 0.0 109.514 175.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.52 -117.31 0.92 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.041 1.336 . . . . 0.0 107.549 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -105.26 8.33 33.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.775 1.23 . . . . 0.0 111.918 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.59 20.08 20.68 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.483 1.04 . . . . 0.0 112.713 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.62 -16.84 17.3 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.889 1.276 . . . . 0.0 110.594 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.94 145.09 50.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.457 0.703 . . . . 0.0 110.98 174.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.557 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -80.13 154.24 28.17 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.429 1.492 . . . . 0.0 109.608 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -66.15 -12.39 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.681 1.193 . . . . 0.0 112.621 177.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.12 -177.37 44.15 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.682 1.128 . . . . 0.0 111.889 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.3 tp -67.05 133.0 49.03 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -113.05 129.11 56.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.8 mt -117.13 154.52 30.9 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.188 0.904 . . . . 0.0 108.597 170.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.52 101.1 4.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.92 -0.64 54.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.835 0.854 . . . . 0.0 112.548 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.03 -26.01 14.37 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.451 0.569 . . . . 0.0 111.134 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.654 HD21 HE22 ' A' ' 90' ' ' GLN . 8.5 p30 -139.84 -27.78 0.76 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -87.94 11.63 15.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.942 0.792 . . . . 0.0 111.449 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -53.66 -25.97 20.41 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.888 1.222 . . . . 0.0 112.525 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.07 -26.15 56.23 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 110.954 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.0 pp -130.61 -6.43 4.13 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.538 0.735 . . . . 0.0 112.957 -169.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.4 m -55.59 -29.65 59.45 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.084 1.311 . . . . 0.0 109.772 177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -57.28 -41.04 78.99 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.445 1.098 . . . . 0.0 111.743 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -75.88 -31.77 59.39 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.461 1.104 . . . . 0.0 109.738 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -74.73 -30.84 61.64 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.32 -59.52 4.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -58.69 -39.42 80.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.7 m -62.53 -38.95 91.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.943 174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -66.74 -44.45 81.51 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.34 -0.85 . . . . 0.0 110.227 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.9 m -57.05 -34.82 68.61 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.937 0.895 . . . . 0.0 109.548 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -31.7 72.65 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 123.618 0.573 . . . . 0.0 110.582 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.38 -45.95 12.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.504 173.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.487 HD11 HD11 ' A' ' 25' ' ' ILE . 5.9 pt -64.18 -38.43 82.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 120.994 1.725 . . . . 0.0 109.833 -170.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.43 -12.26 29.66 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -49.15 5.9 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 125.797 1.639 . . . . 0.0 108.266 170.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.4 -23.49 67.3 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.564 0.746 . . . . 0.0 111.252 -170.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.686 ' HG2' HG21 ' A' ' 81' ' ' ILE . 66.9 mtm -94.09 -45.25 7.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.434 1.094 . . . . 0.0 110.979 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.65 -44.64 49.37 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.477 0.711 . . . . 0.0 110.823 -171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -69.4 -28.06 65.83 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.98 1.312 . . . . 0.0 109.679 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -70.78 -45.71 64.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.814 1.245 . . . . 0.0 110.443 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -22.34 62.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.017 -175.556 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.56 142.78 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 168.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -131.67 148.16 52.57 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.776 2.03 . . . . 0.0 108.488 -169.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.49 118.81 4.93 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-O 118.59 -1.117 . . . . 0.0 111.013 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.45 108.98 19.96 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.212 1.506 . . . . 0.0 109.838 170.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -105.57 145.81 30.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.537 1.535 . . . . 0.0 110.979 174.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -163.47 175.7 10.5 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.736 0.814 . . . . 0.0 110.231 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.49 141.97 9.2 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 106.502 -2.639 . . . . 0.0 106.502 168.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.8 t -150.03 140.29 22.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.528 1.164 . . . . 0.0 110.891 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -36.37 13.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.692 1.197 . . . . 0.0 110.015 171.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 p -93.99 -6.64 44.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.217 1.407 . . . . 0.0 112.009 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 56.1 m 68.05 9.98 7.52 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.588 1.955 . . . . 0.0 113.091 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -63.83 -45.43 89.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 120.33 1.423 . . . . 0.0 110.386 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -33.28 74.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.665 0.786 . . . . 0.0 108.918 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.54 -49.55 70.83 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.43 1.092 . . . . 0.0 109.397 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.45 -38.89 92.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.895 0.316 . . . . 0.0 110.809 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.01 98.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.866 174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.38 -47.09 76.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.956 0.902 . . . . 0.0 110.491 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -59.1 -45.97 89.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.6 mttm -62.21 -55.79 25.0 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 125.106 1.363 . . . . 0.0 108.831 -176.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.6 mt -52.59 -56.48 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 118.458 0.572 . . . . 0.0 109.967 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -38.5 72.78 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.129 0.572 . . . . 0.0 110.258 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.47 -46.87 74.92 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.902 0.481 . . . . 0.0 111.339 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -66.24 -47.85 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.567 1.147 . . . . 0.0 108.854 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 164' ' ' ILE . 71.7 mt -72.13 -49.69 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.702 0.801 . . . . 0.0 110.048 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.84 115.69 0.86 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 170.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -72.64 3.74 4.06 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.256 2.637 . . . . 0.0 112.689 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.76 -34.53 67.06 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.11 1.364 . . . . 0.0 109.027 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.01 -22.7 4.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.552 1.541 . . . . 0.0 111.641 -169.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.3 140.88 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 120.479 1.491 . . . . 0.0 108.924 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.2 m -131.26 128.96 40.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.206 1.003 . . . . 0.0 109.824 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.19 149.1 47.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.636 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.6 111.67 5.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.193 1.797 . . . . 0.0 107.144 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -87.43 111.26 20.95 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.96 -8.19 35.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -60.24 -27.99 67.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.248 0.931 . . . . 0.0 111.584 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -132.42 -33.82 1.25 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.495 1.118 . . . . 0.0 112.122 -171.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -83.05 140.45 32.68 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.177 0.991 . . . . 0.0 108.585 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -83.44 142.23 43.08 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.23 -4.75 15.79 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.774 1.649 . . . . 0.0 111.638 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -55.21 -35.42 64.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.723 1.601 . . . . 0.0 111.977 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -19.34 65.65 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.36 -12.15 19.6 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.324 1.049 . . . . 0.0 112.326 169.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 95.7 mt-10 -78.09 -23.35 48.0 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.828 -1.17 . . . . 0.0 111.543 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -75.4 -48.96 20.52 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -68.98 150.28 47.87 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.21 1.404 . . . . 0.0 108.381 -170.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -81.96 -23.78 35.92 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 110.502 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -142.27 144.55 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 -169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.71 156.11 48.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.398 0.679 . . . . 0.0 110.205 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -129.61 123.59 57.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.7 138.6 54.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -133.3 124.79 3.82 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 118.279 -1.289 . . . . 0.0 113.442 -172.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.685 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -127.49 135.32 27.27 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-N 118.84 1.32 . . . . 0.0 110.842 178.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.11 145.44 12.3 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.793 1.662 . . . . 0.0 108.511 166.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.9 m -90.46 123.49 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -108.11 170.73 7.82 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.455 1.902 . . . . 0.0 110.249 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.1 t0 15.37 69.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 129.542 3.137 . . . . 0.0 115.217 168.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 58.59 67.79 0.9 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.427 1.491 . . . . 0.0 110.401 172.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.66 32.61 70.91 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 114.495 0.558 . . . . 0.0 114.495 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.354 0.5 OUTLIER -99.15 153.83 18.61 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.625 1.17 . . . . 0.0 109.827 168.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.4 mt -95.96 148.87 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -62.38 142.67 57.71 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.85 -28.14 69.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.14 -169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.69 -29.48 70.03 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.646 0.778 . . . . 0.0 110.509 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.9 m95 -81.94 -42.51 19.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.745 0.818 . . . . 0.0 110.785 173.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -55.62 -33.99 64.49 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.408 0.549 . . . . 0.0 110.872 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.46 -31.91 73.21 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.464 1.105 . . . . 0.0 111.838 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -105.09 -11.31 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.547 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.9 t-105 -53.04 -28.8 26.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.846 1.658 . . . . 0.0 111.817 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.71 -45.87 67.28 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.189 1.396 . . . . 0.0 111.414 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -65.67 -31.97 73.27 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.005 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.5 mt -56.66 -32.47 65.42 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.709 1.14 . . . . 0.0 110.842 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -68.42 -31.77 71.34 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.47 0.708 . . . . 0.0 111.166 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -86.95 -16.72 35.01 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.675 0.79 . . . . 0.0 111.448 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 mt -69.98 156.3 39.32 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 122.227 1.013 . . . . 0.0 113.47 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -89.12 75.19 7.92 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.766 2.427 . . . . 0.0 106.335 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.301 56.1 tp -118.11 7.32 12.15 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 125.514 1.526 . . . . 0.0 113.606 -165.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -74.15 138.04 43.57 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 126.406 1.882 . . . . 0.0 109.656 -172.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.69 8.49 86.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 125.599 1.571 . . . . 0.0 114.489 174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 44' ' ' GLU . 54.8 mttm -90.69 148.81 22.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 C-N-CA 124.953 1.301 . . . . 0.0 109.37 -177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.696 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -84.2 139.95 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 170.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.2 t -131.96 127.95 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 C-N-CA 125.052 1.341 . . . . 0.0 108.828 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.95 115.33 30.05 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 167.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.6 mt -86.73 143.19 27.66 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 119.127 0.876 . . . . 0.0 111.184 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 24.4 p90 -136.86 158.76 43.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.77 0.828 . . . . 0.0 109.034 168.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.63 176.96 41.05 Favored Glycine 0 CA--C 1.508 -0.385 0 O-C-N 120.944 -1.098 . . . . 0.0 112.441 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -127.36 145.16 50.9 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 -172.29 32.17 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.93 139.12 23.46 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.151 1.476 . . . . 0.0 108.625 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.48 HE22 ' CG ' ' A' ' 145' ' ' ASP . 0.3 OUTLIER -89.62 -20.24 23.94 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.969 1.308 . . . . 0.0 114.403 -178.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.55 -47.43 69.89 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 120.045 1.293 . . . . 0.0 111.25 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -103.67 -21.03 10.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 124.086 0.851 . . . . 0.0 112.195 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 41.77 2.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.116 0.967 . . . . 0.0 111.307 -166.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.95 -43.54 72.79 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 125.007 1.289 . . . . 0.0 110.634 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.8 mm-40 -67.33 -26.12 66.35 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.636 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -94.0 -10.5 33.38 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.957 2.503 . . . . 0.0 112.628 -171.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -49.57 130.09 20.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.505 2.722 . . . . 0.0 110.913 -169.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 48.91 27.92 1.79 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.228 1.011 . . . . 0.0 112.599 172.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -64.46 -36.48 84.32 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.03 -1.044 . . . . 0.0 110.023 -171.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.88 -34.08 77.14 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.641 0.376 . . . . 0.0 111.515 173.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -60.95 -48.15 83.15 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 123.933 0.893 . . . . 0.0 110.009 174.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.09 97.88 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.5 mtm -64.62 -44.65 89.86 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 118.043 0.922 . . . . 0.0 111.981 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.58 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -63.9 -34.54 78.19 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.508 1.049 . . . . 0.0 111.158 173.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -64.06 -41.91 97.19 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.906 -0.718 . . . . 0.0 110.222 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.59 -31.22 66.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.966 2.106 . . . . 0.0 112.249 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -62.73 -61.87 2.12 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 170.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.2 mt -76.32 -19.75 57.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.39 -168.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -61.15 -31.08 70.81 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.022 1.283 . . . . 0.0 111.427 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -21.16 54.19 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.626 -0.671 . . . . 0.0 109.524 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -83.9 6.02 23.2 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 126.407 1.883 . . . . 0.0 112.46 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.15 32.2 76.08 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.41 170.13 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 123.713 0.805 . . . . 0.0 108.908 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -119.96 142.63 48.59 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -109.95 148.73 31.06 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 119.916 1.235 . . . . 0.0 111.911 -169.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 22.1 m -129.06 179.56 3.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 124.275 1.03 . . . . 0.0 108.992 169.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.26 36.37 40.0 Favored Glycine 0 N--CA 1.439 -1.133 0 CA-C-O 118.398 -1.223 . . . . 0.0 113.894 171.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-30 -79.83 151.55 30.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 119.556 1.678 . . . . 0.0 108.83 170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -126.28 152.52 73.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 117.571 -1.204 . . . . 0.0 109.264 172.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.31 135.12 33.16 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.292 1.328 . . . . 0.0 109.98 169.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.563 HG22 ' CD1' ' A' ' 139' ' ' PHE . 55.1 p -73.59 -15.03 61.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.935 1.694 . . . . 0.0 112.902 172.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.22 145.21 56.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.903 0.881 . . . . 0.0 109.152 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.37 18.75 79.46 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.946 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.09 163.7 25.99 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.694 1.998 . . . . 0.0 109.012 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -128.33 126.19 40.25 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 125.627 1.571 . . . . 0.0 107.648 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -168.54 -48.58 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.999 0.92 . . . . 0.0 109.466 -175.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.32 3.3 t 59.74 7.53 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.075 2.95 . . . . 0.0 114.639 176.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.45 149.03 56.9 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.954 1.302 . . . . 0.0 112.624 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -90.04 -13.67 2.48 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.889 2.393 . . . . 0.0 114.025 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.54 -52.29 2.93 Favored Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 117.965 -1.017 . . . . 0.0 113.297 -169.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -85.96 40.07 0.72 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 121.695 1.641 . . . . 0.0 112.053 -169.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.468 HG13 HG21 ' A' ' 121' ' ' THR . 0.1 OUTLIER -137.19 145.91 28.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.607 1.163 . . . . 0.0 109.227 -168.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.418 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.4 -176.69 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.78 1.232 . . . . 0.0 112.074 178.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 57.94 -110.58 0.53 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 127.026 2.131 . . . . 0.0 109.155 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -99.41 -0.71 40.37 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.552 1.541 . . . . 0.0 111.958 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.0 26.06 9.95 Favored Glycine 0 C--N 1.341 0.837 0 O-C-N 121.146 -0.971 . . . . 0.0 111.798 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -20.48 13.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.142 1.377 . . . . 0.0 108.444 -175.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 mt -117.98 138.9 51.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.993 1.317 . . . . 0.0 110.863 -173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.563 ' CD1' HG22 ' A' ' 121' ' ' THR . 43.2 m-85 -78.47 151.8 32.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 171.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.461 HG23 ' HG ' ' A' ' 101' ' ' LEU . 14.4 m -63.12 -13.71 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.827 1.251 . . . . 0.0 112.201 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.8 -174.08 42.04 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 119.458 1.026 . . . . 0.0 111.737 -174.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.29 128.63 36.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.07 123.36 47.72 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 142' ' ' LEU . 74.9 mt -122.18 156.59 33.39 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.039 1.335 . . . . 0.0 108.363 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.48 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -141.08 123.98 16.24 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -100.78 14.32 32.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.429 1.092 . . . . 0.0 110.824 -169.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.42 -24.3 5.44 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.49 -48.72 3.06 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.605 1.093 . . . . 0.0 108.39 172.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -104.4 21.88 15.87 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.434 1.494 . . . . 0.0 112.659 -168.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -53.47 -24.69 13.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.58 -26.01 41.4 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.805 0.842 . . . . 0.0 111.476 -175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.83 -12.95 8.35 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.043 0.937 . . . . 0.0 112.244 -170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 m -58.85 -27.48 65.19 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.84 1.2 . . . . 0.0 110.781 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -56.87 -47.07 81.3 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.326 1.05 . . . . 0.0 110.967 170.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -67.99 -32.38 72.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.753 0.787 . . . . 0.0 109.485 -171.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -75.18 -27.52 59.68 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.875 -175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -60.34 -55.2 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -51.67 -47.98 63.63 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.922 0.889 . . . . 0.0 109.853 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -68.08 -35.91 78.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.561 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -64.92 -44.37 89.75 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.452 0.644 . . . . 0.0 109.778 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.3 m -58.88 -36.59 74.88 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 123.664 0.786 . . . . 0.0 109.474 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -69.72 -29.26 66.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.959 -0.543 . . . . 0.0 111.31 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.73 -46.64 16.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.355 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.418 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.75 -38.5 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 120.872 1.669 . . . . 0.0 110.21 -170.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.19 -15.34 59.69 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.227 0.611 . . . . 0.0 111.94 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -96.4 -46.16 6.5 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.15 -41.95 89.52 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 118.909 0.777 . . . . 0.0 109.503 -173.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.696 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.2 mtm -75.67 -37.24 59.74 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.561 0.744 . . . . 0.0 110.938 -175.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.01 -47.15 60.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.124 0.97 . . . . 0.0 109.926 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -66.41 -30.72 71.14 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.221 1.408 . . . . 0.0 110.021 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -63.17 -47.27 83.35 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.463 0.574 . . . . 0.0 110.391 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -3.01 49.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.592 1.157 . . . . 0.0 113.765 -175.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.249 0.477 . . . . 0.0 110.647 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.05 144.67 47.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.156 1.382 . . . . 0.0 108.427 169.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.4 mtm -124.01 150.65 44.63 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.935 2.494 . . . . 0.0 108.741 -167.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.43 120.32 4.82 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.11 102.98 15.7 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.621 1.211 . . . . 0.0 110.101 172.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -102.7 145.57 29.5 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.044 1.338 . . . . 0.0 111.467 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -164.14 172.61 13.48 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.981 0.912 . . . . 0.0 109.897 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.69 137.4 8.23 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 106.738 -2.545 . . . . 0.0 106.738 169.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -135.61 130.69 34.82 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.149 1.38 . . . . 0.0 109.978 -172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -91.26 -38.33 12.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.93 0.492 . . . . 0.0 110.016 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 p -93.99 -85.69 0.28 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.8 p -174.18 -3.9 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.491 2.717 . . . . 0.0 111.867 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -68.85 -42.83 76.57 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 119.729 -1.857 . . . . 0.0 112.171 -167.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -35.97 82.77 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -64.68 -49.35 71.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.848 1.259 . . . . 0.0 109.921 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.5 mtm -64.87 -38.71 91.89 Favored 'General case' 0 C--N 1.331 -0.197 0 O-C-N 122.093 -0.379 . . . . 0.0 111.465 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.15 98.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 118.862 -0.589 . . . . 0.0 111.0 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.24 -46.21 79.68 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.031 0.932 . . . . 0.0 110.61 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -57.64 -47.1 83.17 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -61.68 -54.41 43.02 Favored 'General case' 0 CA--C 1.501 -0.919 0 O-C-N 124.733 1.271 . . . . 0.0 108.995 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.97 -57.02 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.83 0.741 . . . . 0.0 109.691 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -39.11 70.29 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 123.431 0.693 . . . . 0.0 110.339 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.68 -47.7 68.71 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.801 0.44 . . . . 0.0 111.486 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 158' ' ' GLN . 12.7 mt -65.79 -45.5 91.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.653 1.181 . . . . 0.0 108.51 -174.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.77 -52.1 27.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 123.913 0.885 . . . . 0.0 110.546 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.72 115.45 0.85 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.83 3.15 4.64 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.451 2.767 . . . . 0.0 112.686 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.09 -34.39 68.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.451 1.5 . . . . 0.0 109.556 172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.16 -4.34 4.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.157 1.783 . . . . 0.0 111.95 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.77 144.46 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 120.955 1.707 . . . . 0.0 109.3 167.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.6 m -134.91 130.67 36.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.856 1.263 . . . . 0.0 110.31 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -71.78 149.62 45.16 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 112.496 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -146.9 108.76 4.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 126.182 1.793 . . . . 0.0 108.345 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -82.64 112.92 19.96 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 171.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.73 -9.82 22.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.8 pttt -58.95 -29.02 66.84 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.261 0.937 . . . . 0.0 111.624 168.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -129.95 -33.8 1.75 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.544 1.138 . . . . 0.0 111.728 -172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -87.57 142.04 28.15 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.314 1.046 . . . . 0.0 109.192 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -83.78 143.15 43.08 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -74.65 -2.19 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 121.706 1.604 . . . . 0.0 111.412 176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -56.82 -33.83 67.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 122.094 2.225 . . . . 0.0 112.459 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.64 -18.59 65.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 44.2 ttm -59.17 -14.31 10.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.973 2.109 . . . . 0.0 111.654 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 65.4 mt-10 -74.36 -30.4 61.98 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.83 -1.169 . . . . 0.0 110.699 173.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -77.48 -48.84 16.08 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.775 0.716 . . . . 0.0 109.721 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -67.74 134.28 50.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -92.95 -6.57 48.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 81' ' ' ILE . 77.1 t -135.27 140.38 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.85 156.47 48.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 118.206 0.457 . . . . 0.0 109.865 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.26 122.56 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 168.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.73 132.66 55.7 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.12 115.98 2.82 Favored Glycine 0 CA--C 1.511 -0.158 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.484 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -118.48 125.15 28.0 Favored Pre-proline 0 N--CA 1.47 0.549 0 CA-C-N 118.775 1.288 . . . . 0.0 109.347 176.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -86.27 143.34 7.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.912 2.408 . . . . 0.0 107.925 168.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.2 m -88.56 128.36 35.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -117.65 170.11 9.03 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.875 1.67 . . . . 0.0 109.688 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 28.21 58.68 0.11 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.117 2.567 . . . . 0.0 115.325 169.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 56.58 73.64 0.44 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.666 1.187 . . . . 0.0 112.427 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.98 15.54 76.32 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 115.318 0.887 . . . . 0.0 115.318 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -82.3 152.7 26.18 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 122.451 1.12 . . . . 0.0 109.095 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -83.97 153.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.752 -1.574 . . . . 0.0 106.752 174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -60.5 141.73 56.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.912 0.863 . . . . 0.0 108.835 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.93 -28.09 68.66 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -79.66 -22.77 43.11 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.822 -0.549 . . . . 0.0 110.289 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' ILE . 11.5 m95 -76.63 -43.79 36.85 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.211 0.604 . . . . 0.0 111.234 170.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -53.5 -34.9 59.76 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.126 0.57 . . . . 0.0 110.943 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -30.21 71.29 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.099 0.96 . . . . 0.0 112.149 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -109.11 -9.32 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.557 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.8 t-105 -53.08 -28.93 27.44 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.457 1.503 . . . . 0.0 111.69 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.51 -45.35 72.49 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.825 1.25 . . . . 0.0 111.623 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.9 -27.74 66.91 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.105 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.7 mt -58.26 -32.02 67.98 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.726 1.148 . . . . 0.0 111.062 -176.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.2 -30.36 69.42 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.536 0.734 . . . . 0.0 111.148 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.53 -11.35 37.65 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.18 0.992 . . . . 0.0 111.631 -171.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.2 mt -73.97 174.02 9.17 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.142 0.973 . . . . 0.0 110.783 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.436 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 5.1 t30 -114.92 103.77 11.26 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.115 1.766 . . . . 0.0 107.582 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 mt -125.8 8.47 7.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.778 1.231 . . . . 0.0 113.068 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -67.32 116.52 8.18 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.22 9.99 85.33 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.305 1.431 . . . . 0.0 114.847 -176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -80.59 152.58 28.5 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.006 0.903 . . . . 0.0 109.693 173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.721 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.2 mt -87.16 141.49 14.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 168.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.3 t -132.11 131.61 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 125.258 1.423 . . . . 0.0 108.851 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -111.14 116.37 30.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.3 mt -87.08 142.75 27.69 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.99 0.814 . . . . 0.0 111.792 174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -136.83 159.09 42.9 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.28 175.88 37.87 Favored Glycine 0 N--CA 1.447 -0.573 0 O-C-N 120.884 -1.135 . . . . 0.0 111.934 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.4 mt -125.44 153.66 43.15 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.82 -155.39 8.96 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -155.69 137.64 14.5 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.081 1.352 . . . . 0.0 108.433 168.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.478 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -87.43 -22.58 24.89 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 113.845 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.9 mt -67.15 -48.01 69.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 119.823 1.192 . . . . 0.0 110.638 -173.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.66 -26.28 9.27 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 124.759 1.171 . . . . 0.0 112.328 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -133.13 33.55 3.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -166.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.57 -42.89 58.61 Favored Glycine 0 N--CA 1.476 1.305 0 CA-C-N 120.659 1.572 . . . . 0.0 111.131 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -61.63 -18.54 59.89 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 117.694 0.747 . . . . 0.0 112.538 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -126.67 11.83 7.33 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.081 1.752 . . . . 0.0 112.563 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.12 122.96 4.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.34 1.456 . . . . 0.0 108.682 171.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 52.33 28.72 5.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.133 0.973 . . . . 0.0 112.959 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.62 -39.66 94.92 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.519 -1.363 . . . . 0.0 110.72 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.34 -33.32 73.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.113 0.565 . . . . 0.0 111.485 173.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.678 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.1 tp -59.91 -47.0 87.54 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.067 0.947 . . . . 0.0 110.458 177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.35 -39.85 97.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.9 mtm -66.47 -43.89 84.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 117.946 0.873 . . . . 0.0 111.717 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.557 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 3.6 mt -64.93 -34.58 78.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.455 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.7 -41.97 98.03 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.927 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -66.16 -42.28 89.22 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.536 1.134 . . . . 0.0 111.578 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -54.67 -58.44 7.5 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 124.798 1.239 . . . . 0.0 108.292 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.4 mt -78.17 -19.62 53.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.453 -170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.9 t -61.58 -28.8 69.6 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.279 0.945 . . . . 0.0 110.298 168.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.92 -22.94 52.58 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.628 -1.295 . . . . 0.0 109.608 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -83.64 4.66 27.54 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.236 1.814 . . . . 0.0 112.371 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.0 33.42 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.624 0.647 . . . . 0.0 112.032 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.87 170.91 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -115.5 143.18 45.69 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 168.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -109.43 147.01 33.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 118.936 0.789 . . . . 0.0 111.358 -170.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.2 m -128.0 178.02 5.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.255 1.022 . . . . 0.0 109.081 170.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.49 37.26 31.57 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-O 118.615 -1.103 . . . . 0.0 114.126 172.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.0 m-30 -79.32 144.2 34.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 119.647 1.724 . . . . 0.0 108.628 171.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -121.81 147.32 48.13 Favored Pre-proline 0 N--CA 1.467 0.39 0 CA-C-O 117.326 -1.321 . . . . 0.0 108.922 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.39 138.59 39.37 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 CA-C-N 120.804 1.323 . . . . 0.0 109.596 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.498 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.0 p -74.14 -6.8 49.87 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.806 1.643 . . . . 0.0 113.383 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.73 140.83 57.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.257 1.027 . . . . 0.0 109.543 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.87 -11.42 59.88 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.556 1.551 . . . . 0.0 113.67 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -92.8 158.97 15.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.815 1.308 . . . . 0.0 111.017 171.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -128.76 125.82 38.67 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.559 2.344 . . . . 0.0 106.086 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' O ' HG22 ' A' ' 127' ' ' THR . 13.3 p90 -163.94 -58.88 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 O-C-N 121.767 -0.583 . . . . 0.0 109.709 -170.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 126' ' ' PHE 0.327 2.7 t 58.83 10.15 1.41 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.505 2.722 . . . . 0.0 114.648 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -67.11 139.84 95.46 Favored Pre-proline 0 CA--C 1.545 0.753 0 O-C-N 120.733 -1.229 . . . . 0.0 108.885 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -87.45 -13.28 4.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.504 2.136 . . . . 0.0 113.735 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -80.35 -48.84 1.23 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.7 37.65 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.017 1.756 . . . . 0.0 112.737 -168.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.32 146.52 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 124.243 1.017 . . . . 0.0 109.74 -166.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.41 -172.5 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 126.024 1.73 . . . . 0.0 109.636 177.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.73 -116.53 0.86 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.173 1.389 . . . . 0.0 107.528 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.36 8.33 33.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.822 1.249 . . . . 0.0 112.068 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.53 20.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.73 1.157 . . . . 0.0 112.823 -173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -100.55 -17.33 17.14 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.744 1.218 . . . . 0.0 110.775 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.49 145.26 51.03 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.308 0.643 . . . . 0.0 111.088 174.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.498 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.1 m-85 -80.84 155.07 26.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.205 1.402 . . . . 0.0 110.005 176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.1 m -66.86 -12.02 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 124.802 1.241 . . . . 0.0 112.869 173.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.11 -179.03 43.53 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 119.659 1.118 . . . . 0.0 112.454 -170.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.428 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 25.1 tp -66.06 128.52 36.39 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.68 119.86 40.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -120.4 159.36 25.26 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.652 1.181 . . . . 0.0 108.728 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.464 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -143.69 122.6 12.74 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 173.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.36 18.42 16.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.673 -169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.59 -20.49 5.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.878 0.871 . . . . 0.0 112.873 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.97 -53.51 2.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.198 1.363 . . . . 0.0 108.652 170.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.53 16.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -168.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -51.72 -26.28 9.07 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.933 0.893 . . . . 0.0 112.504 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.91 -26.81 54.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.175 0.99 . . . . 0.0 111.319 -175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -120.13 -7.66 9.83 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.414 1.086 . . . . 0.0 112.257 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 43.7 m -50.47 -33.82 22.64 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.761 1.164 . . . . 0.0 110.31 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -58.49 -41.39 85.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.303 1.041 . . . . 0.0 111.742 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -33.43 65.01 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.866 1.266 . . . . 0.0 109.796 -178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -22.9 41.44 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.769 0.828 . . . . 0.0 110.363 -176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.16 -60.08 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.424 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.7 pt20 -55.78 -41.81 74.62 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.366 0.53 . . . . 0.0 112.331 -174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 60.0 p -66.56 -35.69 80.82 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.053 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 45.5 t90 -65.46 -43.26 90.89 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.67 0.748 . . . . 0.0 109.528 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.443 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.1 m -58.74 -36.66 74.68 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 123.717 0.807 . . . . 0.0 109.575 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -68.29 -32.8 73.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.359 0.412 . . . . 0.0 111.175 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -77.14 -45.84 25.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.476 172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 5.7 pt -65.28 -38.28 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 120.878 1.672 . . . . 0.0 110.415 -173.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.26 -12.32 50.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.54 0.609 . . . . 0.0 112.267 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -95.02 -47.86 6.22 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 171.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.45 -35.69 78.32 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.846 0.748 . . . . 0.0 110.69 -171.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.721 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.9 mtm -81.48 -39.83 24.18 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 124.249 1.019 . . . . 0.0 110.518 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.83 63.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.933 0.893 . . . . 0.0 110.916 -174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -70.64 -32.08 69.25 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.872 1.269 . . . . 0.0 109.436 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.46 ' CD2' HD11 ' A' ' 81' ' ' ILE . 61.6 t60 -62.78 -49.86 73.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 168.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -3.26 29.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.521 1.129 . . . . 0.0 113.555 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.511 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.92 146.15 51.54 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 126.504 1.922 . . . . 0.0 108.196 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -136.57 146.99 46.76 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.548 1.539 . . . . 0.0 109.271 -166.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.0 119.45 4.88 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.22 111.46 21.68 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.627 1.213 . . . . 0.0 108.315 169.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -107.3 144.68 33.79 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 111.167 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -161.79 175.91 11.45 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.548 0.739 . . . . 0.0 110.716 177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.13 143.9 11.91 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -140.99 143.78 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.131 1.372 . . . . 0.0 110.58 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -93.29 -39.19 11.11 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.675 1.19 . . . . 0.0 109.857 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.7 p -96.56 -85.86 0.33 Allowed 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.8 p -173.91 -4.68 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.97 2.508 . . . . 0.0 112.336 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -66.39 -43.38 86.02 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 119.956 -1.715 . . . . 0.0 111.402 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -34.74 76.77 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.61 -49.33 77.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.166 0.986 . . . . 0.0 109.985 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.2 mtm -66.33 -41.21 89.93 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.917 -0.489 . . . . 0.0 110.837 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.33 93.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.687 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.08 -47.8 77.32 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.01 0.924 . . . . 0.0 110.553 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -59.13 -44.32 92.02 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.71 -55.04 30.34 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 124.762 1.288 . . . . 0.0 108.7 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.05 -56.08 7.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.07 0.85 . . . . 0.0 109.79 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -39.14 82.66 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.814 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.48 -47.76 69.12 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.042 0.537 . . . . 0.0 111.227 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.2 mt -64.31 -47.53 89.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.014 1.326 . . . . 0.0 108.424 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 164' ' ' ILE . 80.0 mt -73.22 -48.99 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.669 0.788 . . . . 0.0 110.324 -175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.49 114.97 0.88 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 170.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.25 3.66 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.432 2.755 . . . . 0.0 112.875 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -73.8 -35.62 64.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.334 1.454 . . . . 0.0 109.18 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.96 -27.19 5.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.282 1.833 . . . . 0.0 110.872 -172.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 141.68 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 120.705 1.593 . . . . 0.0 109.569 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 48.0 m -133.38 129.83 37.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.572 1.149 . . . . 0.0 109.648 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -71.38 150.44 45.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.559 0.744 . . . . 0.0 111.921 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -145.64 112.23 5.88 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.423 1.889 . . . . 0.0 107.087 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -87.12 110.86 20.41 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 74.8 mt -66.17 -8.76 26.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -58.35 -29.24 65.81 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.162 0.892 . . . . 0.0 111.538 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.93 -33.84 1.15 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -82.86 141.43 32.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.121 0.969 . . . . 0.0 108.756 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.5 m -84.74 141.69 38.73 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -73.79 -6.59 18.86 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 121.651 1.567 . . . . 0.0 111.734 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mmtt -55.42 -37.19 67.33 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 120.894 1.679 . . . . 0.0 111.706 -178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -19.3 65.8 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -11.8 16.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 112.534 170.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.61 -31.08 66.52 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.916 -1.115 . . . . 0.0 111.376 173.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -74.3 -46.29 42.1 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.722 0.772 . . . . 0.0 110.431 -169.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -65.99 149.36 50.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.912 1.285 . . . . 0.0 108.719 -169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -73.61 -25.05 60.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.872 0.869 . . . . 0.0 110.337 -175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' O ' HD13 ' A' ' 49' ' ' LEU . 41.0 t -151.93 147.55 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.684 1.993 . . . . 0.0 105.929 -168.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.36 158.69 35.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.288 0.949 . . . . 0.0 111.034 168.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.58 121.53 57.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 168.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.38 136.13 54.42 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.45 120.16 3.44 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-O 117.739 -1.589 . . . . 0.0 112.3 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.5 131.47 24.44 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 119.091 1.445 . . . . 0.0 111.129 176.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.98 149.25 15.64 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.134 1.89 . . . . 0.0 108.331 166.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 m -96.09 128.38 42.94 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -121.11 171.28 8.79 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.721 1.608 . . . . 0.0 109.84 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 30.65 54.89 0.19 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.983 2.513 . . . . 0.0 115.616 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 56.74 75.78 0.34 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 112.267 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.26 31.19 68.94 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 114.458 0.543 . . . . 0.0 114.458 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -100.19 156.13 17.38 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.727 1.611 . . . . 0.0 109.571 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -92.93 151.19 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -65.78 142.99 57.78 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -64.03 -27.16 68.93 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.226 -169.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -66.89 -26.15 66.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.883 0.873 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.506 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.4 m95 -84.45 -42.85 15.2 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.165 0.986 . . . . 0.0 110.782 171.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.42 -34.69 64.65 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 118.45 0.568 . . . . 0.0 110.978 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.57 71.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.576 1.15 . . . . 0.0 112.237 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.5 m -108.05 -10.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.541 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.1 t-105 -53.75 -28.85 36.84 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.476 1.51 . . . . 0.0 111.668 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -70.42 -44.51 67.74 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.81 1.244 . . . . 0.0 111.338 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -68.53 -27.94 66.55 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.438 1.095 . . . . 0.0 112.355 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.7 mt -57.24 -30.06 64.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.755 1.161 . . . . 0.0 111.409 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.95 -32.04 71.35 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.59 0.756 . . . . 0.0 111.366 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -79.96 -27.94 39.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.474 0.71 . . . . 0.0 110.805 -175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.24 160.21 32.6 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.571 1.177 . . . . 0.0 111.431 -169.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.3 96.27 10.46 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.163 -1.835 . . . . 0.0 108.572 172.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.0 4.73 13.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 122.131 0.967 . . . . 0.0 113.132 171.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -69.37 113.97 7.18 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -169.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.84 26.6 55.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.623 -1.098 . . . . 0.0 115.24 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.89 160.78 25.4 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.25 1.525 . . . . 0.0 109.697 168.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.529 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.5 mt -94.03 150.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 118.365 0.53 . . . . 0.0 109.993 -169.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.8 t -135.45 127.9 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.502 1.521 . . . . 0.0 109.136 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.499 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.59 116.94 32.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 166.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.8 mt -89.65 141.51 28.54 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 119.231 0.923 . . . . 0.0 111.327 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -137.39 162.21 34.22 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 168.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.62 177.76 38.62 Favored Glycine 0 CA--C 1.504 -0.645 0 O-C-N 121.037 -1.039 . . . . 0.0 111.931 175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.1 mt -122.84 150.04 43.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.89 -157.9 11.49 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -157.33 137.31 12.51 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.031 1.332 . . . . 0.0 107.879 168.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.474 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -86.86 -21.43 26.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -70.54 -45.47 65.44 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 119.622 1.101 . . . . 0.0 110.776 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.94 -29.13 9.33 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.302 0.953 . . . . 0.0 112.423 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -132.09 33.83 3.87 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -53.07 -42.61 61.66 Favored Glycine 0 N--CA 1.472 1.05 0 CA-C-N 120.155 1.343 . . . . 0.0 111.29 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.46 -17.42 62.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 117.825 0.812 . . . . 0.0 112.728 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -127.06 10.45 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.915 1.686 . . . . 0.0 112.342 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -41.96 124.36 2.63 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.476 1.91 . . . . 0.0 110.393 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 49.47 29.01 2.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.322 1.049 . . . . 0.0 112.72 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.751 -1.218 . . . . 0.0 110.255 -173.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.56 -32.35 73.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.407 0.283 . . . . 0.0 111.094 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.662 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.0 tp -61.69 -46.57 89.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.186 0.994 . . . . 0.0 110.633 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.25 -41.92 98.51 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 28.2 mtm -65.6 -44.72 85.7 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.616 0.708 . . . . 0.0 111.783 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.565 HD12 HD12 ' A' ' 53' ' ' ILE . 4.4 mt -64.74 -35.09 79.94 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.161 175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -63.77 -42.01 97.87 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.946 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.77 -43.45 88.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.615 1.166 . . . . 0.0 111.69 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -54.19 -58.97 5.37 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.516 1.126 . . . . 0.0 108.486 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.25 -19.05 57.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.741 -170.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 t -62.22 -29.37 70.34 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.365 0.984 . . . . 0.0 110.51 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -22.16 56.44 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.604 -1.31 . . . . 0.0 109.735 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.4 mmmt -84.67 5.5 27.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.089 1.755 . . . . 0.0 112.935 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.05 35.15 90.2 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.25 177.36 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 124.326 1.051 . . . . 0.0 109.375 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -121.54 140.31 52.38 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -112.49 147.14 37.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.37 0.986 . . . . 0.0 111.206 -171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -129.22 -178.96 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 123.858 0.863 . . . . 0.0 109.335 169.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.6 34.01 41.0 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 118.498 -1.168 . . . . 0.0 114.006 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -75.97 146.17 39.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 119.694 1.747 . . . . 0.0 108.354 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 144.82 40.57 Favored Pre-proline 0 N--CA 1.466 0.344 0 CA-C-O 117.319 -1.324 . . . . 0.0 108.467 171.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.26 138.78 40.27 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 CA-C-N 120.691 1.282 . . . . 0.0 109.22 169.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.479 HG22 ' CD1' ' A' ' 139' ' ' PHE . 68.0 p -73.98 -4.32 34.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.985 1.714 . . . . 0.0 113.337 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.59 141.58 57.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.997 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.51 -7.33 58.13 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.625 1.583 . . . . 0.0 113.619 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -94.34 161.29 14.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.026 1.331 . . . . 0.0 110.097 171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.55 131.05 46.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -167.22 -46.3 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.438 1.017 . . . . 0.0 110.453 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.3 3.4 t 59.77 8.6 1.38 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 128.764 2.826 . . . . 0.0 115.179 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 p -90.15 147.86 37.99 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.975 1.31 . . . . 0.0 111.458 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.63 -9.33 5.77 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.955 2.436 . . . . 0.0 114.162 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -72.93 -55.01 4.25 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.26 40.52 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 CA-C-N 121.553 1.59 . . . . 0.0 112.413 -168.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.68 149.24 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.588 1.085 . . . . 0.0 110.748 -166.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.27 -172.39 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 C-N-CA 126.209 1.803 . . . . 0.0 109.86 177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.95 -116.54 0.85 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 125.099 1.359 . . . . 0.0 107.81 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.28 8.24 33.78 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.974 1.309 . . . . 0.0 111.89 175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.92 20.56 20.95 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.724 1.154 . . . . 0.0 112.618 -173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -99.43 -18.06 17.65 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.752 1.221 . . . . 0.0 110.782 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.58 143.35 50.29 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.231 0.612 . . . . 0.0 110.927 174.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.0 m-85 -77.68 155.28 31.43 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.232 1.413 . . . . 0.0 109.64 175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.8 m -65.18 -14.94 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 112.422 174.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.91 -178.15 42.72 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 119.763 1.165 . . . . 0.0 111.968 -173.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.449 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 13.9 tp -64.76 129.68 40.69 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.66 110.14 18.73 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 78.4 mt -106.31 151.32 24.99 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 123.374 0.669 . . . . 0.0 109.716 178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.87 138.02 25.37 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -107.87 30.84 5.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.132 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.0 t -133.09 -39.04 0.95 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.474 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.6 OUTLIER -88.04 -53.21 4.84 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.937 1.695 . . . . 0.0 106.76 171.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -100.7 16.89 23.42 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.015 1.326 . . . . 0.0 112.763 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -52.42 -27.92 17.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.214 0.915 . . . . 0.0 112.562 177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -85.86 -19.57 30.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.996 0.518 . . . . 0.0 111.896 -173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.21 -2.96 7.54 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.968 1.307 . . . . 0.0 112.542 -172.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.8 p -55.62 -32.39 63.09 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.869 1.213 . . . . 0.0 110.297 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -59.31 -42.03 90.43 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.401 1.08 . . . . 0.0 111.502 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -33.54 57.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.626 1.17 . . . . 0.0 109.941 -175.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -70.01 -32.88 71.27 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.306 1.042 . . . . 0.0 108.413 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 52.8 mt -67.27 -59.57 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -58.37 -38.47 77.34 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.6 m -64.08 -37.8 88.76 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.667 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.449 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 36.2 t90 -66.5 -44.95 81.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.87 0.843 . . . . 0.0 110.168 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.1 m -56.93 -35.37 68.98 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.946 0.898 . . . . 0.0 109.72 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -70.76 -30.53 67.05 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 123.546 0.529 . . . . 0.0 109.852 -173.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -79.77 -47.22 15.59 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.518 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.472 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.08 -39.71 86.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 CA-C-N 121.132 1.787 . . . . 0.0 110.36 -169.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.62 -14.11 56.54 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.369 0.667 . . . . 0.0 112.136 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -96.64 -45.98 6.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.37 -42.97 88.17 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.758 0.708 . . . . 0.0 109.525 -173.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.529 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -76.9 -36.31 56.75 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.639 0.776 . . . . 0.0 110.961 -174.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.45 63.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.133 0.973 . . . . 0.0 109.959 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.52 -32.02 73.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.23 1.412 . . . . 0.0 109.979 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -63.55 -47.78 80.18 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.161 0.584 . . . . 0.0 110.382 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -6.13 48.03 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.208 1.003 . . . . 0.0 113.707 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.367 0 CA-C-N 118.785 0.72 . . . . 0.0 110.645 -178.572 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.85 140.29 29.81 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 169.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.99 148.25 47.13 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.632 2.373 . . . . 0.0 108.815 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.55 118.66 4.7 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.01 112.49 23.43 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.945 1.373 . . . . 0.0 108.928 170.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -108.0 144.86 34.73 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.159 1.384 . . . . 0.0 111.219 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -162.51 175.6 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.949 0.899 . . . . 0.0 110.74 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.22 140.51 7.91 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.592 -2.603 . . . . 0.0 106.592 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 141.24 43.3 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.727 1.264 . . . . 0.0 109.444 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -83.25 -40.34 19.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.442 1.097 . . . . 0.0 109.723 173.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.6 p -96.7 -82.26 0.4 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.622 1.569 . . . . 0.0 107.271 -173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 p -177.71 -6.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 128.781 2.832 . . . . 0.0 111.619 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -67.22 -41.26 86.05 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 119.769 -1.832 . . . . 0.0 111.806 -168.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -35.05 74.95 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -63.32 -46.46 86.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.991 0.917 . . . . 0.0 110.326 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.9 -38.85 87.02 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.011 -0.431 . . . . 0.0 111.044 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.69 93.89 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.79 -0.624 . . . . 0.0 110.683 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.65 -47.22 77.02 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.041 0.936 . . . . 0.0 110.621 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -59.64 -44.52 93.49 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.81 -55.43 26.48 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 124.546 1.154 . . . . 0.0 109.112 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 mt -52.11 -56.33 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 118.974 0.806 . . . . 0.0 109.719 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -39.17 77.53 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.909 -0.567 . . . . 0.0 110.636 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.28 -46.58 73.19 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.013 0.525 . . . . 0.0 111.347 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 158' ' ' GLN . 14.4 mt -67.39 -45.76 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.826 1.25 . . . . 0.0 108.417 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 164' ' ' ILE . 77.4 mt -71.95 -50.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.765 0.826 . . . . 0.0 110.241 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.51 114.27 0.79 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 124.489 1.042 . . . . 0.0 110.607 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.56 3.79 3.98 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.532 2.821 . . . . 0.0 112.681 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -71.8 -34.61 69.52 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.178 1.391 . . . . 0.0 109.194 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 -20.27 4.11 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.553 1.541 . . . . 0.0 111.602 -169.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.98 143.12 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.958 1.708 . . . . 0.0 109.083 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.6 m -133.68 129.24 36.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.562 1.145 . . . . 0.0 109.76 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.06 149.1 46.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.85 0.86 . . . . 0.0 111.687 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -144.09 112.32 6.38 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.445 1.898 . . . . 0.0 106.929 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -87.71 110.71 20.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.19 -8.39 31.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.8 pttt -59.77 -28.88 67.79 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.225 0.92 . . . . 0.0 111.476 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -132.36 -33.44 1.28 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.418 1.087 . . . . 0.0 112.285 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -83.34 140.6 32.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.218 1.007 . . . . 0.0 108.672 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m -84.88 141.63 38.27 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.05 -5.33 16.89 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.674 1.583 . . . . 0.0 111.764 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -54.06 -38.21 65.02 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.489 1.495 . . . . 0.0 111.338 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.87 -20.55 66.27 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.116 -0.99 . . . . 0.0 113.16 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -12.23 27.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.331 1.053 . . . . 0.0 112.514 169.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -74.01 -26.26 60.34 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.941 -1.099 . . . . 0.0 110.581 173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.31 -50.28 13.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.942 0.792 . . . . 0.0 110.106 -174.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.89 146.16 55.07 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.575 1.15 . . . . 0.0 108.666 -169.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.72 -25.84 54.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.486 0.66 . . . . 0.0 110.648 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.2 t -145.54 140.36 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.09 155.77 41.07 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 118.648 0.658 . . . . 0.0 110.769 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.28 121.9 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 168.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 138.25 54.13 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.03 122.93 3.65 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-O 118.076 -1.402 . . . . 0.0 112.687 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.675 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.75 130.14 24.56 Favored Pre-proline 0 N--CA 1.468 0.473 0 C-N-CA 124.66 1.184 . . . . 0.0 110.307 177.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.04 146.69 14.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.352 2.035 . . . . 0.0 108.368 167.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -93.53 129.35 39.78 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -122.74 172.23 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.17 1.788 . . . . 0.0 110.228 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 26.25 57.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 128.796 2.838 . . . . 0.0 115.702 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 57.84 76.11 0.34 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.412 1.485 . . . . 0.0 111.722 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.54 18.29 73.57 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 115.248 0.859 . . . . 0.0 115.248 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.75 158.33 21.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.809 1.244 . . . . 0.0 109.68 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.56 151.6 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -66.02 143.59 57.27 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.47 -26.74 68.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.141 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -66.67 -26.7 67.17 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.525 0.73 . . . . 0.0 110.74 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.474 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -84.64 -42.36 15.43 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.16 0.984 . . . . 0.0 110.702 172.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.34 -34.34 64.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.206 0.457 . . . . 0.0 111.039 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.257 1.023 . . . . 0.0 112.16 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.04 -10.86 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.548 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.1 t-105 -53.62 -29.02 36.01 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.639 1.576 . . . . 0.0 111.849 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.57 -43.32 69.7 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.989 1.316 . . . . 0.0 111.302 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.62 -29.34 66.82 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 117.667 -1.158 . . . . 0.0 112.549 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.3 mt -57.74 -33.31 68.32 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.17 1.35 . . . . 0.0 110.747 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.84 -29.15 68.99 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.927 0.891 . . . . 0.0 111.795 176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -80.96 -24.52 38.03 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.976 0.511 . . . . 0.0 111.256 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -74.21 162.61 28.76 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 122.919 1.342 . . . . 0.0 112.23 -168.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -98.41 99.02 10.16 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.568 1.947 . . . . 0.0 108.842 173.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.8 10.48 15.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 172.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.9 121.22 12.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -169.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.75 -0.88 89.38 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 125.572 1.558 . . . . 0.0 115.17 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -73.75 154.21 39.69 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 118.239 1.019 . . . . 0.0 109.681 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.702 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.2 mt -91.28 140.67 15.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.46 130.15 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 C-N-CA 124.706 1.202 . . . . 0.0 109.012 177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -109.57 115.5 30.03 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 167.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.4 mt -86.95 143.02 27.56 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 118.869 0.759 . . . . 0.0 111.455 172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -137.7 161.27 36.97 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 167.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.24 176.5 39.44 Favored Glycine 0 CA--C 1.506 -0.488 0 O-C-N 120.844 -1.16 . . . . 0.0 112.558 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.6 mt -121.0 153.33 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.977 -1.119 . . . . 0.0 107.977 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.91 -153.9 9.22 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -154.02 142.48 20.69 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.973 1.709 . . . . 0.0 108.099 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.425 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -90.58 -23.38 20.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 175.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.14 -36.97 80.53 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.805 1.184 . . . . 0.0 112.027 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -77.7 -27.51 58.79 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.94 -69.07 0.25 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.674 -167.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.31 -39.54 3.09 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.576 1.56 . . . . 0.0 110.385 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HB2' ' CE3' ' A' ' 96' ' ' TRP . 5.9 mm-40 -76.71 -35.35 57.91 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.59 -13.43 56.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.879 1.672 . . . . 0.0 111.528 -173.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -50.92 123.87 10.08 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 126.614 1.966 . . . . 0.0 109.322 -176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 53.0 26.71 4.95 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.259 1.023 . . . . 0.0 112.597 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.88 -37.33 86.49 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.688 -1.257 . . . . 0.0 110.622 -173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.58 -32.74 73.77 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.825 0.45 . . . . 0.0 111.761 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.675 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.1 tp -60.93 -47.72 85.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.212 1.005 . . . . 0.0 110.36 176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.86 -40.83 97.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.7 mtm -65.61 -43.83 88.41 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.829 0.814 . . . . 0.0 112.376 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.571 HD12 HD12 ' A' ' 53' ' ' ILE . 3.7 mt -63.84 -33.82 76.55 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.567 174.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -66.55 -38.27 86.74 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.265 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.46 -30.54 64.65 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.091 2.156 . . . . 0.0 112.019 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -63.46 -62.01 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 169.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.07 -19.1 58.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.028 -0.986 . . . . 0.0 112.577 -166.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.1 p -60.23 -31.35 70.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.75 1.159 . . . . 0.0 111.125 169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.35 -23.11 47.08 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -77.96 2.16 18.43 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 124.671 1.188 . . . . 0.0 112.414 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.79 32.88 66.54 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 118.999 0.818 . . . . 0.0 112.113 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.49 176.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.843 0.857 . . . . 0.0 109.743 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 146.92 47.19 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 166.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.6 149.01 31.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 118.991 0.814 . . . . 0.0 111.8 -169.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.514 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.5 m -127.39 -179.76 3.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 124.326 1.05 . . . . 0.0 108.977 169.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.83 33.5 46.18 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.986 172.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.6 m-30 -78.09 144.04 36.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.765 1.783 . . . . 0.0 108.47 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -119.32 145.43 38.56 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-O 117.344 -1.312 . . . . 0.0 108.662 171.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -68.16 138.33 43.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.708 1.289 . . . . 0.0 109.215 168.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.462 HG22 ' CD1' ' A' ' 139' ' ' PHE . 69.0 p -73.94 -6.88 49.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.661 1.585 . . . . 0.0 113.582 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.51 141.93 55.89 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.04 0.924 . . . . 0.0 109.868 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.09 -11.64 59.93 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.499 1.523 . . . . 0.0 113.75 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -88.99 163.44 15.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.591 1.195 . . . . 0.0 110.639 171.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -127.56 124.81 39.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.315 -2.105 . . . . 0.0 105.315 169.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -164.68 -54.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.867 0.758 . . . . 0.0 109.696 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 3.8 t 57.96 8.18 0.7 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 128.19 2.596 . . . . 0.0 114.624 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.5 t -63.97 140.49 97.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 121.113 -0.992 . . . . 0.0 109.531 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.84 -11.5 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.834 2.356 . . . . 0.0 112.863 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -75.64 -52.35 2.84 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 119.922 1.237 . . . . 0.0 114.112 -168.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -90.04 42.02 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.944 1.73 . . . . 0.0 111.609 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.58 150.5 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 120.815 -1.178 . . . . 0.0 110.147 -167.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.84 -172.38 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 126.11 1.764 . . . . 0.0 109.913 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.4 -116.58 0.81 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.566 1.547 . . . . 0.0 107.487 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.1 8.93 34.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.844 1.257 . . . . 0.0 111.764 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.72 21.13 22.34 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.808 1.194 . . . . 0.0 112.486 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -99.24 -18.4 17.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.865 1.266 . . . . 0.0 110.586 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.71 142.49 49.08 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.264 0.626 . . . . 0.0 111.311 175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' CD1' HG22 ' A' ' 121' ' ' THR . 60.3 m-85 -77.38 155.5 31.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.182 1.393 . . . . 0.0 109.923 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 28.9 m -65.97 -12.87 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.601 1.16 . . . . 0.0 112.428 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.22 -178.85 43.5 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 119.907 1.23 . . . . 0.0 112.322 -172.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 18.9 tp -65.46 130.26 42.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.09 117.71 33.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 68.9 mt -113.9 152.08 31.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.92 0.888 . . . . 0.0 108.723 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -145.59 128.22 16.14 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 174.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -102.47 17.89 22.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.59 1.156 . . . . 0.0 110.408 -171.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.62 -21.55 5.65 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.425 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.4 OUTLIER -112.71 -49.02 2.96 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.03 1.332 . . . . 0.0 108.25 172.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -104.55 19.31 20.59 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.107 1.363 . . . . 0.0 113.664 -169.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -52.96 -22.99 6.31 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.58 -25.35 30.99 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.857 0.863 . . . . 0.0 111.864 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -120.56 -10.13 9.29 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.426 1.09 . . . . 0.0 112.381 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.4 p -55.36 -32.41 62.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.096 1.316 . . . . 0.0 110.854 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -58.59 -40.42 83.13 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.603 1.161 . . . . 0.0 111.731 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.67 -31.75 62.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.291 1.037 . . . . 0.0 109.786 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -78.88 -28.97 44.16 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.7 mt -63.12 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -58.0 -41.58 83.37 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.2 m -63.23 -37.05 85.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.772 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.433 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 42.4 t90 -67.12 -44.37 80.07 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.716 0.77 . . . . 0.0 110.22 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 97.3 m -57.11 -36.13 70.26 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.087 0.955 . . . . 0.0 109.506 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -69.78 -29.02 66.24 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.338 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -80.03 -46.55 16.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.318 170.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.501 HD11 HD11 ' A' ' 25' ' ' ILE . 4.7 pt -64.43 -38.64 83.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 CA-C-N 120.961 1.709 . . . . 0.0 110.271 -171.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.2 -15.59 60.24 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.228 0.611 . . . . 0.0 112.036 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -95.92 -46.39 6.56 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -58.66 -40.43 83.47 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 118.711 0.687 . . . . 0.0 109.755 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.702 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -79.19 -37.99 36.92 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 123.737 0.815 . . . . 0.0 110.983 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.01 -46.77 70.32 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.008 0.923 . . . . 0.0 109.901 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -67.62 -29.88 69.32 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.106 1.362 . . . . 0.0 109.777 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -63.6 -48.47 77.21 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.553 0.615 . . . . 0.0 110.506 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.52 50.1 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.414 1.086 . . . . 0.0 113.741 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.485 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 119.704 -0.188 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.56 140.62 30.48 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -129.27 146.78 51.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.648 1.979 . . . . 0.0 108.947 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.27 117.63 4.77 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.597 -1.113 . . . . 0.0 110.445 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.82 113.32 23.37 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 119.254 1.527 . . . . 0.0 108.354 169.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -108.87 145.04 35.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.913 1.285 . . . . 0.0 111.442 173.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -159.96 173.35 16.02 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.652 0.781 . . . . 0.0 109.927 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.49 139.95 8.66 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 106.477 -2.649 . . . . 0.0 106.477 169.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -141.48 131.85 25.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.395 1.478 . . . . 0.0 108.837 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.7 m -84.29 -28.93 26.79 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.741 0.246 . . . . 0.0 110.739 172.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.1 p -112.47 -79.15 0.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.448 1.099 . . . . 0.0 108.165 -172.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 10.8 p -173.04 -13.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -68.18 -42.64 79.65 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 119.711 -1.868 . . . . 0.0 113.333 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -34.38 77.77 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.48 -49.25 76.15 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.454 1.102 . . . . 0.0 109.866 175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.3 mtm -66.34 -41.83 89.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.346 0.521 . . . . 0.0 111.182 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.19 94.08 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.005 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.48 77.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 123.863 0.865 . . . . 0.0 110.436 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.88 -44.26 91.08 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -63.39 -54.93 29.1 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 124.79 1.306 . . . . 0.0 108.996 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.07 -56.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 118.956 0.798 . . . . 0.0 109.716 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -39.11 83.02 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.691 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.3 -46.92 72.15 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 122.939 0.496 . . . . 0.0 111.227 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.4 mt -66.17 -46.62 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 124.962 1.305 . . . . 0.0 108.596 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 164' ' ' ILE . 83.3 mt -72.66 -50.23 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.8 0.84 . . . . 0.0 110.589 -176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.93 114.34 0.78 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 124.399 1.0 . . . . 0.0 110.67 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.12 4.03 3.57 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.494 2.796 . . . . 0.0 112.814 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.56 -34.05 64.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.505 1.522 . . . . 0.0 109.149 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.26 -22.77 3.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.772 1.629 . . . . 0.0 111.409 -169.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.16 140.73 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 120.657 1.571 . . . . 0.0 109.091 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 45.5 m -130.17 129.09 43.0 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.485 1.114 . . . . 0.0 109.679 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.0 mt -71.42 148.96 46.39 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.481 0.712 . . . . 0.0 111.942 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -142.88 110.46 5.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.429 1.892 . . . . 0.0 106.621 173.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -86.74 110.65 20.05 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.0 -8.07 20.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -174.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.6 pttt -60.62 -28.04 68.22 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.25 0.932 . . . . 0.0 111.729 168.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -132.33 -33.97 1.25 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.77 1.228 . . . . 0.0 111.886 -172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -82.73 140.77 32.86 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.091 0.957 . . . . 0.0 108.565 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.7 m -83.96 140.82 40.31 Favored Pre-proline 0 N--CA 1.449 -0.52 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -74.13 -1.9 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 CA-C-N 121.163 1.451 . . . . 0.0 110.983 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -56.36 -33.97 66.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 122.246 2.293 . . . . 0.0 111.921 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -19.36 64.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.428 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.0 ttm -58.17 -16.34 13.13 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 127.266 2.226 . . . . 0.0 111.702 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -73.65 -31.14 63.34 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.056 -1.027 . . . . 0.0 110.795 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -78.16 -47.07 18.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.341 0.591 . . . . 0.0 110.019 -169.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -65.84 140.33 58.38 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.58 -169.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.5 -17.16 56.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.41 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.55 149.9 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 126.434 1.893 . . . . 0.0 106.069 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.428 HD13 ' CG ' ' A' ' 43' ' ' MET . 8.1 mt -138.34 151.31 47.42 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.667 0.787 . . . . 0.0 109.218 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.36 121.43 53.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -120.0 135.75 54.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -127.19 122.79 4.37 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-O 117.773 -1.57 . . . . 0.0 113.12 -174.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.656 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -123.5 126.61 25.78 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-N 119.286 1.543 . . . . 0.0 110.63 177.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.44 144.66 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.689 2.259 . . . . 0.0 107.799 167.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -87.81 131.27 34.59 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -119.98 169.47 10.15 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.22 1.808 . . . . 0.0 109.62 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 28.85 54.67 0.09 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.275 2.63 . . . . 0.0 115.319 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 55.98 78.73 0.19 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.312 1.445 . . . . 0.0 112.23 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.06 13.49 76.11 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 115.289 0.876 . . . . 0.0 115.289 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -85.07 160.8 19.91 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.555 1.142 . . . . 0.0 109.125 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.5 mt -92.18 154.64 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -59.13 140.82 55.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.99 0.916 . . . . 0.0 108.787 170.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.83 -28.92 69.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -167.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -80.33 -20.95 43.07 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.642 -0.661 . . . . 0.0 110.58 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.497 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.1 m95 -77.0 -44.31 31.44 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.83 169.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -53.33 -35.85 60.65 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.473 0.709 . . . . 0.0 110.751 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.82 -30.4 71.46 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.008 0.923 . . . . 0.0 112.209 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.44 -9.78 11.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.56 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.6 t-105 -53.32 -29.46 33.84 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.44 1.496 . . . . 0.0 111.71 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.32 -44.76 74.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.959 1.304 . . . . 0.0 111.459 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -68.48 -29.67 68.34 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 117.928 -1.034 . . . . 0.0 112.113 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.5 mt -57.65 -31.06 65.93 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.995 1.27 . . . . 0.0 111.122 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.56 -28.95 65.3 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.499 0.72 . . . . 0.0 111.205 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.02 -23.34 38.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.139 0.576 . . . . 0.0 111.173 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.6 mt -72.94 157.84 36.64 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 123.038 1.399 . . . . 0.0 112.878 -167.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -90.94 91.53 8.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 112.738 -2.028 . . . . 0.0 107.978 171.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -111.38 11.63 21.54 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -65.84 128.33 35.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.06 30.86 69.57 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.294 0.95 . . . . 0.0 114.469 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.91 156.68 34.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.59 1.195 . . . . 0.0 109.633 169.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.656 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.4 mt -88.63 146.81 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -173.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -132.37 130.17 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 125.084 1.354 . . . . 0.0 109.263 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.06 117.93 35.07 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 167.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.05 143.13 27.05 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.389 0.995 . . . . 0.0 112.085 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -136.38 156.04 49.19 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.229 1.011 . . . . 0.0 109.13 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.55 164.54 35.16 Favored Glycine 0 CA--C 1.506 -0.475 0 O-C-N 120.801 -1.187 . . . . 0.0 112.154 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.4 158.63 36.79 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 178.57 -137.75 3.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -158.5 150.81 21.75 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.535 1.934 . . . . 0.0 108.046 168.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.593 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -89.08 -31.29 18.1 Favored 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 125.919 1.688 . . . . 0.0 114.149 173.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.6 -33.25 62.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.487 1.04 . . . . 0.0 113.082 -167.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.52 -19.33 35.43 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 124.788 1.185 . . . . 0.0 111.206 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 95' ' ' GLU . 26.8 m-85 -126.85 -90.07 0.54 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.547 1.139 . . . . 0.0 108.721 -170.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.59 -50.8 2.55 Favored Glycine 0 N--CA 1.464 0.555 0 C-N-CA 128.517 2.96 . . . . 0.0 107.755 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 93' ' ' TYR . 12.3 mm-40 -69.65 -30.63 68.38 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.67 1.988 . . . . 0.0 110.536 -174.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -115.14 0.73 13.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.75 1.22 . . . . 0.0 112.021 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -53.91 127.04 24.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 124.883 1.273 . . . . 0.0 109.545 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 56.28 23.8 7.55 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.57 1.548 . . . . 0.0 113.666 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -68.74 -36.78 78.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.551 -1.343 . . . . 0.0 110.698 -171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.64 72.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.104 0.561 . . . . 0.0 111.467 172.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.656 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.2 tp -61.38 -46.76 88.84 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 123.799 0.84 . . . . 0.0 110.756 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.52 96.44 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.8 mtm -66.07 -44.94 83.06 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 117.712 0.756 . . . . 0.0 112.152 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.56 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.2 mt -64.33 -32.82 74.58 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 119.606 1.094 . . . . 0.0 111.807 175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -63.53 -40.11 96.17 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.109 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -72.0 -36.13 69.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.758 1.623 . . . . 0.0 112.204 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.4 tptt -57.42 -47.03 82.85 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.688 0.795 . . . . 0.0 109.894 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.0 mt -93.76 -20.65 19.92 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.037 -0.983 . . . . 0.0 112.33 -171.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 79.2 p -61.2 -32.24 72.0 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.748 1.613 . . . . 0.0 111.665 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -79.15 -17.43 55.02 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.071 0.548 . . . . 0.0 110.059 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -79.54 1.42 25.96 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.114 1.366 . . . . 0.0 111.943 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.01 34.79 58.34 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 118.941 0.792 . . . . 0.0 111.908 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.43 171.9 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 123.961 0.904 . . . . 0.0 109.787 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -121.09 142.91 49.4 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -110.44 150.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.903 1.229 . . . . 0.0 111.999 -170.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.8 m -129.88 -178.66 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.649 1.179 . . . . 0.0 109.157 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.12 33.9 43.47 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-O 118.417 -1.213 . . . . 0.0 113.977 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -71.8 147.32 47.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.437 1.619 . . . . 0.0 107.784 170.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.66 144.98 51.69 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.236 169.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -69.58 140.12 42.57 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 CA-C-N 121.012 1.397 . . . . 0.0 109.472 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.509 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p -73.77 -11.01 60.25 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.568 1.547 . . . . 0.0 113.555 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.48 144.8 55.56 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.902 0.858 . . . . 0.0 109.338 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.83 19.2 79.29 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.123 -176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.4 165.49 27.36 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.868 2.067 . . . . 0.0 108.317 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -140.28 133.53 29.71 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.339 1.856 . . . . 0.0 108.485 -173.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -167.15 -57.05 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -170.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.334 2.9 t 56.2 7.52 0.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.844 2.858 . . . . 0.0 114.364 -177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -69.61 144.17 93.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 120.991 -1.068 . . . . 0.0 110.515 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -87.84 -14.5 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.722 2.281 . . . . 0.0 113.76 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -80.53 -48.98 1.18 Allowed Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.26 39.33 0.58 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.383 2.056 . . . . 0.0 112.579 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 148.43 21.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.546 1.139 . . . . 0.0 109.589 -167.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -172.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.998 1.719 . . . . 0.0 109.666 176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.85 -116.37 0.84 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.135 1.374 . . . . 0.0 107.306 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -105.38 7.8 33.41 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 112.202 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.28 20.13 18.85 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.996 1.284 . . . . 0.0 112.475 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.02 -17.11 17.66 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.686 1.194 . . . . 0.0 110.668 -172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.64 144.04 50.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.203 0.601 . . . . 0.0 110.879 173.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.509 ' CD1' HG22 ' A' ' 121' ' ' THR . 50.4 m-85 -78.26 154.87 30.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.953 1.301 . . . . 0.0 109.246 174.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.42 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.1 m -65.44 -14.91 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.463 1.105 . . . . 0.0 112.847 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.15 -176.31 40.22 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.561 1.073 . . . . 0.0 111.901 -171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.437 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 16.3 tp -65.66 129.55 40.17 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.22 129.66 55.68 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.9 mt -130.47 158.68 39.24 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.724 1.61 . . . . 0.0 109.215 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.466 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -137.0 125.6 23.71 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.685 0.794 . . . . 0.0 109.025 176.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -98.91 6.35 46.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.534 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -20.7 11.5 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.244 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.23 -42.33 1.21 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.816 1.189 . . . . 0.0 112.675 172.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -84.13 7.2 19.6 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.091 0.86 . . . . 0.0 112.808 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -55.58 -21.55 17.89 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.522 1.056 . . . . 0.0 113.088 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -83.57 -25.61 30.79 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.086 0.954 . . . . 0.0 111.536 -177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.439 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.0 pp -129.26 3.8 5.19 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.08 0.952 . . . . 0.0 112.446 -169.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -50.96 -29.4 12.11 Favored 'General case' 0 C--O 1.22 -0.458 0 O-C-N 120.81 -1.181 . . . . 0.0 110.842 169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.36 -39.29 94.12 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.747 1.619 . . . . 0.0 110.604 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -72.28 -46.35 56.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 129.374 3.07 . . . . 0.0 108.194 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -25.39 62.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 112.841 -1.981 . . . . 0.0 108.273 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 38.2 mt -72.28 -62.33 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -57.17 -37.34 71.96 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.2 m -63.53 -38.39 90.93 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 123.428 0.455 . . . . 0.0 110.751 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.8 t90 -66.52 -44.56 82.13 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.438 -0.788 . . . . 0.0 110.179 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 72.8 m -55.89 -35.53 66.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 123.553 0.741 . . . . 0.0 109.809 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -33.58 76.28 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.485 0.491 . . . . 0.0 110.259 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -81.93 -46.14 14.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.498 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.456 HD11 HD11 ' A' ' 25' ' ' ILE . 5.3 pt -64.55 -39.47 85.69 Favored 'Isoleucine or valine' 0 C--N 1.337 0.061 0 CA-C-N 121.417 1.917 . . . . 0.0 109.977 -169.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.6 -14.25 57.03 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -96.44 -45.65 6.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.885 1.274 . . . . 0.0 107.888 173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.29 -41.08 88.13 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 118.886 0.767 . . . . 0.0 109.724 -173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.656 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -77.37 -35.65 54.32 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.169 0.988 . . . . 0.0 110.951 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.48 -47.32 42.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.335 1.054 . . . . 0.0 110.004 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.53 -29.56 68.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.405 1.482 . . . . 0.0 110.129 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -60.66 -45.78 92.82 Favored 'General case' 0 C--N 1.344 0.349 0 CA-C-N 118.266 0.485 . . . . 0.0 110.302 172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.78 -1.63 58.09 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 114.055 -174.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.422 177.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 145.26 30.24 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.876 1.27 . . . . 0.0 108.636 169.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.401 ' SD ' HG11 ' A' ' 48' ' ' VAL . 13.8 mtm -130.45 147.25 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 126.127 1.771 . . . . 0.0 108.984 -168.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.4 118.63 5.07 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-O 118.81 -0.995 . . . . 0.0 110.947 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.09 105.9 18.12 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.86 1.33 . . . . 0.0 109.952 171.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -105.0 145.74 30.02 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.47 1.508 . . . . 0.0 111.301 176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -164.93 175.47 9.5 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.007 0.923 . . . . 0.0 110.431 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.91 142.33 10.02 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 106.656 -2.578 . . . . 0.0 106.656 168.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.9 t -146.52 147.69 31.41 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.25 1.025 . . . . 0.0 111.401 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -95.79 -45.89 6.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.828 1.251 . . . . 0.0 109.543 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.5 p -90.19 -10.93 42.6 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.006 1.722 . . . . 0.0 111.41 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.276 44.5 m 73.64 13.67 4.35 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.2 2.2 . . . . 0.0 113.697 -168.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -63.6 -44.2 94.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.593 1.542 . . . . 0.0 110.764 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -34.29 77.28 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -64.45 -49.07 72.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.409 1.084 . . . . 0.0 109.99 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -64.8 -38.89 92.51 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.94 -0.475 . . . . 0.0 111.151 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.76 97.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.7 -0.666 . . . . 0.0 110.848 173.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.13 79.03 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.776 0.83 . . . . 0.0 110.611 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -57.37 -46.74 83.06 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.903 0.481 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -62.32 -54.86 34.44 Favored 'General case' 0 CA--C 1.503 -0.858 0 O-C-N 124.732 1.27 . . . . 0.0 108.923 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.413 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.41 -56.87 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 118.447 0.567 . . . . 0.0 109.584 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -38.99 72.81 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.343 0.657 . . . . 0.0 110.539 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.62 -48.1 67.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 122.992 0.517 . . . . 0.0 111.201 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD13 ' HA ' ' A' ' 158' ' ' GLN . 17.8 mt -64.64 -47.11 90.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.996 1.318 . . . . 0.0 108.8 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.5 mt -72.58 -51.55 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.783 0.833 . . . . 0.0 110.52 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.67 115.59 0.76 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 170.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.44 3.54 4.11 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.29 2.66 . . . . 0.0 112.98 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -73.73 -35.12 65.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.25 1.42 . . . . 0.0 108.966 174.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -26.96 5.57 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.067 1.747 . . . . 0.0 111.369 -173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.47 140.43 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 120.781 1.628 . . . . 0.0 109.088 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.7 m -129.91 129.62 44.1 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 124.54 1.136 . . . . 0.0 110.073 176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 mt -70.79 148.99 47.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.875 0.87 . . . . 0.0 112.154 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -145.21 108.84 4.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.697 1.599 . . . . 0.0 107.762 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -82.31 112.03 18.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.77 -9.44 36.92 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.3 pttt -59.12 -28.49 66.59 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.422 1.01 . . . . 0.0 111.509 169.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -130.64 -34.22 1.56 Allowed 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.473 1.109 . . . . 0.0 112.112 -172.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -82.26 140.2 33.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.6 m -82.95 139.72 42.97 Favored Pre-proline 0 N--CA 1.452 -0.358 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -73.81 -1.62 11.06 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 CA-C-N 121.172 1.454 . . . . 0.0 111.425 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 122.153 2.251 . . . . 0.0 111.713 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -18.78 64.68 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.431 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.2 ttm -58.91 -15.62 13.66 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.993 2.117 . . . . 0.0 111.971 169.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -74.1 -32.99 63.45 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.191 -0.943 . . . . 0.0 110.601 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.62 -48.11 28.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.58 0.705 . . . . 0.0 110.04 -170.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -70.86 131.86 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -171.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.94 -3.34 58.9 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.401 HG11 ' SD ' ' A' ' 3' ' ' MET . 74.8 t -140.57 146.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.6 mt -140.63 153.86 46.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 122.999 0.52 . . . . 0.0 109.789 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -129.32 122.84 56.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.083 -2.191 . . . . 0.0 105.083 169.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.6 mp -119.73 136.71 54.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -130.2 119.71 2.87 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-O 117.957 -1.468 . . . . 0.0 112.785 -171.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.698 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -125.03 133.64 25.0 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 119.046 1.423 . . . . 0.0 110.309 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.74 157.07 15.97 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.222 1.948 . . . . 0.0 108.717 166.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -101.22 125.26 47.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 169.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -113.71 172.18 7.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.802 1.641 . . . . 0.0 109.829 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.96 62.5 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.793 2.837 . . . . 0.0 115.225 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 55.93 71.52 0.55 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 112.363 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.93 17.27 79.34 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.491 0.956 . . . . 0.0 115.491 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -82.27 155.39 24.87 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.548 1.139 . . . . 0.0 109.948 169.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 mt -95.25 151.61 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -65.8 143.5 57.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.91 -26.67 68.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.035 -169.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -67.03 -26.7 66.9 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.674 0.789 . . . . 0.0 110.761 178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.522 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.1 m95 -83.99 -42.74 15.9 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.108 0.963 . . . . 0.0 110.71 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.41 -34.92 64.82 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.581 0.628 . . . . 0.0 110.819 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.7 71.19 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.359 1.064 . . . . 0.0 112.119 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.31 -11.46 10.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.549 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t-105 -53.52 -28.98 34.28 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.653 1.581 . . . . 0.0 111.724 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.29 -44.68 64.73 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 125.006 1.322 . . . . 0.0 111.384 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.73 -30.37 70.58 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.568 -1.206 . . . . 0.0 111.95 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.703 1.138 . . . . 0.0 111.096 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.14 -31.33 70.82 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 111.421 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -80.41 -26.44 38.46 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.355 0.662 . . . . 0.0 110.887 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -70.24 159.79 33.37 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 122.565 1.174 . . . . 0.0 112.062 -169.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.68 96.85 10.43 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 112.832 -1.986 . . . . 0.0 108.215 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -118.92 6.6 11.4 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.122 0.969 . . . . 0.0 113.141 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -69.0 118.35 11.8 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -168.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.15 23.79 70.5 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.943 1.259 . . . . 0.0 115.687 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HD2' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -110.68 154.74 23.42 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.083 1.441 . . . . 0.0 109.106 171.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.5 mt -85.21 143.78 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 118.87 0.759 . . . . 0.0 109.283 -172.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.5 t -132.44 134.13 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.526 1.53 . . . . 0.0 109.854 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.77 120.6 41.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 166.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.6 mt -90.1 143.68 26.56 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 119.145 0.884 . . . . 0.0 111.644 174.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 21.2 p90 -137.13 159.39 42.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 168.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.37 178.13 39.08 Favored Glycine 0 N--CA 1.448 -0.555 0 O-C-N 121.044 -1.035 . . . . 0.0 112.524 174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 mt -127.67 151.12 49.36 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.73 -157.76 9.85 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -155.12 137.68 15.11 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.606 1.562 . . . . 0.0 108.333 168.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.443 HE22 ' CG ' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -90.57 -20.76 22.24 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.4 mt -65.74 -49.33 68.81 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 119.781 1.173 . . . . 0.0 110.836 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.53 -27.36 8.6 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.189 0.9 . . . . 0.0 112.149 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -131.4 33.07 4.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 -166.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.45 -42.66 57.55 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-N 120.354 1.434 . . . . 0.0 111.012 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -60.82 -19.75 60.35 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 117.986 0.893 . . . . 0.0 112.318 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -125.84 12.56 7.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.871 1.668 . . . . 0.0 112.432 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -45.61 122.05 3.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.487 1.515 . . . . 0.0 108.679 170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 52.86 28.2 6.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.033 0.933 . . . . 0.0 112.971 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -61.91 -40.29 94.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 120.648 -1.282 . . . . 0.0 110.113 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.94 -33.75 76.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.23 0.612 . . . . 0.0 111.709 174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.698 ' HA ' HD11 ' A' ' 53' ' ' ILE . 12.6 tp -59.96 -47.72 84.63 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 110.456 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.89 -41.11 97.61 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.3 mtm -65.02 -44.56 88.78 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.01 0.905 . . . . 0.0 111.78 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 53' ' ' ILE . 3.9 mt -64.43 -35.44 80.93 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.295 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -64.24 -41.46 96.98 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.387 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.34 -42.6 92.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -55.06 -59.49 4.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 124.703 1.201 . . . . 0.0 108.267 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.26 -20.84 57.01 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.628 -0.67 . . . . 0.0 110.794 -170.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.8 t -62.2 -30.29 70.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.165 0.893 . . . . 0.0 110.304 168.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.86 -24.12 48.66 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 120.7 -1.25 . . . . 0.0 109.279 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -81.19 2.38 27.97 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.025 1.73 . . . . 0.0 112.59 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 67.69 33.15 79.83 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 118.643 0.656 . . . . 0.0 112.102 169.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.18 169.51 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 117.619 0.709 . . . . 0.0 109.468 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -113.61 140.25 48.35 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 169.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.45 148.08 32.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.072 1.305 . . . . 0.0 112.43 -168.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.8 m -128.6 -179.98 3.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.817 1.247 . . . . 0.0 109.577 168.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.77 33.41 33.98 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 118.342 -1.254 . . . . 0.0 114.741 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -78.86 139.6 38.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.933 1.866 . . . . 0.0 108.784 171.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 148.96 42.1 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-O 117.354 -1.308 . . . . 0.0 108.59 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.33 138.99 37.21 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 CA-C-N 120.949 1.375 . . . . 0.0 109.108 168.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.475 HG22 ' CD1' ' A' ' 139' ' ' PHE . 60.2 p -74.08 -6.78 49.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.803 1.641 . . . . 0.0 113.441 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.15 140.58 57.87 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.207 1.004 . . . . 0.0 109.724 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.15 -10.02 62.04 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.541 1.543 . . . . 0.0 113.881 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -88.94 162.4 16.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.79 1.295 . . . . 0.0 110.752 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -127.64 125.33 39.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.437 ' O ' HG22 ' A' ' 127' ' ' THR . 12.9 p90 -162.49 -61.92 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.167 0.894 . . . . 0.0 110.07 -172.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 126' ' ' PHE 0.333 2.1 t 58.74 11.13 1.69 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.575 2.75 . . . . 0.0 114.801 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.7 p -66.47 142.87 97.94 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.851 -1.156 . . . . 0.0 109.095 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.75 -15.36 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.283 1.989 . . . . 0.0 113.852 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -80.81 -48.21 1.15 Allowed Pre-proline 0 C--N 1.344 0.344 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.34 36.63 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 121.705 1.603 . . . . 0.0 112.484 -168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.81 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 124.093 0.957 . . . . 0.0 109.843 -166.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.77 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 109.456 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.94 -116.83 0.86 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 124.959 1.304 . . . . 0.0 107.62 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -105.14 7.82 33.91 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.761 1.224 . . . . 0.0 111.831 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.68 20.1 20.4 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 124.724 1.154 . . . . 0.0 112.575 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -100.36 -17.25 17.33 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.852 1.261 . . . . 0.0 110.859 -172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.18 145.29 51.25 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.286 0.634 . . . . 0.0 110.876 174.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 121' ' ' THR . 61.2 m-85 -81.27 155.45 26.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 110.221 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.02 -12.44 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.725 1.21 . . . . 0.0 112.755 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.67 -178.28 42.64 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.612 1.097 . . . . 0.0 111.879 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 22.2 tp -65.54 127.92 33.81 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.55 116.02 29.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -116.15 157.57 24.6 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.443 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -140.13 121.98 15.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -98.97 17.26 20.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.883 -169.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.94 -23.57 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.17 -52.6 2.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.702 1.137 . . . . 0.0 109.18 172.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -98.16 14.46 27.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.52 1.128 . . . . 0.0 113.896 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -52.07 -26.13 10.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.906 0.882 . . . . 0.0 112.485 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -78.37 -27.9 46.99 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.534 1.134 . . . . 0.0 111.38 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.54 -7.03 13.91 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.045 0.938 . . . . 0.0 111.218 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 68.2 m -53.07 -26.91 17.7 Favored 'General case' 0 C--O 1.221 -0.408 0 O-C-N 120.719 -1.238 . . . . 0.0 110.862 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -66.16 -40.18 90.33 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 122.035 0.921 . . . . 0.0 110.269 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.409 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -70.92 -46.2 62.92 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 129.827 3.251 . . . . 0.0 107.825 -177.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.4 mmt-85 -69.49 -28.12 65.79 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 113.199 -1.819 . . . . 0.0 108.322 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.34 -61.05 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.493 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.9 pt20 -56.88 -41.19 77.58 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 118.908 0.776 . . . . 0.0 112.259 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 m -65.59 -35.68 81.52 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.635 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 49.0 t90 -66.65 -43.95 83.26 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.464 -0.772 . . . . 0.0 109.79 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 92.7 m -57.55 -35.49 70.4 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 123.903 0.881 . . . . 0.0 109.644 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.12 -27.99 63.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.014 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -80.2 -46.41 16.37 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.148 170.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.2 -39.54 85.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 121.308 1.867 . . . . 0.0 110.614 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.11 -15.37 59.52 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.2 0.6 . . . . 0.0 111.839 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -96.53 -45.11 6.87 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 124.683 1.193 . . . . 0.0 107.799 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -59.31 -42.02 90.41 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 119.122 0.874 . . . . 0.0 109.574 -173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.653 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.9 mtm -74.36 -41.92 60.23 Favored 'General case' 0 C--O 1.223 -0.342 0 C-N-CA 124.142 0.977 . . . . 0.0 110.081 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.94 -44.41 80.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.286 1.035 . . . . 0.0 110.647 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -69.81 -32.2 70.51 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.082 1.353 . . . . 0.0 109.785 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -61.53 -42.44 98.82 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 121.474 0.654 . . . . 0.0 109.913 170.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.97 -2.16 35.6 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.02 1.728 . . . . 0.0 113.758 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 CA-C-N 118.406 0.548 . . . . 0.0 110.567 -179.204 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.498 1.965 0 N-CA-C 111.421 0.156 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.14 142.54 33.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 168.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.0 mtm -131.14 146.43 52.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.648 1.979 . . . . 0.0 108.276 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.55 117.94 5.0 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 118.637 -1.091 . . . . 0.0 110.397 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.72 113.12 24.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.268 169.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -109.92 147.36 33.57 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.77 1.628 . . . . 0.0 111.451 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -164.13 175.25 10.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.748 1.219 . . . . 0.0 109.704 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.54 142.95 11.16 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 106.251 -2.74 . . . . 0.0 106.251 168.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 t -148.87 144.61 27.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.303 1.051 . . . . 0.0 111.452 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.9 m -96.07 -37.87 10.43 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 111.389 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.4 p -95.09 -8.9 35.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.067 0.947 . . . . 0.0 111.594 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.264 56.9 m 71.5 15.01 6.22 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.745 2.018 . . . . 0.0 114.121 -170.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -65.28 -42.94 92.66 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.434 1.47 . . . . 0.0 110.353 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.18 -33.66 75.88 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -64.3 -46.93 81.47 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 123.395 0.678 . . . . 0.0 110.096 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 -40.85 96.98 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.592 -0.692 . . . . 0.0 111.548 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.4 94.02 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.638 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.25 -46.37 79.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.902 0.881 . . . . 0.0 110.788 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -58.34 -45.3 88.4 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -61.73 -54.33 43.92 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 124.701 1.251 . . . . 0.0 108.725 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.1 mt -53.58 -56.73 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.852 0.751 . . . . 0.0 109.958 -176.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.35 -38.22 76.75 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.0 0.52 . . . . 0.0 110.484 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.92 -48.01 69.96 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.995 0.518 . . . . 0.0 111.21 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.698 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -65.27 -47.28 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.133 0.973 . . . . 0.0 108.533 -176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.83 -50.49 37.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.383 0.673 . . . . 0.0 110.402 -175.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.29 113.69 0.73 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 171.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -72.15 4.08 3.55 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.357 2.705 . . . . 0.0 112.69 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.89 -34.4 66.66 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.022 1.329 . . . . 0.0 109.228 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.86 -21.33 4.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.558 1.543 . . . . 0.0 111.814 -169.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -94.04 141.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 120.659 1.572 . . . . 0.0 109.028 173.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 m -130.44 128.23 40.87 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.31 1.044 . . . . 0.0 110.006 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 mt -70.41 148.66 48.12 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.932 0.893 . . . . 0.0 112.163 174.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -145.25 109.7 4.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.094 1.758 . . . . 0.0 107.41 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -83.82 112.11 19.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.9 mt -66.16 -10.53 42.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -58.06 -29.11 65.13 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.19 0.905 . . . . 0.0 111.542 169.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -130.34 -34.37 1.62 Allowed 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.573 1.149 . . . . 0.0 112.08 -172.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -82.26 140.27 33.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m -84.01 139.98 39.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.97 -4.46 15.18 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 CA-C-N 121.087 1.424 . . . . 0.0 111.643 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -54.16 -36.96 63.91 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.08 1.764 . . . . 0.0 111.524 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.0 -20.59 66.24 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.224 -0.923 . . . . 0.0 113.449 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -11.9 26.1 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.329 1.052 . . . . 0.0 112.185 169.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -74.57 -25.7 59.46 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.866 -1.146 . . . . 0.0 110.961 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -76.79 -51.57 11.12 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.183 0.901 . . . . 0.0 110.195 -172.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -66.72 142.13 57.51 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.288 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.44 -27.56 61.49 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 110.694 -175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.2 t -141.26 144.27 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -169.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -135.33 152.77 51.78 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 118.546 0.612 . . . . 0.0 110.293 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -128.88 121.32 54.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -120.72 137.8 54.3 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.145 0.978 . . . . 0.0 108.473 -172.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -128.67 117.71 2.57 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-O 117.543 -1.698 . . . . 0.0 111.85 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -118.14 127.69 26.45 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 119.476 1.638 . . . . 0.0 111.405 176.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -82.47 145.45 13.27 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 121.818 1.679 . . . . 0.0 108.16 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.1 m -89.6 137.43 32.33 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -133.02 173.37 11.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.884 2.074 . . . . 0.0 109.406 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.7 t0 36.13 51.49 0.79 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.331 2.252 . . . . 0.0 114.47 169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 56.05 80.71 0.14 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.271 1.429 . . . . 0.0 112.483 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 75.25 10.27 84.31 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 172.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -91.33 163.88 14.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.708 1.603 . . . . 0.0 110.509 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.4 mt -89.84 152.68 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -68.47 144.44 54.66 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 170.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.39 -29.62 70.88 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.185 0.594 . . . . 0.0 112.193 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -67.59 -23.6 65.4 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.943 -0.473 . . . . 0.0 111.169 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.459 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.9 m95 -86.12 -41.98 14.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.301 1.04 . . . . 0.0 110.937 170.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -55.72 -34.66 65.32 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.586 0.63 . . . . 0.0 111.016 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.27 -30.36 70.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.752 1.221 . . . . 0.0 111.874 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.19 -12.97 10.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.605 ' CH2' HD13 ' A' ' 104' ' ' LEU . 2.9 t-105 -53.31 -29.42 33.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.007 1.323 . . . . 0.0 111.801 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.27 -43.33 70.69 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.147 1.379 . . . . 0.0 111.387 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.23 -31.23 70.58 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.936 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.1 mt -56.59 -31.03 63.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.936 1.244 . . . . 0.0 111.074 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.73 -28.49 65.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.665 0.786 . . . . 0.0 111.545 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.9 -24.97 32.91 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.417 0.687 . . . . 0.0 111.038 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 mt -72.95 158.62 35.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 123.046 1.403 . . . . 0.0 112.679 -167.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -91.53 95.98 10.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.549 174.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.7 mt -118.23 8.09 12.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.61 121.21 13.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.4 8.05 88.04 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 125.284 1.421 . . . . 0.0 114.495 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -76.2 147.89 38.08 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 117.743 0.771 . . . . 0.0 109.203 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.746 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.3 mt -86.64 138.41 19.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 167.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -131.98 129.63 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.765 1.226 . . . . 0.0 108.589 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.69 117.61 34.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 167.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.5 mt -90.92 141.38 28.89 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.941 0.791 . . . . 0.0 111.93 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -137.85 161.91 35.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.673 1.189 . . . . 0.0 108.894 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.25 174.72 36.2 Favored Glycine 0 N--CA 1.45 -0.367 0 O-C-N 121.295 -0.878 . . . . 0.0 112.389 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.0 mt -124.21 148.5 47.24 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.396 1.079 . . . . 0.0 108.755 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.45 27.94 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 123.332 0.492 . . . . 0.0 112.241 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -133.45 112.69 11.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.44 HE22 ' HG2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -83.18 -29.44 28.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.459 0.171 . . . . 0.0 111.271 -172.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.96 -46.25 58.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.148 0.579 . . . . 0.0 110.395 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.08 -34.65 12.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.04 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -130.39 28.95 4.91 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.54 -34.34 60.03 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 120.33 1.423 . . . . 0.0 112.411 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -59.2 -24.32 63.01 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.063 0.932 . . . . 0.0 112.369 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -113.15 -47.5 3.02 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 125.521 1.528 . . . . 0.0 110.089 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.265 1.6 t80 43.97 -131.36 0.77 Allowed 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 128.478 2.711 . . . . 0.0 109.514 -172.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -60.58 39.38 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 130.697 3.599 . . . . 0.0 113.787 174.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 5.9 t70 -58.14 -43.05 87.09 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 119.437 -2.039 . . . . 0.0 111.123 -172.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.98 -32.1 71.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 110.946 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 15.0 tp -63.13 -47.39 82.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.478 0.711 . . . . 0.0 110.189 176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.53 -43.27 99.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.1 mtm -62.97 -48.15 80.12 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 117.556 0.678 . . . . 0.0 111.757 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.605 HD13 ' CH2' ' A' ' 69' ' ' TRP . 13.0 tp -67.06 -30.86 71.04 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.651 -0.656 . . . . 0.0 111.201 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -60.83 -46.29 91.12 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.3 0.5 . . . . 0.0 109.826 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.72 -41.2 92.54 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.448 1.099 . . . . 0.0 111.657 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 7.0 tptt -55.6 -62.27 1.79 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 124.553 1.141 . . . . 0.0 107.936 175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 67.5 mt -71.16 -21.04 62.23 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.536 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.7 t -61.65 -29.4 70.04 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.649 1.113 . . . . 0.0 110.729 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.48 -22.1 54.96 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.819 -1.176 . . . . 0.0 109.799 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.73 1.61 37.87 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.636 1.574 . . . . 0.0 112.541 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.32 33.66 68.62 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.477 0.58 . . . . 0.0 111.842 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -84.25 170.93 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 123.622 0.769 . . . . 0.0 109.319 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -117.26 143.14 46.22 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -110.33 148.05 32.71 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 119.56 1.073 . . . . 0.0 111.899 -170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 18.3 m -128.42 178.17 5.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.664 1.185 . . . . 0.0 108.439 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.78 34.21 39.62 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 118.52 -1.155 . . . . 0.0 114.368 172.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -71.95 155.72 40.05 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.613 1.707 . . . . 0.0 107.948 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.45 142.05 33.48 Favored Pre-proline 0 CA--C 1.514 -0.437 0 CA-C-O 116.939 -1.505 . . . . 0.0 109.227 176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.45 143.08 56.31 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.038 1.406 . . . . 0.0 109.618 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.521 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 73.9 p -74.69 -0.01 16.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.899 1.68 . . . . 0.0 113.776 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -60.27 146.33 44.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.04 0.936 . . . . 0.0 109.948 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.29 22.83 75.28 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.216 0.913 . . . . 0.0 112.967 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -144.15 152.45 40.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.296 1.838 . . . . 0.0 109.459 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -122.75 133.13 54.48 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 128.732 2.813 . . . . 0.0 104.682 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.4 p90 -163.01 -53.88 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 118.752 0.705 . . . . 0.0 109.454 -170.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.361 3.1 t 61.66 8.12 2.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.066 2.547 . . . . 0.0 114.939 176.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.2 t -67.85 138.13 92.8 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -84.7 -10.56 8.42 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 123.251 2.634 . . . . 0.0 112.77 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.3 tptt -78.42 -49.93 1.72 Allowed Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -88.46 39.84 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.381 2.054 . . . . 0.0 112.593 -169.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.11 148.43 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.509 1.124 . . . . 0.0 109.612 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.02 -171.98 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 C-N-CA 126.369 1.867 . . . . 0.0 109.861 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.39 -116.11 0.86 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.203 1.401 . . . . 0.0 107.443 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.55 8.34 33.28 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.059 1.344 . . . . 0.0 112.222 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.99 21.12 19.13 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.76 1.171 . . . . 0.0 112.506 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -100.69 -18.32 16.57 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 124.793 1.237 . . . . 0.0 110.8 -172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.14 144.23 51.24 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.887 0.475 . . . . 0.0 110.876 172.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.3 m-85 -77.78 156.58 30.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 124.773 1.229 . . . . 0.0 109.055 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 101' ' ' LEU . 17.7 m -65.2 -18.11 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.478 0.711 . . . . 0.0 112.108 174.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.07 -178.76 39.66 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.403 1.001 . . . . 0.0 111.114 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.23 128.26 35.5 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 171.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.15 125.5 53.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.1 mt -121.99 150.23 42.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.65 132.4 38.91 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -111.57 10.67 21.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.705 -170.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.258 0.5 OUTLIER -108.21 -31.17 8.01 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 176.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -136.14 -27.33 1.11 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.096 0.862 . . . . 0.0 113.267 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.44 ' HG2' HE22 ' A' ' 90' ' ' GLN . 46.2 mm-40 -89.5 12.08 17.57 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.914 172.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -57.69 -21.77 42.38 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.874 1.215 . . . . 0.0 113.475 -170.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -87.54 -19.29 28.09 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.647 0.779 . . . . 0.0 112.141 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 30.0 mt -113.49 -24.48 9.25 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 126.702 2.001 . . . . 0.0 111.4 -167.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.5 p -51.43 -35.77 40.88 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 113.62 -1.627 . . . . 0.0 108.366 167.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.42 -46.96 80.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.395 0.678 . . . . 0.0 110.26 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -69.88 -29.63 66.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.547 0.339 . . . . 0.0 111.744 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -78.97 -28.11 43.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.704 0.802 . . . . 0.0 110.039 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 33.4 mt -66.05 -54.26 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.698 ' HA ' HD13 ' A' ' 24' ' ' ILE . 3.6 pt20 -56.97 -44.77 82.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.588 0.755 . . . . 0.0 112.257 -176.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 19.4 p -67.19 -35.64 80.06 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.933 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -64.63 -45.12 88.21 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.844 0.83 . . . . 0.0 109.553 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.7 m -57.53 -35.42 70.26 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.134 176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -34.7 77.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.83 0.452 . . . . 0.0 110.273 -175.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -79.24 -46.27 18.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.373 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.513 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -65.18 -38.61 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 120.858 1.663 . . . . 0.0 110.002 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.1 pp -65.28 -14.3 60.41 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.286 0.494 . . . . 0.0 112.016 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -95.03 -46.14 6.95 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.83 1.252 . . . . 0.0 107.871 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.46 -36.02 77.25 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.841 0.746 . . . . 0.0 110.209 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.746 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.1 mtm -77.67 -44.19 28.84 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 124.329 1.052 . . . . 0.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.6 -42.45 78.18 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.819 0.848 . . . . 0.0 111.052 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -70.18 -31.11 68.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.91 1.284 . . . . 0.0 109.791 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -41.91 97.18 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 123.297 0.639 . . . . 0.0 110.487 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -1.25 56.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.901 1.681 . . . . 0.0 113.919 -173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.318 179.239 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.2 143.86 30.17 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.0 mtm -132.12 146.51 52.09 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.773 2.029 . . . . 0.0 108.187 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.75 118.42 4.94 Favored Glycine 0 CA--C 1.518 0.268 0 CA-C-O 118.622 -1.099 . . . . 0.0 110.51 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.93 111.54 22.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.986 1.393 . . . . 0.0 108.885 169.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -110.88 146.44 36.5 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.988 1.315 . . . . 0.0 111.047 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -161.91 174.88 12.49 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.315 1.046 . . . . 0.0 110.234 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.2 10.2 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.578 -2.609 . . . . 0.0 106.578 169.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.4 p -146.38 122.47 10.78 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.326 1.063 . . . . 0.0 111.614 -169.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.1 m -80.83 -37.87 29.28 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.205 0.457 . . . . 0.0 111.638 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.9 p -107.93 8.55 28.55 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.866 1.266 . . . . 0.0 112.092 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 46.7 m 65.35 11.71 7.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.85 2.06 . . . . 0.0 114.192 -171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -66.63 -46.94 74.2 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.318 -1.489 . . . . 0.0 111.224 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.6 -33.44 75.93 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.88 -46.56 87.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.398 0.679 . . . . 0.0 110.312 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.4 mtm -65.49 -43.37 90.38 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.774 -0.578 . . . . 0.0 111.384 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.55 -39.81 89.29 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 122.005 -0.434 . . . . 0.0 110.886 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.74 81.68 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.206 1.002 . . . . 0.0 110.53 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.5 -44.77 85.23 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -62.93 -53.88 47.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.721 1.263 . . . . 0.0 108.997 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 5.9 mt -53.55 -56.82 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.724 0.693 . . . . 0.0 109.768 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -38.49 78.63 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.574 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -66.57 -47.78 71.72 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.004 0.522 . . . . 0.0 111.121 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.733 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.2 mt -65.27 -48.0 85.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.682 1.193 . . . . 0.0 108.697 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 164' ' ' ILE . 77.0 mt -71.96 -50.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.502 0.721 . . . . 0.0 110.54 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.59 114.34 0.75 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.5 1.048 . . . . 0.0 110.707 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.39 3.76 3.92 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.625 2.883 . . . . 0.0 112.677 178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -73.49 -34.12 65.15 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.206 1.403 . . . . 0.0 109.226 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.56 -22.53 3.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.4 1.48 . . . . 0.0 111.824 -169.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.6 141.4 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 120.333 1.424 . . . . 0.0 108.752 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 m -129.17 129.58 45.28 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.539 1.136 . . . . 0.0 110.022 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.05 146.28 45.97 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.299 1.039 . . . . 0.0 112.068 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -144.09 107.97 4.7 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.616 1.567 . . . . 0.0 107.313 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -83.29 112.42 19.87 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.31 -8.95 20.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.94 0.896 . . . . 0.0 113.155 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.7 pttt -58.91 -29.14 66.83 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.209 0.913 . . . . 0.0 111.753 168.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -130.82 -34.25 1.52 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.714 1.206 . . . . 0.0 111.842 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -82.16 141.78 32.77 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.982 0.913 . . . . 0.0 108.756 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.0 m -81.35 147.97 61.7 Favored Pre-proline 0 N--CA 1.45 -0.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 172.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -78.19 -2.95 13.0 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.177 1.251 . . . . 0.0 111.36 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -55.75 -35.3 66.03 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 122.101 2.228 . . . . 0.0 112.011 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -20.09 66.1 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.414 ' CG ' HD13 ' A' ' 49' ' ' LEU . 49.7 ttm -59.28 -15.51 16.21 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.674 1.99 . . . . 0.0 111.477 171.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -73.2 -30.83 63.8 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.194 -0.941 . . . . 0.0 110.913 174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -76.01 -46.28 30.24 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.976 0.807 . . . . 0.0 110.834 -169.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.98 141.87 56.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.1 -168.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -74.54 -19.96 60.15 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.318 0.647 . . . . 0.0 110.509 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.7 t -145.41 148.7 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 43' ' ' MET . 11.2 mt -138.27 150.3 46.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.99 0.916 . . . . 0.0 109.183 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.5 120.65 51.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -119.7 132.59 55.7 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.89 118.33 3.67 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-O 117.541 -1.699 . . . . 0.0 112.757 -174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -119.35 126.01 27.24 Favored Pre-proline 0 N--CA 1.472 0.625 0 CA-C-N 119.608 1.704 . . . . 0.0 111.45 178.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -80.27 144.82 16.63 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.351 2.701 . . . . 0.0 108.987 167.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 m -94.96 131.54 40.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -121.91 171.33 9.0 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.524 1.93 . . . . 0.0 109.442 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 20.12 67.52 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.921 2.888 . . . . 0.0 115.459 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 54.0 70.05 0.65 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.689 1.196 . . . . 0.0 112.112 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 21.11 79.65 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 115.165 0.826 . . . . 0.0 115.165 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.305 0.4 OUTLIER -88.34 156.4 19.19 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 166.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.8 mt -90.21 150.36 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 tm0? -55.34 139.59 42.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.181 0.991 . . . . 0.0 108.545 171.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.63 -28.22 69.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -78.47 -19.51 52.95 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.726 -0.609 . . . . 0.0 110.434 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.508 ' CD1' HG22 ' A' ' 53' ' ' ILE . 14.0 m95 -81.08 -43.06 20.04 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.377 0.671 . . . . 0.0 111.192 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -54.26 -33.44 58.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.531 0.605 . . . . 0.0 111.008 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.72 -30.24 71.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.252 1.021 . . . . 0.0 112.33 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.86 -8.92 12.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.558 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 7.9 t-105 -53.2 -28.96 29.35 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.31 1.444 . . . . 0.0 111.902 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -67.72 -44.71 76.99 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.992 1.317 . . . . 0.0 111.635 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -68.58 -29.01 67.46 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 117.998 -1.001 . . . . 0.0 112.05 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.8 mt -57.75 -29.84 65.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.865 1.211 . . . . 0.0 111.114 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -70.33 -29.47 66.18 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.515 0.726 . . . . 0.0 111.452 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -80.87 -24.62 38.2 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.391 0.676 . . . . 0.0 111.366 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.7 mt -72.4 159.91 33.21 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 122.808 1.289 . . . . 0.0 112.998 -168.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -93.4 92.31 7.59 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 126.663 1.985 . . . . 0.0 108.539 171.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -113.5 10.15 18.14 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.66 126.43 28.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.98 21.66 79.01 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.818 1.199 . . . . 0.0 115.678 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.21 155.8 21.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.802 1.301 . . . . 0.0 108.828 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.637 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.7 mt -87.25 145.79 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.7 t -132.01 130.2 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 125.046 1.338 . . . . 0.0 109.29 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.511 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -108.86 118.07 35.84 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 166.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 mt -90.45 141.73 28.45 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.227 0.921 . . . . 0.0 111.554 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -136.78 160.58 38.43 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.205 1.002 . . . . 0.0 108.43 168.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.13 170.81 36.29 Favored Glycine 0 N--CA 1.446 -0.641 0 O-C-N 121.005 -1.06 . . . . 0.0 111.82 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.8 mt -129.32 153.14 48.13 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.42 -154.87 11.35 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -149.77 137.52 20.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.101 1.36 . . . . 0.0 108.074 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.613 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -90.62 -22.83 21.03 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.306 1.443 . . . . 0.0 113.44 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.7 mt -76.28 -39.55 53.96 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.054 1.297 . . . . 0.0 111.627 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.42 -26.28 16.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.418 1.008 . . . . 0.0 112.232 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.36 35.46 2.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -167.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.66 52.54 Favored Glycine 0 N--CA 1.469 0.893 0 CA-C-N 120.186 1.357 . . . . 0.0 110.973 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.6 mp0 -62.71 -15.02 50.86 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.067 0.947 . . . . 0.0 112.133 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -126.22 8.89 7.28 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.351 1.86 . . . . 0.0 112.128 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -48.93 124.86 9.33 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.496 1.518 . . . . 0.0 109.389 172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.17 28.63 9.29 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 124.182 0.993 . . . . 0.0 112.855 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.1 -36.89 82.91 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 120.444 -1.41 . . . . 0.0 110.684 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.38 -33.42 72.44 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.044 0.538 . . . . 0.0 111.325 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.68 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -60.41 -48.11 83.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.016 0.926 . . . . 0.0 110.535 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.45 98.13 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mtm -65.16 -44.54 88.22 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 117.849 0.825 . . . . 0.0 112.101 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.558 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.3 mt -65.29 -35.31 80.61 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.365 0.984 . . . . 0.0 111.169 174.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -62.94 -42.14 99.72 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.656 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.12 -43.1 88.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.623 1.169 . . . . 0.0 111.665 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.29 -59.11 5.11 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.848 1.259 . . . . 0.0 108.4 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.7 mt -76.69 -22.19 54.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.241 -169.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.8 t -62.02 -28.77 69.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.975 0.807 . . . . 0.0 110.534 169.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.92 -24.36 44.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.588 -1.32 . . . . 0.0 109.495 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -80.57 -0.95 39.98 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.409 1.484 . . . . 0.0 112.489 177.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.1 59.95 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.814 0.734 . . . . 0.0 111.895 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.57 172.1 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.764 0.782 . . . . 0.0 109.696 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -118.09 145.41 44.86 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.89 151.71 33.52 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 120.289 1.404 . . . . 0.0 112.994 -168.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.5 m -131.67 -178.97 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.821 1.248 . . . . 0.0 109.46 169.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.0 35.76 29.92 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.202 -1.332 . . . . 0.0 115.091 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -75.49 152.32 37.88 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.909 1.854 . . . . 0.0 109.008 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.31 148.15 69.02 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 117.16 -1.4 . . . . 0.0 109.088 172.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.87 140.02 41.24 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 CA-C-N 121.11 1.432 . . . . 0.0 110.429 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.556 HG22 ' CD1' ' A' ' 139' ' ' PHE . 66.6 p -76.2 -4.05 39.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.364 1.866 . . . . 0.0 113.296 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.17 141.42 57.49 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.151 -0.968 . . . . 0.0 109.716 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.49 -9.54 61.52 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.445 1.497 . . . . 0.0 113.677 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.28 156.16 16.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 118.896 1.348 . . . . 0.0 110.986 173.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -125.52 126.29 44.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.457 ' O ' HG22 ' A' ' 127' ' ' THR . 11.9 p90 -161.75 -58.76 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -169.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 126' ' ' PHE 0.328 1.9 t 58.64 11.71 1.88 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.103 2.561 . . . . 0.0 114.609 179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.5 p -66.56 133.28 94.25 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.864 -1.148 . . . . 0.0 107.908 167.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.13 -14.26 5.07 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.16 1.907 . . . . 0.0 113.326 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -80.6 -47.41 1.24 Allowed Pre-proline 0 CA--C 1.536 0.426 0 CA-C-O 117.756 -1.116 . . . . 0.0 114.007 -169.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.15 39.37 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.078 1.852 . . . . 0.0 112.428 -168.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.08 145.37 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 121.148 -0.97 . . . . 0.0 109.333 -167.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -172.55 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 C-N-CA 126.069 1.748 . . . . 0.0 109.968 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.08 -116.52 0.84 Allowed 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.054 1.342 . . . . 0.0 107.434 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -105.21 8.0 33.82 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.828 1.251 . . . . 0.0 111.885 176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.42 20.3 20.43 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.129 1.347 . . . . 0.0 112.803 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.25 -16.83 17.59 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.877 1.271 . . . . 0.0 110.944 -172.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 144.53 50.44 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.279 0.631 . . . . 0.0 111.186 173.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.556 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.2 m-85 -78.78 154.37 30.01 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.698 1.599 . . . . 0.0 109.676 175.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.86 -14.32 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.591 1.157 . . . . 0.0 112.707 173.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -168.45 -179.62 40.89 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 119.69 1.132 . . . . 0.0 111.968 -170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 14.5 tp -65.7 129.78 40.97 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.09 124.15 48.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.71 160.16 32.52 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.981 0.912 . . . . 0.0 108.879 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.584 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.13 124.93 31.79 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -105.29 10.24 33.65 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.439 1.087 . . . . 0.0 110.779 -172.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -25.65 11.37 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.207 1.003 . . . . 0.0 110.862 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.06 -46.93 1.93 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.703 1.138 . . . . 0.0 111.169 174.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 145' ' ' ASP . 35.6 mt-30 -89.74 15.35 9.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -53.67 -22.05 8.16 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -82.71 -26.55 31.91 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.258 1.023 . . . . 0.0 111.291 -175.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -116.14 -13.73 11.16 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.293 -173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.7 p -57.3 -27.41 62.13 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.129 1.331 . . . . 0.0 112.381 -171.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -52.76 -39.1 61.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.781 1.632 . . . . 0.0 111.788 173.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.36 -30.47 68.49 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.701 1.6 . . . . 0.0 111.003 -177.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -92.46 -18.16 23.59 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.037 1.335 . . . . 0.0 110.484 -173.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.4 mt -70.84 -60.39 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 170.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.733 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.6 pt20 -51.82 -44.8 63.67 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.128 -175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 p -67.59 -35.22 78.57 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.077 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 37.7 t90 -65.35 -44.87 86.33 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 122.026 0.917 . . . . 0.0 109.656 175.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 96.6 m -57.82 -35.9 71.49 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.808 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -70.74 -29.78 66.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.404 0.547 . . . . 0.0 111.173 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -79.07 -45.76 19.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 117.901 -1.047 . . . . 0.0 110.931 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 25' ' ' ILE . 5.2 pt -64.89 -39.27 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 120.865 1.666 . . . . 0.0 109.862 -171.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.49 -14.64 58.17 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.2 0.6 . . . . 0.0 111.984 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -96.2 -45.94 6.65 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.64 -42.47 88.37 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 118.968 0.804 . . . . 0.0 109.387 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.637 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.3 mtm -77.29 -35.51 55.02 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.706 0.802 . . . . 0.0 110.716 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.32 -48.4 56.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.351 1.06 . . . . 0.0 109.678 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.49 -31.15 72.07 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.216 1.406 . . . . 0.0 109.951 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -63.96 -49.04 74.13 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.487 0.585 . . . . 0.0 110.447 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.23 -3.84 44.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.586 179.325 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 140.23 30.0 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 168.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.4 mtm -123.13 148.67 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.574 2.349 . . . . 0.0 108.386 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.29 118.47 4.69 Favored Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.48 114.44 25.1 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 118.944 1.372 . . . . 0.0 108.754 170.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -109.15 146.32 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.635 1.574 . . . . 0.0 110.535 172.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.01 172.74 16.35 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.189 0.996 . . . . 0.0 109.814 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.72 140.56 9.3 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 169.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -153.3 164.66 37.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.11 0.955 . . . . 0.0 112.007 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.2 m -132.08 -41.32 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.192 1.397 . . . . 0.0 110.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.2 p -76.5 -15.52 59.87 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.502 0.721 . . . . 0.0 110.551 169.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.261 57.5 m 73.57 16.15 3.99 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 127.479 2.311 . . . . 0.0 113.831 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -63.24 -43.6 97.57 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.371 -1.456 . . . . 0.0 110.584 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -33.72 73.24 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.45 -47.38 84.28 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.454 0.702 . . . . 0.0 109.644 175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 77.5 mtm -65.51 -39.54 91.97 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 118.186 0.448 . . . . 0.0 111.145 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.64 93.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.77 -0.633 . . . . 0.0 110.846 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.43 79.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.038 0.935 . . . . 0.0 110.674 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -57.2 -44.95 84.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.34 -56.46 16.19 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 124.804 1.315 . . . . 0.0 108.94 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.2 mt -51.88 -56.24 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 118.274 0.488 . . . . 0.0 110.099 -176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.24 -36.4 73.14 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.877 0.871 . . . . 0.0 111.122 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.32 -45.74 62.28 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 122.682 0.393 . . . . 0.0 111.084 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.67 -47.11 87.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.292 1.037 . . . . 0.0 108.802 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 164' ' ' ILE . 72.8 mt -73.34 -50.47 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.539 0.736 . . . . 0.0 110.279 -174.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.36 112.25 0.41 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.79 -4.29 12.0 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.443 2.762 . . . . 0.0 112.29 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.1 -33.68 59.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.057 1.743 . . . . 0.0 109.387 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.44 -21.42 4.18 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.708 1.603 . . . . 0.0 111.417 -169.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.82 139.17 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 120.397 1.453 . . . . 0.0 109.108 174.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.4 m -128.25 129.09 45.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.606 1.163 . . . . 0.0 110.056 177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.4 mt -73.66 147.9 43.27 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.726 1.21 . . . . 0.0 112.049 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.09 111.94 5.89 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.987 1.715 . . . . 0.0 107.121 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.14 109.98 19.82 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.5 -7.57 26.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -172.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 pttt -62.43 -26.49 68.53 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.597 1.09 . . . . 0.0 111.669 169.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -132.83 -33.59 1.18 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 112.184 -171.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -84.04 141.16 31.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.49 1.116 . . . . 0.0 108.286 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.2 m -86.73 141.64 33.97 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -71.86 -4.24 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.079 1.853 . . . . 0.0 111.186 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -54.97 -35.76 64.63 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 120.347 1.43 . . . . 0.0 112.179 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.71 -20.58 66.0 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 175.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -65.34 -10.96 37.35 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 112.539 169.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.02 -30.19 68.52 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.514 1.052 . . . . 0.0 110.159 169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.62 -51.46 9.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.422 0.63 . . . . 0.0 110.295 -172.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -64.99 143.55 57.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.616 -169.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -76.15 -24.49 54.83 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.543 0.687 . . . . 0.0 110.766 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.8 t -145.18 139.18 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -169.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 153.49 43.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 118.612 0.642 . . . . 0.0 110.875 174.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 125.41 67.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -123.32 136.55 54.73 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.947 0.899 . . . . 0.0 109.886 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.05 116.52 2.99 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 117.006 -1.996 . . . . 0.0 111.689 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.585 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.51 130.1 24.9 Favored Pre-proline 0 N--CA 1.474 0.735 0 CA-C-N 120.229 2.014 . . . . 0.0 112.409 170.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.83 141.69 10.88 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.453 2.102 . . . . 0.0 107.792 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.4 m -89.45 124.35 34.41 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -115.24 174.7 5.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.526 1.93 . . . . 0.0 109.351 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 31.06 55.64 0.22 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.085 2.554 . . . . 0.0 115.253 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 55.69 78.84 0.18 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.71 1.204 . . . . 0.0 112.71 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 99' ' ' ASP . . . 76.09 9.85 85.37 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.287 0.875 . . . . 0.0 115.287 173.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.86 159.67 17.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.15 1.38 . . . . 0.0 110.803 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -91.05 152.9 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.04 144.5 55.08 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -61.68 -28.88 69.71 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.113 0.965 . . . . 0.0 112.4 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.75 -30.8 71.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.262 0.625 . . . . 0.0 111.012 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.441 ' CD1' HG22 ' A' ' 53' ' ' ILE . 6.4 m95 -79.98 -43.49 21.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 110.195 173.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.46 -34.39 61.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.28 0.632 . . . . 0.0 111.024 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.38 72.55 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.379 1.072 . . . . 0.0 112.174 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.27 -10.41 9.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.513 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 6.9 t-105 -53.37 -27.73 25.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.505 1.522 . . . . 0.0 112.166 -178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.23 -45.56 66.27 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.209 1.404 . . . . 0.0 111.524 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -64.91 -33.05 75.1 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 117.892 -1.051 . . . . 0.0 111.929 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 44.3 mt -57.63 -31.68 66.5 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.725 1.148 . . . . 0.0 111.393 -175.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.29 -27.49 61.58 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.345 0.658 . . . . 0.0 111.178 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -85.64 -19.29 31.18 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.832 0.853 . . . . 0.0 111.482 -176.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.99 171.65 12.45 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-O 122.053 0.93 . . . . 0.0 110.721 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -109.47 112.22 24.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.22 171.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -127.02 10.3 6.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.838 0.855 . . . . 0.0 112.945 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.62 119.41 10.46 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -170.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.24 10.83 85.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 124.822 1.201 . . . . 0.0 114.148 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -79.17 149.37 32.0 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 118.002 0.901 . . . . 0.0 108.86 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.739 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.3 mt -86.38 140.35 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 168.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.52 131.38 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.785 1.234 . . . . 0.0 109.447 175.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -112.53 112.91 24.78 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 166.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.39 143.99 26.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 118.799 0.727 . . . . 0.0 111.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -141.87 164.22 30.77 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.948 1.299 . . . . 0.0 109.03 171.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.48 38.88 Favored Glycine 0 N--CA 1.447 -0.629 0 O-C-N 121.195 -0.94 . . . . 0.0 113.218 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -128.56 153.76 46.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.893 1.277 . . . . 0.0 108.437 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.71 -153.9 9.17 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.07 138.83 10.56 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 126.75 2.02 . . . . 0.0 107.775 168.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -89.39 -21.74 22.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.864 1.265 . . . . 0.0 114.267 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.51 -48.11 65.23 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.756 1.162 . . . . 0.0 110.664 -173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.93 -26.27 19.88 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.034 0.826 . . . . 0.0 112.33 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -130.92 27.75 4.87 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.26 -30.44 58.11 Favored Glycine 0 N--CA 1.473 1.128 0 CA-C-N 121.116 1.78 . . . . 0.0 112.524 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -63.12 -15.92 58.3 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.033 -1.275 . . . . 0.0 113.222 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -125.16 -49.65 1.7 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.745 1.618 . . . . 0.0 111.433 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . 0.261 2.0 t80 43.82 -133.59 0.61 Allowed 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 128.204 2.602 . . . . 0.0 109.844 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.98 40.92 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.816 3.646 . . . . 0.0 113.188 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 59' ' ' GLY . 6.6 t70 -58.75 -43.08 90.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 119.554 -1.966 . . . . 0.0 111.42 -169.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.72 71.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.276 0.63 . . . . 0.0 110.584 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.585 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -62.75 -47.98 81.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.649 0.78 . . . . 0.0 110.384 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.71 -40.44 99.19 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 42.6 mtm -62.0 -46.3 89.81 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 117.765 0.782 . . . . 0.0 111.218 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.513 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -67.99 -31.43 71.13 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.735 -0.603 . . . . 0.0 111.7 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.36 -49.97 75.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.011 0.434 . . . . 0.0 109.927 176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -65.45 -40.17 92.92 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.419 1.088 . . . . 0.0 111.27 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 72' ' ' LEU . 17.9 tptt -54.2 -58.8 6.0 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.397 1.479 . . . . 0.0 108.444 173.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.9 -18.59 55.97 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.544 -0.723 . . . . 0.0 110.672 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -60.91 -26.93 67.82 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 118.985 0.811 . . . . 0.0 110.557 168.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -24.19 45.2 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.771 -1.206 . . . . 0.0 109.849 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -82.94 1.66 38.49 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.576 1.55 . . . . 0.0 112.627 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.06 34.27 70.33 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 118.633 0.651 . . . . 0.0 111.982 172.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -83.53 171.24 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 117.823 0.812 . . . . 0.0 109.89 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -116.23 140.6 49.14 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 169.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -108.53 147.6 31.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 119.55 1.068 . . . . 0.0 111.756 -170.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 14.3 m -128.75 179.07 4.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 108.982 169.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.25 33.52 44.23 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-O 118.65 -1.084 . . . . 0.0 114.344 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -71.17 149.69 46.1 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.589 1.694 . . . . 0.0 108.044 169.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.37 135.65 27.75 Favored Pre-proline 0 CA--C 1.516 -0.334 0 CA-C-O 116.917 -1.516 . . . . 0.0 108.578 176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -66.63 138.76 50.67 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 CA-C-N 121.36 1.521 . . . . 0.0 109.776 169.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.441 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 67.3 p -75.25 -4.2 37.62 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.522 1.929 . . . . 0.0 113.191 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.09 139.87 57.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.056 -1.028 . . . . 0.0 109.885 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.18 -7.78 66.2 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.768 1.651 . . . . 0.0 114.023 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -92.5 163.19 13.92 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.179 1.49 . . . . 0.0 110.717 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -129.17 130.39 46.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -166.43 -52.98 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.477 1.035 . . . . 0.0 109.914 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.326 3.1 t 57.45 10.64 1.0 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.237 2.615 . . . . 0.0 114.536 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 141.81 88.0 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.509 1.523 . . . . 0.0 109.783 174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -88.24 -13.37 3.66 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.214 1.943 . . . . 0.0 114.114 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -80.0 -50.33 1.2 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.87 38.65 0.5 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.0 1.8 . . . . 0.0 112.827 -168.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 149.63 19.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 120.942 -1.099 . . . . 0.0 109.963 -166.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -172.28 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 125.906 1.683 . . . . 0.0 110.005 175.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.6 -116.89 0.89 Allowed 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.65 8.0 32.92 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.016 1.326 . . . . 0.0 112.161 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.61 20.35 19.79 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.613 1.102 . . . . 0.0 112.591 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -100.15 -16.97 17.63 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 124.735 1.214 . . . . 0.0 110.713 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.02 142.45 49.58 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.445 0.698 . . . . 0.0 110.404 172.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 60.0 m-85 -77.47 157.7 30.34 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 124.863 1.265 . . . . 0.0 108.725 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.453 HG23 ' HG ' ' A' ' 101' ' ' LEU . 15.9 m -65.19 -18.69 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.915 173.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.04 -179.83 40.31 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 119.604 1.093 . . . . 0.0 112.066 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.483 HD11 HD21 ' A' ' 144' ' ' LEU . 12.8 tp -61.01 129.26 40.53 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -121.03 119.13 31.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 142' ' ' LEU . 85.9 mt -117.15 156.61 27.35 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.134 0.974 . . . . 0.0 109.223 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.423 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -143.97 122.15 12.21 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -97.56 18.15 16.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.843 -170.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.9 -20.92 4.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.879 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.72 -53.95 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.239 1.381 . . . . 0.0 108.547 169.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.78 17.71 17.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -169.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -52.0 -25.2 7.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.036 0.934 . . . . 0.0 112.496 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.99 -26.65 54.13 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 0.0 111.426 -176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -121.46 -8.47 9.11 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 124.111 0.965 . . . . 0.0 112.331 -172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.6 m -51.59 -34.17 35.97 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.982 1.264 . . . . 0.0 110.554 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.54 -49.14 75.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.65 0.78 . . . . 0.0 110.238 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.11 -32.12 73.04 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.27 1.028 . . . . 0.0 109.892 -172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -74.98 -29.31 60.86 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 118.256 -0.878 . . . . 0.0 108.982 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.3 mt -65.15 -58.65 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -52.44 -45.05 65.84 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.555 0.742 . . . . 0.0 110.495 -177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 21.1 m -69.69 -35.23 74.93 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.587 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.438 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 34.6 t90 -67.08 -45.32 77.64 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.628 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 86.5 m -58.73 -33.88 70.74 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.823 0.849 . . . . 0.0 109.765 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -70.88 -32.33 69.27 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -78.63 -47.41 17.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.271 -1.347 . . . . 0.0 112.257 170.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.506 HD11 HD11 ' A' ' 25' ' ' ILE . 5.5 pt -64.24 -37.19 79.28 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 121.23 1.832 . . . . 0.0 109.838 -170.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.3 -13.0 33.7 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -51.07 5.37 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.649 1.58 . . . . 0.0 107.875 169.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.93 -22.8 67.09 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.355 0.662 . . . . 0.0 111.46 -169.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.739 ' HG2' HG21 ' A' ' 81' ' ' ILE . 69.5 mtm -94.43 -44.08 8.06 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.472 1.109 . . . . 0.0 111.472 177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.09 -45.39 57.44 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.506 0.722 . . . . 0.0 110.709 -172.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.49 -27.69 66.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.897 1.279 . . . . 0.0 109.51 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -70.33 -48.27 57.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.282 1.033 . . . . 0.0 110.378 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.42 -17.23 60.23 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.791 -179.205 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -84.55 142.68 29.83 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 168.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 mtm -130.94 147.96 52.65 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.447 1.899 . . . . 0.0 108.516 -169.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.25 117.63 4.77 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-O 118.824 -0.987 . . . . 0.0 110.807 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.93 98.02 11.27 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.879 1.339 . . . . 0.0 109.548 171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -95.88 146.41 24.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.506 1.122 . . . . 0.0 110.447 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 36.3 p90 -165.36 174.6 9.92 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.686 0.794 . . . . 0.0 109.024 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -138.28 133.8 6.52 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 106.188 -2.765 . . . . 0.0 106.188 168.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.28 147.77 28.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 171.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.8 t -126.23 -27.56 3.21 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.944 1.298 . . . . 0.0 109.834 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 57.9 p -81.45 -74.28 0.34 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 169.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.0 p 175.7 -14.16 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.163 1.785 . . . . 0.0 113.839 173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -63.44 -48.2 78.74 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.646 -1.284 . . . . 0.0 114.359 -164.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -33.71 74.93 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 6.5 tt0 -62.98 -47.79 81.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.18 0.592 . . . . 0.0 110.237 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.2 mtm -64.48 -41.05 96.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 118.004 0.365 . . . . 0.0 111.444 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.45 -41.65 90.13 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.717 -0.658 . . . . 0.0 110.69 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.07 -46.76 82.25 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 123.995 0.918 . . . . 0.0 110.754 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.82 -44.96 90.97 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -62.2 -56.64 16.62 Favored 'General case' 0 CA--C 1.501 -0.935 0 O-C-N 124.616 1.198 . . . . 0.0 108.43 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.403 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 7.0 mt -51.58 -56.72 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 118.821 0.737 . . . . 0.0 109.966 -177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -38.96 71.71 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.428 0.691 . . . . 0.0 110.514 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -66.88 -46.9 73.53 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.792 0.437 . . . . 0.0 111.442 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.6 mt -65.66 -47.85 84.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.517 1.127 . . . . 0.0 108.727 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 164' ' ' ILE . 68.3 mt -72.32 -50.97 32.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 123.876 0.87 . . . . 0.0 110.309 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.28 114.92 0.7 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 170.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.86 2.83 4.34 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.374 2.716 . . . . 0.0 112.812 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.91 -34.01 66.34 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 -23.89 3.95 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.672 1.589 . . . . 0.0 111.549 -169.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 t -93.81 140.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.45 1.477 . . . . 0.0 109.278 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.7 m -129.36 128.66 43.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.689 1.195 . . . . 0.0 110.477 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.12 148.07 49.18 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.223 1.009 . . . . 0.0 112.094 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -148.87 110.26 4.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.61 1.564 . . . . 0.0 107.618 171.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -86.92 113.14 22.45 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 mt -66.23 -10.45 42.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -58.68 -26.91 64.31 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.981 0.809 . . . . 0.0 111.88 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -140.74 -28.72 0.69 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.889 0.875 . . . . 0.0 112.005 -167.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -87.63 145.36 26.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.377 1.471 . . . . 0.0 108.614 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.3 m -83.63 148.42 54.82 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.633 0.773 . . . . 0.0 108.976 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -79.27 -11.21 14.71 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.793 2.329 . . . . 0.0 111.204 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -56.68 -36.6 69.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 120.446 1.476 . . . . 0.0 111.488 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.82 -20.23 66.17 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.332 -0.855 . . . . 0.0 113.023 177.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -61.6 -13.82 25.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.403 1.081 . . . . 0.0 112.156 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.94 -26.7 60.64 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.079 -1.013 . . . . 0.0 110.897 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -76.35 -50.65 13.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.786 0.803 . . . . 0.0 110.107 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -65.29 144.03 57.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.093 1.357 . . . . 0.0 108.248 -169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -75.52 -25.13 56.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.753 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 49' ' ' LEU . 42.2 t -144.15 140.24 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -168.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -126.8 158.65 36.04 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.659 0.663 . . . . 0.0 110.757 173.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -126.23 123.31 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.9 135.65 55.14 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.832 0.853 . . . . 0.0 108.872 -172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.44 123.24 3.67 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.48 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.697 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.83 130.09 24.89 Favored Pre-proline 0 N--CA 1.47 0.552 0 CA-C-N 118.824 1.312 . . . . 0.0 110.558 177.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.24 138.31 7.6 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.289 2.659 . . . . 0.0 107.887 168.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.1 m -87.19 126.32 34.72 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -113.19 172.77 6.75 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.253 1.821 . . . . 0.0 109.89 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t0 21.94 63.73 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.241 3.017 . . . . 0.0 115.469 169.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.17 71.39 0.54 Allowed 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.713 1.205 . . . . 0.0 112.151 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.89 13.35 80.8 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -76.97 151.14 35.8 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.662 1.22 . . . . 0.0 109.302 168.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.8 mt -88.63 148.84 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -64.35 144.75 56.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.44 -27.65 68.71 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.162 -172.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -64.82 -27.75 69.09 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.806 0.842 . . . . 0.0 112.401 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.1 m95 -88.53 -40.5 13.36 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.832 1.253 . . . . 0.0 110.59 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.12 -35.83 65.07 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.726 0.694 . . . . 0.0 111.009 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.11 71.33 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.165 0.986 . . . . 0.0 112.139 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.99 -12.4 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.727 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.546 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.0 t-105 -54.85 -28.76 52.35 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.114 1.366 . . . . 0.0 111.804 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -72.51 -44.86 61.63 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.681 1.192 . . . . 0.0 110.876 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -69.24 -29.6 67.55 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.22 -1.371 . . . . 0.0 112.559 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.4 mt -55.66 -32.86 63.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.228 1.376 . . . . 0.0 110.895 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.07 -33.68 76.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.69 0.796 . . . . 0.0 111.819 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -77.99 -26.62 48.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.277 0.631 . . . . 0.0 110.767 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.4 mt -73.95 152.82 40.01 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-O 122.88 1.324 . . . . 0.0 110.511 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -85.11 103.59 14.25 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 112.589 -2.096 . . . . 0.0 108.558 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.5 mt -124.75 4.41 8.15 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.767 1.227 . . . . 0.0 113.032 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -68.48 113.14 5.76 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.05 9.74 79.86 Favored Glycine 0 CA--C 1.525 0.719 0 C-N-CA 125.34 1.447 . . . . 0.0 115.094 -176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -82.76 153.0 25.48 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 118.324 1.062 . . . . 0.0 109.914 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.713 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -87.99 141.59 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 168.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -133.53 129.1 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.163 1.385 . . . . 0.0 108.632 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -106.71 117.81 35.02 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.0 mt -89.92 142.26 27.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 119.082 0.856 . . . . 0.0 111.524 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -140.37 161.33 37.95 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.006 0.922 . . . . 0.0 108.95 169.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.04 179.53 39.58 Favored Glycine 0 N--CA 1.45 -0.415 0 O-C-N 120.841 -1.162 . . . . 0.0 112.338 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -125.46 153.96 42.72 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.014 0.925 . . . . 0.0 109.233 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.44 -157.86 13.33 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 169.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -148.88 141.94 24.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.486 1.514 . . . . 0.0 109.254 168.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.443 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.5 OUTLIER -88.96 -21.03 23.75 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.2 mt -71.79 -40.94 68.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.874 1.216 . . . . 0.0 111.804 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.91 -22.93 19.22 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 124.592 1.091 . . . . 0.0 111.512 -170.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' GLU . 47.6 m-85 -121.38 -84.8 0.66 Allowed 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 124.764 1.225 . . . . 0.0 108.071 -170.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.0 -50.27 2.64 Favored Glycine 0 N--CA 1.466 0.681 0 C-N-CA 128.237 2.827 . . . . 0.0 108.6 -168.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' TYR . 1.3 mp0 -71.74 -36.21 70.39 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 126.613 1.965 . . . . 0.0 110.169 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -106.66 1.27 24.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.334 1.054 . . . . 0.0 112.085 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.29 120.83 2.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.587 1.555 . . . . 0.0 109.009 168.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 55.46 25.7 8.06 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.13 0.972 . . . . 0.0 113.465 174.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.88 -38.57 91.4 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 120.855 -1.153 . . . . 0.0 110.743 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.61 -32.99 73.14 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.074 -0.391 . . . . 0.0 111.795 172.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.697 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.8 tp -60.75 -46.29 91.04 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.116 0.966 . . . . 0.0 110.797 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.66 -40.35 96.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.5 mtm -68.52 -43.1 77.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.875 0.837 . . . . 0.0 112.461 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.585 HD12 HD12 ' A' ' 53' ' ' ILE . 4.7 mt -63.5 -33.27 75.2 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.3 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -65.35 -42.46 92.79 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.969 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -65.33 -42.46 92.89 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.675 1.19 . . . . 0.0 111.743 175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -55.19 -59.33 4.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.619 1.168 . . . . 0.0 108.403 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.6 mt -76.95 -20.17 56.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.445 -169.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -62.31 -28.81 70.0 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.234 0.924 . . . . 0.0 110.425 168.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.09 -24.07 47.7 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.646 -1.284 . . . . 0.0 109.572 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 18.8 mmmt -80.83 3.64 21.84 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.295 1.838 . . . . 0.0 113.08 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.17 80.4 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 118.593 0.633 . . . . 0.0 111.635 170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.74 171.67 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.674 0.79 . . . . 0.0 109.046 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.3 ptpt -117.98 141.9 47.95 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.51 147.69 32.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 119.487 1.039 . . . . 0.0 111.514 -169.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.9 m -128.27 178.4 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.315 1.046 . . . . 0.0 108.802 169.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 35.94 37.57 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 118.608 -1.107 . . . . 0.0 114.286 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -77.87 152.82 33.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.667 1.733 . . . . 0.0 109.201 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -128.18 147.44 63.51 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 117.411 -1.281 . . . . 0.0 108.45 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.52 140.53 40.05 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.132 1.221 . . . . 0.0 109.651 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 139' ' ' PHE . 78.8 p -74.37 -7.73 53.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.878 1.671 . . . . 0.0 113.822 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -61.95 142.7 57.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.065 0.936 . . . . 0.0 110.273 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.93 -5.4 62.28 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.675 1.607 . . . . 0.0 114.038 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 2.0 m-30 -100.69 155.15 18.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.635 1.574 . . . . 0.0 109.904 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -124.11 126.93 47.05 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.998 1.719 . . . . 0.0 106.592 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -163.52 -53.01 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.218 0.607 . . . . 0.0 109.711 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 2.9 t 58.64 8.81 0.97 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.969 2.508 . . . . 0.0 114.616 177.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 t -68.46 139.74 92.03 Favored Pre-proline 0 CA--C 1.537 0.456 0 O-C-N 120.835 -1.166 . . . . 0.0 108.817 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -85.03 -11.3 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.9 2.4 . . . . 0.0 113.085 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -77.85 -50.61 1.88 Allowed Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -168.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -88.39 42.54 0.7 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.179 1.919 . . . . 0.0 112.163 -169.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.4 147.66 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 O-C-N 120.771 -1.206 . . . . 0.0 109.806 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 -172.47 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 C-N-CA 125.968 1.707 . . . . 0.0 110.182 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.07 -116.49 0.84 Allowed 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.1 1.36 . . . . 0.0 107.579 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.25 8.56 33.96 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.839 1.256 . . . . 0.0 111.871 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.25 21.56 19.73 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.986 1.279 . . . . 0.0 112.504 -173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -99.77 -18.32 17.27 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.693 1.197 . . . . 0.0 110.764 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.5 144.35 51.07 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.285 0.634 . . . . 0.0 111.257 174.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.5 m-85 -78.13 154.98 30.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.114 1.366 . . . . 0.0 109.826 176.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.449 HG23 ' HG ' ' A' ' 101' ' ' LEU . 16.1 m -65.61 -12.49 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.587 1.155 . . . . 0.0 112.618 175.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.84 -177.21 44.69 Favored Glycine 0 C--N 1.341 0.836 0 CA-C-N 119.763 1.165 . . . . 0.0 112.475 -172.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 160' ' ' TRP . 24.7 tp -65.77 131.26 45.87 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -118.08 112.88 20.8 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.9 mt -110.96 154.2 24.45 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.268 1.027 . . . . 0.0 109.59 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.422 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -144.47 128.27 17.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -102.5 13.79 33.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.399 1.079 . . . . 0.0 110.793 -169.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.21 -22.44 5.14 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.443 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -112.1 -49.24 2.98 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.765 1.226 . . . . 0.0 108.153 172.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.48 22.38 15.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.36 1.464 . . . . 0.0 112.809 -168.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -52.52 -26.86 14.29 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.138 0.575 . . . . 0.0 112.411 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.75 -25.19 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.43 0.692 . . . . 0.0 111.677 -174.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -125.13 -11.31 7.03 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.121 0.969 . . . . 0.0 112.153 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 28.0 m -56.94 -29.77 63.44 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.017 1.28 . . . . 0.0 109.351 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.83 -37.78 77.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 125.219 1.408 . . . . 0.0 111.882 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.8 -37.49 27.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.577 1.151 . . . . 0.0 110.039 -178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -67.89 -31.06 70.6 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.4 mt -59.33 -54.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -52.67 -47.73 66.98 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.061 1.344 . . . . 0.0 110.411 -177.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 24.3 m -66.41 -36.31 82.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.256 -177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.411 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 31.2 t90 -66.27 -44.67 82.94 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.547 0.689 . . . . 0.0 109.963 177.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.5 m -58.18 -36.1 72.57 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 123.794 0.838 . . . . 0.0 109.691 178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -69.62 -31.33 69.39 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.597 0.561 . . . . 0.0 109.854 -173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -79.59 -47.58 15.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 117.917 -1.039 . . . . 0.0 111.674 170.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.419 HD11 HD11 ' A' ' 25' ' ' ILE . 5.8 pt -64.32 -38.85 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 CA-C-N 121.018 1.735 . . . . 0.0 110.349 -169.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.94 -14.28 59.52 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.104 0.561 . . . . 0.0 111.976 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -96.23 -46.54 6.4 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -58.57 -39.5 80.46 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 123.292 0.637 . . . . 0.0 110.062 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.713 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.5 mtm -78.49 -38.3 41.17 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.621 0.768 . . . . 0.0 111.156 -176.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.07 -46.3 62.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.145 0.978 . . . . 0.0 109.96 -176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.15 -29.68 70.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 110.036 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -64.36 -47.63 78.58 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 110.58 174.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -82.34 -2.12 51.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.601 1.161 . . . . 0.0 113.649 -173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.332 -0.842 . . . . 0.0 110.49 178.738 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.604 ' SD ' HG21 ' A' ' 48' ' ' VAL . 27.2 ttm . . . . . 0 N--CA 1.501 2.079 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.58 144.24 51.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.943 2.097 . . . . 0.0 106.344 169.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 mtm -126.95 146.4 50.33 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.26 1.424 . . . . 0.0 109.822 -166.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.29 114.27 3.93 Favored Glycine 0 CA--C 1.517 0.208 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.09 101.32 13.98 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.816 1.308 . . . . 0.0 110.665 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -99.84 146.65 26.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.773 1.229 . . . . 0.0 111.57 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 15' ' ' GLU . 39.0 p90 -163.84 173.86 12.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.364 1.066 . . . . 0.0 109.61 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.23 139.85 8.66 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 106.766 -2.534 . . . . 0.0 106.766 169.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -136.83 133.18 35.59 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.763 1.225 . . . . 0.0 110.551 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.48 -42.24 13.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.806 0.843 . . . . 0.0 109.307 174.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.3 p -97.27 -84.24 0.38 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.5 p -174.83 -5.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.189 2.596 . . . . 0.0 112.104 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -67.73 -40.91 84.18 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 119.796 -1.815 . . . . 0.0 111.449 -168.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.83 -34.86 78.73 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.408 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 5.6 tt0 -64.74 -48.48 74.44 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.016 0.926 . . . . 0.0 109.918 177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.3 mtm -66.76 -36.86 83.42 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.644 -0.66 . . . . 0.0 111.452 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.99 97.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.646 -0.659 . . . . 0.0 110.69 174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.65 -45.07 85.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.544 1.137 . . . . 0.0 111.278 177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.82 -48.52 81.04 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 124.182 0.993 . . . . 0.0 109.238 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -59.71 -56.44 21.88 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.8 mt -50.35 -56.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 118.344 0.52 . . . . 0.0 110.066 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -53.78 -43.19 69.04 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.129 0.971 . . . . 0.0 110.349 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -70.91 -42.5 69.86 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.024 0.53 . . . . 0.0 111.144 -176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.8 mt -65.25 -49.83 76.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.893 1.277 . . . . 0.0 108.822 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 164' ' ' ILE . 61.0 mt -71.87 -52.0 28.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 124.143 0.977 . . . . 0.0 110.254 -173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.07 112.56 0.4 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -67.65 -3.99 11.3 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.243 2.628 . . . . 0.0 112.639 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -75.98 -34.46 59.78 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.693 1.597 . . . . 0.0 109.546 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -27.71 6.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.152 1.781 . . . . 0.0 109.99 -173.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.5 140.08 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 120.953 1.706 . . . . 0.0 109.428 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 m -132.69 129.73 39.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.28 1.7 pt? -101.39 156.78 17.25 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 119.549 1.068 . . . . 0.0 113.044 -175.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -147.93 113.93 5.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.164 1.386 . . . . 0.0 109.142 -166.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -82.9 112.38 19.64 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.74 -10.53 20.13 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.973 0.909 . . . . 0.0 113.309 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -57.88 -29.19 64.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.115 0.871 . . . . 0.0 111.798 168.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -130.05 -33.93 1.72 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.785 1.234 . . . . 0.0 111.708 -172.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -84.04 141.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.12 0.968 . . . . 0.0 108.933 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.0 m -85.09 143.15 39.25 Favored Pre-proline 0 C--O 1.225 -0.218 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.79 -6.51 18.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.781 1.654 . . . . 0.0 111.736 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -54.92 -37.4 66.35 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.781 1.628 . . . . 0.0 111.313 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.68 -21.22 66.53 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -13.65 22.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.43 1.092 . . . . 0.0 112.364 169.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -72.72 -26.0 61.42 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.89 -1.131 . . . . 0.0 110.669 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -77.6 -50.3 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.062 0.847 . . . . 0.0 110.273 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.09 139.44 58.17 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.89 -21.93 54.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.23 0.538 . . . . 0.0 111.399 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG21 ' SD ' ' A' ' 1' ' ' MET . 57.6 t -140.38 141.96 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -172.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -129.74 158.14 40.21 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 120.892 0.377 . . . . 0.0 110.755 174.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.6 mp -124.63 122.49 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 168.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -119.87 134.28 55.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . -127.77 119.11 3.08 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 117.826 -1.541 . . . . 0.0 112.725 -172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.71 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -121.89 132.54 24.22 Favored Pre-proline 0 N--CA 1.469 0.499 0 CA-C-N 119.114 1.457 . . . . 0.0 110.864 178.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -82.46 149.1 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.427 2.085 . . . . 0.0 108.297 166.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 m -94.52 130.15 41.03 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -124.54 170.93 10.42 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.881 1.673 . . . . 0.0 109.472 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.6 t0 31.92 54.89 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.736 2.414 . . . . 0.0 115.313 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 57.23 76.65 0.31 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.111 1.364 . . . . 0.0 112.755 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.42 25.42 75.5 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.791 -0.568 . . . . 0.0 114.482 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -97.37 164.23 12.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.72 1.608 . . . . 0.0 110.318 169.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.8 mt -101.73 151.85 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 126.153 1.781 . . . . 0.0 106.461 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.1 144.08 56.91 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -64.65 -27.2 68.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.114 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -66.77 -26.49 66.99 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.806 0.843 . . . . 0.0 110.642 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' ILE . 9.9 m95 -84.55 -43.05 14.87 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.27 1.028 . . . . 0.0 110.819 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.26 -36.09 63.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.443 0.565 . . . . 0.0 110.746 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.16 -31.07 71.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.49 1.116 . . . . 0.0 112.174 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -107.12 -10.8 10.61 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.4 t-105 -53.57 -29.29 36.52 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.711 1.604 . . . . 0.0 111.621 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -70.8 -43.64 68.24 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.004 1.322 . . . . 0.0 111.154 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -69.24 -29.71 67.7 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.114 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.8 mt -56.99 -31.1 64.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 120.086 1.312 . . . . 0.0 111.055 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.48 -28.17 64.78 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.625 0.77 . . . . 0.0 111.22 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.96 -23.59 36.01 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.511 0.724 . . . . 0.0 111.114 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 mt -75.68 158.22 32.62 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 122.937 1.351 . . . . 0.0 111.961 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -91.72 99.87 12.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.866 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.77 9.08 11.96 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 175.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.17 122.16 15.94 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -172.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.98 84.88 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.93 1.252 . . . . 0.0 114.564 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -83.05 147.35 28.19 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 118.206 1.003 . . . . 0.0 110.274 174.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.7 mt -80.99 139.11 18.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 167.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -131.73 123.98 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 125.016 1.326 . . . . 0.0 109.127 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.461 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -104.44 115.43 30.35 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 167.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.8 mt -88.78 141.58 28.38 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 118.828 0.74 . . . . 0.0 111.572 173.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' CE1' ' HA3' ' A' ' 52' ' ' GLY . 18.2 p90 -140.2 163.36 32.94 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.431 1.093 . . . . 0.0 108.5 169.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.33 179.24 38.59 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.115 -0.99 . . . . 0.0 112.519 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.8 mt -123.67 152.76 41.68 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.148 0.979 . . . . 0.0 108.809 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -160.91 -163.04 13.27 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.834 0.73 . . . . 0.0 111.306 172.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -146.77 117.21 7.46 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 126.753 2.021 . . . . 0.0 105.99 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -28.75 24.9 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.992 0.36 . . . . 0.0 111.397 -171.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.93 -45.86 55.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.164 0.585 . . . . 0.0 110.284 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.36 -36.29 17.76 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.332 -0.704 . . . . 0.0 111.727 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -135.24 37.8 2.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -167.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.75 -39.75 68.72 Favored Glycine 0 N--CA 1.468 0.778 0 CA-C-N 119.687 1.13 . . . . 0.0 111.322 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -62.41 -17.15 58.5 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 117.962 0.881 . . . . 0.0 112.626 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -129.54 13.19 5.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.031 1.732 . . . . 0.0 112.342 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -44.6 126.38 5.45 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.796 1.638 . . . . 0.0 110.013 175.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 50.87 25.83 2.35 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.186 1.395 . . . . 0.0 113.34 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.03 -37.2 84.04 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 120.402 -1.436 . . . . 0.0 110.707 -170.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.72 73.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.24 0.616 . . . . 0.0 111.961 174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.8 tp -60.92 -46.26 91.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.199 0.999 . . . . 0.0 110.771 176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.64 99.51 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.9 mtm -62.08 -45.67 92.48 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 117.578 0.689 . . . . 0.0 111.607 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 HD12 ' A' ' 53' ' ' ILE . 4.0 mt -65.54 -33.44 75.93 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.84 177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -62.01 -39.53 92.6 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.246 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -73.11 -36.23 66.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.796 1.638 . . . . 0.0 112.192 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 23.9 tptt -57.51 -46.05 84.24 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.726 0.81 . . . . 0.0 109.98 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 mt -94.39 -19.07 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.623 -171.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p -61.4 -31.94 71.87 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 120.663 1.574 . . . . 0.0 111.88 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -78.36 -18.35 55.24 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.794 -0.566 . . . . 0.0 110.368 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -78.96 1.39 23.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.134 1.373 . . . . 0.0 112.031 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.23 32.96 65.01 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 118.79 0.723 . . . . 0.0 111.908 174.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.38 170.32 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.738 0.815 . . . . 0.0 109.603 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -118.33 135.09 54.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -102.81 147.1 27.29 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 119.373 0.988 . . . . 0.0 111.072 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.5 m -127.3 175.61 8.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.58 39.09 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-O 118.121 -1.377 . . . . 0.0 114.822 173.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -72.98 150.78 42.19 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 120.124 1.962 . . . . 0.0 108.008 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.53 145.12 56.15 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.009 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -70.04 141.89 45.29 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 CA-C-N 121.177 1.456 . . . . 0.0 109.238 168.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 ' CD1' ' A' ' 139' ' ' PHE . 81.9 p -75.49 -3.82 36.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.81 1.644 . . . . 0.0 113.894 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.37 146.12 45.43 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.747 0.819 . . . . 0.0 109.244 172.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.88 17.17 78.99 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.478 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.53 156.18 49.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.238 1.815 . . . . 0.0 109.491 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.89 129.08 48.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 169.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -160.09 -57.0 0.06 Allowed 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.799 0.727 . . . . 0.0 110.265 -169.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.353 4.3 t 58.59 10.81 1.52 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.935 2.494 . . . . 0.0 114.572 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.6 t -62.96 131.52 94.69 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -84.28 -13.41 7.52 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.397 2.065 . . . . 0.0 112.836 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -80.64 -48.03 1.2 Allowed Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -169.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -88.04 39.06 0.51 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.089 1.859 . . . . 0.0 112.212 -168.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.32 147.04 23.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 119.212 0.914 . . . . 0.0 109.4 -166.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 -172.53 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.852 1.661 . . . . 0.0 109.794 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.81 -116.29 0.84 Allowed 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.318 1.447 . . . . 0.0 107.491 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -105.21 7.89 33.78 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.791 1.237 . . . . 0.0 112.111 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.16 20.23 18.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.639 1.114 . . . . 0.0 112.463 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.05 -17.86 17.28 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 110.863 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.96 143.96 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.897 0.479 . . . . 0.0 110.706 171.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.505 ' CD1' HG22 ' A' ' 121' ' ' THR . 63.1 m-85 -77.9 156.09 30.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.818 1.247 . . . . 0.0 109.111 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.43 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.01 -15.65 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.087 0.955 . . . . 0.0 112.315 173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.02 -176.63 40.35 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 119.985 1.266 . . . . 0.0 111.763 -172.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.441 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.8 tp -63.81 126.86 28.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -110.0 119.79 40.42 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.5 mt -113.5 146.09 40.17 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.39 131.11 55.62 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 170.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -111.57 30.23 7.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.243 -171.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.47 -34.52 0.84 Allowed 'General case' 0 C--N 1.345 0.376 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 168.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -116.91 -30.77 5.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 120.131 1.332 . . . . 0.0 111.788 174.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -89.95 3.5 52.91 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.599 -0.715 . . . . 0.0 110.872 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -58.28 -21.88 50.51 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.298 0.954 . . . . 0.0 112.137 -175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.29 -24.43 42.9 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.277 1.031 . . . . 0.0 111.508 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.2 pp -126.29 -5.8 6.58 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.735 0.814 . . . . 0.0 112.864 -170.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -56.72 -29.89 62.94 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.078 0.854 . . . . 0.0 110.482 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.73 -38.18 64.08 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.849 1.66 . . . . 0.0 111.731 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -36.6 23.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.745 1.218 . . . . 0.0 109.945 -177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -67.44 -26.37 66.37 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.986 0.915 . . . . 0.0 109.52 -177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 58.0 mt -65.38 -57.58 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 170.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -49.78 -48.26 50.6 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 110.563 -176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.3 m -65.35 -37.46 87.12 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.385 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 33.8 t90 -66.36 -43.43 86.04 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 95.8 m -58.18 -35.44 71.6 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.568 0.747 . . . . 0.0 109.426 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -33.78 76.42 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.433 0.458 . . . . 0.0 110.047 -176.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.79 -46.13 15.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.56 -1.21 . . . . 0.0 111.85 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.402 HD11 HD11 ' A' ' 25' ' ' ILE . 6.5 pt -65.02 -39.78 86.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.375 1.898 . . . . 0.0 109.959 -169.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.87 -21.93 66.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.819 -0.551 . . . . 0.0 110.749 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -89.63 -42.66 11.25 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -58.75 -31.26 68.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.807 0.73 . . . . 0.0 109.979 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.9 mtm -86.01 -44.03 12.66 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.889 1.275 . . . . 0.0 109.029 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.5 83.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.317 1.047 . . . . 0.0 111.961 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -71.52 -27.54 63.27 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.959 1.304 . . . . 0.0 109.766 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -67.63 -31.77 72.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.558 0.617 . . . . 0.0 111.52 170.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.443 ' CE1' ' CE ' ' A' ' 1' ' ' MET . 2.8 m-30 -58.43 -29.91 66.48 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 O-C-N 123.745 0.653 . . . . 0.0 111.084 -167.617 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.56 140.83 30.31 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mtm -123.78 146.65 48.18 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.995 2.118 . . . . 0.0 108.769 -173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.29 116.49 4.41 Favored Glycine 0 CA--C 1.519 0.294 0 CA-C-O 118.49 -1.172 . . . . 0.0 111.215 -174.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.91 100.2 12.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.339 1.569 . . . . 0.0 110.051 172.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -98.96 145.31 27.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.454 1.502 . . . . 0.0 111.551 175.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -165.87 173.13 10.87 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.742 1.217 . . . . 0.0 109.014 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.22 127.88 2.89 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 106.674 -2.57 . . . . 0.0 106.674 172.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.5 p -128.85 131.73 47.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.714 1.606 . . . . 0.0 109.148 -170.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -84.59 -36.47 22.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 66.9 p -103.7 -81.65 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.7 p -177.6 -4.92 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.621 2.768 . . . . 0.0 112.111 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -69.46 -43.44 73.22 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 122.088 2.222 . . . . 0.0 111.054 -167.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -67.89 -30.94 70.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.757 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.86 -46.41 75.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.962 0.905 . . . . 0.0 110.594 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.12 -35.67 81.53 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.42 98.85 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.029 172.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.52 74.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.808 0.843 . . . . 0.0 110.666 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.54 -47.14 85.18 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 122.89 0.476 . . . . 0.0 110.031 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 24' ' ' ILE . 57.0 mttm -61.3 -55.04 36.23 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 124.788 1.235 . . . . 0.0 108.905 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.8 mt -53.55 -56.49 8.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 118.388 0.54 . . . . 0.0 109.99 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -38.66 70.84 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.117 0.567 . . . . 0.0 110.372 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.42 -47.01 74.61 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.827 0.451 . . . . 0.0 111.786 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LYS . 6.9 mt -66.21 -47.98 82.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 124.299 1.04 . . . . 0.0 108.898 -175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 164' ' ' ILE . 69.5 mt -71.03 -50.5 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.765 0.826 . . . . 0.0 110.415 -176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.55 114.55 0.76 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 170.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.63 2.97 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.454 2.769 . . . . 0.0 112.889 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.4 -34.36 67.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.056 1.342 . . . . 0.0 109.09 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.46 -21.43 3.83 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.44 1.496 . . . . 0.0 111.509 -169.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.5 t -93.93 142.05 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 120.828 1.649 . . . . 0.0 108.992 172.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.4 m -132.58 129.47 39.02 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.437 1.095 . . . . 0.0 110.054 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -70.21 147.77 49.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 111.539 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -144.91 107.16 4.35 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 107.604 171.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -82.96 112.79 20.06 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.2 mt -64.23 -10.24 22.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.795 1.238 . . . . 0.0 112.999 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -59.93 -28.33 67.52 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.08 0.855 . . . . 0.0 111.847 168.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -129.15 -33.96 1.91 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.9 1.28 . . . . 0.0 111.882 -173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -86.21 141.71 29.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.29 1.036 . . . . 0.0 109.05 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -84.78 142.53 39.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -73.0 -6.28 18.72 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.481 1.454 . . . . 0.0 111.419 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -54.15 -37.84 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 120.986 1.721 . . . . 0.0 111.422 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.78 -21.86 66.53 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -14.7 19.44 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.061 1.344 . . . . 0.0 112.235 169.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -72.7 -26.14 61.49 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.942 -1.099 . . . . 0.0 110.775 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -78.15 -49.21 14.3 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.869 0.759 . . . . 0.0 110.092 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -65.27 140.0 58.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.74 1.216 . . . . 0.0 108.436 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -73.04 -29.32 62.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.656 0.741 . . . . 0.0 110.827 -174.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.0 t -142.52 143.81 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.66 155.5 49.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.597 0.635 . . . . 0.0 109.512 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 mp -126.76 122.21 60.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 168.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.37 145.58 47.02 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.97 147.3 15.79 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 119.754 -1.212 . . . . 0.0 115.759 175.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -134.72 134.35 22.03 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.67 1.988 . . . . 0.0 109.582 -169.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -84.92 140.69 8.04 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 107.274 165.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 85.3 m -88.58 103.99 16.42 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -88.07 169.13 12.21 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.832 0.853 . . . . 0.0 110.709 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 22.97 66.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.886 2.875 . . . . 0.0 115.602 167.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 55.63 71.29 0.56 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.367 1.067 . . . . 0.0 112.096 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.42 15.7 77.28 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.01 148.41 32.53 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 122.632 1.206 . . . . 0.0 109.737 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.6 mt -79.97 153.08 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 172.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -60.98 142.84 56.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.773 0.829 . . . . 0.0 108.941 171.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.37 -27.85 68.19 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -166.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -82.07 -24.31 35.32 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.732 -0.605 . . . . 0.0 110.468 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 53' ' ' ILE . 13.1 m95 -72.91 -43.76 62.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.914 170.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -53.34 -35.51 60.3 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.661 0.664 . . . . 0.0 110.973 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.74 -30.76 71.78 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.538 0.735 . . . . 0.0 111.9 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.1 -11.46 10.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.98 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.55 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.8 t-105 -53.46 -28.9 32.94 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.73 1.612 . . . . 0.0 111.6 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -70.59 -43.88 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.093 1.357 . . . . 0.0 111.346 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -69.45 -30.01 67.82 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.092 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.6 mt -57.28 -30.46 64.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.945 1.248 . . . . 0.0 111.236 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -70.32 -28.47 65.19 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.689 0.796 . . . . 0.0 111.467 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.88 -24.33 35.78 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.184 0.594 . . . . 0.0 111.275 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.61 158.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 123.169 1.462 . . . . 0.0 112.205 -168.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -92.2 98.51 11.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.931 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -119.64 8.81 11.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -64.83 120.75 13.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -171.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.22 12.32 84.25 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.12 1.343 . . . . 0.0 114.12 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -79.52 148.53 31.77 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 117.659 0.729 . . . . 0.0 109.143 171.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.5 mt -85.15 141.24 14.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 166.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -135.02 119.6 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 125.758 1.623 . . . . 0.0 107.167 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -98.85 116.63 31.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 121.127 -0.983 . . . . 0.0 108.617 168.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 mt -86.08 141.89 29.1 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.19 0.904 . . . . 0.0 112.242 174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -137.36 155.43 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.995 0.918 . . . . 0.0 109.162 168.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.81 172.17 36.3 Favored Glycine 0 N--CA 1.451 -0.345 0 O-C-N 120.698 -1.251 . . . . 0.0 112.296 174.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.78 155.83 40.42 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.389 1.076 . . . . 0.0 108.443 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.19 -155.64 12.96 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -149.23 140.28 22.97 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.846 1.658 . . . . 0.0 107.324 167.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -90.91 -24.6 20.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.002 1.321 . . . . 0.0 113.811 178.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.34 -33.24 43.22 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 120.164 1.347 . . . . 0.0 112.862 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.5 -20.73 36.83 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.454 1.026 . . . . 0.0 111.266 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -122.37 -86.36 0.65 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.689 1.196 . . . . 0.0 108.051 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.42 -53.3 3.15 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 128.719 3.056 . . . . 0.0 107.703 -168.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -64.6 -28.0 69.33 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.605 1.962 . . . . 0.0 110.776 -172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -118.34 6.63 11.88 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.971 1.308 . . . . 0.0 112.228 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.56 122.22 5.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.976 1.31 . . . . 0.0 109.905 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 54.41 26.8 7.42 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.195 1.398 . . . . 0.0 113.056 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.47 -38.81 92.32 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 120.928 -1.108 . . . . 0.0 110.443 -172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.15 -33.22 75.28 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.209 0.604 . . . . 0.0 111.907 174.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.653 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.4 tp -60.34 -45.93 91.71 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.996 0.918 . . . . 0.0 110.403 175.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.11 -39.34 97.5 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.6 mtm -66.46 -42.6 87.34 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-N 118.0 0.9 . . . . 0.0 111.971 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.556 HD12 HD12 ' A' ' 53' ' ' ILE . 4.1 mt -63.16 -35.11 79.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.546 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -65.31 -42.44 93.01 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.18 -175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.7 -42.57 95.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.576 1.15 . . . . 0.0 111.347 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -55.35 -60.67 3.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.719 1.208 . . . . 0.0 108.224 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.7 mt -76.75 -20.36 56.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.906 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 t -60.96 -29.26 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.579 1.081 . . . . 0.0 110.499 169.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -22.21 55.69 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.875 -1.14 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.6 mmmt -85.09 2.54 42.95 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.804 1.642 . . . . 0.0 112.458 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 68.67 36.44 82.87 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 118.37 0.532 . . . . 0.0 112.12 172.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.8 169.02 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.838 0.855 . . . . 0.0 110.076 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -104.3 136.36 44.03 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -106.76 146.8 30.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 119.881 1.219 . . . . 0.0 110.658 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.7 m -129.85 178.09 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 123.786 0.834 . . . . 0.0 108.799 169.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.95 38.96 34.35 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-O 118.767 -1.019 . . . . 0.0 113.855 172.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -79.59 153.99 29.06 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.462 1.631 . . . . 0.0 109.085 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.21 149.95 75.14 Favored Pre-proline 0 N--CA 1.468 0.428 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.635 171.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.47 140.39 39.93 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.44 1.426 . . . . 0.0 110.158 169.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 139' ' ' PHE . 59.4 p -75.51 -4.69 41.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.472 1.909 . . . . 0.0 113.503 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.16 140.81 57.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 120.99 -1.069 . . . . 0.0 109.961 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.42 -9.43 61.58 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.508 1.528 . . . . 0.0 113.515 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -93.81 150.17 20.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 119.096 1.448 . . . . 0.0 111.389 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -111.36 126.15 54.61 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 127.529 2.332 . . . . 0.0 105.308 167.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.408 ' O ' HG22 ' A' ' 127' ' ' THR . 12.3 p90 -162.03 -60.43 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -174.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 126' ' ' PHE 0.315 1.9 t 56.95 9.4 0.62 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 128.276 2.63 . . . . 0.0 114.19 -179.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.8 p -66.82 135.97 94.41 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 120.832 -1.168 . . . . 0.0 108.974 169.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -85.98 -13.9 5.38 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.431 2.087 . . . . 0.0 113.671 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -80.99 -48.41 1.09 Allowed Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -85.2 36.96 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.983 1.789 . . . . 0.0 112.965 -168.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.66 147.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.131 0.972 . . . . 0.0 109.529 -167.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.76 -172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.7 . . . . 0.0 109.372 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.01 -117.12 0.87 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.062 1.345 . . . . 0.0 107.518 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -104.88 7.45 34.36 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.667 1.187 . . . . 0.0 112.003 175.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 99.57 20.15 18.12 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.56 1.076 . . . . 0.0 112.787 -172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -100.36 -17.26 17.33 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 124.831 1.252 . . . . 0.0 111.007 -172.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.06 145.25 50.61 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.512 0.725 . . . . 0.0 110.809 174.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.574 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.4 m-85 -79.84 154.61 28.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.209 1.404 . . . . 0.0 109.845 177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.98 -12.41 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.813 1.245 . . . . 0.0 112.829 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.29 -176.23 41.65 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 119.617 1.099 . . . . 0.0 111.863 -172.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.539 HD11 HD21 ' A' ' 144' ' ' LEU . 34.4 tp -63.0 126.8 28.54 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.28 121.21 44.24 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 153' ' ' SER . 55.8 mt -123.05 155.69 36.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.085 0.954 . . . . 0.0 109.512 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.556 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -137.49 120.82 16.96 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.07 3.66 44.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.553 -172.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.6 -30.84 10.23 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.537 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -122.9 -46.61 2.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.257 0.935 . . . . 0.0 110.637 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -99.57 24.01 8.75 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.334 1.054 . . . . 0.0 111.31 -171.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -53.48 -29.27 35.18 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.712 0.687 . . . . 0.0 111.841 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -77.97 -22.85 48.82 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.922 0.889 . . . . 0.0 111.213 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 25.9 mt -100.69 -31.04 11.41 Favored 'General case' 0 CA--C 1.489 -1.394 0 C-N-CA 126.497 1.919 . . . . 0.0 110.245 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.613 ' HA ' HD22 ' A' ' 144' ' ' LEU . 70.6 m -55.92 -26.11 46.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.993 169.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.56 -54.71 11.02 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.071 0.85 . . . . 0.0 109.959 167.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -62.55 -32.68 73.68 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 122.092 0.949 . . . . 0.0 111.793 -170.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -83.94 -24.07 30.85 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.435 1.494 . . . . 0.0 109.692 -170.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 41.9 mt -60.73 -52.83 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -54.84 -44.99 74.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.861 0.864 . . . . 0.0 110.582 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.1 m -71.3 -33.64 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.686 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CZ2' ' HB1' ' A' ' 83' ' ' ALA . 35.4 t90 -65.45 -44.39 87.41 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.37 -0.831 . . . . 0.0 109.747 176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 87.0 m -59.52 -36.24 75.73 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.995 179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -68.79 -32.5 72.27 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 122.789 0.435 . . . . 0.0 110.564 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -79.11 -46.42 18.06 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.741 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.416 HD11 HD11 ' A' ' 25' ' ' ILE . 7.0 pt -65.0 -38.0 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 120.597 1.544 . . . . 0.0 109.838 -171.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.46 -12.26 50.82 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.477 0.581 . . . . 0.0 112.187 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -95.29 -46.6 6.67 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 171.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -61.28 -36.23 79.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.947 0.794 . . . . 0.0 110.637 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 71.5 mtm -82.04 -37.38 26.57 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.209 1.003 . . . . 0.0 110.834 -176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.24 -45.28 56.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 110.228 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.79 -30.07 68.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 110.084 -176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 81' ' ' ILE . 68.0 t60 -63.98 -53.11 55.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.068 0.547 . . . . 0.0 109.822 169.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -9.3 58.83 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -170.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.681 178.224 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.499 1.975 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.53 143.49 31.98 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mtm -132.18 149.56 52.36 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.72 2.008 . . . . 0.0 107.55 -170.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.16 121.23 5.24 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.759 -1.023 . . . . 0.0 110.671 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.61 113.59 25.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 118.826 1.313 . . . . 0.0 109.07 170.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 43' ' ' MET . 73.8 m-85 -109.69 145.93 35.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.395 1.478 . . . . 0.0 111.748 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -162.67 172.23 15.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.237 1.015 . . . . 0.0 109.602 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.36 136.58 7.77 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 168.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 p -134.52 128.82 34.09 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.813 1.245 . . . . 0.0 110.871 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.1 m -89.79 -42.26 11.38 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 122.933 0.493 . . . . 0.0 110.014 170.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 67.5 p -92.62 -82.33 0.33 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.7 p -177.13 -6.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.464 2.306 . . . . 0.0 112.559 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -64.42 -44.47 91.1 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 119.817 -1.802 . . . . 0.0 112.062 -168.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.62 -37.99 88.16 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.3 -46.58 89.72 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.632 0.773 . . . . 0.0 110.316 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.6 mtm -67.34 -43.23 82.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.158 0.436 . . . . 0.0 110.979 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.5 87.51 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.709 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.6 -46.72 80.7 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.776 0.83 . . . . 0.0 110.823 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.65 -44.13 93.66 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -63.2 -53.86 46.63 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.004 1.321 . . . . 0.0 108.992 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.402 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -53.24 -56.53 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 118.843 0.747 . . . . 0.0 110.091 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -38.29 79.75 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.385 -178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -66.36 -47.9 71.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.056 0.542 . . . . 0.0 111.033 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.678 HD13 ' HA ' ' A' ' 158' ' ' GLN . 15.6 mt -65.75 -48.24 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.437 1.095 . . . . 0.0 108.674 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 164' ' ' ILE . 79.5 mt -71.1 -49.9 45.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 C-N-CA 123.461 0.704 . . . . 0.0 110.25 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.97 114.31 0.77 Allowed Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.19 4.15 3.52 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 123.48 2.787 . . . . 0.0 112.577 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.59 -34.38 67.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.225 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.75 -21.24 3.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.424 1.49 . . . . 0.0 111.694 -169.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.13 141.63 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.583 1.538 . . . . 0.0 108.995 172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.3 m -131.56 128.91 40.23 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.328 1.051 . . . . 0.0 109.817 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.55 149.12 47.44 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.521 0.729 . . . . 0.0 112.048 175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -146.97 111.85 5.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.995 1.718 . . . . 0.0 106.926 174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -86.82 112.48 21.77 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.3 mt -65.23 -8.79 19.15 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -59.27 -28.64 66.92 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.255 0.934 . . . . 0.0 111.762 168.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -132.26 -33.64 1.29 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.545 1.138 . . . . 0.0 111.973 -171.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -85.66 140.5 30.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 109.019 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 m -86.03 141.66 35.6 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 75' ' ' LEU . 18.4 Cg_endo -72.57 1.41 6.3 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.666 2.244 . . . . 0.0 111.695 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -59.6 -34.79 73.2 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 119.057 -2.277 . . . . 0.0 111.576 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.03 -17.97 63.29 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 178.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.442 ' HG3' ' CZ ' ' A' ' 6' ' ' PHE . 15.7 mtm -59.09 -15.84 16.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 0.0 111.791 168.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 54.6 mt-10 -72.3 -26.53 62.0 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.976 -1.078 . . . . 0.0 111.529 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -78.96 -50.33 11.32 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.984 0.811 . . . . 0.0 110.347 -171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -67.68 147.19 53.0 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.682 1.193 . . . . 0.0 108.124 -170.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -79.13 -23.41 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.968 -0.457 . . . . 0.0 110.938 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.4 t -143.21 138.49 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 -168.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.91 152.4 47.91 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 176.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.15 125.4 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.8 mp -125.29 134.47 52.25 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.686 0.794 . . . . 0.0 109.321 -169.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -119.54 117.54 3.64 Favored Glycine 0 N--CA 1.463 0.436 0 CA-C-O 116.989 -2.006 . . . . 0.0 111.705 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -115.32 126.74 27.46 Favored Pre-proline 0 N--CA 1.476 0.873 0 CA-C-N 120.168 1.984 . . . . 0.0 110.932 172.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -82.98 141.79 10.74 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.548 2.832 . . . . 0.0 108.354 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -91.23 112.03 23.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -98.53 170.46 8.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.476 1.111 . . . . 0.0 110.592 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.3 t0 23.74 62.92 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.783 2.833 . . . . 0.0 115.449 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 57.09 74.87 0.39 Allowed 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.762 1.225 . . . . 0.0 112.626 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.33 11.11 71.08 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -80.12 164.28 23.46 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.564 1.173 . . . . 0.0 108.762 168.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.1 mt -100.12 153.27 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -59.85 141.61 55.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.57 -29.36 69.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -166.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -77.64 -21.17 52.64 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.614 -0.679 . . . . 0.0 110.283 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CD1' HG22 ' A' ' 53' ' ' ILE . 12.0 m95 -77.84 -45.27 24.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.497 168.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -53.76 -36.0 61.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.182 0.593 . . . . 0.0 110.886 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.73 70.99 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.299 1.04 . . . . 0.0 112.061 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.9 m -109.9 -8.69 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.569 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 9.0 t-105 -54.31 -28.95 45.74 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.508 1.523 . . . . 0.0 111.677 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -69.02 -45.11 71.34 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.771 1.228 . . . . 0.0 111.646 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -67.43 -26.11 66.25 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 117.727 -1.13 . . . . 0.0 112.388 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.16 -30.95 68.55 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.055 1.298 . . . . 0.0 111.042 -176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -70.12 -26.92 64.18 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.238 0.615 . . . . 0.0 111.583 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -83.09 -23.16 33.22 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.289 0.635 . . . . 0.0 111.484 -175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 40' ' ' PRO . 21.3 mt -72.14 171.83 11.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 122.504 1.145 . . . . 0.0 111.073 -170.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.473 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 13.7 t30 -111.78 103.26 11.51 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 126.029 1.732 . . . . 0.0 108.442 173.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -121.83 10.79 10.3 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.337 0.865 . . . . 0.0 113.337 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -63.67 121.95 15.18 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -171.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.9 8.91 86.8 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.169 1.366 . . . . 0.0 114.605 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -78.79 151.19 32.12 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 117.976 0.888 . . . . 0.0 109.032 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.733 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.0 mt -88.99 141.4 14.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.3 t -131.34 126.34 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 C-N-CA 125.002 1.321 . . . . 0.0 108.328 176.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.39 110.29 22.58 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 105' ' ' HIS . 58.0 mt -88.5 142.76 27.44 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.925 0.784 . . . . 0.0 110.637 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -137.62 162.37 33.98 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.168 1.387 . . . . 0.0 108.163 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.1 173.64 36.77 Favored Glycine 0 N--CA 1.448 -0.552 0 O-C-N 121.369 -0.832 . . . . 0.0 112.119 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.8 mt -128.99 154.6 46.45 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.97 1.308 . . . . 0.0 108.087 -172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.67 -152.4 9.43 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.729 -0.949 . . . . 0.0 110.729 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -157.22 142.76 17.41 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.739 2.016 . . . . 0.0 107.142 167.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.63 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -91.98 -26.78 18.23 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.81 -32.93 63.98 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.894 1.224 . . . . 0.0 112.835 -168.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.7 -16.52 48.45 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 124.251 0.929 . . . . 0.0 111.795 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -127.54 -88.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.49 1.516 . . . . 0.0 108.761 -168.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.26 -50.74 2.8 Favored Glycine 0 N--CA 1.471 0.988 0 C-N-CA 129.247 3.308 . . . . 0.0 108.364 -169.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -68.22 -25.78 65.38 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 125.636 1.574 . . . . 0.0 110.885 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -119.12 8.09 11.48 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.949 1.3 . . . . 0.0 112.449 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -46.7 123.08 4.71 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.191 1.397 . . . . 0.0 110.399 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 52.36 27.52 4.93 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 125.011 1.324 . . . . 0.0 113.122 173.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.22 -34.75 78.14 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.529 -170.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.27 71.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.453 0.701 . . . . 0.0 111.606 172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.624 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -62.42 -47.17 85.27 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.133 0.973 . . . . 0.0 109.972 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.87 -40.87 97.36 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 174.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.2 mtm -66.58 -45.31 79.69 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.156 0.978 . . . . 0.0 112.214 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.569 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -66.48 -32.0 73.09 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.552 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CD2' HD12 ' A' ' 84' ' ' LEU . 2.1 m-70 -59.12 -47.93 83.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.064 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -65.02 -41.26 95.44 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.286 1.035 . . . . 0.0 111.427 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -55.4 -57.99 9.57 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 108.883 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.8 -19.63 48.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.446 -169.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.9 t -61.27 -29.13 69.66 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.109 0.868 . . . . 0.0 110.246 169.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -22.48 56.28 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.68 -1.263 . . . . 0.0 109.769 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -84.48 1.19 46.74 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.555 1.542 . . . . 0.0 112.36 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.95 34.87 71.44 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 118.666 0.666 . . . . 0.0 112.155 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.74 173.02 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.956 0.902 . . . . 0.0 109.85 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -118.28 143.74 46.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.37 147.71 34.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 119.823 1.192 . . . . 0.0 111.62 -170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 15.3 m -128.82 -179.79 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 123.661 0.784 . . . . 0.0 109.945 171.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.96 38.41 30.64 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.807 170.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -77.98 151.94 33.38 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.521 1.66 . . . . 0.0 108.368 170.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.62 146.56 60.97 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-O 116.968 -1.491 . . . . 0.0 109.461 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.49 139.48 45.1 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 CA-C-N 120.953 1.376 . . . . 0.0 110.186 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.541 HG22 ' CD1' ' A' ' 139' ' ' PHE . 74.0 p -74.8 -6.27 48.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.228 1.811 . . . . 0.0 113.931 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.87 141.3 53.77 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 122.03 0.919 . . . . 0.0 110.033 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.04 -10.33 68.9 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.191 1.377 . . . . 0.0 113.628 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -100.82 150.04 23.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.149 1.475 . . . . 0.0 111.107 172.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -115.86 128.55 55.89 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.874 2.469 . . . . 0.0 105.143 168.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -164.57 -49.45 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.679 0.672 . . . . 0.0 110.09 -171.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.305 2.5 t 58.7 9.05 1.03 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 128.149 2.58 . . . . 0.0 114.391 173.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.98 134.91 52.1 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.175 1.39 . . . . 0.0 109.449 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -86.42 -11.37 6.09 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.53 2.154 . . . . 0.0 113.948 -172.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 29.2 tptt -76.46 -48.86 3.04 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -89.77 38.32 0.38 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.708 1.646 . . . . 0.0 112.113 -169.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.44 150.05 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.632 1.173 . . . . 0.0 110.166 -166.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.413 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -127.96 -172.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 126.322 1.849 . . . . 0.0 109.805 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.02 -116.64 0.85 Allowed 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.123 1.369 . . . . 0.0 107.606 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -105.22 8.38 33.96 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.964 1.306 . . . . 0.0 111.957 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.17 21.0 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.875 1.226 . . . . 0.0 112.593 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -99.58 -17.36 17.88 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.781 1.232 . . . . 0.0 110.573 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.93 142.71 49.72 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.043 0.537 . . . . 0.0 111.305 173.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.541 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.3 m-85 -77.4 155.8 31.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 125.375 1.47 . . . . 0.0 108.926 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.413 HG12 HG23 ' A' ' 133' ' ' ILE . 30.9 m -68.24 -14.56 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.356 173.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -162.46 179.83 37.52 Favored Glycine 0 N--CA 1.47 0.948 0 O-C-N 119.974 -1.704 . . . . 0.0 111.987 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.477 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 12.9 tp -63.31 128.1 34.29 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 170.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.91 126.44 55.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt -124.28 156.37 37.04 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.547 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.77 115.36 15.87 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 173.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -93.0 26.17 2.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.934 -168.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.7 -25.87 3.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.778 168.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.39 -36.05 3.01 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.343 1.429 . . . . 0.0 111.654 176.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -84.26 -2.82 57.63 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 117.439 -1.267 . . . . 0.0 111.863 170.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -55.29 -24.63 29.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 121.056 1.753 . . . . 0.0 112.376 -169.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -85.97 -20.84 28.32 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.038 1.335 . . . . 0.0 112.83 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 -6.78 8.91 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.957 1.303 . . . . 0.0 113.025 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -54.23 -28.63 42.57 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.46 1.482 . . . . 0.0 111.329 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -52.35 -40.49 62.04 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.843 1.257 . . . . 0.0 111.611 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -31.49 69.25 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.33 1.852 . . . . 0.0 111.318 -177.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -92.46 -19.4 22.06 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.765 1.226 . . . . 0.0 110.606 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 64.6 mt -70.46 -58.53 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.2 pt20 -54.04 -42.57 69.33 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 123.861 0.864 . . . . 0.0 112.617 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.5 p -68.16 -35.22 77.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.477 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 35.9 t90 -65.64 -45.02 84.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.041 0.924 . . . . 0.0 109.604 175.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 91.2 m -58.0 -34.59 70.17 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.336 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -71.42 -28.19 63.82 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.947 0.499 . . . . 0.0 110.386 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -83.55 -45.92 13.01 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.67 171.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.509 HD11 HD11 ' A' ' 25' ' ' ILE . 6.3 pt -63.64 -36.96 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 120.945 1.702 . . . . 0.0 109.75 -171.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.9 -12.31 35.64 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.51 -51.23 5.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.679 1.592 . . . . 0.0 107.795 169.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.77 -22.61 66.99 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.161 0.584 . . . . 0.0 111.752 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.733 ' HG2' HG21 ' A' ' 81' ' ' ILE . 68.7 mtm -93.78 -42.11 9.3 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 124.926 1.29 . . . . 0.0 111.514 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.45 -43.8 38.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.584 0.753 . . . . 0.0 110.854 -173.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.03 -28.86 65.82 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.217 1.407 . . . . 0.0 109.603 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -61.57 -43.54 98.67 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.97 -1.59 57.98 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.348 1.459 . . . . 0.0 113.454 -173.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.35 -0.833 . . . . 0.0 110.384 178.217 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 pmm? . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 111.322 0.119 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.19 142.98 30.79 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 168.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 mtm -131.62 147.35 52.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.383 1.873 . . . . 0.0 107.858 -170.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.74 119.24 5.02 Favored Glycine 0 N--CA 1.46 0.28 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.2 99.49 12.47 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.799 1.3 . . . . 0.0 109.326 171.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -97.86 146.79 25.09 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.704 1.202 . . . . 0.0 109.979 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -165.27 173.11 11.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.49 132.45 6.21 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 105.889 -2.885 . . . . 0.0 105.889 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -152.52 147.86 26.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -125.23 -31.98 3.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.294 1.438 . . . . 0.0 108.876 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.6 p -88.36 -6.51 57.67 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.348 1.859 . . . . 0.0 111.618 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . 0.25 43.8 m 71.69 10.13 6.34 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 127.754 2.422 . . . . 0.0 115.144 176.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -65.87 -44.79 84.36 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 120.807 1.64 . . . . 0.0 111.016 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -34.96 79.57 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -65.45 -46.97 77.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.014 0.926 . . . . 0.0 110.422 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.0 mtm -63.89 -39.4 94.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 118.388 0.54 . . . . 0.0 110.9 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.02 99.63 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.739 172.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 -46.39 76.83 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.928 0.891 . . . . 0.0 110.539 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -57.21 -47.32 81.59 Favored 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 123.013 0.525 . . . . 0.0 109.69 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.61 -54.02 45.82 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 124.598 1.186 . . . . 0.0 108.525 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -52.94 -56.78 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 118.733 0.697 . . . . 0.0 109.562 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -38.98 72.68 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.262 0.625 . . . . 0.0 110.529 -178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.23 -46.69 73.05 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 122.745 0.418 . . . . 0.0 111.275 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 158' ' ' GLN . 16.0 mt -66.17 -48.15 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.785 1.234 . . . . 0.0 108.704 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.7 mt -70.97 -50.92 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 C-N-CA 123.768 0.827 . . . . 0.0 110.415 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.98 115.22 0.73 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 170.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.06 3.47 3.95 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.479 2.786 . . . . 0.0 112.788 178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.12 -34.35 66.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.036 1.334 . . . . 0.0 109.236 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.16 -23.49 3.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.838 1.655 . . . . 0.0 111.422 -169.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.0 t -94.55 141.04 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 120.696 1.589 . . . . 0.0 109.352 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -130.23 128.61 42.01 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.216 1.007 . . . . 0.0 110.043 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.38 145.26 51.24 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.98 0.912 . . . . 0.0 111.216 174.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -148.66 112.71 5.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -93.3 116.59 29.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.517 0.675 . . . . 0.0 110.461 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 71.6 mt -67.15 -11.12 56.44 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.768 -174.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -58.72 -25.82 63.32 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.521 0.6 . . . . 0.0 111.618 168.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -134.8 -31.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.804 0.842 . . . . 0.0 111.85 -167.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.12 154.12 18.27 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.658 1.183 . . . . 0.0 112.05 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 m -96.28 134.39 23.64 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 125.153 1.381 . . . . 0.0 109.715 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.45 -6.62 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 112.366 -176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -49.22 -40.03 32.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.441 1.473 . . . . 0.0 111.526 173.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.25 -23.09 67.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -14.6 31.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.374 1.07 . . . . 0.0 112.378 171.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -71.97 -25.51 61.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.053 -1.029 . . . . 0.0 110.615 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -75.89 -49.89 16.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.23 0.923 . . . . 0.0 110.24 -173.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -66.73 147.68 52.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.436 -169.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.0 -28.06 60.38 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.829 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 49' ' ' LEU . 38.7 t -144.95 142.56 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -168.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -127.84 160.28 32.27 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 118.681 0.673 . . . . 0.0 111.133 173.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.26 123.66 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 166.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mp -121.53 145.69 47.7 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.04 150.66 22.23 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 119.668 -1.253 . . . . 0.0 114.855 173.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -133.26 135.11 24.93 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 126.382 1.873 . . . . 0.0 109.453 -169.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.11 141.45 9.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 N-CA-C 107.64 -1.716 . . . . 0.0 107.64 166.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.0 m -86.33 104.92 16.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -86.89 168.77 13.11 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.926 1.29 . . . . 0.0 109.613 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 19.72 68.12 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 129.483 3.113 . . . . 0.0 115.878 166.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 56.24 72.39 0.5 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.338 1.055 . . . . 0.0 112.279 176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.79 11.58 78.01 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.306 0.882 . . . . 0.0 115.306 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.46 149.21 35.07 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-O 122.61 1.195 . . . . 0.0 110.635 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.8 mt -84.72 153.51 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 172.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -62.19 143.47 56.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.72 -27.23 68.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -166.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.39 -28.94 31.14 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 121.635 -0.666 . . . . 0.0 110.653 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 53' ' ' ILE . 7.2 m95 -65.55 -44.02 88.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 169.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -55.92 -37.78 69.4 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.37 0.532 . . . . 0.0 110.92 174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.51 -31.8 73.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.947 0.499 . . . . 0.0 111.761 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 m -99.64 -11.85 8.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.727 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.567 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -53.87 -28.81 38.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.184 1.793 . . . . 0.0 111.606 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.34 -43.22 64.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.267 1.427 . . . . 0.0 111.125 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.33 -31.03 70.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 117.772 -1.108 . . . . 0.0 111.843 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.1 mt -56.5 -32.76 65.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.863 1.21 . . . . 0.0 110.923 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -68.94 -28.53 66.73 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.375 0.67 . . . . 0.0 111.43 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.02 -25.58 34.56 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.327 0.651 . . . . 0.0 111.193 -178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 159.6 34.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.972 1.367 . . . . 0.0 112.511 -168.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.5 98.3 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.678 -2.056 . . . . 0.0 108.694 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -120.09 8.8 11.02 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.4 120.52 12.97 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.4 12.85 83.93 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.984 1.278 . . . . 0.0 113.88 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -81.45 150.76 28.17 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 117.796 0.798 . . . . 0.0 109.309 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.749 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.8 mt -87.13 141.03 14.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 167.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.6 t -133.52 121.29 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 124.87 1.268 . . . . 0.0 108.052 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -97.95 115.73 28.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 120.93 -1.106 . . . . 0.0 108.328 168.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.74 HD12 ' CD2' ' A' ' 105' ' ' HIS . 51.1 mt -91.2 140.4 29.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.195 0.907 . . . . 0.0 112.448 175.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -139.73 157.83 45.1 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.455 1.502 . . . . 0.0 109.405 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.02 179.53 35.5 Favored Glycine 0 CA--C 1.512 -0.129 0 O-C-N 120.668 -1.27 . . . . 0.0 112.619 174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.83 153.58 40.83 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.949 0.9 . . . . 0.0 109.35 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.41 -167.98 28.89 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.85 136.19 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 168.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -86.18 -24.25 26.19 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 124.052 0.941 . . . . 0.0 113.356 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.8 mt -81.14 -33.25 33.29 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.779 1.172 . . . . 0.0 112.71 -169.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.1 -22.5 32.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.102 0.858 . . . . 0.0 111.039 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -125.23 -87.88 0.6 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.0 -47.95 1.98 Allowed Glycine 0 N--CA 1.468 0.767 0 C-N-CA 128.41 2.91 . . . . 0.0 108.866 -169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -65.72 -28.84 69.35 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.837 1.655 . . . . 0.0 110.725 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 16.9 m-90 -117.46 9.14 13.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.205 1.402 . . . . 0.0 112.133 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -47.65 122.61 5.0 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 125.034 1.334 . . . . 0.0 109.582 169.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.22 25.62 5.95 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 125.403 1.481 . . . . 0.0 113.379 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.95 -36.97 86.09 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -172.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.98 -30.95 71.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.886 -0.509 . . . . 0.0 112.043 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.641 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.7 tp -63.0 -45.69 91.22 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 124.146 0.978 . . . . 0.0 111.009 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.13 96.11 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 174.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 30.9 mtm -67.01 -44.39 80.44 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 118.132 0.966 . . . . 0.0 112.115 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.567 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 2.7 mt -64.64 -33.04 75.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.924 0.784 . . . . 0.0 111.55 174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.74 ' CD2' HD12 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -60.23 -47.49 85.77 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.22 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.21 -40.8 94.65 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.581 1.153 . . . . 0.0 111.086 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 14.1 tptt -55.21 -60.07 3.9 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 124.784 1.234 . . . . 0.0 108.795 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.29 -19.21 54.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 118.535 -0.745 . . . . 0.0 111.063 -169.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 17.0 t -61.2 -28.73 69.35 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.088 0.858 . . . . 0.0 110.274 169.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.36 -21.84 55.59 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.733 -1.229 . . . . 0.0 109.992 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -85.24 1.59 47.56 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 125.642 1.577 . . . . 0.0 112.659 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 69.14 34.36 75.64 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 118.419 0.554 . . . . 0.0 111.897 173.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -86.26 170.33 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.979 0.912 . . . . 0.0 109.449 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -116.48 140.8 48.97 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 168.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -105.16 148.25 27.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 118.598 0.635 . . . . 0.0 110.531 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 21.1 m -126.97 177.43 5.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 169.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.22 39.18 27.59 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-O 118.441 -1.199 . . . . 0.0 113.983 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -76.35 151.7 36.57 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.704 1.752 . . . . 0.0 108.182 169.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.48 146.25 61.1 Favored Pre-proline 0 N--CA 1.468 0.425 0 CA-C-O 116.77 -1.586 . . . . 0.0 109.653 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.56 139.41 37.41 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 CA-C-N 121.128 1.439 . . . . 0.0 109.52 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.458 HG22 ' CD1' ' A' ' 139' ' ' PHE . 64.4 p -76.28 -5.06 45.31 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.019 1.728 . . . . 0.0 113.334 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.43 140.04 58.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.178 0.99 . . . . 0.0 109.703 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.14 -8.95 61.97 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.378 1.466 . . . . 0.0 113.891 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -89.44 161.94 16.01 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.915 1.357 . . . . 0.0 110.661 173.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -126.35 127.14 45.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.402 ' O ' HG22 ' A' ' 127' ' ' THR . 13.1 p90 -164.02 -60.21 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.002 0.819 . . . . 0.0 109.611 -174.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 126' ' ' PHE 0.337 2.0 t 58.06 9.94 1.08 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 128.671 2.788 . . . . 0.0 114.768 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.9 p -66.02 139.16 96.52 Favored Pre-proline 0 CA--C 1.542 0.636 0 O-C-N 120.785 -1.197 . . . . 0.0 108.953 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -86.9 -15.54 3.82 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.444 2.096 . . . . 0.0 113.383 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -80.55 -47.33 1.26 Allowed Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -86.88 35.94 0.46 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.072 1.848 . . . . 0.0 112.165 -169.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.65 148.75 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.92 1.288 . . . . 0.0 109.556 -167.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.508 HG23 HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -126.49 -172.95 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 C-N-CA 125.978 1.711 . . . . 0.0 110.128 176.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.88 -116.22 0.83 Allowed 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.302 1.441 . . . . 0.0 107.531 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -104.99 7.55 34.11 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.995 1.318 . . . . 0.0 111.879 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.45 18.85 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.998 1.285 . . . . 0.0 112.455 -172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -99.65 -17.59 17.71 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.645 1.178 . . . . 0.0 110.934 -172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.93 143.07 50.45 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.925 0.49 . . . . 0.0 111.212 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.458 ' CD1' HG22 ' A' ' 121' ' ' THR . 58.3 m-85 -77.56 155.8 31.32 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.169 1.388 . . . . 0.0 108.658 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 133' ' ' ILE . 35.0 m -69.12 -16.35 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.763 176.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.88 -176.64 38.61 Favored Glycine 0 C--N 1.338 0.669 0 O-C-N 120.572 -1.33 . . . . 0.0 111.65 -172.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.417 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 21.2 tp -65.96 130.13 42.2 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.38 117.63 32.97 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.289 1.035 . . . . 0.0 108.27 -177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.03 153.66 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.317 1.047 . . . . 0.0 109.71 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -139.79 122.83 16.75 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 169.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -105.23 7.97 33.78 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.263 1.025 . . . . 0.0 110.716 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 -27.41 12.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.494 1.118 . . . . 0.0 110.39 178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -124.9 -47.08 1.81 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.302 0.955 . . . . 0.0 111.025 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -90.18 17.14 7.37 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.7 0.8 . . . . 0.0 112.493 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -51.76 -22.88 3.94 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.043 0.937 . . . . 0.0 112.952 172.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -79.72 -25.85 41.0 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.846 0.858 . . . . 0.0 111.472 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -122.74 -13.12 7.98 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 124.241 1.017 . . . . 0.0 112.623 -171.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.1 p -55.71 -31.37 62.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.655 1.116 . . . . 0.0 110.681 -175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -57.58 -38.69 75.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.096 1.358 . . . . 0.0 111.476 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.46 -34.01 60.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.442 1.097 . . . . 0.0 109.414 -178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -26.72 60.26 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.676 0.79 . . . . 0.0 109.651 -177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.23 -60.32 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.546 ' HA ' HD13 ' A' ' 24' ' ' ILE . 6.1 pt20 -56.09 -40.21 73.32 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 46.4 m -68.65 -33.3 73.76 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.017 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 44.5 t90 -66.28 -43.37 86.57 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 174.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 90.6 m -58.98 -34.75 72.18 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.794 0.837 . . . . 0.0 110.062 178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.75 -31.35 68.13 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 122.93 0.492 . . . . 0.0 109.989 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -79.47 -45.82 18.66 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.515 171.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.1 pt -64.69 -38.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 CA-C-N 120.944 1.702 . . . . 0.0 110.032 -171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -65.4 -12.17 49.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.216 0.462 . . . . 0.0 112.18 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.92 -46.27 6.61 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.742 1.217 . . . . 0.0 107.893 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.3 -36.36 79.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.114 0.87 . . . . 0.0 110.719 -172.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.749 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.4 mtm -80.94 -35.15 32.66 Favored 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 123.941 0.896 . . . . 0.0 110.972 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -46.42 33.89 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.382 1.073 . . . . 0.0 110.335 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.1 -30.21 70.17 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.259 1.424 . . . . 0.0 110.253 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.44 ' CD2' HD11 ' A' ' 81' ' ' ILE . 64.4 t60 -63.25 -54.31 39.24 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.95 0.5 . . . . 0.0 110.293 169.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.31 -7.21 55.63 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -169.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.246 0 C-N-CA 123.159 0.583 . . . . 0.0 110.632 179.189 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 111.419 0.155 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 142.99 31.23 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.2 mtm -130.92 147.06 52.52 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.49 1.916 . . . . 0.0 108.18 -170.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 118.37 5.07 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-O 118.563 -1.132 . . . . 0.0 110.409 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.39 109.96 19.93 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 119.026 1.413 . . . . 0.0 108.573 169.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -103.25 143.91 32.03 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.933 1.293 . . . . 0.0 111.398 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -158.8 172.86 17.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.162 0.585 . . . . 0.0 110.79 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.18 139.34 8.06 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.576 -1.809 . . . . 0.0 108.576 169.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 t -160.52 135.29 7.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.942 1.297 . . . . 0.0 108.207 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 55.8 m -99.86 -27.7 13.48 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.226 1.011 . . . . 0.0 110.909 169.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 p -99.37 -3.15 34.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.887 1.675 . . . . 0.0 111.753 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.7 m 70.87 8.55 6.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.657 2.383 . . . . 0.0 115.126 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -63.66 -45.3 90.75 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 120.365 1.438 . . . . 0.0 110.76 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 -35.67 79.57 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -62.0 -46.0 91.13 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 123.463 0.705 . . . . 0.0 110.085 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.7 mtm -64.71 -39.37 93.52 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.96 -0.462 . . . . 0.0 110.734 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.26 95.45 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.503 -0.76 . . . . 0.0 111.013 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.69 -47.69 73.36 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.951 0.9 . . . . 0.0 110.641 177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -59.89 -44.23 94.33 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -63.41 -54.2 40.41 Favored 'General case' 0 CA--C 1.502 -0.899 0 O-C-N 124.596 1.185 . . . . 0.0 109.321 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -52.53 -55.83 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.973 0.806 . . . . 0.0 109.614 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -39.04 79.26 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.966 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -66.62 -46.72 74.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.102 0.477 . . . . 0.0 111.21 -178.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -68.23 -46.89 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 125.152 1.381 . . . . 0.0 108.484 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 164' ' ' ILE . 78.5 mt -71.37 -49.56 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.604 0.762 . . . . 0.0 110.286 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.99 115.99 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.46 1.029 . . . . 0.0 110.548 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.22 3.18 4.25 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.427 2.751 . . . . 0.0 112.48 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -71.82 -34.74 69.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.28 1.432 . . . . 0.0 109.253 174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.84 -23.06 3.74 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.641 1.576 . . . . 0.0 111.484 -169.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.48 139.95 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 120.509 1.504 . . . . 0.0 108.652 173.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.0 m -129.14 129.54 45.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.223 1.009 . . . . 0.0 109.349 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.65 146.26 51.78 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.607 0.64 . . . . 0.0 110.29 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -145.4 99.67 3.33 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -81.49 124.47 29.5 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.61 -8.62 58.15 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -37.38 62.25 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.411 1.085 . . . . 0.0 108.986 169.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -98.55 -31.48 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.884 1.673 . . . . 0.0 112.822 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -135.13 172.17 13.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.305 1.442 . . . . 0.0 111.299 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.0 m -92.59 155.47 42.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 C-N-CA 126.128 1.771 . . . . 0.0 109.986 -173.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -79.71 -9.73 14.51 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.779 2.319 . . . . 0.0 111.368 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -57.1 -36.87 71.13 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.962 1.71 . . . . 0.0 111.203 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -13.15 21.32 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.404 1.081 . . . . 0.0 112.355 170.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -73.37 -26.4 60.99 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.798 -1.188 . . . . 0.0 111.176 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -76.09 -51.33 12.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.097 0.862 . . . . 0.0 110.206 -171.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -66.16 142.99 57.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.301 1.44 . . . . 0.0 109.246 -169.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -73.05 -27.6 61.84 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.1 t -142.41 144.19 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.79 152.54 51.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -127.2 119.65 53.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 169.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mp -118.79 144.56 46.23 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.82 148.56 19.55 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.461 -1.352 . . . . 0.0 115.839 173.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -134.17 136.67 26.52 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 126.94 2.096 . . . . 0.0 109.502 -169.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -82.04 141.21 11.66 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 N-CA-C 107.839 -1.639 . . . . 0.0 107.839 166.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.7 m -87.82 116.35 25.92 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -99.43 167.79 10.4 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.104 1.762 . . . . 0.0 110.164 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.0 t70 13.16 75.44 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 130.093 3.357 . . . . 0.0 115.272 167.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 56.54 65.03 1.51 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.842 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.16 70.15 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 114.48 0.552 . . . . 0.0 114.48 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . 0.358 0.5 OUTLIER -94.28 152.92 18.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.381 1.073 . . . . 0.0 109.956 168.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.1 mt -95.86 151.21 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 125.582 1.553 . . . . 0.0 106.812 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -59.78 140.41 56.56 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.39 -27.46 69.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.134 0.574 . . . . 0.0 111.947 -172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -28.92 64.69 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.979 0.511 . . . . 0.0 111.207 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.562 ' CD1' HG22 ' A' ' 53' ' ' ILE . 8.3 m95 -77.76 -42.85 32.71 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.676 0.79 . . . . 0.0 110.268 170.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -55.78 -35.9 66.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.597 0.635 . . . . 0.0 110.909 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.98 -31.56 72.7 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.89 0.876 . . . . 0.0 111.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.9 m -102.9 -12.37 8.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.689 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.542 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 4.9 t-105 -54.25 -28.86 44.32 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.551 1.541 . . . . 0.0 111.656 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.49 -44.08 62.75 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.97 1.308 . . . . 0.0 111.025 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -69.21 -30.13 68.25 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.457 -1.259 . . . . 0.0 112.675 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.2 mt -56.85 -31.55 64.89 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 120.186 1.357 . . . . 0.0 110.685 -178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -68.3 -28.56 67.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.878 0.871 . . . . 0.0 111.566 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -81.45 -24.42 36.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.642 0.777 . . . . 0.0 111.254 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.5 mt -75.89 157.33 33.38 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 123.122 1.439 . . . . 0.0 112.503 -167.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -90.64 95.88 10.37 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.673 -2.058 . . . . 0.0 108.936 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.53 7.78 12.77 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.06 120.94 13.0 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.83 -0.39 89.14 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 125.393 1.473 . . . . 0.0 114.824 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -72.35 150.48 43.44 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-N 118.035 0.918 . . . . 0.0 109.46 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 168' ' ' MET . 5.4 mt -88.98 139.78 16.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.3 t -132.67 128.03 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 124.427 1.091 . . . . 0.0 108.655 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.98 118.45 36.63 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 167.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.8 mt -90.06 142.85 27.31 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 118.966 0.803 . . . . 0.0 111.692 173.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -140.59 158.76 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.079 0.952 . . . . 0.0 108.875 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -165.45 -179.93 39.5 Favored Glycine 0 CA--C 1.508 -0.367 0 O-C-N 120.678 -1.264 . . . . 0.0 112.125 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.8 mt -118.39 145.2 45.36 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.21 -164.71 11.79 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 169.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -159.63 135.0 8.28 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.463 1.505 . . . . 0.0 107.224 167.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.531 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -88.85 -20.81 24.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.57 -47.84 68.62 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 119.655 1.116 . . . . 0.0 110.608 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.88 -29.13 7.43 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 124.491 1.043 . . . . 0.0 112.391 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -132.27 33.95 3.81 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -166.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -54.43 -38.77 63.47 Favored Glycine 0 N--CA 1.47 0.939 0 CA-C-N 120.024 1.284 . . . . 0.0 111.725 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -63.91 -17.01 62.79 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.362 1.081 . . . . 0.0 112.737 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -128.52 14.37 6.54 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 112.079 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -41.65 123.17 2.16 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.717 1.607 . . . . 0.0 109.762 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 49.52 27.85 2.24 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.939 1.296 . . . . 0.0 112.978 174.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.16 -37.82 86.69 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 120.68 -1.263 . . . . 0.0 110.628 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.92 76.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.527 0.331 . . . . 0.0 111.454 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.681 ' HA ' HD11 ' A' ' 53' ' ' ILE . 14.2 tp -60.1 -47.41 86.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 124.366 1.066 . . . . 0.0 110.505 174.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.75 -40.78 98.58 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 32.1 mtm -64.15 -45.03 90.29 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 117.927 0.864 . . . . 0.0 111.829 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.584 HD12 HD12 ' A' ' 53' ' ' ILE . 4.9 mt -63.3 -35.14 79.37 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.345 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -64.23 -43.38 95.13 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.202 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -64.82 -42.1 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.776 1.23 . . . . 0.0 111.571 175.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -54.89 -59.85 4.17 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 124.679 1.191 . . . . 0.0 108.311 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.39 -20.45 54.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 118.525 -0.75 . . . . 0.0 110.871 -169.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.4 t -60.98 -29.09 69.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.256 0.934 . . . . 0.0 110.499 169.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.01 -22.15 53.55 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.868 -1.145 . . . . 0.0 110.012 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -83.66 1.6 41.62 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 125.582 1.553 . . . . 0.0 112.583 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.47 31.88 68.16 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.641 0.655 . . . . 0.0 112.207 172.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.22 173.12 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.004 0.922 . . . . 0.0 109.193 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.51 148.6 44.25 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 166.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.32 150.49 30.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 119.098 0.863 . . . . 0.0 112.275 -169.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 20.1 m -128.01 -179.7 3.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 124.718 1.207 . . . . 0.0 109.059 169.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.03 35.75 37.78 Favored Glycine 0 N--CA 1.439 -1.143 0 CA-C-O 118.463 -1.187 . . . . 0.0 114.165 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.1 m-30 -79.05 145.92 33.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.711 1.755 . . . . 0.0 108.713 170.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -120.53 148.29 47.5 Favored Pre-proline 0 N--CA 1.465 0.309 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.363 170.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.41 139.16 37.35 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 CA-C-N 120.703 1.287 . . . . 0.0 109.187 168.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.488 HG22 ' CD1' ' A' ' 139' ' ' PHE . 72.8 p -73.5 -5.7 41.76 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.774 1.63 . . . . 0.0 113.161 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.91 140.79 57.63 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 121.173 -0.955 . . . . 0.0 109.463 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.79 -10.34 57.15 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.307 1.432 . . . . 0.0 113.735 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -90.06 160.31 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.969 1.384 . . . . 0.0 110.377 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -129.15 127.62 41.77 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.49 -57.74 0.04 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 119.364 0.984 . . . . 0.0 110.487 -171.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.345 4.0 t 58.17 11.07 1.41 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 128.282 2.633 . . . . 0.0 114.567 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.3 t -63.94 132.71 95.34 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -83.92 -12.23 8.54 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.718 2.278 . . . . 0.0 112.694 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.8 tptt -80.51 -48.83 1.19 Allowed Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -168.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -88.3 38.81 0.48 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.314 2.009 . . . . 0.0 112.643 -168.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.97 146.72 26.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 121.205 -0.934 . . . . 0.0 110.056 -167.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.2 -172.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 126.107 1.763 . . . . 0.0 109.594 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.47 -117.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 124.988 1.315 . . . . 0.0 107.588 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -104.97 7.74 34.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.753 1.221 . . . . 0.0 112.011 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.85 20.02 20.21 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.572 1.082 . . . . 0.0 112.749 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -100.04 -17.47 17.48 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 124.746 1.218 . . . . 0.0 110.767 -172.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.55 144.67 50.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.306 0.642 . . . . 0.0 110.88 174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.488 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.1 m-85 -79.93 154.64 28.16 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.147 1.379 . . . . 0.0 110.048 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.1 m -65.79 -12.61 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 124.7 1.2 . . . . 0.0 112.654 175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.75 -177.69 44.06 Favored Glycine 0 C--N 1.34 0.787 0 CA-C-N 119.479 1.036 . . . . 0.0 111.83 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 17.3 tp -64.67 127.84 33.24 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 172.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.71 107.55 16.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 54.0 mt -97.48 155.21 17.03 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -143.56 115.89 8.51 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 170.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -91.55 27.13 2.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.489 -168.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.5 t -133.31 -19.89 2.15 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.76 -45.02 2.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.428 1.467 . . . . 0.0 109.309 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -79.62 -0.44 33.75 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 117.815 -1.088 . . . . 0.0 112.416 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.18 -25.27 21.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 121.018 1.735 . . . . 0.0 112.787 -171.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.7 -20.68 25.92 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.76 1.224 . . . . 0.0 112.738 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pp -124.48 -6.98 7.52 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.215 1.406 . . . . 0.0 113.088 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.7 m -53.49 -32.12 48.81 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.037 1.289 . . . . 0.0 110.24 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -57.94 -40.79 81.35 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.125 0.57 . . . . 0.0 111.455 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -72.68 -34.53 67.26 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.134 1.374 . . . . 0.0 109.564 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -78.83 -28.58 44.44 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.143 0.977 . . . . 0.0 109.224 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.9 mt -66.71 -60.62 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -57.1 -41.08 78.27 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 118.727 0.694 . . . . 0.0 112.479 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.1 m -64.77 -36.22 83.61 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.536 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 39.9 t90 -66.35 -45.02 81.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 110.037 176.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 98.1 m -56.53 -37.06 69.95 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.168 0.987 . . . . 0.0 109.506 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -69.71 -29.06 66.37 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.474 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -80.74 -45.76 16.56 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 118.044 -0.979 . . . . 0.0 111.22 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 25' ' ' ILE . 4.9 pt -64.6 -38.7 83.32 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 CA-C-N 120.84 1.654 . . . . 0.0 110.238 -171.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -64.17 -15.2 59.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.304 0.642 . . . . 0.0 112.034 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -96.16 -45.88 6.68 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -59.06 -41.59 88.31 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 118.704 0.684 . . . . 0.0 109.574 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 81' ' ' ILE . 72.4 mtm -76.27 -38.01 56.8 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.706 0.803 . . . . 0.0 110.837 -175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.76 66.48 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.813 0.845 . . . . 0.0 109.927 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.58 -30.38 70.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.452 1.501 . . . . 0.0 109.921 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -63.28 -47.46 82.23 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 118.558 0.617 . . . . 0.0 110.502 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.43 -2.74 47.03 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.775 1.23 . . . . 0.0 113.688 -175.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.418 179.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.011 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.95 141.46 44.37 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.138 1.375 . . . . 0.0 108.652 169.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 48' ' ' VAL . 15.3 mtm -120.68 147.59 45.06 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.291 2.237 . . . . 0.0 108.657 -169.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.84 120.1 5.61 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-O 118.666 -1.075 . . . . 0.0 110.711 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 116.03 27.28 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 118.828 1.314 . . . . 0.0 108.601 169.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.37 147.25 35.59 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.807 1.643 . . . . 0.0 111.403 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -161.99 173.88 13.82 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.023 0.929 . . . . 0.0 110.81 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.35 138.51 7.98 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 106.476 -2.65 . . . . 0.0 106.476 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 p -140.68 131.61 26.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.34 1.456 . . . . 0.0 108.715 -173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.4 m -90.33 -36.85 14.42 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.0 p -94.58 -84.99 0.31 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 6.2 p -174.68 -6.63 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.739 2.016 . . . . 0.0 113.106 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -68.85 -42.39 77.18 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 119.839 -1.788 . . . . 0.0 112.249 -168.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -35.78 82.28 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.25 -47.55 83.85 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 110.432 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 73.4 mtm -66.69 -41.06 88.63 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 121.906 -0.496 . . . . 0.0 111.295 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.19 92.33 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 118.835 -0.603 . . . . 0.0 110.655 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.51 -47.41 79.4 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.979 0.912 . . . . 0.0 110.872 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -58.68 -43.97 90.09 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -63.09 -55.32 26.42 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 124.813 1.245 . . . . 0.0 108.81 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.412 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.5 mt -52.51 -56.66 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 119.018 0.826 . . . . 0.0 109.832 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -38.98 77.12 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 119.053 -0.498 . . . . 0.0 110.759 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.51 -47.22 70.58 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 122.737 0.415 . . . . 0.0 111.553 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 158' ' ' GLN . 13.0 mt -66.12 -45.56 90.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.743 1.217 . . . . 0.0 108.456 -175.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 164' ' ' ILE . 78.1 mt -72.35 -51.81 27.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.636 0.774 . . . . 0.0 110.484 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.3 114.06 0.75 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.432 1.015 . . . . 0.0 110.592 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.28 3.61 3.97 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.351 2.701 . . . . 0.0 112.693 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.97 -35.05 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.222 1.409 . . . . 0.0 109.118 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.13 -24.7 5.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.876 1.67 . . . . 0.0 111.438 -173.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.77 140.87 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 121.103 1.774 . . . . 0.0 109.242 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 m -130.69 130.13 43.47 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.541 1.137 . . . . 0.0 109.788 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.79 148.53 46.18 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.734 0.814 . . . . 0.0 112.06 174.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -138.56 115.14 10.56 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.872 1.669 . . . . 0.0 108.666 174.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -81.16 100.57 9.15 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.7 mt -65.96 -21.65 66.43 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.844 1.656 . . . . 0.0 112.847 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -60.41 -28.84 68.57 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.383 0.673 . . . . 0.0 112.468 168.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -109.89 -32.51 7.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.339 1.056 . . . . 0.0 112.993 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.63 167.62 16.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.636 1.175 . . . . 0.0 111.476 -169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m -93.46 147.41 33.62 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 125.812 1.645 . . . . 0.0 109.07 -170.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -76.0 -1.52 11.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.588 1.525 . . . . 0.0 111.107 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -55.97 -33.74 65.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 122.346 2.339 . . . . 0.0 111.908 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.39 -19.87 65.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.425 ' CG ' HD13 ' A' ' 49' ' ' LEU . 47.5 ttm -58.91 -16.04 15.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.913 2.085 . . . . 0.0 111.627 169.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -76.37 -27.69 56.51 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.241 -0.912 . . . . 0.0 110.753 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.88 -51.55 12.26 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.891 0.769 . . . . 0.0 109.751 -174.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -69.36 133.18 47.5 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -87.01 -10.2 53.71 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.269 -0.572 . . . . 0.0 112.22 -174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.407 HG11 ' SD ' ' A' ' 3' ' ' MET . 71.4 t -134.09 143.84 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD13 ' CG ' ' A' ' 43' ' ' MET . 7.9 mt -140.34 149.05 42.24 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.8 121.63 56.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.63 147.08 44.95 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -175.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 85' ' ' TYR . . . -151.93 147.49 17.36 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 119.589 -1.291 . . . . 0.0 115.66 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -135.5 135.93 23.13 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 126.894 2.078 . . . . 0.0 109.602 -171.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -86.97 144.02 7.07 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 N-CA-C 107.348 -1.828 . . . . 0.0 107.348 165.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.9 m -88.73 117.21 27.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -98.77 169.95 9.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.592 1.157 . . . . 0.0 110.561 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.2 t0 22.72 64.99 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.915 2.886 . . . . 0.0 115.517 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.75 70.8 0.6 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.586 1.154 . . . . 0.0 112.097 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.42 17.3 79.77 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 115.46 0.944 . . . . 0.0 115.46 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -81.81 151.26 27.47 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.314 1.054 . . . . 0.0 109.555 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.7 mt -85.31 153.03 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -61.14 141.02 57.76 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.862 0.839 . . . . 0.0 108.774 170.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.62 -27.4 68.37 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -166.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.11 -23.63 35.58 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.063 0.545 . . . . 0.0 110.391 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.529 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.5 m95 -73.44 -43.95 59.26 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 169.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -53.51 -34.24 57.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.336 0.655 . . . . 0.0 111.084 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.12 -31.18 71.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 111.862 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.9 m -104.98 -9.36 9.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.59 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 8.6 t-105 -53.09 -29.49 30.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.708 1.603 . . . . 0.0 111.932 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -68.42 -43.81 76.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.718 1.207 . . . . 0.0 111.474 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.33 -29.76 66.55 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 117.712 -1.137 . . . . 0.0 112.247 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.9 mt -58.02 -31.03 66.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.828 1.194 . . . . 0.0 111.157 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.77 -26.92 62.63 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.549 0.74 . . . . 0.0 111.558 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -82.22 -22.34 35.96 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.316 0.646 . . . . 0.0 110.934 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.1 mt -73.93 156.89 37.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 122.982 1.372 . . . . 0.0 112.313 -167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -90.08 97.45 11.2 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.686 -2.052 . . . . 0.0 108.666 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.0 mt -119.26 8.92 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -64.08 123.9 20.25 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -172.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.36 9.0 87.08 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.494 1.521 . . . . 0.0 114.329 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.48 146.94 34.12 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-N 117.646 0.723 . . . . 0.0 109.617 175.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.743 HG21 ' HG2' ' A' ' 168' ' ' MET . 4.9 mt -85.62 139.02 18.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 167.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.2 t -130.41 132.43 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 C-N-CA 124.867 1.267 . . . . 0.0 109.143 176.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -113.03 119.46 37.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 167.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 mt -89.69 143.82 26.49 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.122 0.874 . . . . 0.0 112.032 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 52' ' ' GLY . 24.0 p90 -139.94 157.81 45.08 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.095 0.958 . . . . 0.0 109.253 169.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -161.68 177.04 38.1 Favored Glycine 0 CA--C 1.506 -0.511 0 O-C-N 120.452 -1.405 . . . . 0.0 112.849 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.69 157.24 36.1 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.195 0.998 . . . . 0.0 108.478 -177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -174.12 -152.75 9.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -154.73 135.13 13.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.548 1.539 . . . . 0.0 107.493 166.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.636 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -87.47 -22.83 24.7 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.733 1.213 . . . . 0.0 113.277 -178.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.5 mt -77.59 -40.19 43.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 120.016 1.28 . . . . 0.0 111.556 -171.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.43 -28.4 11.57 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.814 1.197 . . . . 0.0 112.166 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -134.78 34.61 3.15 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -168.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.06 61.11 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 119.99 1.268 . . . . 0.0 111.381 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -62.53 -16.4 55.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.757 0.778 . . . . 0.0 112.169 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.7 10.01 7.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.506 1.922 . . . . 0.0 112.112 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -47.5 124.01 6.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.38 1.472 . . . . 0.0 109.411 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 52.55 27.48 5.13 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 124.42 1.075 . . . . 0.0 112.781 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.09 -37.39 87.34 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.505 -1.372 . . . . 0.0 110.605 -172.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.36 75.07 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.917 0.487 . . . . 0.0 111.696 173.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.657 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.5 tp -59.72 -47.62 84.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.167 0.987 . . . . 0.0 110.29 175.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.78 97.75 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 176.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 29.4 mtm -64.97 -42.76 94.3 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 117.853 0.827 . . . . 0.0 111.864 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.659 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 mt -66.0 -33.78 76.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.814 1.188 . . . . 0.0 111.856 175.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -62.3 -40.64 96.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.741 -0.599 . . . . 0.0 110.334 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -71.81 -35.07 69.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.432 1.493 . . . . 0.0 111.813 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' HB3' HD23 ' A' ' 104' ' ' LEU . 20.6 tptt -58.11 -43.98 87.48 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.614 0.765 . . . . 0.0 109.916 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 45.4 mt -98.58 -18.16 18.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.917 -1.039 . . . . 0.0 112.446 -170.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 77.6 p -60.64 -32.23 71.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 120.477 1.49 . . . . 0.0 111.611 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 t -79.8 -18.74 50.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.1 0.56 . . . . 0.0 110.23 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -79.33 1.42 25.18 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.408 1.483 . . . . 0.0 111.969 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.69 32.83 63.86 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 118.601 0.637 . . . . 0.0 111.883 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.2 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.827 0.851 . . . . 0.0 109.376 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -118.27 141.33 48.63 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -106.15 147.14 29.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 119.336 0.971 . . . . 0.0 111.526 -171.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 19.2 m -127.35 177.76 5.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.715 1.206 . . . . 0.0 108.921 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.35 35.73 32.63 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.389 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -79.86 146.87 31.97 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.888 1.844 . . . . 0.0 109.138 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -122.82 148.57 54.09 Favored Pre-proline 0 N--CA 1.468 0.427 0 C-N-CA 124.986 1.314 . . . . 0.0 108.488 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.71 138.07 31.18 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.585 1.524 . . . . 0.0 110.465 169.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.526 HG22 ' CD1' ' A' ' 139' ' ' PHE . 48.0 p -77.99 -6.6 54.99 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.381 1.872 . . . . 0.0 112.939 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.33 139.19 58.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.21 1.005 . . . . 0.0 110.201 -173.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.9 -3.46 50.73 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.454 1.502 . . . . 0.0 113.519 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.94 164.14 13.75 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.092 1.357 . . . . 0.0 110.799 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -128.89 124.7 35.9 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.105 1.762 . . . . 0.0 107.568 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 127' ' ' THR . 11.2 p90 -165.2 -57.57 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 123.907 0.883 . . . . 0.0 108.929 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 126' ' ' PHE 0.339 2.1 t 59.71 10.52 2.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.873 2.869 . . . . 0.0 114.895 179.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.7 p -67.33 139.12 94.53 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 120.867 -1.146 . . . . 0.0 108.683 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -86.91 -14.79 4.08 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.245 1.963 . . . . 0.0 113.532 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -81.7 -46.68 1.05 Allowed Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -86.31 38.35 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 121.979 1.786 . . . . 0.0 112.395 -169.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.6 146.52 26.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 124.183 0.993 . . . . 0.0 108.988 -167.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -172.84 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.737 1.615 . . . . 0.0 109.708 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 58.98 -116.01 0.82 Allowed 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.479 1.512 . . . . 0.0 107.371 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -105.03 7.63 34.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.886 1.274 . . . . 0.0 111.881 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.72 20.84 17.97 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.94 1.257 . . . . 0.0 112.601 -173.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.56 -16.8 17.36 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.945 1.298 . . . . 0.0 110.844 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.99 145.3 50.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.427 0.691 . . . . 0.0 110.882 174.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 121' ' ' THR . 59.7 m-85 -80.18 153.91 28.31 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.715 1.606 . . . . 0.0 109.295 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.4 m -66.7 -12.55 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 112.599 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -173.99 -177.42 43.16 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 119.523 1.056 . . . . 0.0 112.019 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.45 ' HB2' ' CG ' ' A' ' 160' ' ' TRP . 20.0 tp -66.15 129.64 40.52 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.99 123.53 48.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.35 157.63 27.76 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.478 1.111 . . . . 0.0 108.136 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.475 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -142.93 120.04 11.43 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -98.19 12.8 33.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.972 -169.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.62 -21.5 11.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 117.863 -1.065 . . . . 0.0 111.196 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.4 -40.7 1.11 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.366 1.439 . . . . 0.0 113.249 172.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -80.63 4.92 17.02 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.386 0.994 . . . . 0.0 112.57 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -55.12 -25.02 28.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.439 1.472 . . . . 0.0 112.663 -171.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.77 -26.05 49.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.749 1.22 . . . . 0.0 111.5 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.21 -6.49 6.56 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.321 1.049 . . . . 0.0 112.753 -169.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 36.1 m -51.76 -33.8 36.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 120.208 1.367 . . . . 0.0 110.172 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.48 -42.65 78.61 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.836 1.255 . . . . 0.0 111.516 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -75.08 -33.43 61.66 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.797 1.239 . . . . 0.0 109.817 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -76.26 -30.98 58.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 121.704 -0.623 . . . . 0.0 109.651 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 47.0 mt -62.9 -55.96 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.403 ' HA ' HD13 ' A' ' 24' ' ' ILE . 5.8 pt20 -58.18 -43.1 87.32 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -175.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.0 m -65.21 -35.19 80.28 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.971 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.45 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 38.3 t90 -66.05 -45.3 81.9 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.841 0.829 . . . . 0.0 110.247 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 84.5 m -57.09 -36.48 70.64 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.161 0.985 . . . . 0.0 109.416 177.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -69.44 -28.65 66.31 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.323 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -81.27 -45.36 16.37 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.407 171.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 25' ' ' ILE . 4.5 pt -64.82 -38.82 83.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 120.923 1.692 . . . . 0.0 110.008 -172.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.58 -14.14 56.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.835 -0.541 . . . . 0.0 112.108 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -94.47 -46.9 6.8 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 172.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -61.7 -34.79 76.39 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.681 0.673 . . . . 0.0 110.477 -172.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.743 ' HG2' HG21 ' A' ' 81' ' ' ILE . 73.0 mtm -81.39 -43.12 19.44 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.32 1.048 . . . . 0.0 110.182 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.34 -42.12 72.32 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.054 0.942 . . . . 0.0 111.222 -174.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.06 -30.51 66.68 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.802 1.241 . . . . 0.0 109.607 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.41 ' CD2' HD11 ' A' ' 81' ' ' ILE . 67.5 t60 -66.45 -47.61 72.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -12.0 61.23 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.506 1.122 . . . . 0.0 113.388 -174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 C-N-CA 122.962 0.505 . . . . 0.0 110.793 -178.49 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.498 1.934 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.48 144.08 29.8 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 168.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.4 mtm -131.21 146.11 52.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.621 1.969 . . . . 0.0 107.854 -170.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.42 117.22 4.98 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-O 118.478 -1.179 . . . . 0.0 110.628 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.63 115.41 26.14 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 119.245 1.522 . . . . 0.0 108.461 169.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.39 146.36 37.27 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.198 1.399 . . . . 0.0 111.382 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -161.93 176.44 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.166 0.986 . . . . 0.0 110.755 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.7 144.51 12.53 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 168.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.4 p -152.67 139.82 19.32 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.64 1.22 . . . . 0.0 112.647 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 52.7 m -99.87 -34.72 10.02 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.7 p -93.59 0.59 56.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.133 0.973 . . . . 0.0 111.86 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.2 m 65.4 13.36 8.78 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.869 2.068 . . . . 0.0 113.538 -168.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.37 -48.43 77.96 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.217 -1.552 . . . . 0.0 111.149 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -32.82 74.33 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -59.27 -48.75 80.46 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.517 0.727 . . . . 0.0 109.679 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -65.35 -40.41 93.59 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.05 -0.406 . . . . 0.0 111.133 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.52 98.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.872 174.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.03 -47.42 77.86 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.279 1.032 . . . . 0.0 110.764 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -58.89 -45.23 90.74 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' HD12 ' A' ' 24' ' ' ILE . 58.9 mttm -61.77 -56.5 18.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 O-C-N 124.825 1.328 . . . . 0.0 108.994 -177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.7 mt -51.96 -56.08 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 118.649 0.659 . . . . 0.0 110.108 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -38.93 78.31 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.27 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.06 -47.47 74.22 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 122.802 0.441 . . . . 0.0 111.496 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.8 mt -65.74 -47.42 85.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.502 1.121 . . . . 0.0 108.966 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 164' ' ' ILE . 78.8 mt -72.35 -49.26 43.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 123.605 0.762 . . . . 0.0 110.173 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.09 115.57 0.89 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.599 1.095 . . . . 0.0 110.47 170.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.38 3.85 3.84 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.412 2.742 . . . . 0.0 112.814 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.68 -34.55 67.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.943 1.297 . . . . 0.0 109.054 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.99 -21.35 4.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 111.639 -169.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 t -94.21 141.33 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 120.592 1.542 . . . . 0.0 108.944 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.5 m -131.56 128.83 40.06 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.436 1.094 . . . . 0.0 109.974 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.49 148.78 46.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.932 0.893 . . . . 0.0 112.034 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.73 110.89 6.02 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.582 1.953 . . . . 0.0 107.081 174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -86.55 109.97 19.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.0 mt -66.17 -8.54 24.75 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -174.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -58.93 -29.14 66.88 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.113 0.87 . . . . 0.0 111.425 169.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -132.45 -33.79 1.24 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.478 1.111 . . . . 0.0 111.995 -172.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -80.95 139.96 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 m -84.27 139.94 39.18 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -74.31 -0.39 9.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 CA-C-N 121.256 1.484 . . . . 0.0 111.107 177.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -56.84 -33.16 66.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 121.939 2.154 . . . . 0.0 112.208 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -19.45 65.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.421 ' HG2' HD13 ' A' ' 49' ' ' LEU . 42.9 ttm -58.59 -16.22 14.87 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.752 2.021 . . . . 0.0 111.435 169.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.481 ' HG2' ' H ' ' A' ' 76' ' ' ASN . 69.0 mt-10 -74.1 -29.29 61.78 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.028 -1.045 . . . . 0.0 111.095 175.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -76.75 -47.15 22.61 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.852 0.751 . . . . 0.0 109.974 -171.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -67.26 139.23 57.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.601 -1.181 . . . . 0.0 107.968 -169.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.54 -26.96 61.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.228 0.537 . . . . 0.0 110.272 -178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -141.35 147.46 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -169.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.421 HD13 ' HG2' ' A' ' 43' ' ' MET . 6.3 mt -139.29 150.59 45.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 122.964 0.505 . . . . 0.0 109.985 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.4 120.48 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 170.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.29 138.61 53.59 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.025 0.93 . . . . 0.0 108.629 -172.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -131.23 122.56 3.5 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-O 118.239 -1.312 . . . . 0.0 112.442 -173.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.692 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -124.99 130.93 24.04 Favored Pre-proline 0 N--CA 1.471 0.577 0 CA-C-N 118.613 1.206 . . . . 0.0 109.963 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -84.84 146.63 10.47 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.642 2.228 . . . . 0.0 108.387 166.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.3 m -88.33 129.57 35.35 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -119.7 170.65 9.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.091 1.757 . . . . 0.0 109.618 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 27.36 57.65 0.08 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.255 2.622 . . . . 0.0 115.265 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 56.85 76.99 0.28 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.983 1.313 . . . . 0.0 112.247 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.42 14.23 71.68 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -83.41 160.07 21.67 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.603 1.161 . . . . 0.0 109.666 169.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.9 mt -97.4 152.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 175.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -67.55 144.0 55.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 171.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.54 -28.59 69.96 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.164 0.586 . . . . 0.0 112.354 -168.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -69.73 -24.33 63.54 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.925 -0.484 . . . . 0.0 110.682 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.492 ' CD1' HG22 ' A' ' 53' ' ' ILE . 10.0 m95 -83.37 -42.8 16.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.933 0.893 . . . . 0.0 110.866 170.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -55.55 -35.49 65.76 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.624 0.647 . . . . 0.0 110.818 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.02 71.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.596 1.158 . . . . 0.0 111.88 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 m -106.07 -11.64 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.68 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.544 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -52.89 -29.06 26.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.693 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.79 -46.56 65.47 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.15 1.38 . . . . 0.0 111.248 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -66.79 -29.53 69.5 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 117.435 -1.269 . . . . 0.0 112.14 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 mt -56.36 -35.91 68.2 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.798 1.181 . . . . 0.0 110.867 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.48 -33.14 75.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.384 0.674 . . . . 0.0 111.701 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -87.78 -12.92 43.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.001 0.921 . . . . 0.0 111.184 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.7 mt -72.28 171.38 12.24 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.381 1.086 . . . . 0.0 110.65 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' H ' ' HG2' ' A' ' 44' ' ' GLU . 6.2 t30 -111.02 98.82 7.82 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.812 1.645 . . . . 0.0 107.641 171.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mt -118.77 6.29 11.52 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.318 1.047 . . . . 0.0 112.71 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -65.12 112.86 3.58 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -168.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.48 -3.21 68.5 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.849 1.69 . . . . 0.0 116.076 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -75.36 155.12 36.8 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 118.537 1.168 . . . . 0.0 110.115 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.684 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.0 mt -89.41 140.05 16.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 168.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.44 133.33 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.676 1.19 . . . . 0.0 109.416 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -110.8 117.41 33.34 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 167.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.9 mt -90.11 142.75 27.41 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-N 119.023 0.829 . . . . 0.0 111.752 173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.75 159.89 41.0 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.222 1.009 . . . . 0.0 108.878 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -163.02 177.51 39.05 Favored Glycine 0 N--CA 1.447 -0.578 0 O-C-N 121.14 -0.975 . . . . 0.0 112.207 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mt -124.77 153.67 42.09 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.17 -158.15 10.75 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -152.2 141.08 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.094 1.358 . . . . 0.0 109.141 169.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.446 HE21 ' ND2' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -87.35 -22.36 25.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.37 -39.92 70.95 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 119.931 1.241 . . . . 0.0 112.265 -171.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.97 -18.44 31.86 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.171 0.891 . . . . 0.0 111.512 -173.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.93 -89.91 0.54 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 124.939 1.296 . . . . 0.0 108.13 -169.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.58 -50.21 2.47 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 128.497 2.951 . . . . 0.0 107.936 -168.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -67.77 -28.42 67.6 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.365 1.866 . . . . 0.0 110.767 -175.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -117.53 6.61 12.55 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.651 1.181 . . . . 0.0 112.349 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -43.96 121.87 2.61 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.496 1.518 . . . . 0.0 109.592 168.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 52.85 25.88 4.21 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.588 1.155 . . . . 0.0 113.512 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -65.47 -36.0 82.59 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 120.516 -1.365 . . . . 0.0 110.603 -172.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.69 74.07 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.255 0.622 . . . . 0.0 112.06 172.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.692 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -60.48 -46.49 89.91 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 124.141 0.976 . . . . 0.0 110.413 176.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.85 -40.21 97.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 31.6 mtm -67.14 -42.73 83.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.841 0.821 . . . . 0.0 112.239 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.577 HD12 HD12 ' A' ' 53' ' ' ILE . 4.5 mt -63.49 -36.15 82.82 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.201 172.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -63.6 -41.25 98.33 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.973 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.18 -43.19 92.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.749 1.219 . . . . 0.0 111.663 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.423 ' HE2' ' CD1' ' A' ' 69' ' ' TRP . 0.1 OUTLIER -55.6 -58.44 7.8 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.4 mt -75.97 -20.27 58.03 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.728 -0.608 . . . . 0.0 110.385 -169.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 t -62.95 -29.66 70.97 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.846 0.748 . . . . 0.0 110.022 167.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.0 -27.38 39.58 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.047 1.294 . . . . 0.0 108.427 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB3' ' HE3' ' A' ' 111' ' ' LYS . 14.8 mmmt -73.58 2.47 7.91 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.503 1.121 . . . . 0.0 113.176 170.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.6 33.35 85.96 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.427 1.012 . . . . 0.0 112.378 169.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.66 173.75 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.795 0.838 . . . . 0.0 109.304 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 145.75 45.2 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 165.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -109.96 150.1 28.97 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 118.854 0.752 . . . . 0.0 111.878 -169.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 17.7 m -127.47 179.59 3.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 109.304 169.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 36.24 43.4 Favored Glycine 0 N--CA 1.438 -1.23 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.532 172.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -71.73 153.52 41.96 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.091 1.445 . . . . 0.0 108.139 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.23 145.87 58.56 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-O 116.944 -1.503 . . . . 0.0 108.835 169.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.68 140.46 39.29 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 CA-C-N 120.895 1.355 . . . . 0.0 109.618 168.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.499 HG22 ' CD1' ' A' ' 139' ' ' PHE . 80.6 p -74.98 -6.48 49.55 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.142 1.777 . . . . 0.0 113.583 -178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.1 141.06 57.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.053 0.93 . . . . 0.0 110.246 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.55 -8.83 66.93 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.005 1.764 . . . . 0.0 113.816 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -89.76 163.17 15.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.746 1.273 . . . . 0.0 110.622 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -126.48 123.96 39.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 169.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -163.9 -50.97 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 118.952 0.796 . . . . 0.0 110.275 -173.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . 0.303 2.8 t 57.79 8.93 0.77 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.479 2.712 . . . . 0.0 114.512 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -83.55 144.51 46.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.977 1.311 . . . . 0.0 110.861 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -88.94 -12.52 3.4 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.895 2.397 . . . . 0.0 113.775 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.0 -50.91 3.77 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-O 117.916 -1.04 . . . . 0.0 113.402 -168.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -88.29 38.98 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.751 1.634 . . . . 0.0 112.091 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.28 148.23 21.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.083 -1.011 . . . . 0.0 110.241 -166.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.37 -172.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 126.361 1.864 . . . . 0.0 109.981 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.03 -116.03 0.81 Allowed 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 125.486 1.515 . . . . 0.0 107.327 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -105.09 8.14 34.13 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.579 1.152 . . . . 0.0 111.889 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 97.87 21.03 19.69 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.993 1.282 . . . . 0.0 112.506 -173.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -100.06 -18.16 17.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 110.837 -172.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.86 143.31 50.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.303 0.641 . . . . 0.0 111.328 174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.499 ' CD1' HG22 ' A' ' 121' ' ' THR . 56.8 m-85 -78.14 155.39 30.5 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.076 1.35 . . . . 0.0 109.457 175.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.5 -14.88 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.546 1.138 . . . . 0.0 112.804 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -172.32 -178.3 42.4 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 119.65 1.114 . . . . 0.0 112.184 -171.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 144' ' ' LEU . 28.2 tp -64.97 130.29 42.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 172.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -116.33 117.96 31.43 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 142' ' ' LEU . 71.6 mt -117.13 152.52 34.56 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.433 1.093 . . . . 0.0 109.164 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' CG ' HE22 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -144.72 124.06 13.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -99.26 15.05 27.38 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.235 1.014 . . . . 0.0 110.576 -169.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.1 t -123.04 -22.27 5.25 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.446 ' ND2' HE21 ' A' ' 90' ' ' GLN . 0.3 OUTLIER -113.2 -48.54 2.96 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.759 1.223 . . . . 0.0 108.041 171.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -105.21 22.64 15.02 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.641 1.577 . . . . 0.0 112.474 -169.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -52.6 -25.78 11.62 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.826 0.739 . . . . 0.0 112.279 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -77.09 -25.32 52.13 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.781 . . . . 0.0 111.478 -174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pp -125.02 -14.44 6.61 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.5 m -57.67 -28.95 64.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.098 1.317 . . . . 0.0 109.769 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.23 -49.21 78.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.595 0.758 . . . . 0.0 111.06 170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -66.7 -33.17 75.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 122.081 0.943 . . . . 0.0 109.329 -171.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -79.13 -23.46 44.01 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.219 -174.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.59 -53.71 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -53.64 -47.07 70.67 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 123.636 0.775 . . . . 0.0 110.136 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.9 m -66.83 -36.79 83.17 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.146 0.278 . . . . 0.0 110.521 -177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.4 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 29.5 t90 -65.79 -46.06 80.11 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.545 0.688 . . . . 0.0 109.716 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -58.04 -34.55 70.2 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -31.81 71.9 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.028 0.531 . . . . 0.0 110.601 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -83.03 -45.52 13.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.942 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 25' ' ' ILE . 5.7 pt -64.24 -37.82 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 120.849 1.658 . . . . 0.0 110.048 -170.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.83 -11.8 30.44 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.5 -49.82 5.72 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 125.704 1.601 . . . . 0.0 108.088 169.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.33 -28.44 70.01 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.951 -0.468 . . . . 0.0 110.913 -169.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.684 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.2 mtm -89.34 -40.71 12.59 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 124.132 0.973 . . . . 0.0 111.429 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.39 -43.28 33.23 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.575 0.75 . . . . 0.0 110.784 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.0 -29.72 63.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.233 1.413 . . . . 0.0 109.452 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -63.06 -49.79 73.16 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.227 0.467 . . . . 0.0 109.914 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.1 -2.4 34.06 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.332 0 CA-C-O 119.133 -0.461 . . . . 0.0 110.648 179.824 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.5 141.5 31.6 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.3 mtm -129.17 145.05 51.4 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.582 1.953 . . . . 0.0 108.489 -169.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.48 115.52 4.09 Favored Glycine 0 C--O 1.229 -0.216 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.99 121.63 28.05 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -115.63 144.7 43.54 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.335 1.054 . . . . 0.0 111.679 171.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -156.62 169.88 23.67 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.762 1.225 . . . . 0.0 110.29 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.33 138.57 8.02 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 106.222 -2.751 . . . . 0.0 106.222 169.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 p -142.05 136.47 30.22 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.707 1.203 . . . . 0.0 109.814 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.3 m -92.75 -39.23 11.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.14 0.976 . . . . 0.0 110.09 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -85.99 -86.34 0.14 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.0 p -177.76 4.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.04 3.336 . . . . 0.0 110.763 173.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -67.27 -45.43 76.66 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.091 -1.631 . . . . 0.0 111.59 -166.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.25 -34.28 77.11 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -60.98 -47.67 85.35 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.302 0.641 . . . . 0.0 110.151 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.3 mtm -64.89 -40.43 95.09 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 122.217 -0.302 . . . . 0.0 111.035 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.07 97.42 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 118.824 -0.607 . . . . 0.0 110.623 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.97 -45.7 78.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.085 0.954 . . . . 0.0 110.971 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -59.86 -45.21 93.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 24' ' ' ILE . 59.7 mttm -63.43 -57.55 9.9 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.699 1.249 . . . . 0.0 108.84 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 6.4 mt -51.92 -55.53 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 118.248 0.476 . . . . 0.0 110.015 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -38.23 74.52 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.868 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -67.77 -48.79 65.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.826 0.451 . . . . 0.0 111.423 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.43 HD12 ' O ' ' A' ' 20' ' ' LYS . 7.6 mt -65.76 -46.32 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.242 1.017 . . . . 0.0 108.788 -173.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 164' ' ' ILE . 72.3 mt -71.14 -50.14 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.812 0.845 . . . . 0.0 110.038 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.08 114.9 0.8 Allowed Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.57 1.33 5.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.326 2.684 . . . . 0.0 112.458 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.22 -33.83 65.58 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.6 1.56 . . . . 0.0 109.404 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.04 -19.63 3.94 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.534 1.534 . . . . 0.0 111.43 -169.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.63 141.61 15.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 120.702 1.592 . . . . 0.0 108.755 172.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.6 m -131.66 129.03 40.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.75 145.53 25.56 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -135.17 127.55 30.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.007 2.123 . . . . 0.0 107.935 -168.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.26 88.2 3.07 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.724 1.609 . . . . 0.0 107.373 -168.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.45 -16.11 21.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.925 1.29 . . . . 0.0 114.352 -169.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -13.55 62.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.721 -0.612 . . . . 0.0 112.45 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -129.75 -35.43 1.68 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.313 1.445 . . . . 0.0 112.145 170.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -81.56 145.08 30.84 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.054 1.342 . . . . 0.0 109.553 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.82 147.69 59.26 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -76.1 -8.95 19.12 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.431 2.087 . . . . 0.0 111.029 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -55.05 -36.54 65.67 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.699 1.59 . . . . 0.0 111.325 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -22.94 67.13 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.119 -0.988 . . . . 0.0 113.397 176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -14.15 31.0 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -73.06 -26.65 61.36 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.767 -1.208 . . . . 0.0 110.716 174.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -76.75 -51.11 12.02 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.524 1.056 . . . . 0.0 109.97 -171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -66.01 142.02 57.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.615 -169.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.73 -24.0 56.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.806 0.812 . . . . 0.0 111.611 -172.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -142.31 144.18 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -172.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.2 mt -133.56 153.21 51.83 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 118.672 0.669 . . . . 0.0 110.47 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.54 120.03 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.4 mp -118.84 132.4 56.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -172.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' HA3' ' CZ ' ' A' ' 85' ' ' TYR . . . -122.18 116.32 3.02 Favored Glycine 0 C--O 1.227 -0.318 0 CA-C-O 117.793 -1.56 . . . . 0.0 112.571 -173.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.709 HD11 ' HA ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -117.49 121.45 32.04 Favored Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 119.314 1.557 . . . . 0.0 110.758 178.503 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -76.8 146.41 26.44 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.941 2.427 . . . . 0.0 108.941 168.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 m -94.06 139.81 30.5 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -133.05 167.73 19.77 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.624 2.37 . . . . 0.0 109.905 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t0 27.5 56.7 0.08 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 129.244 3.018 . . . . 0.0 116.663 167.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . 0.253 3.0 m-85 51.97 81.83 0.07 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.14 2.576 . . . . 0.0 112.093 -175.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.81 16.9 79.18 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 173.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -85.8 152.89 22.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.254 1.022 . . . . 0.0 108.324 168.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -87.03 156.97 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.36 138.47 50.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -64.53 -24.86 67.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -165.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -86.01 -26.9 25.15 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.738 -0.602 . . . . 0.0 110.552 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -67.26 -40.74 86.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.914 -0.491 . . . . 0.0 109.853 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -56.34 -32.32 64.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.85 0.46 . . . . 0.0 111.148 175.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.41 72.37 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.274 0.63 . . . . 0.0 111.869 -178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -98.95 -11.52 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.545 ' CH2' ' HG ' ' A' ' 104' ' ' LEU . 5.5 t-105 -54.48 -28.79 47.15 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.509 1.524 . . . . 0.0 111.886 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.16 -44.09 66.2 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 125.042 1.337 . . . . 0.0 111.309 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -69.41 -29.77 67.59 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 117.493 -1.241 . . . . 0.0 112.057 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.4 mt -56.64 -31.38 64.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.188 1.358 . . . . 0.0 111.225 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.82 -29.17 68.27 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.838 0.855 . . . . 0.0 111.479 177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.93 -24.17 35.76 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.457 0.703 . . . . 0.0 111.441 -178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.1 157.65 34.39 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 123.013 1.387 . . . . 0.0 112.326 -167.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -92.12 97.01 10.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 112.766 -2.016 . . . . 0.0 108.778 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -119.34 8.08 11.35 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.57 120.89 13.21 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -170.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.56 87.0 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 125.363 1.459 . . . . 0.0 114.287 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -76.99 145.55 37.98 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 117.775 0.787 . . . . 0.0 109.239 173.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.703 HG21 ' HG2' ' A' ' 168' ' ' MET . 6.1 mt -84.27 138.07 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 167.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -131.66 127.39 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 C-N-CA 124.722 1.209 . . . . 0.0 108.835 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -105.48 117.78 34.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 167.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.5 mt -89.86 141.76 28.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.182 0.901 . . . . 0.0 111.557 174.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.406 ' CZ ' ' HA3' ' A' ' 52' ' ' GLY . 27.2 p90 -137.04 159.58 41.48 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.19 0.996 . . . . 0.0 109.289 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -160.56 173.43 37.11 Favored Glycine 0 N--CA 1.45 -0.392 0 O-C-N 121.268 -0.895 . . . . 0.0 111.857 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.2 mt -131.0 154.37 48.24 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 125.296 1.438 . . . . 0.0 107.632 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.26 -155.6 11.86 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 114.88 0.712 . . . . 0.0 114.88 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -131.84 121.23 23.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.089 3.356 . . . . 0.0 105.997 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.497 HE22 ' HG2' ' A' ' 149' ' ' GLN . 0.0 OUTLIER -97.43 -25.25 15.27 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-N 119.986 1.266 . . . . 0.0 112.836 178.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 46.9 mt -79.09 -41.22 29.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.196 0.198 . . . . 0.0 110.729 -169.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.53 -34.21 36.37 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-O 118.539 -1.145 . . . . 0.0 111.501 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.725 ' CE2' ' HB2' ' A' ' 96' ' ' TRP 0.277 0.0 OUTLIER -153.87 41.89 0.53 Allowed 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -167.84 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -49.16 -24.73 5.03 Favored Glycine 0 N--CA 1.475 1.29 0 O-C-N 119.646 -1.909 . . . . 0.0 114.069 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 -27.06 6.38 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.806 1.242 . . . . 0.0 111.497 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 19.9 m-90 -119.22 -55.31 2.16 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 116.173 -1.87 . . . . 0.0 111.341 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 24.8 t80 7.27 122.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 130.066 3.346 . . . . 0.0 115.8 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 62.85 30.07 16.6 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.536 1.534 . . . . 0.0 111.655 -169.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.57 -39.09 91.25 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 120.938 -1.101 . . . . 0.0 110.685 -173.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.53 72.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.032 0.533 . . . . 0.0 111.34 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.709 ' HA ' HD11 ' A' ' 53' ' ' ILE . 13.9 tp -61.28 -47.79 84.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.715 0.806 . . . . 0.0 110.54 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.47 -39.93 96.99 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.5 mtm -65.92 -44.66 84.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 117.918 0.859 . . . . 0.0 112.23 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.545 ' HG ' ' CH2' ' A' ' 69' ' ' TRP . 4.0 mt -64.29 -34.77 78.9 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.449 1.022 . . . . 0.0 111.494 173.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -63.4 -42.34 98.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.048 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -65.59 -42.86 91.2 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.538 1.135 . . . . 0.0 111.695 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -54.33 -58.6 6.77 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.631 1.172 . . . . 0.0 108.41 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 mt -78.14 -20.7 51.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.434 -169.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 t -61.32 -28.64 69.35 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.365 0.984 . . . . 0.0 110.502 168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -77.6 -22.73 50.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.873 1.215 . . . . 0.0 109.787 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -83.35 1.26 42.14 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.854 1.662 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 70.67 34.04 66.93 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.458 0.572 . . . . 0.0 111.731 172.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.9 m -85.13 169.07 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 117.705 0.752 . . . . 0.0 109.38 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -116.13 143.85 44.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 169.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -112.34 148.01 35.13 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.73 1.15 . . . . 0.0 112.138 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' ALA . 16.1 m -128.52 -179.39 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 124.194 0.998 . . . . 0.0 109.589 169.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.95 35.72 38.27 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-O 118.473 -1.182 . . . . 0.0 113.987 172.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 22.5 m-30 -78.55 148.59 33.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 119.48 1.64 . . . . 0.0 108.587 170.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -124.91 148.1 58.71 Favored Pre-proline 0 CA--C 1.516 -0.35 0 CA-C-O 117.26 -1.352 . . . . 0.0 108.786 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.82 139.3 43.22 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 N-CA-C 108.877 -1.24 . . . . 0.0 108.877 167.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.479 ' HA ' ' CE2' ' A' ' 139' ' ' PHE . 74.4 p -72.41 -15.57 61.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.443 1.497 . . . . 0.0 113.289 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.62 145.32 54.81 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.956 0.902 . . . . 0.0 109.77 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.23 19.94 79.34 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 124.367 0.984 . . . . 0.0 112.839 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.45 167.16 22.81 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.129 1.772 . . . . 0.0 108.289 175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -126.94 132.22 50.91 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.738 1.615 . . . . 0.0 107.418 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.508 ' O ' HG22 ' A' ' 127' ' ' THR . 2.7 p90 -165.11 -69.67 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 126' ' ' PHE 0.353 2.8 t 58.62 12.17 2.05 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.11 2.964 . . . . 0.0 114.384 -170.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.3 p -64.59 141.2 98.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.742 -1.224 . . . . 0.0 110.172 168.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -88.46 -15.28 2.89 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.854 2.37 . . . . 0.0 113.558 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 -49.54 1.35 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-O 118.034 -0.984 . . . . 0.0 113.466 -168.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -91.58 44.37 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.866 1.711 . . . . 0.0 112.266 -168.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.94 146.56 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 O-C-N 120.944 -1.097 . . . . 0.0 109.467 -168.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -172.7 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 C-N-CA 125.843 1.657 . . . . 0.0 109.819 177.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 59.18 -116.3 0.82 Allowed 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.162 1.385 . . . . 0.0 107.546 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -105.37 7.46 33.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.876 1.27 . . . . 0.0 111.965 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 98.84 20.73 18.01 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.779 1.181 . . . . 0.0 112.838 -172.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.55 -17.29 17.17 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 124.734 1.214 . . . . 0.0 110.857 -173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.15 144.54 50.75 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.303 0.641 . . . . 0.0 111.155 174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 121' ' ' THR . 57.7 m-85 -79.33 154.22 29.24 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.351 1.46 . . . . 0.0 109.866 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.4 HG23 ' HG ' ' A' ' 101' ' ' LEU . 19.2 m -66.07 -13.74 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 124.178 0.991 . . . . 0.0 112.591 174.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -169.68 -177.56 40.23 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 120.035 1.289 . . . . 0.0 112.206 -174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 144' ' ' LEU . 23.1 tp -63.68 125.96 26.0 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.2 121.28 44.49 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 142' ' ' LEU . 69.9 mt -121.29 160.53 23.75 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.9 135.77 41.84 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 172.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -117.65 15.4 14.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.129 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.257 0.6 OUTLIER -117.63 -22.82 7.9 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -140.23 -28.66 0.72 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.202 1.001 . . . . 0.0 113.139 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.497 ' HG2' HE22 ' A' ' 90' ' ' GLN . 35.4 mm-40 -86.91 8.38 23.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.411 1.005 . . . . 0.0 111.809 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -54.95 -24.16 22.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.274 0.943 . . . . 0.0 112.589 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.76 -26.27 44.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.286 1.034 . . . . 0.0 111.667 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 pp -124.97 -13.74 6.79 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 8.3 m -55.55 -28.86 57.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.277 0.944 . . . . 0.0 111.533 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.5 -43.07 71.49 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.271 1.029 . . . . 0.0 111.318 172.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -67.87 -31.68 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.856 0.836 . . . . 0.0 109.677 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -77.42 -25.23 50.52 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.275 0.63 . . . . 0.0 109.667 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.7 -55.17 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -52.65 -47.22 67.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.633 1.173 . . . . 0.0 110.187 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -68.51 -35.49 77.56 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.315 0.384 . . . . 0.0 110.58 -177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 142' ' ' LEU . 25.3 t90 -65.72 -45.54 82.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.627 0.727 . . . . 0.0 109.816 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 21' ' ' ILE . 85.3 m -59.1 -34.53 72.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.667 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -30.49 70.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.051 0.54 . . . . 0.0 110.889 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -85.4 -45.58 11.74 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 117.73 -1.129 . . . . 0.0 112.16 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.56 HD11 HD11 ' A' ' 25' ' ' ILE . 6.7 pt -64.34 -37.9 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 120.603 1.547 . . . . 0.0 109.897 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 pp -62.58 -13.2 28.48 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -49.67 5.85 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 108.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.91 -28.13 69.85 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.376 0.535 . . . . 0.0 111.051 -169.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.703 ' HG2' HG21 ' A' ' 81' ' ' ILE . 70.5 mtm -89.4 -41.22 12.22 Favored 'General case' 0 N--CA 1.461 0.078 0 C-N-CA 124.46 1.104 . . . . 0.0 111.416 -178.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.93 -44.09 27.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.393 0.677 . . . . 0.0 110.727 -174.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -73.25 -28.44 62.14 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.331 1.452 . . . . 0.0 109.862 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -60.16 -49.9 75.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 170.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -1.0 48.03 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -174.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 122.853 0.461 . . . . 0.0 110.581 178.188 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' FMN . . . . . 0.468 ' N3 ' ' CZ ' ' A' ' 93' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_